since december <NUMBER> wuhan city hubei province successively discovered multiple cases patients pneumonia infected novel type coronavirus spread epidemic cases china abroad also found march <NUMBER> <NUMBER> total <NUMBER> covid<NUMBER> cases china confirmed new coronavirus belongs betatype coronavirus envelope round oval usually polymorphic <NUMBER> nm diameter genetic characteristics significantly different sarsrcov mersrcov current research shows <NUMBER> homology bat sarslike coronavirus batslcovzc<NUMBER> recently international virus classification commission proposal named novel coronavirus sarscov<NUMBER> world health organization officially named novel coronavirus pneumonia covid<NUMBER> present confirmed receptorbinding mechanism infection host cells novel coronavirus binding coronavirus protein human angiotensinconverting enzyme <NUMBER> ace<NUMBER> protein involves regulation blood pressure human body <NUMBER> widely present lungs heart kidneys intestines additionally studies reported considerable number patients covid<NUMBER> complicated underlying diseases hypertension proportion patients hypertension high peng et al showed among <NUMBER> covid<NUMBER> patients proportion patients hypertension highest <NUMBER> <NUMBER> <NUMBER> <NUMBER> huang et al also found <NUMBER> patients covid<NUMBER> hypertension ranking second among comorbidities <NUMBER> addition reports deaths disclosed early stage covid<NUMBER> epidemic complicated hypertension however present researches clinical characteristics covid<NUMBER> patients hypertension effects taking acei arb drugs patients prognosis therefore selected hypertension casecontrol retrospective study investigate clinical characteristics hypertensive patients exposed covid<NUMBER> case series approved institutional ethics board wuhan fourth hospital ky<NUMBER> study cases confirmed patients covid<NUMBER> wuhan fourth hospital discharged january <NUMBER> february <NUMBER> <NUMBER> wuhan fourth hospital located wuhan hubei province one first batch covid<NUMBER> diagnosis treatment hospitals requisitioned wuhan municipal government patients included study diagnosed treated accordance covid<NUMBER> diagnosis treatment program issued chinese national health committee medical records patients collected analyzed research team department critical care medicine wuhan fourth hospital clinical data included demographic data medical history underlying comorbidities symptoms signs laboratory findings treatment measures clinical outcomes study cases grouped according whether history hypertension hypertensive patients divided two groups based whether take acei arb prism <NUMBER> graphpad software la jolla ca usa spss <NUMBER> spss inc chicago il usa used perform statistical analysis means two groups tested statistical difference using unpaired students ttest distribution categorical variables evaluated using chisquare test p <NUMBER> considered statistically significant association whether take acei arb prognosis covid<NUMBER> patients hypertension examined logistic regression analysis performed spss study included <NUMBER> patients covid<NUMBER> discharged mean age patients <NUMBER> years range <NUMBER> years <NUMBER> <NUMBER> male patients shown table <NUMBER> compared nonhypertensive group patients hypertensive group significantly older average age <NUMBER> vs <NUMBER> showed significantly higher occurrence dyspnea <NUMBER> <NUMBER> vs <NUMBER> <NUMBER> diabetes <NUMBER> <NUMBER> vs <NUMBER> cardiovascular disease <NUMBER> vs <NUMBER> remarkably lymphocyte count admission significantly lower hypertensive group average value <NUMBER> × <NUMBER> <NUMBER> l vs <NUMBER> × <NUMBER> <NUMBER> l statistical difference time onset hospitalization two groups clinical outcomes showed two groups significant differences crude cure rate rate referral highlevel hospitals length stay crude mortality rate higher hypertensive group control group <NUMBER> vs <NUMBER> taking acei arb drugs may change prognosis covid<NUMBER> patients hypertension clinical features covid<NUMBER> patients taking acei arb covid<NUMBER> patients history hypertension divided two groups according whether take acei arb drugs <NUMBER> patients previously taken acei arb divided acei arb group patients divided control group patients acei arb group younger control group difference statistically significant average age <NUMBER> vs <NUMBER> significant differences lymphocyte counts crude cure rate crude mortality rate onset time length hospital stay two groups table <NUMBER> classify patients transfer highlevel hospital clinical death poor prognosis prognosis two groups examined logistic regression analysis adjustment age sex hospitalization time time onset hospital admission whether take acei arb shown table <NUMBER> whether take acei arb significantly associated prognosis report recruited <NUMBER> patients covid<NUMBER> results found fever commonest symptom early stage besides patient also showed symptoms dry cough fatigue dyspnea terms underlying diseases hypertension commonest comorbidity <NUMBER> first time report showed compared nonhypertension group hypertension group significantly lower lymphocyte count addition grouped covid<NUMBER> patients history hypertension based whether take acei arb antihypertensive treatment found difference clinical outcomes two groups reported researchers <NUMBER> patients covid<NUMBER> common symptoms fever dry cough fatigue alert clinical manifestations patients without fever time consultation besides also wary patients without clinical manifestations respiratory tract anorexia nausea vomiting diarrhea clinical manifestations digestive system well clinical manifestations nervous system dizziness headache observed onethird patients covid<NUMBER> complicated hypertension result consistent peng et al results showed <NUMBER> <NUMBER> covid<NUMBER> cases hypertension <NUMBER> effective drugs treatment covid<NUMBER> observed patients used antiviral drugs arbidol tablets lopinavir ritonavir tablets antibiotics patients used lowdose hormones methylprednisolone immune globulin critically ill patients used oxygen therapy studies limited conditions data seen difference cure rate hypertension group nonhypertension group mortality rate hypertension group higher prognosis seems worse however noted patients hypertension group older higher proportion major comorbidities indicates elderly comorbidities together constitute risk factors poor prognosis certain extent blood pressure affected many molecules endothelin<NUMBER> <NUMBER> angii etc <NUMBER> <NUMBER> like angii ace<NUMBER> belongs reninangiotensinaldosterone system kallikreinbradykinin system family also blood pressure regulating protein <NUMBER> degrade angii form ang<NUMBER> degrade desarg <NUMBER> bradykinin dabk active peptide <NUMBER> know angii dabk bind corresponding receptors play physiological roles constricting blood vessels promoting valueadded inflammation neutrophil infiltration pulmonary fibrosis <NUMBER> <NUMBER> ang<NUMBER> bind specific mas receptors exert diastolic blood vessels antiinflammatory antiproliferative antifibrotic antialveolar epithelial cell apoptosis therefore ace<NUMBER> indirectly exerts antiinflammatory antilung injury effects animal experiments show ace<NUMBER> expression hypertensive rats decreased <NUMBER> <NUMBER> ace<NUMBER> also binding protein novel coronaviruses <NUMBER> like severe acute respiratory syndrome sars <NUMBER> studies sars researchers found coronavirus cause ace <NUMBER> levels decline even absent <NUMBER> <NUMBER> expression ace remains unchanged balance ace<NUMBER> ace lung broken <NUMBER> leading angⅱ elevation activation dabkbk<NUMBER> receptor pathway work association whether take acei arb prognosis covid<NUMBER> patients hypertension examined logistic regression analysis performed spss adjustment age sex hospitalization time time onset hospital admission whether take acei arb together cause lung inflammation apoptosis accelerated lung injury novel coronavirus sars use ace<NUMBER> receptor speculate novel coronavirus sars similar mechanisms action figure <NUMBER> reduced lymphocyte count one diagnostic criteria national health commissions diagnosis treatment program results study show covid<NUMBER> patients history hypertension lower lymphocyte count reports peng et al persistent decline lymphocyte counts observed death cases <NUMBER> chen et al also reported patients covid<NUMBER> <NUMBER> years age low lymphocyte counts easily turn severe cases <NUMBER> maybe lymphocyte count could reflect severity condition patients covid<NUMBER> extent may explain increased mortality patients history hypertension whether lymphopenia due reduction ace<NUMBER> caused novel coronavirus invasion covid<NUMBER> patients hypertension increase angii desarg bradykinin caused lung injury inflammatory response needs basic experimental research scientists announced novel coronavirus enters target cells receptor ace<NUMBER> many experts cardiovascular field began discuss whether covid<NUMBER> patients history hypertension continue use acei arb antihypertensive drugs scholars believe aceis discontinued scholars believe recommendations discontinue aceis scientific basis data analysis saw considerable number cases complicated hypertension collected patients previous medication situation grouped according whether taking acei arb drugs statistical analysis limited data showed prognosis two groups statistically different need note statistical difference age two groups logistic regression analysis showed patients whether history taking acei arb correlated prognosis studies show acei arb cause increased expression ace<NUMBER> <NUMBER> <NUMBER> angiotensin type receptor arb increase ang<NUMBER> compensatingly increasing ace<NUMBER> expression acei prevents ang<NUMBER> forming ang<NUMBER> turn promotes ace<NUMBER> expression whether types drugs affect covid<NUMBER> patients hypertension require research study several limitations first patients referred hospitals calculate crude cure rate crude mortality rate second singlecenter study sample size also limited especially patients hypertension therefore difficult accurately assess risk factors poor outcomes general current work demonstrated <NUMBER> discharged patients confirmed covid<NUMBER> wuhan china hypertensive patients significantly lower lymphocyte count admission elderly comorbidities hypertension may together constitute risk factors poor prognosis taking acei arb drugs may change prognosis covid<NUMBER> patients hypertension however mentioned sample size hypertensive patients collected small researches needed confirm first case pneumonia caused severe acute respiratory syndrome coronavirus <NUMBER> sars‐cov‐<NUMBER> reported wuhan hubei province china december <NUMBER> <NUMBER> march coronavirus disease <NUMBER> covid‐<NUMBER> caused virus spread around world sars‐cov‐<NUMBER> human coronavirus belong group benign coronaviruses cause common cold smaller group coronaviruses cause acute respiratory distress syndrome severe acute respiratory syndrome coronavirus—sars middle east respiratory syndrome coronavirus—mers <NUMBER> <NUMBER> recently published studies showed arterial hypertension diabetes cardiovascular diseases chronic obstructive pulmonary disease prevalent among patients covid‐<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> investigations outcome patients scarce data limited nevertheless hypertension considered one important risk factors covid‐<NUMBER> relationship hypertension adverse outcome still questionable aim review paper summarize current knowledge relationship hypertension covid‐<NUMBER> role hypertension outcome patients comprehensive search performed pubmed scopus web science google scholar find review papers topic published may <NUMBER> <NUMBER> sars‐cov‐<NUMBER> infection triggered s‐protein virus binds angiotensin‐converting enzyme <NUMBER> ace<NUMBER> highly expressed heart lungs kidney gastrointestinal tract plays important role several cardiovascular immune pathways <NUMBER> sars‐cov‐<NUMBER> binds ace<NUMBER> much higher affinity compared sars‐cov <NUMBER> additionally sars‐cov‐<NUMBER> shows pathogenic activity attacking type ii alveolar epithelial cells expressing ace<NUMBER> previous studies coronavirus causes sars demonstrated virus binds ace<NUMBER> pulmonary alveoli superficial spike proteins causes lung damage even lung function failure <NUMBER> loss ace<NUMBER> caused binding sars‐cov‐<NUMBER> may shift system overall higher angiotensin ii lower angiotensin‐<NUMBER>‐<NUMBER> tone role angiotensin ii covid‐<NUMBER> hypertensive patients seems crucial due role functioning renin‐angiotensin‐aldosterone system raas promotes vasoconstriction sodium retention oxidative stress inflammation fibrosis increases bioactive peptide angiotensin‐<NUMBER>‐<NUMBER> <NUMBER> epidemiological data coming china indicate arterial hypertension cardiovascular diseases diabetes chronic obstructive pulmonary disease prevalent concomitant diseases patients covid‐<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> table <NUMBER> number investigations provided least short follow‐up intrahospital outcome limited even though data demonstrated prevalence hypertension covid‐<NUMBER> patients lethal outcome high <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> still debated whether hypertension predictor mortality independently cardiovascular risk factors age obesity diabetes comorbidities coronary artery disease heart failure atrial fibrillation cerebrovascular disease renal impairment prevalence hypertension among patients covid‐<NUMBER> different studies ranged <NUMBER>‐<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER>‐<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> several reasons variations average age significantly higher patients elevated prevalence hypertension <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> might important reason different prevalence hypertensive patients among studies advanced age associated higher prevalence comorbidities diabetes renal impairment arterial hypertension obesity altogether increased proportion hypertensive patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> prevalence overweight obesity reported available studies covid‐<NUMBER> “circulus vitiosus” hypertension obesity diabetes difficult break therefore conclusion cannot made without detailed data links chain impact smoking forgotten relation copd hypertension higher propensity covid‐<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> however results conflicting majority authors find higher prevalence smoking patients adverse outcome <NUMBER> <NUMBER> <NUMBER> level renal damage cannot excluded one contribute factor higher percentage hypertension advance stage covid‐<NUMBER> hypertensive patients studies reported large prevalence cardiovascular diseases covid‐<NUMBER> patients also classified therefore difficult estimate individual effect coronary artery disease heart failure atrial fibrillation occurrence severity covid‐<NUMBER> li et al summarized findings <NUMBER> studies showed prevalence hypertension cardio‐ cerebrovascular disease diabetes patients covid‐<NUMBER> <NUMBER> <NUMBER> <NUMBER> respectively <NUMBER> incidences hypertension cardio‐cerebrovascular diseases diabetes two‐ threefolds higher patients severe type covid‐<NUMBER> non‐severe counterparts yang et al included <NUMBER> covid‐<NUMBER> patients <NUMBER> studies reported prevalent comorbidities hypertension diabetes cardiovascular diseases respiratory system disease <NUMBER> frequent comorbidities severe patients hypertension respiratory system disease cardiovascular disease large meta‐analysis included <NUMBER> patients covid‐<NUMBER> found pooled prevalence hypertension cardiovascular disease smoking history diabetes <NUMBER> <NUMBER> <NUMBER> <NUMBER> respectively <NUMBER> table <NUMBER> authors meta‐analyses agreed large heterogeneity studies obviously limited quality study partly explained different designs large variation sample size among studies <NUMBER> <NUMBER> essential data still missing would dangerous ascribe large portion risk sars‐cov‐<NUMBER> infection severity covid‐<NUMBER> risk factor including hypertension would reasonable hypothesize uncontrolled comorbidities well combination concomitant diseases may increase risk infection severity covid‐<NUMBER> examined many controversies effect angiotensin‐converting enzyme inhibitors acei angiotensin ii receptor blockers arb covid‐<NUMBER> patients <NUMBER> authors expressed concern use renin‐angiotensin‐aldosterone system raas inhibitors variation ace<NUMBER> expression may partly responsible sars‐cov‐<NUMBER> virulence <NUMBER> <NUMBER> population‐based studies estimated small proportion hypertensive patients china <NUMBER> <NUMBER> treated antihypertensive therapy raas inhibitors used <NUMBER> <NUMBER> treated patients <NUMBER> <NUMBER> therefore anticipated small percentage covid‐<NUMBER> patients china actually treated acei arb hand prevalence cardiac damage covid‐<NUMBER> patients negligible associated adverse outcome subjects <NUMBER> <NUMBER> data regarding frequency heart failure covid‐<NUMBER> patients scarce valid chronic kidney disease therapeutic point view acei arb important roles treatment conditions—cardiac injury heart failure renal impairment particularly albuminuria therefore withdrawing raas inhibitors switching medications would uncertain benefits certain disadvantages would expected problem raas inhibitors would escalate western countries europe usa patients taking antihypertensive medications particularly raas inhibitors significantly higher percentage china however studies italy usa show association raas inhibitors susceptibility coronavirus complications mortality covid‐<NUMBER> <NUMBER> <NUMBER> <NUMBER> even new investigation china confirmed findings <NUMBER> switching raas inhibitors another antihypertensive therapy would lead insufficient blood pressure control could induce complications covid‐<NUMBER> patients infection sars‐cov‐<NUMBER> novel data showed raas inhibitors could even improve outcome hypertensive patients covid‐<NUMBER> <NUMBER> authors hypothesized raas inhibitors indirect antiviral role regulating immune function inhibiting inflammatory responses <NUMBER> based available data despite theoretical possibilities multiple specialty societies recommended covid‐<NUMBER> patients continue therapy raas inhibitors <NUMBER> <NUMBER> <NUMBER> limited number studies provided outcome data short follow‐up therefore one careful interpretation findings guan et al demonstrated patients severe covid‐<NUMBER> primary end point admission intensive care unit use mechanical ventilation death significantly higher percentage hypertension diabetes coronary artery disease cerebrovascular disease copd chronic renal disease cancer <NUMBER> authors investigate relationship different demographic clinical parameters severity disease outcome shi et al reported hypertension diabetes coronary artery disease cerebrovascular disease copd cancer prevalent patients myocardial injury diagnosed elevation high‐sensitivity troponin creatinine kinase‐myocardial band ck‐mb <NUMBER> cardiac injury associated significantly higher mortality <NUMBER> vs <NUMBER> authors investigate comorbidities associated cardiac injury mortality must noted patients cardiac injury significantly older guo et al demonstrated similar results compared covid‐<NUMBER> patients without elevation troponin found <NUMBER> patients covid‐<NUMBER> cardiac injury <NUMBER> study chronic renal dysfunction usage raas also prevalent patients cardiac injury however patients cardiac injury almost <NUMBER> years older frequently men without injury also taken account also reported underlying cardiovascular disease worsening outcome patients myocardial injury <NUMBER> defining myocardial injury elevation troponin circumstances could questionable biomarker may increased many conditions inflammation andor sepsissystemic inflammatory response syndrome kidney injury authors clearly stated disorders included term “cardiovascular disease” clear whether hypertension included term furthermore difficult understand cardiomyopathies included whether patients heart failure included chen et al reported hypertension cardiovascular disease diabetes prevalent among covid‐<NUMBER> patients died comparison survivors <NUMBER> however large difference age sex distribution groups authors investigate effect comorbidities outcome population <NUMBER> table <NUMBER> zhou et al reported hypertension diabetes coronary heart disease chronic renal disease copd frequent among non‐survivors survivors <NUMBER> authors found hypertension diabetes coronary heart disease predictors mortality covid‐<NUMBER> patients nevertheless none comorbidities remained significant predictor mortality adjustment age sex smoking status findings confirmed importance comprehensive risk assessment including relevant risk factors comorbidities large original study included <NUMBER> patients guan et al showed adjusting age smoking status patients copd diabetes hypertension malignancy likely reach composite end points admission intensive care unit invasive ventilation death without <NUMBER> malignancy copd hypertension diabetes increased risk adverse outcome <NUMBER>‐ <NUMBER>‐ <NUMBER>‐ <NUMBER>‐fold respectively <NUMBER> patients two comorbidities significantly higher risk composite end point patients single comorbidity stratification patients according age <NUMBER> years vs ≥<NUMBER> years show significant difference strength associations number comorbidities mortality covid‐<NUMBER> <NUMBER> however cannot excluded confounding factors besides aging smoking might also responsible association comorbidities outcome would also helpful divide primary outcome two separate outcomes admission intensive care unit andor invasive ventilation b death would provide separated information independent predictors severity mortality covid‐<NUMBER> performed small study authors found hypertension diabetes predictors acute respiratory distress syndrome mortality covid‐<NUMBER> patients <NUMBER> unfortunately multivariable analysis adjustment relevant confounding factors performed investigation number limitations mentioned investigations self‐reporting comorbidities hospital admission represents one under‐reporting comorbidities due lack awareness andor lack diagnostic testing could interfere associations comorbidities clinical outcome importantly duration follow‐up short patients remained hospital time publishing studies means real outcome unknown obesity reported available studies influence could investigated furthermore one study reported basal values systolic diastolic blood pressure would help estimate percentage uncontrolled hypertension refers prevalence patients uncontrolled diabetes studies included small number patients additional obstacle one forget fact majority studies come china cautious extrapolating findings countries outbreak covid‐<NUMBER> studies consider potential sources bias confounding additional investigations improved design warranted recent findings reported arterial hypertension represented one common comorbidities patients covid‐<NUMBER> prevalence ranged <NUMBER> <NUMBER> impact hypertension outcome particularly mortality covid‐<NUMBER> patients clear due lack data studies provide evidence raas inhibitors avoided switched patients large studies consider potential sources bias confounding factors well longer follow‐up necessary public pressure find answers high physicians duty stay rational scientific approach available upcoming data <NUMBER> covid<NUMBER> inpatients included study <NUMBER> discharged <NUMBER> dead hospital <NUMBER> <NUMBER> dead patients complicated chronic comorbidities <NUMBER> patients <NUMBER> <NUMBER> combined chronic comorbidities showed cfr <NUMBER> times patients without underlying disease number patients hypertension accounted three fourths concomitant underlying diseases univariable regression revealed patients simple hypertension group showed overall risk higher simple diabetes mellitus group agegrouped research patients hypertension senile group proved highest risk might associated level ldh egfr retrospective cohort study <NUMBER> <NUMBER> patients hypertension took ccb hospitalization odds ratio cfr patients hypertension taking ccb group <NUMBER> p <NUMBER> compared data shows clinical manifestations hospitalized patients covid<NUMBER> actually systemic syndromes although covid<NUMBER> defined novel coronavirus pneumonia china hypertension chronic underlying comorbidity also risk factor affecting severity covid<NUMBER> play critical role worsening patients clinical outcomes therefore hypertension management patients covid<NUMBER> regarded major challenge diagnostic therapeutic strategies including optimal management blood pressure pathophysiological status recent outbreak covid<NUMBER> rapidly spread worldwide large proportion covid<NUMBER> patients chronic underlying complications reported severe condition show unpromising clinical outcomes whether chronic comorbidities risk factors affecting severity covid<NUMBER> well described included covid<NUMBER> patients admitted tongji hospital tongji medical college hust wuhan china january <NUMBER> <NUMBER> march <NUMBER> <NUMBER> retrospective cohort study final date followup march <NUMBER> <NUMBER> patients diagnosed covid<NUMBER> according prevention control schemefor novel coronavirus pneumonia published national health commission peoples republic china interim demographic data medical history clinical symptoms signs laboratory findings chest computed tomography ct treatment clinical outcomes extracted electronic medical records standardized data collection forms compared among different groups <NUMBER> covid<NUMBER> inpatients included study <NUMBER> discharged <NUMBER> dead hospital <NUMBER> <NUMBER> dead patients complicated chronic comorbidities <NUMBER> patients <NUMBER> <NUMBER> combined chronic comorbidities showed cfr <NUMBER> times patients without underlying disease number patients hypertension accounted three fourths concomitant underlying diseases univariable regression revealed patients simple hypertension group showed overall risk higher simple diabetes mellitus group agegrouped research patients hypertension senile group proved highest risk might associated level ldh egfr retrospective cohort study <NUMBER> <NUMBER> patients hypertension took ccb hospitalization odds ratio cfr patients hypertension taking ccb group <NUMBER> p <NUMBER> compared data shows clinical manifestations hospitalized patients covid<NUMBER> actually systemic syndromes although covid<NUMBER> defined novel coronavirus pneumonia china hypertension chronic underlying comorbidity also risk factor affecting severity covid<NUMBER> play critical role improving patients clinical outcomes therefore hypertension management patients covid<NUMBER> major challenge diagnostic therapeutic strategies including optimal management blood pressure pathophysiological status infection covid<NUMBER> swiftly spread worldwide clinical spectrum covid<NUMBER> patients appears wide ranging asymptomatic infection mild critical illness <NUMBER> <NUMBER> significant portion covid<NUMBER> patients reported least one underlying complication admitted hospital hypertension diabetes mellitus cardiovascular diseases common <NUMBER> <NUMBER> covid<NUMBER> patients abruptly progressing mild normal condition severe critical illness critical determinants remain identified early detection early prediction early treatment identifying factors biological indicators particular early warning value development disease progression prognosis critical clinical decision making medical resource allocation article conducted indepth retrospective analysis covid<NUMBER> inpatients received treated intensively early stage pandemic aim reveal factors great influence predictive value covid<NUMBER> progression medical history laboratory indicators prognosis outcomes retrospective cohort study included <NUMBER> covid<NUMBER> inpatients tongji hospital tongji medical college hust wuhan china patients diagnosed covid<NUMBER> according prevention control scheme novel coronavirus pneumonia <NUMBER> th edition published national health commission peoples republic china <NUMBER> interim guidance confirmed case covid<NUMBER> defined positive result serum antibody realtime reversetranscriptasepolymerasechainreaction rtpcr assay nasal pharyngeal swab specimens admission date hospitalized patients january <NUMBER> <NUMBER> march <NUMBER> <NUMBER> date cutoff study march <NUMBER> <NUMBER> study designed investigators conducted accordance principles declaration helsinki institutional review board tongji hospital wuhan china approved retrospective study written informed consent waived tjc<NUMBER> data analyzed interpreted authors obtained raw data regarding <NUMBER> hospitalized covid<NUMBER> patients tongji hospital demographic data medical history clinical symptoms signs laboratory ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint findings chest computed tomography ct treatment clinical outcomes extracted electronic medical records standardized data collection forms hospitalized covid<NUMBER> patients data doubled checked two experienced physicians ensure accuracy data collection disagreement two major reviewers adjudicated third reviewer demographic data included age sex clinical symptoms signs included fever cough dyspnea myalgia diarrhea chest congestion heart rate blood pressure oos laboratory findings laboratory information system consist complete blood count ldh pt aptt scr egfr alt ast serum albumin ddimer ntprobnp tni crp esr il<NUMBER> sarscov<NUMBER> igg sarscov<NUMBER> igm sarscov<NUMBER> nucleic acid detection chest ct report data obtained image acquisition communication systems smoking history baseline comorbidities hypertension dm chd copd aki stroke cancer extracted medical history drug use condition antihypertension anticoronary drugs antiviral drugs antibiotics corticosteroids gamma globulin traditional chinese medicine mechanical interventions noninvasive ventilator tracheal intubation ecmo crrt covid<NUMBER> patients hospitalization collected medical advice information time symptom onset admission hospital severity illness normalsevere clinical outcome discharge death obtained electronic medical system according diagnosis treatment scheme novel coronavirus pneumonia trial <NUMBER> th edition published national health commission peoples republic china <NUMBER> severity covid<NUMBER> inpatients classified mild common severe critically ill acute cardiac injury aci diagnosed serum levels tni <NUMBER> μgl males <NUMBER> μgl females acute kidney injury aki diagnosed egfr less <NUMBER> mlmin composite endpoint occurrence aci aki use tracheal intubation different groups divided basis collected medical history patients hypertension included hypertension group patients without hypertension included nonhypertension group simple hypertension group referred patients hypertension without diabetes mellitus simple diabetes mellitus group referred patients diabetes mellitus without hypertension hypertension diabetes mellitus group referred patients hypertension diabetes mellitus others group referred patients without hypertension diabetes mellitus patients without hypertension dm chd copd cancer included nonunderlying disease group <NUMBER> continuous variables presented medians standard deviation sd compared independent sample test categorical variables summarized counts percentages n compared pearson χ² test missing data ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> removed used univariable multivariable logistic regression models look insights risk factors associated incidence critically ill cases fatality cases composite endpoint twosided α less <NUMBER> considered statistically significant analyses performed using spss software version <NUMBER> <NUMBER> patients chronic comorbidities total <NUMBER> covid<NUMBER> inpatients accounting <NUMBER> two thirds one chronic comorbidities cfr <NUMBER> patients chronic comorbidities <NUMBER> times patients underlying disease <NUMBER> difference cfr among patients different number chronic comorbidities <NUMBER> discharged patients <NUMBER> dead patients total <NUMBER> covid<NUMBER> inpatients clinical characteristics prognosis conditions including demographic data clinical symptoms signs chronic comorbidities drug therapy two groups listed table <NUMBER> among dead patients <NUMBER> chronic comorbidities table <NUMBER> <NUMBER> <NUMBER> hypertension diabetes mellitus appendix table <NUMBER> <NUMBER> hypertension table <NUMBER> <NUMBER> patients included others group others <NUMBER> simple hypertension group htn <NUMBER> simple diabetes mellitusgroup dm <NUMBER> hypertension diabetes mellitus group htndm multiple indicators including ccir cfr incidence aci aki tracheal intubation use noninvasive ventilator ecmo crrt compared among four groups figure <NUMBER> ccir cfr relatively higher groups chronic comorbidities compared others group various prognostic indicators significantly higher htn group dm group patients htndm group showed higher incidence aci aki tracheal intubation use noninvasive ventilator odds ratio three major prognostic indicators incidence severe cases fatality cases cases composite endpoint adjusted age figure <NUMBER> covid<NUMBER> inpatients htn dm htndm group showed simple hypertension higher risk simple diabetes mellitus odds ratio occurrence composite endpoint <NUMBER> htn group p<NUMBER> <NUMBER> p<NUMBER> htndm group figure <NUMBER> appendix table <NUMBER> total <NUMBER> covid<NUMBER> inpatients divided four groups ie hypertension discharged group <NUMBER> patients hypertension dead group <NUMBER> patients nonhypertension discharged group <NUMBER> patients nonhypertension dead group <NUMBER> patients demographic data clinical signs oos hr sbp map laboratory indicators crp、ddimer、ldh、scr、egfr compared among four groups shown table <NUMBER> significant difference discharged dead ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint patients hypertension nonhypertension group age sex oos many laboratory indicators however indicator egfr significantly lower hypertension dead group nonhypertension dead group <NUMBER>±<NUMBER> vs <NUMBER>±<NUMBER> p<NUMBER> <NUMBER> patients nonhypertension nonsenile group <NUMBER> patients hypertension nonsenile patients <NUMBER> patients nonhypertension senile group <NUMBER> patients hypertension senile group patients hypertension divided according age age <NUMBER> demographic data clinical signs sbp dbp map oos laboratory indicators ldh egfr ccir cfr<NUMBER> cfr<NUMBER> compared among four groups appendix table <NUMBER> results showed ccir hypertension senile group significantly higher nonhypertension senile group <NUMBER> vs <NUMBER> p＜<NUMBER> different nonsenile patients senile patients showed significantly difference indicator crp ldh hypertension group nonhypertension group comparing probability survival among four groups figure <NUMBER> probability survival hypertension senile group continuously declined start hospitalization lowest among four groups due various reasons chinese hypertensive patients insisting antihypertensive therapy taking long acting calcium channel blockers ccb accounting nearly half <NUMBER> total number patients hypertension hypertensive patients using reninangiotensinaldosterone system inhibitors rasi less severe disease condition accounting nearly one eighth <NUMBER> comparison demographic data clinical signs oos hr sbp dbp map laboratory indicators crp ldh egfr cfr hypertensive patients taking ccb listed appendix table <NUMBER> age proved show significant difference two groups univariable multivariable logistic regression analyses revealed odds ratio death hypertensive patients taking ccb compared <NUMBER> p <NUMBER> appendix table <NUMBER> ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> clinical manifestations covid<NUMBER> patients range asymptomatic infection mild critical illness requiring ventilators even ecmo sustain lives <NUMBER> <NUMBER> wuhan scholars china first reported half patients severe infection complicated chronic comorbidities hypertension diabetes mellitus coronary heart disease <NUMBER> among infected underlying diseases <NUMBER> progressed severe cases <NUMBER> <NUMBER> severe cases chronic comorbidities died hospital <NUMBER> however whether chronic comorbidities regarded risk factor affecting severity covid<NUMBER> remains controversial time recently many reports age concomitant diseases might aggravate disease progression affect clinical outcomes among covid<NUMBER> patients covid<NUMBER> patients preexisting complications observed show higher cfr<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> patients cardiovascular disease diabetes mellitus chronic respiratory disease hypertension cancer respectively <NUMBER> reported greater number underlying diseases combined greater severity covid<NUMBER> <NUMBER> retrospective analyses covid<NUMBER> patients zhejiang province <NUMBER> province across mainland china revealed underlying hypertension independent risk factor severe cases even adjustment age <NUMBER> <NUMBER> among <NUMBER> covid<NUMBER> patients admitted icu available data italy <NUMBER> underlying hypertension excluding patients still icu deadline study cfr ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> patients without hypertension <NUMBER> <NUMBER> <NUMBER> result populationbased cohort study england supported patients hypertension included highrisk group <NUMBER> retrospective study found determinants severity covid<NUMBER> closely related age chronic comorbidities chronic comorbidities hypertension diabetes mellitus major risk factors affecting disease progression prognosis patients simple hypertension may higher risk simple diabetes mellitus senile hypertensive patients highest risk progression prognosis covid<NUMBER> chronic comorbidities hypertension increase risk disease progression prognosis important investigated article named viral host factors related clinical outcome covid<NUMBER> published online <NUMBER> analyze viral genome variation sample collection <NUMBER> patients shanghai public health center significant variation viral sequences observed severe cases covid<NUMBER> therefore ruling possibility mutation sarscov<NUMBER> multiple major laboratory indicators compared among discharged dead patients without hypertension significant difference observed general also significant difference found sbp map among four groups results suggest likely due pathophysiological status target organ damage patients hypertension ras system laboratory indicator egfr rather blood pressure makes hypertension risk factor illness development prognosis known infection sarscov<NUMBER> needs combination ace<NUMBER> tmprss<NUMBER> human alveolar epithelial cells type <NUMBER> tissues subsequent replication multiplication amount virus leads increased expression ace<NUMBER> neighboring cells affects macrophages inflammatory cytokines released <NUMBER> consequently increased expression activity ace<NUMBER> tissue could identified critical factor patients susceptibility disease progression huanggang study published online conducted serological tests ace<NUMBER> <NUMBER> covid<NUMBER> patients <NUMBER> noncovid<NUMBER> patients revealing serum level ace<NUMBER> increased <NUMBER> hours infection remained high <NUMBER> hours infection <NUMBER> expression ace<NUMBER> mildly expressed lung tissue healthy human however brazilian researchers recently found expression ace<NUMBER> lung tissue upregulated covid<NUMBER> patients underlying diseases <NUMBER> including hypertension might provide reasonable explanation increased severity covid<NUMBER> patients underlying complications knowledge study retrospective report mainly focusing patients hypertension accounts highest proportion covid<NUMBER> patients risk early targeted interventions prevent disease progressing reasonable management strategy hypertension necessary might help improve clinical outcomes hospitalized covid<NUMBER> patients high risk retrospective cohort study limitations firstly admission examination indicator egfr captured collected data overall level aki might therefore underestimated secondly information patients prior admission put medical history could determined whether patients continued take changed medication hospitalization thirdly national unified standard normal reference values laboratory indicators thus followed standards set hospital finally data entry underlying diseases based inquiries patients enrolled hospital might underestimated due influence awareness rate retrospective cohort study revealed <NUMBER> covid<NUMBER> inpatients <NUMBER> combined chronic comorbidities showed cfr <NUMBER> times patients without underlying disease <NUMBER> <NUMBER> dead patients complicated chronic comorbidities number patients hypertension accounted three fourths concomitant underlying diseases odds ratio occurrence composite endpoint covid<NUMBER> inpatients simple hypertension <NUMBER> p<NUMBER> indicating overall risk higher simple hypertension group simple diabetes mellitus group according agegrouped research found hypertension senile group highest risk suggests hypertension management patients covid<NUMBER> would major challenge therapeutic strategies including optimal management blood pressure pathophysiological status might help improve clinical outcomes hospitalized covid<NUMBER> patients high risk hesong zeng weizhong zhang yin shen conceived study design full access data take responsibility integrity data accuracy analysis xingwei yuxin du yan tong organised entered data tianlu zhang yuxin du xueli wang contributed data analyses hesong zeng weizhong zhang yin shen xingwei tianlu zhang participated discussion made crucial suggestions interpreting findings weizhong zhang tianlu zhang drafted manuscript authors approved final version article decalre competing interests study supported covid<NUMBER> emergency response project wuhan science technology department <NUMBER> ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint december <NUMBER> cluster severe cases pneumonia unknown cause emerged wuhan china clinical presentations greatly resembling viral pneumonia <NUMBER> deep sequencing analysis lower respiratory tract samples indicated novel coronavirus named coronavirus disease mar <NUMBER> <NUMBER> hypertension rates range <NUMBER> nonsevere patients <NUMBER> severe patients total incidence high <NUMBER> <NUMBER> interestingly angiotensinconverting enzyme <NUMBER> ace<NUMBER> involved pathogenesis hypertension covid<NUMBER> pneumonia reasons prompted us speculate organs attacked sarscov<NUMBER> might lungs may also include ace<NUMBER> expression organs especially cardiovascular system addition patients comorbid hypertension especially longterm oral aceiarb medication hypertension might different susceptibility severity levels pneumonia upon infection sarscov<NUMBER> therefore investigated compared demographic characteristics coexisting diseases severity pneumonia effect antihypertensive drugs aceiarb versus nonaceiarb covid<NUMBER> patients coexisting hypertension findings may hopefully reduce mortality morbidity associated hypertension patients covid<NUMBER> ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint httpsdoiorg<NUMBER> doi medrxiv preprint singlecenter retrospective observational study conducted hankou hospital one hospitals designated treat covid<NUMBER> pneumonia patients wuhan china criteria suspected confirmed cases covid<NUMBER> based criteria previously established <NUMBER> <NUMBER> patients met criteria included study patients <NUMBER> years whose entire stay hospital lasted <NUMBER> hours excluded analysis study approved national health commission china ethics commission hankou hospital hkyy<NUMBER> ethics commission hankou hospital waived requirement obtaining informed consent obtained epidemiological demographic clinical laboratory management outcome data patients medical records using standardized data collection forms clinical outcomes followed march <NUMBER> <NUMBER> analyze relationship stage hypertension clinical outcome minimum followup time <NUMBER> days required including followup patients discharged march <NUMBER> <NUMBER> data missing records clarification needed researchers also directly communicated patients families ascertain epidemiological symptom data data checked two physicians ts hh initial investigations included complete blood count coagulation profile serum biochemical test including renal liver function creatine kinase lactate dehydrogenase ldh electrolytes <NUMBER> common respiratory pathogens description treatment procedures measurements ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint httpsdoiorg<NUMBER> doi medrxiv preprint <NUMBER> published previously <NUMBER> definition classification hypertension obtained previously published literature <NUMBER> definitions severe nonsevere pneumonia obtained published literature <NUMBER> patients received chest computed tomography ct scan admission ct images reviewed two fellowshiptrained cardiothoracic radiologists gx fw approximately <NUMBER> years experience using electronic medical record system hankou hospital images reviewed independently final decisions reached consensus cases disagreement two primary radiologist interpretations third fellowshiptrained cardiothoracic radiologist <NUMBER> years experience hl adjudicated final decision negative control cases examined blinding occurred radiologists evaluated initial ct scans assigned quantitative scores characteristics using recently published scoring system <NUMBER> total ct score sum lung involvement <NUMBER> lobes score <NUMBER> lobe range <NUMBER> none <NUMBER> maximum <NUMBER> primary variable interest <NUMBER>day mortality calculated day admission secondary outcome variables included severity pneumonia length hospital stay discharge rate hospital hospitalization rate study approved national health commission china ethics ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint httpsdoiorg<NUMBER> doi medrxiv preprint commission hankou hospital hkyy<NUMBER> ethics commission hankou hospital waived requirement obtaining informed consent statistical analysis performed using spss software windows version <NUMBER> ibm corp armonk ny usa descriptive analyses performed demographic clinical laboratory data bivariate analyses used assess association hypertension status different parameters interest continuous data white blood cell count converted categorical variables normal low high levels multivariate analysis performed due small sample size odds ratio obtained logistic regression used measure strength association factor hypertension p value <NUMBER> considered indicate statistical significance date symptom onset used starting date conducted death certificate search medical records determine whether patients alive discharge died subsequently included data analysis applicable study period total <NUMBER> patients admitted met case definition clinically confirmed covid<NUMBER> inclusion criteria characteristics patients admission overall according hypertension status shown table <NUMBER> <NUMBER> patients hypertension <NUMBER> patients without ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint httpsdoiorg<NUMBER> doi medrxiv preprint hypertension compared patients without hypertension patients hypertension significantly older likely underlying comorbidities including chronic renal insufficiency cardiovascular disease diabetes mellitus cerebrovascular disease patients hypertension tended longer time onset admission higher positive covid<NUMBER> pcr detection rates table <NUMBER> shows results laboratory tests performed admission according hypertension status patients hypertension higher levels serum creatinine scr lower levels hemoglobin ddimer whole blood patients without hypertension differences clinical outcomes found patients hypertension without hypertension table <NUMBER> compared characteristics clinical outcomes patients covid<NUMBER> history hypertension previously taken aceiarb drugs cases severe pneumonia seen among patients taken aceiarb drugs patients even though taken aceiarb drugs younger age p <NUMBER> pneumonia severity status admission p <NUMBER> significant differences indexes found two groups table <NUMBER> observation shows patients hypertension previously taken aceiarb drugs antihypertensive treatment increased tendency develop severe pneumonia infection sarscov<NUMBER> hypertensive patients may need ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint httpsdoiorg<NUMBER> doi medrxiv preprint adjust medications eliminate aceiarb drugs reduce risk severe pneumonia mechanistically increase zinc metallopeptidase ace<NUMBER> might help sarscov<NUMBER> enter cells accelerate replication ace<NUMBER> known human homologue key regulator blood pressure angiotensinconverting enzyme ace since discovery <NUMBER> ace<NUMBER> implicated play important role preservation heart function balance blood pressure effects mediated part ability convert angiotensin ii ang ii angiotensin<NUMBER> unexpectedly ace<NUMBER> also serves cellular entry point severe acute respiratory syndrome sars virus enzyme therefore prime target pharmacological intervention coronavirusrelated diseases <NUMBER> <NUMBER> ace<NUMBER> identified receptor severe acute respiratory syndrome coronavirus sarscov mediates infection transmission sarscov effect rely protease activity ace <NUMBER> structural analysis showed spinous protein sarscov contact headend ace<NUMBER> catalytic domain subunit involve subunit ii block active region sarscov connected ace<NUMBER> extracellular part ace<NUMBER> lysed transmembrane part transferred cell mediates fusion virus particles host cells <NUMBER> nextgeneration sequencing technology entire genome sequence covid<NUMBER> successfully determined <NUMBER> compared genomic sequences previous coronaviruses found sarscov<NUMBER> <NUMBER> similarity sarscov <NUMBER> worth noting aceiarb drugs administered hypertensive patients resulted increased expression ace<NUMBER> lungs role ace<NUMBER> opposite ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint httpsdoiorg<NUMBER> doi medrxiv preprint ace ace<NUMBER> hydrolyze angiotensin ang produce angiotensin <NUMBER> peptides thereby generating vasodilation lowering blood pressure aceiarb drugs may increase protein concentration ace<NUMBER> rat plasma mrna level ace<NUMBER> even activity ace<NUMBER> cardiac tissue <NUMBER> thus possible hypertensive patients taking aceiarb might increased level mrna protein expression ace<NUMBER> lungs making vulnerable sarscov<NUMBER> entry well development severe covid<NUMBER> pneumonia findings worth investigating however scholars believe downregulation ace<NUMBER> expression neo coronavirus challenge aggravates lung injuries opinion mainly comes animal model studies multiple laboratories small sample clinical study studies shown ace<NUMBER> expression decreases viral infection causing acute lung injury exogenous supplementation ace<NUMBER> could alleviate acute lung injury <NUMBER> human recombinant ace <NUMBER> rhuace<NUMBER> angiotensin ii type <NUMBER> receptors protect mice severe acute lung injuries induced acid aspiration sepsis <NUMBER> found patients acute respiratory distress syndrome ards treated rhuace<NUMBER> injections rapidly decreasing levels ang ii increasing levels ang<NUMBER> <NUMBER> downregulation ace<NUMBER> caused imbalance aceang ii ace<NUMBER> activity ang ii reninangiotensinaldosterone system raas enhanced lack antagonism <NUMBER> ang ii mediates increased pulmonary vascular permeability binding receptor at<NUMBER> might also cause pulmonary vascular contraction resulting hydrostatic pressure elevation pulmonary edema <NUMBER> <NUMBER> clinical evidence required determine whether expression ace<NUMBER> downregulated humans coronavirus including ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity nevertheless results study suggest widespread covid<NUMBER> pandemic hypertensive population may need quickly consider choice antihypertensive medications reduce possibility developing severe pneumonia investigation found covid<NUMBER> patients taking aceiarb agents younger patients taking nonaceiarb agents may related doctors prescribing habits however cannot directly conclude covid<NUMBER> patients taking aceiarb antihypertensive drugs severe pneumonia taking aceiarb drugs many confounding factors coexisting diseases yet excluded survey shows population hypertension seem susceptible covid<NUMBER> comparing nonhypertension population previously large sample study <NUMBER> patients showed hypertension coexisting disease ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint research following limitations first survey focused hankou hospital wuhan number patients included small larger sample size multicenter clinical data needed support conclusions future study second investigation included clinically confirmed cases many patients tested lack nucleic acid test kits beginning outbreak patients suspected covid<NUMBER> excluded study tested negative hospital however based exact epidemiological history patients signs symptoms chest ct examination results trust reliability covid<NUMBER> diagnosis patients third due urgent data collection shorter followup time patients shortest hospital stay patients <NUMBER> days may interfere final prognosis lead failure analyze survival times fourth analyze comorbidities shock ards focus analyze risk associated hypertension provide evidence issue covid<NUMBER> prevention treatment guidelines covid<NUMBER> patients coexisting hypertension significantly older ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint httpsdoiorg<NUMBER> doi medrxiv preprint <NUMBER> likely underlying comorbidities including chronic renal insufficiency cardiovascular disease diabetes mellitus cerebrovascular disease patients hypertension tended longer time onset admission higher positive covid<NUMBER> pcr detection rates patients hypertension taken aceiarb drugs antihypertensive treatment increased tendency develop severe pneumonia infection sarscov<NUMBER> future studies larger sample size multicenter clinical data needed support conclusions ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint httpsdoiorg<NUMBER> doi medrxiv preprint ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint httpsdoiorg<NUMBER> doi medrxiv preprint <NUMBER> bai c gao song j xia p dong j zhao j wang fs pathological findings covid<NUMBER> associated acute respiratory distress syndrome lancet respir med <NUMBER> ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint onset admission days <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> made available authorfunder granted medrxiv license display preprint perpetuity  copyright holder preprint data presented n mean sd median iqr p values compare hypertension nonhypertension patients na applicable covid<NUMBER> <NUMBER> novel coronavirus  made available authorfunder granted medrxiv license display preprint perpetuity  copyright holder preprint novel coronavirus pandemic worldwide public health concern <NUMBER> progressive public health emergency global significance <NUMBER> first case reported wuhan province china <NUMBER> december <NUMBER> unexplained lower respiratory infections <NUMBER> disease rapid human human transmission capacity varied fatality due acute respiratory distress syndrome ards multiorgan failure serious complications <NUMBER> viruses termed severe acute respiratory syndromecoronavirus<NUMBER> sarscov<NUMBER> similar one caused sars outbreak <NUMBER> large family singlestranded rna viruses ssrna isolated different animal species <NUMBER> according recent estimates <NUMBER> population suggested healthy carriers coronavirus viruses responsible <NUMBER> <NUMBER> acute respiratory infections <NUMBER> primarily covid<NUMBER> patients fever myalgia fatigue dry cough time admission <NUMBER> although patients thought favorable prognosis older patients chronic underlying conditions like diabetes hypertension coronary heart diseases etc show worse outcomes <NUMBER> <NUMBER> patients severe illness develop dyspnea hypoxemia within <NUMBER>week onset disease might quickly progress ards endorgan failure <NUMBER> various studies reported clinical characteristics patients covid<NUMBER> need management intensive care units old age comorbidities particularly hypertension diabetes believed risk factors disease severity death sarscov<NUMBER> infected patients <NUMBER> <NUMBER> <NUMBER> another study also reported comorbid hypertension common followed diabetes coronary heart disease <NUMBER> several studies demonstrated higher prevalence diabetes covid<NUMBER> patients however effect prevalence diabetes severity disease needs exploration understanding association might helpful early vigilant monitoring better management covid<NUMBER> patients high risk leading ards organ failure death thus metaanalysis aim assess association diabetes hypertension severity disease systematic literature review followed preferred reporting items systematic review metaanalysis prisma guidelines extension scoping reviews <NUMBER> searched pubmed medline cochrane march <NUMBER> <NUMBER> using keywords covid<NUMBER> diabetes <NUMBER> novel coronavirus diabetes <NUMBER> novel coronavirus hypertension covid<NUMBER> hypertension also searched grey literature using google scholar reference list eligible articles studies describing prevalence diabetes hypertension according disease severity included excluded duplicate publications reviews editorials case reports letters metaanalysis protocols studies language english studies reporting required data first author rp searched data screened article eligibility senior author na double checked included articles dispute resolved consensus two reviewers rp ns assessed quality data included studies using national institute health nih quality assessment tools <NUMBER> preferred nih tool comprehensive widely accepted exhaustive assessment data quality rated overall quality included studies good fair poor incorporated metaanalysis results data inputted standardized data extraction table excel independently checked second reviewer ns accuracy following variables extracted name first author year publication study design age gender current smoking number patients severe nonsevere condition comorbidities hypertension diabetes included studies designated severe group respiratory distress rr ≥ <NUMBER> beatsminute resting state mean oxygen saturation ≤ <NUMBER> arterial blood oxygen partial pressure pao<NUMBER>oxygen concentration fio<NUMBER> ≤ <NUMBER> mmhg <NUMBER> performed exploratory metaanalysis understand magnitude direction effect estimate odds ratios ors calculated presented respective <NUMBER> confidence intervals cis mantelhaenszel randomeffects metaanalysis using dersimonian laird method used pool ors <NUMBER> heterogeneity studies assessed using χ <NUMBER>based cochrans q statistic p<NUMBER> considered presence heterogeneity isquared <NUMBER> statistics <NUMBER> representing moderate heterogeneity <NUMBER> forest plot produced studies grouped according design publication bias assessed total number studies less ten <NUMBER> systematic search yielded total <NUMBER> publications <NUMBER> studies <NUMBER> studies found using keyword covid<NUMBER> diabetes <NUMBER> studies keyword <NUMBER> novel coronavirus diabetes <NUMBER> studies term covid<NUMBER> hypertension <NUMBER> studies keyword <NUMBER> novel coronavirus hypertension two studies found sources removing duplicates <NUMBER> articles found potential publications screening application predefined inclusion exclusion criteria total seven studies included metaanalysis included studies conducted china prevalence diabetes hypertension reported survivors nonsurvivors two studies icu care nonicu care patients two studies prevalence diabetes hypertension severe nonsevere patients reported three studies among seven included studies three cohort studies <NUMBER> <NUMBER> <NUMBER> four caseseries <NUMBER> <NUMBER> <NUMBER> <NUMBER> studies enrolled total <NUMBER> patients including <NUMBER> males <NUMBER> females demographic characteristics subjects included studies provided table <NUMBER> assessed quality data included studies using nih quality assessment tools quality assessment indicated included studies acceptable quality papers clearly stated research question objective study population clearly specified defined subjects selected similar populations detailed result quality assessment provided supplementary file <NUMBER> figure <NUMBER>c recent evidence sarscov<NUMBER> suggest presence comorbidities increase mortality risk covid<NUMBER> patients diabetes one important components predict adverse outcomes <NUMBER> thus present metaanalysis conducted assess association diabetes disease severity covid<NUMBER> patients present metaanalysis based data <NUMBER> studies covid<NUMBER> patients present metaanalysis demonstrated prevalence diabetes lower survivors nonsurvivors covid<NUMBER> patients however difference diabetes prevalence patients requiring requiring icu care additionally positive association diabetes disease severity found several studies demonstrated higher prevalence diabetes covid<NUMBER> patients however effect prevalence diabetes severity disease needs exploration recent metaanalysis comorbidities suggested diabetes one prevalent comorbidities <NUMBER>±<NUMBER> <NUMBER> ci <NUMBER> covid<NUMBER> patients however significant difference found diabetes severe nonsevere group <NUMBER> another similar metaanalysis demonstrated pooled prevalence diabetes <NUMBER> <NUMBER>ci <NUMBER> <NUMBER> metaanalysis reported proportions diabetes patients covid<NUMBER> <NUMBER> incidences diabetes two folds higher icusevere cases nonicusevere counterparts <NUMBER> retrospective study showed <NUMBER> severe patients diabetes cardiovascular diseases significantly higher mild group <NUMBER> caseseries reported <NUMBER> covid<NUMBER> patients comorbid diabetes mellitus <NUMBER> although pathophysiology involved comorbidity remains unexplained several hypotheses suggested blood glucose level suggested play essential role pathogenesis infectious diseases immune system diabetes patients might altered abnormal blood glucose level resulting dysregulation reduced responses immune components consequently patients susceptible sarscov<NUMBER> various types bacteria <NUMBER> another hypothesis states human pathogenic coronaviruses sarscov sarscov<NUMBER> bind target cells angiotensinconverting enzyme <NUMBER> ace<NUMBER> expressed epithelial cells lung intestine kidney blood vessels expression ace<NUMBER> significantly increased diabetes patients treated ace inhibitors angiotensin ii typei receptor blockers use thiazolidinediones ibuprofen also increased ace<NUMBER> consequently increased expression ace<NUMBER> would facilitate infection covid<NUMBER> <NUMBER> present metaanalysis showed hypertension lower survivors nonsurvivors covid<NUMBER> patients additionally positive association hypertension disease severity icu care found recent metaanalysis demonstrated hypertension prevalent comorbidity <NUMBER>±<NUMBER> <NUMBER> ci <NUMBER> covid<NUMBER> patients additionally higher risk hypertension found severe group compared nonsevere group <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> according another metaanalysis pooled prevalence hypertension people infected sarscov<NUMBER> estimated <NUMBER> <NUMBER>ci <NUMBER> <NUMBER> metaanalysis reported proportions hypertension patients covid<NUMBER> <NUMBER> incidence hypertension two folds higher icusevere cases nonicusevere counterparts <NUMBER> understanding disease establish risk stratification patients authors contributed significantly manuscript funding research receive specific grant funding agencies public commercial notforprofit sectors n number end <NUMBER> series unexplained pneumonia cases appeared showed tendency transmission person person soon scientists isolated causative pathogen new type β coronavirus <NUMBER> subsequently named international committee taxonomy viruses severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> <NUMBER> disease named coronavirus disease <NUMBER> covid<NUMBER> world health organization <NUMBER> april <NUMBER> <NUMBER> cumulative number confirmed cases worldwide <NUMBER> cumulative death toll <NUMBER> <NUMBER> angiotensinconverting enzyme <NUMBER> ace<NUMBER> considered receptor sarscov<NUMBER> enter human cells <NUMBER> ace<NUMBER> widely expressed various organ systems human body including respiratory system cardiovascular system <NUMBER> enzyme catalyze conversion angiotensin ii ang ii angiotensin <NUMBER> peptide counteracts proinflammatory prooxidation vasoconstrictive effects ang ii studies shown hypertension may one common comorbid diseases patients covid<NUMBER> <NUMBER> study involving <NUMBER> covid<NUMBER> patients prevalence hypertension <NUMBER> severe patients <NUMBER> interaction sarscov<NUMBER> ace<NUMBER> role ace<NUMBER> pathogenesis hypertension many speculations hypertension may involved pathogenesis covid<NUMBER> however early reports revealed whether relationship hypertension disease severity therefore remains unclear whether high blood pressure risk factor covid<NUMBER> whether blood pressure control hypertensive patients covid<NUMBER> lowrisk factor understand whether hypertension risk factor affecting progress prognosis covid<NUMBER> study included <NUMBER> cases covid<NUMBER> patients admitted wuhan jinyintan hospital central hospital wuhan outbreak <NUMBER> demographic data clinical manifestations laboratory indicators treatment methods collected analyzed study collected clinical data <NUMBER> patients diagnosed covid<NUMBER> wuhan jinyintan hospital central hospital wuhan outbreak <NUMBER> according world health organizations temporary guidelines patients enrolled study diagnosed covid<NUMBER> first part study patients divided two groups according whether high blood pressure avoid effects complications second part study excluded patients complications hypertension divided remaining patients hypertension group nonhypertension group monitored patients study recorded entire course disease final clinical outcome person demographic data epidemiological characteristics clinical features severity disease laboratory tests treatment results patients obtained medical record system recorded date onset defined date first onset symptoms patients covid<NUMBER> met following criteria <NUMBER> epidemic history <NUMBER> fever respiratory symptoms <NUMBER> abnormal ct imaging typical viral pneumonia <NUMBER> positive sarscov<NUMBER> rna rtpcr according medical history patients divided hypertension group nonhypertension group clinical classification patients based mainly novel coronavirus pneumonia diagnosis treatment plan trial version <NUMBER> developed national health committee peoples republic china <NUMBER> classifications could summarized follows <NUMBER> mild type mild clinical symptoms sign pneumonia imaging features <NUMBER> common type complicated fever respiratory symptoms imaging features pneumonia <NUMBER> severe type complicated following respiratory distress respiratory rate ≥ <NUMBER> beatsmin b mean oxygen saturation ≤ <NUMBER> rest c ratio partial pressure arterial oxygen fraction inspired oxygen pao <NUMBER> fio <NUMBER> ≤ <NUMBER> mmhg <NUMBER> mmhg <NUMBER> kpa <NUMBER> critical type complicated following respiratory failure mechanical ventilation required b shock c organ dysfunction intensive care unit admission required research combined severe type critical type patients severe group using spss<NUMBER> software ibm inc chicago il usa categorical variables expressed frequencies percentages continuous variables expressed mean ± standard deviation median quartile interval whenever appropriate students test mannwhitney u test used continuous variables chisquare test fisher exact test used categorical variables multivariable logistic regression model adjusted age sex used multivariate analysis p value <NUMBER> considered statistically significant <NUMBER> patients covid<NUMBER> median age <NUMBER> years interquartile range <NUMBER> number women <NUMBER> <NUMBER> number men <NUMBER> <NUMBER> common symptom patients fever observed <NUMBER> patients frequencies symptoms cough <NUMBER> dyspnea <NUMBER> expectoration <NUMBER> muscle ache <NUMBER> diarrhea <NUMBER> whereas headache occurred <NUMBER> cases <NUMBER> common complications hypertension <NUMBER> diabetes <NUMBER> followed cerebrovascular diseases <NUMBER> cardiovascular diseases <NUMBER> number deaths hospital <NUMBER> <NUMBER> total <NUMBER> patients <NUMBER> severe group including severe type critically ill type according definition better explore impact hypertension progression prognosis covid<NUMBER> avoid confounding effects complications following analysis excluded patients complications hypertension results shown tables <NUMBER> <NUMBER> compared nonhypertensive patients hypertensive patients older <NUMBER> iqr <NUMBER> vs <NUMBER> iqr <NUMBER> higher proportion severe cases <NUMBER> vs <NUMBER> higher proportion icu admission <NUMBER> vs <NUMBER> however terms mortality length hospital stay significant differences two groups patients addition regard laboratory indexes white blood cell count <NUMBER> multivariate analysis table <NUMBER> separately used severity mortality covid<NUMBER> dependent variables age sex hypertension candidate independent variables establish multivariable logistic study median age covid<NUMBER> patients <NUMBER> years prevalence rate hypertension <NUMBER> national survey conducted china october <NUMBER> december <NUMBER> showed total prevalence hypertension chinas adult population ≥<NUMBER> years old <NUMBER> <NUMBER> addition previous multicenter study showed <NUMBER> covid<NUMBER> patients median age <NUMBER> previously coexisting hypertension <NUMBER> another large sample <NUMBER> covid<NUMBER> cases median age <NUMBER> prevalence hypertension <NUMBER> <NUMBER> higher prevalence hypertension study may explained higher median age general sufficient evidence show people high blood pressure likely infected covid<NUMBER> without hypertension study revealed hypertensive covid<NUMBER> patients tend show higher mortality previous clinical studies sars middle east respiratory syndrome showed hypertension risk factor increased mortality infected patients <NUMBER> <NUMBER> specific pathogenesis hypertension may lead severe covid<NUMBER> remains studied imbalance cytokines may considered explanation correlation hypertension severe covid<NUMBER> increasing clinical data shown relationship deterioration covid<NUMBER> cytokine storms <NUMBER> elevated levels il<NUMBER> interleukin<NUMBER> granulocytemacrophage colonystimulating factor tumor necrosis factor α worth noting previous clinical studies found increase cytokines also associated development hypertension <NUMBER> notable example il<NUMBER> observed closely related poor prognosis patients covid<NUMBER> <NUMBER> also one important cytokines regulating immuneinflammatory responses hypertension addition hypertensive patients covid<NUMBER> due imbalance reninangiotensin system ras nadhnadph oxidase system may activated excessive inflammatory reactions large number cytokines <NUMBER> resulting cell damage vasoconstriction <NUMBER> aggravating lung damage covid<NUMBER> leading poor prognosis pathophysiology inflammatory disorders hypertension may partly explain poor prognoses covid<NUMBER> addition effect antihypertensive drugs covid<NUMBER> patients hypertension controversial one hand use angiotensinconverting enzyme inhibitors aceis result decrease angiotensinconverting enzyme ace increase expression ace<NUMBER> lungs <NUMBER> ace<NUMBER> may mediate invasion infection sarscov<NUMBER> lung cells resulting viral spread aggravation symptoms hand negative regulator ras system ace<NUMBER> catalyze hydrolysis ang ii ang<NUMBER> ang<NUMBER> binds mas receptor plays important role antialveolar epithelial apoptosis lowering blood pressure protecting wbc white blood cell count nc neutrophil count lc lymphocyte count nlr neutrophiltolymphocyte ratio sao<NUMBER> oxyhemoglobin saturation tb total bilirubin alt alanine aminotransferase ast aspartate aminotransferase ldh lactate dehydrogenase esr erythrocyte sedimentation rate crp creactive protein il<NUMBER> interleukin<NUMBER> bnp btype natriuretic peptide fib fibrinogen pt prothrombin time aptt activated partial thromboplastin time endothelium <NUMBER> reducing effect ang ii increasing production ang<NUMBER> ace<NUMBER> induce vasodilation antiinflammatory response <NUMBER> helps reduce degree lung injury prevent emergence acute respiratory distress syndrome ards acute lung injury study china involving <NUMBER> hypertensive covid<NUMBER> patients showed hypertensive patients used aceis angiotension receptor blocker arbs hospitals lower risk allcause death use aceisarbs <NUMBER> addition article covid<NUMBER> working group european society hypertension pointed evidence support ras inhibitors harmful covid<NUMBER> patients reason hypertensive patients stable conditions stop using ras inhibitors <NUMBER> multivariate analysis showed adjusting age sex hypertension show significant correlation increased covid<NUMBER> disease severity mortality contrary results previous largesample study <NUMBER> speculate possible reasons sample size data small number end events small test efficiency insufficient time regression models used studies different adjusted variables also different present lack research hypertensive covid<NUMBER> patients especially adjusted age sex study regarded reference overall comparative analysis covid<NUMBER> patients without hypertension showed hypertensive patients greater disease severity adverse progression nonhypertensive patients however result may related higher age group nonhypertension group addition severe symptoms greater likelihood complications diabetes likelihood transfer icu worse laboratory indicators covid<NUMBER> patients hypertension need additional attention prevent adverse outcomes study following limitations first number patients included survey enough effectiveness testing may sufficient future studies need larger sample size clinical data support conclusions second analyze complications acute renal injury ards focused analyzing risks associated hypertension addition due retrospective nature wbc white blood cell count nc neutrophil count lc lymphocyte count nlr neutrophiltolymphocyte ratio sao<NUMBER> oxyhemoglobin saturation tb total bilirubin alt alanine aminotransferase ast aspartate aminotransferase ldh lactate dehydrogenase esr erythrocyte sedimentation rate crp creactive protein il<NUMBER> interleukin<NUMBER> bnp btype natriuretic peptide fib fibrinogen pt prothrombin time aptt activated partial thromboplastin time study well urgency time difficulties collection lack use antihypertensive drugs patients third diagnosis hypertension extracted medical history data may small number patients hypertension may accurately recorded however limitations affect reliability overall results coronavirus disease <NUMBER> covid<NUMBER> newly emerging acute respiratory disease caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> mainly transmitted via respiratory droplets <NUMBER> compared sarscov merscov sarscov<NUMBER> well capable sustained community transmission case estimated infect another <NUMBER>−<NUMBER> uninfected persons average <NUMBER> <NUMBER> april <NUMBER> approximate one million covid<NUMBER> cases <NUMBER> <NUMBER> deaths reported <NUMBER> countriesregions around world <NUMBER> therefore urgently needed identify risk factors associated severity fatality sarscov<NUMBER> infection recently several clinical studies noticed hypertension one common comorbidities patients sarscov<NUMBER> infection <NUMBER> <NUMBER> <NUMBER> example one cohort <NUMBER> patients wuhan china zhou et al reported half patients different comorbidities hypertension common <NUMBER> <NUMBER> cohort <NUMBER> hospitalised patients covid<NUMBER> wang et al observed hypertension <NUMBER> diabetes <NUMBER> cardiovascular disease <NUMBER> malignancy <NUMBER> common coexisting medical conditions <NUMBER> addition analysis outpatient inpatient cohort <NUMBER> patients covid<NUMBER> showed <NUMBER> patients history hypertension <NUMBER> however published articles different study designs populations usually yield different estimates effect sizes therefore comprehensive systematic analysis necessary variability one important public health problems <NUMBER>st century hypertension affects one billion individuals worldwide <NUMBER> however influence hypertension sarscov<NUMBER> infection remains unclear therefore conducted present metaanalysis evaluate associations hypertension severity fatality sarscov<NUMBER> infection assessment might helpful understand characteristics sarscov<NUMBER> infection hypertensive patients metaanalysis conducted accordance preferred reporting items systematic reviews metaanalyses prisma statement <NUMBER> articles published <NUMBER> march <NUMBER> pubmed elsevier science direct web science wiley online library cnki considered review searched medical subject heading mesh terms <NUMBER>ncov ncip covid<NUMBER> sarscov<NUMBER> hypertension additionally performed manual searches references selected articles avoid omission included metaanalysis study <NUMBER> covid<NUMBER> cases diagnosed according new coronavirus infected pneumonia diagnosis treatment program <NUMBER>th version <NUMBER> included covid<NUMBER> cases laboratory confirmed hospitalised patients basis positive qrtpcr results sarscov<NUMBER> swab samples <NUMBER> <NUMBER> study population least included <NUMBER> cases case reports reviews metaanalysis articles letters comments editorials expert opinions studies without adequate information articles published languages english chinese excluded detail retrieval process shown figure <NUMBER> types covid<NUMBER> severity determined according new coronavirus infected pneumonia diagnosis treatment program <NUMBER>th version <NUMBER> briefly criteria disease severity determination follows <NUMBER> mild cases clinical symptoms mild sign pneumonia imaging <NUMBER> moderate cases showing fever respiratory symptoms radiological findings pneumonia <NUMBER> severe cases adults ①respiratory distress ⩾<NUMBER> breathsmin ② oxygen saturation ⩽<NUMBER> rest ③ arterial partial pressure oxygen pao <NUMBER> fraction inspired oxygen study hypertension defined systolic blood pressure greater <NUMBER> mmhg diastolic blood pressure greater <NUMBER> mmhg use antihypertensive medications selfreported history hypertension <NUMBER> titles abstracts full texts screened independently two reviewers first step jingqi zhang jing wu discrepancies data interpretation resolved discussion third author chen dong necessary data extracted selected studies included first authors name publication date average age type study design severity covid<NUMBER> hypertensive nonhypertensive patients reviewers performed quality control check final data used metaanalysis original publications prevent extraction errors quality included article assessed using newcastleottawa scale nos based following dimensions <NUMBER> covid<NUMBER> cases selection comparability outcomes disease severity fatality cases selection contained four items <NUMBER> representativeness cases <NUMBER> appropriate determination severe cases <NUMBER> appropriate determination nonsevere cases <NUMBER> appropriate determination hypertension comparability contained one item consider comparability patients without hypertension designing statistical analysis lowest quality literature <NUMBER> highest quality <NUMBER> stars assessment scores <NUMBER> points <NUMBER> points <NUMBER> points considered poor fair good studies respectively simultaneously quality included study evaluated using strengthening reporting observational studies epidemiology strobe <NUMBER> version checklist study study mildmoderate severecritical covid<NUMBER> cases classified nonsevere severe groups respectively forest plots used illustrate severity fatality sarscov<NUMBER> infection hypertensive nonhypertensive patients described pooled odds ratio pooled <NUMBER> confidence intervals ci magnitude heterogeneity betweenstudy tested using <NUMBER> statistics <NUMBER> values <NUMBER> <NUMBER> <NUMBER> represented low moderate high degrees heterogeneity respectively evidence betweenstudies heterogeneity <NUMBER> ⩽ <NUMBER> fixedeffects model used calculate combined otherwise randomeffects model selected <NUMBER> sensitivity analysis performed excluding studies successively furthermore subgroup analysis performed according age <NUMBER> ⩾<NUMBER> years study possibility publication bias evaluated using visual inspection funnel plot eggers test p value eggers test <NUMBER> considered indication potential publication bias analysis performed using package meta r software version <NUMBER> significance defined p <NUMBER> use twosided test unless otherwise specified total <NUMBER> articles obtained electronic manual search duplicated articles excluded first stage n <NUMBER> <NUMBER> studies removed screening titles abstracts addition <NUMBER> studies excluded thoroughly reviewing full texts due following reasons studies without available data n <NUMBER> patients classified severe severecritical nonsevere mildmoderate groups n <NUMBER> case reports study design n <NUMBER> finally <NUMBER> studies recorded <NUMBER> patients included analysis figure <NUMBER> summarised flow diagram studies selection results shown table s<NUMBER> included patients china including hubei <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> jiangxi <NUMBER> beijing <NUMBER> henan <NUMBER> chongqing <NUMBER> <NUMBER> anhui <NUMBER> china cdc <NUMBER> <NUMBER> among <NUMBER> studies analysed severity covid<NUMBER> hypertensive patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> significant associations hypertension covid<NUMBER> severity reported five studies <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> additionally among studies analysed fatality sarscov<NUMBER> infection hypertensive patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> three studies reported hypertensive patients carried higher risk covid<NUMBER> fatality <NUMBER> <NUMBER> <NUMBER> included studies retrospective studies results shown table s<NUMBER> methodological qualities included studies similar nine studies moderate risk participant comparability confounding variables <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> six seven five studies <NUMBER> <NUMBER> <NUMBER> points assessment score analysis respectively addition significant difference observed results obtained nos strobe analysis table s<NUMBER> twelve studies <NUMBER> covid<NUMBER> patients <NUMBER> severe cases included disease severity analysis shown table <NUMBER> figure <NUMBER>a severity rate sarscov<NUMBER> infection hypertensive patients much higher nonhypertensive cases <NUMBER> vs <NUMBER> pooled <NUMBER> <NUMBER> ci <NUMBER> considerable heterogeneity observed study <NUMBER> <NUMBER> pheterogeneity <NUMBER> individual study excluded analysis oneatatime pooled ors ranged <NUMBER> <NUMBER> ci <NUMBER> study wang dw et al <NUMBER> excluded <NUMBER> <NUMBER> ci <NUMBER> study cheng kb et al <NUMBER> excluded fig <NUMBER>b neither evidence publication bias eggers test p <NUMBER> asymmetry indicated funnel plot fig s<NUMBER>a severity illness significantly correlated age covid<NUMBER> cases performed subgroup analysis evaluate effects hypertension covid<NUMBER> severity different age groups results shown pooled ors covid<NUMBER> severity hypertensive patients vs nonhypertensive cases <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> age <NUMBER> years ⩾<NUMBER> years patients respectively fig <NUMBER> considerable heterogeneity detected studies within group six studies <NUMBER> deaths among <NUMBER> covid<NUMBER> patients included metaanalysis shown table <NUMBER> figure <NUMBER>a fatality rate sarscov<NUMBER> infection hypertensive patients <NUMBER> much higher nonhypertensive cases <NUMBER> pooled analysis showed hypertensive patients carried nearly <NUMBER>fold higher risk dying covid<NUMBER> <NUMBER> ci <NUMBER> moderate heterogeneity betweenstudy <NUMBER> <NUMBER> pheterogeneity <NUMBER> sensitivity analysis showed exclusion single study oneatatime alter direction statistical difference fig <NUMBER>b similarly eggers test suggest existence potential publication bias p <NUMBER> fig s<NUMBER>b similarly stratified analysis results suggested pooled ors covid<NUMBER> mortality hypertensive patients vs nonhypertensive cases <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> age <NUMBER> years ⩾<NUMBER> years patients respectively fig <NUMBER> significant heterogeneity presented studies within subgroup study reported overall rates severity fatality <NUMBER> <NUMBER> covid<NUMBER> patients included literatures respectively moreover hypertensive patients sarscov<NUMBER> infection shown <NUMBER>and <NUMBER>fold higher risks severity fatality compared covid<NUMBER> cases without hypertension respectively sensitivity analysis exclusion studies one one change results materially suggesting included study might particularly strong influence results indeed chronic conditions influencing severity sarscov<NUMBER> hypertension diabetes obesity also addressed respiratory illnesses mers influenza etc example alqahtani et al reported hypertension diabetes mellitus prevalent <NUMBER> cases mers moreover hypertension showed significant association fatality merscov infection <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> addition compared subjects without hypertension severe pandemic influenza occurred significantly often hypertension <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> currently exact mechanism hypertension involvement severe covid<NUMBER> remains unclear one potential explanation direct injury mediated via angiotensinconverting enzyme <NUMBER> ace<NUMBER> similar sarscov chinese study recently indicated sarscov<NUMBER> infection caused binding viral surface spike protein ace<NUMBER> receptor following activation spike protein <NUMBER> ace<NUMBER> monocarboxy peptidase best known cleaving several peptides within renin− angiotensin system <NUMBER> since discovery <NUMBER> ace<NUMBER> considered protective factor increases blood pressure therefore rational hypothesise binding sarscov<NUMBER> ace<NUMBER> reduce physiological function ace<NUMBER> lead acute adverse outcomes hypertension multiorgan dysfunction <NUMBER> besides severale studies indicated ace<NUMBER> played critical role acute lung disease especially acute respiratory distress syndrome <NUMBER> <NUMBER> <NUMBER> addition heart lung ace<NUMBER> could expressed intestinal epithelium vascular endothelium brain liver kidneys <NUMBER> providing potential mechanism severity symptoms multiorgan dysfunction seen severe sarscov<NUMBER> infection epidemiological data sarscov<NUMBER> infection suggested severe covid<NUMBER> cases likely older patients underlying comorbidities diabetes mellitus hypertension <NUMBER> <NUMBER> <NUMBER> indicating age important risk factor severity fatality covid<NUMBER> example china cdc recently reported patients aged ⩾<NUMBER> years highest case fatality rate <NUMBER> among different age groups <NUMBER> herein observed hypertension significantly associated severity fatality sarscov<NUMBER> infection age <NUMBER> years ⩾<NUMBER> years groups suggesting hypertension could independently increase risk disease severity predict poor outcomes sarscov<NUMBER> infection although present results implied patients aged <NUMBER> years fatalities covid<NUMBER> compared patients ⩾<NUMBER> years could conclude younger patients likely die hypertension older patients paucity related data indeed subgroup analysis show significant difference covid<NUMBER> fatality patients without hypertension group consisted studies small sample size references <NUMBER> <NUMBER> <NUMBER> pooled <NUMBER> <NUMBER> ci <NUMBER> fig s<NUMBER> however results carefully interpreted wide confidence interval therefore studies needed characterize impacts hypertension covid<NUMBER> severity fatality future study several limitations firstly publication bias inevitable metaanalysis relevant articles might missed included englishand chinesewritten studies secondly could address potential impact antihypertension medicines although hypertensive cases might treated thus would underestimate true difference severity fatality sarscov<NUMBER> infection patients without hypertension thirdly estimate found study derived hospitalised cases might introduce bias disease severity fatality addition overlap cases could completely avoided patients references <NUMBER> <NUMBER> collected china cdc provide exact hospital information reason pooled estimate would never represent actual pooled outcome data however remove references <NUMBER> <NUMBER> analysis largest sample size alter direction statistical difference present results fourthly sample size included metaanalysis relatively small thus would introduce bias results last due included studies retrospective studies may bias regarding collecting medical information retrospective manner therefore caution considered interpret findings summary current results provided evidence hypertension could significantly increase risks severity fatality sarscov<NUMBER> infection therefore necessary establish awareness programmes implement effective preventive policies improve outcomes sarscov<NUMBER> infection persons hypertension helpful reduction global burden disease conflicts interest authors declare competing interests jingqi zhang et al pulmonary hypertension chronic disease developing progressively high mortality pulmonary hypertension patients need persistent medical care however limited reports focused outbreak coronavirus disease <NUMBER> china national survey aimed evaluate overall condition pulmonary hypertension patients period questionnaire regarding living condition pulmonary hypertension patients coronavirus disease <NUMBER> designed pulmonary hypertension diagnostic experts wuhan asia heart hospital pulmonary hypertension patients family members invited participate survey online onehundred twenty pulmonary hypertension patients <NUMBER> family members participated survey <NUMBER> n <NUMBER> participants came hubei others <NUMBER> provinces <NUMBER> n <NUMBER> participants home quarantine <NUMBER> n <NUMBER> pulmonary arterial hypertension associated congenital heart disease <NUMBER> n <NUMBER> patients proclaimed heart function well maintained class ii one <NUMBER> patient confirmed severe acute respiratory syndrome coronavirus <NUMBER> infection two <NUMBER> patients hospitalized due heart function worsening nearly <NUMBER> n <NUMBER> participants implied shortage medications coronavirus disease <NUMBER> outbreak total <NUMBER> n <NUMBER> patients indicated medications discontinued due insufficient supply participants stayed optimistic either coronavirus disease <NUMBER> outbreak pulmonary hypertension disease <NUMBER> n <NUMBER> patients would go hospital followup immediately outbreak preliminary data show pulmonary hypertension patients able avoid severe disease home quarantine medication supplement important pulmonary hypertension patients heart function well maintained addition might increasing requirements medical care pulmonary hypertension patients outbreak understanding current status patients pulmonary hypertension covid<NUMBER> outbreak smallscale national survey china pulmonary hypertension ph chronic progressive lung disease caused multiple differing etiologies increasing pulmonary vascular resistance led overloading right ventricle eventually death <NUMBER> ph characterized mean pulmonary artery pressure mpap <NUMBER> mmhg rest addition treatment relieving symptoms targeted therapy aiming improve heart function extended threeyear survival pulmonary arterial hypertension pah <NUMBER> <NUMBER> <NUMBER> <NUMBER> coronavirus disease <NUMBER> covid<NUMBER> caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> first reported wuhan china last december <NUMBER> studies observed severe damage lung raised hypothesis ph patients might vulnerable others <NUMBER> subsequently whole country placed lockdown prevent spread disease potentially could compromise ph patient care factors made ph patients potentially vulnerable group hereby designed questionnaire ph patients understand disease condition mental condition medication supplement requirements medical care covid<NUMBER> outbreak survey would provide general information future medical care support ph patients conditions study conducted experts congenital heart disease center wuhan asia heart hospital wuhan collaboration ph centers unofficial patients groups patients diagnosed ph families considered survey ph defined mpap <NUMBER> mmhg rest diagnosis made according right heart catheter examination smallscale national online survey performed ph patients one family members invited participate survey via quick response qr code answers listed nonmedical descriptions reviewed unprofessional individuals better understanding personal information included study protocol questionnaire reviewed approved ethics committee wuhan asia heart hospital <NUMBER>s<NUMBER> participants given informed consent survey questionnaire designed experts ph wuhan asia heart hospital wuhan china understand status ph patients covid<NUMBER> outbreak china questions designed cover following issues <NUMBER> basic clinical information patients including age gender medical history ph current heart function <NUMBER> physical mental conditions associated covid<NUMBER> <NUMBER> details medications using requirements medical care questions designed single choice multiple choices yes offered questions answers choices required fill questionnaire still open recruitment questionnaire supplement present preliminary data first respondents baseline characteristics presented number categorical data mean ae standard deviation median interquartile range appropriate continuous data percentage applied illustrating constitution comparison made variables using students ttest wilcoxon signedrank test continuous variables regarding distributions v <NUMBER> test categorical variables pvalue <NUMBER> considered statistically significant statistical analyses performed spss <NUMBER> ibm corp armonk ny <NUMBER> individuals invited participate survey total <NUMBER> ph patients <NUMBER> family members <NUMBER> provinces responded <NUMBER> march <NUMBER> <NUMBER> march <NUMBER> questionnaires included final analysis total <NUMBER> n ¼ <NUMBER> participants hubei among <NUMBER> n ¼ <NUMBER> wuhan <NUMBER> n ¼ <NUMBER> henan <NUMBER> n ¼ <NUMBER> anhui <NUMBER> n ¼ <NUMBER> came <NUMBER> provinces shown fig <NUMBER> patients family members completed survey <NUMBER> families however failed identify due design table <NUMBER> shows general information participants overall participants aged <NUMBER> ae <NUMBER> years total <NUMBER> patients suffered ph seven years three family participants know ph history relatives possibly due different etiology <NUMBER> chdpah contributed ph groups <NUMBER> <NUMBER> patients <NUMBER> <NUMBER> family participants p <NUMBER> total <NUMBER> n ¼ <NUMBER> participants home quarantine covid<NUMBER> outbreak table <NUMBER> shows majority participants <NUMBER> <NUMBER> felt much change disease progress surprisingly patients less severe symptoms <NUMBER> n ¼ <NUMBER> participants proclaimed new york heart association heart functional class <NUMBER> <NUMBER> class ii total <NUMBER> n ¼ <NUMBER> patients <NUMBER> n ¼ <NUMBER> family participants reported disease progression fatigue less active reported patients <NUMBER> vs <NUMBER> p ¼ <NUMBER> however cough common patients family participants <NUMBER> vs <NUMBER> p ¼ <NUMBER> shown fig <NUMBER> symptoms others included sleeping well chest pain aching pain limbs catching cold recovered three <NUMBER> patients hospitalized covid<NUMBER> outbreak two heart failure one due pneumonia none family participants reported death patients actually three patients passed away <NUMBER> march <NUMBER> one patients died due unexpected fall unable go hospital outbreak two died worsening pah deaths reported family privately included survey fever important symptom indicating covid<NUMBER> survey <NUMBER> n ¼ <NUMBER> patients fever highest temperature <NUMBER> c one patient confirmed sarscov<NUMBER> infection two patients reported covid<NUMBER> related symptoms cough families family participants denied covid<NUMBER> related symptoms either patients bosentan ambrisentan tadalafil sildenafil commonly used medications target therapy shown fig <NUMBER> specifically ambrisentan preferred <NUMBER> n ¼ <NUMBER> patients <NUMBER> n ¼ <NUMBER> family participants total <NUMBER> n ¼ <NUMBER> patients <NUMBER> n ¼ <NUMBER> family participants chose chinese generic ambrisentan lower price chinese generic medication <NUMBER> patients enrolling clinical trial using macitentan free patients sensitive shortage medications family participants <NUMBER> <NUMBER> vs <NUMBER> <NUMBER> p ¼ <NUMBER> <NUMBER> participants <NUMBER> patients <NUMBER> family participants thought enough medications time survey least <NUMBER> days national lockdown shown fig <NUMBER>a total <NUMBER> n ¼ <NUMBER> patients able buy medications great effort however <NUMBER> n ¼ <NUMBER> discontinued one medications <NUMBER> <NUMBER> patients changing medications without consulting doctors shown fig <NUMBER>a two previously took macitentan total <NUMBER> participants <NUMBER> thought medications shortage covid<NUMBER> outbreak shown fig <NUMBER>b psychological conditions <NUMBER> patients n ¼ <NUMBER> family participants n ¼ <NUMBER> panic <NUMBER> <NUMBER> thought protection important shown fig <NUMBER>a though <NUMBER> n ¼ <NUMBER> patients <NUMBER> n ¼ <NUMBER> family participants felt bad due disease <NUMBER> <NUMBER> patients <NUMBER> family participants participants still kept optimistic time shown fig <NUMBER>b ph patients families requested medical care despite lack clear clinical worsening according survey total <NUMBER> n ¼ <NUMBER> patients <NUMBER> n ¼ <NUMBER> family participants would like contact doctors covid<NUMBER> outbreak <NUMBER> n ¼ <NUMBER> patients would go hospital followup immediately public transportation available eight preferred hospitalization <NUMBER> n ¼ <NUMBER> family participants would ask relatives ph go hospital soon possible similar patients additionally <NUMBER> n ¼ <NUMBER> family participants would also encourage patients positive outbreak covid<NUMBER> changed peoples life last winter specifically patients chronic diseases might suffer high risk covid<NUMBER> uncontrolled existing diseases time ph patients require sustained medical care similar chronic diseases interruption medications may result clinical worsening death however living condition covid<NUMBER> unknown smallscale national survey brought insight group results questionnaire indicated incidence covid<NUMBER> higher ph patients according survey regardless incidental cough fever patients one patient confirmed sarscov<NUMBER> infection medication insufficiency common problem patients nearly <NUMBER> participants implied medications shortage covid<NUMBER> outbreak total <NUMBER> patients discontinued medications <NUMBER> patients changed medications without consulting doctor total <NUMBER> participants stayed home outbreak depressed either ph covid<NUMBER> according survey however requirements medical care might significantly increase due high desire followup even hospitalization patients families covid<NUMBER> outbreak early studies covid<NUMBER> patients often stayed wuhan history exposure confirmed cases family cluster also observed several cases <NUMBER> <NUMBER> n ¼ <NUMBER> participants wuhan study might result hospital location one patients groups hubei none reported covid<NUMBER> neither patients family participants persontoperson transmission confirmed covid<NUMBER> <NUMBER> lockdown wuhan began <NUMBER> january <NUMBER> prevent spread infectious disease total <NUMBER> patients families home quarantine covid<NUMBER> outbreak might key factor prevented patients infected previous studies showed <NUMBER> patients covid<NUMBER> existing diseases diabetes hypertension cardiovascular diseases males vulnerable mean age patients <NUMBER> years different study cohort <NUMBER> <NUMBER> <NUMBER> participants <NUMBER> years old mean age much younger previous covid<NUMBER> patients study cohort consisted <NUMBER> females quite different proportion covid<NUMBER> addition patients chdpah maintained fairly well heart function therefore younger age females different etiology better cardiac function ph patients might result lower incidence covid<NUMBER> similar chronic diseases ph patients take lifetime medications higher medication adherence <NUMBER> bosentan first used pah <NUMBER> <NUMBER> significantly improved sixminute walk distance heart function since targeted treatment extended half patients life three even five years <NUMBER> combination therapy recommended recent years reduced adverse events slowed ph progression <NUMBER> <NUMBER> <NUMBER> <NUMBER> study patients took ambrisentan bosentan partly due lower price chinese generic medication total <NUMBER> patients taking macitentan free treprostinil used patients high price inconvenience chdpah pulmonary arterial hypertension associated congenital heart disease cteph chronic thrombotic embolism pulmonary hypertension ctdpah pulmonary arterial hypertension associated connective tissue disease ipah idiopathic pulmonary arterial hypertension na applicable nyha new york heart association ph pulmonary hypertension intravenous application <NUMBER> luckily <NUMBER> patients able continue medications great effort national lockdown different cardiovascular diseases ph target medications expensive unavailable small cities might result shortage medications ph patients lockdown cities additionally prevented patients getting supplement nearly <NUMBER> patients either discontinued medications changed without consultation tried help patients buy medications however shutdown public transportations made process difficult could hardly predict prognosis changed treatment less <NUMBER> days interruption treatment around three days might tolerated <NUMBER> clinical worsening might happen due discontinuation medications <NUMBER> patients preferred clinic visiting consult doctors modification patients showed higher desire contact doctors even though provided online consultation survey mental condition ph patients aroused attentions recent years concerns invasive examination disease progression social interactions may directly impact tolerance treatment <NUMBER> outbreak covid<NUMBER> brought unexpected crisis first wuhan spread cities surprisingly ph patients families mostly panicking outbreak overall positive optimistic even though shortages medications reasons response might follows first ph patients stayed home familiar comfort second many clinical worsening patients disease condition mostly constant outbreak maintained optimism third doctors active patients groups including available consultation online offering assistance medication supplement might helpful reduce anxiety results provided preliminary view living condition ph patients covid<NUMBER> china however several limitations study need addressed first <NUMBER> ph patients participating survey smallscale survey might give us general information also might bring bias aspects results might highlight chdpah due chdpah contributed study population study try include patients get details questionnaire designed generate information patients family members however failed match patients family members beginning studies could avoid mistakes focus patients second survey started <NUMBER> days wuhan lockdown lasted <NUMBER> days ph patients might still stable short time studies conducted later longer might observe clinical worsening anxiety patients families although death reported survey three patients passed away based knowledge neither patients families would participate survey critical condition therefore results might optimistic real world followup real mortality initialed third many uncertainties online survey involved question estimate whether participants seriously taking survey result showed <NUMBER> patients <NUMBER> family participants went survey carefully indicated might misunderstanding incorrect answers smallscale national survey first investigated living condition ph patients covid<NUMBER> disease spreading world doctors aware ph patients could invulnerable covid<NUMBER> good protection sustaining medical care including medication supplement important ph patients time covid<NUMBER> might impact ph patients psychologically physically higher hospitalization even death might seen outbreak since december <NUMBER> unexperienced pneumonia emerged wuhan china soon spread globally guo et al <NUMBER> wu et al <NUMBER> pneumonia verified caused novel coronavirus named coronavirus disease <NUMBER> world health organization based phylogeny taxonomy established practice novel coronavirus designated severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> coronavirus study group csg gorbalenya et al <NUMBER> similar former two pathogenic coronaviruses severe acute respiratory syndrome coronavirus sarscov middle east respiratory syndrome coronavirus merscov beginning <NUMBER>st century cui et al <NUMBER> sarscov<NUMBER> likely originated bat zhou peng et al <NUMBER> ability spread person person chan et al <NUMBER> cause pneumonia severe respiratory syndrome chen n et al <NUMBER> typic evaluation version novapdf used create pdf file purchase license generate pdf files without notice regardless covid<NUMBER> patients mild patients severe type may quickly progress acute respiratory distress syndrome ards multiple organ failure mof even death wang et al <NUMBER> therefore exploring potential risk factors severity covid<NUMBER> crucial delay halt progression disease previous studies revealed patients old age underlying diseases likely aggravated wang et al <NUMBER> wang z et al <NUMBER> aberrant immuneinflammatory response cytokine storm may played important role disease progression zhou yonggang et al <NUMBER> therefore retrospective study performed compare clinical features immuneinflammatory parameters cytokines severe nonsevere groups tried establish predict model assessing severe cases hwa pjnbeyky<NUMBER> written informed consent obtained enrolled patients throatswab nasopharynxswab sputum specimens suspected sarscov<NUMBER> infection patients collected sarscov<NUMBER> rna detected table <NUMBER> showed baseline laboratory parameters included patients neutrophil neutrophiltolymphocyte ratio nlr fibrinogen sialic acid sa creaction protein crp il<NUMBER> interleukin<NUMBER> il<NUMBER> interferonγ ifnγ severe group significantly higher nonsevere group p<NUMBER> lymphocyte lymphocyte count platelet count significantly lower severe group compared nonsevere group p<NUMBER> significant differences ctni ntprobnp severe nonsevere groups arterial blood gas parameters higher levels po <NUMBER> pco <NUMBER> found nonsevere group p<NUMBER> ph lactate showed differences two groups result multivariate logistic regression analysis demonstrated high level peripheral blood cytokine il<NUMBER> crp hypertension independent risk factors assessing severity covid<NUMBER> odd ratios figure <NUMBER> baseline il<NUMBER> positively correlated neutrophil r<NUMBER> dynamic changes il<NUMBER> analyzed <NUMBER> nonsevere cases <NUMBER> severe cases level il<NUMBER> severe group significantly higher nonsevere group baseline <NUMBER> days disease onset dropped gradually daybyday reached level equal nonsevere group ≥ <NUMBER> days evaluation version novapdf used create pdf file purchase license generate pdf files without notice study performed hwa mei hospital university chinese academy sciences ningbo largest local designated hospital treating covid<NUMBER> different wuhan patients treated immediately relative symptoms appeared time interval illness onset hospitalization <NUMBER>±<NUMBER> days <NUMBER> nonsevere cases therefore may sever representative general situation except severely affected area found higher age bmi index proportion hypertension highest temperature<NUMBER> chest distress dyspnea severe group nausea often nonsevere group also observed significant increases neutrophil nlr fibrinogen sa crp il<NUMBER> il<NUMBER> ifnγ po <NUMBER> pco <NUMBER> decreases lymphocyte lymphocyte count platelet count severe group previous studies indicated severe aberrant host immune response responsible severity covid<NUMBER> zhou yonggang et al <NUMBER> meanwhile companied sharp change peripheral blood immuneinflammation parameters therefore emerging studies focus accessible laboratory data assessing severity disease increased neutrophil counts indicate intensity inflammatory response decreased evaluation version novapdf used create pdf file purchase license generate pdf files without notice j u r n l p r e p r f <NUMBER> lymphocyte counts suggest damage immune system therefore higher nlr maybe potential maker risk factor liu jing et al <NUMBER> cytokines small protein molecules aimed celltocell communications play immunomodulating function chousterman et al <NUMBER> however infection diseases excessive inflammation activate cytokine storm lead evaluation version novapdf used create pdf file purchase license generate pdf files without notice <NUMBER> serious pathological changes even responsible multiorgan dysfunction liu et al <NUMBER> cytokine storm implicated severe influenza liu et al <NUMBER> sars mers channappanavar perlman <NUMBER> evidence revealed cytokine storm may cause deleterious consequence sarscov<NUMBER> infection zhou yonggang et al <NUMBER> consist previous studies liu jing et al <NUMBER> cytokine il<NUMBER> il<NUMBER> ifnγ severe group significantly higher nonsevere group especially il<NUMBER> recognized independent risk factor using multivariate logistic regression analysis <NUMBER> <NUMBER> ci <NUMBER> mentioned il<NUMBER> highest auroc among inflammation parameters study analyzed correlations found il<NUMBER> significantly correlated inflammation parameters close relationship observed il<NUMBER> il<NUMBER> r<NUMBER> p<NUMBER> il<NUMBER> antiinflammatory cytokine increased il<NUMBER> maybe reflect selfprotection cytokine storm level il<NUMBER> also directly related degree inflammation chousterman et al <NUMBER> high il<NUMBER> associated immunosuppression sepsis hotchkiss et al <NUMBER> il<NUMBER> plays key role cytokine storm owing pleiotropic property gupta et al <NUMBER> apart robust proinflammatory function induces variety line prior studies study also demonstrated severe cases older likely underlying diseases wang et al <NUMBER> wang z et al <NUMBER> however apart hypertension number patients without diabetes cardiovascular disease hepatic disease chronic lung disease cancer evaluation version novapdf used create pdf file purchase license generate pdf files without notice <NUMBER> showed differences nonsevere severe groups low number patients underlying diseases may cause certain bias relatively large number hypertension sufficient make certain comparison additionally level il<NUMBER> patients hypertension higher without hypertension study demonstrated severe inflammation lesion hypertension patients hypertension patients always associated immune activation resulted immune system impaired norlander et al <NUMBER> therefore speculated abnormal immune function hypertension patients may played role covid<NUMBER> progression intriguingly angiotensinconverting enzyme <NUMBER> ace<NUMBER> played protect role hypertension povlsen et al <NUMBER> sarscov<NUMBER> use ace<NUMBER> enter target cells may reduce ace<NUMBER> expression like sarscov kuba et al <NUMBER> likely carry burden weakness patients aggravate disease eventually study existing hypertension severed independent risk factor severity covid<NUMBER> reminded us take specially care highrisk patients prevent development disease ctni ntprobnp two biomarkers cardiac dysfunction baseline level ctni patients covid<NUMBER> <NUMBER> ngml significant difference found severe nonsevere groups level ntprobnp consistent study peng et al tests performed admission peng et al <NUMBER> however chen et al found elevated ctni ntprobnp hospitalization significantly correlated critical disease status chen chen et al <NUMBER> unfortunately test evaluation version novapdf used create pdf file purchase license generate pdf files without notice j u r n l p r e p r f <NUMBER> two markers dynamically value deserve investigation blood gas analysis measures level oxygen carbon dioxide lactate ph blood helpful show well lungs working previous study indicated higher level lactate lower levels po <NUMBER> pco <NUMBER> found death patients covid<NUMBER> peng et al <NUMBER> present study also showed lower levels po <NUMBER> pco <NUMBER> severe group ph lactate showed differences two groups however patients nonsevere group performed blood gas analyses partial patients received oxygen therapy blood gas analysis thus making difficult explore role present study however study limitations first il<NUMBER> routine laboratory test would limit usage second sample size included study relatively small especially severe group third retrospective singlecenter study effectiveness model validated us others forth laboratory analyses eg blood gas analysis performed partial patients therefore prospective multicenter study larger sample size warranted study demonstrated high level peripheral blood cytokine il<NUMBER> crp existence hypertension independent risk factors assessing severity covid<NUMBER> risk model established upon il<NUMBER> crp hypertension evaluation version novapdf used create pdf file purchase license generate pdf files without notice coronavirus disease <NUMBER> covid<NUMBER> current pandemic disease caused positivesense rna virus named severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> along highly infectious capacity virus mortality rates reported range <NUMBER> <NUMBER> <NUMBER> reported patients covid<NUMBER> hypertension may increased risk adverse outcomes unadjusted epidemiological studies summarizing characteristics covid<NUMBER> epidemic china despite limited sample sizes previous studies reported hypertension hazard ratio hr <NUMBER> <NUMBER> confidence interval ci <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> mortality respectively <NUMBER> <NUMBER> however neither previous studies adjusted confounding factors example age emerging strongest predictor covid<NUMBER>related death <NUMBER> <NUMBER> angiotensinconverting enzyme <NUMBER> ace<NUMBER> required viral entry sarscov<NUMBER> <NUMBER> ace<NUMBER> widely expressed human body expression found gastrointestinal tract heart kidney alveolar cells lungs <NUMBER> <NUMBER> angiotensinconverting enzyme inhibitors aceis angiotensin receptor blockers arbs two types reninangiotensinaldosterone system raas inhibitors widely used treating hypertension heart renal failure reports animal models <NUMBER> humans <NUMBER> suggesting expression ace<NUMBER> may increased treatment acei arb reports incriminated arbs <NUMBER> might augment patients susceptibility viral host cell entry propagation <NUMBER> although effects aceis arbs ace<NUMBER> humans still inconclusive previous findings led growing concern aceis arbs may increase decrease mortality patients covid <NUMBER> <NUMBER> therefore evidence impact medications patients covid<NUMBER> urgently needed investigated <NUMBER> consecutive patients admitted huo shen hospital hospital dedicated solely treatment covid<NUMBER> wuhan china tested hypothesis treatment hypertension especially raas inhibitors might impact mortality patients covid <NUMBER> retrospective observational study comparing association hypertensive status antihypertensive treatment class mortality among hospitalized patients covid <NUMBER> <NUMBER> <NUMBER> brief clinical manifestations covid<NUMBER> defined development fever andor respiratory symptoms computed tomography ct imaging showing characteristics consistent covid<NUMBER> normal decreased white blood cell wbc count normal decreased lymphocyte count early stage disease patients suspicious epidemiological history ie contact novel coronavirusinfected people patients wuhan fever respiratory symptoms plus two clinical manifestations clear epidemiological history three clinical manifestations considered possible covid<NUMBER> case patients considered possible covid<NUMBER> cases without laboratory confirmation sarscov<NUMBER> infection admitted huo shen hospital confirmation sarscov<NUMBER> infection defined suspect cases one following serological findings realtime fluorescent reverse transcriptionpcr rtpcr positive new coronavirus nucleic acid ii viral gene sequence highly homologous known new coronaviruses iii sarscov<NUMBER>specific igm igg detected serum sarscov<NUMBER>specific igg detectable reaches titration least fourfold increase convalescence compared acute phase study approved national health commission china institutional review board huo shen hospital wuhan china written informed consent waived ethics committee designated hospital patients emerging infectious diseases patients demographic characteristics clinical data symptoms comorbidities laboratory findings outcomes hospitalization collected electronic medical records two investigators rz yc data independently reviewed entered computer database two analysts cg yc primary endpoint allcause mortality hospitalization endpoints included time elapsed onset symptoms discharge rates use invasive mechanical ventilation severity covid <NUMBER> severity covid<NUMBER> categorized mild severe critical mild included nonpneumonia mild pneumonia cases severe characterized dyspnoea respiratory frequency <NUMBER>min blood oxygen saturation <NUMBER> pao <NUMBER> fio <NUMBER> ratio <NUMBER> andor lung infiltrates <NUMBER> within <NUMBER> h critical cases defined respiratory failure requiring mechanic ventilation septic shock andor multiple organ dysfunctionfailure <NUMBER> <NUMBER> final date followup <NUMBER> april <NUMBER> median duration followup hospitalization <NUMBER> <NUMBER> days diagnosis hypertension given patients physician prior infection sarscov<NUMBER> data collected patients documented medical files eg diagnosed patients antihypertensive drugs blood pressure <NUMBER> mmhg upon admission still identified history hypertension impact antihypertensive treatments covid formal committee adjudicate status hypertension however diagnoses rechecked two individual investigators rz yc data collection using office systolic blood pressure <NUMBER> mmhg andor diastolic blood pressure values <NUMBER> mmhg <NUMBER> criteria figure <NUMBER> shows flow chart study antihypertensive regimens principle unchanged hospitalization whenever patients previous prescriptions admission discontinuation alteration antihypertensive treatment hospitalization physicians discretion required antihypertensive medication hospitalization prior prescription discontinued medications prior admission treated calcium channel blockers ccbs diuretics cohorts without antihypertensive antihypertensive treatments well cohorts raas inhibitors aceiarbs nonraas inhibitors betablockers ccbs diuretics stratified time admission according preadmission medications <NUMBER> patients death events taking spirolactone categorized nonraas inhibitors group analysis patients included raas inhibitor cohort whenever least one raas inhibitor acei arb prescribed disregarding whether treated betablocker ccb diuretics nevertheless sensitivity analysis performed including patients treated solely one medication supplementary material online table s<NUMBER> continuous variables normal distribution expressed mean ± standard deviation sd skewed distribution expressed median ± interquartile range iqr categorical variables presented counts percentages means two continuous variables compared independent students ttest mannwhitney utest appropriate frequencies categorical variables compared using fishers exact test survival estimated kaplanmeier method figure <NUMBER> variances outcomes exposure cohorts assessed multivariable cox proportional hazards model covariates multivariable model included age continuous variable sex medical history diabetes insulintreated diabetes myocardial infarction treatment percutaneous coronary intervention pci coronary artery bypass grafting cabg renal failure chronic heart failure asthma chronic obstructive coronary disease copd stroke binary variables cox proportionality assumptions checked using schoenfeld residuals transformed time assumptions met models formal correction multiple testing taking account observational nature analysis <NUMBER> details statistical approaches metaanalysis provided supplementary material online methods analyses performed using rproject r foundation vienna austria twosided pvalue <NUMBER> considered statistically significant total <NUMBER> consecutive hospitalized patients confirmed covid<NUMBER> enrolled study median time symptom onset discharge last followup <NUMBER> <NUMBER> days baseline characteristics presented table <NUMBER> results laboratory tests presented supplementary material online tables s<NUMBER>s<NUMBER> among patients <NUMBER> <NUMBER> <NUMBER> medical history hypertension compared patients without hypertension hypertension older often prior history diabetes angina stroke renal failure previous revascularization pci cabg receiving medication diabetes hypertension spectrum symptoms covid<NUMBER> admission two cohorts differ significantly <NUMBER> <NUMBER> patients hypertension taking antihypertensive medications medical history symptoms onset blood pressure admission differ significantly patients antihypertensive medications medications except patients antihypertensive medications treated often oral medication diabetes <NUMBER> <NUMBER> patients treated raas inhibitors <NUMBER> <NUMBER> treated betablockers ccbs diuretics nonraas inhibitors supplementary material online table s<NUMBER> medical history blood pressure admission differ significantly raas inhibitortreated raasi þ nonraas inhibitortreated patients raasi <NUMBER> patients reported shivering admission raasi cohort compared none raasi þ cohort table <NUMBER> total <NUMBER> <NUMBER> patients died hypertension cohort <NUMBER> <NUMBER> died hypertension cohort crude hr <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> figure <NUMBER>a adjustment confounders hypertension still associated twofold increase risk mortality compared hypertension adjusted hr <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> table <NUMBER> time symptom onset discharge comparable two cohorts however patients hypertension propensity develop severecritical covid<NUMBER> disease p trend <NUMBER> likely receive invasive mechanical ventilation p <NUMBER> table <NUMBER> patients hypertension without antihypertensive treatment <NUMBER> significantly higher rate mortality compared antihypertensive <NUMBER> treatments <NUMBER> vs <NUMBER> <NUMBER> hr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p <NUMBER> figure <NUMBER>b table <NUMBER> adjustment risk mortality still higher patients without antihypertensive treatment hr <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> <NUMBER> <NUMBER> patients treated raas inhibitors <NUMBER> <NUMBER> betablockers ccbs diuretics nonraas inhibitors numerical difference rates mortality raas inhibitor nonraas inhibitor cohorts nonsignificant adjustment <NUMBER> vs <NUMBER> <NUMBER> adjusted hr <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> time symptom onset discharge severity covid<NUMBER> percentage ventilation similar two cohorts understand whether aceis arbs distinct effects outcomes also compared influence aceis arbs nonraas inhibitors compared nonraas inhibitors risks mortality patients arbs aceis numerically lower since sample size small groups results could largely due play chance however results show obvious propensity arbs aceis adverse hr <NUMBER> far mortality concerned supplementary material online table s<NUMBER> explore potential risk factors mortality performed multivariable cox regression analysis backwardsstepwise selection identify predictors mortality total seven variables identified namely fatigue age hypertension myocardial infarction renal failure respiratory rate chronic heart failure results shown supplementary material online tables s<NUMBER> s<NUMBER> figure s<NUMBER> recently three groups china reported data regarding influence raas inhibitors covid<NUMBER> patients summarized available data metaanalysis <NUMBER> <NUMBER> <NUMBER> together current data found compared nonraas inhibitors raas inhibitors associated lower risk mortality relative risk <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> regardless model used main findings analysis summarized follows adjustment confounders compared nonhypertensive patients hypertensive patients continued demonstrate twofold relative increase risk covid<NUMBER> mortality ii patients history hypertension without antihypertensive treatment associated significantly higher risk mortality compared antihypertensive treatments iii relative rates mortality severity covid<NUMBER> percentages ventilation statistically different patients treated raas inhibitors nonraas inhibitors however metaanalysis raas inhibitors tend associated lower risk mortality patients covid<NUMBER> hypertension reported increased risk adverse outcomes chen et al suggested chronic hypertension frequent among patients died compared recovered patients <NUMBER> line finding wu et al found hypertension hr <NUMBER> death <NUMBER> patients covid<NUMBER> <NUMBER> zhou et al found hypertension hr <NUMBER> inhospital mortality <NUMBER> patients covid <NUMBER> <NUMBER> meanwhile also study enrolled <NUMBER> patients suggested adjustment confounders hypertension longer independent risk factor covid <NUMBER> <NUMBER> current study found adjustment confounders patients hypertension still significantly twofold higher risk mortality compared patients hypertension far limited clinical evidence demonstrating antihypertensive treatments could influence prognosis covid <NUMBER> despite lack evidence council hypertension european society cardiology esc recommends physicians patients continue treatment usual antihypertensive therapy <NUMBER> analysis showed patients antihypertensive treatments preadmission lower rate mortality compared without treatment hypertension data support escs recommendation stating patients discontinue change antihypertensive treatment unless instructed physician recently ace<NUMBER> identified necessary viral entry sarscov<NUMBER> ace generates angiotensin ii angiotensin ace<NUMBER> degrades angiotensin ii angiotensin <NUMBER> binding mas receptor shifts balance vasoconstriction angiotensin ii vasodilation normal circumstances circulating levels soluble ace<NUMBER> low functional role ace<NUMBER> lungs appears relatively limited <NUMBER> may upregulated certain medications clinical states led twofold concern whereby aceis arbs might affect severity mortality covid <NUMBER> <NUMBER> one aceis could directly inhibit ace<NUMBER> however despite substantial structural homology ace ace<NUMBER> enzyme active sites distinct result aceis clinical use directly affect ace<NUMBER> functions <NUMBER> addition concern use aceis arbs increase expression ace<NUMBER> <NUMBER> therefore increase patient susceptibility viral host cell entry propagation conflicting limited evidence stemming laboratory clinical studies shown changes serum pulmonary ace<NUMBER> levels response aceis arbs <NUMBER> however even acei arb could actually modify ace<NUMBER> levels activity target tissue beds evidence still lacking indicate whether would facilitate greater involvement spike protein cell entry sarscov<NUMBER> given uncertainty due lack clinical data advocates objectors toward use raas inhibitors covid<NUMBER> pandemic study found risks mortality adjustment significantly different raas inhibitors nonraas inhibitors furthermore pooling previously published data <NUMBER> <NUMBER> <NUMBER> studylevel metaanalysis found patients raas inhibitor use possibly associated lower risk mortality take home figure underlying mechanism patients could eventually benefit raas inhibitors covid<NUMBER> putative however results laboratory studies reported initial engagement sarscov<NUMBER> spike protein ace<NUMBER> abundance downregulated cell surfaces <NUMBER> downregulation ace<NUMBER> dysregulation activity lungs may facilitate initial neutrophil infiltration response bacterial endotoxin may result unopposed angiotensin ii accumulation local raas activation <NUMBER> animal study also shown mouse models exposure sarscov<NUMBER> spike protein induced acute lung injury limited raas blockade <NUMBER> therefore researchers hypothesized high ace<NUMBER> expression could deleterious contamination phase whereas high ace<NUMBER> expression could contrast beneficial inflammation phase <NUMBER> may possibly prevent organ injury covid <NUMBER> <NUMBER> verify results well hypothesis also designed randomized controlled trial ongoing investigating issue nct<NUMBER> described data showed untreated hypertensive patients highest risk remaining questions kind medication given patients ccbs raas inhibitors ii could medications mitigate risk patients iii use raas inhibitors affect risk infection equally exposed virus limitations multivariableadjusted cox proportional hazard models performed attempt estimate true treatment effects antihypertensive medications however usual deficiency observational studies exists inability include relevant confounders especially unmeasured causing bias cannot adjusted ii although current study enrolled <NUMBER> patients knowledge far one largest cohorts reported <NUMBER> patients raas inhibitors <NUMBER> patients nonraas inhibitors compared statistically underpowered findings interpreted cautiously iii retrospective study data electrocardiogram echocardiography recorded detail study owing limitations imposed isolation ward urgency containing covid<NUMBER> epidemic iv data study permit shortterm assessment clinical outcomes impact antihypertensive treatments longterm prospective studies investigating effects treatments still needed hypertension independently associated mortality covid<NUMBER> discontinuation antihypertensive treatment suspected associated increased risk mortality patients raas inhibitors exposed higher risk mortality study pooling previously published data studylevel metaanalysis use raas inhibitors shown possibly associated lower risk mortality nevertheless due observational nature study results interpreted cautiously considered obvious additional risk continue raas inhibitors patients covid<NUMBER> infection recent outbreak novel covid<NUMBER> disease rapid worldwide spread poses global health emergency novel virus thought belong family middle east respiratory syndrome mers coronavirus severe acute respiratory syndrome sars coronavirus unique right <NUMBER> researchers around globe investigating several risk factors may contribute severity covid<NUMBER> world health organization indicated elderly individuals well underlying medical conditions higher risk developing severe covid<NUMBER> disease <NUMBER> today june <NUMBER> th <NUMBER> <NUMBER> million people infected virus <NUMBER> lost lives deaths believed associated existence comorbidities generally patients compromised immune systems considered particularly vulnerable <NUMBER> several research works targeted epidemiological clinical characteristics patients infected covid<NUMBER> however risk factors severity mortality sufficiently investigated <NUMBER> identifying major risk factors taking corresponding clinical measures could contribute massively saving lives previous studies identified comorbidities hypertension diabetes mellitus stroke cancer kidney issues high cholesterol among highrisk factors thus paper represents systematic review literature shed light effects preexisting conditions covid<NUMBER> disease severity additionally method currently exists determine level risk comorbidities pose paper serves purpose achieving reasonable option draw lessons earlier experiences practices search conducted freely available covid<NUMBER> open research dataset cord<NUMBER> <NUMBER> cord<NUMBER> resource consisting <NUMBER> scholarly articles including <NUMBER> articles full text related covid<NUMBER> sarscov<NUMBER> coronaviruses dataset frequently updated new research appears peerreviewed publications archive services became available screen every article dataset developed search engine addition bm<NUMBER> search index <NUMBER> bm<NUMBER> retrieval function ranks set documents based query terms appearing document regardless proximity within document papers indexed simply applying preprocessing function clean tokenize abstracts documents indexed created document vectors loading optimized cached json tokens followed applying document similarity index using annoy <NUMBER> details implantation please visit httpsgithubcomdgunningcord<NUMBER> filtering articles undertaken using keywords questions eg effects hypertension covidnormal coronavirussarscov<NUMBER>ncovcovid<NUMBER> disease severity mortality icu search terms repeated comorbidities considered paper illustrated fig <NUMBER> systematic approach used screen full covid<NUMBER> open research dataset <NUMBER> systematic method <NUMBER> articles found scored highly confidence rating additional search run employing google scholar pubmed ensure every relevant article included <NUMBER> papers read thoroughly causing <NUMBER> articles excluded list additional <NUMBER> articles manually added list ultimate list <NUMBER> articles split six categories <NUMBER> articles focusing cancer <NUMBER> diabetes mellitus <NUMBER> kidney issues <NUMBER> stroke <NUMBER> hypertension <NUMBER> high cholesterol diabetes one serious comorbidities linked severity three wellknown human pathogenic coronavirus infections including sarscov <NUMBER> patients diabetes increased risk severe complications including adult respiratory distress syndrome ards multiorgan failure depending global region <NUMBER> covid<NUMBER> pandemic patients diabetes emphasizes importance link covid<NUMBER> diabetes <NUMBER> according gupta et al <NUMBER> individuals diabetes risk infections especially influenza pneumonia patients diabetes severely affected contract respiratory viruses therefore diabetes seen important risk factor mortality patients infected pandemic influenza <NUMBER> h<NUMBER>n<NUMBER> sars coronavirus middle east respiratory syndromerelated coronavirus merscov <NUMBER> <NUMBER> <NUMBER> several studies show among covid<NUMBER> patients also noticeable percentage patients suffering diabetes mellitus dm yang et al <NUMBER> found among <NUMBER> nonsurvivors group <NUMBER> covid<NUMBER> patients <NUMBER> diabetes patients additionally <NUMBER> patients confirmed covid<NUMBER> autonomous regions china <NUMBER> severe disease comorbidities <NUMBER> dm <NUMBER> zhang et al <NUMBER> analyzed data <NUMBER> patients admitted hospitals wuhan china confirmed covid<NUMBER> cases <NUMBER> patients diabetes moreover zhang et al <NUMBER> reviewed <NUMBER> confirmed covid<NUMBER> patients hospitalized wuhan china authors indicated patients diabetes significantly higher leukocyte neutrophil counts well higher levels fasting blood glucose serum creatinine urea nitrogen creatine kinase isoenzyme mb admission compared without diabetes cox proportional hazard model showed diabetes adjusted hazard ratio ahr<NUMBER> <NUMBER> ci <NUMBER> fasting blood glucose ahr<NUMBER> <NUMBER> ci <NUMBER> associated fatality covid<NUMBER> adjusting potential confounders authors concluded dm associated greater disease severity therefore recommended primary secondary prevention strategies needed covid<NUMBER> patients diabetes bloomgarden et al <NUMBER> stated mortality rates pneumonia among patients diabetes hong kong age ≥ <NUMBER> exceed mortality rates age group cardiovascular disease cancer <NUMBER> similar evidence risk amid persons diabetes reported two earlier cov infections sars <NUMBER> <NUMBER> <NUMBER> mers <NUMBER> <NUMBER> furthermore diabetes present <NUMBER> <NUMBER> fatalities due covid<NUMBER> study wuhan china <NUMBER> huang et al <NUMBER> investigated <NUMBER> hospitaladmitted patients identified laboratoryconfirmed <NUMBER>ncov infection however cases small proportion patients affected report <NUMBER> cases <NUMBER> confirmed covid<NUMBER> cases published chinese centre disease control prevention showed increased mortality rate people diabetes <NUMBER> overall <NUMBER> patients diabetes <NUMBER> bellochavolla oy <NUMBER> predicted mortality due sarscov<NUMBER> developed mechanistic score relating obesity diabetes covid<NUMBER> outcomes data mexico among <NUMBER> subjects authors observed <NUMBER> subjects sarscov<NUMBER> <NUMBER> deaths sarscov<NUMBER> causes risk factors lethality covid<NUMBER> included earlyonset diabetes obesity advanced age immunosuppression ckd authors used stratified points score diabetes <NUMBER> indicated mild risk <NUMBER> deaths sarscov<NUMBER> <NUMBER> diabetes total <NUMBER> patients confirmed covid<NUMBER> studied guo et al <NUMBER> authors found <NUMBER> patients comorbidities except diabetes higher risk severe pneumonia release tissue injuryrelated enzymes excessive uncontrolled inflammation responses hypercoagulable state associated dysregulation glucose metabolism authors recommended diabetes considered risk factor rapid progression poor prognosis covid<NUMBER> authors described mortality rate covid<NUMBER> amongst diabetic patients without comorbidities <NUMBER> abovementioned studies summarized table <NUMBER> na available apparent individuals diabetes increased risk covid<NUMBER> infection medical complications including death suggestions made possible pathophysiological mechanisms relationship diabetes covid<NUMBER> management definite conclusions made based current limited evidence data <NUMBER> research regarding relationship clinical management warranted <NUMBER> furthermore article guo et al <NUMBER> left several relevant questions addressed association covid<NUMBER> diabetes differ different types diabetes antidiabetic drugs impact disease progression impact aging diabetics without diabetes results study read light limitations small sample size large age difference study groups patients comorbidities excluded still provides relevant insights could inform covid<NUMBER> interacts preexisting conditions <NUMBER> according recently published results mainly chinese cohort patients cancer vulnerable covid<NUMBER> complications however susceptible cancer patients infection covid<NUMBER> yet established liang et al <NUMBER> collected analyzed <NUMBER> cases <NUMBER> hospitals <NUMBER> provincial administrative regions china cases diagnosed laboratoryconfirmed covid<NUMBER> number covid<NUMBER> cases history cancer <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> covid<NUMBER> cases according <NUMBER> cancer epidemiology statistics seems higher incidence cancer overall chinese population <NUMBER>·<NUMBER> per <NUMBER> people lung cancer frequent type <NUMBER> compared patients without cancer patients cancer relatively older significant differences sex baseline symptoms comorbidities baseline severity xray importantly patients cancer observed higher risk severe events compared patients without cancer <NUMBER> vs <NUMBER> <NUMBER> patients fishers exact p<NUMBER> authors concluded patients cancer might higher risk covid<NUMBER> individuals without cancer additionally showed patients cancer poorer outcomes covid<NUMBER> providing timely reminder physicians cancer patients require intensive care infected zhang et al <NUMBER> nonsmallcell lung carcinoma nsclc authors stated patients nsclc older <NUMBER> years higher incidence covid<NUMBER> aged <NUMBER> years younger <NUMBER> vs <NUMBER> table <NUMBER> summarize details three mentioned case studies mentioned studies lung cancer frequently observed covid<NUMBER> cases analyzed hospitals china however according moujaess et al <NUMBER> reports could lead many oncologists change daily practice cancer care without solid evidence recommendations data presented carefully interpreted small sample also cancer patients cohort mentioned <NUMBER> instance significantly older median age control <NUMBER>·<NUMBER> vs <NUMBER>·<NUMBER> years well significant history smoking suggesting two factors might associated poor covid<NUMBER> outcomes cancer history moreover results interpreted caution absence adjustment prevalence different comorbidities chinese population <NUMBER> also xia et al <NUMBER> commented mentioned studies highlighted reasons cautious suggesting current evidence remains insufficient explain conclusive association cancer covid<NUMBER> though one effect risen concern due number covid<NUMBER> patients surpassing hospital healthcare capacity cancer patients may overlooked resulting negative consequences treatments high blood pressure hypertension one common conditions severe covid<NUMBER> patients <NUMBER> section review several studies looked relationship hypertension severity covid<NUMBER> relationship high blood pressure increased risk pneumonia subject study analyzed uk biobank data <NUMBER> hypertension patients <NUMBER> patients developing pneumonia afterward <NUMBER> data analysis shows risk respiratory disease significantly higher patients hypertension patients hypertension also found higher risk acute respiratory disease chronic lower respiratory disease independent age sex smoking status bmi generalizing results covid<NUMBER> plausible led many studies focus hypertension strong indication covid<NUMBER> severity several recent studies investigated variability covid<NUMBER> disease severity patients hypertension medicinal therapy <NUMBER> authors reported among <NUMBER> hospitalized covid<NUMBER> patients <NUMBER> diagnosed hypertension furthermore mortality rates among patients angiotensinconverting enzyme inhibitors acei hypertension treatment <NUMBER> p<NUMBER> well patients angiotensin ii receptor blockers arbs <NUMBER> p<NUMBER> lower compared antihypertensive agents <NUMBER> therefore results support continuation acei arb therapy covid<NUMBER> hypertensive patients results supported another study <NUMBER> <NUMBER> covid<NUMBER> patients hypertension retrospectively grouped arbsaceis n<NUMBER> nonarbsaceis n<NUMBER> according antihypertensive medications group covid<NUMBER> patients without hypertension randomly selected match previous group based age sex results study show arbsaceis group lower proportion critical patients <NUMBER> vs <NUMBER> p<NUMBER> lower death rate <NUMBER> vs <NUMBER> p<NUMBER> however differences statistically significant similarly liu et al <NUMBER> investigated disease severity patients hypertension used acei arb ccb betablockers bb compared patients take hypertension medication considering <NUMBER> elderly patients age <NUMBER> results show patients took arb significantly lower risk developing severe disease compared patients took drugs however although patients took acei ccb bb also lower risk developing severe disease statistical significance compared patients took drugs could due limited number patients drugs compared arb another study <NUMBER> authors argued based retrospective investigation different hypertension drugs calcium channel blockers ccbs show significant efficacy covid<NUMBER> patients also conducted vitro experiments examine efficacy ccbs hypertension drugs blocking sarscov<NUMBER> replication cells results show ccbs block virus replication however blocking mechanism apparent therefore investigations ccbs efficacy postentry virus replication vitro clinically needed although studies cited show hypertension medications beneficial covid<NUMBER> patients recent retrospective observational study <NUMBER> found patients hypertension took aceiarb drugs higher risk developing severe case covid<NUMBER> p <NUMBER> however statistically significant difference may due limited number patients hypertension <NUMBER> <NUMBER> covid<NUMBER> patients also group patients hypertension older comorbidities chronic renal insufficiency cardiovascular disease diabetes mellitus cerebrovascular disease patients without hypertension interestingly another study <NUMBER> hypothesizes hypertension treatment acei arbs results upregulation ace<NUMBER> may increase risk developing severe covid<NUMBER> based structural study suggesting sarscov<NUMBER> uses ace<NUMBER> receptor <NUMBER> also noted ccb treatment hypertension lead upregulation ace<NUMBER> turn makes safe treatment hypertension covid<NUMBER> patients however theory supported previously cited retrospective studies covid<NUMBER> patients took acei arbs <NUMBER> besides sanchisgomar et al <NUMBER> noted several health organizations recommended continued use aceis arbs treating hypertension covid<NUMBER> patients also found based review study significant differences aceis arbs managing hypertension arbs favorable option severe cases covid<NUMBER> also reviewed several articles employed systematic reviews metaanalysis published studies effects hypertension covid<NUMBER> disease severity <NUMBER> systematic reviews show hypertension one major comorbidities fatality table <NUMBER> hypertension like diabetes proven linked significantly higher risk respiratory infection making solid indicator covid<NUMBER> severity additionally systematic reviews indicate hypertension common comorbidity covid<NUMBER> death cases well linked significantly higher mortality risk increased incidence icu admission although noted studies comorbidities connected hypertension necessary nonetheless evident many patients virus also suffer hypertension result comorbidity well medicinal therapies covid<NUMBER> observed also found hypertension treatment continued lower severity risk researchers recommended ccbs treatment others found significant differences using aceis arbs ccbs however seems general agreement health organizations recommended hypertension treatment continued covid<NUMBER> patients <NUMBER> cholesterol level alteration found occur viral infection hiv hepatitis c virus hcv <NUMBER> mechanism alteration involves virus binding scavenger receptor b type <NUMBER> srb<NUMBER> facilitates selective uptake highdensity lipoprotein hdl cholesterol lipid components receptorbound hdl particles including free cholesterol fc triglycerides tg <NUMBER> also found membrane cholesterol important component facilitate viral entry host cells <NUMBER> role cholesterol viral infection investigated even current pandemic sarscov<NUMBER> ren et al <NUMBER> found cholesterol depletion cellular membrane significantly impaired efficiency viral infection wei et al <NUMBER> studied cholesterol metabolism covid<NUMBER> patients compared normal reference population general found fc hdl ldl cholesterol level significantly low covid<NUMBER> patients compare reference population tg levels also lower significant level moreover cholesterol metabolism mild moderate severe critical covid<NUMBER> patients also presented discussed levels hdlc significantly lower patients severe critical disease patients moderate mild disease another study <NUMBER> hdl cholesterol levels along serum albumin levels used predictors severity covid<NUMBER> disease study investigated differences clinical features mild severe covid<NUMBER> patients features studied included hypoproteinemia hypoalbuminemia decreased apoa<NUMBER> patients grouped two types mild severe critical condition included also noted patients severe disease significantly older median age <NUMBER> compared patients mild disease median age <NUMBER> results show patients severe disease significantly lower hdl cholesterol also observed increased levels albumin hdl cholesterol patients late stage recovering covid<NUMBER> another recent study <NUMBER> looked serum cholesterol level patients covid<NUMBER> wenzhou china laboratory test results show patients significantly low fc hdlcholesterol ldlcholesterol levels compared healthy control moreover investigated cholesterol levels two categories patients primary infection cases wuhan secondary infection cases never wuhan infected persontoperson transmission reported hdlcholesterol primary infection group significantly lower secondary infection group similar results <NUMBER> cholesterol levels fc hdl ldl improving patients recovered inverse correlation hdl cholesterol level severity covid<NUMBER> also highlighted <NUMBER> author argued taking statin drug therapy cholesterol may increase covid<NUMBER> infections statins drugs used lower cholesterol protect heart attack stroke taking statins results low production endogenous cholesterol leads upregulation ldl cell membrane stated earlier found important component facilitate viral entry host cells overview articles investigating cholesterol levels covid<NUMBER> patients summarized table <NUMBER> cholesterol previously investigated concerning many viral infections typically selective uptake cholesterol viruses bind cellular membrane ultimately enables severe infection therefore analyses conducted connection covid<NUMBER> cholesterol publications indicated fc hdl ldl cholesterol levels significantly low patients viral infection compared control studies explained ability sarscov<NUMBER> virus use serum cholesterol entry host cells therefore low serum cholesterol level used early predictor covid<NUMBER> severity patients also observing improvement serum cholesterol levels may indicate improvement conditions patients also worth noting statin drugs cholesterol may contribute severity covid<NUMBER> disease inhibiting endogenous cholesterol leading upregulation ldl leads higher membrane cholesterol levels enhance ability sarscov<NUMBER> enter host cells apart fever respiratory complications acute kidney injury observed patients covid<NUMBER> investigate possible cause kidney damage covid<NUMBER> patients lin et al <NUMBER> used published kidney bladder cell atlas data well independent unpublished kidney singlecell rnaseq data generated inhouse evaluate ace<NUMBER> gene expressions cell types healthy kidneys bladders results showed enriched expression subtypes proximal tubule cells kidney low detectable levels expression bladder epithelial cells results indicated urinary system potential route covid<NUMBER> infection along respiratory system digestion system findings suggested kidney abnormalities sars covid<NUMBER> patients may due proximal tubule cell damage subsequent systematic inflammatory response induced kidney injury beyond laboratory tests viruses related indicators urine may needed special patients covid<NUMBER> novel coronavirus recent study reported human kidney specific target sarscov<NUMBER> infection <NUMBER> authors examined viral nucleocapsid protein situ kidney postmortem found sarscov<NUMBER> antigens accumulated kidney tubules suggesting sarscov<NUMBER> infects human kidney directly inducing aki contributing viral spreading body <NUMBER> alberici et al <NUMBER> describe <NUMBER> kidney transplant recipients median age <NUMBER> years <NUMBER> male sarscov<NUMBER> induced pneumonia patients presented fever one complained difficulty breathing overall <NUMBER> kidney transplant recipients died median period <NUMBER> days symptom onset preliminary findings describe rapid clinical deterioration associated chest radiographic deterioration escalating oxygen requirement renal transplant recipients sarscov<NUMBER> pneumonia thus limited cohort longterm kidney transplant patients sarscov<NUMBER> induced pneumonia characterized high risk progression significant mortality wang et al <NUMBER> conducted study one male patient age <NUMBER> history close contact confirmed covid<NUMBER> case type <NUMBER> diabetes <NUMBER> years hypertension <NUMBER> years patient underwent comprehensive treatment covid<NUMBER> organ transplant patients covid<NUMBER> infection might poorer prognosis systemic immunosuppressive state however severe case cured even without discontinuing reducing immunosuppressant therapy immunosuppressed case might help physicians establish optimal treatment strategies similar severe cases whether covid<NUMBER> causes significant acute kidney injury aki remains controversial zhou et al <NUMBER> retrospectively analyzed clinical characteristics urine blood routine tests well laboratory parameters <NUMBER> hospitalized covid<NUMBER> patients wuhan china total <NUMBER> <NUMBER> patients showed increased blood urea nitrogen bun indicating cases kidney dysfunction however among <NUMBER> <NUMBER> patients history kidney disease received routine urine test upon hospitalization <NUMBER> <NUMBER> patients displayed abnormality urinalyses proteinuria hematuria leukocyturia none patients recorded acute kidney injury aki throughout study meanwhile patients abnormal urinalysis typically displayed worse disease progression reflected laboratory parameter presentations including markers liver injury inflammation coagulation authors concluded urinalysis better unveiling potential kidney impairment covid<NUMBER> patients blood chemistry tests additionally urinalysis could used reflect predict disease severity cheng et al <NUMBER> determined prevalence acute kidney injury aki patients covid<NUMBER> evaluated association markers abnormal kidney function death patients covid<NUMBER> authors studied cohort <NUMBER> patients covid<NUMBER> wuhan <NUMBER> <NUMBER> <NUMBER> died hospitals study period aki occurred <NUMBER> patients kaplanmeier analysis demonstrated patients kidney disease significantly higher risk inhospital death thus authors believed prevalence kidney disease admission development aki hospitalization patients covid<NUMBER> high associated inhospital mortality hence clinicians increase awareness kidney disease patients severe covid<NUMBER> overview articles investigating kidney disease among covid<NUMBER> patients summarized table <NUMBER> addition multiple complications observed acute kidney injury also detected covid<NUMBER> patients results indicated urinary system respiratory system digestion system potential routes covid<NUMBER> infection one study indicating human kidney specific target virus findings propose kidney abnormalities covid<NUMBER> patients may due proximal tubule cell damage subsequent systematic inflammatory response induced kidney injury additionally one study sarscov<NUMBER> antigens seen accumulate kidney tubules implying direct impact kidney leading aki induction viral spread within body also studies describing rapid clinical deterioration escalating oxygen requirement high risk progression significant mortality kidney transplant patients similarly incidence kidney disease admission well development aki correlated fatality covid<NUMBER> patients however covid<NUMBER> causes acute kidney injury remains uncertain many authors concluded clinicians must still try increase awareness kidney issues patients severe infection urinalysis may used predict extent disease severity note eur neurol journal editor morelli et al <NUMBER> mentioned february <NUMBER> <NUMBER> first covid<NUMBER> patient recorded italy march <NUMBER> <NUMBER> <NUMBER> admissions casualty department ischemic stroke authors suggested reason could controversial role il<NUMBER> plays stroke although high il<NUMBER> levels reported harm brain infarct volume longterm outcome <NUMBER> ischemic stroke also experimental evidence il<NUMBER> protective effect helps improvement poststroke angiogenesis <NUMBER> could also due presence thrombocytopenia covid<NUMBER> patients indeed may true influenza pneumonia ie increased stroke risk may true sarscov<NUMBER> main limitation remark however certainly short observation period <NUMBER> month oxley et al <NUMBER> reported <NUMBER> <NUMBER> male <NUMBER> female largevessel stroke patients confirmed sarscov<NUMBER> presented health system new york city severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> infection diagnosed five patients although patients covid<NUMBER> related symptoms fever cough lethargy reduced nih stroke scalescore nihss overview articles investigating stroke among covid<NUMBER> patients summarized table <NUMBER> one study identified <NUMBER> covid patients neurological symptoms mainly patients severe disease several mechanisms covid<NUMBER> increase stroke risk recognized neither proven significant studies required investigate neurological pathology covid<NUMBER> infection additionally may need improve specific vte diagnostic strategies safety thromboprophylaxis identify role il<NUMBER> plays ischemic stroke however risks associated ischemic stroke covid<NUMBER> patients still uncertain cancer patients medical resources must allocated target strain covid<NUMBER> placed ischemic stroke care meanwhile relationship covid<NUMBER> stroke must examined studies reviewed paper assessed effects diabetes cancer hypertension high cholesterol kidney issues stroke covid<NUMBER> severity thorough examination evidence provided reports inferences relationship preexisting conditions covid<NUMBER> made conclusion observed diabetes hypertension cholesterol levels possess apparent relation covid<NUMBER> severity comorbidities cancer kidney issues stroke must evaluated detect strong relationship virus additionally treatment options must examined provide optimal treatment ensure better outcomes patients suffering comorbidities however noted whether definitive measurements exist care patients well research involved largely prioritized tackle deadly pandemic recent outbreak novel covid<NUMBER> disease rapid worldwide spread poses global health emergency novel virus thought belong family middle east respiratory syndrome mers coronavirus severe acute respiratory syndrome sars coronavirus unique right <NUMBER> researchers around globe investigating several risk factors may contribute severity covid<NUMBER> world health organization indicated elderly individuals well underlying medical conditions higher risk developing severe covid<NUMBER> disease <NUMBER> today june <NUMBER> th <NUMBER> <NUMBER> million people infected virus <NUMBER> lost lives deaths believed associated existence comorbidities generally patients compromised immune systems considered particularly vulnerable <NUMBER> several research works targeted epidemiological clinical characteristics patients infected covid<NUMBER> however risk factors severity mortality sufficiently investigated <NUMBER> identifying major risk factors taking corresponding clinical measures could contribute massively saving lives previous studies identified comorbidities hypertension diabetes mellitus stroke cancer kidney issues high cholesterol among highrisk factors thus paper represents systematic review literature shed light effects preexisting conditions covid<NUMBER> disease severity additionally method currently exists determine level risk comorbidities pose paper serves purpose achieving reasonable option draw lessons earlier experiences practices search conducted freely available covid<NUMBER> open research dataset cord<NUMBER> <NUMBER> cord<NUMBER> resource consisting <NUMBER> scholarly articles including <NUMBER> articles full text related covid<NUMBER> sarscov<NUMBER> coronaviruses dataset frequently updated new research appears peerreviewed publications archive services became available screen every article dataset developed search engine addition bm<NUMBER> search index <NUMBER> bm<NUMBER> retrieval function ranks set documents based query terms appearing document regardless proximity within document papers indexed simply applying preprocessing function clean tokenize abstracts documents indexed created document vectors loading optimized cached json tokens followed applying document similarity index using annoy <NUMBER> annoy c library python bindings search documents space close given query details implantation please visit httpsgithubcomdgunningcord<NUMBER> filtering articles undertaken using keywords questions eg effects diabetes covidnormal coronavirussarscov<NUMBER>ncovcovid<NUMBER> disease severity mortality search terms repeated comorbidities considered paper illustrated fig <NUMBER> systematic approach used screen full covid<NUMBER> open research dataset <NUMBER> systematic method <NUMBER> articles found scored highly confidence rating additional search run employing google scholar pubmed ensure every relevant article included <NUMBER> papers read thoroughly causing <NUMBER> articles excluded list additional <NUMBER> articles manually added list ultimate list <NUMBER> articles split six categories <NUMBER> articles focusing cancer <NUMBER> diabetes mellitus <NUMBER> kidney issues <NUMBER> stroke <NUMBER> hypertension <NUMBER> high cholesterol diabetes one serious comorbidities linked severity three wellknown human pathogenic coronavirus infections including sarscov <NUMBER> patients diabetes increased risk severe complications including adult respiratory distress syndrome ards multiorgan failure depending global region <NUMBER> covid<NUMBER> pandemic patients diabetes emphasizes importance link covid<NUMBER> diabetes <NUMBER> according gupta r et al <NUMBER> individuals diabetes risk infections especially influenza pneumonia patients diabetes severely affected contract respiratory viruses therefore diabetes seen important risk factor mortality patients infected pandemic influenza <NUMBER> h<NUMBER>n<NUMBER> sars coronavirus middle east respiratory syndromerelated coronavirus merscov <NUMBER> <NUMBER> <NUMBER> several studies show among covid<NUMBER> patients also noticeable percentage patients suffering diabetes mellitus dm yang x et al <NUMBER> found among <NUMBER> nonsurvivors group <NUMBER> covid<NUMBER> patients median age <NUMBER> <NUMBER> male <NUMBER> diabetes patients additionally <NUMBER> patients confirmed covid<NUMBER> median age <NUMBER> <NUMBER> male autonomous regions china <NUMBER> severe disease comorbidities <NUMBER> diabetes mellitus <NUMBER> zhang jj et al <NUMBER> analyzed data <NUMBER> patients median age <NUMBER> <NUMBER> male admitted hospitals wuhan china confirmed covid<NUMBER> cases <NUMBER> patients diabetes <NUMBER> reviewed <NUMBER> confirmed covid<NUMBER> patients <NUMBER> diabetes hospitalized west court union hospital wuhan china patient median age <NUMBER> significant difference observed males females however indicated authors patients diabetes significantly higher leukocyte neutrophil counts well higher levels fasting blood glucose serum creatinine urea nitrogen creatine kinase isoenzyme mb admission compared without diabetes cox proportional hazard model showed diabetes adjusted hazard ratio ahr<NUMBER> <NUMBER> ci <NUMBER> fasting blood glucose ahr<NUMBER> <NUMBER> ci <NUMBER> associated fatality covid<NUMBER> adjusting potential confounders authors concluded diabetes mellitus associated greater disease severity well higher risk mortality patients covid<NUMBER> recommended primary secondary prevention strategies needed covid<NUMBER> patients diabetes bloomgarden zt et al <NUMBER> stated mortality rates pneumonia among patients diabetes hong kong age <NUMBER> exceed mortality rates age group cardiovascular disease cancer <NUMBER> similar evidence risk amid persons diabetes reported two earlier cov infections sars <NUMBER> affecting <NUMBER> individuals mainly asia <NUMBER> <NUMBER> mers <NUMBER> affecting <NUMBER> individuals mainly saudi arabia <NUMBER> furthermore diabetes present <NUMBER> <NUMBER> fatalities due covid<NUMBER> study wuhan china <NUMBER> huang c et al <NUMBER> investigated <NUMBER> hospitaladmitted patients identified laboratoryconfirmed <NUMBER>ncov infection infected patients men <NUMBER> median age <NUMBER> years <NUMBER> diabetes however cases small proportion patients affected report <NUMBER> cases <NUMBER> confirmed covid<NUMBER> cases published chinese centre disease control prevention showed increased mortality rate people diabetes <NUMBER> overall <NUMBER> patients diabetes <NUMBER> bellochavolla oy <NUMBER> predicted mortality due sarscov<NUMBER> developed mechanistic score <NUMBER> relating obesity diabetes covid<NUMBER> outcomes data mexico among <NUMBER> subjects predominantly male median age <NUMBER> authors observed <NUMBER> subjects sarscov<NUMBER> <NUMBER> deaths sarscov<NUMBER> causes risk factors lethality covid<NUMBER> included earlyonset diabetes obesity advanced age immunosuppression ckd additionally observed obesity mediates <NUMBER> effect diabetes covid<NUMBER> lethality authors used stratified points according categories low risk ≤<NUMBER> mild risk <NUMBER> <NUMBER> moderate risks <NUMBER> high risk <NUMBER> <NUMBER> <NUMBER> high risk ≥<NUMBER> score diabetes <NUMBER> <NUMBER> deaths sarscov<NUMBER> <NUMBER> diabetes total <NUMBER> patients median age <NUMBER> <NUMBER> male confirmed covid<NUMBER> studied guo w et al <NUMBER> demographic data medical history symptoms signs laboratory findings chest computed tomographies ct well treatment measures collected analyzed authors found <NUMBER> covid<NUMBER> patients comorbidities except diabetes higher risk severe pneumonia release tissue injuryrelated enzymes excessive uncontrolled inflammation responses hypercoagulable state associated dysregulation glucose metabolism authors recommended diabetes considered risk factor rapid progression poor prognosis covid<NUMBER> extensive care administered patients diabetes case rapid deterioration authors described mortality rate covid<NUMBER> amongst diabetic patients without comorbidities <NUMBER> abovementioned studies summarized table <NUMBER> according recently published results mainly chinese cohort patients cancer vulnerable covid<NUMBER> complications however susceptible cancer patients infection covid<NUMBER> yet established liang w et al <NUMBER> collected analyzed <NUMBER> cases <NUMBER> hospitals <NUMBER> provincial administrative regions china cases diagnosed laboratoryconfirmed covid<NUMBER> total <NUMBER> cases excluded insufficient records previous disease history number covid<NUMBER> cases history cancer <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> covid<NUMBER> cases according <NUMBER> cancer epidemiology statistics seems higher incidence cancer overall chinese population <NUMBER> <NUMBER>·<NUMBER> per <NUMBER> people lung cancer frequent type five <NUMBER> <NUMBER> patients compared patients without cancer patients cancer older mean age <NUMBER> years significant differences sex baseline symptoms comorbidities baseline severity xray importantly patients cancer observed higher risk severe events compared patients without cancer seven <NUMBER> <NUMBER> patients vs <NUMBER> <NUMBER> <NUMBER> patients fishers exact p<NUMBER> authors concluded patients cancer might higher risk covid<NUMBER> individuals without cancer additionally showed patients cancer poorer outcomes covid<NUMBER> providing timely reminder physicians cancer patients require intensive care infected diabetes considered risk factor rapid progression poor prognosis covid<NUMBER> na available ccbync <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> zhang l et al <NUMBER> regarded cancer patients highly vulnerable group current covid<NUMBER> pandemic authors included <NUMBER> cancer patients laboratoryconfirmed covid<NUMBER> <NUMBER> designated hospitals wuhan china jan <NUMBER> <NUMBER> feb <NUMBER> median age patients <NUMBER> <NUMBER> males <NUMBER> lung cancer authors mentioned cancer patients show deteriorating conditions poor outcomes covid<NUMBER> infection addition yu j et al <NUMBER> reviewed medical records including demographic clinical treatment data <NUMBER> patients cancer admitted zhongnan hospital wuhan university china dec <NUMBER> <NUMBER> feb <NUMBER> <NUMBER> outcomes covid<NUMBER> among patients cancer reported authors estimated infection rate sarscov<NUMBER> patients cancer single institution <NUMBER> <NUMBER> <NUMBER> patients <NUMBER> ci <NUMBER> higher cumulative incidence diagnosed covid<NUMBER> cases reported city wuhan time <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> cases data cutoff february <NUMBER> <NUMBER> median age infected patients <NUMBER> years seven <NUMBER> <NUMBER> patients nonsmall cell lung carcinoma nsclc five <NUMBER> treated either chemotherapy without immunotherapy n <NUMBER> radiotherapy n <NUMBER> three patients <NUMBER> developed sars one patient required intensivelevel care march <NUMBER> <NUMBER> <NUMBER> patients <NUMBER> discharged whereas <NUMBER> deaths <NUMBER> recorded <NUMBER> patients cancer screened <NUMBER> nsclc authors stated patients nsclc older <NUMBER> years higher incidence covid<NUMBER> aged <NUMBER> years younger <NUMBER> vs <NUMBER> table <NUMBER> summarize details three mentioned case studies high blood pressure hypertension one common conditions severe covid<NUMBER> patients <NUMBER> section review several studies looked relationship hypertension severity covid<NUMBER> relationship high blood pressure increased risk pneumonia subject study analyzed uk biobank data <NUMBER> hypertension patients <NUMBER> patients developing pneumonia afterward <NUMBER> data analysis shows risk respiratory disease significantly higher patients hypertension patients hypertension also found higher risk acute respiratory disease chronic lower respiratory disease independent age sex smoking status bmi generalizing results covid<NUMBER> plausible led many studies focus hypertension strong indication covid<NUMBER> severity several recent studies investigated variability covid<NUMBER> disease severity patients hypertension medicinal therapy <NUMBER> authors reported among <NUMBER> hospitalized covid<NUMBER> patients <NUMBER> diagnosed hypertension furthermore mortality rates among patients angiotensinconverting enzyme inhibitors acei hypertension treatment <NUMBER> p<NUMBER> well patients angiotensin ii receptor blockers arbs <NUMBER> p<NUMBER> lower compared antihypertensive agents <NUMBER> therefore results support continuation acei arb therapy covid<NUMBER> hypertensive patients results supported another study <NUMBER> <NUMBER> covid<NUMBER> patients hypertension retrospectively grouped arbsaceis n<NUMBER> nonarbsaceis n<NUMBER> according antihypertensive medications group covid<NUMBER> patients without hypertension randomly selected match previous group based age sex results study show arbsaceis group lower proportion critical patients <NUMBER> vs <NUMBER> p<NUMBER> lower death rate <NUMBER> vs <NUMBER> p<NUMBER> however differences statistically significant similarly liu et al <NUMBER> investigated disease severity patients hypertension used acei arb ccb betablockers bb compared patients take hypertension medication considering <NUMBER> elderly patients age <NUMBER> results show patients took arb significantly lower risk developing severe disease compared patients took drugs however although patients took acei ccb bb also lower risk developing severe disease statistical significance compared patients took drugs could due limited number patients drugs compared arb another study <NUMBER> authors argued based retrospective investigation different hypertension drugs calcium channel blockers ccbs show significant efficacy covid<NUMBER> patients also conducted vitro experiments examine efficacy ccbs hypertension drugs blocking sarscov<NUMBER> replication cells results show ccbs block virus replication however blocking mechanism apparent therefore investigations ccbs efficacy postentry virus replication vitro clinically needed although studies cited show hypertension medications beneficial covid<NUMBER> patients recent retrospective observational study <NUMBER> found patients hypertension took aceiarb drugs higher risk developing severe case covid<NUMBER> p <NUMBER> however statistically significant difference may due limited number patients hypertension <NUMBER> <NUMBER> covid<NUMBER> patients also group patients hypertension older comorbidities chronic renal insufficiency cardiovascular disease diabetes mellitus cerebrovascular disease patients without hypertension interestingly another study <NUMBER> hypothesizes hypertension treatment acei arbs results upregulation ace<NUMBER> may increase risk developing severe covid<NUMBER> based structural study suggesting sarscov<NUMBER> uses ace<NUMBER> receptor <NUMBER> also noted ccb treatment hypertension lead upregulation ace<NUMBER> turn makes safe treatment hypertension covid<NUMBER> patients however theory supported previously cited retrospective studies covid<NUMBER> patients ccbync <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> took acei arbs <NUMBER> besides sanchisgomar et al <NUMBER> noted several health organizations recommended continued use aceis arbs treating hypertension covid<NUMBER> patients also found based review study significant differences aceis arbs managing hypertension arbs favorable option severe cases covid<NUMBER> also reviewed several articles employed systematic reviews metaanalysis published studies effects hypertension covid<NUMBER> disease severity <NUMBER> systematic reviews show hypertension one major comorbidities fatality covid<NUMBER> cases similarly zuin et al <NUMBER> carried systematic review metaanalysis show covid<NUMBER> patients hypertension significantly higher mortality risk however noted studies comorbidities either linked linked hypertension needed also roncon et al <NUMBER> looked rate icu admission covid<NUMBER> patients hypertension found among <NUMBER> patients mean age <NUMBER> years <NUMBER> males patients hypertension significantly increased risk icu admission or<NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p<NUMBER> abovementioned cases summarized table <NUMBER> cholesterol level alteration found occur viral infection hiv hepatitis c virus hcv <NUMBER> mechanism alteration involves virus binding scavenger receptor b type <NUMBER> srb<NUMBER> facilitates selective uptake highdensity lipoprotein hdl cholesterol lipid components receptorbound hdl particles including free cholesterol fc triglycerides tg <NUMBER> also found membrane cholesterol important component facilitate viral entry host cells <NUMBER> role cholesterol viral infection investigated even current pandemic sarscov<NUMBER> ren et al <NUMBER> found cholesterol depletion cellular membrane significantly impaired efficiency viral infection wei et al <NUMBER> studied cholesterol metabolism covid<NUMBER> patients compared normal reference population general found fc hdl ldl cholesterol level significantly low covid<NUMBER> patients compare reference population tg levels also lower significant level moreover cholesterol metabolism mild moderate severe critical covid<NUMBER> patients also presented discussed levels hdlc significantly lower patients severe critical disease patients moderate mild disease another study <NUMBER> hdl cholesterol levels along serum albumin levels used predictors severity covid<NUMBER> disease study investigated differences clinical features mild severe covid<NUMBER> patients features studied included hypoproteinemia hypoalbuminemia decreased apoa<NUMBER> ccbync <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint patients grouped two types mild severe critical condition included also noted patients severe disease significantly older median age <NUMBER> compared patients mild disease median age <NUMBER> results show patients severe disease significantly lower hdl cholesterol also observed increased levels albumin hdl cholesterol patients late stage recovering covid<NUMBER> another recent study <NUMBER> looked serum cholesterol level patients covid<NUMBER> wenzhou china laboratory test results show patients significantly low fc hdlcholesterol ldlcholesterol levels compared healthy control moreover investigated cholesterol levels two categories patients primary infection cases wuhan secondary infection cases never wuhan infected persontoperson transmission reported hdlcholesterol primary infection group significantly lower secondary infection group similar results <NUMBER> cholesterol levels fc hdl ldl improving patients recovered inverse correlation hdl cholesterol level severity covid<NUMBER> also highlighted <NUMBER> author argued taking statin drug therapy cholesterol may increase covid<NUMBER> infections statins drugs used lower cholesterol protect heart attack stroke taking statins results low production endogenous cholesterol leads upregulation ldl cell membrane stated earlier found important component facilitate viral entry host cells overview articles investigating cholesterol levels covid<NUMBER> patients summarized table <NUMBER> apart fever respiratory complications acute kidney injury observed patients covid<NUMBER> investigate possible cause kidney damage covid<NUMBER> patients lin w al <NUMBER> used published kidney bladder cell atlas data well independent unpublished kidney singlecell rnaseq data generated inhouse evaluate ace<NUMBER> gene expressions cell types healthy kidneys bladders results showed enriched expression subtypes proximal tubule cells kidney low detectable levels expression bladder epithelial cells results indicated urinary system potential route covid<NUMBER> infection along respiratory system digestion system findings suggested ccbync <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> kidney abnormalities sars covid<NUMBER> patients may due proximal tubule cell damage subsequent systematic inflammatory response induced kidney injury beyond laboratory tests viruses related indicators urine may needed special patients covid<NUMBER> novel coronavirus recent study reported human kidney specific target sarscov<NUMBER> infection <NUMBER> authors examined viral nucleocapsid protein situ kidney postmortem found sarscov<NUMBER> antigens accumulated kidney tubules suggesting sarscov<NUMBER> infects human kidney directly inducing aki contributing viral spreading body <NUMBER> alberici f et al <NUMBER> describe <NUMBER> kidney transplant recipients median age <NUMBER> years <NUMBER> male sarscov<NUMBER> induced pneumonia patients presented fever one complained difficulty breathing overall <NUMBER> kidney transplant recipients died median period <NUMBER> days symptom onset preliminary findings describe rapid clinical deterioration associated chest radiographic deterioration escalating oxygen requirement renal transplant recipients sarscov<NUMBER> pneumonia thus limited cohort longterm kidney transplant patients sarscov<NUMBER> induced pneumonia characterized high risk progression significant mortality wang j et al <NUMBER> conducted study one male patient age <NUMBER> history close contact confirmed covid<NUMBER> case type <NUMBER> diabetes <NUMBER> years hypertension <NUMBER> years patient underwent comprehensive treatment covid<NUMBER> organ transplant patients covid<NUMBER> infection might poorer prognosis systemic immunosuppressive state however severe case cured even without discontinuing reducing immunosuppressant therapy immunosuppressed case might help physicians establish optimal treatment strategies similar severe cases whether covid<NUMBER> causes significant acute kidney injury aki remains controversial zhou h et al <NUMBER> retrospectively analyzed clinical characteristics urine blood routine tests well laboratory parameters <NUMBER> hospitalized covid<NUMBER> patients wuhan china patient presented increased serum creatinine scr <NUMBER> <NUMBER> patients showed increased blood urea nitrogen bun indicating cases kidney dysfunction however among <NUMBER> <NUMBER> patients history kidney disease received routine urine test upon hospitalization <NUMBER> <NUMBER> patients displayed abnormality urinalyses proteinuria hematuria leukocyturia none patients recorded acute kidney injury aki throughout study meanwhile patients abnormal urinalysis typically displayed worse disease progression reflected laboratory parameter presentations including markers liver injury inflammation coagulation authors concluded urinalysis better unveiling potential kidney impairment covid<NUMBER> patients blood chemistry tests additionally urinalysis could used reflect predict disease severity cheng et al <NUMBER> determined prevalence acute kidney injury aki patients covid<NUMBER> evaluated association markers abnormal kidney function death patients covid<NUMBER> authors studied cohort <NUMBER> patients median age <NUMBER> <NUMBER> male covid<NUMBER> wuhan <NUMBER> <NUMBER> <NUMBER> died hospitals study period aki occurred <NUMBER> patients kaplanmeier analysis demonstrated patients kidney disease significantly higher risk inhospital death thus authors believed prevalence kidney disease admission development aki hospitalization patients covid<NUMBER> high associated inhospital mortality hence clinicians increase awareness kidney disease patients severe covid<NUMBER> acute stroke remains medical emergency even covid<NUMBER> pandemic avula et al <NUMBER> investigated <NUMBER> patients covid<NUMBER> also presented acute stroke <NUMBER> patients table <NUMBER> radiographic evidence stroke pcrconfirmed covid<NUMBER> infection authors elucidated clinical characteristics imaging findings clinical course warned covid<NUMBER> patients present cerebrovascular accidents ccbync <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> use appropriate personal protective equipment every suspected patient studies urgently needed improve current understandings neurological pathology setting covid<NUMBER> infection ischemic stroke also experimental evidence il<NUMBER> protective effect helps ccbync <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> improvement poststroke angiogenesis <NUMBER> could also due presence thrombocytopenia covid<NUMBER> patients indeed may true influenza pneumonia ie increased stroke risk may true sarscov<NUMBER> main limitation remark however certainly short observation period <NUMBER> month oxley tj et al <NUMBER> reported <NUMBER> <NUMBER> male <NUMBER> female largevessel stroke patients confirmed sarscov<NUMBER> mean age <NUMBER> patients younger <NUMBER> years presented health system new york city severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> infection diagnosed five patients although patients covid<NUMBER> related symptoms fever cough lethargy reduced nih stroke scalescore nihss studies reviewed paper assessed effects diabetes cancer hypertension high cholesterol kidney issues stroke covid<NUMBER> severity thorough examination evidence provided reports inferences relationship preexisting conditions covid<NUMBER> madeit apparent individuals diabetes increased risk covid<NUMBER> infection medical complications including death suggestions made possible pathophysiological mechanisms relationship diabetes covid<NUMBER> management definite conclusions made based current limited evidence data <NUMBER> research regarding relationship clinical management warranted <NUMBER> furthermore article guo et al <NUMBER> left several relevant questions addressed association covid<NUMBER> diabetes differ different types diabetes antidiabetic drugs impact disease progression impact aging diabetics without diabetes results study read light limitations small sample size large age difference study groups patients comorbidities excluded still provides relevant insights could inform covid<NUMBER> interacts preexisting conditions <NUMBER> recently published reports provided results suggesting cancer patients susceptible covid<NUMBER> complications studies lung cancer frequently observed covid<NUMBER> cases analyzed hospitals china however according moujaess e et al <NUMBER> reports could lead many oncologists change daily practice cancer care without solid evidence recommendations data presented carefully interpreted small sample also cancer patients cohort mentioned <NUMBER> instance significantly older median age control <NUMBER>·<NUMBER> vs <NUMBER>·<NUMBER> years well significant history smoking suggesting two factors might associated poor covid<NUMBER> outcomes cancer history moreover results interpreted caution absence adjustment prevalence different comorbidities chinese population <NUMBER> also xia et al <NUMBER> commented mentioned studies highlighted reasons cautious suggesting current evidence remains insufficient explain conclusive association cancer covid<NUMBER> though one effect risen concern due number covid<NUMBER> patients surpassing hospital healthcare capacity cancer patients may overlooked resulting negative consequences treatments hypertension like diabetes proven linked significantly higher risk respiratory infection making solid indicator covid<NUMBER> severity additionally systematic reviews indicate hypertension common comorbidity covid<NUMBER> death cases well linked significantly higher mortality risk increased incidence icu admission although noted studies comorbidities connected hypertension necessary nonetheless evident many patients virus also suffer hypertension result comorbidity well medicinal therapies covid<NUMBER> observed also found hypertension treatment continued lower severity risk researchers recommended ccbs treatment others found significant differences using aceis arbs ccbs however seems general agreement health organizations recommended hypertension treatment continued covid<NUMBER> patients <NUMBER> cholesterol previously investigated concerning many viral infections typically selective uptake cholesterol viruses bind cellular membrane ultimately enables severe infection therefore analyses conducted connection covid<NUMBER> cholesterol publications indicated fc hdl ldl cholesterol levels significantly low patients viral infection compared control studies explained ability sarscov<NUMBER> virus use serum cholesterol entry host cells therefore low serum cholesterol level used early predictor covid<NUMBER> severity patients also observing improvement serum cholesterol levels may indicate improvement conditions patients also worth noting statin drugs cholesterol may contribute severity covid<NUMBER> disease inhibiting endogenous cholesterol leading upregulation ldl leads higher membrane cholesterol levels enhance ability sarscov<NUMBER> enter host cells addition multiple complications observed acute kidney injury also detected covid<NUMBER> patients results indicated urinary system respiratory system digestion system potential routes covid<NUMBER> infection one study indicating human kidney specific target virus findings propose kidney abnormalities covid<NUMBER> patients may due proximal tubule cell damage subsequent systematic inflammatory response induced kidney injury additionally one study sarscov<NUMBER> antigens seen accumulate kidney tubules implying direct impact kidney leading aki induction viral spread within body also studies describing rapid clinical deterioration escalating oxygen requirement high risk progression significant mortality kidney transplant patients similarly incidence kidney disease admission well development aki correlated fatality covid<NUMBER> patients however covid<NUMBER> causes acute kidney injury remains uncertain many authors concluded clinicians must still try increase awareness kidney issues patients severe infection urinalysis may used predict extent disease severity one study identified <NUMBER> covid patients neurological symptoms mainly patients severe disease several mechanisms covid<NUMBER> increase stroke risk recognized neither proven significant studies required investigate neurological pathology covid<NUMBER> infection additionally may need improve specific vte diagnostic strategies safety thromboprophylaxis identify role il<NUMBER> plays ischemic stroke however risks associated ischemic stroke covid<NUMBER> patients still uncertain cancer patients medical resources must allocated target strain covid<NUMBER> placed ischemic stroke care meanwhile relationship covid<NUMBER> stroke must examined december <NUMBER> <NUMBER> cluster cases pneumonia unknown origin people associated huanan seafood wholesale market reported wuhan china days later chinese health authorities confirmed cluster associated novel coronavirus <NUMBER> comorbidities importantly patients admitted intensive care unit icu higher number comorbidities<NUMBER> admitted icu<NUMBER> suggests complications may risk factor adverse outcomes <NUMBER> assessing prevalence chronic diseases basis mitigating complications patients covid<NUMBER> infections however effort hampered limited number cases get convincing result provide systematic evaluation detail estimate prevalence comorbidities patients also assess risk underlying diseases severe patients compared nonsevere patients result may aid management developing policies prevention response covid<NUMBER> critical outcomes two investigators j yang yp wang performed literature search also independently extracted data included studies disagreements resolved third investigator yn zhou consensus extracted following variables author date age gender number participates severe nonsevere prevalence clinical symptoms fever cough fatigue dyspnea together comorbidities including hypertension diabetes respiratory system disease cardiovascular diseases calculations performed stata mp version <NUMBER> odds ratio <NUMBER> confidence intervals ci used describe ratio probability coronavirus occurring severe patients vs nonsevere owing heterogeneity within studies random effect model used estimating average effect precision would give conservative estimate <NUMBER> ci using <NUMBER> statistic cochrans q test assess statistical heterogeneity terms initially searched total <NUMBER> articles removed duplicates checked title abstract reviewed fulltext eight studies <NUMBER> eventually met predetermined inclusion exclusion criteria february <NUMBER> <NUMBER> total j u r n l p r e p r f <NUMBER> participants included metaanalysis presented table <NUMBER> median age <NUMBER> years <NUMBER> <NUMBER> men result metaanalysis showed prevalent clinical symptom fever <NUMBER>±<NUMBER> <NUMBER> ci <NUMBER> followed cough <NUMBER>±<NUMBER> <NUMBER> ci <NUMBER> fatigue <NUMBER>±<NUMBER> <NUMBER> ci <NUMBER> dyspnea <NUMBER>±<NUMBER> <NUMBER> ci <NUMBER> however <NUMBER> varying <NUMBER> <NUMBER> evaluates clinical features showed significant statistic heterogeneity p<NUMBER> prevalence comorbidities including hypertension diabetes respiratory system disease cardiovascular diseases shown figure <NUMBER> inserts b c prevalent comorbidity hypertension <NUMBER>±<NUMBER> <NUMBER> ci <NUMBER> diabetes <NUMBER>±<NUMBER> <NUMBER> ci <NUMBER> followed cardiovascular diseases <NUMBER>±<NUMBER> <NUMBER> ci <NUMBER> respiratory system disease <NUMBER>±<NUMBER> <NUMBER> ci <NUMBER> analysis proportion comorbidities significant heterogeneity observed estimates hypertension diabetes cardiovascular diseases p<NUMBER> respiratory system disease p<NUMBER> <NUMBER> index ranging <NUMBER> <NUMBER> figure <NUMBER> analyzed relationship complications severe group nonsevere group higher risk hypertension respiratory system disease cardiovascular diseases severe group compared nonsevere result <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> ci <NUMBER>respectively showed low heterogeneity <NUMBER> <NUMBER> <NUMBER> however statistically significant difference diabetes <NUMBER> <NUMBER> ci <NUMBER> metaanalysis based data <NUMBER> studies laboratoryconfirmed covid <NUMBER> cases hospitals china result observed men women statistics <NUMBER> covid<NUMBER> infection merscov sarscov also found infect males females <NUMBER> <NUMBER> customary think women less likely affect many bacteria viruses men partly robust innate adaptive immune responses <NUMBER> however may related occupational risk factors men huanan wet market exposure history huangs report <NUMBER> aged people severe patients susceptible covid<NUMBER> may associated higher frequency comorbidities <NUMBER> metaanalysis comorbidities suggests hypertension prevalent approximately <NUMBER> patients diabetes cardiovascular diseases respiratory system disease present <NUMBER> <NUMBER> <NUMBER> cases respectively hypertension diabetes mellitus consistent prevalence hypertension diabetes china <NUMBER> <NUMBER> <NUMBER> comorbidities effect also noted similar effects respiratory illnesses merscov <NUMBER> study association also showed hypertension cardiovascular diseases respiratory system disease group overall severe patients older <NUMBER> significant number comorbid conditions nonsevere results suggest age comorbidities may risk factors critical patients diseases hypertension diabetes respiratory system disease study require ethical approval metaanalysis based published research original data anonymous authors declared conflicts interest work coronavirus disease <NUMBER> covid <NUMBER> declared pandemic word health organization march <NUMBER> <NUMBER> soon satisfied epidemiological criteria infection <NUMBER> people <NUMBER> countries <NUMBER> march <NUMBER> <NUMBER> world witnessed half million cases covid<NUMBER> <NUMBER> deaths <NUMBER> suggests magnitude spread across world since first reported december <NUMBER> <NUMBER> wuhan hubei province china emerging data suggests older covid<NUMBER> patients comorbid conditions diabetes hypertension cardiac pulmonary disease particular susceptible compared general populations higher mortality therefore necessary relook subgroups covid<NUMBER> patients associated comorbidities review article collated available evidence emerged far outcomes comorbidities patients covid<NUMBER> focused outcomes patients covid<NUMBER> hypertension analyzed controversies surrounding use reninangiotensin system blockers rasb systematically searched pubmed medical database till march <NUMBER> <NUMBER> using mesh key words include covid<NUMBER> coronavirus hypertension diabetes cardiovascular disease angiotensin receptor blockers angiotensin converting enzyme inhibitors retrieved available literature published english language covid<NUMBER> reported outcomes different comorbidities association hypertension diabetes patients covid<NUMBER> unexpected given rising prevalence chronic diseases globally interestingly pooled data ten chinese studies n ¼ <NUMBER> reported characteristics comorbidities patients covid<NUMBER> associations hypertension diabetes presence established cardiovascular disease cvd larger varying <NUMBER> <NUMBER> average <NUMBER> <NUMBER>e<NUMBER> average <NUMBER> <NUMBER>e<NUMBER> average <NUMBER> respectively table <NUMBER> established cvd also present nearly <NUMBER> italian study <NUMBER> patients covid<NUMBER> consistent association hypertension patients covid<NUMBER> across studies unique concern needs serious attention increase mortality two chinese studies worked direction todate <NUMBER> patients covid<NUMBER> zhou et al found hypertension odds ratio <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p <NUMBER> diabetes <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p <NUMBER> whereas presence coronary artery disease <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p <NUMBER> inhospital mortality univariate analysis <NUMBER> however association disorders covid<NUMBER> mortality longer significant multivariate regression analysis similarly analysis <NUMBER> patients covid<NUMBER> wu et al found hypertension hazard ratio hr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p ¼ <NUMBER> acute respiratory distress syndrome ards <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p ¼ <NUMBER> death diabetic patients hr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p ¼ <NUMBER> ards hr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p ¼ <NUMBER> death bivariate cox regression analysis <NUMBER> noted however neither studies adjusted confounding variables nevertheless study <NUMBER> patients covid<NUMBER> guo et al reported nearly twice increase mortality patients established cvd raised troponin tnt compared patients without cvd raised tnt <NUMBER> vs <NUMBER> respectively <NUMBER> chinese center disease control prevention summary report covid<NUMBER> reported case fatality rate cfr <NUMBER> <NUMBER> deaths among <NUMBER> confirmed cases however cfr elevated <NUMBER> hypertension <NUMBER> diabetes <NUMBER> presence cvd <NUMBER> unsurprisingly based findings researchers recently proposed course treatment prognosis covid<NUMBER> stratified based absence presence comorbidities type b c type denotes covid<NUMBER> patients pneumonia without comorbidities type b denotes covid<NUMBER> pneumonia comorbidities whereas type c denotes covid<NUMBER> patients multiorgan dysfunction <NUMBER> nonetheless still remains unclear whether increased association hypertension covid<NUMBER> heightened risk mortality directly related hypertension associated comorbidities antihypertensive treatment growing concern association hypertension cvd may confounded treatment certain antihypertensive medications rasb although recent paper proposed stop rasb suggested replace calcium channel blocker treating hypertension patients covid<NUMBER> <NUMBER> hypothesis questioned several colleagues <NUMBER>e<NUMBER> entry coronavirus cell facilitated spike protein attachment receptor host cell protein needs primed serine protease named tmprss<NUMBER> proteins different coronaviruses may utilise different receptors mers utilises cd<NUMBER> sars cov sars cov<NUMBER> utilise angiotensin converting enzyme<NUMBER> ace<NUMBER> <NUMBER> efficiency interaction sprotein ace<NUMBER> may key determinant transmissibility virus viral replication severity disease theory efficiency could influenced changes amino acid substitutions either viral sprotein <NUMBER> major outbreak sars cov occurred <NUMBER>e<NUMBER> minor localised outbreak mild symptoms <NUMBER>e<NUMBER> observed sprotein sars cov <NUMBER>e<NUMBER> outbreak bound ace<NUMBER> receptor much efficiently sars cov <NUMBER>e<NUMBER> outbreak consistent absence humantohuman transmission latter outbreak several molecular changes sprotein influence binding human ace<NUMBER> example substitution threonine serine position <NUMBER> protein reduces binding <NUMBER> similarly asparagine position <NUMBER> increased binding affinity <NUMBER> methylation position <NUMBER> also shown influence binding recently sprotein sars cov<NUMBER> shown similar sars cov barring gains function mutations important glutamine position <NUMBER> receptor binding domain explains increased transmissibility compared sars cov <NUMBER> b changes ace<NUMBER> receptor regard merscov employs cd<NUMBER> dpp<NUMBER> receptor cellular entry naturallyoccurring polymorphisms dpp<NUMBER> impact cellular entry merscov might thus modulate mers development infected patients <NUMBER> possibility similar variations polymorphisms ace<NUMBER> could affect viral entry disease course polymorphisms ace<NUMBER> gene identified however evidence affect susceptibility severity sars cov<NUMBER> infection <NUMBER> recent study found differential ace<NUMBER> gene expression human lung tissue racialgender differences higher gene expression lungs smokers compared nonsmokers could explain higher risk infection smokers <NUMBER> role ace<NUMBER> vascular bed opposite angiotensin converting enzyme ace ace converts angiotensin angiotensin ii vasoconstrictor ace<NUMBER> converts angiotensin ii angiotensin <NUMBER>e<NUMBER> causes vasodilatation binding mas receptor vascular bed <NUMBER> downregulation ace<NUMBER> observed animal models lung injury induced sars cov <NUMBER> recombinant ace<NUMBER> improved pulmonary blood flow oxygenation animals lung injury indicating ace<NUMBER> may main determinant lung injury caused sars cov <NUMBER> however lack human data except small study <NUMBER> patients acute respiratory distress syndrome showed recombinant ace<NUMBER> well tolerated led increase angiotensin <NUMBER>e<NUMBER> <NUMBER> considerable interest regarding role ras blockers covid<NUMBER> infection benefit harm postulated figure <NUMBER> illustrates interactions effect rasb covid<NUMBER> fig <NUMBER> rationale evidence harm evidence ace<NUMBER> expression increases use ace inhibitors arb especially heart kidney <NUMBER> <NUMBER> raised theoretical concern increasing ace<NUMBER> expression aceis arbs could facilitate entry virus host cell increase chances infection severity <NUMBER> also increased ace<NUMBER> expression elderly <NUMBER> extent predisposes elderly infection sarscov<NUMBER> known study <NUMBER> patients covid<NUMBER> guo et al reported increased trend mortality receiving rasb compared receiving mortality <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> patients without rasb respectively <NUMBER> indeed increased association heightened mortality covid<NUMBER> observed consistently across studies elderly hypertensive diabetics known cvd however exactly known whether causal relation use rasb subgroups rasb due illness compared rest population moreover solid evidence back concern either covid<NUMBER> infection coronaviruses b rationale evidence benefit discussed increasing ace<NUMBER> levels coronavirus infection could reduce lung injury experimental study mice kuba et al found losartan showed significantly diminished lung injury pulmonary edema acid aspirationinduced acute lung injury addition sarscov spike protein compared placebo <NUMBER> similarly severe lung injury pulmonary edema prevented recombinant human ace<NUMBER> infusions losartan ace<NUMBER>knockout mice <NUMBER> mice coronavirus induced lung injury showed improvement treated losartan <NUMBER> moreover retrospective analysis found reduced rates death endotracheal intubation patients viral pneumonia continued ace inhibitors <NUMBER> treatment arbs reported reduce mortality ebola virus infection <NUMBER> exact mechanism apparent benefit drugs coronavirus infection yet clear however could several explanations <NUMBER> increased ace<NUMBER> expression may result viral entry cell limited availability serine protease tmprss<NUMBER> camostat mesylate tmprss<NUMBER> inhibitor shown inhibit cellular entry sars cov<NUMBER> could potential therapeutic option <NUMBER> ii increased ace<NUMBER> expression cell membrane may also lead increased soluble ace<NUMBER> blood may actually bind sars cov<NUMBER> prevent interaction membrane bound receptor iii ras blockers increase angiotensin ii substrate ace<NUMBER> interaction ace<NUMBER> angiotensin ii could induce conformational change receptor binding domain ace<NUMBER> limiting ability bind sars cov<NUMBER> <NUMBER> iv ace<NUMBER> receptors present much higher density lung tissue children young adults compared older individuals thus upregulation ace<NUMBER> receptors use rasb time older people may emulate ace expression young people also possible ace<NUMBER> receptors increased ace<NUMBER> functions likely produce angiotensin <NUMBER>e<NUMBER> might provide resilience targetmediated destruction development pulmonary failure patients covid<NUMBER> <NUMBER> postulated positive effects lung also protective overwhelming infection covid<NUMBER> v indiscriminate discontinuation rasb patients heart failure may also lead readmission hospital increase mortality <NUMBER> collectively relationship ras activity use rasb sars cov<NUMBER> infection scarce indirect evidence ras activation covid<NUMBER> high incidence hypokalaemia <NUMBER> regards use rasb retrospective analysis <NUMBER> covid<NUMBER> hospitalised patients cardiovascular disease wuhan significant difference proportion aceiarb medication nonsurvivors survivors <NUMBER> however study <NUMBER> patient reported guo et al trend increase mortality patients covid<NUMBER> receiving rasb <NUMBER> compared receiving <NUMBER> <NUMBER> covid<NUMBER> increasingly associated comorbidities include hypertension diabetes special care required patients covid<NUMBER> associated comorbidities given heightened risk inhospital death view lack robust evidence either benefit harm bulk experimental evidence favour benefit reasonable patients continue using ace inhibitors arb recommended european society cardiology hypertension canada canadian cardiovascular society uk renal association international society hypertension european society hypertension american heart association <NUMBER>e<NUMBER> future studies reporting outcome stratified basis different antihypertensive agents covid<NUMBER> may enlighten us regard hereby declare conflict interest related article coronavirus disease covid<NUMBER> spread around world short period time recent data showing significant prevalence arterial hypertension cardiovascular diseases cvd among patients covid<NUMBER> raised many questions higher susceptibility patients comorbidities novel coronavirus well role hypertension cvd progression prognosis covid<NUMBER> patients limited amount data usually obtained small population regarding effect underlying disease outcome patients covid<NUMBER> evaluation treatment comorbidities baseline covid<NUMBER> scarce results conflicting hypertension cvd adjustment clinical demographic parameters primarily age remain independent predictors lethal outcome covid<NUMBER> patients investigations speculated association reninangiotensinaldosterone system raas susceptibility covid<NUMBER> well relationship raas inhibitors adverse outcome patients withdrawing switching raas inhibitors would uncertain benefits would definitely many disadvantages uncontrolled hypertension cardiac function deterioration renal function impairment could potentially induce complications patients covid<NUMBER> infection coronavirus aim review article summarize prevalence hypertension cvd patients covid<NUMBER> influence outcome effect treatment hypertension cvd covid<NUMBER> patients covid<NUMBER> hypertension cardiovascular diseases change therapy outbreak infection severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> caused pandemic disease called covid<NUMBER> beginning <NUMBER> <NUMBER> almost country world affected covid<NUMBER> healthcare systems around globe never worked j u r n l p r e p r f enormous pressure tens thousands newly infected patients thousands deaths reported day everything started wuhan china rapidly spread around world europe united states currently center pandemic covid<NUMBER> respiratory infection caused novel coronavirus high virulence considerable high mortality difficult estimate pandemic however currently available data show mortality rate china <NUMBER> italy <NUMBER> spain <NUMBER> usa <NUMBER> germany <NUMBER> <NUMBER> significantly higher influenza <NUMBER> comparable lower sars <NUMBER> significantly lower mers <NUMBER> <NUMBER> <NUMBER> data coming predominantly china showing significant percentage arterial hypertension cardiovascular diseases cvd among patients covid<NUMBER> raised many questions higher susceptibility patients comorbidities novel coronavirus well role hypertension cvd progression prognosis covid<NUMBER> patients recent findings showed important role reninangiotensinaldosterone system raas patients explained fact sarscov<NUMBER> using angiotensinconvertingenzyme <NUMBER> ace<NUMBER> binding surface epithelial cells <NUMBER> conflicting data effect raas inhibitors covid<NUMBER> patients <NUMBER> <NUMBER> <NUMBER> however seems first studies adverse impact raas inhibitors premature newly published data even showed positive effect raas survival patients covid<NUMBER> <NUMBER> obvious data topic necessary considering high prevalence j u r n l p r e p r f hypertension cvd patients covid<NUMBER> regular use raas inhibitors treatment hypertension cvd aim article provide overview prevalence hypertension cvd patients covid<NUMBER> influence outcome effect treatment hypertension cvd covid<NUMBER> patients prevalence hypertension ranged <NUMBER> noncritically ill patients <NUMBER> older patients covid<NUMBER> whereas prevalence cvd significantly lower varied <NUMBER> <NUMBER> table <NUMBER> expected prevalence significantly higher older patients comorbidities diabetes kidney impairment one notice different studies used various definitions cvd included coronary heart disease heart failure whereas others also included cerebrovascular disease therefore one cautious interpretation results metaanalyses confirmed considerable prevalence hypertension cvd among patients covid<NUMBER> <NUMBER> table <NUMBER> indicated importance hypertension cvd covid<NUMBER> patients raised question susceptibility cvd hypertensive patients sarscov<NUMBER> nevertheless risk factors smoking obesity underestimated studies effect obesity possible estimated due lack data limited number studies provided followup data consequence rapid publication large interest healthcare professionals around world information regarding covid<NUMBER> table <NUMBER> guan et al included <NUMBER> patients reported hypertension diabetes copd malignancy likely reach composite endpoints admission intensive care unit invasive ventilation death adjusting age smoking status <NUMBER> patients <NUMBER> comorbidities significantly increased risk adverse outcome small study wu et al hypertension diabetes predictors acute respiratory distress syndrome ards lethal outcome covid<NUMBER> patients <NUMBER> recently published study involved <NUMBER> patients covid<NUMBER> demonstrated cvd hypertension prevalent patients aggravation disease comparing experience deterioration covid<NUMBER> <NUMBER> however analysis predictors disease deterioration performed another investigation revealed incidence comorbidities higher covid<NUMBER> patients severe critical clinical course patients moderately severe clinical course <NUMBER> chen et al reported hypertension cvd diabetes prevalent among covid<NUMBER> patients lethal outcome comparing survivors <NUMBER> table <NUMBER> however large difference age sex distribution groups authors investigate effect comorbidities outcome population <NUMBER> zhou et al reported hypertension diabetes coronary heart disease chronic renal disease copd j u r n l p r e p r f frequent among nonsurvivors survivors <NUMBER> authors found hypertension diabetes coronary heart disease predictors mortality covid<NUMBER> patients nevertheless adjustment age none comorbidities remained significant predictors mortality ace<NUMBER> gained widespread interest cellular receptor sarscov<NUMBER> cause covid<NUMBER> pandemic ace<NUMBER> master regulator raas reduced increased function ace<NUMBER> induce systemic pulmonary hypertension heart failure myocardial infarction diabetic cardiovascular complications <NUMBER> ace<NUMBER> highly expressed heart lungs kidney gastrointestinal tract plays important role several cardiovascular immune pathways binding affinity novel coronavirus ace<NUMBER> appears stronger virus causes sars may explain significantly higher global influence covid<NUMBER> initial sars potential therapeutic strategies may include preventing binding human ace<NUMBER> sarscov<NUMBER> postmortem autopsy heart tissues patients sars <NUMBER> detectable viral sarscov genome myocardium characterized increased myocardial fibrosis inflammation reduced myocardial ace<NUMBER> expression <NUMBER> <NUMBER> patients much aggressive disease associated earlier mortality data still available covid <NUMBER> patients studies investigated cardiac injury elevation cardiac enzymes showed prevalence cardiac injury frequent prevalent among patients lethal outcome <NUMBER> <NUMBER> chen et al recently revealed human cardiac pericytes high expression ace<NUMBER> could j u r n l p r e p r f target cell sarscov<NUMBER> <NUMBER> virusinduced pericytes damage provoke capillary endothelial cells dysfunction microvascular dysfunction patients heart failure disease baseline demonstrated elevated ace<NUMBER> expression mrna protein levels increases risk heart attack critically ill condition patients infected coronavirus <NUMBER> biological effects ace<NUMBER> focused formation angiotensin<NUMBER> angiotensin ii ace<NUMBER> unlike ace convert angiotensin angiotensin ii ace inhibitors block activity crucial understanding biological properties effect raas inhibitors influence raas inhibitors ace<NUMBER> activity expression known animal human studies large confusion panic regarding usage angiotensinconvertingenzyme inhibitors acei angiotensin ii receptor blockers arb erupted two reasons confusion ace ace<NUMBER> inhibitors ii studies reported significantly higher percentage raas inhibitors usage among covid<NUMBER> patients lethal outcome ace ace<NUMBER> two different enzymes two different active sites effect acei ace<NUMBER> activity must therefore indirect one corresponding substrates sarscov<NUMBER> binding unlikely relationship ace acei nevertheless limited data aceis affect expression ace<NUMBER> heart kidney <NUMBER> hand evidence arbs modify ace<NUMBER> expression <NUMBER> <NUMBER> upregulation primarily found cardiac tissue renal vasculature however results inconsistent require high arbs dosages vary according arb j u r n l p r e p r f organ additionally investigations measured blood ace<NUMBER> activity reveals soluble ace<NUMBER> protein circulating low levels membranebound ace<NUMBER> arbs upregulated membranebound ace<NUMBER> reasonable hypothesize would consequence at<NUMBER> receptor blockade aceis would similar effect arbs even though limited data aceiinduced upregulation ace<NUMBER> however currently available data mostly obtained animal studies could directly applied humans therefore sufficient evidence arbs aceis could facilitate sarscov<NUMBER> entry cause covid<NUMBER> recent stateofart review sanchisgomar et al suggested arbs might better treatment option covid<NUMBER> patients higher risk severe forms disease due equal efficacy fewer side effects aceis <NUMBER> nevertheless existing studies included large number patients give advantage group medications within raas inhibitors disease severe critical course disease <NUMBER> difference usage aceis covid<NUMBER> patients different severity disease data regarding association raas inhibitors outcome however investigators studied use raas inhibitors hypertensive patients patients indications acei arb heart failure diabetes renal impairment moreover number patients taking aceis arbs low <NUMBER> <NUMBER> respectively <NUMBER> interestingly percentage arbs significantly higher aceis inhibitors significantly higher patients detected cardiac injury patients without injury <NUMBER> vs <NUMBER> <NUMBER> underlying diseases hypertension coronary artery disease cardiomyopathy chronic renal disease also significantly prevalent patients cardiac injury <NUMBER> comorbidities may largely contributed cardiac injury patients diseases also reason taking raas inhibitors explains higher prevalence raas inhibitors covid<NUMBER> patients cardiac injury defined elevated serum level troponin great confusion social media among healthcare professionals preliminary studies due uncertainties whether aceis reported aceisarbs associated severity mortality covid<NUMBER> patients <NUMBER> recent large study italy involved <NUMBER> patients covid<NUMBER> <NUMBER> noncovid patients showed use aceis arbs frequent among covid<NUMBER> patients control group due higher prevalence cardiovascular disease <NUMBER> nevertheless association aceiarb use risk covid<NUMBER> <NUMBER> american study included <NUMBER> patients covid<NUMBER> found association single medication class including raas inhibitors positive test covid<NUMBER> <NUMBER> europe north america revealed association use aceiarb increased inhospital mortality <NUMBER> study investigated covid<NUMBER> patients hypertension treated raas inhibitors showed patients receiving acei arb therapy lower rate severe diseases trend toward lower level il<NUMBER> peripheral blood <NUMBER> moreover acei arb treatment increased level cd<NUMBER> cd<NUMBER> cell peripheral blood reduced peak viral load compared antihypertensive drugs findings first evidence supports benefit aceis arbs covid<NUMBER> patients hypertension potentially improve clinical outcomes patients authors hypothesized raas inhibitors directly inhibit viral replication indirect antiviral role regulation immune function inhibition inflammatory response nevertheless potential mechanisms need clarified future large human studies large study included <NUMBER> hypertensive patients covid<NUMBER> showed inpatient use aceiarb adjustment age gender comorbidities related lower allcause mortality compared aceiarb nonusers <NUMBER> analysis revealed use raas inhibitors also associated reduced mortality covid<NUMBER> patients hypertension comparison use antihypertensive drugs <NUMBER> several specialty societies recommended covid<NUMBER> patients continue therapy raas inhibitors <NUMBER> <NUMBER> <NUMBER> <NUMBER> agreement latest studies find association raas inhibitors increased morbidity andor mortality covid<NUMBER> patients important discuss evident limitations available data one important limitations selfreporting comorbidities hospital admission cause significant underestimation comorbidities lack awareness andor lack diagnostic testing followup period short patients remained hospital data analyzed meaning actual outcome unknown interfere published results obesity reported studies influence bmi could investigated included adjustment would great importance data therapy baseline therapy poor important potentially confounding factor evaluation hypertension cvd independent predictors susceptibility sarscov<NUMBER> outcome covid<NUMBER> investigations reported negative association raas inhibitors covid<NUMBER> included limited number covid<NUMBER> patients additional limitation reaching statistical significance prevalence hypertension cvd clinically relevant patients covid<NUMBER> particularly elderly impact hypertension cvd aceiangiotensin converting enzyme inhibitor arbangiotensin receptor blockerards acute respiratory distress syndrome copd chronic obstructive pulmonary disease cvdcardiovascular disease coronary heart disease heart failure withwithout cerebrovascular disease <NUMBER> patients <NUMBER> comorbidities significant hypertension cvd diabetes ards acute respiratory distress syndrome copd chronic obstructive pulmonary disease cvdcardiovascular disease coronary heart disease heart failure withwithout cerebrovascular disease sarscov<NUMBER> virus newly discovered member coronavirus family first described end <NUMBER> wuhan china third severe respiratory syndrome caused coronavirus <NUMBER> due easy spread via droplets direct contact quickly spread globally leading world health organization declare public health emergency <NUMBER> countries around world taking measures aimed preventing spread coronavirus main mechanism fighting disease <NUMBER> measures significant impact peoples lives many countries imposed travel restrictions <NUMBER> <NUMBER> leaving millions people change travel plans psychological economic impact mandatory isolation following possible exposure virus another matter concern <NUMBER> <NUMBER> <NUMBER> clinically disease presents incubation period <NUMBER> <NUMBER> days <NUMBER> cdc reports common symptoms fever cough shortness breath dyspnea chest pain confusion cyanosis represent alarm symptoms prompt people seek medical attention <NUMBER> largest metaanalysis available time writing article reports fever cough presenting symptoms <NUMBER> <NUMBER> patients respectively <NUMBER> fatigue gastrointestinal symptoms also frequently reported <NUMBER> hypertension diabetes mellitus commonly reported comorbidities <NUMBER> <NUMBER> <NUMBER> older individuals comorbidities likely develop endorgan damage requiring icu admission <NUMBER> acute respiratory distress syndrome ards acute kidney injury aki cardiac injury reported severe cases ards common <NUMBER> leukopenia less commonly eosinopenia typical laboratory findings bilateral groundglass patchy opacities lungs common radiologic abnormalities <NUMBER> <NUMBER> <NUMBER> creactive protein ddimer procalcitonin levels elevated especially cases severe disease <NUMBER> time writing clear guidelines treating sarscov<NUMBER> infections published clinicians seem treating manner similar seasonal flu purpose article look impact sarscov<NUMBER> infection hypertensive patients considering extremely high prevalence hypertension society fact hypertension among frequent comorbidities patients severe cases sarscov<NUMBER> infections believe important look deeply relationship two conditions angiotensin converting enzyme ace enzyme essential component human metabolism dysregulation associated number different clinical conditions including hypertension many studies done assess potential role ace ards development multiple animal models shown protective effect ace ii ards development <NUMBER> <NUMBER> <NUMBER> sarscov<NUMBER> similarly sarscov uses ace ii receptor invade alveolar epithelium considered potential target future anticovid<NUMBER> therapies <NUMBER> <NUMBER> cardiovascular pathology ace inhibitorsangiotensin receptor ar blockers lead increased ace ii levels potentially increasing risk sarscov<NUMBER> infections pointed hanff et al <NUMBER> also evidence sarscov<NUMBER> lead downregulation ace ii toxic accumulation angiotensin ii <NUMBER> also noted ace ii expressed organs tissues well fact ace expressed gut heart kidney sarscov infections associated gastrointestinal symptoms virus often isolated stool cardiac damage aki speaks favor strong correlation ace expression covid infection <NUMBER> overall exact role ace enzyme angiotensin lung injury general well pathogenesis sarscov<NUMBER> covid <NUMBER> infections clear models true ace ii protective role ards ards feared complication covid <NUMBER> would reasonable assume ace ii would protective effect covid <NUMBER> ace ii receptor used virus infect alveolar epithelium raises issue whether availability receptor associated severity clinical findings moreover large percentage population treated ace inhibitors arbs whether treatments associated change outcomes covid <NUMBER> infections currently debated recognize difficulties performing basic science research especially animal models light current epidemic agree hanff et al would strongly encourage scientists keep researching possible connection ace receptor angiotensin ards ace inhibitors ar blockers currently among frequently prescribed medications western world commonly used patients suffering hypertension congestive heart failure proteinuria commonly due diabetes mellitus act reducing activity reninangiotensin system ras ras plays significant role sarscov<NUMBER> pathogenesis ards development would reasonable assume patients treated ace inhibitorsar blockers would impacted animal models suggest administration ace inhibitors ar blockers leads elevated number ace ii receptors pulmonary circulation <NUMBER> marin reported many patients latin america spain intending discontinue taking ace inhibitorsar blockers due fear infection <NUMBER> despite animal models showing potential association ace inhibition worsening lung injuries due sarscov clinical evidence support association <NUMBER> european society cardiology recommends discontinuing either drugs potential risks associated uncontrolled hypertension seem outweigh risks ace inhibition worsening covid <NUMBER> infection <NUMBER> danser et al reached conclusion <NUMBER> french health minister claimed use antiinflammatory medications ibuprofen could worsen covid <NUMBER> symptoms <NUMBER> although ace ii levels increased use nsaids evidence association severity covid <NUMBER> symptoms weak <NUMBER> fang et al however recommend monitoring patients taking controversial drugs possible choosing alternative treatments <NUMBER> despite health authorities including nhs suggest using paracetamolacetaminophen instead precautionary measure <NUMBER> overall impact ace inhibition sarscov<NUMBER> covid <NUMBER> pathogenesis point time difficult establish belief association two exists mostly based animal models clinical evidence association lacking despite lack clinical evidence appears case number patients plan discontinuing longterm therapies believing would decrease risk contracting andor dying covid <NUMBER> evidence relationship nsaid use severe sarscov<NUMBER> infections also weak although possible pathophysiologic link hypothesized case however many health authorities recommend using nsaids evidence comes light believe lot basic science research pathophysiology coronavirus infections ards development general needed clearer patterns emerge point may reasonable avoid starting new patients nsaids ace inhibitorsarbs avoided comes patients require treatments conditions discontinuation unlikely benefit patients evidence exacerbations comorbidities stronger evidence covid <NUMBER> disease severity news reports expert opinions patients hypertension presenting severe cases covid <NUMBER> moreover hypertension among frequently reported comorbidities patients <NUMBER> <NUMBER> <NUMBER> taken account however hypertension among prevalent chronic conditions western world affecting millions people fang et al point association diabetes hypertension covid <NUMBER> infections likely due association ace ii enzyme <NUMBER> li et al reported significantly higher prevalence hypertension cardiovascular comorbidities among covid <NUMBER> patients treated icu compared require icu treatment <NUMBER> also reported <NUMBER> infected sarscov<NUMBER> developed cardiac injury <NUMBER> chen et al also reported similar association <NUMBER> elevated troponin levels seen icu patients also pointed towards development myocardial injury <NUMBER> odds ratio developing severe case compared nonsevere case hypertensive patients <NUMBER> <NUMBER> confidence interval <NUMBER> <NUMBER> <NUMBER> none studies analyzed age potential confounder considering prevalence hypertension rises age older patients general likely suffer serious complications infectious diseases addressed international society hypertension point evidence patients hypertension overrepresented among severe sarscov<NUMBER> infections adjusted age <NUMBER> difficult assess impact hypertension outcome patients infected sarscov<NUMBER> multiple studies point significant association hypertension adverse outcomes however number potential confounders main age vast previously mentioned association antihypertensives severe covid <NUMBER> presentations also needs taken account number studies published far insufficient properly address questions hope case reports review articles become available literature clearer pattern emerge outcomes patients uncontrolled hypertension compared normotensive controls similar baseline characteristics outcomes hypertensive patients managed ace inhibitorsar blockers compared hypertensive patients managed calcium channel antagonists besides hypertension cardiovascular comorbidities also frequently reported patients severe cases covid <NUMBER> considering significant associations hypertension cardiac disease correlation would expected moreover significant association heart failure pulmonary disease particularly pulmonary hypertension possible consequences even mild cardiac damage would expected significant among patients preexisting cardiac disease li et al reported cardiocerebrovascular disease among prevalent comorbidities among patients severe cases covid <NUMBER> second hypertension <NUMBER> <NUMBER> respectively <NUMBER> zhou et al reported coronary disease third prevalent comorbidity hypertension diabetes <NUMBER> chen et al also found previous history coronary disease independent risk factor adverse outcomes <NUMBER> proposed mechanism findings pericytes high ace ii expression might cells targeted sarscov<NUMBER> <NUMBER> pericyte injury could lead endothelial dysfunction <NUMBER> patients preexisting heart failure likely elevated ace ii expression due pathophysiology chf could increase risk infection <NUMBER> et al found mortality critically ill patients infected sarscov<NUMBER> develop cardiac injury high <NUMBER> <NUMBER> also found elevation nterminal probtype natriuretic peptide levels usually biomarker congestive heart failure associated myocardial injury caused covid <NUMBER> considered together studies point association preexisting cardiovascular comorbidities adverse outcomes following sarscov<NUMBER> infections likely contributing factor finding observed myocardial damage subset covid <NUMBER> patients patients preexisting heart disease less likely recover moreover increased expression ace ii congestive heart failure could explain increased susceptibility virus ability address myocardial damage icu may prove important prognostic factor patients considering lack currently approved treatments aimed virus especially important ensure people comorbidities exposed first place research needed exact impact sarscov<NUMBER> cardiovascular system order develop protective potentially curative strategies covid <NUMBER> caused sarscov<NUMBER> talkedabout disease first half <NUMBER> elderly suffering chronic conditions risk adverse outcomes hypertension frequently reported comorbidity among patients severe infections followed diabetes cardiovascular diseases possibly related expression ace ii facilitating viral entry cells relationship ace inhibitorar blocker use incidence severe covid<NUMBER> conflicting present authorities recommend discontinuing longterm ace inhibitorar blocker treatments concern remains patients may inclined stop taking prescribed medicines fear another point contention use nsaids number public health authorities released statements claiming evidence association existed nevertheless recommended choosing alternative drugs possible pending investigation nsaids finally available evidence clearly points correlation preexisting cardiovascular comorbidities adverse outcomes sarscov<NUMBER> infections severe cases associated myocardial damage considering high prevalence hypertension cardiovascular diseases important continue researching association conditions covid<NUMBER> disclosures respectively diabetes <NUMBER> <NUMBER> respectively cardiovascular disease <NUMBER> <NUMBER> respectively presented fever <NUMBER> <NUMBER> respectively shortness breath <NUMBER> <NUMBER> respectively compared nonspecific antiviral therapy prevent clinical progression severe pneumonia although fewer hypertensive patients angiotensinconverting enzyme inhibitors angiotensinreceptor blockers aceiarb therapy developed severe pneumonia contrast nonaceiarb hypertension without receiving aceiarb therapy independent risk factor odds ratio <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> developing severe pneumonia irrespective age besides none patients treated chloroquine developed severe pneumonia though without significance difference <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> propensity score matching conclusions relevance hypertensive patients acei arb may protective severe pneumonia covid<NUMBER> hence therapies ceased unless strong indication epidemiological evidence though none current antiviral immunoregulation therapy showed benefit preventing covid<NUMBER> progression chloroquine deserved investigation world witnessed rapid escalation <NUMBER> coronavirus disease caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> becoming global pandemic <NUMBER> many patients may asymptomatic experience mild symptoms reports far identified elderly patients chronic comorbidities hypertension diabetes cardiovascular disease higher risk progression severe covid<NUMBER> pneumonia characterized acute respiratory distress syndrome ards andor multiorgan failure <NUMBER> <NUMBER> <NUMBER> severe patients require intensive medical resource utilization worse prognosis case fatality rate <NUMBER> times higher nonsevere patients <NUMBER> <NUMBER> implementation effective prevention measures essential clearly exists urgent need interventions modulate disease progression face increasing number infected individuals overwhelmed capacity hospital systems countries specific therapy covid<NUMBER> current progress investigational therapies includes development trial coronavirus vaccine interrogation several orphan drugs randomized control trials rcts <NUMBER> includes remdesivir garnered interest ongoing adaptive rct nucleotide analogues including ritonavir favipiravir galidesvir <NUMBER> recently published openlabel rct showed benefit protease inhibitors lopinavirritonavir reducing clinical severity mortality associated covid<NUMBER> despite vitro evidence activity sarscov<NUMBER> <NUMBER> drugs interest include antiviral therapy pegylated interferonalpha arbidol immunomodulators hydroxychloroquine also investigation results eagerly monitored <NUMBER> <NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint inhibition spike glycoprotein sprotein may also viable target recently garnered increasing interest particularly potential interactions angiotensinogen converting enzyme <NUMBER> ace<NUMBER> proposed binding sarscov<NUMBER> sprotein functional receptor ace<NUMBER> results proteolytic cleavage type ii transmembrane serine proteases tmprss<NUMBER> <NUMBER> <NUMBER> <NUMBER> considerable interest debate regarding risk severe covid<NUMBER> pneumonia patients angiotensinogen converting enzyme inhibitors acei angiotensin receptor blocker arb therapy presumably modulation ace<NUMBER> expression <NUMBER> <NUMBER> <NUMBER> role acei arb covid<NUMBER> infection remains controversial data adjusted confounding factors age comorbidities definitively show acei arb independently associated worse outcomes course show causality either <NUMBER> hence various independent medical societies put position statements recognize potential risks given current quality evidence recommend inappropriate cessation switch aceiarb therapy hypertension given proven benefits <NUMBER> <NUMBER> therefore objective study investigate role several adjuvant treatments preventing severe pneumonia covid<NUMBER> patients seven cities hunan province china institutional review board third xiangya hospital central south university approved study waived informed consent retrospective nature study consecutive adult patients confirmed covid<NUMBER> treated third xiangya hospital central ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint extracted demographic exposure history comorbidities clinical symptoms laboratory data admission electronic medical records medication history among individuals hypertension recorded including aceiarb calciumantagonists β blocker diuretic agents laboratory tests performed according clinical care needs patient hospitalization including complete blood count assessment liver renal function coagulation testing measures electrolytes creatine kinase lactate dehydrogenase procalcitonin creactive protein use antiviral therapy arbidol lopinavirritonavir interferon α chloroquine obtained medication administration record severity degree covid<NUMBER> time admission defined follows <NUMBER> mild type fever respiratory tract symptoms without radiological pneumonia <NUMBER> moderate type fever respiratory tract symptoms radiological evidence pneumonia <NUMBER> severe type ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint one following respiratory distress respiratory rate ≥ <NUMBER> beatsmin b hypoxia oxygen saturation ≤ <NUMBER> resting state c hypoxemia arterial blood oxygen partial pressureoxygen concentration ≤ <NUMBER>mmhg <NUMBER> critical type one following respiratory failure requiring mechanical ventilation b shock c intensive care unit icu admission required combined organs failure study severe covid<NUMBER> pneumonia broadly included severe critical types ct images acquired admission intervals <NUMBER> days reviewed independently two experienced radiologists typical ct findings covid<NUMBER> defined peripherally distributed multifocal groundglass opacities ggos patchy consolidations posterior part lower lobe involvement predilection <NUMBER> five lung lobes reviewed ggo consolidation lesions extent within lung lobe semiquantitatively evaluated scoring <NUMBER> <NUMBER> based degree involvement score <NUMBER> none involvement score <NUMBER> ≤ <NUMBER> involvement score <NUMBER> <NUMBER> involvement score <NUMBER> <NUMBER> involvement score <NUMBER> <NUMBER> involvement score <NUMBER> <NUMBER> involvement total score calculated summing scores five lobes provide lung ct score ranging <NUMBER> <NUMBER> <NUMBER> mean value lung ct scores evaluated two radiologists used analysis primary outcome analysis progression severe covid<NUMBER> pneumonia continuous variables presented median interquartile range iqr categorical variables presented frequency percentage differences groups analyzed using students ttest mannwhitney u test quantitative variables according normal distribution chisquare test fishers exact test categorical variables meanwhile differences ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint distributions also reported using differences <NUMBER> confidence intervals cis univariate multivariate logistic regression backward stepwise selection based likelihood ratio used identify risk factors development severe pneumonia corresponding odds ratios ors <NUMBER> cis determined also employed propensity score matching psm <NUMBER> ratio minimize selection bias adjust imbalance patients without chloroquine therapy onetoone nearestneighbour matching algorithm optimal calliper <NUMBER> without replacement used generate pairs patients analyses regarding different factors based nonmissing data missing data imputed statistical analyses performed using spss statistics software version <NUMBER> ibm spss inc chicago il usa twosided p value less <NUMBER> considered statistically significant study population included <NUMBER> adult patients confirmed covid<NUMBER> nine hospitals seven cities figure <NUMBER> clinical characteristics admission presented table <NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint median lung ct score <NUMBER> iqr <NUMBER> range <NUMBER> total <NUMBER> <NUMBER> <NUMBER> patients identified severe pneumonia summarized table <NUMBER> patients older likely preexisting comorbidities including hypertension diabetes cardiovascular disease copd chronic renal disease compared nonsevere patients clinical symptoms illness onset also differed severe patients likely present fever shortness breath <NUMBER> ci <NUMBER> <NUMBER> p <NUMBER> however lymphocyte count difference <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p <NUMBER> significantly lower patients severe pneumonia thirty patients classified severe pneumonia admission excluded leave <NUMBER> patients nonsevere covid<NUMBER> admission analysis amongst group <NUMBER> <NUMBER> patients developed severe pneumonia hospitalization n <NUMBER> <NUMBER> patients received single combined antiviral therapy admission adjusting age gender smoking history hypertension diabetes cardiovascular disease copd lung ct score none investigational antiviral therapies p <NUMBER> associated reduced risk progression severe disease shown table <NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint eightytwo individuals recorded hypertension <NUMBER> patients aceiarb therapy including <NUMBER> cases receiving arb monotherapy <NUMBER> cases receiving combined arb calciumantagonist <NUMBER> case receiving aeci monotherapy <NUMBER> patients nonaceiarb antihypertensive therapy including <NUMBER> cases receiving calciumantagonist monotherapy <NUMBER> cases receiving β blocker monotherapy <NUMBER> cases receiving diuretic monotherapy <NUMBER> cases receiving combined calciumantagonist β blocker maintained usual antihypertensive regimen hospitalization remaining <NUMBER> cases antihypertensive medications limited unavailable data received amlodipine nitrendipine control blood pressure necessary summarized table <NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint table <NUMBER> none patients treated chloroquine developed severe pneumonia though without significance difference <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p <NUMBER> addition significant difference reported adverse events ≥ grade <NUMBER> adverse events two groups p <NUMBER> <NUMBER> respectively study described use several adjuvant treatments preventing severe pneumonia development covid<NUMBER> patients hypertensive patients received aceiarb therapy lower risk developing severe pneumonia compared nonaceiarb antihypertensive therapy suggested aceiarb therapy may protective severe pulmonary injury hypertensive patients however results interpreted caution owing potential bias residual confounders observational study consistent earlier reports clinical experience around world cohort confirmed ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint older age hypertension without aceiarb therapy independently associated developing severe pneumonia covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> association age severe pneumonia may attributed accumulation medical comorbidities age decline immune function time given close collinearity age hypertension study adjusted age multivariate regression analysis revealed hypertension remained independent risk factor disease progression irrespective age patients without receiving aceiarb therapy study examined controversial topic covid<NUMBER> aceiarb therapy hypertensive patients found hypertensive patients aceiarb therapy less likely develop severe pneumonia although acknowledged analysis conducted limited sample size <NUMBER> <NUMBER> patients acei arb therapy dynamic profile laboratory radiological findings showed patient aceiarb therapy lactose dehydrogenase ct lung score lower nonaceiarb therapy <NUMBER> days admission together findings suggestive acei arb therapy may protective hypertensive patients covid<NUMBER> covid<NUMBER> patients hypertension may endure worse outcomes due decreased ace<NUMBER> levels ace<NUMBER> important component reninangiotensinaldosterone system raas highly expressed lung myocardium converts angiotensin ii aii angiotensin <NUMBER> downregulate ace directly cause vasodilatation <NUMBER> <NUMBER> <NUMBER> downregulation ace<NUMBER> level also shown hypertensive animal models although limited success translational confirmation human studies <NUMBER> <NUMBER> none less may exacerbated reduction available ace<NUMBER> following coronavirus infection sarscov ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint sarscov<NUMBER> gain entry host cell binding sprotein membranebound ace<NUMBER> aminopeptidase cleaved serine proteases allow membrane fusion invasion <NUMBER> following infection reduction pulmonary ace<NUMBER> either internalization viral entry andor downregulation ace<NUMBER> enzyme process hence may exacerbate lower baseline ace<NUMBER> function hypertensive patients lead accumulation aii reduced angiotensin <NUMBER> subsequently worse immunerelated cytolysis lung injury validated linear association elevated plasma aii level viral load lung injury covid<NUMBER> patients <NUMBER> use acei arb likely promotes feedback upregulation ace<NUMBER> expression hypertension although animal human studies also found either effect downregulation ace<NUMBER> level setting diabetes hypertension cardiovascular disease without acearb therapy <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> nonetheless may explain finding aceiarb therapy protective sarscov<NUMBER> infection evidence would support come earlier studies aceistatins protective severe pneumonia recombinant ace<NUMBER> protected mice lung injury following sarscov infection raas blockade reduced acute lung injury rats injected sarscov sprotein <NUMBER> <NUMBER> currently still specific treatment covid<NUMBER> except supportive care cohort <NUMBER> nonsevere patients received nonspecial antiviral therapy admission combination protocol medication dose varied different hospitals however results support single combined antiviral treatments limit progression covid<NUMBER> addition none <NUMBER> patients treated chloroquine developed severe pneumonia though without statistical significance unfortunately limited degree heterogeneity ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint cohort relatively small size chloroquine known block virus infection increasing endosomal ph required viruscell fusion well interfering glycosylation cellular receptors coronavirus confirmed inhibit sarscov<NUMBER> vitro <NUMBER> <NUMBER> <NUMBER> recent open label non randomized clinical trial reported hydroxychloroquine combined azithromycin significantly associated viral load reductiondisappearance covid<NUMBER> patients <NUMBER> even rcts assess therapeutic effects chloroquine covid<NUMBER> need conducted several limitations study first study conducted retrospective data analysis second cases incomplete laboratory test results given variation clinical management among different hospitals data generation clinically driven systematic third patients recovered discharged time data cutoff <NUMBER> patients died admission impact adjuvant treatment clinical outcomes cannot analyzed forth limited hypertensive patients received acei arb therapy cannot analyze effect aeci arb respectively larger cohort study covid<NUMBER> patients hypertension cities china countries would help validate potential protective effect aeciarb therapy covid<NUMBER> fastevolving global pandemic high mortality severe pneumonia ards multiorgan failure highest risk elderly patients underlying hypertension current adjuvant antiviral immunoregulation therapies yet proven ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint httpsdoiorg<NUMBER> doi medrxiv preprint benefits clinical settings importantly results show potential protective effects acei arb therapy limiting progression severe lung disease hypertensive patients ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint figure <NUMBER> study design flow chart included patients ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint httpsdoiorg<NUMBER> doi medrxiv preprint abbreviations acei angiotensinconverting enzyme inhibitors arb angiotensinreceptor blockers ci confidence interval copd chronic obstructive pulmonary disease ct computed tomography ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint httpsdoiorg<NUMBER> doi medrxiv preprint ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint coronavirus disease <NUMBER> covid<NUMBER> ongoing pandemic acute respiratory <NUMBER> disease caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> <NUMBER> mortality rates well infectious capacity virus ranging <NUMBER> <NUMBER> <NUMBER> raised major concern worldwide older people comorbid conditions pulmonary <NUMBER> disease cardiac disease kidney disease diabetes hypertension associated higher <NUMBER> mortality rates <NUMBER> according recent literature reports well accepted <NUMBER> hypertension associated increased mortality rates covid<NUMBER> patients mechanism sarscov<NUMBER> infection necessitates binding virus <NUMBER> membranebound form angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor internalization <NUMBER> complex host cell figure <NUMBER> apart role receptor sarscov<NUMBER> <NUMBER> sarscov related human respiratory coronavirus nl<NUMBER> ace<NUMBER> well<NUMBER> known role hypertension ace<NUMBER> modulates blood pressure maintains blood <NUMBER> pressure homeostasis negatively regulating reninangiotensin system ras <NUMBER> <NUMBER> angiotensinconverting enzyme ace homolog ace<NUMBER> two key enzymes involved <NUMBER> synthesis bioactive components ras <NUMBER> ace<NUMBER> exerts functions cleaving <NUMBER> either angiotensin angiotensin ii inactive peptides angiotensin <NUMBER> <NUMBER> angiotensin <NUMBER> respectively figure <NUMBER> angiotensin <NUMBER> gets metabolized <NUMBER> angiotensin <NUMBER> angiotensin <NUMBER> vasodilator hence ace<NUMBER> counteracts <NUMBER> vasoconstrictor effects aceangiotensin ii axis mechanism ace<NUMBER> <NUMBER> antagonizes effects angiotensin ii either cleaving precursor angiotensin <NUMBER> reduces ang ii synthesis tissues directly hydrolyzing angiotensin ii reducing <NUMBER> levels plasma <NUMBER> ace ace<NUMBER> endotheliumbound carboxypeptidases cleaved <NUMBER> different metalloproteases located cell surface released soluble form contrary <NUMBER> ace widely expressed many tissues organs ace<NUMBER>s high expression confined <NUMBER> endothelial cells arteries arterioles venules heart kidney <NUMBER> <NUMBER> therefore ace<NUMBER> potential therapeutic target treating hypertension well <NUMBER> cardiac dysfunctions several animal studies carried dietinduced hypertension rat <NUMBER> models established link increased blood pressure reduced mrna <NUMBER> expression protein levels ace<NUMBER> data showed low levels ace<NUMBER> lead elevated <NUMBER> levels ang ii consequently hypertension <NUMBER> animal studies suggested <NUMBER> angiotensinconvertingenzyme ace inhibitors angiotensinreceptor blockers arbs may <NUMBER> upregulate ace<NUMBER> expression thus increasing availability target molecules sarscov<NUMBER> <NUMBER> leeds family study rice et al <NUMBER> one first studies demonstrate <NUMBER> link ace<NUMBER> polymorphisms inheritance hypertension levels circulating <NUMBER> ace<NUMBER> <NUMBER> several genetic association studies examined relationship ace<NUMBER> <NUMBER> genetic variants risk developing hypertension different ethnic populations table <NUMBER> <NUMBER> <NUMBER> one highly reported variants rs<NUMBER> ag genotype variant protective <NUMBER> poses lower risk develop hypertension females <NUMBER> contrast aa genotype <NUMBER> opposed aggg snp rs<NUMBER> reported associated <NUMBER> higher risk hypertension different ethnic populations <NUMBER> highly reported variants <NUMBER> known associated high risk develop hypertension rs<NUMBER> tt genotype <NUMBER> rs<NUMBER> c allele <NUMBER> however european population study revealed <NUMBER> absence association rs<NUMBER> high blood pressure <NUMBER> concerns whether medical management hypertension involving use <NUMBER> inhibitors reninangiotensinaldosterone system raas aceis arbs <NUMBER> favorable impact people infected sarscov<NUMBER> deleterious one mainly acei <NUMBER> arb therapies modulate expression ace<NUMBER> concern use aceis <NUMBER> arbs increase expression ace<NUMBER> increase patient susceptibility viral host <NUMBER> cell entry propagation result call discontinuation <NUMBER> aceiarb usage prophylactically context suspected covid<NUMBER> cases <NUMBER> review shed light current debate ace<NUMBER> role mortality <NUMBER> associated covid<NUMBER> cases hypertension weigh current argument <NUMBER> usage discontinuation aceiarb hypertensive medication finally explore role <NUMBER> ace<NUMBER> genetic variants predisposition hypertension response however critical question remains unanswered whether <NUMBER> association solely attributed pathogenesis hypertension associated <NUMBER> comorbidity therapy section review recent findings regarding role <NUMBER> antihypertensive medications center considerable debate namely <NUMBER> angiotensinconverting enzyme inhibitors aceis angiotensin receptor blockers arbs <NUMBER> main question whether favorable impact people infected <NUMBER> sarscov<NUMBER> deleterious one mainly since acei arb therapies modulate <NUMBER> expression angiotensinconverting enzyme <NUMBER> ace<NUMBER> identified receptor <NUMBER> sarscov<NUMBER> concern use aceis arbs increase expression <NUMBER> ace<NUMBER> increase patient susceptibility viral host cell entry propagation result <NUMBER> call discontinuation aceisarbs usage prophylactically <NUMBER> hand groups suggesting opposite increased <NUMBER> ace<NUMBER> act vasodilator antioxidant antiinflammatory since ace<NUMBER> primarily <NUMBER> acts counterpoise effect ace ace produces angiotensin ii angiotensin ace<NUMBER> <NUMBER> generates angiotensin <NUMBER> angiotensin angiotensin <NUMBER> angiotensin ii none medications aceis arbs betablockers calciumchannel blockers <NUMBER> thiazide diuretics associated increased infectivity sarscov<NUMBER> increased covid<NUMBER> <NUMBER> severity study predefined <NUMBER> difference substantial difference even though <NUMBER> study powered detect low <NUMBER> difference worth mentioning data <NUMBER> pointed modest decrease likelihood testing positive sarscov<NUMBER> <NUMBER> severity patients taking betablockers slightly significant analysis included insurance health care access propensity scores <NUMBER> nonetheless studies <NUMBER> highlighted aceis arbs well antihypertensive drugs safe use <NUMBER> data showed treatment aceinhibitors associated reduced risk <NUMBER> rapidly deteriorating severe disease lesser rate death transfer icu <NUMBER> within <NUMBER> days patients aceinhibitor odds ratio <NUMBER> ci <NUMBER> p<NUMBER> <NUMBER> observed adjusting age gender several comorbidities hypertension diabetes <NUMBER> mellitus ischemic heart disease heart failure concluded among hospitalized table <NUMBER> <NUMBER> two variants namely rs<NUMBER> rs<NUMBER> downregulate expression <NUMBER> ace<NUMBER> others upregulate eqtl variants following genes intergenic <NUMBER> region ace<NUMBER> bmx fancb intergenic region mospd<NUMBER> asb<NUMBER> ace<NUMBER> intergenic <NUMBER> region ca<NUMBER>bp<NUMBER> ca<NUMBER>b cltrn almost variants common variants minor <NUMBER> allele frequency ≥ <NUMBER> one population raising possibility genetic <NUMBER> regulation ace<NUMBER> expression widespread however none variants <NUMBER> associated hypertension global studies ruling possibility common <NUMBER> genetic mechanism onset hypertension sarscov<NUMBER> infection even level <NUMBER> genes harbor eqtl variants none ace<NUMBER> known directly <NUMBER> involved onset hypertension covid<NUMBER> however requires studies <NUMBER> examine whether genes contributing extensive pathways regulating <NUMBER> hypertension covid<NUMBER> disease <NUMBER> several trials covid<NUMBER> patients already taking drugs <NUMBER> randomized continue stop furthermore must consider higher rate <NUMBER> cardiac injury adverse outcomes hypertensive patients covid<NUMBER> pandemic <NUMBER> undeniably loss aceisarbs cardiopulmonary protective effects could damaging <NUMBER> additionally based genetic analysis eqtl variants regulating expression ace<NUMBER> <NUMBER> gene far shown associated hypertension however ace<NUMBER> <NUMBER> polymorphisms associated hypertension efficacy acei arb could <NUMBER> potential alter binding sarscov<NUMBER> spike protein ace<NUMBER> receptor moreover <NUMBER> requires studies involving large cohorts evaluate genetic association <NUMBER> abovementioned eqtl variants gene loci hypertension traits evaluate <NUMBER> involvement abovementioned gene loci affect efficacy acei arb sars<NUMBER> cov<NUMBER> infection proliferation hence aceisarbs chronic therapy <NUMBER> discontinued hypertensive patients covid<NUMBER> moreover absence adequate <NUMBER> followup visits changing aceisarbs another antihypertensive therapy could lead <NUMBER> inadequate control blood pressure thus recommended several medical associations <NUMBER> light scientific evidence supporting beneficialnonharmful impact <NUMBER> aceisarbs continued covid<NUMBER> patients december <NUMBER> pneumonia caused unknown pathogen broke wuhan city capital hubei province china january <NUMBER> severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> identified pathogen underlying disease sarscov<NUMBER> forms unique clade sarbecovirus subgroup orthocoronavirus subfamily emerged seventh coronavirus infect human beings <NUMBER> march <NUMBER> <NUMBER> number confirmed cases coronavirus disease <NUMBER> caused sarscov<NUMBER> surpassed <NUMBER> globally resulting <NUMBER> deaths <NUMBER> previous studies shown patients underlying comorbidities worse outcomes laboratory indicators also associated mortality <NUMBER> <NUMBER> studies shown hypertension risk factor patients severe covid<NUMBER> <NUMBER> patients hypertension among died among survivors however effect hypertension outcomes covid<NUMBER> patients completely clear uniform therefore designed study investigate effect hypertension outcomes patients using propensity scorematching psm method eliminate influence confounding factors singlecenter retrospective cohort study conducted central hospital wuhan tertiary teaching hospital responsible treatment patients covid<NUMBER> assigned chinese government participants included study local residents wuhan hospitalized central hospital wuhan january <NUMBER> february <NUMBER> <NUMBER> relevant laboratory examinations commonpathogen detection chest computedtomography ct scanning conducted patient also underwent sarscov<NUMBER> nucleicacid swab test patients testing positive others negative immaturity methods incorrect sampling method used sarscov<NUMBER> nucleicacid detection might contributed falsenegative results highresolution ct scans scan layer thickness <NUMBER> mm reconstruction <NUMBER>to <NUMBER>mm thick layer recommended radiological examination covid<NUMBER> patients included patients clinically diagnosed covid<NUMBER> according world health organization whos interim guidelines <NUMBER> patients suspected illness two senior respiratory doctors made joint diagnosis divided participants study two groups survivors nonsurvivors critically ill patients defined following clinical signs fever suspected respiratory infection plus one following respiratory rate <NUMBER> breathsmin severe respiratory distress oxygen saturation spo<NUMBER> <NUMBER> room air patients acute respiratory distress syndrome ards sepsis septic shock also included patients viral bacterial fungal infections admission missing data excluded participants hypertension study previously diagnosed clinician regularly took oral antihypertensive medications long period time outcomes observed study either inhospital death discharge hospital study approved ethics committee wuhan central hospital retrospective study require protection patients privacy exempted obtaining informed consent reviewed electronic medical records obtained chronic comorbidities demographic data laboratory examination results chest ct images data counts levels white blood cells wbcs lymphocytes l neutrophils n alanine transaminase alt aspartate aminotransferase ast serum albumin alb serum creatinine scr blood urea nitrogen bun ddimer creactive protein crp included diagnoses hypertension came electronic medical records system length hospital stay obtained discharge records also learned patients outcome scores acute physiology chronic health evaluation ii apache ii calculated critically ill patients within <NUMBER> h admission obtained dosage duration hormone use physician medication order entry systems physicians acquired data via examination first day admission data checked another researcher ascertain accuracy continuous variables presented means standard deviation sd compared using tests normally distributed described using medians interquartile ranges iqrs mannwhitney u test used comparisons expressed descriptive data number categorical variables compared via chisquare test fishers exact test used kaplanmeier km method evaluate relationships variables outcome cox proportionalhazard model cphm analysis clarify effects factor outcome twosided α value <NUMBER> considered statistically significant analyzed data using ssps software version <NUMBER> ibm corp armonk new york us performing statistical analysis described conducted psm analysis minimize effect selection bias control potential confounding factors psm analysis attempts compare outcomes patients similar distributions covariates measured thus enabling clarification variables effects outcome matching performed using <NUMBER> matching protocol without replacement greedymatching algorithm caliper width <NUMBER> standard deviation logit propensity score adjusted comparative risks outcomes matched cohort using cphm total <NUMBER> patients covid<NUMBER> enrolled analysis january <NUMBER> february <NUMBER> <NUMBER> <NUMBER> <NUMBER> tested positive sarscov<NUMBER> nucleic acids nonsurvivors accounted <NUMBER> participants basic characteristics study population shown table <NUMBER> nonsurvivors tended older chronic comorbidities hypertension type <NUMBER> diabetes mellitus t<NUMBER>dm coronary heart disease chd however significant difference proportion patients chronic obstructive pulmonary disease copd two groups compared survivors nonsurvivors significantly higher serum n counts higher levels crp ast scr bun ddimer serum alb levels l counts nonsurvivors lower survivors ratio neutrophils lymphocytes nl significantly higher nonsurvivors addition significant differences sex alt levels time onset admission apparent multivariate cox regression analysis performed km analysis screen appropriate variables order make results accurate categorical variables statistically significant differences two groups directly analyzed km analysis continuous variables converted categorical variables according median number km analysis km analysis found age hypertension t<NUMBER>dm nl crp ast alb bun ddimer effects patient outcomes table s<NUMBER> supplementary appendix conducted multivariate cphm analysis certify whether variables affected patient outcomes incorporated cphm analysis sex scr results demonstrated patients hypertension higher mortality risk hazard ratio hr <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> fig <NUMBER> addition elevated ddimer levels higher nl might also increased patients risk death table <NUMBER> basic characteristics critically ill patients listed table s<NUMBER> supplementary appendix patients <NUMBER> died nonsurvivors older nonsurvivors survivors hypertension <NUMBER> vs <NUMBER> p <NUMBER> nl ddimer levels significantly higher nonsurvivors survivors hormone use slightly different two groups severely ill patients treated methylprednisolone significant difference average daily dose methylprednisolone groups surprisingly methylprednisolone used shorter durations patients died survivors addition nonsurvivors higher apache ii scores also conducted multivariate cphm analysis critically ill patients hypertension increased ddimer fig <NUMBER> methylprednisolone dose days use significant effect outcomes covid<NUMBER> patients abovementioned results indicated hypertension great influence outcomes patients covid<NUMBER> decrease effects confounding factors relationship hypertension outcomes used onetoone psm analysis psm patients hypertension differed significantly without covariates applied analysis critically ill patients using psm matched <NUMBER> patients hypertension <NUMBER> without results prematching postmatching presented table s<NUMBER> supplementary appendix cphm analysis results similar obtained matching table <NUMBER> effect hypertension outcomes still significant critically ill patients fig<NUMBER> retrospective cohort study showed hypertension increased levels ddimer higher nl associated increased mortality patients covid<NUMBER> high apache ii score also correlated death critically ill patients hypertension prominent abovementioned risk factors cohorts study first report risk factors mortality covid<NUMBER> patients using psm analysis results psm already obtained psm analysis via psm analysis provided robust evidence support association hypertension increased mortality study involving <NUMBER> patients covid<NUMBER> logisticregression analysis showed odds inhospital death higher patients hypertension <NUMBER> another study conducted january <NUMBER> <NUMBER> <NUMBER> patients covid<NUMBER> died <NUMBER> <NUMBER> hypertension <NUMBER> yang et al performed systematic review metaanalysis including <NUMBER> covid<NUMBER> patients <NUMBER> results showed pooled odds ratio hypertension severe patients <NUMBER> <NUMBER> ci <NUMBER> compared nonsevere patients indicating hypertension might risk factor severely ill patients addition previous studies shown hypertension also factor prognoses patients infected viruses hypertension one predictor ards patients severe acute respiratory syndrome per results study clinical features outcomes severe acute respiratory syndrome <NUMBER> based six indices multilobular infiltration hypolymphocytosis bacterial coinfection smoking history hypertension age guo et al created mulbsta score system based multivariate logisticregression model predict mortality patients viral pneumonia within <NUMBER> days <NUMBER> hypertension <NUMBER> mulbsta score <NUMBER> study influenza suggested patients hypertension suffered significantly higher risk death <NUMBER> <NUMBER> ci <NUMBER> patients comorbidities <NUMBER> researchers reported deaths three people infected avianinfluenza h<NUMBER>n<NUMBER> virus shanghai <NUMBER> two hypertension <NUMBER> role hypertension covid<NUMBER> progression remains unclear results showed l count hypertensive group significantly lower nonhypertensive group true critically ill patients speculated poor outcome hypertension group might associated impairment immune function caused decrease lymphocytes consistent hypothesis recent study involving <NUMBER> patients hypertension showed significant decrease peripheral blood cd<NUMBER> cd<NUMBER> cd<NUMBER> tcell hypertensive patients versus healthy controls <NUMBER> additionally found angiotensinconverting enzyme inhibitor angiotensin ii receptor blocker drugs could significantly increase expression angiotensinconverting enzyme <NUMBER> ace<NUMBER> messenger ribonucleic acid rat hearts <NUMBER> ace<NUMBER> receptor sarscov<NUMBER> humans increase ace<NUMBER> messenger ribonucleic acid expression could aggravate illness study needed determine whether certain antihypertensive drugs contribute poor clinical outcomes patients covid<NUMBER> finally hypertension chronic diseases share common characteristics proinflammatory state attenuation innate immune response therefore body cannot effectively control virus early stage leads aggravation illness covid<NUMBER> patients <NUMBER> <NUMBER> study needed role hypertension disease addition hypertension found high ddimer levels high nl associated increased inhospital mortality covid<NUMBER> patients general critically ill ones particular consistent previous studies nl might reflect levels inflammation immune response human body viral infection studies shown coronaviruses consume many immune cells leading great reduction lymphocytes inhibits cellular immune function damage cells might important factor leading deterioration patients <NUMBER> <NUMBER> neutropenia represents aggravation inflammatory response cytokine storm lymphocytes main immuneactive cells body l count early marker physiological stress systemic inflammation <NUMBER> <NUMBER> <NUMBER> wang et al reported <NUMBER> patients covid<NUMBER> survivors higher n counts lower l counts nonsurvivors <NUMBER> neutrophils proven related development ards progression ards death patients covid<NUMBER> <NUMBER> study zhou et al univariate analysis showed decreased l count associated inhospital death patients <NUMBER> consistent results recent study <NUMBER> patients covid<NUMBER> showed ddimer <NUMBER> μgml associated fatal outcomes <NUMBER> two studies including <NUMBER> <NUMBER> patients covid<NUMBER> ddimer levels significantly higher nonsurvivors versus survivors <NUMBER> <NUMBER> recently bivariate cox regression analysis also suggested higher ddimer levels related development ards progression ards death patients covid<NUMBER> hr <NUMBER> <NUMBER> ci <NUMBER> hr <NUMBER> <NUMBER> ci <NUMBER> respectively <NUMBER> mechanism fatal outcome patients higher ddimer could systemic proinflammatory cytokine responses induce production procoagulant factors hemodynamic changes <NUMBER> <NUMBER> addition study showed high score apache ii tool estimating disease severity mortality inhospital critically ill patients associated increased mortality patients severe covid<NUMBER> patients high apache ii scores also found higher risk death studies studies suggest clinicians pay attention patients high apache ii scores following shortcomings existed research first singlecenter study limited fig <NUMBER> cox regression survival plot according hypertension propensity score matching psm critically ill patients number cases included writing epidemic spread throughout world multicenter study carried includes hospitals wuhan cities china countries worldwide yield comprehensive understanding factors affecting outcomes covid<NUMBER> patients second study retrospective indicators included study finite findings chest ct viral load respiratory tract circulation angiotensin ii lymphocyte subsets could potential indicators outcomes patients confirmed studies finally due failure record classification stratification use antihypertensive drugs patients hypertension necessary explore whether factors could influence patient outcomes hypertension high ddimer levels high neutrophiltolymphocyte ratio increased mortality patients covid<NUMBER> hypertension prominent factors clinicians note findings multicenter prospective studies large samples needed validate findings supplementary information accompanies paper httpsdoiorg<NUMBER> <NUMBER>s<NUMBER> additional file <NUMBER> table s<NUMBER> shown thant results univariate kaplanmeier analysis participators table s<NUMBER> listed baseline characteristics critically ill patients baseline characteristics critically ill patients without hypertension presented table s<NUMBER> coronavirus disease <NUMBER> covid<NUMBER> spread across globe officially confirmed world health organization public health emergency <NUMBER> covid<NUMBER> infected <NUMBER> million people killed <NUMBER> people globally total number cases deaths increasing every day covid<NUMBER> patients present mild symptoms portions patients may develop severe pneumonia progression lethal complications including acute respiratory distress syndrome ards multiorgan failure death determining risk factors anticipate severity covid<NUMBER> essential efficient resource allocation <NUMBER> especially pandemic season hypertension one prevalent chronic diseases affecting approximately <NUMBER> adults <NUMBER> billion worldwide year <NUMBER> <NUMBER> postulated hypertensive patients increased angiotensinconverting enzyme <NUMBER> ace<NUMBER> expression due associated genetic polymorphism use angiotensinconverting enzyme inhibitor acei angiotensinreceptor blocker arb even though still controversial may increase susceptibility severity study aimed investigating association hypertension poor outcome patients covid<NUMBER> pneumonia performing systematic review metaanalysis included research studies enrolling adult covid<NUMBER> patients information hypertension specific outcome interests mortality severe covid<NUMBER> ards intensive care unit icu care disease progression excluded review articles nonresearch letters communications commentaries studies samples <NUMBER> case reports small case series nonenglish language articles research paediatric populations <NUMBER> years age younger comprehensive systematic literature search performed using pubmed scopus europepmc google scholar electronic databases using search terms covid<NUMBER> sarscov<NUMBER> hypertension b covid<NUMBER> sarscov<NUMBER> characteristics records curated initial search screened duplicates removed two independent authors ih mal screened title abstracts potential articles fulltexts remaining articles evaluated applying inclusion exclusion criteria systematic literature search finalized <NUMBER> april <NUMBER> study carried accordance preferred reporting items systematic reviews metaanalyses prisma guideline standardized forms containing first author year study design age gender cardiovascular diseases hypertension diabetes chronic obstructive pulmonary disease copd need icu care severe covid<NUMBER> used data extraction two authors mal rp performed data extraction independently outcome interest metaanalysis composite poor outcome comprised mortality severe covid<NUMBER> ards need icu care disease progression severe covid<NUMBER> defined according report whochina joint mission covid<NUMBER> <NUMBER> ards defined per interim guidance severe acute respiratory infection sari covid<NUMBER> <NUMBER> perform metaanalysis used review manager <NUMBER> cochrane collaboration stata version <NUMBER> softwares calculate dichotomous variables used mantelhaenszel formula generate pooled effect estimate form risk ratios rrs along <NUMBER> confidence intervals cis randomeffects model used regardless heterogeneity account interstudy variability pvalues study twotailed statistical significance set ⩽ <NUMBER> assess influence covariates restrictedmaximum likelihood random effects metaregression performed age gender cardiovascular disease diabetes copd individual components composite poor outcome subanalysed sensitivity analysis leaveoneout method used single cause heterogeneity test statistical robustness evaluate smallstudy effects regressionbased harbords test binary outcome performed funnelplot analysis performed assess risk publication bias qualitatively <NUMBER> records initial database searching <NUMBER> records remained removal duplicates screening titleabstract <NUMBER> records excluded <NUMBER> residual articles evaluated eligibility assessing fulltext article <NUMBER> fulltext articles excluded hypertension variable n <NUMBER> b specific groups ie myocarditis cardiac injury n <NUMBER> c groups divided based outcome n <NUMBER> thereby <NUMBER> studies total <NUMBER> patients included final qualitative quantitative synthesis figure <NUMBER> table <NUMBER> metaanalysis showed hypertension associated increased composite poor outcome rr <NUMBER> <NUMBER> <NUMBER> p <NUMBER> <NUMBER> <NUMBER> p <NUMBER> figure <NUMBER> subgroup analysis showed hypertension associated increased mortality metaregression analysis showed association hypertension increased composite poor outcome influenced gender p <NUMBER> figure <NUMBER> age p <NUMBER> figure <NUMBER> b cardiovascular diseases p <NUMBER> diabetes p <NUMBER> copd p<NUMBER> subgroup analysis studies percentage males ⩾ <NUMBER> rr <NUMBER> <NUMBER> <NUMBER> p <NUMBER> <NUMBER> <NUMBER> p <NUMBER> lower rr composite poor outcome compared <NUMBER> rr <NUMBER> <NUMBER> <NUMBER> p <NUMBER> <NUMBER> <NUMBER> p <NUMBER> figure <NUMBER> c subgroup analysis studies median age ⩾ <NUMBER> years old rr <NUMBER> <NUMBER> <NUMBER> p <NUMBER> <NUMBER> <NUMBER> p <NUMBER> slightly higher rr composite poor outcome compared <NUMBER> years old rr <NUMBER> <NUMBER> <NUMBER> p <NUMBER> <NUMBER> <NUMBER> p <NUMBER> funnelplot analysis showed qualitatively symmetrical funnel plot association hypertension increased composite poor outcome figure <NUMBER>a regressionbased harbords test showed indication smallstudy effects hypertension increased composite poor outcome p <NUMBER> figure <NUMBER>b based metaanalysis hypertension shown associated increased composite poor outcome consists mortality severe covid<NUMBER> ards need icu care disease progression patients covid<NUMBER> association influenced gender age cardiovascular disease diabetes copd association hypertension increased poor outcome stronger studies lower percentage male patients still unclear whether hypertensive people likely contract covid<NUMBER> infection however individuals hypertension tend severely affected covid<NUMBER> ace<NUMBER> becomes likely explanation <NUMBER> ace<NUMBER> type <NUMBER> integral membrane glycoprotein found epithelial cells cardiac kidney lung intestinal tissue converts angiotensin ii angiotensin <NUMBER> <NUMBER> <NUMBER> thus presence ace<NUMBER> neutralizes inflammatory effects angiotensin ii reduces levels proinflammatory cytokine interleukin<NUMBER> enhances antiinflammatory antioxidant roles angiotensin <NUMBER> increases concentration alveolar surfactant protein triggers vasodilation <NUMBER> <NUMBER> likely novel coronavirus responsible covid<NUMBER> worked similar pathway coronavirus caused sarscov use ace<NUMBER> surfaces epithelial cells receptor attach enter host pneumocytes <NUMBER> <NUMBER> <NUMBER> viral surface spike protein covid<NUMBER> binds ace<NUMBER> receptor following spike protein activation transmembrane protease serine <NUMBER> tmprss<NUMBER> <NUMBER> <NUMBER> activation reninangiotensin system ras various tissues associated conditions hypertension regular use medications including arb acei upregulates ace<NUMBER> expression therefore facilitating entry sarscov<NUMBER> pneumocytes ultimately increases severity fatality infection <NUMBER> <NUMBER> overexpression ace<NUMBER> supposed provide protection lungs downregulated viral uptake enzyme gets diminished resulting reduced angiotensinii degradation increased aldosterone secretion consequently loss potassium via urine <NUMBER> interplay hypertension gender ras may explanation result regarding association hypertension outcome lower percentage male patients hypertensive females greater activity angiotensin ii type <NUMBER> receptor at<NUMBER>r angiotensin ii type at<NUMBER>r translates attenuation harmful response at<NUMBER>r activation <NUMBER> expression activation at<NUMBER>r seen hypertensive males hypothesized causing vasoconstriction proinflammatory response increasing oxidative stress leading ards severe covid<NUMBER> <NUMBER> <NUMBER> condition provides explanation higher incidence severe covid<NUMBER> males compared females oestrogen postulated bringing predisposition towards good ras females <NUMBER> although data concerning menopausal status women included studies majority subjects included studies older age groups could explain association hypertension outcome stronger studies lower percentage male patients nevertheless result interpreted cautiously due known limitations metaregression hypothesisgenerating finding individual patientlevel subgroup analysis preferably adjustment various confounders needs performed confirm deny preliminary finding currently scientific evidence showing termination acei arb patients covid<NUMBER> infection would beneficial authorities field still recommend patients continue regular antihypertensives theoretically inhibiting breakdown angiotensin ii using acei blocking angiotensin at<NUMBER>r using arb could decrease inflammation systematically specifically lung heart kidney ultimately reduces potential complication covid<NUMBER> including ards myocarditis acute kidney injury <NUMBER> discontinuation acei arb covid<NUMBER> patients hypertension might potentially harmful continue offer cardiovascular renal protection fact use arb studied treatment covid<NUMBER> complications studies shown covid<NUMBER> downregulates ace<NUMBER> expression hinders organoprotective effect <NUMBER> hypothesized unregulated angiotensinii activity leads multiple organ injury <NUMBER> <NUMBER> furthermore ace<NUMBER> shown protect lungs ards <NUMBER> hence drugs may increase ace<NUMBER> may offer protection rather harm although ace<NUMBER> singled port entry covid<NUMBER> plays substantial antiinflammatory role reninangiotensinaldosterone system ras signalling elderly hypertension lower ace<NUMBER> levels higher ras signalling develops extremely low ace<NUMBER> levels markedly elevated ras signalling covid<NUMBER> infection resulting likely reduced incidence disease greater severity <NUMBER> contrary younger individuals without hypertension higher ace<NUMBER> levels lower ras signalling turns modestly low ace<NUMBER> levels modestly enhanced ras signalling infected covid<NUMBER> resulting potentially increased incidence disease lesser severity supports suggestion continuing treatment ras antagonists aceiarb order prevent lung injury due covid<NUMBER> including sepsisassociated lung injury <NUMBER> effect estimate subgroup analysis age ⩾ <NUMBER> <NUMBER> years old differs slightly ⩾ <NUMBER> years old associated slightly higher risk however metaregression demonstrate significant differences across age groups significance remains uncertain direct comparison older younger patients needed regardless potential benefit harm associated aceiarb controlling blood pressure important prevent cardiovascular complications data hypertensive medications lacking included studies hence unable provide metaanalysis metaregression aceiarb hypertension associated increased poor outcome patients covid<NUMBER> association affected age gender presence cardiovascular disease diabetes copd designates hypertension may act one potential prognostic factors covid<NUMBER> severity sought triage label hypertension universal included studies may different definition hypertension stage hypertension whether controlled poorly controlled also unknown data chronic hypertensive medications adequately reported included studies cannot analysed data may provide insight aceiarb impact prognosis additionally included studies subject potential confounders may weaken strengthen effect estimate result metaregression interpreted cautiously due known limitations analysis articles included study published preprints servers yet peer reviewed majority studies originated china patients perhaps overlapping across reports studies included retrospective design hypertension associated increased mortality severe covid<NUMBER> ards need icu care disease progression patients covid<NUMBER> association stronger studies lower percentage male patients authors declared potential conflicts interest respect research authorship andor publication article authors received financial support research authorship andor publication article new coronavirus severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> infection began spread wuhan china early december <NUMBER> rapidly spread around globe disease condition associated novel coronavirus referred coronavirus disease <NUMBER> covid <NUMBER> outbreak declared pandemic march <NUMBER> <NUMBER> world health organization <NUMBER> may <NUMBER> <NUMBER> outbreak reached globally <NUMBER> confirmed cases <NUMBER> deaths <NUMBER> patients recovered <NUMBER> numbers much greater <NUMBER> despite fact covid<NUMBER> mortality rate date lower <NUMBER> <NUMBER> sarscov<NUMBER> binds mainly angiotensin converting enzyme <NUMBER> ace<NUMBER> receptors host cells abundant lungs heart blood vessels intestine decade research still specific treatments effective vaccines coronavirus <NUMBER> <NUMBER> <NUMBER> <NUMBER> covid<NUMBER> presents respiratory symptoms mild severe significant percentage patients develop acute respiratory disease syndrome ards severe symptoms associated true cytokine storm particular il<NUMBER> death one outcomes <NUMBER> old age underlying morbidities cardiovascular diseases particular hypertension metabolic disorders obesity diabetes identified significant risk factors covid<NUMBER> morbidity mortality <NUMBER> <NUMBER> <NUMBER> however asthma copd may common comorbidities <NUMBER> moreover real impact sarscov<NUMBER> asthma control unclear systematic search carried following <NUMBER> electronic databases embase medline medrxiv scopus assess relationship asthma covid<NUMBER> using studies english language may <NUMBER> <NUMBER> search terms included covid<NUMBER> sarscov<NUMBER> coronavirus asthma allergy case series comorbidities epidemiology hospitalization risk factors additionally references initial included studies hand searched identify possibly eligible studies results first epidemiologic studies covid<NUMBER> pandemic china apparently identify asthma risk factor severe covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> children treated wuhan childrens hospital wuhan china <NUMBER> <NUMBER> required intensive care mechanical ventilation underlying diseases asthma reference <NUMBER> data found crosssectional multicenter study carried <NUMBER> hospitals across hubei province china including hospitalized children covid<NUMBER> <NUMBER> table <NUMBER> dong et al <NUMBER> china nationwide case series <NUMBER> pediatric patients mean age <NUMBER> years covid<NUMBER> observed cases chinese center disease control prevention january <NUMBER> <NUMBER> february <NUMBER> <NUMBER> hubei province report asthma case survey <NUMBER> adult patients admitted covid<NUMBER> china clinical characteristics allergy status patients investigated patients communityacquired cases hypertension <NUMBER> diabetes mellitus <NUMBER> common comorbidities drug hypersensitivity <NUMBER> urticaria <NUMBER> selfreported several patients asthma allergic diseases reported patients authors concluded allergic diseases asthma risk factors sarscov<NUMBER> infection older age high number comorbidities ie cardiovascular metabolic diseases associated covid<NUMBER> severity <NUMBER> authors studied larger sample <NUMBER> confirmed covid<NUMBER> adult patients hospitalized found <NUMBER> patient asthma <NUMBER> hypertension diabetes mellitus frequently found comorbidities <NUMBER> another retrospective multicenter cohort study included <NUMBER> adult inpatients confirmed covid<NUMBER> wuhan china <NUMBER> least <NUMBER> comorbid disease hypertension common followed diabetes coronary heart dis ease asthma reference <NUMBER> survey <NUMBER> adult patients admitted covid<NUMBER> tongji hospital wuhan china asthma prevalence rate <NUMBER> found markedly lower adult population region <NUMBER> <NUMBER> study asthma identified risk factor disease severity contrast hypertension <NUMBER> nationwide analysis china <NUMBER> including <NUMBER> covid<NUMBER> cases <NUMBER> hospitals <NUMBER> provincial administrative regions reported overall rate severe cases mortality <NUMBER> <NUMBER> respectively prevalent comorbidity hypertension <NUMBER> followed diabetes <NUMBER> one hundred thirty <NUMBER> patients reported <NUMBER> comorbidities none cases physiciandiagnosed asthma adjusting age smoking status copd hr <NUMBER> <NUMBER> ci <NUMBER> diabetes hr <NUMBER> <NUMBER> ci <NUMBER> hypertension hr <NUMBER> <NUMBER> ci <NUMBER> malignancy hr <NUMBER> <NUMBER> ci <NUMBER> identified significant severity risk factors including intensive care unit icu admission mechanical ventilation death <NUMBER> europe sample <NUMBER> patients covid<NUMBER> died italy mean age <NUMBER> years reported comorbidities associated increased mortality risk thirty percent patients ischemic heart disease <NUMBER> diabetes <NUMBER> active cancer <NUMBER> atrial fibrillation <NUMBER> dementia <NUMBER> history stroke reference chronic respiratory diseases made ie asthma chronic obstructive pulmonary disease copd <NUMBER> also retrospective case series <NUMBER> consecutive patients laboratoryconfirmed covid<NUMBER> admitted icu <NUMBER> hospitals lombardy region italy february <NUMBER> march <NUMBER> <NUMBER> <NUMBER> patients least <NUMBER> comorbidity hypertension common comorbidity affecting <NUMBER> <NUMBER> patients available data second common comorbidities cardiovascular disease <NUMBER> hypercholesterolemia <NUMBER> <NUMBER> history copd reference patients asthma <NUMBER> confidence study <NUMBER> included <NUMBER> pediatric covid<NUMBER> cases also italy median age <NUMBER> years <NUMBER> mild disease <NUMBER> severe disease reference chronic respiratory diseases found previous pediatric chinese surveys lu et al <NUMBER> dong et al <NUMBER> borobia et al <NUMBER> la paz university hospital madrid spain sample <NUMBER> adult patients median age <NUMBER> years admitted hospital either died <NUMBER> discharged <NUMBER> identified common comorbidity hypertension <NUMBER> followed chronic cardiovascular diseases <NUMBER> diabetes <NUMBER> asthma identified <NUMBER> covid<NUMBER> patients lower prevalence rate <NUMBER> fatal cases copd affected <NUMBER> population prevalence <NUMBER> fatal cases also spain catalonia prietoalhambra et al <NUMBER> analyzed primary care database covering <NUMBER> million people including <NUMBER> covid<NUMBER> patients hospitalized outpatients common comorbidities hypertension <NUMBER> obesity <NUMBER> asthma present <NUMBER> patients copd found <NUMBER> <NUMBER> patients treated inhalers <NUMBER> covid<NUMBER> patients hospitalized lausanne university hospital switzerland <NUMBER> asthma prevalence rate <NUMBER> found asthma prevalence rate <NUMBER> patients required mechanical ventilation usa bhatraju et al <NUMBER> seattle wa usa reported <NUMBER> patients covid<NUMBER> admitted icu mortality rate <NUMBER> coexisting disorders <NUMBER> diabetes <NUMBER> current former tobacco smokers <NUMBER> chronic kidney disease <NUMBER> asthma corresponding <NUMBER> cases mild asthma treated systemic corticosteroids week icu admission outpatients presumed asthma exacerbation patients subsequently admitted icu severe respiratory failure requiring invasive mechanical ventilation <NUMBER> arentz et al <NUMBER> wausa described case series characteristics outcomes <NUMBER> patients covid<NUMBER> admitted icu evergreen hospital mean age <NUMBER> years range <NUMBER> years common comorbidities identified chronic kidney disease <NUMBER> congestive heart failure <NUMBER> diabetes <NUMBER> copd <NUMBER> two patients asthma <NUMBER> data usa regarding <NUMBER> cases children <NUMBER> years showed <NUMBER> least <NUMBER> comorbidity <NUMBER> chronic respiratory diseases ie asthma common associated diseases although authors quantify prevalence comorbidities frequently present pediatric patients required hospitalization compared admitted hospital <NUMBER> vs <NUMBER> reference asthma significant risk factor <NUMBER> sample <NUMBER> adult covid<NUMBER> patients admitted california usa hospitals <NUMBER> nondiscriminated asthma copd <NUMBER> data analysis patients hospitalized <NUMBER> states usa covid<NUMBER> march <NUMBER> n <NUMBER> <NUMBER> confirmed hospitalization much frequent adults <NUMBER> aged ≥<NUMBER> years among patients information underlying conditions n <NUMBER> <NUMBER> <NUMBER> comorbidities common hypertension cardiovascular diseases <NUMBER> followed obesity <NUMBER> diabetes mellitus <NUMBER> seventeen percent covid<NUMBER>positive patients asthma <NUMBER> copd according centers disease control prevention cdc report admitted patients aged <NUMBER> years obesity prevalent underlying condition <NUMBER> followed asthma <NUMBER> <NUMBER> report <NUMBER> hospitals georgia usa also summarized medical data <NUMBER> adult patients confirmed covid<NUMBER> admitted march <NUMBER> overall <NUMBER> <NUMBER> patients underlying conditions hypertension <NUMBER> diabetes <NUMBER> cardiovascular diseases <NUMBER> found severe obesity bmi ≥<NUMBER> present <NUMBER> patients asthma identified <NUMBER> patients <NUMBER> patients aged <NUMBER> years <NUMBER> aged <NUMBER> years <NUMBER> aged ≥<NUMBER> years statistically significant differences copd <NUMBER> <NUMBER> large sample hospitalized covid patients <NUMBER> adults included <NUMBER> patients hospitalized covid<NUMBER> new york city area ny usa <NUMBER> treated icu <NUMBER> received invasive mechanical ventilation <NUMBER> died <NUMBER> asthma prevalence found <NUMBER> reference asthma severitycontrol copd found <NUMBER> common comorbidities hypertension <NUMBER> obesity <NUMBER> diabetes <NUMBER> <NUMBER> ny mount sinai hospitals <NUMBER> prevalence asthma found <NUMBER> hospitalized patients significantly different died <NUMBER> <NUMBER> also ny usa first <NUMBER> consecutive adult patients positive sarscov<NUMBER> pcr test presented emergency department hosasthma covid<NUMBER> pandemic <NUMBER> int arch allergy immunol doi <NUMBER> pitalized new yorkpresbyteriancolumbia university irving medical center march <NUMBER> april <NUMBER> <NUMBER> asthma prevalence <NUMBER> found also significantly different admitted icu <NUMBER> <NUMBER> isaric prospective observational cohort study <NUMBER> near realtime analysis participation <NUMBER> uk hospitals <NUMBER> covid<NUMBER> hospitalized patients included february <NUMBER> april <NUMBER> <NUMBER> mostly adults commonest comorbidities chronic cardiac disease <NUMBER> uncomplicated diabetes <NUMBER> nonasthmatic chronic pulmonary disease <NUMBER> asthma <NUMBER> <NUMBER> documented reported comorbidity increased age comorbidities including obesity associated higher probability mortality <NUMBER> recent data opensafely collaborative study <NUMBER> identified asthma significant risk factor death covid<NUMBER> england uk authors conducted cohort study included <NUMBER> adults using national primary care electronic health record data linked inhospital covid<NUMBER> death data february <NUMBER> <NUMBER> april <NUMBER> <NUMBER> older age age strongly associated risk age group ≥<NUMBER> years <NUMBER>fold increased risk compared aged <NUMBER> years comorbidities associated higher risk covid<NUMBER> hospital death including asthma fully adjusted hr <NUMBER> <NUMBER> <NUMBER> greater hr recent use oral corticosteroid ocs hr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> data uk biobank <NUMBER> prospective casecontrol study showed asthma prevalence <NUMBER> <NUMBER> covid<NUMBER> hospitalized patients adults asthma prevalence <NUMBER> control population disease identified independent risk factor covid<NUMBER> hospitalizationseverity contrast hypertension copd oldest population age ≥<NUMBER> years included uk biobank <NUMBER> tendency asthma prevalence found hospitalized covid<NUMBER> patients versus controls <NUMBER> vs <NUMBER> asthma identified independent risk factor severity report middle east saudi arabia <NUMBER> included <NUMBER> hospitalized adult patients mean age <NUMBER> years found <NUMBER> <NUMBER> covid<NUMBER> population hypertension diabetes respectively asthma prevalence <NUMBER> <NUMBER> patient asthma admitted icu study aiming estimate risk factors hospitalization death mexican population <NUMBER> infected sarscov<NUMBER> n <NUMBER> mean age <NUMBER> years <NUMBER> hospitalized <NUMBER> fatal cases hypertension prevalent comorbidity found <NUMBER> followed obesity <NUMBER> diabetes <NUMBER> asthma prevalence <NUMBER> population <NUMBER> hospitalized patients <NUMBER> fatal cases patients hypertension obesity diabetes likely hospitalized die people without comorbidities asthma identified independent risk factor hospitalization andor mortality <NUMBER> based available literature clear evidence patients asthma higher risk infected becoming severely ill sarscov<NUMBER> although recent reports usa uk suggest asthma much common children adults covid<NUMBER> previously reported asia first surveys continental europe nevertheless prevalence several underlying conditions identified us hospitalized patients covid<NUMBER> similar hospitalized influenza patients influenza seasons <NUMBER> <NUMBER> ie regarding chronic respiratory diseases <NUMBER> <NUMBER> particular note uk association asthma higher risk covid<NUMBER> hospital death hr increasing received ocs probably indicating greater severity disease contrasts previous findings several countries asthma chronic respiratory diseases underrepresented hospitalized patients <NUMBER> also uk asthma reported <NUMBER> <NUMBER> hospitalized patients increased risk death <NUMBER> <NUMBER> among school age children viral infection reportedly accounts <NUMBER> asthma exacerbations viruses frequently isolated symptomatic patients asymptomatic patients <NUMBER> <NUMBER> even though respiratory viruses one common triggers asthma exacerbations age groups viruses affect patients equally particular human rhinovirus identified main individual contributor asthma exacerbations coronavirus one less identified triggers asthma exacerbations children well adults <NUMBER> recent literature review concerning virus detection asthma exacerbations confirmed exacerbations mainly associated rhinovirus infection continents <NUMBER> previous sars outbreaks patients asthma particular children appeared less susceptible coronavirus reported low rate asthma exacerbations good prognosis followup <NUMBER> <NUMBER> contrast influenza epidemics asthma associated severe disease including need mechanical ventilation adults also children <NUMBER> exact reasons remain unknown confirmed current coronavirus pandemic <NUMBER> recent covid<NUMBER> literature definite conclusions drawn regarding asthma control severity similarly information extrapolated asthma phenotypes ie regarding whether asthma allergic covid<NUMBER> outcomes vary asymptomatic infection death possible clinical range reflects different airway levels sarscov<NUMBER> receptor ace<NUMBER> spike protein activator transmembrane protease serine <NUMBER> tmprss<NUMBER> considering virus cell entry also depends sprotein priming host cell proteases blood eosinophil levels wellknown predictor airway t<NUMBER> inflammation <NUMBER> measurement blood eosinophil levels used accessible strong proxy investigation association airway t<NUMBER> inflammation covid<NUMBER> outcomes early reports china detailed clinical investigation hospitalized covid<NUMBER> cases suggested severe eosinopenia together lymphopenia potential indicator diagnosis worse prognosis including death <NUMBER> believed low eosinophil counts peripheral blood would related sarscov<NUMBER> infection however recent studies china italy reported eosinopenia patients severe covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> although relationship eosinophil counts covid<NUMBER> uncertain attention warranted monitor eosinophil counts among patients asthma using biological therapies lead decreased eosinophil counts clinical course covid<NUMBER> cases infected sarscov<NUMBER> <NUMBER> sajuthi et al <NUMBER> studied children role t<NUMBER> inflammation viral infection regulating gene expression ace<NUMBER> tmprss<NUMBER> found strong influence t<NUMBER> cytokinedriven inflammation ace<NUMBER> downregulation tmprss<NUMBER> upregulation expression levels clinical implications covid<NUMBER> outcomes contrast authors found equally strong positive influence respiratory virus infections ace<NUMBER> expression <NUMBER> least theoretically patients asthma high t<NUMBER> inflammation consequence interferondependent inflammation requires close monitoring given enhanced risk complications due sarscov<NUMBER> infection recent study included asthma patients <NUMBER> different cohorts children adults found ace<NUMBER> receptor expression lower patients high allergic sensitization nonatopic asthma associated reduced expression <NUMBER> data suggest reduced ace<NUMBER> expression may potential contributor among several factors reduced covid<NUMBER> severity patients respiratory allergies ie allergic asthma <NUMBER> additionally early evidence coming severe asthma research program<NUMBER> sarp inhaled corticosteroid therapy also associated reduction ace<NUMBER> tmprss<NUMBER> gene expression sputum <NUMBER> data stress importance maintain asthma controlled using treatment according best practices including inhaled steroids also evidence support taking ics may beneficial dealing coronavirus infections vitro studies shown inhibitory actions budesonide coronavirus hcov<NUMBER>e replication cytokine production <NUMBER> preliminary yet peerreviewed data suggest ciclesonide blocks sarscov<NUMBER> ribonucleic acid replication <NUMBER> inhibits cytopathic activity <NUMBER> may clinical implications although gene expression ace<NUMBER> tmprss<NUMBER> differ healthy asthmatic patients also found males african americans patients diabetes increased expression ace<NUMBER> tmprss<NUMBER> sputum cells may associated poor prognosis patients infected sarscov<NUMBER> <NUMBER> dong et al <NUMBER> elegantly described selected cases patients covid<NUMBER> children adults demonstrating profile complexity different clinical presentations mild severe cases patients common allergic diseases rhinitis atopic dermatitis develop distinct symptoms severe courses may suggest positive balance type <NUMBER> immune regulation covid<NUMBER> pathogenesis new data emerging daily rapidly updating understanding novel coronavirus crucial patients asthma allergic diseases allergic rhinitis maintain controller medication inhaled corticosteroids biologics <NUMBER> <NUMBER> <NUMBER> including allergen immunotherapy <NUMBER> without making dose adjustments stopping medication may lead higher risk asthma exacerbations increased ocs use higher probability need emergency room access hospitalization risk factors coronavirus exposure spread likewise important maintain wellcontrolled rhinitis rhinosinusitis together known risk factors asthma exacerbations <NUMBER> available data ocs use asthma exacerbations though limited <NUMBER> reported cases mild asthmatics <NUMBER> accordance data previous coronavirus outbreaks showing systemic corticosteroids associated higher viral load <NUMBER> <NUMBER> uk data suggesting increased death risk patients int arch allergy immunol doi <NUMBER> asthma especially recently received systemic steroids <NUMBER> stress clinicians must cautious recognize differences hypoxic respiratory failure bronchospasm carefully balance need ocs prescription <NUMBER> bronchodilators must delivered metered dose inhalers spacers order prevent viral spread related nebulizer use <NUMBER> shown kaye et al <NUMBER> evidence increased adherence asthma copd pharmacologic treatment first months covid<NUMBER> encouraging hopefully positive effect improvement control asthma minimize need acute care inflammatory chronic respiratory disease conclusion unclear whether patients asthma higher risk developing covid<NUMBER> andor becoming severely ill future studies age groups needed provide greater understanding impact underlying asthma allergic diseases t<NUMBER> inflammation covid<NUMBER> susceptibility disease outcomes better understand interactions better able protect vulnerable people including highrisk groups past two decades outbreak prevalence severe acute respiratory infections seen one serious hazards global health two prominent coronaviruses <NUMBER> sarscov <NUMBER> merscov markedly affected humans causing <NUMBER> <NUMBER> infections well <NUMBER> <NUMBER> deaths respectively <NUMBER> <NUMBER> early december <NUMBER> series pneumonia cases unknown reason emerged wuhan hubei china highthroughput sequencing lower respiratory tract samples revealed novel coronavirus named <NUMBER> novel coronavirus <NUMBER>ncov also named sarscov<NUMBER> <NUMBER> february <NUMBER>th <NUMBER> <NUMBER> confirmed cases <NUMBER> death cases documented china <NUMBER>ncov also targets respiratory tract shares many similar clinical symptoms sarscov merscov <NUMBER> common symptoms include fever fatigue dry cough followed always anorexia myalgia dyspnea bo li jing yang contributed equally article bo li libosubmit<NUMBER>com yunhe zhao zhaoyunhemedmailcomcn <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> lymphopenia prolonged prothrombin time also common characteristics <NUMBER> <NUMBER> <NUMBER> addition cardiologists also concerned whether patients cardiovascular disease greater risk <NUMBER>ncov whether new coronavirus infections impact cardiovascular system previous studies shown relationship cardiovascular metabolic diseases sars mers <NUMBER> <NUMBER> <NUMBER> systematic analysis <NUMBER> merscov cases showed diabetes hypertension prevalent <NUMBER> patients cardiac diseases present <NUMBER> cases <NUMBER> diabetes seen independent predictor mortality morbidity patients sars <NUMBER> spread <NUMBER>ncov increase cases <NUMBER>ncov infected individuals exhibit comorbidities hypertension diabetes cardiacerebrovascular disease chens study <NUMBER> cases <NUMBER> patients cardiacerebrovascular disease <NUMBER> huangs study <NUMBER> cases <NUMBER> patients diabetes <NUMBER> cardiovascular metabolic comorbidities might render susceptible poor prognosis given rapid spread <NUMBER>ncov updated metaanalysis significantly larger sample sizes integrating published studies urgently warranted accordingly present analysis identify cardiovascular epidemiological clinical characteristics <NUMBER>ncov infection greater precision also unravel impact infection cardiac injury preferred reporting items systematic reviews metaanalyses individual participant data prismaipd statement followed conduct reporting metaanalysis <NUMBER> identify studies illustrating prevalence impact cardiovascular metabolic diseases <NUMBER> novel coronavirus infection china embase pubmed carefully searched december <NUMBER> february <NUMBER> following search terms keywords used alone combination novel coronavirus influenza pneumonia cardiovascular disease hypertension diabetes cardiac injury inclusion criteria follows <NUMBER> comparative studies randomised controlled trials rcts nonrcts published english <NUMBER> study population ten participants included study <NUMBER> study intervention patients studies confirmed infected <NUMBER> novel coronavirus <NUMBER> parameters comorbidities cardiovascular metabolic diseases outcome cardiac injury given case reports nonhuman studies studies without adequate information studies written chinese fear data duplication excluded present metaanalysis prevalence comorbidities including hypertension cardiovascular cerebrovascular diseases diabetes table <NUMBER> fig <NUMBER> together clinical outcome cardiac injury confirmed elevation troponin creatine kinase seen second choice troponin provided extracted identified studies table <NUMBER> fig <NUMBER> primary outcome measure compare prevalence comorbidities impact cardiac injury icu nonicu cases severe nonsevere data second choice icu data provided cochrane collaborations tool followed assess risk bias analyses performed using openmeta analyst version <NUMBER> https wwwcebmbrown eduopenmeta revman software version <NUMBER> forest plots used illustrate prevalence cardiovascular metabolic diseases <NUMBER>ncov infection severity selected studies well impact <NUMBER>ncov infection cardiac injury results included studies performed fixedeffect models mantelhaenszel method <NUMBER> randomeffect models cases significant heterogeneity estimates <NUMBER> used <NUMBER> statistics assess magnitude heterogeneity <NUMBER> <NUMBER> <NUMBER> represented low moderate high degrees heterogeneity respectively chosen proper effect model based analysis results fixed effect model used <NUMBER> <NUMBER> random effect model used <NUMBER> ≥ <NUMBER> <NUMBER> initially identifying <NUMBER> articles <NUMBER> duplicate documents identified leaving trials review titles abstracts <NUMBER> documents nonhuman researches reviews studies clinical trials excluded leaving <NUMBER> studies carefully detailed evaluated last six studies excluded participants trials meet criteria set one study published medrxiv added finally total six studies <NUMBER> patients included <NUMBER> <NUMBER> <NUMBER> <NUMBER> fig <NUMBER> selected studies published <NUMBER> different sample patient sizes ranged <NUMBER> <NUMBER> patients table <NUMBER> summarizes study characteristics systematic analysis studies described epidemiological clinical features covid<NUMBER> cases reported prevalence cardiovascular metabolic diseases well impact cardiac injury infectious disease identified six reports <NUMBER> patients table <NUMBER> majority cases localized wuhan recent travel wuhan contact people wuhan median ages respectively <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> years old according six studies infection diagnosed throughout whole spectrum age covering new born <NUMBER> years old studies men likely infected women overall proportion male <NUMBER> metaanalysis identified studies showed prevalent cardiovascular metabolic comorbidities hypertension <NUMBER> <NUMBER> ci <NUMBER> cardiacerebrovascular disease <NUMBER> <NUMBER> ci <NUMBER> followed diabetes <NUMBER> <NUMBER> ci <NUMBER> fig <NUMBER> significant heterogeneity cochrans q estimates comorbidities among identified studies <NUMBER> index varied <NUMBER> <NUMBER> fig <NUMBER> compared difference prevalence three diseases severe patients nonsevere patients icu patients vs nonicu patients according data studies hypertension cardiacerebrovascular disease heterogeneity test results calculated <NUMBER> <NUMBER> <NUMBER> thus fixedeffect model used analyses results three included studies total amount <NUMBER> patients showed hypertension accounted <NUMBER> icu severe cases <NUMBER> nonicusevere cases similar pattern found cardiacerebrovascular disease statistics accounted <NUMBER> icusevere cases <NUMBER> nonicusevere cases proportion hypertension cardiacerebrovascular disease statistically significant higher icusevere patients compared nonicusevere patients hypertension rr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> z <NUMBER> p <NUMBER> cardiacerebrovascular disease rr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> z <NUMBER> p <NUMBER> fig <NUMBER> diabetes heterogeneity test showed <NUMBER> <NUMBER> random effect model used diabetes accounted <NUMBER> icusevere cases <NUMBER> nonicusevere cases result indicated higher proportion diabetes icusevere patients without statistical significance rr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> z <NUMBER> p <NUMBER> fig <NUMBER> last focused impact covid<NUMBER> cardiac injury two studies gave clear data statistically analyzed data showed <NUMBER> <NUMBER> ci <NUMBER> patients might suffered acute cardiac injury another two studies gave data creatine kinase seen biomarker cardiac injury proportion might <NUMBER> <NUMBER> ci <NUMBER> attempted compare differences cardiac injury incidences icusevere patients nonicusevere patients included two studies specifically identified myocardial injury data showed significant higher incidence acute cardiac injury icusevere patients compared nonicusevere patients rr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> z <NUMBER> p <NUMBER> fig <NUMBER> funnel plots demonstrated symmetrical distributions effect size hypertension cardiacerebrovascular diseases cardiac injury either side pooled estimate nonsymmetrical distribution effect size diabetes fig <NUMBER> coronaviruses enveloped rna viruses include six species cause diseases humans knowledge <NUMBER> four viruses among <NUMBER>e oc<NUMBER> nl<NUMBER> hku<NUMBER> reported cause common cold symptoms immunocompetent individuals <NUMBER> however two strains infamous sarscov merscov linked fatal illness caused plagues large numbers deaths <NUMBER> complete genome sequences <NUMBER>ncov showed identified novel betacoronavirus belonging sarbecovirus subgenus coronaviridae family subgenus sarscov <NUMBER> according previous research sarscov presence comorbidities increased mortality risk cardiac disease diabetes important components predict adverse outcomes <NUMBER> cardiac disease diabetes increase risk death twice much risk factors <NUMBER> thus necessary us evaluate prevalence cardiac metabolic diseases covid<NUMBER> present systematic analysis summarized data five studies covid<NUMBER> results demonstrated overall proportion hypertension cardiacerebrovascular disease diabetes respectively <NUMBER> <NUMBER> <NUMBER> according summary <NUMBER> report cardiovascular diseases china morbidities hypertension diabetes respectively <NUMBER> <NUMBER> <NUMBER> million cerebrovascular disease patients <NUMBER> million cardiovascular patients <NUMBER> therefore comparing data report find people hypertension diabetes susceptible <NUMBER>ncov infection prevalence hypertension diabetes people infected virus general population even slightly lower however comparing general population incidence cardiacerebrovascular disease patients covid<NUMBER> obviously much higher due sample size limited time far data collection still incomplete studies analyzed comorbidities death cases relationship cardiovascular metabolic diseases covid<NUMBER>induced death cannot determined assuredly patients hypertension cardiacerebrovascular diseases diabetes likely develop severeicu cases <NUMBER>ncov infection overall proportion hypertension cardiacerebrovascular diseases diabetes twofolds threefolds twofolds respectively higher icusevere cases nonicusevere counterparts although difference diseases metaanalysis statistical fig <NUMBER> metaanalysis proportion hypertension cardiacerebrovascular disease diabetes covid<NUMBER> cases weights calculated binary randomeffects model analysis values represent proportions <NUMBER> diseases covid<NUMBER> patients <NUMBER> ci heterogeneity analysis carried using q test among studies variation <NUMBER> index forest plots depict comparison incidences <NUMBER> diseases icusevere nonicusevere patients ◂ fig <NUMBER> metaanalysis incidence cardiac injury covid<NUMBER> cases weights calculated binary randomeffects model analysis values represent proportions cardiac injury covid<NUMBER> patients <NUMBER> ci heterogeneity analysis carried using q test among studies variation <NUMBER> index forest plots depict comparison incidences cardiac injury icu severe nonicusevere patients fig <NUMBER> funnel plots comparisons hypertension cardiacerebrovascular disease diabetes acute cardiac injury icusevere nonicusevere patients rr value <NUMBER> consider might sample size included studies algorithm adopts random effect model conservative approach speculate result might reach statistical significance researches publish data another important finding damage virus heart according present summary least <NUMBER> patients covid<NUMBER> suffered acute cardiac injury chens report first death <NUMBER>year old man previous chronic underlying disease admitted icu developed severe respiratory failure heart failure sepsis experienced sudden cardiac arrest <NUMBER>th day admission declared dead <NUMBER> case reminded us patients novel coronavirus might develop acute cardiac injury analysis indicates us incidence myocardial injury much higher icusevere patients <NUMBER> folds nonicucardiac patients furthermore observation also reminded us patients covid<NUMBER> associated unstable angina stemi poor cardiac reserve lower tolerance severe pneumonia likely develop cardiac insufficiency leading deterioration according information released shanghai health commission first covid<NUMBER> death shanghai patient <NUMBER> years old serious history hypertension cardiac dysfunction analysis death causes suggested patient died heart failure systemic multiple organ dysfunction course onset <NUMBER> ncov infection inducement pathogenesis <NUMBER> ncov infectionrelated acute myocardial injury still unknown according clinical presentation lab data disease well pathogenesis sarscov speculated <NUMBER>ncov infection may affect cardiovascular system multiple mechanisms first viral infection directly causes damage cardiomyocyte according oudits study sarscov viral rna detected <NUMBER> autopsied human heart samples sarscov infected patients toronto sars outbreak <NUMBER> also confirmed pulmonary infection human sarscov mice led ace<NUMBER>dependent myocardial infection <NUMBER> ace<NUMBER> important target sarscov <NUMBER> molecular modelling shown high structural similarity receptorbinding domains sarscov <NUMBER>ncov <NUMBER> ace<NUMBER> expression highly tissuespecific mainly expressed cardiovascular renal gastrointestinal systems small amount expressed lung cells therefore addition coronaviruses causing pneumonia ace<NUMBER> receptors lung epithelial cells also need pay attention possible viral effects myocardial tissue second hypoxaemia may also important reason cardiac injury huangs study <NUMBER> covid<NUMBER> patients various degree hypoxaemia need required highflow nasal cannula higherlevel oxygen support chens study <NUMBER> patients require oxygen therapy due severe <NUMBER>ncov infection pneumonia may cause significant gas exchange obstruction leading hypoxaemia significantly reduces energy supply cell metabolism increases anaerobic fermentation causing intracellular acidosis oxygen free radicals destroy phospholipid layer cell membrane meanwhile hypoxiainduced influx calcium ions also leads injury apoptosis cardiomyocytes third huangs study noted high concentration il<NUMBER>β ifnγ ip<NUMBER> mcp<NUMBER> could detected patients infected <NUMBER>ncov might lead activated thelper<NUMBER> th<NUMBER> cell responses <NUMBER> furthermore also found icu patients much higher concentrations inflammatory factors nonicu patients suggesting cytokine storm associated disease severity <NUMBER> addition repeated floods catecholamines due anxiety side effects medication also lead myocardial damage conclusion patients previous cardiovascular metabolic diseases may face greater risk infection <NUMBER>ncov also greatly affect development prognosis pneumonia simultaneously pay close attention viral infectionrelated heart damage course disease treatment dr william h stewart us surgeon general <NUMBER> remembered primarily infamous statement time close book infectious diseases… five decades later erroneous statement <NUMBER> humanity facing one devastating health urgencies known modern history leading health system collapse economies shutting unemployment surges thousands deaths worldwide due covid<NUMBER> infection <NUMBER> cardiovascular medical community important issues clarified editorial attempt provide latest evidencebased directions intriguing labyrinthlike associations hypertension reninangiotensin system covid<NUMBER> hype hypertension link covid<NUMBER> pandemic fueled initial reports wuhan china hypertension present <NUMBER> cases <NUMBER> nonsurvivors <NUMBER> <NUMBER> hospitalized patients covid<NUMBER> hypertension observed <NUMBER> <NUMBER> intensive units <NUMBER> official data national health commission china demonstrate <NUMBER> patients diagnosed covid<NUMBER> hypertension overall case fatality rate <NUMBER> entire cohort significantly higher <NUMBER> patients hypertension <NUMBER> available metaanalysis wuhan <NUMBER> cases supports hypertension constitutes prevalent comorbidity <NUMBER> patients infected novel coronavirus <NUMBER> globality pandemic stresses need international data italy current analysis shows <NUMBER> deceased patients hypertensives <NUMBER> used angiotensin converting enzyme inhibitors aceis <NUMBER> angiotensin receptor blockers arbs <NUMBER> despite observations robust data suggest clearly independent link hypertension increased covid<NUMBER> morbidity mortality <NUMBER> similarly lower respiratory track infections diabetes heart failure independently related adverse outcome hypertension per se <NUMBER> major pathophysiological pathways covid<NUMBER> causes cardiovascular systemic complications diffuse inflammatory response ace<NUMBER> figure <NUMBER> characteristic covid<NUMBER> cytokine storm reflected increased il<NUMBER> il<NUMBER> il<NUMBER> interferonc tnfa <NUMBER> <NUMBER> focusing il<NUMBER> associated outcome viral infection also plays key regulator role immuneinflammatory response essential hypertension <NUMBER> supportive latter hypertension pathogenesis progression target organ damage closely associated lowgrade inflammation <NUMBER> could partially explain fact hypertension common comorbidity covid<NUMBER> cohorts related worst course infection <NUMBER> confounding effect however ageing comorbidities like diabetes renal dysfunction inflammatory link taken mind future studies urgently needed setting humans entry new coronavirus target cells facilitated spike protein anchored angiotensin converting enzyme<NUMBER> ace<NUMBER> parallel cellular serine protease tmprss<NUMBER> actions <NUMBER> ace<NUMBER> converts angiotensin ii angiotensin <NUMBER> figure <NUMBER> <NUMBER> <NUMBER> receptors ace<NUMBER> expressed epithelial cells lungs intestine kidneys heart vessels activation causes vascular dilatation provide renal cardiovascular protection <NUMBER> <NUMBER> <NUMBER> sense promoters ace<NUMBER> studied potential antihypertensive drugs <NUMBER> <NUMBER> novel coronavirus sarscov<NUMBER> using ace<NUMBER> consumes enzyme protective actions latter significantly attenuated noncounterbalanced actions angiotensin ii partially responsible along inflammation thrombotic milieu covid<NUMBER> related severe complications level lungs virus reduces activity ace<NUMBER> regionally stimulates reninangiotensin system leucocytes infiltration facilitation accelerating progression inflammatory response relative study covid<NUMBER> patients characterized higher angiotensin ii levels closely related total viral load degree lung injury <NUMBER> recombinant ace<NUMBER> administration proposed means reduce angiotensin ii levels lung tissue lesions <NUMBER> <NUMBER> concerning heart vascular component covid<NUMBER> infection dysregulation ace<NUMBER> related pathways linked cardiac muscle injury potential hemodynamic collapse <NUMBER> <NUMBER> given consideration million dollars question effects renin angiotensin blockers ace<NUMBER> expressionaction importantly clinical relevance modulation humans context covid<NUMBER> data animal studies consistent upregulation ace<NUMBER> majority arbs effect aceis variable <NUMBER> knowledge led opinion potential susceptibility patients aceis arbs covid<NUMBER> infection <NUMBER> currently unjustified firstly data humans scarce small intestine enterocytes upregulation ace<NUMBER> reported due acei <NUMBER> regarding lungs zero evidence humans even existed cannot directly lead conclusion upregulation indeed facilitate viral cell entry <NUMBER> one wants focus pneumonia outside covid<NUMBER> setting use aceis arbs reduces risk infection <NUMBER> related mortality <NUMBER> era covid<NUMBER> social distancing scientific approaching rapid free exchange knowledge provides scaffold better therapeutic answers therefore thankful researchers important emerging data <NUMBER> <NUMBER> <NUMBER> <NUMBER> firstly zhang p et al conducted retrospective multicenter study including <NUMBER> adult patients hypertension diagnosed covid<NUMBER> admitted hospitals hubei province <NUMBER> showed incidence <NUMBER>day allcause death among hypertensives inpatient treatment aceisarbs significant lower compared aceiarb nonusers <NUMBER> vs <NUMBER> p <NUMBER> <NUMBER> even matching adjusting variables inhospital use aceisarbs still exhibits remarkable association reduced allcause mortality even recently three simultaneous publications shed light debate reninangiotensin therapies covid<NUMBER> setting <NUMBER> <NUMBER> <NUMBER> work reynolds h et al showed among <NUMBER> patients tested covid<NUMBER> association aceisarbs increased likelihood positive test severe infection <NUMBER> insight provided mancia g et al focusing <NUMBER> cases severe covid<NUMBER> <NUMBER> adjustment confounders independent association use aceisarbs susceptibility infection worse clinical outcome contrast loop diuretics linked enhanced risk <NUMBER> interestingly publication mehra et al included international data <NUMBER> hospitals <NUMBER> countries asia europe north america <NUMBER> patients covid<NUMBER> discharge status available <NUMBER> harmful association either aceis arbs mortality also demonstrated use statins aceis linked less inhospital deaths <NUMBER> findings clearly support recently published recommendations many societies regarding continuation aceis arbs among patients coexisting hypertension cardiovascular disease covid<NUMBER> <NUMBER> moreover provide rationale ongoing studies drugs targeting reninangiotensin system therapy covid<NUMBER> like losartan hospitalized νct<NUMBER> nonhospitalized patients nct<NUMBER> <NUMBER> trending notion second wave covid<NUMBER> pandemic linked infection per se worried also third maybe important one third wave upcoming months years related major events would lead massive burden health systems covid<NUMBER> related postponed guideline care major disease states among cardiovascular ones hypertensive patients highly relevant due lack regular followup along destabilization blood pressure levels due unjustified discontinuation modification dosage aceisarbs lead heightened cardiovascular risk <NUMBER> outsidethenorm approach chronic diseases might reaction public well health providers mediainduced frenzy novel coronavirus attention paid latter phenomenon cardiovascular community already played key role establishing guidance treatment continuity care high risk patients <NUMBER> <NUMBER> interplay organization health systems governments needed sufficiently address burden cardiovascular emergencies routine cases throughout covid<NUMBER> era recent severe acute respiratory syndrome sars due coronavirus <NUMBER> cov<NUMBER> infection pandemic subsequent spread disease called covid<NUMBER> brought back discussion topic already highlighted sarscov<NUMBER> coronavirusrelated sars known middle east respiratory distress syndrome mers <NUMBER> <NUMBER> outbreaks observed particularly elevated incidence cardiovascular disease among patients also characterized elderly particular mers prevalently male <NUMBER> <NUMBER> another main topic discussion role angiotensinconverting enzyme ace <NUMBER> indeed carboxypeptidase identified functional receptor spike protein coronaviruses outer membrane including sarscov<NUMBER> <NUMBER> ace<NUMBER> strongly expressed epithelium different organs kidney heart lungs ace<NUMBER> shares large affinity amino peptidase ace target ace inhibitors class antihypertensive drugs ace inhibitors represent used class cardiovascular agents world treatment epidemic cardiovascular conditions hypertension heart failure although directly inhibited ace inhibitors ace<NUMBER> affected chronic treatment class drugs leads increase ace<NUMBER> expression several tissues <NUMBER> interestingly feature also shared another class drugs angiotensin receptor<NUMBER> blockers arbs whose chronic administration well able increase level expression ace<NUMBER> also activity assessed circulating levels ace<NUMBER> product angiotensin <NUMBER> <NUMBER> findings support concern treatment reninangiotensin system ras inhibitors could make covid<NUMBER> symptoms severe due increased expression ace<NUMBER> remarkably issues reproposed occurrence present epidemic covid<NUMBER> particular issue prevalence cardiovascular diseases among covid<NUMBER> patients proposed observational data obtained chinese <NUMBER> italian patients <NUMBER> context still lack analysis confounding effects age apparent association cardiovascular disease covid<NUMBER> infection clinical severity indeed observed prevalence male elderly patients observed especially italian covid<NUMBER> population confounding factor needs corrected conclusive association drawn concern expressed many <NUMBER> <NUMBER> <NUMBER> similarly ace<NUMBER> upregulation argument never demonstrated humans indeed conflicting evidence animal studies arbs probably ace inhibitors may upregulate membranebound ace<NUMBER> tissuespecific manners eg heart kidney data cannot extrapolated humans sufficient support facilitation sarscov<NUMBER> entry <NUMBER> particular never demonstrated ace<NUMBER> upregulation human lung occurs upon ras inhibition even less causes worsening covid<NUMBER> disease furthermore also speculated ace<NUMBER> upregulation protective indeed shown binding coronavirus ace<NUMBER> leads downregulation ace<NUMBER> <NUMBER> turn causes aceace<NUMBER> imbalance excessive production angiotensin ii related ace enzyme excess angiotensin ii stimulates angiotensin ii receptor type <NUMBER> at<NUMBER>r might cause increase pulmonary vascular permeability lung damage <NUMBER> therefore according hypothesis upregulation ace<NUMBER> caused chronic intake at<NUMBER>r ace inhibitors could protective two mechanisms first blocking increased production angiotensin <NUMBER> advocated possible mechanism protection lung second reducing production angiotensin ii removes cause lung damage <NUMBER> context uncertainty advocates within scientific community raising voices cessation ace inhibitors arbs among patients taking drugs claimed prevention infection attenuation symptoms case infection speculative claims taken laical press starting word mouth sustains panic behaviors among general population italian society hypertension siia therefore takes clear firm position line statements international societies see table <NUMBER> furthermore siia reiterates subsequent points acute suspension without medical control cardiovascular therapy specifically antihypertensive treatment increases occurrence acute events including hypertensive emergencies heart failure decompensation heart attacks stroke b favorable effects ace inhibitors arbs control progression cvds general particular hypertensive patients confirmed many years reason ras inhibitors represent central agents management cardiovascular conditions cannot easily substituted <NUMBER> c hypertensive patients covid<NUMBER> risk covid<NUMBER> infection ace inhibitors arbs treatment maintained according recommendations contained <NUMBER> escesh guidelines <NUMBER> similarly patients currently therapy ace inhibitors arbs case patients heart failure also arnis drugs must suspended e patients covid<NUMBER> severe symptoms sepsis ace inhibitors arbs like antihypertensive drugs used discontinued case case basis taking account current guidelines siia hopes promotes research analyzes constantly increasing data impact hypertension antihypertensive drugs particular ace inhibitors arbs clinical course covid<NUMBER> infections order update positions new evidence becomes available particular clarify mechanism prevalent role clinical manifestation covid<NUMBER> siia launched factfinding investigation verify impact therapy inhibitors reninangiotensin system onset clinical manifestation disease covid<NUMBER> observational research based online questionnaire made <NUMBER> questions collect information medical history evolution disease covid<NUMBER> patients id nct<NUMBER> clinicaltrialsgov conflict interest behalf authors corresponding author states conflict interest open access article licensed creative commons attributionnoncommercial <NUMBER> international license permits noncommercial use sharing adaptation distribution reproduction medium format long give appropriate credit original authors source provide link creative commons licence indicate changes made images third party material article included articles creative commons licence unless indicated otherwise credit line material material included articles creative commons licence intended use permitted statutory regulation exceeds permitted use need obtain permission directly copyright holderto view copy licence visit httpcreat iveco mmons orglicen sesbync<NUMBER> recent severe acute respiratory syndrome sars due coronavirus <NUMBER> cov<NUMBER> infection pandemic subsequent spread disease called covid<NUMBER> brought back discussion topic already highlighted sarscov<NUMBER> coronavirusrelated sars known middle east respiratory distress syndrome mers <NUMBER> <NUMBER> outbreaks observed particularly elevated incidence cardiovascular disease among patients also characterized elderly particular mers prevalently male <NUMBER> <NUMBER> another main topic discussion role angiotensinconverting enzyme ace <NUMBER> indeed carboxypeptidase identified functional receptor spike protein coronaviruses outer membrane including sarscov<NUMBER> <NUMBER> ace<NUMBER> strongly expressed epithelium different organs kidney heart lungs ace<NUMBER> shares large affinity amino peptidase ace target ace inhibitors class antihypertensive drugs ace inhibitors represent used class cardiovascular agents world treatment epidemic cardiovascular conditions hypertension heart failure although directly inhibited ace inhibitors ace<NUMBER> affected chronic treatment class drugs leads increase ace<NUMBER> expression several tissues <NUMBER> interestingly feature also shared another class drugs angiotensin receptor<NUMBER> blockers arbs whose chronic administration well able increase level expression ace<NUMBER> also activity assessed circulating levels ace<NUMBER> product angiotensin <NUMBER> <NUMBER> findings support concern treatment reninangiotensin system ras inhibitors could make covid<NUMBER> symptoms severe due increased expression ace<NUMBER> remarkably issues reproposed occurrence present epidemic covid<NUMBER> particular issue prevalence cardiovascular diseases among covid<NUMBER> patients proposed observational data obtained chinese <NUMBER> italian patients <NUMBER> context still lack analysis confounding effects age apparent association cardiovascular disease covid<NUMBER> infection clinical severity indeed observed prevalence male elderly patients observed especially italian covid<NUMBER> population confounding factor needs corrected conclusive association drawn concern expressed many <NUMBER> <NUMBER> <NUMBER> similarly ace<NUMBER> upregulation argument never demonstrated humans indeed conflicting evidence animal studies arbs probably ace inhibitors may upregulate membranebound ace<NUMBER> tissuespecific manners eg heart kidney data cannot extrapolated humans sufficient support facilitation sarscov<NUMBER> entry <NUMBER> particular never demonstrated ace<NUMBER> upregulation human lung occurs upon ras inhibition even less causes worsening covid<NUMBER> disease furthermore also speculated ace<NUMBER> upregulation protective indeed shown binding coronavirus ace<NUMBER> leads downregulation ace<NUMBER> <NUMBER> turn causes aceace<NUMBER> imbalance excessive production angiotensin ii related ace enzyme excess angiotensin ii stimulates angiotensin ii receptor type <NUMBER> at<NUMBER>r might cause increase pulmonary vascular permeability lung damage <NUMBER> therefore according hypothesis upregulation ace<NUMBER> caused chronic intake at<NUMBER>r ace inhibitors could protective two mechanisms first blocking increased production angiotensin <NUMBER> advocated possible mechanism protection lung second reducing production angiotensin ii removes cause lung damage <NUMBER> context uncertainty advocates within scientific community raising voices cessation ace inhibitors arbs among patients taking drugs claimed prevention infection attenuation symptoms case infection speculative claims taken laical press starting word mouth sustains panic behaviors among general population italian society hypertension siia therefore takes clear firm position line statements international societies see table <NUMBER> furthermore siia reiterates subsequent points acute suspension without medical control cardiovascular therapy specifically antihypertensive treatment increases occurrence acute events including hypertensive emergencies heart failure decompensation heart attacks stroke b favorable effects ace inhibitors arbs control progression cvds general particular hypertensive patients confirmed many years reason ras inhibitors represent central agents management cardiovascular conditions cannot easily substituted <NUMBER> c hypertensive patients covid<NUMBER> risk covid<NUMBER> infection ace inhibitors arbs treatment maintained according recommendations contained <NUMBER> escesh guidelines <NUMBER> similarly patients currently therapy ace inhibitors arbs case patients heart failure also arnis drugs must suspended e patients covid<NUMBER> severe symptoms sepsis ace inhibitors arbs like antihypertensive drugs used discontinued case case basis taking account current guidelines siia hopes promotes research analyzes constantly increasing data impact hypertension antihypertensive drugs particular ace inhibitors arbs clinical course covid<NUMBER> infections order update positions new evidence becomes available particular clarify mechanism prevalent role clinical manifestation covid<NUMBER> siia launched factfinding investigation verify impact therapy inhibitors reninangiotensin system onset clinical manifestation disease covid<NUMBER> observational research based online questionnaire made <NUMBER> questions collect information medical history evolution disease covid<NUMBER> patients id nct<NUMBER> clinicaltrialsgov conflict interest behalf authors corresponding author states conflict interest open access article licensed creative commons attributionnoncommercial <NUMBER> international license permits noncommercial use sharing adaptation distribution reproduction medium format long give appropriate credit original authors source provide link creative commons licence indicate changes made images third party material article included articles creative commons licence unless indicated otherwise credit line material material included articles creative commons licence intended use permitted statutory regulation exceeds permitted use need obtain permission directly copyright holderto view copy licence visit httpcreat iveco mmons orglicen sesbync<NUMBER> first cases respiratory illness reported december <NUMBER> novel coronavirus designated severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> identified cause socalled coronavirus disease meanwhile become worldwide pandemic <NUMBER> <NUMBER> general three distinct phases characterize progression covid<NUMBER> initial infection phase followed respiratory distress phase finally culminating severe hyperinflammation state <NUMBER> sarscov<NUMBER> infections showing mild even absent symptoms <NUMBER> characteristics covid<NUMBER> outbreak reported china <NUMBER> provided important lessons respect cardiovascular involvements primary target well comorbidity infection phase marks virus infiltration proliferation epithelium lung parenchyma accompanied mild symptoms monocyte macrophage activation initial immune response ensuing inflammatory processes like vasodilation endothelial leakiness leukocyte extravasation lead pulmonary distress pulmonary damage fluid extravasation hypoxemia turn augments cardiovascular stress finally amplification host inflammatory response essentially culminate systemic inflammation eliciting cytokine storm <NUMBER> importantly cardiovascular system emerges primary target well important secondary comorbidity factor three covid<NUMBER> progression phases fig <NUMBER> accumulating evidence heart might direct target viral infection sarscov<NUMBER> <NUMBER> previous studies examining cardiovascular effects viral respiratory infections influenza epidemics revealed profound sixfold increased incidence ratio acute myocardial infarction within <NUMBER> days infection part due heightened prothrombotic activity leading intracoronary thrombotic events <NUMBER> hypotension tachycardia imbalance metabolic demand diseased heart exaggerated systemic inflammation profoundly increased circulating levels prototypical inflammatory markers il<NUMBER> il<NUMBER> tnfalpha mcp<NUMBER> crp well established contribute cardiac injury irrespective presence hypoxemia indeed biomarkers shown associated high mortality retrospective clinical series covid<NUMBER> patients hospitalized china <NUMBER> indicating potential serious bystander effects organs including heart support collateral damage heart increased inflammatory markers correlate electrocardiographic abnormalities biomarkers cardiac injury <NUMBER> finally elevation cardiac biomarkers documenting cardiac involvement prominent feature covid<NUMBER> also associated profoundly worse clinical outcome <NUMBER> <NUMBER> myocardial damage heart failure contributed almost <NUMBER> deaths critically ill cohort hospitalized wuhan <NUMBER> cox regression analyses revealed mortality risk associated acute cardiac damage significantly higher age chronic pulmonary disease prior history cardiovascular disease <NUMBER> <NUMBER> thus direct indirect mechanisms cardiovascular injury likely play pivotal role deleterious consequences sarscov<NUMBER> infection addition severe acute respiratory distress syndrome ards last patients underlying cardiovascular disease likely infected sarscov<NUMBER> likely develop severe symptoms infected sarscov<NUMBER> may also vulnerable adverse cardiotoxic effects treatment antiviral drugs recent analysis leoss registry <NUMBER> displaying prevalence comorbidities covid<NUMBER> patients germany disclosed classes disease severity <NUMBER> patients suffered cardiovascular comorbidity fig <NUMBER> summary consequences sarscov<NUMBER> infection cardiovascular system summarizing primary targets left secondary comorbidities right far prominent comorbidity associated covid<NUMBER> fig <NUMBER> taken together cardiovascular involvement highly prevalent significant prognostic importance covid<NUMBER> therefore important fully involve cardiologists managing cardiovascular complications severe cases covid<NUMBER> also pay particular attention cardiovascular protection patients risk develop covid<NUMBER> essential allocate sufficient resources cardiovascular diagnostic therapeutic procedures even times health care systems globally overwhelmed hospitals guided measures contain treat infectious disease need advice patients cardiovascular emergencies like stemi decompensated heart failure lifethreatening arrhythmias need immediate attention treatment emergency calls delayed fear admitted hospital potential acquire covid<NUMBER> need setup emergency treatment strategies noncovid<NUMBER> patients inhospital assure protection patients sarscov<NUMBER>infected patients additionally need make sure hospital staff health care workers general adequately protected diagnostic interventional procedures covid<NUMBER> patients guided clinical necessity fortunately major cardiovascular professional societies meanwhile process publishing guidance various aspects cardiovascular care covid<NUMBER> patients including perform diagnostic therapeutic interventions guidance publications referenced following chapters article without doubt lead greater awareness immediate cardiovascular implications infectious disease nevertheless stop hospitalization pneumonia previously shown associated significantly increased risk cardiovascular disease <NUMBER> years followup <NUMBER> likely sarscov<NUMBER> infections respiratory impairment also lead similar longterm adverse events need monitor covid<NUMBER> patients acutely elevated markers cardiac damage respect longterm consequences cardiac function including definite proof sarscov<NUMBER>induced myocarditis myocardial biopsy likewise important assess potential longterm cardiotoxic effects antiviral therapy thus cardiovascular care covid<NUMBER> pandemic already implement strategies capture longerterm implications prolonged clinical followup covid<NUMBER> spread almost countries world unexplained different impact disease different countries slow increase infections africa southeast asia surprisingly low fatality rate <NUMBER>th april <NUMBER> south africa <NUMBER> infections <NUMBER> deaths despite detailed surveillance system wwwcoron aviru sjhuedu accessed <NUMBER>th april <NUMBER> currently unknown far slower expected rise cases case mortality lowtomiddle income countries population demographics underlying comorbidities vastly different countries mean age many lowtomiddle income countries <NUMBER> decades lower higher income countries example uganda life expectancy birth males females <NUMBER> <NUMBER> years wwwwhoorg <NUMBER> population age range <NUMBER> years old <NUMBER> population older <NUMBER> years age pyramid influences current uganda cardiovascular health challenges include hypertension coronary artery disease mainly urban areas rheumatic heart disease rhd heart failure due cardiomyopathies remain enormous challenges patients access balloon valvotomy surgery <NUMBER> untreated symptomatic patients rheumatic heart disease mortality rate <NUMBER> per annum leaving patients able live beyond <NUMBER> years age <NUMBER> however factors might impact countrybycountry difference covid<NUMBER> morbidity mortality could possibly explained national policies bacillus calmette guerin bcg vaccination bcg live attenuated strain derived isolate myocobacterium bovis used widely across world vaccine tuberculosis many lowtomiddle income countries also highincome countries japan universal bcg vaccination policy newborns bcg vaccinations shown produce nonspecific immune effects leading improved response nonmyocardial pathogens another possible protective mechanism could high number people living hivaids antiretroviral therapy south africa population <NUMBER> million <NUMBER> hivinfected sa worlds largest antiretroviral therapy art program subsidized government provided freeofcharge time tell lowto middle income countries catch pandemic <NUMBER> <NUMBER> remain relatively spared <NUMBER> world heart federation published briefing prevention coronavirus disease <NUMBER> lowincome countries <NUMBER> includes six easy rules reduce risk corona virus transmission staying home avoiding large gathering total shut country far biggest impact lower number infections early case detection role reninangiotensinaldosterone system covid<NUMBER> reninangiotensinaldosterone system raas regulates blood pressure also involved cardiovascular endorgan damage like myocardial hypertrophy interstitial myocardial fibrosis atherosclerosis plaque rupture acute coronary syndromes therefore blockers raas recommended use hypertension prevent cardiovascular events heart failure <NUMBER> <NUMBER> protease renin cleaves angiotensin angiotensinogen ang <NUMBER> processed angiotensin ii ang <NUMBER> angiotensinconverting enzyme ace <NUMBER> angiotensin ii stimulates at<NUMBER>receptors results adverse cardiovascular effects like vasoconstriction cell proliferation hypertrophy <NUMBER> contrast at<NUMBER>receptor mediates vasodilation antiproliferative actions apoptosis suggested involved antiproliferative effects upon binding angiotensin ii <NUMBER> angiotensin ii <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> cleaved angiotensinconverting enzyme <NUMBER> ace<NUMBER> angiotensin <NUMBER> <NUMBER> exerts directly stimulation called masreceptor mediating vasodilation antiproliferative effects antiinflammatory responses <NUMBER> well established corona virus family binds via spike protein ace<NUMBER> <NUMBER> <NUMBER> well characterized binding residues <NUMBER> proteolytic modification ace<NUMBER> <NUMBER> coronavirus spike protein <NUMBER> <NUMBER> membranebound proteinase adam<NUMBER> virus internalized clathrincoated pits trypsin cleavage viral rna released cellular cytoplasm causing sars infection <NUMBER> <NUMBER> ace<NUMBER> degraded shedfrom cell membrane circulation cleavage adam<NUMBER> <NUMBER> <NUMBER> result downregulation ace<NUMBER> corona virus <NUMBER> role ace<NUMBER> corona virus infection scrutinized fact several animals cannot infected corona virus knockout ace<NUMBER> renders resistant infection <NUMBER> role ace<NUMBER> specific corona virus ace<NUMBER> also used respiratory syncytial rs virus types influenza viruses <NUMBER> <NUMBER> ace<NUMBER> also regulated several cardiopulmonary disease conditions like copd pulmonary hypertension asthma viral infections influenza h<NUMBER>n<NUMBER> h<NUMBER>n<NUMBER> h<NUMBER>n<NUMBER> well sepsis <NUMBER> ace<NUMBER> potentially degrading maladaptive angiotensin ii stimulating antiinflammatory responses mas receptor <NUMBER> shown improve lung injury viral infections clinical injuries <NUMBER> furthermore ards prominent rs virus infections ace<NUMBER> knocked <NUMBER> addition recombinant human ace<NUMBER> tested pilot study human ards shown reduce circulating interleukin<NUMBER> concentrations accompanied increases ang <NUMBER> reductions angiotensin ii <NUMBER> therefore ace<NUMBER> might crucial entry corona viruses cells hence infectivity <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> however might also mediate beneficial effects pulmonary complications infection <NUMBER> <NUMBER> fact major risk factor adverse outcomes covid<NUMBER> age ace<NUMBER> downregulated aging population argues favor role poor outcome risk group <NUMBER> furthermore drugs like chloroquine indometazine <NUMBER> well ace inhibitors arbs <NUMBER> <NUMBER> <NUMBER> shown upregulate ace<NUMBER> human heart systemic well pulmonary vasculature <NUMBER> association outcomes heart failure <NUMBER> atrial fibrillation <NUMBER> pulmonary hypertension <NUMBER> findings highlight complex interaction covid<NUMBER> ace<NUMBER> inhibition would thus raise hypothesis pathophysiological conditions drugs enhancing ace<NUMBER> expression might lead greater infectivity time potentially reduce mortality due lung complications fig <NUMBER> arterial hypertension prevalent risk factor cardiovascular disease particular china <NUMBER> several early trials covid<NUMBER> populations hypertension prevalent cardiovascular risk factor comorbidity amounting approximately <NUMBER> overall population diseased individuals china <NUMBER> <NUMBER> <NUMBER> italy <NUMBER> patients complications even died hypertension prevalent diabetes coronary <NUMBER> hypothetical scheme interaction corona virus angiotensin converting enzyme<NUMBER> ace<NUMBER> corona virus binding spike protein ace<NUMBER> processed proteinase adam<NUMBER> leading internalization corona virus ace<NUMBER> cell viral genome released internalization well shedding ace<NUMBER> cell surface release circulation reduces membranebound ace<NUMBER> furthermore ace<NUMBER> reduced pathological conditions like pulmonary fibrosis asthma copd pulmonary hypertension smoking old age <NUMBER> contrary membranebound ace<NUMBER>concentrations higher following treatment aceinhibitors at<NUMBER>blockers potentially ibuprofen ace<NUMBER> abundantly expressed childhood young age ace<NUMBER> forms ang <NUMBER> angiotensionii stimulate masreceptor mediating antiproliferative antiinflammatory action hypothetically enhanced ace<NUMBER>expression might cause infection acting receptor viral cell entry protect pulmonary complications conditions downregulation ace<NUMBER> less infection might occur severity covid<NUMBER>related ards severe hypothesis fits higher likelihood pulmonary complications certain disease conditions aging notably data derived experimental observational data controlled clinical studies need scrutinized clinical conditions artery disease chronic obstructive lung disease malignancies <NUMBER> hypertension comorbidity highest prevalence deceased patients claimed risk factor covid<NUMBER> however would case deviation overall prevalence hypertension chinese population china prevalence hypertension high comparing chinese populations agematched reports covid<NUMBER> approximately <NUMBER> years becomes clear overall prevalence hypertension <NUMBER> increase populations higher age <NUMBER> therefore prevalence comorbidity hypertension covid<NUMBER> patients lower exceed overall prevalence relevant populations china therefore evidence hypertension increases likelihood suffer covid<NUMBER> cardiovascular risk factors comorbidities elevated patients fatal outcomes covid<NUMBER> <NUMBER> therefore cardiovascular comorbidities concert add myocardial injury shown closely associated death measured cardiac troponin levels <NUMBER> next question arises whether cardiac treatments treatments reninangiotensin system inhibitors rasi particular aceinhibitors acei angiotensin receptor blockers arbs associated differential outcome covid<NUMBER> guidelines management hypertension european society cardiology <NUMBER> also chinese guidelines <NUMBER> guidelines american college cardiology acc american heart association aha <NUMBER> recommend ace arbs treatment hypertension drugs shown effective secondary prevention heart failure protection adverse renal outcomes germany countries europe prescription rate ace arbs higher prescribed daily doses antihypertensive drugs combined <NUMBER> however adequate blood pressure control china age group covid<NUMBER> prevalent <NUMBER> <NUMBER> according <NUMBER> chinese guidelines <NUMBER> <NUMBER> according <NUMBER> accaha guidelines <NUMBER> particular frequency aceinhibitor treatment particularly low asian population particular females aceinduced coughing prevalent populations <NUMBER> therefore low density treatment rasi argue favor significant role drugs likelihood covid<NUMBER> upregulation ace<NUMBER> rasi allow argue favor use rasinhibitors hypertension recently expressed various short communications letters causing lot discussion media attention <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> although large body evidence generated cell models animal models observational studies data necessary scrutinize definite role ace<NUMBER> infection frequency causation pulmonary complications corona infections moment thus compelling evidentiary background change rasi therapy hypertension cardiovascular conditions cardiac manifestations sarscov<NUMBER> infection include acute myocardial injury heart failure myocarditis ventricular tachyarrhythmias <NUMBER> along ards acute myocardial injury identified important independent predictor outcomes associated <NUMBER>fold higher risk death <NUMBER> cohort <NUMBER> hospitalized patients prevalence cardiac injurybased presence elevated hsctni values <NUMBER>th percentile healthy reference populationwas <NUMBER> risk death increased magnitude myocardial injury expressed multiples reference value hstni <NUMBER> unequivocally cohorts investigating prevalence prognostic implications myocardial injury covid<NUMBER> outbreak wuhan china reported similar rates acute myocardial injury ranging <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> presentation based elevations hsctn uln report <NUMBER> patients hospitalized covid<NUMBER> <NUMBER> patients received care intensive care unit likely cardiac injury nonicu patients <NUMBER> vs <NUMBER> ´consistently another study <NUMBER> admitted hospital patients laboratoryconfirmed covid<NUMBER> <NUMBER> proportion patients requiring care intensive care unit icu significantly higher among patients evidence acute myocardial injury <NUMBER> vs <NUMBER> several studies demonstrate association acute myocardial injury mortality <NUMBER> <NUMBER> study <NUMBER> patients covid<NUMBER> evaluated role hsctnt relative presence cardiovascular disease <NUMBER> mortality rates highest among patients elevated hsctnt uln history cardiovascular disease lowest among normal hsctn irrespective presence absence cv disease <NUMBER> survey <NUMBER> hospitalized patients wuhan <NUMBER> <NUMBER> patients <NUMBER> <NUMBER> patients received ecg particularly periods elevation cardiac biomarkers imaging tests echocardiography reported consistently reports <NUMBER> <NUMBER> report rates ecg imaging tests except lung ct hence limited diagnostic workup selection bias precludes speculations etiology hsctni elevation discordant recommendations <NUMBER>th version universal myocardial infarction mi definition udmi <NUMBER> investigators wuhan studies used different definition acute myocardial injury differentiate acute chronic myocardial injury concentration change rise andor fall hsctni acute myocardial injury rather defined blood levels high sensitivity troponin <NUMBER>th percentile upper limit normal upper limit normal uln <NUMBER> ngl new abnormalities shown electrocardiography echocardiography <NUMBER> investigators report rates subtypes acute myocardial infarction based criteria <NUMBER>th version udmi <NUMBER> interestingly hsctn values increased serial monitoring patients fatal outcome whereas persistently low values observed among survivors allowing speculate whether monitoring hsctn might useful even absence suspected acute coronary syndrome <NUMBER> overall presence myocardial injury ed populations uncommon occurring many <NUMBER> consecutive patients presenting chest pain dyspnea less specific symptoms <NUMBER> however fraction elevations ultimately attributed type <NUMBER> type <NUMBER> mi majority cases unrelated myocardial ischemia often multifactorial exact reason remained unsettled <NUMBER> stable asymptomatic cardiovascular ischemic heart disease cardiac troponin elevation may explained presence underlying structural heart disease stable cad chronic kidney disease <NUMBER> accordingly western countries presence hsctn <NUMBER>th percentile uln reported many <NUMBER> asymptomatic patients without cardiovascular disease presenting routine outpatient visits <NUMBER> across different subspecialities patients hospitalized reasons acute coronary syndrome <NUMBER> <NUMBER> regardless underlying reason acuity clinical presentation presence myocardial injury indicated hsctn <NUMBER>th percentile uniformly associated adverse longterm outcomes patients elevated hsctn baseline higher risk die acutely precipitating event due cardiovascular morbidity <NUMBER> accordingly data pandemia wuhan confirm current knowledge provide fundamental new information interpretation troponin elevations based findings corona influenza infections past speculated acute myocardial injury might triggered facilitated covid<NUMBER> infection <NUMBER> <NUMBER> previous study incidence myocardial infarction outbreak influenza infections ontario reported sixfold higher incidence ratio ami within <NUMBER> days positive influenza test compared negative test time frame <NUMBER> hypothesized exaggerated inflammatory response mediated viral infection influenza b respiratory syncytial virus rsv virus potential trigger acute plaque rupture addition anecdotal evidence sporadic case reports raised suspicion acute myocarditis although direct sarscov<NUMBER> infiltration heart confirmed absence histological confirmation endocardial biopsy detection viral genome myocardial tissue yet <NUMBER> previously decline left ventricular ejection fraction lvef highly prevalent reversible subclinical diastolic left ventricular impairment reported acute sarscov<NUMBER> infection attributed cytokine storm syndrome characterized uncontrolled dysfunctional immune response <NUMBER> finally cardiotoxic effects antiviral therapies reported <NUMBER> acute myocardial injury may occur independently covid<NUMBER> may manifest type <NUMBER> myocardial infarction stemi nstemi type <NUMBER> mi absence plaque rupture intracoronary thrombus acute myocardial injury independent myocardial ischemia fig <NUMBER> cases acute mi autopsy hospitalization covid<NUMBER> reported <NUMBER> systematic evaluation lacking given paucity data exact prevalence reasons acute myocardial injury covid<NUMBER> interpretation hsctn elevations discussed knowledge previously derived acute critical conditions foremost severe infections causing sepsis septic shock <NUMBER> investigation hsctnt setting severe infection median concentrations hsctnt found increase <NUMBER> ngl sepsis <NUMBER> ngl severe sepsis <NUMBER> ngl septic shock <NUMBER> likewise prevalence hsctnt uln increased <NUMBER> sepsis <NUMBER> septic shock <NUMBER> similar covid<NUMBER> mild elevations hsctnt associated high mortality rate <NUMBER> days <NUMBER> however risk associated myocardial injury baseline persisted <NUMBER> years index event suggesting major prognostic role preexisting structural heart disease longterm outcomes similar sarscov<NUMBER> infection impairment right left ventricular function echocardiography common severe infections clear association myocardial injury cardiac overload hemodynamic stress indicated natriuretic peptides inflammatory response <NUMBER> significant elevations hsctn demonstrated following rapid atrial pacing irrespective presence inducible myocardial ischemia <NUMBER> experimental human model utilized transcardiac production lactate objective evidence myocardial ischemia hsctnt increased absence cad lactate suggesting tachycardia capable induce acute myocardial injury likewise administration catecholamines found release hsctnt healthy volunteers <NUMBER> mechanisms related release ctn include respiratory failure due severe hypoxemia sepsis acute kidney failure hypertension hypotension bradycardia fever anemia many causes <NUMBER> <NUMBER> acute mi without covid<NUMBER> represents lifethreatening condition requires adjunctive medical therapies potent antiplatelet drugs monitoring anticipate complications however enhanced infectious potency humans <NUMBER> mandates fundamental risk assessment carefully weigh relative advantages disadvantages treating cardiovascular disease preventing risk sarscov<NUMBER> transmission patients suspected acs without stsegment elevation absence hemodynamic rhythm instability covid<NUMBER> cannot ruledout due suspicious clinical presentation personal recommendation author obtain nasopharyngeal swabs realtime reverse transcriptasepolymerase chain reaction rtpcr assay available perform ct lung scan waiting pcr result covid<NUMBER>associated pneumonia provides typical picture characterized bilateral lung infiltrates glass ground opacities consolidation reticular pattern socalled crazy paving pattern <NUMBER> <NUMBER> sensitivity ct reported high <NUMBER> superior rtpcr <NUMBER> ct scan could ideally performed multidetector ct angiography providing additional information coronary anatomy presence pulmonary embolism since elevations ddimer uncommon <NUMBER> <NUMBER> values exceeding twosixfold uln associated high mortality <NUMBER> <NUMBER> <NUMBER> <NUMBER> regarding measurement cardiac biomarkers american college cardiology acc released statements liberal use troponin covid <NUMBER> <NUMBER> given frequency nonspecific nature abnormal troponin results among patients covid<NUMBER> clinicians advised measure cardiac troponin acute myocardial infarction suspected clinical grounds <NUMBER> european society cardiology esc expands recommendations restricting measurement cardiac troponin ti concentrations patients suspected type <NUMBER> mi infarct type likely benefit adjunctive antiplatelet therapies early revascularization therapies personal communication paper revision moreover order reduce length stay ed dedicate monitoring capacities critically diseased patients accelerated rapid ruleout andor rulein mi seem particularly helpful <NUMBER> real world evidence suggests patient disposition may completed within <NUMBER> h without increase adverse outcomes compared standard protocols <NUMBER> <NUMBER> use echocardiography coronary angiography restricted patients procedures would expected meaningfully affect outcomes <NUMBER> timing invasive coronary angiography depends individual estimation anticipated risk death heart failure infarctrelated complications factors supposed favor immediate early coronary angiography full protection medical staff include stemi high risk nonst segment elevation mi suggested either unstable hemodynamics dynamic st segment changes rhythm instability high clinical score recommended <NUMBER> esc guidelines <NUMBER> cardiac troponin values interpreted continuous variables since risk death benefits early invasive strategy incline increasing values <NUMBER> <NUMBER> unclear whether benefit revascularization outweighs potential disadvantages contamination medical staff patients smalltointermediate elevations hsctn whether yet unsettled refined risk stratification required identify patients likely benefit <NUMBER> hence patients nstemi lower risk managed according local expertise capability deliver echocardiography invasive procedures effectively patient without exposing medical staff increased risk contamination <NUMBER> <NUMBER> <NUMBER> <NUMBER> heart failure risk factor covid<NUMBER> long known patients chronic heart failure chf increased risk adverse consequences seasonal influenza <NUMBER> causes pneumonia <NUMBER> conversely infections particular pneumonia frequent triggers heart failure exacerbations <NUMBER> note influenza vaccination decreases mortality chf patients beneficial effects repetitive influenza vaccinations may even exceed guidelinedirected pharmacotherapy <NUMBER> severe coronavirus infections sarscov<NUMBER> shown result severe course disease patients preexisting cardiovascular disease including heart failure <NUMBER> thus surprising covid<NUMBER> associated higher morbidity mortality patients cardiovascular comorbidities <NUMBER> <NUMBER> yet likely due lower prevalence known chf china still limited specific information patients preexisting heart failure nevertheless early reports <NUMBER> indicate covid<NUMBER> associated myocardial injury frequent patients heart failure cardiovascular comorbidities <NUMBER> hospitalized covid<NUMBER> patients <NUMBER> <NUMBER> reveal elevated troponin levels marker myocardial injury precise mechanisms myocardial necrosis context sarscov<NUMBER> unknown troponin elevations potent predictors adverse outcome shi et al <NUMBER> reported increased troponin levels associated higher likelihood mechanical ventilation development ards acute kidney failure remarkably <NUMBER> <NUMBER> patients myocardial injury died <NUMBER> whereas <NUMBER> <NUMBER> troponin negative patients lethal outcome similarly guo et al <NUMBER> showed elevated troponin predicted ards ventricular arrhythmias vts vfib death interestingly continuous increase ntprobnp troponin observed patients ultimately died survivors revealed constant levels note troponin elevations appear predictive prognosis presence comorbidities patients higher troponin levels without preexisting cardiovascular pulmonary disease significantly worse prognosis troponin negative patients cardiovascular comorbidities guo seems likely myocardial injury marker adverse outcome also direct cause notion supported data show covid<NUMBER> nonsurvivors frequently develop heart failure <NUMBER> shock <NUMBER> <NUMBER> similarly ruan et al <NUMBER> reported <NUMBER> patients died covid<NUMBER> myocardial dysfunction sole contributing factor death <NUMBER> cases obvious reason elevated troponin level could acute coronary syndrome obviously may also occur covid<NUMBER> patients likely underdiagnosed due reluctance invasive management however high proportion typically rather moderately increased high sensitive troponin levels hospitalized covid<NUMBER> patients renders explanations likely including acute myocarditis due sarscov<NUMBER> myocardial damage due proinflammatory cytokines cytokine storm ace<NUMBER> potential receptor coronavirus infection highly expressed cardiomyocytes vascular pericytes <NUMBER> thus seems plausible sarscov<NUMBER> may directly cause viral myocarditis associated cell death subsequent myocardial injury measured increased troponin levels indeed first still anecdotal autopsy endomyocardial biopsy reports describe evidence acute lymphocytic myocarditis <NUMBER> <NUMBER> however sarscov<NUMBER> genome could detected myocardium several early cases indicating mechanisms myocardial injury must involved least subset patients myocardial injury another attractive hypothesis myocardial injury context covid<NUMBER> may explained hyperinflammatory state dysregulated cytokines mediate cardiomyocyte stress ultimately cell death cytokine storm wellknown <NUMBER> underappreciated syndrome complicating sepsis <NUMBER> cases <NUMBER> clinical characteristics include multiorgan failure associated persistent fever lymphopenia well high levels ferritin several cytokines interleukin<NUMBER> example elevated interleukin<NUMBER> il<NUMBER> levels closely correlate mortality sepsis il<NUMBER> shown directly impair contractile function cardiomyocytes <NUMBER> similarly lymphopenia excessively elevated ferritin interleukin<NUMBER> levels demonstrated severe cases covid<NUMBER> also revealed myocardial injury increased high sensitive troponin specific treatment cytokine storm heart failure covid<NUMBER> multiple clinical trials underway test antiviral agents potentially effective sarscov<NUMBER> remdesivir several antivirals previously shown effective eg hiv infections reviewed <NUMBER> myocardial injury associated dramatically worsened outcome covid<NUMBER> question arises whether therapy also specifically aimed prevention myocardial damage andor hyperinflammation indeed limited experience inhibition cytokine storm immunosuppression points towards possibility example interleukin<NUMBER> blockade anakinra shown reduce mortality sepsis hyperinflammation <NUMBER> similarly tocilizumab interleukin<NUMBER> receptor blocking antibody shows early promise covid<NUMBER> nonrandomized trial involving <NUMBER> patients crp levels oxygen levels almost normalized within days <NUMBER> promising targets include jak inhibitors baricitinib <NUMBER> immunoglobulins fingolimod finally even proposed angiotensin receptors blockers eg losartan may harmful covid<NUMBER> fact beneficial upregulate ace<NUMBER> could ameriolate tissue damage due sarscov<NUMBER> <NUMBER> data removal cytokines adsorbent polymer beads cytosorb sparse coronavirus disease <NUMBER> covid<NUMBER> pandemic outbreak pneumonia caused novel coronavirus occurred wuhan china meanwhile spread throughout world associated mortality rates <NUMBER> <NUMBER> cardiovascular disease important risk indicator adverse outcomes covid<NUMBER> might affect cardiovascular system directly angiotensinconverting enzyme <NUMBER> ace<NUMBER> shown coreceptor viral entry downregulating ace<NUMBER> cardiovascular consequences cardiovascular disease dyspnea prime symptom like heart failure myocardial ischemia hypertensive emergency important differential diagnosis ignored covid<NUMBER> needs recognized important indicator poor outcome evidence changing cardiovascular therapy complete cardiovascular workup necessary covid<NUMBER> patients particular patients cardiorespiratory symptoms even acute respiratory distress syndrome turn cardiopulmonary symptoms distract physicians unbiased workup cardiovascular conditions patients could suffer lifethreatening cardiovascular conditions absence covid<NUMBER> healthcare providers high middle low income countries need aware importance cardiovascular disease patients sars covid<NUMBER> infections providing optimal cardiovascular care infectious disease caused new severe acute respiratory syndrome coronavirus‐<NUMBER> sars‐cov‐<NUMBER> covid‐<NUMBER> broke wuhan china spread almost every country world millions people infected many died everyday life changed completely disease accompanied range different symptoms figure <NUMBER> rapidly accumulating data show prognosis patients covid‐<NUMBER> good mild disease severe cases show relatively asymptomatic early progression followed rapid worsening symptom onset culminating acute respiratory distress syndrome ards significant disease manifestations figure <NUMBER> presence sars‐cov‐<NUMBER> detected multiple organs autopsy including pharynx lungs heart liver brain kidneys highlighting multiorgan tropism virus <NUMBER> early clinical experience suggested older age presence number comorbidities including hypertension cardiovascular disease diabetes mellitus chronic respiratory disease increased risk death patients covid‐<NUMBER> <NUMBER> <NUMBER> addition renin‐angiotensin aldosterone ras system specifically angiotensin‐converting enzyme <NUMBER> ace<NUMBER> protein identified playing important role facilitating entry coronaviruses including sars‐cov‐<NUMBER> target cells especially lungs <NUMBER> <NUMBER> therefore suggested angiotensin receptor blockers arbs ace inhibitors affect ace<NUMBER> expression may influence susceptibility severity infection sars‐cov‐<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> hypertension common affecting estimated <NUMBER> billion individuals worldwide <NUMBER> prevalence hypertension increases age affecting approximately <NUMBER> older adults <NUMBER> addition ras inhibitors ace inhibitors arbs recommended widely used treatment hypertension <NUMBER> <NUMBER> <NUMBER> however hypertension single clinical entity instead manifests number different phenotypes asians disease characterized salt sensitivity high rates masked hypertension exaggerated morning bp surge nocturnal hypertension <NUMBER> nearly half patients hypertension worldwide <NUMBER> live south east asia <NUMBER> hope asia network established <NUMBER> member world hypertension league <NUMBER> <NUMBER> mission hope asia network improve management hypertension organ protection toward achieving “zero” cardiovascular events asia <NUMBER> <NUMBER> become even relevant current pandemic high rates infection several asian countries guidance hope asia network summarizes latest findings covid‐<NUMBER> hypertension including evidence‐based recommendations management hypertension current pandemic march <NUMBER> <NUMBER> italian institute health announced <NUMBER> covid‐<NUMBER> deaths italy <NUMBER> patients died average age <NUMBER> years median <NUMBER> years range <NUMBER>‐<NUMBER> years <NUMBER> least one comorbidity <NUMBER> hypertension common comorbidity italian cases affecting <NUMBER> patients <NUMBER> taking arbs ace inhibitors <NUMBER> however number factors could potentially confound possible relationship hypertension severe covid‐<NUMBER> table <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> first age severe covid‐<NUMBER> hypertension common elderly addition identified risk factors table <NUMBER> generally associated aging andor vascular disorders common patients hypertension therefore risk developing severe covid‐<NUMBER> likely due underlying vascular endothelial dysfunction andor organ damage high blood pressure bp per se ace<NUMBER> receptors expressed endothelial cells <NUMBER> post‐mortem examinations detected presence viral infection endothelial cells <NUMBER> spike protein surface sars‐cov‐<NUMBER> binds extracellular domain transmembrane ace<NUMBER> protein priming transmembrane serine protease <NUMBER> tmprss<NUMBER> gain entry host cells figure <NUMBER> <NUMBER> <NUMBER> <NUMBER> ace<NUMBER> plays regulatory role ras converting angiotensin ang angiotensin <NUMBER>‐<NUMBER> ang <NUMBER>‐<NUMBER> angiotensin ii ang ii angiotensin <NUMBER>‐<NUMBER> ang <NUMBER>‐<NUMBER> <NUMBER> <NUMBER> currently available data reflect possible role ace<NUMBER> heart failure myocardial infarction hypertension cardiovascular complications diabetes mellitus preclinical investigations suggest activation ace<NUMBER> might potential protect hypertension cardiovascular disease <NUMBER> <NUMBER> <NUMBER> <NUMBER> addition angiotensin <NUMBER>‐<NUMBER> appears counteract negative effects ang ii attenuating inflammation suppressing vascular permeability vasorelaxant effects <NUMBER> <NUMBER> <NUMBER> furthermore ace<NUMBER> lungs renin‐angiotensin system shown play role pulmonary manifestations coronavirus infection <NUMBER> interaction ang ii angiotensin type <NUMBER> receptors at<NUMBER>r activates disintegrin metalloproteinase <NUMBER> adam<NUMBER> cell membrane via phosphorylation <NUMBER> turn adam<NUMBER> cleaves precursors tumor necrosis factor‐α tnfα interleukin il‐<NUMBER> receptor‐α il‐<NUMBER>rα cell membrane release tnfα soluble il‐<NUMBER>rα <NUMBER> tnfα activates nuclear transcription factor system nf‐κb induce production various inflammatory cytokines including il‐<NUMBER> figure <NUMBER> <NUMBER> represents potential mechanism cytokine storm seen patients covid‐<NUMBER> highlights potential agents blocking cytokine pathways especially il‐<NUMBER>‐stat<NUMBER> axis managing covid‐<NUMBER>‐related cytokine storm <NUMBER> fact sars‐cov‐<NUMBER> virus uses ace<NUMBER> mechanism enter infect cells meant concern cells high ace<NUMBER> expression would susceptible infection sars‐cov‐<NUMBER> given arb ace inhibitors shown experimentally increase expression ace<NUMBER> cell membranes <NUMBER> <NUMBER> much discussion potential higher infection rates severe disease patients treated agents despite theoretical possibility use ras inhibitors increases risk infection sars‐cov‐<NUMBER> severity covid‐<NUMBER> illness analyses including patients current pandemic indicate seem case table <NUMBER> effect hypertension therapy ace inhibitors arbs evaluated least three published studies date table <NUMBER> <NUMBER> <NUMBER> <NUMBER> reynolds et al looked history antihypertensive usage <NUMBER> <NUMBER> patients undergoing covid‐<NUMBER> testing new york usa <NUMBER> find association use ace inhibitors arbs beta‐blockers calcium channel blockers thiazide diuretics likelihood positive negative result covid‐<NUMBER> testing <NUMBER> also united states mehta colleagues failed find significant association use ace inhibitors arbs covid‐<NUMBER> test positivity <NUMBER> similar findings reported population case‐control study italy <NUMBER> data four studies published early may <NUMBER> also failed find significant association ras inhibitor use worse outcomes patients covid‐<NUMBER> table <NUMBER> <NUMBER> <NUMBER> <NUMBER> one retrospective case series proportion patients using ace inhibitors arbs differ significantly severe vs non‐severe covid‐<NUMBER> survivors non‐survivors <NUMBER> however in‐hospital covid‐<NUMBER> mortality rate higher patients vs without hypertension <NUMBER> vs <NUMBER> <NUMBER> studies death rates patients taking ace inhibitors andor arbs actually lower patients receiving antihypertensive therapies <NUMBER> <NUMBER> one studies china reported levels inflammatory markers high sensitivity c‐reactive protein procalcitonin significantly lower patients hypertension vs receiving ace inhibitors arbs <NUMBER> two possible mechanisms cardiovascular damage covid‐<NUMBER> first direct viral infection myocardial vascular cells systemic inflammatory reaction cytokine storm figure <NUMBER> myocardial injury time admission due disease progression strong indicator poor prognosis patients covid‐<NUMBER> troponin highly sensitive well‐known marker myocardial injury systematic review meta‐analysis data published <NUMBER> december <NUMBER> <NUMBER> march <NUMBER> including <NUMBER> patients <NUMBER> studies showed significant trend higher levels cardiac biomarkers patients severe covid‐<NUMBER> <NUMBER> meta‐regression analysis factor significantly associated higher levels cardiac injury biomarkers presence hypertension p <NUMBER> addition severe covid‐<NUMBER> markedly increased risk acute cardiac injury risk ratio vs mild disease <NUMBER> <NUMBER> confidence interval ci <NUMBER>‐<NUMBER> p <NUMBER> turn risk covid‐<NUMBER>‐related death significantly increased presence acute cardiac injury risk ratio <NUMBER> <NUMBER> ci <NUMBER>‐<NUMBER> <NUMBER> another analysis also reported patients severe covid‐<NUMBER> significantly higher levels troponin without severe disease standardized mean difference <NUMBER> ngl <NUMBER> ci <NUMBER>‐<NUMBER> ngl <NUMBER> early data wuhan china showed <NUMBER> patients admitted hospital covid‐<NUMBER> acute cardiac injury <NUMBER> subsequent analyses investigated associations underlying cardiovascular disease myocardial injury mortality hospitalized patients covid‐<NUMBER> n <NUMBER> <NUMBER> patients vs without myocardial injury defined elevated troponin levels significantly older <NUMBER> vs <NUMBER> years p <NUMBER> likely hypertension <NUMBER> vs <NUMBER> p <NUMBER> <NUMBER> <NUMBER> hospitalization myocardial injury higher rates ards <NUMBER> vs <NUMBER> p <NUMBER> acute renal injury <NUMBER> vs <NUMBER> p <NUMBER> death <NUMBER> vs <NUMBER> p <NUMBER> appearance myocardial injury increased risk death <NUMBER>‐fold compared patients without myocardial damage independent cardiac function based ecg echocardiography findings figure <NUMBER> <NUMBER> <NUMBER> d‐dimer biomarker reflects activation coagulation fibrinolysis <NUMBER> d‐dimer levels <NUMBER> µgml independent predictor in‐hospital death patients hospitalized covid‐<NUMBER> wuhan china hazard ratio <NUMBER> <NUMBER> ci <NUMBER>‐<NUMBER> p <NUMBER> <NUMBER> <NUMBER> µgml cutoff <NUMBER> sensitivity <NUMBER> specificity predicting in‐hospital mortality therefore might useful biomarker predicting outcome informing treatment decisions patients covid‐<NUMBER> cumulative rate thromboembolic events patients admitted hospital milan italy covid‐<NUMBER> n <NUMBER> <NUMBER> <NUMBER> intensive care <NUMBER> intensive care despite use thromboprophylaxis patients admitted intensive care unit three‐quarters treated general ward <NUMBER> half thromboembolic events occurred within <NUMBER> hours hospitalization <NUMBER> patients developed dic <NUMBER> consensus statement prevention treatment venous thromboembolism‐associated covid‐<NUMBER> infection published <NUMBER> recommends patients covid‐<NUMBER> undergo assessment risk venous thromboembolism bleeding monitored regularly facilitate diagnosis treatment venous thromboembolism use strategies pharmacologic andor mechanical prevent venous thromboembolism <NUMBER> key points regarding clinical management covid‐<NUMBER> particularly patients hypertension based evidence published may <NUMBER> <NUMBER> shown table <NUMBER> data rapidly compiled pandemic date indicate number factors biomarkers used identify patients covid‐<NUMBER> high risk severe disease adverse outcomes including death age seems important risk factor especially covid‐<NUMBER>‐related death hypertension common comorbidity covid‐<NUMBER>‐positive deceased patients <NUMBER> comorbidities cardiovascular diseases smoking chronic lung disease chronic kidney disease suppressed immune system also increase risks associated covid‐<NUMBER> infection especially multiple comorbidities exist patient <NUMBER> thorough history taking baseline assessments therefore important another important screening tool oxygen saturation indicates severe disease ≤<NUMBER> admission <NUMBER> <NUMBER> relevance ability tolerate hypoxia highlighted analysis china showing covid‐<NUMBER> patients high‐altitude origin lower mortality risk lower altitudes <NUMBER> determination relevant biomarkers especially troponin d‐dimer provides indication myocardial injury thrombotic risk help inform appropriate treatment strategies non‐hospitalized patients covid‐<NUMBER> ongoing management comorbid conditions essential minimize risk includes lifestyle factors diet sleep along maintaining regular medications eg antihypertensives antidiabetics patients hypertension current therapy ace inhibitors arbs continue treatment without negative effects covid‐<NUMBER> outcomes ras inhibitors particularly beneficial patients heart failure renal disease positive effect prognosis older patients hypertension comorbidities risk factors calcium channel antagonists might good option antihypertensive therapy maintaining good glycaemic control also important might help reduce risk infection sars‐cov‐<NUMBER> severity covid‐<NUMBER> <NUMBER> addition regular monitoring home bp help ensure achievement maintenance bp targets patients hypertension lockdown requirements could impact ability individuals get regular exercise regular exercise important maintaining health status <NUMBER> counteract negative consequences cardiovascular metabolic respiratory diseases <NUMBER> even unable get outside continuing form home‐based exercise would beneficial especially older adults <NUMBER> maintaining regular exercise could help ensure current viral pandemic contribute worldwide obesity epidemic turn increases rate cardiovascular metabolic comorbidities <NUMBER> ensuring world population burdened high rates noncommunicable diseases might help lessen impact future pandemics given patients comorbidities tend fare poorly infectious disease pandemic <NUMBER> another potential benefit physical activity ability stimulate immune function <NUMBER> something highly relevant global pandemic health care professionals also aware potential non‐infectious impacts covid‐<NUMBER> example non‐infected individuals might risk developing stress‐related physical health conditions gastrointestinal disturbances cardiovascular disease psychological disturbances anxiety depression strict lockdown social distancing rules enforced many countries slow spread novel coronavirus addition large proportion “elective” “non‐essential” procedures postponed canceled allow health care systems cope influx infectious disease cases created requirement large proportion health consultations conducted remotely telemedicine strategies ideally suited facilitating patient management absence face‐to‐face consultations value approach otherwise slow widely used clinical practice become clear <NUMBER> <NUMBER> one hidden “blessings” covid‐<NUMBER> pandemic may widespread adoption telemedicine approaches improve patient management out‐of‐office bp monitoring recommended approach diagnosis management hypertension <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> therefore field medicine better placed many able continue effectively manage patients global pandemic new information communication technology‐based home bp monitoring devices perform automatic fixed‐interval bp measurement sleep store transmit data could facilitate novel approach patient management <NUMBER> validated wearable technologies evaluation home bp <NUMBER> <NUMBER> might also useful patient monitoring management covid‐<NUMBER> outbreak telemedicine‐based strategies managing bp implemented used effectively aftermath great east japan earthquake tsunami march <NUMBER> <NUMBER> highlighting potential use covid‐<NUMBER> pandemic ensure patients hypertension well‐controlled bp potential help mitigate negative effects hypertension prognosis patients covid‐<NUMBER> patients hypertension increased risk morbidity mortality become infected sars‐cov‐<NUMBER> although confounded factors age vascular disorders however usual antihypertensive therapy including ras inhibitors continue physicians need take holistic approach patient management due wide range possible complications biomarkers provide important prognostic information overall multidisciplinary management covid‐<NUMBER> based rapidly growing body evidence help ensure best possible outcomes patients including risk factors hypertension authors report potential conflicts interest relation article currently midst covid<NUMBER> pandemic caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> global shutdown third worlds population facing form lockdown quarantine measures unprecedented scale doubt etched history time writing <NUMBER> million people diagnosed infection <NUMBER> deaths worldwide expected even larger number asymptomatic mildly symptomatic undiagnosed time worlds focus novel coronavirus danger illnesses might overlooked members public urged attend emergency departments nonurgent matters dual intention protecting healthcare workers whilst freeing resources treat covid<NUMBER> patients indeed hospitals reported decrease number patients attending emergency departments myocardial infarctions cerebrovascular accidents <NUMBER> <NUMBER> likely patients concerned contracting virus attending hospital staying away reports delayed presentation patients acute myocardial infarctions <NUMBER> imperative lifethreatening conditions forgotten deal coronavirus addition acute conditions management stable chronic illnesses hypertension diabetes may also affected many hospitals worldwide cancelled inperson elective patient care including routine outpatient clinics moved towards telemedicine part social distancing measures also preserves resources help tackle supply chain problems challenges created surge patients infected novel coronavirus even circumstances important blood pressure blood glucose levels monitored regularly particularly important patients diabetes hypertension may higher risk complications covid<NUMBER> <NUMBER> early data china united states suggest hypertension appears prevalent comorbidity among patients admitted covid<NUMBER> present least <NUMBER> <NUMBER> <NUMBER> hypertensive patients develop covid<NUMBER> likely admitted hospital normotensive individuals <NUMBER> presence hypertension also seems associated poorer outcomes covid<NUMBER> <NUMBER> clear whether hypertension per se contributes increased morbidity whether patients hypertension underlying health problems data confirmed patients multiple comorbidities likely fare worse <NUMBER> bear mind though retrospective data patients admitted covid<NUMBER> therefore suggest association causation nevertheless interaction sarscov<NUMBER> virus ace<NUMBER> endothelial cell <NUMBER> raise possibility endothelial dysfunction commonly occurs hypertension <NUMBER> may exacerbate effect virus major problem pandemic hithertounknown organism early conflicting data cause uncertainty confusion management patients shown sarscov<NUMBER> binds cells via angiotensin converting enzyme ace <NUMBER> receptor <NUMBER> thereby gaining entry cells concern therefore raised start pandemic ace inhibitors angiotensin receptor blockers arbs medications commonly used hypertension heart failure could potential deleterious effect <NUMBER> ace<NUMBER> widely expressed cardiovascular system regulated drugs tissues subset animal models <NUMBER> <NUMBER> initial publications led considerable amount discussion debate counter argument ace inhibitors arbs shown protect lung injury experimental models coronavirus infections <NUMBER> agents also previously demonstrated reduce systemic inflammation could potentially reduce degree multiorgan failure seen severe covid<NUMBER> <NUMBER> also considered uncontrolled blood pressure heart failure could ensue result discontinuation therapies could contribute morbidity infected patients guidance promptly issued advising drugs discontinued <NUMBER> <NUMBER> subsequent data raised possibility patients treated ace inhibitors arbs indeed better outcome crucial caveat possibility unmeasured confounding bias precludes drawing causeeffect conclusions clinical studies available thus far recent retrospective study china comparing outcomes hospitalised patients covid<NUMBER> without ace inhibitors arbs hypertension suggested former allcause mortality lower adjusted hr <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> <NUMBER> another retrospective study china showed fewer patients ace inhibitors arbs severe disease compared drugs <NUMBER> <NUMBER> respectively ace inhibitorarbtreated group also significantly higher cd<NUMBER> cd<NUMBER> cells trend towards lower il<NUMBER> levels <NUMBER> recent analyses preprints though suggested adjustment certain likely confounders signal improved outcomes longer strong first believed <NUMBER> end effects treatment ace inhibitors arbs positively identified rcts ongoing <NUMBER> also mounting concern possible thromboembolic complications virus possible procoagulable state <NUMBER> various factors lead hypercoagulable state inflammation hypoxia immobilisation dehydration diffuse intravascular coagulation described covid<NUMBER> addition hypertension also known associated hypercoagulable state <NUMBER> possible interaction two conditions might lead worsening thrombotic milieu still learning new virus information continues mount meantime would prudent continue guidelinebased management chronic conditions cardiovascular risk factors diabetes hypertension healthcare practitioners need ensure patients appropriately advised access drugs patients made aware despite lockdown pharmacies hospitals still open indeed british heart foundation recently issued notice reminding public ignore chest pain seek help immediately also report <NUMBER> drop patients presenting myocardial infarction since start pandemic <NUMBER> general practitioners family physicians still available consultations even telephone patients also encouraged monitor blood pressure home adherent treatment adopt healthy lifestyles many countries individuals allowed go exercise ensuring maintain social distancing take necessary precautions advised public health authorities current pandemic brought profound changes social economic lives many also changed way healthcare delivered prioritised even social restrictions relaxed hard imagine things would quickly ever go back pandemic whilst get used new normal way life remember diseases illness still still need care perhaps time much control chronic illnesses go back community patients ensure patients chronic illnesses forgotten fight sarscov<NUMBER> end collateral damage conflict interest authors declare conflict interest publishers note springer nature remains neutral regard jurisdictional claims published maps institutional affiliations reninangiotensinaldosterone system raas complex peptide cascade prominent role multiple important physiological processes vascular tone vascular permeability myocardial remodeling <NUMBER> <NUMBER> <NUMBER> pharmacologic modulation system agents angiotensinconverting enzyme inhibitors acei angiotensin receptor blockers arbs resulted major clinical benefits medical management hypertension heart failure <NUMBER> furthermore consequences pharmacologic blockade raas perioperative cardiothoracic vascular practice wellrecognized leading emergence rescue therapies support vascular tone <NUMBER> <NUMBER> severe acute respiratory syndrome coronavirus<NUMBER> infects human cells alveolar endothelium lung binding membrane receptor angiotensinconverting enzyme <NUMBER> ace<NUMBER> <NUMBER> <NUMBER> <NUMBER> although physiologic functions ace<NUMBER> include counteracting effects raas activation also functions membrane receptor coronavirus <NUMBER> <NUMBER> <NUMBER> binding results endocytosis viral complex consequent local activation raas resulting acute lung injury may progress adult respiratory distress syndrome <NUMBER> <NUMBER> purpose freestanding editorial highlight considerations concerning raas patients presenting severe coronavirus disease <NUMBER> perspective focus clinical relevance considerations inform management challenging patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> references provide detail healthcare teams manage demands pandemic respective institutions <NUMBER> prevalence coexisting hypertension estimated <NUMBER> range amongst patients presenting covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> coexisting conditions hypertension older age diabetes cardiovascular disease reported common patients severe covid<NUMBER> requiring intensive care <NUMBER> <NUMBER> <NUMBER> <NUMBER> comorbidities including hypertension also significantly associated adverse outcomes covid<NUMBER> adult respiratory distress syndrome cardiovascular compromise mortality <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> since comorbidity hypertension associated severe covid<NUMBER> consequences question emerged roles raas inhibitors acei arbs pathogenesis severe covid<NUMBER> given raas inhibitors common therapies hypertension may upregulate expression ace<NUMBER> clinical concern formulated therapy agents may increase risk severity coronavirus infection <NUMBER> <NUMBER> <NUMBER> <NUMBER> currently insufficient evidence address question definitive fashion <NUMBER> <NUMBER> published literature preclinical clinical studies conflicting results potential harm respect interactions raas inhibitors coronavirus <NUMBER> trials likely focus current evidence gaps related question severe covid<NUMBER> including mechanisms prevalence raas inhibitors careful correlation prevalence clinical outcomes <NUMBER> <NUMBER> although hypertension consequent exposure acei arbs likely common severe covid<NUMBER> association link causality outlined <NUMBER> <NUMBER> may also confounding association patients severe covid<NUMBER> likely <NUMBER> hypertensive diabetic older comorbidity burden rather associated drug therapy may better explain adverse outcomes coronavirus infection <NUMBER> <NUMBER> <NUMBER> contrast animal studies clearly documented ace<NUMBER> may protective role acute lung injury related coronavirus infection <NUMBER> <NUMBER> functional ace<NUMBER> typically converts angiotensin ii angiotensin <NUMBER> thereby reducing adverse effects angiotensin ii via angiotensin type receptor lung lead acute lung injury <NUMBER> <NUMBER> since therapy acei andot arbs also reduces angiotensin ii levels follows agents may also protect acute lung injury setting covid<NUMBER> patients severe covid<NUMBER> may also develop vasoplegic shock without concomitant sepsis <NUMBER> initial wave covid<NUMBER> seattle patients cardiovascular compromise seldom superinfection suggesting cardiovascular instability mostly due consequences viral infection <NUMBER> furthermore patient cohort echocardiography also rarely identified ventricular dysfunction although myocarditis possibility disease <NUMBER> latest data pandemic united states suggests vasoplegic shock effects coronavirus likely clinical presentation severe covid<NUMBER> status quo respect acei arbs covid<NUMBER> confusing clinicians front lines patient care pandemic given possibilities benefit <NUMBER> harm <NUMBER> <NUMBER> priority clinical guidance coronavirus virus prompted recent statements multiple professional societies including canadian cardiovascular society european society hypertension international society hypertension european society cardiology american college cardiology <NUMBER> <NUMBER> summary expert consensus professional societies patients covid<NUMBER> continue regular home blood antihypertensive regimen even includes acei arbs <NUMBER> patients covid<NUMBER> develop shock vasodilator regimen raas inhibitors discontinued <NUMBER> although specifically addressed multiple professional guidelines roles rescue therapy vasoplegic shock also considered refractory cases including angiotensin ii <NUMBER> furthermore treatmentresistant cases copvid<NUMBER> mechanisms cardiogenic shock supportive roles extracorporeal membrane oxygenation entertained early considerations often lead therapeutic breakthroughs <NUMBER> <NUMBER> <NUMBER> spectrum severe covid<NUMBER> includes significant disruption raas significant implications organ dysfunction vascular tone well therapy acei arbs although clinical trials progress close current evidence gaps current expert consensus recommended cases existing therapy acei arbs continued setting circulatory shock agents may discontinued early consideration therapies medical mechanical rescue may lifesaving management patients pandemic must also consider infection control prevent viral transmission reninangiotensin system ras plays key role maintaining blood pressure homeostasis well fluid salt balance angiotensin ii key effector peptide system causes vasoconstriction exerts multiple biological functions angiotensinconverting enzyme ace plays central role generating angiotensin ii angiotensin capillary blood vessels lung one major sites ace expression angiotensin ii production human body ras implicated pathogenesis pulmonary hypertension pulmonary fibrosis commonly seen chronic lung diseases chronic obstructive lung disease recent studies indicate ras also plays critical role acute lung diseases especially acute respiratory distress syndrome ards ace<NUMBER> close homologue ace functions negative regulator angiotensin system identified key receptor sars severe acute respiratory syndrome coronavirus infections lung ace<NUMBER> protects acute lung injury several animal models ards thus ras appears play critical role pathogenesis acute lung injury indeed increasing ace<NUMBER> activity might novel approach treatment acute lung failure several diseases many decades roles reninangiotensin system ras studied physiology multiple disorders particular cardiovascular diseases <NUMBER> <NUMBER> angiotensin ii ang ii key effector peptide ras exerts multiple biological functions including vasoconstriction sodium balance involved blood pressure homeostasis angiotensinconverting enzyme ace plays central role generating ang ii angiotensin ang <NUMBER> <NUMBER> figure <NUMBER> ace inhibitors ang ii receptor blockers exhibit beneficial effects cardiovascular diseases capillary blood vessels lung major site highlevel expression ace <NUMBER> thus lung important organ generating circulating ang ii acting classical circulationborne endocrine system contrast endocrine ras model numerous studies highlighted importance local rass <NUMBER> example increase endothelial ace expression muscularized intraacinar arteries lungs shown patients pulmonary hypertension <NUMBER> rats hypoxiainduced pulmonary hypertension <NUMBER> addition ace components ras expressed lungs including renin <NUMBER> angiotensinogen <NUMBER> ang ii receptors <NUMBER> <NUMBER> ace<NUMBER> homologue ace identified discovery instantaneously added new complexity ras <NUMBER> <NUMBER> although ace<NUMBER> functions similarly ace carboxypeptidase ace<NUMBER> different substrate specificity <NUMBER> <NUMBER> <NUMBER> shown vitro analyses using recombinant ace<NUMBER> protein whereas ace removes dipeptides cterminus peptide substrates generating octapeptide ang ii decapeptide ang <NUMBER> <NUMBER> ace<NUMBER> cleaves single residue ang ii generating angiotensin<NUMBER> <NUMBER> <NUMBER> single residue ang ii generate angiotensin<NUMBER> <NUMBER> genetic inactivation ace using homologous recombination results phenotype characterized spontaneous hypotension reduced male fertility kidney malformation <NUMBER> contrast targeted disruption murine ace<NUMBER> resulted increased systemic ang ii levels impaired cardiac contractility aged mice <NUMBER> loss ace ace<NUMBER> background reversed cardiac phenotype <NUMBER> thus ace<NUMBER> appears negative regulator ras counterbalances function ace figure <NUMBER> importance ras lung diseases recently reemerged since identification ace<NUMBER> severe acute respiratory syndrome sars coronavirus receptor several months <NUMBER> sars newly identified illness spread rapidly china throughout world causing <NUMBER> deaths <NUMBER> <NUMBER> novel coronavirus identified sars pathogen triggered atypical pneumonia characterized high fever severe dyspnea <NUMBER> <NUMBER> death rate following sars coronavirus exposure approached almost <NUMBER> infected people owing development acute respiratory distress syndrome ards ards severe form acute lung injury characterized pulmonary oedema accumulation inflammatory cells severe hypoxia <NUMBER> <NUMBER> clinical well experimental animal studies implicated ace pathogenesis ards <NUMBER> <NUMBER> <NUMBER> ace<NUMBER> expressed lungs healthy diseased humans <NUMBER> recent ards sars studies shown ace<NUMBER> protects murine lungs severe acute injury <NUMBER> <NUMBER> importantly experiments also revealed ace<NUMBER> essential receptor sars infections vitro vivo <NUMBER> <NUMBER> review review role ras particular sars receptor ace<NUMBER> lung diseases focusing pulmonary hypertension pulmonary fibrosis acute lung injury possible applications blocking ras andor modulating ace<NUMBER> treatment lung diseases discussed pulmonary hypertension characterized elevations pulmonary artery pressure pulmonary vascular resistance caused multiple etiologies including primary pulmonary hypertension chronic obstructive pulmonary disease copd high altitude pulmonary embolism abnormal pulmonary vasoconstriction pulmonary vascular remodeling major pathological features seen forms pulmonary hypertension <NUMBER> <NUMBER> although ang ii well known potent vasopressor peptide pathogenesis pulmonary hypertension ang ii seems play role pulmonary vascular remodeling rather pulmonary vasoconstriction vitro cell culture models ang ii shown directly cause growthproliferation pulmonary artery smooth muscle cells largely ang ii type <NUMBER> rather type ii <NUMBER> receptors <NUMBER> figure <NUMBER> pulmonary hypertension vivo expression ace increased endothelial layer small well elastic pulmonary arteries <NUMBER> <NUMBER> addition hypoxic monocrotalinetreated <NUMBER> pulmonary hypertensive rats ang ii binding number <NUMBER> receptors increased <NUMBER> <NUMBER> human patients association ace insertiondeletion polymorphism allele human ace gene confers increased ace activity plasma pulmonary hypertension reported association however controversial instance one study showed ace dd genotype associated less right ventricular hypertrophy <NUMBER> whereas another reported correlation ace dd genotype severity symptoms <NUMBER> pharmacologic treatment animals either ace blocker ang ii receptor antagonist inhibited pulmonary vascular remodeling associated development pulmonary hypertension chronically hypoxic rats mice <NUMBER> <NUMBER> monocrotalinetreated rats <NUMBER> contrast tissue acedeficient mice exhibit undetectable lung ace activity retain <NUMBER> ace activity plasma show remodeling pulmonary arterioles wildtype mice <NUMBER> addition despite earlier studies acute ace inhibition <NUMBER> <NUMBER> <NUMBER> recent pilot study patients pulmonary hypertension secondary copd showed treatment <NUMBER> receptor blocker losartan <NUMBER> mg showed statistically significant beneficial effect terms pulmonary artery pressure exercise capacity breathlessness score <NUMBER> discrepancy hypoxic rat studies human trial might caused differences pathogenesis hypoxic rats versus patients copdrelated pulmonary hypertension studies required solve important issues pulmonary fibrosis frequent response insults injuries lung etiologies include idiopathic pulmonary fibrosis sarcoidosis irradiationinduced pneumonitis ards excess deposition extracellular matrix proteins key feature interstitial fibrosis lung pathogenesis pulmonary fibrosis includes endothelial epithelial cell injury influx inflammatory cells production chemical mediators leading proliferation activation fibroblasts <NUMBER> <NUMBER> although various initiating mechanisms etiologies terminal phases fibrosis commonly characterized proliferation progressive <NUMBER> respiratory figure <NUMBER> current view ras pulmonary hypertension pulmonary fibrosis ang serves substrate ace ace<NUMBER> ang ii known act vasoconstrictor well mitogen smooth muscle cells fibroblasts mainly <NUMBER> receptor function angiotensin<NUMBER> well understood ace ace<NUMBER> involved production vasodilator peptide angiotensin<NUMBER> accumulation connective tissue replacing normal functional parenchyma ang ii immunoreactivity also significantly increased within lung fibroblasts macrophages bronchiolar alveolar epithelium irradiation <NUMBER> addition angiotensinogen produced fibroblasts fibrotic normal human lung ang ii upregulates expression profibrotic cytokine transforming growth factorb<NUMBER> involved conversion fibroblasts myofibroblasts accumulation collagen <NUMBER> figure <NUMBER> vivo role ang ii pulmonary fibrosis implied animal models bleomycinor irradiationmediated lung injury bleomycininduced pulmonary fibrosis rats mice ace inhibitors <NUMBER> receptor blockers attenuate epithelial apoptosis interstitial fibrosis collagen deposition <NUMBER> <NUMBER> <NUMBER> irradiationinduced lung fibrosis ace inhibitors attenuate endothelial dysfunction fibrosis rats <NUMBER> conversely retrospective comparison incidence irradiationinduced lung injury subjects took ace inhibitors failed reveal protective effect <NUMBER> however serum concentrations ace inhibitors used subjects human study would expected considerably less achieved animal models cited published prospective retrospective studies regarding use ace inhibitors <NUMBER> receptor blockers human pulmonary fibrosis induced factors irradiation therefore still unclear inhibition ras would indeed beneficial effects lung fibrosis ards severe form acute lung injury affects approximately one million individuals worldwide year mortality rate least <NUMBER> <NUMBER> <NUMBER> ards triggered multiple diseases sepsis aspiration trauma acute pancreatitis pneumonias following infections sars coronavirus avian human influenza viruses recent cohort studies ards showed significant association ace insertiondeletion polymorphism susceptibility outcome ards <NUMBER> <NUMBER> dd genotype frequency increased patients ards compared control cohort <NUMBER> addition ace dd allele significantly associated mortality ards group <NUMBER> another study showed patients carrying ace ii genotype significantly increased survival rate <NUMBER> thus results inhibitor experiments rodents <NUMBER> ace allelic correlation studies humans <NUMBER> <NUMBER> suggested ras could play role acute lung failure group investigated role ace<NUMBER> ards using ace<NUMBER> knockout mice acidaspirationinduced ards endotoxininduced ards peritoneal sepsisinduced ards ace<NUMBER> knockout mice exhibited severe disease compared control mice express ace<NUMBER> <NUMBER> loss ace<NUMBER> expression mutant mice resulted enhanced vascular permeability increased lung edema neutrophil accumulation worsened lung function importantly treatment catalytically active enzymatically inactive recombinant ace<NUMBER> protein improved symptoms acute lung injury wildtype mice well ace<NUMBER> knockout mice <NUMBER> thus ace<NUMBER> plays protective role acute lung injury mechanistically negative regulation ang ii levels ace<NUMBER> accounts part protective function ace<NUMBER> ards example <NUMBER> receptor inhibitor treatment additional ace gene deficiency ace<NUMBER> knockout background rescues severe phenotype ace<NUMBER> single mutant mice acute lung injury <NUMBER> addition ace knockout mice <NUMBER>a receptor knockout mice showed improved symptoms acute lung injury <NUMBER> therefore acute lung injury ace ang ii <NUMBER> receptors function lung injurypromoting factors <NUMBER> <NUMBER> whereas ace<NUMBER> protects lung injury <NUMBER> figure <NUMBER> findings suggest beneficial effects ace inhibitors <NUMBER> receptor blockers lung injury models induced bleomycin irradiation observed earlier studies derive largely effects acute phase injuries within months following publication sarscov genome <NUMBER> <NUMBER> ace<NUMBER> identified potential receptor cell line studies vitro <NUMBER> ace<NUMBER> demonstrated bind sarscov spike support syncytia formation fusion spikeproteinexpressing cells large multinucleated cells also seen real sars infections using mouse sars infection model ace<NUMBER> knockout mice group provided evidence ace<NUMBER> indeed essential sars infections vivo <NUMBER> ace<NUMBER> knockout mice infected sars coronavirus become resistant virus infection <NUMBER> virus titers lung tissues infected ace<NUMBER> knockout mice <NUMBER> <NUMBER> fold lower isolated lung sarscovinfected wildtype mice <NUMBER> lung histology ace<NUMBER> knockout mice challenged sars coronavirus showed signs inflammation <NUMBER> whereas sarsinfected wildtype mice displayed mild inflammation leukocyte infiltration <NUMBER> <NUMBER> thus ace<NUMBER> essential receptor sars infections vivo despite many studies sarscov reasons sarscov infections trigger severe lung disease high mortality contrast coronaviruses remain mystery accumulating evidence indicates severe sars infections dependent upon burden viral replication well immunopathologic consequences host response review see <NUMBER> <NUMBER> addition aberrant activation immune systems studies implicated involvement ras sars pathogenesis firstly ace<NUMBER> critical sars receptor vivo secondly ace<NUMBER> components ras play central role controlling severity acute lung failure disease process initiated <NUMBER> figure <NUMBER> intriguingly wildtype mice infected sarscov showed markedly downregulated ace<NUMBER> expression lungs <NUMBER> similarly treatment recombinant sarsspike protein absence virus components downregulates ace<NUMBER> expression vitro vivo <NUMBER> thus sarscovinfected spike proteintreated wildtype mice resemble ace<NUMBER> knockout mice similar ace<NUMBER> mutant mice spiketreated wildtype mice show markedly severe pathology acute lung injury additionally spiketreated mice ang ii peptide levels increased worsened ards symptoms could partially reversed <NUMBER> receptor blocker treatment <NUMBER> contrast spike affect ards symptoms ace<NUMBER> knockout mice <NUMBER> thus downregulation ace<NUMBER> expression sarscov infections might play causal role sars pathogenesis especially disease progression ards ang ii plays roles tissue remodeling fibrotic changes acting fibroblasts smooth muscle cells thereby contributing pathogenesis progression pulmonary fibrosis pulmonary hypertension notion strongly supported successful treatment disease conditions using ace inhibitors <NUMBER> receptor blockers animal models however pilot clinical trials failed observe significant beneficial effects ace inhibitors radiationinduced pulmonary fibrosis positive effects <NUMBER> receptor blockers copdrelated pulmonary hypertension recently critical importance ras pathogenesis acute lung disease ie ardsacute lung injury emerged hypothetically ras appears contribute initial severity lung diseases rather later stages define chronic fibrosis tissue remodeling line notion dd polymorphism ace gene associated incidence pneumonias japanese elderly patients <NUMBER> mortality ards patients <NUMBER> <NUMBER> importantly ace<NUMBER> identified key sars receptor ace<NUMBER> protects murine lungs acute lung injury induced acid aspiration endotoxin shock peritoneal sepsis sars spike challenge findings might provide opportunity develop ace<NUMBER> novel drug ards develops emerging lung infectious diseases avian influenza h<NUMBER>n<NUMBER> <NUMBER> diseases affect lung function <NUMBER> ace<NUMBER> nonspecific protease would also interesting investigate role ace<NUMBER> metabolites including angiotensin<NUMBER> desarg<NUMBER>bradykinin apelin dynorphin ards <NUMBER> look forward use angiotensin systemmodulating agentsmolecules particular ace<NUMBER> schematic diagram proposed role ras development severe ards acute lung injury sarscov infections acid aspiration pneumonias sepsis generation ang ii ang enhanced ace ang ii contributes acute lung failure stimulation <NUMBER> receptor whereas ace<NUMBER> <NUMBER> receptor negatively regulate pathway protect acute lung failure however additional ace<NUMBER>regulated ang iiindependent pathways seem also contribute ards novel therapeutic agents treat severe acute lung failure syndrome currently affects millions people without effective drug treatment outbreak coronavirus disease <NUMBER> covid<NUMBER> aroused peoples concern coronavirus seven human coronaviruses hcovs discovered far including hcov<NUMBER>e hcovnl<NUMBER> hcovoc<NUMBER> hcovhku<NUMBER> severe acute respiratory syndrome coronavirus middle east respiratory syndrome coronavirus severe acute respiratory syndrome coronavirus <NUMBER> existing studies show cardiovascular disease increased incidence severity coronavirus infection time myocardial injury caused coronavirus infection one main factors contributing poor prognosis review recent clinical findings relationship coronaviruses cardiovascular diseases underlying pathophysiological mechanisms discussed review aimed provide assistance prevention treatment covid<NUMBER> advances relationship coronavirus infection cardiovascular diseases hcov<NUMBER>e hcovoc<NUMBER> <NUMBER> discovered <NUMBER>s hcovnl<NUMBER> <NUMBER> hcovhku<NUMBER> <NUMBER> later discovered upper respiratory tract infections asthma bronchiolitis pneumonia evidence showing infant elderly immunocompromised patients likely infected high mortality rates <NUMBER> <NUMBER> <NUMBER> <NUMBER> infected patients likely develop severe disease states <NUMBER> <NUMBER> <NUMBER> <NUMBER> varghese et al <NUMBER> retrospectively analyzed clinical data <NUMBER> children hcov infection including <NUMBER>e hku<NUMBER> nl<NUMBER> oc<NUMBER> found approximately <NUMBER> children cardiovascular disease hcovinfected children cardiovascular disease likely receive respiratory support enter pediatric intensive care unit picu suggesting underlying cardiovascular disease increased severity hcov infection children cabeça et al found children heart disease likely infected hcovs <NUMBER> presence congenital heart disease significant risk factor severe coronavirus infection children less five years old <NUMBER> table <NUMBER> hypotension found small number patients four hcov infections <NUMBER> table <NUMBER> relevant evidence showing hcov infection cause heart injury however kim et al reported hcovs detected children kawasaki disease characterized acute systemic vasculitis childhood may induce severe cardiovascular complications <NUMBER> serological tests suggest hcov<NUMBER>e may involved occurrence kawasaki disease <NUMBER> therefore still need pay attention cardiovascular complications facing four kinds hcov infection severe acute respiratory syndrome <NUMBER> broke globally <NUMBER> different human coronavirus described previously severe acute respiratory infection clinical manifestations fever dry cough lungs main locations lesions patients quickly develop acute respiratory distress syndrome ards multiple organ failure high mortality <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> much relevant evidence showing preexisting comorbid conditions one major determinants fatality <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> reported presence cardiovascular diseases hypertension heart disease associated adverse outcomes mortality sars patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> wong et al reviewed medical records fatal cases found <NUMBER> patients died comorbid conditions hypertension coronary artery disease <NUMBER> chen et al found patients combined hypertension cerebrovascular diseases likely develop ards <NUMBER> another study hu et al showed incidence rates critical conditions multiple organ dysfunction syndrome mods among sars patients cardiovascular cerebrovascular diseases <NUMBER>fold <NUMBER>fold higher patients without underlying disease suggesting cardiovascular cerebrovascular diseases major risk factors sars patients devolve critical conditions mods eventually lead death <NUMBER> table <NUMBER> regarding cardiovascular complications sars patients found sars patients subclinical diastolic impairment without contraction involvement damage may reversible upon clinical recovery <NUMBER> another study yu et al found cardiovascular complications including hypotension tachycardia common sars patients usually selflimiting bradycardia cardiac hypertrophy less common arrhythmias rare <NUMBER> acute myocardial infarction also seen sars patients <NUMBER> sarscov reported found <NUMBER> <NUMBER> patients heart samples patients died sars toronto outbreak <NUMBER> might explain myocardial damage discovered sars patients <NUMBER> reports indicating sarscov also attacks small blood j u r n l p r e p r f cardiovascular disease increased mortality mers <NUMBER> banik suggested sufficient attention paid mers patients combined underlying diseases reduce occurrence serious complications mortality <NUMBER> table <NUMBER> heart damage also reported mers patients <NUMBER> merscov found kidneys deceased patients detected heart tissue heart showed significant histological changes <NUMBER> <NUMBER> however animal model study clearly stated merscov rna could seen cardiac tissue implying direct cardiac pathology <NUMBER> mechanism heart injury mers infection remains unclear requires research covid<NUMBER> broke end <NUMBER> disease caused infection sarscov<NUMBER> <NUMBER> <NUMBER> <NUMBER> similar sarscov merscov sarscov<NUMBER> βcov <NUMBER> covid<NUMBER> similar sars mers manifests extensively pathological viral lung inflammation <NUMBER> although similar sarscov merscov sarscov<NUMBER> characteristics <NUMBER> <NUMBER> early cases suggest covid<NUMBER> may severe sars mers however rapidly increasing number cases increasing evidence humantohuman transmission suggest sarscov<NUMBER> contagious sarscov merscov lower fatality <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> april <NUMBER> <NUMBER> overall mortality covid<NUMBER> <NUMBER> globally <NUMBER> fatality rate different different regions times ranging <NUMBER> <NUMBER> <NUMBER> <NUMBER> symptoms covid<NUMBER> infection appear incubation period approximately <NUMBER> days <NUMBER> fever fatigue dry cough main manifestations covid<NUMBER> patients symptoms nasal congestion runny nose sore throat diarrhea <NUMBER> <NUMBER> <NUMBER> <NUMBER> patients severe cases often experience dyspnea andor hypoxemia one week onset <NUMBER> severe cases covid<NUMBER> progress rapidly acute respiratory distress syndrome septic shock metabolic acidosis difficult correct coagulopathy <NUMBER> current case reports show sarscov<NUMBER> infection may cardiovascular symptoms addition typical respiratory symptoms small number patients atypical clinical manifestations may start cardiovascular symptoms chest tightness palpitations chest pain study liu et al found <NUMBER> <NUMBER> patients palpitations first symptom <NUMBER> also reported <NUMBER> patients experienced chest pain hospitalization <NUMBER> addition wang et al found <NUMBER> patients covid<NUMBER> arrhythmias <NUMBER> according relevant studies <NUMBER> <NUMBER> <NUMBER> <NUMBER> proportion covid<NUMBER> patients comorbid cvds hypertension coronary artery disease cerebrovascular disease larger patients comorbidities without comorbidities suggesting patients cvd may susceptible sarscov<NUMBER> infection moreover incidence cvd patients severe fatal cases covid<NUMBER> higher patients nonsevere cases survived <NUMBER> <NUMBER> <NUMBER> according reports chinese center disease control prevention <NUMBER> deaths hypertension <NUMBER> cardiovascular diseases suggesting underlying cardiovascular diseases may one important risk factors poor prognosis patients covid<NUMBER> <NUMBER> seen number covid<NUMBER> patients cardiovascular disease large also patients poor tolerance severe pneumonia likely develop severe cases table <NUMBER> cardiac complications electrocardiography abnormities diastolic dysfunction acute myocardial injury reported patients covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> cases severe myocarditis reduced systolic function reported covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> sarscov<NUMBER> infectionrelated myocarditis likely associated myocardial injury <NUMBER> <NUMBER> according study li et al common organ damage outside lungs heart injury<NUMBER> serum myocardial necrosis markers hypersensitive troponin hstni creatine kinase ck increased varying degrees patients mild severe cases covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> however risk heart injury higher patients severe cases approximately <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> patients mild cases approximately <NUMBER> <NUMBER> <NUMBER> <NUMBER> percentage heart injury covid<NUMBER> patients died approximately <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> higher survived nterminal probrain natriuretic peptide ntprobnp levels also reported increased<NUMBER> <NUMBER> <NUMBER> increased hstni probnp expression levels may risk factors severe illness high mortality covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> furthermore found high hstni levels associated increased levels inflammation neutrophils il<NUMBER> crp pct decreased levels immunity lymphocytes monocytes cd<NUMBER> cd<NUMBER> cells suggesting cardiac injury may something cytokine storm resulting overaggressive host immune response <NUMBER> <NUMBER> table <NUMBER> two recent studies published jama cardiology reported cardiovascular complications covid<NUMBER> detail <NUMBER> <NUMBER> shi et al found cardiac injury common condition among hospitalized patients covid<NUMBER> wuhan china associated higher risk inhospital mortality <NUMBER> guo et al reported myocardial injury significantly associated fatal outcome covid<NUMBER> myocardial injury associated cardiac dysfunction arrhythmias inflammation may potential mechanism myocardial injury <NUMBER> table <NUMBER> j u r n l p r e p r f covid<NUMBER> may induce new cardiovascular diseases aggravate potential cardiovascular diseases shortterm longterm cardiovascular effects covid<NUMBER> effects specific treatments unclear need investigation epidemic spread sarscov<NUMBER> evolved multiple subtypes recent study researchers proposed subdivision global sarscov<NUMBER> population sixteen welldefined subtypes focusing widely shared polymorphisms nonstructural nsp<NUMBER> nsp<NUMBER> nsp<NUMBER> nsp<NUMBER> nsp<NUMBER> nsp<NUMBER> cistrons structural spike nucleocapsid accessory orf<NUMBER> genes <NUMBER> six virus subtypes predominant population accounting <NUMBER> samples isolated around world subtypes showed geographical structure two clusters smaller one comprised isolates mostly sampled western hemisphere subtypes ii vi ix x xi larger one whose isolates sampled western eastern hemispheres subtypes iii iv v vii viii xii xiii xiv xv xvi <NUMBER> researchers believed genetic structure determined sarscov<NUMBER> population provides substantial guidelines maximizing effectiveness trials testing candidate vaccines drugs <NUMBER> another earlier study population genetic analyses <NUMBER> sarscov<NUMBER> genomes indicated viruses evolved two major types designated l well defined two different single nucleotide polymorphisms snps <NUMBER> l type <NUMBER> prevalent type <NUMBER> type found ancestral version l type aggressive spread quickly prevalent early stages outbreak wuhan frequency l type decreased early january <NUMBER> severe j u r n l p r e p r f selective pressure placed human intervention l type <NUMBER> contrary l type stype evolutionarily older less aggressive might increased relative frequency due weaker selective pressure <NUMBER> also reported among <NUMBER> viruses isolated wuhan <NUMBER> <NUMBER> l type <NUMBER> <NUMBER> type <NUMBER> however among <NUMBER> viruses isolated outside wuhan <NUMBER> <NUMBER> l type <NUMBER> <NUMBER> type <NUMBER> comparison suggests l type significantly prevalent wuhan places recent studies clinical characteristics outcomes patients covid<NUMBER> wuhan <NUMBER> <NUMBER> <NUMBER> <NUMBER> outside wuhan <NUMBER> <NUMBER> <NUMBER> showed mortality covid<NUMBER> patients proportion patients cardiac injury outside wuhan lower wuhan table <NUMBER> although many reasons different incidence cardiac injury outcome covid<NUMBER> outside wuhan shortage medical resources wuhan role different sarscov<NUMBER> subtypes cannot ignored relationship sarscov<NUMBER> subtypes mortality covid<NUMBER> cvd complications need immediate comprehensive studies combine genomic data epidemiological data records clinical symptoms patients coronavirus disease <NUMBER> according references see patients underlying cvd may likely become infected coronavirus cvd may one risk factors poor prognosis high mortality cov infection studies however explored mechanisms underlying associations believe possible mechanisms may related inflammation cardiovascular diseases hypertension coronary heart disease cerebrovascular disease metabolicrelated diseases reported metabolic syndrome downregulate key mediator hosts innate immune response pathogenesis affecting function innate humoral immune systems <NUMBER> chronic lowgrade inflammatory disease widely recognized feature coronary heart disease occurrence closely related inflammation <NUMBER> occurrence hypertension associated oxidative stress inflammation activation immune system <NUMBER> il<NUMBER> il<NUMBER> tumor necrosis factor α tnfα levels higher patients hypertension patients normal blood pressure <NUMBER> may explain patients underlying cardiovascular disease found clinic susceptible infection kulcsar et al showed merscov infection lead prolonged respiratory tract inflammation immune cell dysfunction changes expression profile inflammatory mediators <NUMBER> lymphopenia increased inflammatory mediators found sarscov<NUMBER> infection <NUMBER> immune disorders caused sarscov infection also reported <NUMBER> may lead exacerbation original cardiovascular disease related death patients found clinic due heart failure <NUMBER> <NUMBER> <NUMBER> according information released shanghai municipal health family planning commission first covid<NUMBER> death shanghai individual <NUMBER> years old severe history hypertension cardiac insufficiency analysis cause death suggested patient died heart failure systemic multiple organ dysfunction therefore sarscov<NUMBER> infection inducement exacerbations <NUMBER> overall heart lungs inseparable normal physiological functions human body one hand comorbidities complications heart increase risk pneumonia infection exacerbation hand pneumonia infection may aggravate existing cardiovascular diseases increased blood pressure increased heart failure recurrence myocardial infarction fever common symptom patients coronavirus infection <NUMBER> <NUMBER> <NUMBER> fever promotes immune functions humans animals decreases pathogenicity microbes antibody production tcell activation neutrophil function macrophage oxidative metabolism reported increase presence fever <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> however avoid excessively elevated body temperature affecting normal physiological functions body activate sympathetic nerves regulate circulatory function increase heart rate cardiac output <NUMBER> increase heart rate long period time lead increased myocardial oxygen consumption decreased cardiac output may cause ischemia heart failure <NUMBER> many diseases fever symptoms may complicated myocarditis spotted fever rickettsioses infection <NUMBER> severe fever thrombocytopenia syndrome <NUMBER> drug reaction eosinophilia systemic symptoms <NUMBER> dengue <NUMBER> <NUMBER> <NUMBER> complicated scrub typhus <NUMBER> herpes simplex virus infection <NUMBER> enteric fever <NUMBER> decrease cardiac function may occur febrile illnesses whether myocardial damage due fever underlying infection known <NUMBER> weissinger et al found pigs bacterial infection elevated body temperature serum ck lactate dehydrogenase ld j u r n l p r e p r f gammaglobulin gg levels increased administration antibiotics pigs lowering body temperature reduced ck ld levels gg levels remained elevated suggesting infection decrease study indicated levels ck ld elevated due fever caused infection <NUMBER> k l et al discovered longer duration fever related occurrence pericarditis myocardial infarction <NUMBER> therefore heart injury coronavirus infection may related fever severe pneumonia cause significant gas exchange disturbances lead hypoxemia hypoxia reduces energy production required cell metabolism increases bodys anaerobic digestion acidosis oxygen free radicals accumulated cell destroy phospholipid layer cell membrane hypoxia continues intracellular calcium ion concentration increases significantly leading series cell damage processes including apoptosis <NUMBER> time hypoxia also induce inflammatory reactions infiltration inflammatory cells release cytokines leading tissue ischemia may even cause myocardial infarction<NUMBER> <NUMBER> <NUMBER> previous lessons coronavirus influenza shown viral infections cause acute coronary syndrome <NUMBER> <NUMBER> arrhythmia <NUMBER> exacerbation heart failure <NUMBER> mainly due combination significant systemic inflammation response localized vascular inflammation arterial plaque along effects <NUMBER> <NUMBER> <NUMBER> evidence shown sarscov induces expression proinflammatory cytokines monocyte chemotactic protein <NUMBER> mcp<NUMBER> transforming growth factorbeta <NUMBER> tgfbeta<NUMBER> tnf il<NUMBER> ilj u r n l p r e p r f <NUMBER> interferonβ ifnβ sars patients experimental animal models infected sarscov <NUMBER> <NUMBER> tnf il<NUMBER> family il<NUMBER> family cytokines considered proinflammatory mediators heart failure obvious negative inotropic effects may explain heart failure complications sars infection <NUMBER> acute heart injury might due cytokine storm resulting overaggressive host immune response sars infection <NUMBER> evidence indicating myocardial inflammation induced sarscov mainly mediated macrophages resultant production chemokines <NUMBER> <NUMBER> nuclear factorκb nfκb signaling pathway associated induction proinflammatory cytokines activated sarscovinfected mice treatment drugs inhibited nfκb activation led reduction inflammation sarscovinfected cultured cells mice significantly increased mouse survival sarscov infection indicating activation nfκb signaling pathway represents major contribution inflammation induced sarscov infection nfκb inhibitors promising antivirals infections caused sarscov potentially pathogenic human coronaviruses <NUMBER> sarscov<NUMBER> appears affect themyocardium cause myocarditis <NUMBER> myocardial injury likely associated infectionrelated myocarditis andor ischemia <NUMBER> increases inflammatory factors crp il<NUMBER> il<NUMBER> also discovered sarscov<NUMBER> infection <NUMBER> <NUMBER> <NUMBER> wu et al believed sarscov<NUMBER> may cause heart damage cytokine storm <NUMBER> evidence shown sarscov<NUMBER> may mainly affect lymphocytes especially cd<NUMBER> cells resulting significant decrease lymphocyte numbers <NUMBER> extent lymphopenia increase inflammatory cytokines related severity disease <NUMBER> critically ill covid<NUMBER> patients higher levels il<NUMBER> il<NUMBER> tnfα lactate dehydrogenase ldh creactive protein patients mild covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> suggesting inflammatory indicators important factor early diagnosis severe covid<NUMBER> patients coronavirus infection inflammatory state places patients hypercoagulable state example covid<NUMBER> leads increase ddimer levels <NUMBER> patients decrease activated partial thromboplastin time aptt <NUMBER> patients decrease pt <NUMBER> patients increasing risk embolism <NUMBER> hypercoagulability induced inflammation might contribute plaque rupture subsequent thrombosis myocardial injury <NUMBER> therefore clinicians pay attention covid<NUMBER> patients coronary heart disease prevent myocardial injury myocardial infarction septic shock seen serious complication sars mers covid<NUMBER> <NUMBER> <NUMBER> approximately <NUMBER> sarscov<NUMBER> infections complicated shock <NUMBER> reported left ventricular dysfunction occurs approximately <NUMBER> patients within <NUMBER> hours onset septic shock incidence increase <NUMBER> <NUMBER> <NUMBER> days onset septic shock <NUMBER> myocardial dysfunction cardiovascular inflammation might lead elevated creatine kinase troponin <NUMBER> might explain high hstni deceased patients addition abovementioned accompanying symptoms anxiety stress also lead adverse reactions accelerated heart rhythms elevated blood pressure especially critically ill patients <NUMBER> <NUMBER> health anxiety could found coronavirusinfected patients <NUMBER> generally everyone experiences health anxiety degree associated vigilance potential healthrelated threat protective however excessive health anxiety detrimental <NUMBER> literature indicates stress activate hypothalamicpituitaryadrenal axis j u r n l p r e p r f sympathetic nervous system leading increase peripheral glucocorticoid catecholamine levels <NUMBER> high plasma catecholamine levels associated increased risk heart failure altered autonomic activity depression lead arrhythmias activated sns alters cardiac wall contractility increases apoptotic pathways cardiomyocytes contributing cvd development although relevant study covid<NUMBER> patients suffering anxiety medical workers reported anxious direct contact patients <NUMBER> <NUMBER> study sun et al showed chinese showed acute posttraumatic stress symptoms covid<NUMBER> outbreak <NUMBER> therefore psychological counseling conducted patients timely manner anxiolytic drugs could used necessary mentioned sarscov reported lead myocardial infection marked decrease ace<NUMBER> expression may responsible myocardial dysfunction adverse cardiac outcomes patients sars <NUMBER> direct sarscov infection cardiomyocytes may also lead myocarditis impaired myocardial function coronavirusinduced myocarditis subsequent progression dilated cardiomyopathy described rabbit models <NUMBER> sarscov found heart samples patients died sars <NUMBER> pathological findings showed marked increase macrophage infiltration patients sarscov heart evidence myocardial damage merscov detected heart tissue heart showed significant histological changes mers patients <NUMBER> <NUMBER> however animal model study clearly stated merscov rna could seen cardiac tissue implying direct cardiac pathology <NUMBER> although myocarditis reported sporadic autopsy cases <NUMBER> still clear pathological evidence supporting sarscov<NUMBER> directly cause heart damage frequently used drugs hospitalization glucocorticoids antiviral drugs well antibiotics secondary qt interval prolongation caused use drugs hospitalization cannot ignored antiviral drugs lopinavir ritonavir antibiotics azithromycin moxifloxacin levofloxacin antifungal drugs glucocorticoids antiarrhythmic drugs potential risk prolonging qtc interval <NUMBER> <NUMBER> drugassociated qt prolongation associated increased arrhythmic nonarrhythmic mortality therefore continues important metric drug safety <NUMBER> small study france enrolling <NUMBER> treated patients <NUMBER> nonrandomized controls showed hydroxychloroquine alone combination azithromycin shortened time resolution viral shedding covid<NUMBER> <NUMBER> based study clinicians many countries begun using medications clinical practice multiple randomized trials initiated occasional case reports hydroxychloroquine prolonging qt interval provoking torsade de pointes used treat systemic lupus erythematosus <NUMBER> <NUMBER> <NUMBER> <NUMBER> widely used antibiotic azithromycin gradually recognized rare cause prolonged qt severe arrhythmia increased risk sudden death <NUMBER> <NUMBER> <NUMBER> <NUMBER> although reports arrhythmia death caused use hydroxychloroquine use hydroxychloroquine azithromycin also noted <NUMBER> j u r n l p r e p r f active support expected management based early prognostic indicators may improve recovery appropriate treatment heart failure arrhythmia acute coronary syndrome thrombosis still important continued global cooperation multiple methods specific evidencebased treatment strategies covid<NUMBER> emerge order protect wider population antibody testing effective vaccines needed make history covid<NUMBER> treatment related issues need attention firstly use acei arb drugs controversial earlier phase covid<NUMBER> epidemic recently published studies suggested need patients hypertension stop using acei arb switch antihypertensive medicine <NUMBER> <NUMBER> <NUMBER> conjectures <NUMBER> based disease mechanism early stage outbreak acei arb may increase infection new coronavirus aggravation covid<NUMBER> increasing expression ace<NUMBER> denied clinical evidence see continuous treatment covid<NUMBER> patients hypertension acei arb cause deterioration condition also continue exert cardiovascular protection even improve prognosis <NUMBER> <NUMBER> <NUMBER> secondly pay attention application hydroxychloroquine <NUMBER> <NUMBER> <NUMBER> <NUMBER> azithromycin <NUMBER> <NUMBER> <NUMBER> <NUMBER> side effects prolonging qt interval drugs used treat covid<NUMBER> patients antiviral drugs lopinavir ritonavir antibiotics moxifloxacin levofloxacin antifungal drugs glucocorticoids antiarrhythmic drugs cause qt interval prolongation attract attention reference sapp et al would help minimize risk druginduced ventricular arrhythmia treatment covid<NUMBER> <NUMBER> thirdly recent study jama reported mortality rate patients mechanical ventilation treatment <NUMBER> <NUMBER> multiple studies around world shown mortality rate covid<NUMBER> patients using ventilator still high <NUMBER> <NUMBER> <NUMBER> believed ventilator used cautiously patients covid<NUMBER> reduce mortality patients using ventilator <NUMBER> <NUMBER> new guidelines established use ventilator patients covid<NUMBER> advocate application staged breathing support methods delay use ventilator simple oxygen treatment like nasal oxygen supply may safer effective fourth methylprednisolone classical immunosuppressive drugs important stop delay progress pneumonia proved effective treatment acute respiratory distress syndrome ards recent study <NUMBER> wu al found administration methylprednisolone appeared reduce risk death covid<NUMBER> patients ards however received methylprednisolone treatment <NUMBER> <NUMBER> patients died rather high mortality <NUMBER> indication timing dosage duration application methylprednisolone needs investigation fifth early report showed remdesivir highly effective control sarscov<NUMBER> infection vitro <NUMBER> recent study published lancet showed remdesivir reduce mortality covid<NUMBER> patients <NUMBER> however another clinical trial showed remdesivir accelerates recovery advanced covid<NUMBER> <NUMBER> another clinical trial showed significant difference clinical outcome <NUMBER>day <NUMBER>day course remdesivir <NUMBER> data suggested remdesivir reduce mortality covid<NUMBER> patients j u r n l p r e p r f effect shortening course disease mild patients early medication may better application remdesivir needs researches clinical data indicate comorbid cardiovascular disease aggravate severity coronavirus infection leading poor prognosis coronavirus may cause myocardial injury prognosis patients complicated myocardial injury poor mechanism coronavirus causing myocardial injury drug treatment options remain studied authors declared conflicts interest work j u r n l p r e p r f abbreviation ck creatine kinase ldh lactate dehydrogenase hstni hypersensitive troponin ckmb creatine kinasemyocardial band isoenzyme probnp pro brain natriuretic peptide crp creactive protein il interleukin tnt troponin <NUMBER> <NUMBER> <NUMBER> <NUMBER> death <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> coronavirus disease <NUMBER> covid<NUMBER> newly identified strain coronavirus causes illness ranging effects similar common cold fatal diseases people across world <NUMBER>am cest <NUMBER> evidence covid<NUMBER> transmitted person person respiratory droplets close contact poses huge challenge public health <NUMBER> according latest research singlecell rnaseq researchers believe sarscov<NUMBER> rna expression replication related angiotensinconverting enzyme <NUMBER> ace<NUMBER> <NUMBER> importantly ace<NUMBER> confirmed sarscov<NUMBER> cell entry receptor sarscov<NUMBER> renin angiotensin system inhibitor rasi commonly used antihypertensive drug however clear whether rasi increase expression ace<NUMBER> leading higher risk sarscov<NUMBER> infection patients hypertension stop using rasi explored question effects administering rasi patients covid<NUMBER> hypertension analyzing data shanghai public health clinical center january <NUMBER> <NUMBER> january <NUMBER> <NUMBER> received total <NUMBER> patients hypertension combined covid<NUMBER> shanghai public health clinical center cases confirmed covid<NUMBER> cases hypertension history <NUMBER> months clinical criteria diagnosis discharge refer diagnosis treatment new <NUMBER> exempted need informed consent patients research team collected analyzed <NUMBER> patients medical records epidemiological clinical laboratory characteristics information treatment outcome patients obtained inpatient management system blood pressure medication recorded hospitalization patients rested bed monitored vital signs finger oxygen saturation given effective oxygen therapy time basic principles treatment nutritional support symptomatic treatment maintain water electrolyte balance stable internal environment antiviral therapy tried interferon lopinavirlitonavir dnrunavir abidol antibiotics used necessary therapy include γglobulin， thymosin alpha，vitamin c traditional chinese medicine existing antihypertensive drugs continued used unless blood pressure continued exceed <NUMBER>mmhg increased amount added new drugsdiuretic ccb confirmed cases examined peripheral white blood cell count absolute lymphocyte value red blood cell sedimentation rate esr procalcitonin pct creactive protein crp total triglyceride tg cardiac troponin ctni brain natriuretic peptide continuous measurements compared students test mannwhitney u test normal distributions expressed mean ± standard deviation sd categorical variables shown percentages compared using fishers exact test statistical analysis software spss<NUMBER> used analyses study january <NUMBER> <NUMBER> <NUMBER> cases covid<NUMBER> hypertension admitted shanghai public health clinical center <NUMBER> <NUMBER> female <NUMBER> <NUMBER> male age patients <NUMBER> ± <NUMBER> years range <NUMBER> years <NUMBER> years patients clinical manifestations fever <NUMBER> cough <NUMBER> phlegm <NUMBER> specific drugs antihypertension treatment shown table <NUMBER> patients received <NUMBER> <NUMBER> oral antihypertensive drugs including diuretics calcium antagonists βblockers acei arb patients <NUMBER> need adjust antihypertensive drugs arterial pressure rasi group <NUMBER> ± <NUMBER>mmhg statistically different p <NUMBER> nonrasi group <NUMBER> ± <NUMBER>mmhg <NUMBER> <NUMBER> cases rasi group including <NUMBER> males <NUMBER> <NUMBER> cases nonrasi group including <NUMBER> males table <NUMBER> statistically significant difference age sex ratio two groups difference found clinical symptoms fever cough phlegm well time onset admission length stay laboratory tests two groups classic ras regulation pathway renin acts angiotensinogen produce angiotensin ang ang produces ang ii action ace hand nonclassical ras regulatory pathway also known negative ace<NUMBER>angiotensin <NUMBER> ang <NUMBER> axis refers generation ang <NUMBER> ang ii action ace<NUMBER> reninangiotensin system inhibitors rasi acei arb drugs may indirectly improve ace<NUMBER> activity restraining ace level worth noting sarscov<NUMBER> invades human body way sarscov <NUMBER> spike protein surface virus receptor ace<NUMBER> surface respiratory epithelial cells combine enter cell causing series pathological changes one important changes human ace<NUMBER> expression significantly downregulated classic ras regulatory pathway activated <NUMBER> imbalance positive negative axis ras relative absolute increase ang ii levels overstimulation at<NUMBER> result increased pulmonary capillary permeability subsequent lung emergence edema severe lung injury acute lung failure <NUMBER> however controversial whether one classical antihypertensive drugs rasi may increase risk coronavirus infection beneficial coronavirus infection control cough main adverse effect acei mechanism increased bradykinin cough also common symptom coronavirus respiratory infections patients taking acei long period time usually need stop acei respiratory infections coronavirus infection downregulates ace<NUMBER> level affect ace <NUMBER> ace<NUMBER> levels change bradykinin levels <NUMBER> even rasi could change level activity ace<NUMBER> target tissue clinical data insufficient indicate whether turn promotes binding entry sarscov<NUMBER> spikes <NUMBER> data shows increase severity coughing patients treated rasi theoretically ace<NUMBER> level downregulated coronavirus binds ace<NUMBER> leading imbalance positive negative regulation ras abnormal increase ang ii level activity <NUMBER> rasi may suitable antihypertensive agent cases using acei arb drugs effects patients symptoms laboratory tests prognosis acei arb exact antihypertensive effects well clinical effects protecting cardiovascular cerebrovascular improving renal function reducing left ventricular hypertrophy preventing heart failure preventing atrial fibrillation existing studies suggest aceis captopril lisinopril affect activity ace<NUMBER> <NUMBER> evidence acei arb may bring special effects patients covid<NUMBER> infection new coronary pneumonia damage recommend overall control patients new coronary pneumonia persistent need adjust hypertension drugs ongoing outbreak corona virus disease <NUMBER> covid <NUMBER> infection posed significant threats international health economy <NUMBER> <NUMBER> <NUMBER> <NUMBER> january <NUMBER> world health organization declared public health emergency international concern <NUMBER> march <NUMBER> <NUMBER> countries <NUMBER> cases covid<NUMBER> <NUMBER> deaths reported world number confirmed patients china gradually decreased increasing rapidly countries especially italy south korea iran lots doctors engaged combating <NUMBER> <NUMBER> sarscov<NUMBER> first reported samples bronchoalveolar lavage fluid three patients wuhan jinyintan hospital confirmed cause covid<NUMBER> january <NUMBER> <NUMBER> <NUMBER> deep examining fulllength genome found virus belongs betacoronavirus <NUMBER>b lineage phylogenetic tree <NUMBER> new humaninfecting betacoronavirus previously detected humans animals named covid<NUMBER> sarscov<NUMBER> international committee taxonomy viruses similar coronavirus responsible severe acute respiratory syndrome sarscov <NUMBER> shares <NUMBER> identity sequencing bat sarslike coronavirus shares <NUMBER> identity nucleotide original sars epidemic virus <NUMBER> <NUMBER> <NUMBER> coronavirus spike glycoproteins promote entry cells main target antibodies bind high affinity angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor humans manner similar sarscov <NUMBER> <NUMBER> <NUMBER> however sarscov<NUMBER> glycoprotein harbors furin cleavage site boundary s<NUMBER>s<NUMBER> subunits processed biogenesis sets virus apart sarscov sarsrelated covs <NUMBER> <NUMBER> present research reports incubation period people range <NUMBER> <NUMBER> days median <NUMBER> days incubation period may even long <NUMBER> days <NUMBER> reproductive number r<NUMBER> sarscov<NUMBER> although still preliminary estimated <NUMBER> <NUMBER> suggesting higher pandemic potential sars <NUMBER> fever cough may major symptom asymptomatic individuals also identified potential sources infection <NUMBER> present think new coronavirus mainly transmitted respiratory droplets close contact transmission asymptomatic carrier appears possible <NUMBER> report <NUMBER> pregnant patients suggests perinatal transmission unlikely larger studies needed confirm finding <NUMBER> although viral rna found stool whether transmitted fecaloral route still needs confirmed subsequent investigations <NUMBER> <NUMBER> recently patients found repositive treated negative nucleic acid tests twice symptoms disappeared difficult us decrease severity covid<NUMBER> owing complex structure unclear physiological mechanism increasing number confirmed cases clinical investigation patients antiviral treatment solution insufficient urgent need find alternative methods control spread disease order prove accurate conclusions prevalence comorbidity relation clinical characteristics mortality patients covid<NUMBER> searched relevant literatures carried single arm metaanalysis describe epidemiological clinical characteristics complications outcomes patients confirmed <NUMBER>ncov infection compare severity diabetes hypertension nondiabetes nonhypertension patients findings provide vital guidance current clinical work prevention treatment <NUMBER>ncov infection ethical approval patient consent required present study review previously published articles fulltext articles obtained detailed evaluation eligible studies included systematic review inclusion criteria following randomized controlled trial clinical trials series cases patients either sex diagnosed covid<NUMBER> patients laboratoryidentified sarscov<NUMBER> infection realtime reversetranscriptase polymerasechainreaction detection sarscov<NUMBER> nucleic acid positive throat swabs lower respiratory tract ct scanning lung inclusion epidemiological clinical characteristics laboratory radiological characteristics treatment outcome clear description clinical characteristics comorbidities including hypertension diabetes cardiovascular disease malignancy signs symptoms fever cough fatigue dyspnea clear description outcomes including major complications acute respiratory distress syndrome ards acute cardiac injuryaci acute kidney injuryaki shock incidence severity mortality exclusion criteria following absence clinical characteristics treatment outcome clinical experience case reports two authors independently extracted data reviewing titles abstracts searched papers disagreement choice literature exists third evaluator join make decision following information recorded included trials first author year publication number participants residence patients basic data gender age diagnosis extracted analyzed evaluate proportion comorbidity diabetes hypertension cardiovascular disease malignancy proportion symptoms fever cough fatigue dyspnea proportion clinical complications including ards aci aki shock severity mortality two readers independently extracted reviewed data enrolled studies ensure consistency quality included studies assessed newcastleottawa scale order objectively evaluate publication bias included studies egger test p <NUMBER> existence publication bias performed larger values considered publication bias single arm metaanalysis proportions <NUMBER> ci calculated clinical symptoms complication outcome selected comorbidities using stata <NUMBER> presence heterogeneity among identified studies cochrans q extent heterogeneity <NUMBER> index examined described previously original data included literature first transformed double arcsine method make conform normal distribution analyzed stata initial conclusion obtained metaanalysis restored using formula psintp<NUMBER> <NUMBER> reach final conclusion performed sensitivity analysis assess stability results investigate influence study omitting single study sequentially using egger test found evidence bias lag periods initial <NUMBER> citations identified based study subject summary literature <NUMBER> articles thereafter excluded duplication reviewing title abstract remaining <NUMBER> studies <NUMBER> fulltext studies evaluated assessment <NUMBER> obviously irrelevant records excluded eventually <NUMBER> clinical studies <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> consistent inclusion requirements detailed study flowdiagram shown fig <NUMBER> basic characteristics quality included studies illustrated table <NUMBER> twentyone studies selected total <NUMBER> patients <NUMBER> male <NUMBER> females representing approximately <NUMBER> confirmed one clinical trial investigated characteristics patients singapore others came china mainly wuhan systematic analysis studies describing epidemiological demographic clinical features covid<NUMBER> cases reporting prevalence number chronic diseases infectious disease undertaken number cases selected studies varied approximately <NUMBER>fold ranged <NUMBER> <NUMBER> cases sex ratio male female <NUMBER> overall average age subjects greater <NUMBER> years fortyone cases reported jinyintan hospital earliest confirmed cases patients treated wenzhou hospital almost mild xiaobo yang et al reported <NUMBER> cases covid<NUMBER> critical patients studies detailed pretreatment biochemical characteristics subsequent treatment eighteen studies reported comorbidity diabetes <NUMBER> introduced proportion severity <NUMBER> studies reported hypertension <NUMBER> introduced proportion severity <NUMBER> studies reported malignant <NUMBER> studies reported cad regard symptoms <NUMBER> studies recorded fever cough <NUMBER> studies reported fatigue <NUMBER> studies reported dyspnea seven studies recorded complication ards aci shock recorded <NUMBER> <NUMBER> studies respectively fifteen studies showed critical patients <NUMBER> research reported mortality studies provided incidence data least one kind comorbidity symptom complication sixteen forest plots used illustrate prevalence comorbidities covid<NUMBER> selected studies inspect heterogeneity individual findings metaanalysis identified studies showed prevalent clinical symptoms fever <NUMBER> <NUMBER>ci <NUMBER> cough <NUMBER> <NUMBER>ci <NUMBER> followed fatigue <NUMBER> <NUMBER>ci <NUMBER> shortness breath <NUMBER> <NUMBER>ci <NUMBER> fig <NUMBER> significant heterogeneity cochrans q estimates clinical symptoms among examined studies p <NUMBER> <NUMBER> index varying <NUMBER> <NUMBER> prevalence diabetes hypertension comorbidities <NUMBER> <NUMBER>ci <NUMBER> <NUMBER> <NUMBER>ci <NUMBER> respectively incidence cardiovascular disease malignancy <NUMBER> <NUMBER>ci <NUMBER> <NUMBER> <NUMBER>ci <NUMBER> respectively fig <NUMBER> case complications including ards risk ranged <NUMBER> <NUMBER> pooled estimate <NUMBER> acute cardiac injury <NUMBER> <NUMBER>ci <NUMBER> acute kidney injury <NUMBER> <NUMBER>ci <NUMBER> shock <NUMBER> <NUMBER>ci <NUMBER> also present fig <NUMBER> risks severity mortality rate ranged <NUMBER> <NUMBER> <NUMBER> <NUMBER> pooled estimates <NUMBER> <NUMBER> respectively percentage severe cases diabetes hypertension cases <NUMBER> <NUMBER>ci <NUMBER> fig <NUMBER> sensitivity analysis performed assess stability pooled results among <NUMBER> studies significant results obviously altered sequentially omitting study pooled results comparing incidence mortality excluding report chaolin huang et al heterogeneity decreased significantly <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> i² <NUMBER> showed significant difference preventing ards rate two groups hence regarded result heterogeneity likewise studies considered source heterogeneity heterogeneity significantly changed showed significant difference preventing ards two groups studies excluded pooled results comparing incidence ards sensitivity analysis conducted determine whether exclusion study would alter result exclusion study metaanalysis substantially influence results part study ards used assess publication bias egger test results showed pr jzj <NUMBER> therefore believe risk publication bias low metaanalysis outbreak covid<NUMBER> declared public health emergency international concern march <NUMBER> <NUMBER> epidemic spread <NUMBER> countries around world accordance experience china surgical masks widespread use beneficial prevent acquisition covid<NUMBER> addition italy started taking measures block traffic lockdown villages rising incidence covid<NUMBER> world feasible effective messaging clinical characteristics covid<NUMBER> greatly needed therefore focus analysis evaluate prevalence symptoms comorbidity complications different outcomes china singapore metaanalysis identified <NUMBER> published studies assessed proportion published rcts rapid development epidemic limited medical resources addition presence uncontrollable risk treatment much evidence effects cannot adequately studied randomized trials longterm rare outcomes therefore analyzed retrospective studies study main results found cases reported date suggest older adults difference susceptibility male female fever common symptom patients <NUMBER>ncov infection prevalent comorbidities hypertension diabetes associated rapid development severe illness ards aci may main obstacles patients treatment recovery severity mortality patients <NUMBER>ncov infection lower severe acute respiratory syndrome sars middle east respiratory syndrome mers prevalence covid<NUMBER> much higher sars mers two coronaviruses previously caused significant outbreaks associated critical disease sars coronavirus <NUMBER> middle east respiratory syndrome coronavirus emerged <NUMBER> <NUMBER> <NUMBER> <NUMBER> lot studies reported clinical characteristics patients covid<NUMBER> lack studies relation severity mortality comorbidity similarly metaanalysis published complications patients covid<NUMBER> infected therefore novel systematic review metaanalysis due inadequate evidence present metaanalysis consolidating multiple studies enable enhanced clinical decision making future report cohort patients laboratoryconfirmed <NUMBER>ncov infection patients serious sometimes fatal complications admitted designated hospital clinical presentations greatly resemble sarscov patients severe illness developed ards aki aci shock required icu admission oxygen therapy however despite comprehensive analysis also many limitations taken consideration metaanalysis first studies included metaanalysis rcts second literatureincluded studies treatment every hospital completely similar third owing treatment grading mild ordinary critical severity patients different hospitals varies greatly addition cause physio pathological mechanism unknown onset emerging infections treatment wuhan based clinical experience leading higher complication mortality fourth partial missing information articles may lead biased results attempted contact investigators study sponsors verify key study characteristics obtain missing numerical outcome data moreover clinical methodological heterogeneities observed several parameters metaanalysis given variation intervention techniques patient composition preferences among different cities true heterogeneity poor methodological quality could also lead asymmetric plot future larger higher quality clinical trials conducted conduct detailed subgroup analysis explore sources heterogeneity obtain reliable conclusion effort made answer questions future studies covid<NUMBER> emerging infectious disease global public health concern results note similarity clinical symptoms complications covid<NUMBER> previous betacoronavirus infections incidence severity mortality covid<NUMBER> much higher ordinary influenza prevalence chronic diseases including diabetes hypertension rising populations age lifestyle dietary habits change addition found diabetes hypertension closely related severity mortality improving protection covid<NUMBER> persons chronic disorders essential last least need limit humantohuman transmission including reducing secondary infections among close contacts healthcare workers thus preventing transmission amplification events preventing international spread authors declare known competing financial interests personal relationships could appeared influence work reported paper agencies public commercial notforprofit sectors cases coronavirus disease <NUMBER> covid<NUMBER> rapidly increasing globally april <NUMBER> <NUMBER> <NUMBER> million cases confirmed <NUMBER> deaths reported <NUMBER> countries <NUMBER> several studies rapidly provided crucial data eg incubation period related various aspects novel coronavirus sarscov<NUMBER> severe acute respiratory syndrome coronavirus <NUMBER> infection <NUMBER> however risk factors severity prognosis covid<NUMBER> poorly understood information critical identify high risk patients facilitate planning eg forecasting need hospital beds mechanical ventilators risk factors also implications workforce allocation eg assignment healthcare providers specific risk factors positions reduced risk exposure date several studies reported history cardiovascular disease cvd traditional cvd risk factors eg age male sex current smoking hypertension diabetes associated severe covid<NUMBER> however age results inconsistent furthermore studies accounted potential confounding age sex evaluated potential risk factors example studies reported hypertension risk factor severe covid<NUMBER> observations may simply reflect fact hypertension common older adults <NUMBER> nonetheless despite lack robust evidence observation together fact sarscov<NUMBER> uses angiotensinconverting enzyme <NUMBER> entry human body <NUMBER> raised concern continued use reninangiotensin system increase among clinicians researchers <NUMBER> <NUMBER> context conducted systematic review studies reporting cardiovascular risk factors relation severe manifestation covid<NUMBER> ie death acute respiratory distress syndrome ards need mechanical ventilator support admission intensive care unit icu particular interest studies adjusted key confounders age sex ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> conducted systematic review following prisma statement according predetermined protocol systematically searched pubmed embase eligible reports search terms listed web appendix <NUMBER> included full reports letters original data written english eligible study designs cohort study crosssectional case series clinical trials conducted literature search march <NUMBER> <NUMBER> restricted publications december <NUMBER> <NUMBER> review included studies reported adult patients aged <NUMBER> years older restriction respect gender raceethnicity comorbidities primary outcome interest severe covid<NUMBER> defined following allcause mortality icu admission ards need mechanical ventilation included studies reporting least <NUMBER> cases severe covid<NUMBER> obtain reliable estimates enough number outcomes considering clinical cascade eg death final outcome one study reported results multiple outcomes prioritized composite outcome followed icu admission ards need mechanical ventilation mortality potential risk factors interest preexisting cvd including cardiac disease cerebrovascular disease traditional risk factors recognized major cvd clinical guidelines age sex smoking hypertension diabetes found one study reporting severity covid<NUMBER> lipids lowdensity lipoprotein categorized risk factors sociodemographic factors age sex smoking clinical factors hypertension diabetes preexisting cvd ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted april <NUMBER> <NUMBER> eight reviewers collected relevant data elements identified publication recorded microsoft excel microsoft corporation redmond washington usa overall quality based newcastle ottawa quality assessment scale nos <NUMBER> includes eight items selection comparability outcome web appendix <NUMBER> nos score cohorts studies ranges <NUMBER> <NUMBER> score greater <NUMBER> considered highquality crosssectional studies applied adapted form nos <NUMBER> maximum score <NUMBER> <NUMBER> points used identify studies high qualitythe paired reviewers resolved conflicts related data collection quality assessment summarized relative risk estimates odds ratios hazard ratios association risk factor primary outcome relevant studies pooled estimates using randomeffects metaanalysis studies report measures association prevalence risk factors interest outcome status eg survivors vs nonsurvivors calculated crude odds ratios <NUMBER> cis process cell zero count added <NUMBER> cell appropriate <NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted april <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint potential confounding age sex relevant prior cvd hypertension diabetes since comorbidities become prevalent increased age <NUMBER> studies report adjusted risk estimates comorbidities ran metaregression randomeffects log odds ratio log hazard ratio comorbidities difference mean median age vs without primary outcome across eligible studies obtain reliable estimates conducted metaregression analyses least five studies also depicted funnel plots visually checked possibility publication bias heterogeneity study estimates assessed <NUMBER> statistic <NUMBER> <NUMBER> considered high heterogeneity <NUMBER> pvalue <NUMBER> considered statistically significant analyses conducted stata <NUMBER> <NUMBER> statacorp llc college station texas usa systematic review identified <NUMBER> potentially eligible publications removing duplicate publications figure <NUMBER> <NUMBER> publications excluded screening titles abstracts remaining <NUMBER> publications reviewed fulltext screening excluded <NUMBER> publications meet inclusion criteria leaving <NUMBER> publications <NUMBER> qualitative quantitative analyses publications considered high quality web table <NUMBER> included studies death reported <NUMBER> studies icu admission <NUMBER> studies ards <NUMBER> studies mechanical ventilation <NUMBER> studies two studies reported composite outcome studies reported covid<NUMBER> patients china <NUMBER> studies small sample size <NUMBER> <NUMBER> studies table <NUMBER> studies included confirmed covid<NUMBER> patients laboratory tests total <NUMBER> covid<NUMBER> patients included studies <NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> table <NUMBER> case fatality rate three databases exceeded <NUMBER> around age <NUMBER> years <NUMBER> <NUMBER> years <NUMBER> years italy two studies reported relative risk age unadjusted multivariable models studies observed effect size age materially changed adjustment comorbidities <NUMBER> <NUMBER> studies showed higher risk severe covid<NUMBER> men women pooled crude relative risk estimate severe covid<NUMBER> men women <NUMBER> <NUMBER> ci <NUMBER> figure <NUMBER>a metaregression demonstrated consistent results regardless differences mean median age vs without severe covid<NUMBER> web figure <NUMBER> funnel plot indicate major publication bias web figure <NUMBER>a three studies reported associations current smoking severe covid<NUMBER> one study reaching statistical significance figure <NUMBER>b pooled estimate relative risk severe covid<NUMBER> <NUMBER> <NUMBER> ci <NUMBER> one study reported association across three categories current smoking odds ratio <NUMBER> <NUMBER> former smoking <NUMBER> <NUMBER> <NUMBER> vs never smoking <NUMBER> corresponding funnel plot shown web figure <NUMBER>b clinical factors hypertension diabetes prior cvd ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> diabetes <NUMBER> study cancer chronic obstructive pulmonary disease similar independent associations severe covid<NUMBER> metaregression analyses demonstrated studies greater age difference vs without severe covid<NUMBER> tended greater relative risk according presence hypertension diabetes preexisting cvd indicating levels potential confounding age figure <NUMBER> although none analyses reached statistical significance similar pattern seen cvd difference proportion male sex vs without severe covid<NUMBER> web figure <NUMBER> hand meta ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint regression indicate higher proportion male sex confounded association hypertension diabetes severe covid<NUMBER> knowledge first systematic review metaanalysis focusing relationship severe covid<NUMBER> cvd risk factors confirmed robust association age male sex severe covid<NUMBER> contributions likely independent studies demonstrated positive associations current smoking severe covid<NUMBER> several studies reported preexisting cvd hypertension diabetes also associated severe covid<NUMBER> however two studies reported estimates comorbidities adjusted age andor sex one study found association coronary heart disease severe covid<NUMBER> longer statistically significant age adjustment <NUMBER> whereas showed independent associations hypertension diabetes severe covid<NUMBER> analyses adjusted age comorbidities <NUMBER> although primary estimate statistically significant metaregression analyses indicated degree confounding age necessarily sex associations hypertension diabetes prior cvd severe covid<NUMBER> positive association sociodemographic factors age male sex smoking severe covid<NUMBER> consistent reports infectious diseases eg influenza virus sars <NUMBER> <NUMBER> <NUMBER> <NUMBER> several plausible mechanisms older age linked reduced immune reaction comorbidities limited organ reserve <NUMBER> <NUMBER> <NUMBER> male sex related higher prevalence comorbidities less frequency washing hands immunological disadvantage given xchromosome coding proteins immune system <NUMBER> whereas smoking damage respiratory system <NUMBER> metaanalysis confirmed overall positive crude associations cvd hypertension diabetes severe covid<NUMBER> pooled relative risk estimates around <NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint <NUMBER> important question whether associations independent major confounders particularly age although could obtain definite answer studies ran multivariable models metaregression analysis indicated degree confounding age one study zhou et al showed substantial attenuation association coronary heart disease severe covid<NUMBER> hand liang et al showed independent associations hypertension diabetes severe covid<NUMBER> relatively large sample size <NUMBER> patients also biologic plausibility hypertension diabetes leading risk factors cvd kidney diseases evidence covid<NUMBER> damages organs <NUMBER> <NUMBER> available studies provide scant evidence related hypothesized adverse effect reninangiotensin system inhibitors severity covid<NUMBER> infection noted biological plausibility potential associations covid<NUMBER> hypertension diabetes two comorbidities associated use reninangiotensin system inhibitors one study reported prevalence reninangiotensin system inhibitors use <NUMBER> study <NUMBER> patients reported prevalent hypertension <NUMBER> patients taking reninangiotensin system inhibitors <NUMBER> thus reasonable many expert organizations recommend continuing category medications better evidence becomes available <NUMBER> results potentially used guide decisionmaking lack discrete age thresholds severe covid<NUMBER> complicates process data case fatality rates three countries web table <NUMBER> suggest age older <NUMBER> <NUMBER> years confers high risk severe covid<NUMBER> relative risk <NUMBER> compared <NUMBER> years results also indicate male sex independent risk factor pooled relative risk <NUMBER> although likely pooled crude relative risk <NUMBER> hypertension diabetes cvd overestimate impact beyond age sex may confer <NUMBER> times greater risk thus using factors possible estimate least crudely risk severe covid<NUMBER> example man aged <NUMBER> years old either hypertension diabetes prior cvd would ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint risk <NUMBER> fold higher risk approximation <NUMBER> x <NUMBER> x <NUMBER> compared woman younger <NUMBER> years without clinical factors information could used inform decisions testing covid<NUMBER> clinical management covid<NUMBER> workforce planning study limitations first reflecting fact outbreak started china studies china however given similar casefatality rates clinical manifestations across different countries seems likely results largely generalizable nonetheless need acknowledge regional variations risk factors eg <NUMBER>fold difference prevalence smoking men vs women china <NUMBER> thus future investigations different regions would valuable second include nonenglish publications third studies reported odds ratios known overestimate risk ratio prevalence exposures relatively high fourth cannot deny possibility patients included multiple studies especially china cdc report <NUMBER> chinese studies nonetheless pooled estimates largely similar analyses excluded china cdc data data shown finally literature covid<NUMBER> growing rapidly thus lag time literature search publication hand systematic review several strengths indepth review cvd risk factors clinically relevant definitions severe covid<NUMBER> minimize subjective reporting metaregression explore potential confounding relatively short elapsed time <NUMBER> weeks literature search manuscript submission conclusion systematic review metaanalysis found robust associations older age male sex risk factors severe covid<NUMBER> studies reported association current smoking severe covid<NUMBER> unadjusted analyses hypertension diabetes prior cvd significantly associated severe covid<NUMBER> however twostudies conducted ageadjusted analyses one relatively large study showing independent contributions hypertension diabetes severe covid<NUMBER> study explicitly assessed relationship reninangiotensin system inhibitors covid<NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint results suggest combination age male sex cvd risk factors identify substantial gradient risk developing severe covid<NUMBER> compared without factors ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> studies published <NUMBER> abbreviations covid<NUMBER> coronavirus disease <NUMBER> cvd cardiovascular disease htn hypertension nr reported authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted april <NUMBER> <NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted april <NUMBER> <NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted april <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint human coronaviruses pose huge threat global public health outbreak led significant morbidity mortality economic damage worldwide <NUMBER> crucial differences sarscov<NUMBER> benign coronaviruses function specific adaptations sarscov<NUMBER> made human host example immuneevasive character sarscov<NUMBER> enables covid<NUMBER> pandemic spread asymptomatic individuals <NUMBER> symptoms primarily produced host immune response spread asymptomatic carriers key portion covid<NUMBER>s rapid spread ongoing inquiry specific adaptations hampered lack structured integrative resources standard data metadata formats deeper study interactions hosts human others coronaviruses sarscov<NUMBER> sarscov merscov others would help understanding covid<NUMBER> mechanisms rational design vaccines drugs covid<NUMBER> however achieve goal two major bottlenecks exist first although intensive research generated large amounts data data multidimensional heterogeneous disintegrated noninteroperable data cannot efficiently interpreted computers preventing computerassisted reasoning analysis second bottleneck lack efficient computational algorithms bioinformatics tools integrate analyze heterogeneous data knowledge deep scientific understanding bottleneck slows integration hostcoronavirus interaction hci data discovery hci mechanisms new applications ontologies solve problems analysis integrating big data computerinterpretable way informatics field ontology humanand computerinterpretable set terms relations represent entities specific domain relate ontology played important role standard knowledge data representation integration sharing analysis major field artificial intelligence knowledge representation reasoning kr² krr ontology foundation krr coronavirus infectious disease ontology cido new communitybased biomedical ontology domain coronavirus diseases httpsgithubcomcidoontologycido <NUMBER> better study hci mechanisms explain various covid<NUMBER> phenomena propose use cido platform standard computerunderstandable representation hostcoronavirus interactions influences patient outcomes manuscript introduce set hpioutcome postulates laying set basic rules understanding hostpathogen interactions hpis roles disease outcomes propose model study relations hostcoronavirus interactions hcis coronavirus disease outcomes used ontologybased strategy annotate classify human coronaviruses hosts experimentally verified hostcoronavirus interactions hcis obtained literature mining bioinformatics studies using annotations proposed ontological model interactions sarscov<NUMBER> human explain humansarscov<NUMBER> interactions would induce different disease outcomes hypertension cytokine storm furthermore using known ppis baits developed computational method predict new ppis associations multiorgan disease phenotypes caused sarscov<NUMBER> interacions literature manually annotated identified coronavirus virulence factors host genesproteins interact coronaviruses experimentally confirmed coronavirus virulence factors added victors manually curated webbased database analysis system <NUMBER> ignet literature mining analysis ignet interaction network tool httpignethegrouporg powered inhouse sciminer <NUMBER> literature mining tool used mine genegene interactions specific domain coronaviruses among host genes collected string database medium confidence score <NUMBER> host species mapped ncbitaxon taxonomy ontology <NUMBER> human phenotype ontology hpo <NUMBER> disease phenotype outcomes including different symptoms signs mapped hpo mapped terms ontofox <NUMBER> used generate subsets slimes ncbitaxon hpo ontologies prediction hostcoronavirus ppis used domaininferred prediction method infer interspecies ppis supported conservation importance domains proteins <NUMBER> domaindomain interaction ddi infers potential interaction two proteins one domain pathogen protein interacted another domain host protein b visualization hostcoronavirus ppis cytoscape <NUMBER> utilized visualization coronavirushuman ppis kochs postulates <NUMBER> <NUMBER> <NUMBER> long provided criteria designed establish causal relationship exposure microbe emergence disease four criteria kochs postulates microbe must found organisms suffering disease found healthy organisms based hpioutcome postulates lay integrative hostcoronavirus interaction framework shown figure <NUMBER> basically framework includes three major processes viral side three major processes host side coronaviruses crucial processes include viral entry host cell viral replication viral release infected cell host three responses exist naïve response innate response adaptive response initially host response coronavirus entry receptorligand interaction naïve since host realize danger react virus routine procedure naïve host response stage neither signalling molecules selected immune cell populations yet present coordinate immune response signalling molecules produced infected cells eg cytokines interferons host show delayed innate responses coronavirus infection innate immune response may may become effective strong viral infection eventually process recombination followed clonal selection multiple immune cell subtypes host mount adaptive immune response effective viral infection figure <NUMBER> viral host process includes many subprocesses interactions dynamic hostvirus interactions used explain disease outcomes according impact many subprocesses viruses wins result viral survival replication host wins host eventually control viral replication kill viruses model analyze complex adversarial interactions host pathogen propose apply ontology integrative systematic platform due solid semantic logic behind ontology computerinterpretable nature used ontology represent coronavirus disease knowledge including taxonomical structure <NUMBER> coronaviruses ncbitaxon ontology taxonomy ontology based ncbi taxonomy database <NUMBER> shown figure <NUMBER>a human coronaviruses infect transmit among mammal hosts identified <NUMBER> organisms serve hosts reservoirs human coronaviruses bats found reservoir wide variety coronaviruses including sarscov merscov viruses <NUMBER> sarscov also found masked palm civets raccoon dog antibodies sarscov also found chinese ferret badgers liveanimal market shenzhen china <NUMBER> analysis found many animals might served reservoir hosts sarscov figure <NUMBER>b merscov virus likely transmitted dromedary camels <NUMBER> host organisms classified using ncbitaxon ontology figure <NUMBER>b host organisms belong boreoeutheria clade magnorder placental mammals clades within boreoeutheria include euarchontoglires supraprimates including humans rodents laurasiatheria laurasiatheria includes artiodactyla even toed ungulates cattle camels chiroptera bats ferae carnivores canines felines civets relatives including pangolins figure <NUMBER>b taxonomy hierarchy also extracted ncbitaxon ontology become part cido ncbitaxonbased ontology analysis coronavirus hosts shows zoonotic human coronaviruses including sarscov merscov sarscov<NUMBER> obligate mammal parasites figure <NUMBER>b suggesting molecular factor distinguishes mammals animals host transmit coronaviruses humans hypothesize zoonotic human coronaviruses sarscov<NUMBER> originate mammals contrast influenza transmit humans avians however hypothesis need substantial additional study recent paper suggests snake intermediate host human zoonotic coronavirus based similarity codon usage bias <NUMBER>ncov eg sarscov<NUMBER> <NUMBER> since snakes mammals would disprove hypothesis overall pattern makes proposed transmission via snakes extreme claim thus requiring extreme evidence according us cdc common symptoms covid<NUMBER> include fever cough shortness breath difficulty breathing chills repeated shaking chills muscle pain headache sore throat new loss taste smell figure <NUMBER>a hierarchical display <NUMBER> common symptoms associated hierarchical phenotype representation using human phenotype ontology hpo <NUMBER> comorbidity presence additional conditions disease phenotype concurrent coronavirus infection covid<NUMBER> annotation analysis show patients many comorbid conditions eg emphysema chronic bronchitis hypertension coronary heart disease diabetes heightened risk severe symptoms death figure <NUMBER>b shows comorbidities covid<NUMBER> outcome frequencies case reports peerreviewed articles analyze host interactions leading outcomes important build data structures data visualizations draw upon clinical electronic records clinical coronavirus disease outcomes result hostcoronavirus interactions collected <NUMBER> <NUMBER> <NUMBER> virulence factors sarscov merscov sarscov<NUMBER> respectively table <NUMBER> figure <NUMBER> table <NUMBER> based hpioutcome postulates model given figure <NUMBER> literature mining results generated integrative framework formally specify interactions host sarscov<NUMBER> factors associated disease outcomes attenuated blocking reninangiotensin system ras pathway <NUMBER> know figure <NUMBER> patients hypertension susceptible death severe outcomes phenomenon explained downregulation ace<NUMBER> due infection associated hypertension figure <NUMBER> specifically downregulation ace<NUMBER> would lead excessive production angiotensin ii ace would bind receptor induce vasocontraction hypertension <NUMBER> although ace ace<NUMBER> act key players ras serve oppositional roles angiotensin ii angiotensin ii receptor blocker drug eg azilsartan would block angiotensin ii binding receptor thus help treat hypertension way ontological model links hostpathogen interactions hypertension outcome patient already hypertension increased blood pressure due interactions would exacerbate underlying comorbidity may explain increased death rate patients superimposed covid hypertension however pathogen factors likely play role extreme pathogenicity sarscov<NUMBER> evidenced fact despite markedly weak pathogenicity hcovnl<NUMBER> prevalent human coronavirus also uses sace<NUMBER> interaction cellular entry <NUMBER> however hcovnl<NUMBER> considerably benign sarscov<NUMBER> may consequence molecular differences proteinace<NUMBER> interaction two strains ontologydriven comparative analysis covs provides formal representation similarities differences among proteins different viruses proteins differ significantly hypothesize factor eg coreceptor sarscov<NUMBER> contributes viral binding entry recent vaccine design study <NUMBER> predicts many sarscov<NUMBER> nonstructural proteins possible adhesins may serve possible coreceptor testable predictions cytokine storm excessive immune response external stimuli associated high levels cytokine production <NUMBER> cytokine storm major cause acute respiratory distress syndrome ards multipleorgan failure severe covid<NUMBER> patients resulting death within short time <NUMBER> il<NUMBER> major cytokine involved cytokine storm <NUMBER> il<NUMBER> induced angiotensin ii human cells <NUMBER> links cytokine storm sace<NUMBER> bindingassociated interaction network figure <NUMBER> tocilizumab recombinant humanized antihuman il<NUMBER> receptor monoclonal antibody bind il<NUMBER> receptor high affinity thus prevent il<NUMBER> binding native receptor inducing downstream immune damage recently reported tocilizumab improved clinical outcome severe critical covid<NUMBER> patients effectively reduced mortality <NUMBER> figure <NUMBER> provides logical structured graphical summary knowledge introduced representation covers knowledge learned many studies without integrative representation difficult put pieces together another unique feature figure <NUMBER> representation ontologyoriented terms relations represented using computerinterpretable ontological format figure <NUMBER> subset comprehensive hostcoronavirus interaction network expanded understanding hostinteractions coronavirus grows demonstrate ontological representation process sarscov<NUMBER> sace<NUMBER> binding defined two logical axioms figure <NUMBER> ontological logical axioms define relations sarscov<NUMBER> sace<NUMBER> binding process two participants sarscov<NUMBER> protein serves ligand role ace<NUMBER> protein serves receptor role addition define logical axiom sarscov<NUMBER> sace<NUMBER> binding tmprss<NUMBER> defines role tmprss<NUMBER> activate sarscov<NUMBER> sace<NUMBER> binding process major difference ontology taxonomy taxonomy built based isa relation beside representation isa relation ontology also provide additional relations entities different hierarchies activates relation links tmprss<NUMBER> protein protein hierarchy sarscov<NUMBER> sace<NUMBER> binding interaction process hierarchy excessive production proinflammatory cytokines chemokines esp il<NUMBER>b il<NUMBER> il<NUMBER> cxcl<NUMBER> ccl<NUMBER> detected sars patients <NUMBER> <NUMBER> <NUMBER> indicating initiation cytokine storm eventually associated progression ards death obvious timing critical early ifn response would beneficial however coronaviruses especially sarscov<NUMBER> manipulate immune system delay response allowing widespread infection prior onset symptoms understanding dynamics helps rational design proper treatments timing treatments appears similar sarscov merscov sarscov<NUMBER> also affects ifn response <NUMBER> <NUMBER> sarscov<NUMBER> even displayed higher sensitivity ifni vitro compared sarscov<NUMBER> infected vero cells <NUMBER> difference terms ifni activation sarscov sarcov<NUMBER> likely due difference sequences two proteins orf <NUMBER>b orf <NUMBER> two human coronaviruses <NUMBER> considering different human coronaviruses induce varied phenotype outcomes important include coronaviruses systematic comparison identify differential action ifn production isgs likely plays critical role delayed host recognition responses infection supporting survival replication viruses inside host proposed hpi postulates combined structured ontology support systemslevel investigation mechanisms potential avenues prophylaxis treatment second key component host response coronavirus interaction activation adaptive host response also key long term immunity severe sars disease also related lack delayed activation adaptive immunity <NUMBER> sars patients severe outcomes maintained high levels many innate immune systemlinked cytokines eg cxcl<NUMBER> ccl<NUMBER> isgencoded proteins low levels spikespecific antibodies <NUMBER> conversely surviving patients higher levels spikespecific antibodies findings suggest prompt formation adaptive immunity important reduce disease severity improve outcomes adaptive immune response induced effective vaccines covid<NUMBER> sarscov merscov s<NUMBER> used vaccine antigensimmunogens due ability induce neutralizing antibodies prevent host cell attachment infection <NUMBER> <NUMBER> numerous sarscov<NUMBER> vaccine trials underway <NUMBER> hope safe effective vaccines ready near future control covid<NUMBER> pandemic previous victors ppi predictions based analyses protein domains phylogeny <NUMBER> nature ppi domaindomain interaction therefore identify domains virus proteins based known interactions domains host proteins predict virus proteins interact host proteins using known ppis baits developed domaininferred ppi prediction strategy predict ppis ppis could possibly affect organs tissues prediction found sarscov<NUMBER> could induce <NUMBER> humanvirus interactions <NUMBER> human proteins many ppis tissuespecific tissuespecific information identified human protein atlas <NUMBER> using predicted ppis sarscov<NUMBER> predicted affect many tissues skin liver intestine blood glands reproductive tissues figure <NUMBER> addition computational methods prediction described also depends prior knowledge preidentified ppis tissuespecific protein intergrative ontological modeling also support different applications rational drug repurposing design vaccine development shown figure <NUMBER> ontological representation provides several paths rational drug repurposing design covid<NUMBER> treatment camostat mesylate serine protease inhibitor capable inhibiting function tmprss<NUMBER> <NUMBER> crucial effective sace<NUMBER> binding tmprss<NUMBER> <NUMBER> angiotensin ii receptor blockers used block activation angiotensin ii <NUMBER> therefore blocking vacoconstriction following hypertension tocilizumab able inhibit il<NUMBER> activity <NUMBER> block formation cytokine storm sarscov<NUMBER> appears use many pathways cause different phenotypes reasonable hypothesize drugs blocking early stages disease pathways would effective later starges pathways also important consider drugs block paths leading severe disease outcomes hypertension cytokine storm addition also need consider side effects drugs used treatment integrative ontology framework provides foundation rational design ontologybased software tools algorithms also developed support intelligence queries <NUMBER> covid<NUMBER> outbreak caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> continues endanger global health hamper world economy outbreak started december <NUMBER> wuhan hubei province unfortunately currently still specific effective treatment covid<NUMBER> evidence shows elderly people sarscov<NUMBER> infections cardiovascular diseases including hypertension risk developing severe cases <NUMBER> hypertension survey <NUMBER> <NUMBER> reported <NUMBER> chinese people ≥<NUMBER> years age hypertension whereas prevalence hypertension <NUMBER> among citizens ≥<NUMBER> years age <NUMBER> ras plays important role regulating electrolyte balance blood pressure comprises two pathways aceang iiat<NUMBER>r pathway ace<NUMBER>ang <NUMBER>mas receptor pathway <NUMBER> normal physiological conditions activity aceang iiat<NUMBER>r axis ace<NUMBER>ang <NUMBER> mas receptor axis dynamic equilibrium state maintaining normal function corresponding system similar sars sarscov<NUMBER> believed invade host cell entry receptor ace<NUMBER> <NUMBER> sarscov infections reduce ace<NUMBER> expression resulting imbalance aceang ii at<NUMBER>r axis ace<NUMBER>ang <NUMBER>mas receptor axis <NUMBER> targeting aceang iiat<NUMBER>r axis novel therapeutic strategy hypertension aceis aras inhibit aceang iiat<NUMBER>r pathway also modulate ace<NUMBER>ang <NUMBER>mas receptor pathway <NUMBER> dysfunction reninangiotensin system ras observed coronavirus infection disease covid<NUMBER> patients whether ras inhibitors angiotensinconverting enzyme inhibitors aceis angiotensin ii type <NUMBER> receptor blockers arbs associated clinical outcomes remains unknown aimed evaluate ability ras inhibitors protect covid<NUMBER> patients hypertension study approved shenzhen third peoples hospital ethical committee verbal informed consent obtained patients patients family members performed retrospective review medical records hospitalized patients covid<NUMBER> admitted shenzhen third peoples hospital <NUMBER> january <NUMBER> february <NUMBER> information patients hypertension extracted enrolled covid<NUMBER> patients reviewed clinical data extracted electronic medical records including clinical symptoms signs laboratory findings commercial realtime pcr kit geneodx co ltd shanghai china used detect sarscov<NUMBER> samples considered positive cycle threshold value ctvalue less <NUMBER> negative ctvalue <NUMBER> samples ctvalue <NUMBER> <NUMBER> require confirmation retesting samples identified positive local laboratory validated key laboratory shenzhen cdc severity covid<NUMBER> wasidentified hospitalization according guidelines established national health commission peoples republic china therapeutic regimens covid<NUMBER> patients complied guidelines established national health commission peoples republic china hypertension classified grade <NUMBER> grade <NUMBER> grade <NUMBER> according <NUMBER> guidelines european society hypertension esh hypertensive patients covid<NUMBER> divided two subgroups based antihypertensive drug treatments detailed information enrolled patients shown supplementary table s<NUMBER> spss <NUMBER> software package used statistical analysis measurement data expressed median interquartile range iqr difference groups compared unpaired test count data expressed percentages difference groups tested chisquare test p <NUMBER> considered statistically significant total <NUMBER> covid<NUMBER> patients admitted shenzhen third peoples hospital <NUMBER> february <NUMBER> among patients <NUMBER> <NUMBER> hypertension nine patients <NUMBER> grade <NUMBER>hypertension take antihypertensive drugs hospitalization excluded subsequent analysis <NUMBER> patients <NUMBER> receiving antihypertensive therapy included studies <NUMBER> analyzed patients divided two groups based antihypertensive therapies aceiarb group <NUMBER> patients included patients treated acei arb drugs nonaceiarb group <NUMBER> patients included patients treated antihypertensive drugs including calcium channel blockers ccbs βblockers diuretics eight patients <NUMBER> nonaceiarb group <NUMBER> patients <NUMBER>in aceiarb group comorbidities type <NUMBER> diabetes t<NUMBER>d coronary heart disease chd vast majority hypertensive patients received current therapeutic regimens shown supplementary table s<NUMBER> one year blood pressure patients wellcontrolled therapeutic regimens hospitalization comparison baseline characteristics two groups summarized supplementary table s<NUMBER> median age analyzed subjects <NUMBER> years iqr <NUMBER> years <NUMBER> males significant differences hypertension grades observed aceiarb group nonaceiarb group groups showed similar signs symptoms median number days onset symptoms hospital admission <NUMBER> nonaceiarb group <NUMBER> aceiarb group meanwhile median number days symptom onset hospital discharge <NUMBER> days nonaceiarb group <NUMBER> days aceiarb group median heart rate respiratory rate nonaceiarb group <NUMBER> bpm <NUMBER> respectively comparison median heart rate respiratory rate nonaceiarb group <NUMBER> bmp <NUMBER> respectively baseline characteristics shown table s<NUMBER> significantly different two groups hospitalization <NUMBER> patients nonaceiarb group <NUMBER> categorized severe subgroups one patient died contrast aceiarb group <NUMBER> patients <NUMBER> categorized severe subgroups patients died figure <NUMBER>a percentage severe cases aceiarb group higher nonaceiarb group difference significant possibly due small number clinical cases next examined effects taking acei arb drugs laboratory findings covid<NUMBER> patients hypertension shown figure <NUMBER>b trend toward lower il<NUMBER> levels patients aceiarb group marked variation creactive protein crp observed two groups figure <NUMBER>b absolute number cd<NUMBER> cd<NUMBER> cells aceiarb group significantly higher nonaceiarb group significant changes cd<NUMBER> cell counts two groups figure <NUMBER>c addition although viral load different two groups hospital admission peak viral load hospitalization acei arb group significantly lower nonaceiarb group figure <NUMBER>d laboratory findings white blood cell counts neutrophil counts platelet counts lactate dehydrogenase shown supplementary table s<NUMBER> significant differences observed two groups reported ras plays critical role regulating hypertension acute lung injury caused viruses sars h<NUMBER>n<NUMBER> <NUMBER> <NUMBER> changes ras activity related pathogenesis hypertension inflammatory lung disease targeting ras effective antihypertension therapeutic strategy aceis arb inhibit aceang iiat<NUMBER>r system commonly used drugs hypertensive patients recent evidence suggests hypertensive covid<NUMBER> patients predisposed develop severe cases <NUMBER> thus important determine effect ras inhibitors covid<NUMBER> patients hypertension studies suggested covid<NUMBER> patients increased angiotensin ii compared healthy people <NUMBER> abnormal increase angiotensin ii related hypertension lung failure addition ras inhibitors shown associated reduced mortality patients sepsis <NUMBER> angiotensin ii positively regulates expression inflammatory cytokines activation at<NUMBER>r <NUMBER> excessively high levels inflammatory cytokines harmful outcomes covid<NUMBER> patients thus suggested beneficial covid<NUMBER> patients use aceis arbs inhibit ras however confirmed clinical evidence available study covid<NUMBER> patients hypertension enrolled found aceiarb therapy attenuated inflammatory response potentially inhibition il<NUMBER> levels consistent findings acei arb therapy alleviated lpsinduced pneumonic injury <NUMBER> patients chronic heart failure proven acei therapy associated decreased th<NUMBER> th<NUMBER> cytokine ratios inflammatory cytokine production <NUMBER> study also suggests acei arb therapy beneficial effect immune system avoiding peripheral cell depletion furthermore viral load reported highly correlated severe lung injury <NUMBER> also observed aceiarb therapy decreased viral load hypothesize ras inhibitors directly inhibit viral replication rather play indirect antiviral role regulating immune function inhibiting inflammatory responses mechanism needs clarified vitro vivostudies future taken together first clinical evidence demonstrating ras inhibitors improve clinical outcomes covid<NUMBER> patients hypertension suggesting patients could benefit persistent preferential usage aceiarb antihypertensive treatment data expressed median iqr unpaired test used p <NUMBER> considered significant potential conflict interest reported authors orcid guoliang zhang httporcidorg<NUMBER> novel coronavirus named severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> discovered december <NUMBER> wuhan china ongoing pandemic coronavirus disease <NUMBER> covid<NUMBER> spreading around world early april <NUMBER> clinical spectrum covid<NUMBER> ranges asymptomatic upper respiratory infection critically ill pneumonia associated acute respiratory distress syndrome ards <NUMBER> <NUMBER> <NUMBER> initial reports china prevalence older age hypertension diabetes mellitus cardiovascular disease cvd high covid<NUMBER> patients individuals comorbidities tended greater case fatality rates <NUMBER> <NUMBER> addition shown angiotensinconverting enzyme <NUMBER> ace<NUMBER> functional receptor sarscov<NUMBER> infection <NUMBER> <NUMBER> <NUMBER> given experimental studies suggested angiotensin receptor blockers arbs ace inhibitor acei could increase ace<NUMBER> expression cardiovascular renal systems <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> concerns may raised regarding whether arbs aceis would augment infection sarscov<NUMBER> severity covid<NUMBER> hypertension cvd patients receiving drugs <NUMBER> contrast arbs potential benefits prevention treatment lung injury caused covid<NUMBER> <NUMBER> conflicting views appear arise based results experimental studies especially severe acute respiratory syndrome coronavirus sarscov direct clinical data covid<NUMBER> lacking present sarscov caused sars epidemic china <NUMBER> <NUMBER> virological characteristics closely related sarscov<NUMBER> <NUMBER> <NUMBER> available investigations association reninangiotensin system ras particularly ace<NUMBER> angiotensin ii sarscovinduced lung injury latest information covid<NUMBER> reviewed early april <NUMBER> would provide insight covid<NUMBER> direction future research covid<NUMBER> ace<NUMBER> receptor sarscov sarscov<NUMBER> ace<NUMBER> belongs membranebound carboxydipeptidase family widely distributed human body including heart kidney small intestine lesser extent lung lung ace<NUMBER> expression concentrated mainly type ii alveolar cells macrophages modestly bronchial tracheal epithelial cells <NUMBER> ace<NUMBER> degrades angiotensin ii generate angiotensin <NUMBER> activates mas oncogene receptor negatively regulates variety angiotensin ii actions mediated angiotensin ii type <NUMBER> receptor at<NUMBER>r <NUMBER> therefore thought ace<NUMBER>angiotensin <NUMBER>mas receptor axis counteracting effects excessively activated aceangiotensin iiat<NUMBER>r axis seen hypertension cardiac hypertrophy heart failure cvds <NUMBER> hand human ace<NUMBER> established functional receptor sarscov enters host target cells fig <NUMBER> <NUMBER> <NUMBER> transmembrane spike glycoprotein protein sarscov binds cellular membrane ace<NUMBER> sarscov attaches target cells followed sarscovs protein priming cellular surface proteases transmembrane protease serine <NUMBER> tmprss<NUMBER> allowing fusion viral cellular membranes resulting sarscov entry replication target cells <NUMBER> moreover ace<NUMBER> knockout greatly reduces viral infection replication mice experimental sarscov infection <NUMBER> thus suggested binding sarscovs protein ace<NUMBER> crucial sarscov infection recently shown sarscov<NUMBER>s protein shares nearly <NUMBER> amino acid identity sarscovs protein binding affinity sarscov<NUMBER>s protein human ace<NUMBER> similar sarscovs protein <NUMBER> <NUMBER> <NUMBER> antihuman ace<NUMBER> antibodies antisera inhibit sarscov<NUMBER>s proteinmediated entry cultured cells vitro <NUMBER> <NUMBER> <NUMBER> accordingly sarscov<NUMBER> utilizes ace<NUMBER> target cell entry well however still clear whether ace<NUMBER> sole receptor sarscov<NUMBER> infection cd<NUMBER>l glycoprotein ctype lectin also called lsign identified possible secondary receptor sarscov cultured chinese hamster ovary cells <NUMBER> experimental sarscov infection induces acute respiratory failure lung parenchymal injury characterized alveolar wall thickening pulmonary vascular hyperpermeability inflammatory cell infiltration mice <NUMBER> sarscov infection mice lung ace<NUMBER> fig <NUMBER> possible scheme association ace<NUMBER> angiotensin ii at<NUMBER>r acute lung injury sars covid<NUMBER> ang ii angiotensin ii ace angiotensinconverting enzyme ace<NUMBER> angiotensinconverting enzyme <NUMBER> acei angiotensinconverting enzyme inhibitor at<NUMBER>r angiotensin ii type<NUMBER> receptor arb angiotensin ii type<NUMBER> receptor blocker sarscov severe acute respiratory syndrome coronavirus sarscov<NUMBER> severe acute respiratory syndrome coronavirus <NUMBER> sprotein spikeglycoprotein protein levels greatly reduced ace levels changed <NUMBER> findings consistent previous observation coronaviruses specifically downregulate ace<NUMBER> expression host cells depending virus replication <NUMBER> addition sarscovinduced acute lung injury remarkably attenuated ace<NUMBER> knockout mice compared wildtype mice <NUMBER> lung angiotensin ii levels increase wildtype mice sarscov infection <NUMBER> acid aspiration mice ards model show functional pathological changes mimicking sarscovinduced lung injury <NUMBER> lung angiotensin ii levels increase acid aspiration sarscovs protein treatment elicits angiotensin ii increase <NUMBER> interestingly exogenous recombinant ace<NUMBER> treatment rescues acid aspirationinduced acute lung injury <NUMBER> taking evidence together following hypothesis raised mechanism underlying sarscovinduced lung injury sarscov infection downregulates lung ace<NUMBER> turn shifts balance toward dominance ace angiotensin iiat<NUMBER>r system ace<NUMBER>angiotensin <NUMBER>mas receptor system lung result noncompeting angiotensin ii accumulation occurs resulting acute lung injury at<NUMBER>r activation <NUMBER> noted similar mechanism proposed severe lung injury caused avian influenza virus h<NUMBER>n<NUMBER> spread worldwide humans high mortality rate h<NUMBER>n<NUMBER> virus infection mice lung ace<NUMBER> expression downregulated serum angiotensin ii levels increase <NUMBER> acute lung injury augmented ace<NUMBER> knockout h<NUMBER>n<NUMBER>infected mice administration recombinant human ace<NUMBER> ameliorates h<NUMBER>n<NUMBER>induced lung injury mice <NUMBER> moreover mouse models acute lung injury ards acid aspiration sepsis druginduced lung fibrosis shown ace<NUMBER> expression downregulated response noxious stimuli acute lung injury aggravated ace<NUMBER> knockout rescued exogenous ace<NUMBER> administration at<NUMBER>r knockout <NUMBER> <NUMBER> accordingly suggested angiotensin ii at<NUMBER>rinduced aggravation resulting ace<NUMBER> downregulation protective effects ace<NUMBER> specific lung injury sars rather may common acute lung injuryards induced various viral infections lung diseases several kinds arbs eg olmesartan telmisartan losartan azilsartan shown increase mrna protein levels ace<NUMBER> animal models heart diseases hypertensive hypertrophy autoimmune myocarditis dilated cardiomyopathy myocardial infarction diabetic cardiomyopathy <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> chronic kidney disease hypertensive nephropathy diabetic nephropathy <NUMBER> <NUMBER> well normal rat heart renal vasculature <NUMBER> <NUMBER> hypertensive rat aorta carotid artery <NUMBER> <NUMBER> acei inhibit ace<NUMBER> pharmacological property normal rats lisinopril shown modestly increase cardiac ace<NUMBER> mrna levels c effects losartan <NUMBER> mgkg lung edema wetdry weight ratio acid plus spikefc proteintreated mice n <NUMBER> per group p <NUMBER> vs vehicletreated wildtype mice acid injury at<NUMBER> angiotensin ii type<NUMBER> receptor cited ref <NUMBER> changing cardiac ace<NUMBER> activity <NUMBER> myocardial infarction model valsartan ramipril combination effects cardiac ace<NUMBER> expression <NUMBER> noted doses arbs aceis used animal studies much greater clinical practice observed effects drugs ace<NUMBER> expression activity could extrapolated clinical situations humans importantly clinical data exist regarding effects arbs aceis human tissue ace<NUMBER> expression activity vivo although several clinical studies investigating changes plasma urine levels soluble form ace<NUMBER> hypertension cvd patients receiving arbs aceis soluble form ace<NUMBER> plasma urine reliable indicator activity tissue ace<NUMBER> namely membranebound ace<NUMBER> <NUMBER> importantly data effects arbs aceis lung ace<NUMBER> expression either animal models humans still unknown whether changes ace<NUMBER> levels example arbinduced upregulation actually facilitate greater engagement entry sarscov viruses even animal models hand shown pretreatment losartan arb ameliorates acute pulmonary edema lung injury sarscovs proteintreated mice acid aspiration fig <NUMBER> <NUMBER> taken together lung angiotensin ii level elevation <NUMBER> evidence suggested even considering speculation viral load would enhanced ace<NUMBER> upregulation net effects arbs would favorable prevent sarscovinduced acute lung injury model addition another possibility arb pretreatmentinduced baseline ace<NUMBER> increase prior sarscov infection would result higher ace<NUMBER> levels remained sarscovinduced downregulation consequently conferred protection lung injury model <NUMBER> <NUMBER> however interpreting results study noted effects losartan observed merely mice treated sarscovs protein addition acid aspiration mice treated sarscovs protein alone additionally data lung ace<NUMBER> levels treatment sarscovs protein acid aspiration lacking mice pretreated without losartan earlier studies reported case fatality rate high covid<NUMBER> patients comorbidities older age hypertension diabetes mellitus cvd chronic pulmonary disease malignancy <NUMBER> <NUMBER> patients hypertension cvd likely treated aceis arbs concern raised regarding whether use aceis arbs may aggravate morbidity mortality covid<NUMBER> <NUMBER> however possible observed phenomenon would result reverse causality older patients highest risk covid<NUMBER> concurrently tend multiple comorbidities including hypertension cvd adjustments age possible confounding factors performed earlier studies <NUMBER> <NUMBER> <NUMBER> indeed recent retrospective multicenter cohort study enrolling <NUMBER> confirmed covid<NUMBER> patients wuhan china multivariable regression analysis revealed independent risk factors inhospital death older age higher sequential organ failure assessment score higher ddimer levels early stage covid<NUMBER> although hypertension diabetes coronary artery disease included <NUMBER> small case study reported plasma angiotensin ii levels markedly elevated linearly associated viral load lung injury severity covid<NUMBER> pneumonia patients <NUMBER> given remarkable elevation circulating levels also documented various kinds cytokines il<NUMBER> il<NUMBER> tnfalpha etc unknown whether findings angiotensin ii cause result systemic cytokine storm covid<NUMBER> patients <NUMBER> context effects arbs aecis retrospective singlecenter analysis enrolling <NUMBER> covid<NUMBER> patients showed use arbs aceis effects morbidity mortality covid<NUMBER> patients cvd <NUMBER> currently casecontrol study underway clarify effects aceis arbs severity covid<NUMBER> italy nct<NUMBER> importantly present largescale study convincing evidence determine whether arbs aceis play neutral beneficial harmful role susceptibility sarscov<NUMBER> severity outcomes covid<NUMBER> patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> addition vaccine development antiviral agents modulation ras especially ace<NUMBER> angiotensin ii highlighted potential therapeutic target covid<NUMBER> based animal study suggesting beneficial net effects arb sarscovinfected acute lung injury mice <NUMBER> multicenter doubleblinded placebocontrolled randomized trials rcts currently conducted investigate effects losartan mortality hospital admission covid<NUMBER> patients requiring hospital admission nct<NUMBER> requiring hospital admission nct<NUMBER> respectively recombinant ace<NUMBER> another candidate prevent covid<NUMBER> pneumonia described efficacy exogenous recombinant ace<NUMBER> shown animal models acute lung injuryards <NUMBER> <NUMBER> also possible circulating soluble form ace<NUMBER> may act decoy receptor binds sarscov<NUMBER> competitively inhibits virus entry host target cells mediated membranebound ace<NUMBER> investigate efficacy human recombinant ace<NUMBER> treatment covid<NUMBER> patients randomized controlled pilot clinical study planned nct<NUMBER> however study withdrawn march <NUMBER> <NUMBER> tmprss<NUMBER> membrane protease ace<NUMBER> priming crucial step fusion sarscov<NUMBER> target cell membranes resultant viral entry cells <NUMBER> nafamostat mesylate camostat mesylate tmprss<NUMBER> inhibitors used treatment acute pancreatitis japan currently clinical trial evaluating efficacy nafamostat camostat treating covid<NUMBER> underway japan httpswwwutokyoacjpfocusenarticlesz<NUMBER>html concern regarding whether arbs aceis may harmful effects morbidity mortality covid<NUMBER> patients based speculation drugs would upregulate ace<NUMBER> receptor sarscov<NUMBER> would increase viral load augment lung injury however evidence ace<NUMBER> upregulation limited animal studies using relatively high namely pharmacological doses several arbs one acei additionally remains unclear whether arb aceinduced ace<NUMBER> increase actually enhances susceptibility sarscov<NUMBER> sarcov importantly clinical studies exist supporting arbs aceis augment susceptibility infection worsen improve allcause cardiovascular outcomes covid<NUMBER> patients also sars patients present therefore hypothesis underlying concern would readily extrapolated humans particularly covid<NUMBER> patients patients heart failure prior myocardial infarction cvds cerebrovascular disease benefit arbs aceis established improvement quality life survival outcomes discontinuation leads new onset exacerbation heart failure cvd stroke worsening prognosis <NUMBER> thus ras inhibitors continued highrisk patients received guidelinedirected medical therapy gdmt general switching one another class antihypertensive agents infrequently result destabilization blood pressure control requires frequent visits drug titration achieve appropriate stable blood pressure control avoid adverse effects blood pressure destabilization increases incidence heart failure stroke cvds addition frequent visits clinic hospital expose patients greater risk infection covid<NUMBER> pandemic situation accordingly even stably controlled hypertension patients without compelling indications thought simple discontinuation also switching arb acei antihypertensive agents avoided unless physicians make decision based specific considerations cardiovascular comorbidities common covid<NUMBER> patients patients great risk morbidity mortality <NUMBER> <NUMBER> <NUMBER> <NUMBER> myocardial damage ranging silent troponin elevation fulminant myocarditis documented covid<NUMBER> patients <NUMBER> confirmed suspected covid<NUMBER> patients acei arb medications recommended treatment heart failure cvd according gdmt based available evidence time <NUMBER> conclusion present use arbs aecis withheld established standard therapy highrisk patients heart failure prior myocardial infarction cvd cerebrovascular disease also patients hypertension stable condition according recent statements released european society hypertension european society cardiology american heart association heart failure society americaamerican college cardiology <NUMBER> <NUMBER> <NUMBER> evidence covid<NUMBER> accumulated day largescale clinical studies convincing evidence rcts also realworld big data analyses well experimental studies awaited solve question whether arbs aceis neutral favorable harmful effects susceptibility sarscov<NUMBER> severity outcomes covid<NUMBER> finally learn lessons covid<NUMBER> without bound common sense antecovid<NUMBER> era addition reconstruct novel strategy treatment hypertension cvd postcovid<NUMBER> era funding work supported part jsps kakenhi grant <NUMBER>k<NUMBER> conflict interest authors declare conflict interest publishers note springer nature remains neutral regard jurisdictional claims published maps institutional affiliations december <NUMBER> group case unexplained pneumonia occurred wuhan hubei province china <NUMBER> spread epidemic cases consecutively appeared parts china abroad april <NUMBER> <NUMBER> number countries involved tripled <NUMBER> cases worldwide <NUMBER> deaths <NUMBER> epidemic resulted serious negative effects health socioeconomic development march <NUMBER> <NUMBER> declared covid<NUMBER> pandemic <NUMBER> agent disease novel coronavirus february <NUMBER> <NUMBER> international committee virus classification officially termed virus sarscov<NUMBER> formerly temporarily named <NUMBER>ncov disease caused novel coronavirus termed corona virus disease <NUMBER> pneumonia caused novel coronavirus uniformly named novel coronavirus pneumonia national health commission peoples republic china virus seventh member envelope rna coronavirus sarbecovirus subgenus coronavirus subfamily novel coronavirus belongs novel coronavirus β genus enveloped round oval particles often pleomorphic <NUMBER> nm diameter <NUMBER> novel coronavirus similar bat sarslike coronavirus chinese chrysanthemumheaded bat nucleotide homology <NUMBER> <NUMBER> <NUMBER> bat sarslike coronavirus human sars virus mers virus respectively <NUMBER> primitive host novel coronavirus chinese chrysanthemumheaded bat <NUMBER> diseases caused spread pangolin hosts humans first <NUMBER> confirmed cases <NUMBER> reported contact south china seafood market <NUMBER> therefore present believed original source novel coronavirus south china seafood market wuhan source infection patients infected novel coronavirus asymptomatic infections incubation periods considered potential sources infection <NUMBER> route transmission droplet contact aerosol fecaloral andor motherto child transmission <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> average incubation period <NUMBER> days basic regeneration number r<NUMBER> early stage epidemic <NUMBER> <NUMBER> clinical symptoms include fever cough myalgia fatigue atypical symptoms include expectoration headache hemoptysis diarrhea approximately half patients dyspnea complications include acute respiratory distress syndrome acute heart injury secondary infection <NUMBER> chest ct revealed common radiological manifestations admission ground glass shadow bilateral patchy shadow <NUMBER> novel coronavirus cases often complicated high risk cerebrovascular diseases cardiocerebrovascular disease hypertension diabetes <NUMBER> death occurring mainly elderly chronically ill patients <NUMBER> according influence novel coronavirus cerebrovascular disease clinical manifestations covid<NUMBER> patients paper expounds pathophysiological hypothesis covid<NUMBER> effect cerebrovascular disease based current epidemiological data people ages generally susceptible novel coronavirus latest findings published chinese journal epidemiology based findings <NUMBER> cases covid<NUMBER> <NUMBER> majority confirmed cases ages <NUMBER> <NUMBER> years <NUMBER> mainly middleaged elderly individuals proportion patients hypertension diabetes cardiovascular disease <NUMBER> <NUMBER> <NUMBER> respectively indicating middleaged elderly individuals chronic diseases may likely infected compared healthy individuals stroke patients mainly middleaged elderly individuals higher proportion diseases hypertension diabetes thus elderly individuals chronic diseases individuals poor resistance may susceptible infection recent study clinical characteristics <NUMBER> patients novel coronavirus infection wuhan <NUMBER> revealed median age <NUMBER> years old higher proportion middleaged elderly people cases <NUMBER> complicated underlying diseases including <NUMBER> cases diabetes <NUMBER> cases hypertension <NUMBER> cases cardiocerebrovascular diseases <NUMBER> cases cancer study demonstrated elderly patients cerebrovascular diseases risk factors hypertension diabetes may highest risk infection zhong nanshans team reported median age critical recombination <NUMBER> years old noncritical group <NUMBER> years old males accounted <NUMBER> females accounted <NUMBER> patients <NUMBER> years old accounted <NUMBER> suggesting rate infection higher males females infection children rare approximately quarter patients hypertension diabetes coronary heart disease diseases proportion patients smoking history less <NUMBER> <NUMBER> collectively data suggest elderly cerebrovascular diseases may infectious groups patients admitted hospital <NUMBER> patients fever patients presented fever hospital conversely almost patients sars middle east respiratory syndrome mers caused coronavirus symptoms fever time diagnosis <NUMBER> patients fever case fatality rate covid<NUMBER> lower sars mers covid<NUMBER> associated mortality rate approximately <NUMBER> <NUMBER> case fatality rates sars mers <NUMBER> <NUMBER> respectively <NUMBER> <NUMBER> study reported elderly patients cardiovascular cerebrovascular diseases diabetes hypertension higher case fatality rate populations blackburn et al <NUMBER> reported respiratory virus infection associated increased risk stroke hospitalized stroke patients existing studies suggest novel coronavirus conducive prognosis patients cerebrovascular diseases special attention paid changes clinical condition lymphocyte counts low prothrombin time prolonged lactate dehydrogenase levels significantly increased covid<NUMBER> patients white blood cell neutrophil counts severely infected patients significantly increased ddimer creatinine creatine kinase levels also increased <NUMBER> patients require oxygen therapy may even require extracorporeal membrane oxygenation ecmo provide respiratory support suggested patients body state hypoxia inflammation hypercoagulability pathophysiological changes may underpin development stroke hematological reports covid<NUMBER> patients often include counts white blood cells neutrophils high creactive protein common complications include presence inflammatory reactions covid<NUMBER> patients cerebrovascular diseases often present complications hypertension diabetes hyperlipidemia stroke risk factors risk factors associated proinflammatory changes including leukocyte activation cerebrovascular thrombosis inflammatory stimulation inflammatory cells begin accumulate vascular wall early stage atherosclerosis increase bloodbrain barrier permeability destroy brain cells activate formation atherosclerosis anterior internal cerebral arteries endothelial dysfunction affects automatic regulation cerebral circulation processes may lead plaque rupture thrombosis increasing risk stroke inflammatory markers leukocytes fibrinogen creactive protein independent predictors ischemic stroke <NUMBER> longterm chronic infection increase risk stroke casecontrol study <NUMBER> acute infection previous week reported trigger ischemic stroke acute aggravated chronic infections may play role activating blood clotting chronic infection may lead atherosclerosis inflammatory reactions patients covid<NUMBER> may critical common determinant atherosclerosis stroke risk individual infected novel coronavirus individuals immune function may experience excessive systemic immune responses even die acute respiratory distress syndrome septic shock <NUMBER> mechanism termed immunopathogenicity virus stimulates immunity causes immune system attack currently critical avoid excessive immune responses whole body well improve immune function individuals weak immunity cytokine storm overactivation immune system caused infection leads massive accumulation exudation inflammatory substances leading multiple organ failure acute respiratory distress may important cause death severe critical patients covid<NUMBER> <NUMBER> accumulating evidence suggests severe covid<NUMBER> patients might present cytokine storm syndrome <NUMBER> although symptoms patients coronavirus infection mild present patients present milder symptoms early stage rapidly worsen later stage patients eventually die multiple organ failure mainly due cytokine storm cytokines include interferon ifn interleukin il chemokine chemokines colony stimulating factor csf tumor necrosis factor tnf secreted immune cells cytokines either proinflammatory antiinflammatory effects sars swept china <NUMBER> cytokine storm also direct cause death many patients <NUMBER> <NUMBER> excessive inflammation observed patients acute respiratory distress syndrome caused h<NUMBER>n<NUMBER>a infection <NUMBER> toxicity virus depends severity induced immune response however different viruses trigger cytokine storms via various mechanisms cause different cytokine changes example sarsrelated cytokine storms mainly related interleukin il<NUMBER>β il<NUMBER> il<NUMBER> interferon ifnγ inducible protein ip<NUMBER> monocyte chemoattractant protein<NUMBER> mcp<NUMBER> <NUMBER> contrast cytokine storms caused mers coronavirus mainly associated ifn γ tumour necrosis factor tnfα il<NUMBER> il<NUMBER> <NUMBER> abovementioned study doctors wuhan zhongnan hospital observed blood levels il<NUMBER> il<NUMBER> il<NUMBER> granulocyte colony stimulating factor gscf mcp<NUMBER> macrophage inflammatory protein mip<NUMBER>α tnfα critically ill patients significantly increased suggesting cytokine storm associated disease severity <NUMBER> low levels cd<NUMBER>t cd<NUMBER>t higher levels il<NUMBER> il<NUMBER> observed severe patients regard cell subsets cytokines positively correlated severity covid<NUMBER> symptoms <NUMBER> january <NUMBER> lancet published online paper novel coronavirus <NUMBER> coronavirus shows neuroinvasive characteristics secondary peripheral organ replication humans animals invasion bloodbrain barrier coronavirus related destruction tight junctions brain microvascular endothelial cells induced coronavirus leads bloodbrain barrier dysfunction enhanced bloodbrain barrier permeability <NUMBER> researchers detected sarscov nucleic acid cerebrospinal fluid patients sars <NUMBER> invading brain tissue sars virus attracts cd<NUMBER> monocytesmacrophages cd<NUMBER>t lymphocytes infected tissues mixed cells participate immune process however large number cytokines chemokines released viral infection induces inflammatory cascade reaction promotes atherosclerosis plaque rupture thrombosis <NUMBER> tolllike receptor tlr activated coronavirus infection plays important role mechanism innate immunity promote atherosclerosis accelerate occurrence ischemic stroke <NUMBER> cytokine cascade aggravates ischemic brain damage increases risk intracerebral hemorrhage tissue plasminogen activator treatment <NUMBER> il<NUMBER> contribute increased probability thrombotic event induction platelet production promotion plaque disruption <NUMBER> angiotensinconverting enzyme <NUMBER> ace<NUMBER> angiotensinconverting enzyme <NUMBER> ace<NUMBER> cellular receptor sarscov sarscov<NUMBER> spike protein s<NUMBER> interacts host ace<NUMBER> receptor adherence viral particles cell membrane <NUMBER> <NUMBER> <NUMBER> sars ace<NUMBER> signaling plays important role pathogenesis severe lung failure viral infection <NUMBER> ace<NUMBER> highly expressed vascular endothelial cells heart kidney liver digestive tract organs <NUMBER> tissues organs expressing ace<NUMBER> may sites interaction novel coronavirus immune cells ace<NUMBER> negative regulator reninangiotensin system ras balance many functions ace targeting angiotensin ii ang ii ace<NUMBER> shows protective effects cardiovascular system many organs <NUMBER> ace<NUMBER> deficiency impaired endothelial function cerebral arteries adult mice augmented endothelial dysfunction aging <NUMBER> indicating ace<NUMBER> provides endothelial protection ace<NUMBER> inactivates ang ii generating angiotensin ang <NUMBER> exerts potent vasodilator effects via activation mas receptor <NUMBER> ace<NUMBER> important metabolic enzyme ras plays central role maintaining heart brain homeostasis <NUMBER> sarscov infections spike protein sarscov reduce ace<NUMBER> expression <NUMBER> decrease ace<NUMBER> associated decrease ang <NUMBER> vasoprotective effects balance classical ras aceang iiangiotensin <NUMBER> receptor at<NUMBER>r regulatory axis ace<NUMBER>ang <NUMBER>masr counterregulatory axis ras system disturbed leading higher ang ii levels blood angii levels covid<NUMBER> patients markedly elevated linearly associated viral load lung injury <NUMBER> ang ii stimulates nuclear factorκb nfκb activation human monocytes nfκb participates signaling pathways involved inflammation atherosclerosis may contribute pathogenesis atherosclerosis <NUMBER> angiotensin <NUMBER> stimulates mas receptors promote angiogenesis brain tissue inhibit oxidative stress resist neuroinflammation improve cerebral blood flow resist apoptosis <NUMBER> therefore ace<NUMBER> target receptor inhibit beneficial effects ras system brain due ace<NUMBER> involvement blood pressure regulation subset hypertensive patients covid<NUMBER> may present abnormal increase blood pressure increased risk cerebral hemorrhage addition critically ill patients covid<NUMBER> often associated severe thrombocytopenia may risk factors acute cerebrovascular events patients therefore assume angiotensinconverting enzyme inhibitors acei at<NUMBER>r inhibitors may used reduce pulmonary inflammation mortality patients covid<NUMBER> pneumonia conditions controlled blood pressure <NUMBER> however experiments animals revealed acei angiotensin receptor blockers increase number ace<NUMBER> receptors cardiopulmonary circulation increases risk severe disease outcomes <NUMBER> clinical studies demonstrated blood covid<NUMBER> patients contained higher levels ddimer prolonged prothrombin time <NUMBER> reflecting hypercoagulable state blood pulmonary infection related platelet aggregation activation coagulation system <NUMBER> significantly increased levels ddimer severe covid<NUMBER> patients observed <NUMBER> superior prognosis severe covid<NUMBER> patients markedly elevated ddimer levels <NUMBER> decreased blood oxygen saturation leads release inflammatory factors <NUMBER> one possible explanation increase blood coagulability decrease blood oxygen triggers inflammatory factors catecholamine increased plasma levels tissue factors platelet aggregation alter capillary blood flow due increased sympathetic activity widespread microendothelial damage resulting blood coagulability <NUMBER> covid<NUMBER> patients remain prolonged state hypoxia production erythropoietin may increase causing secondary polycythemia increased hematocrit levels increased blood viscosity slowing blood flow <NUMBER> patients concurrently complicated risk factors cerebrovascular disease <NUMBER> making prone embolic vascular events increasing probability acute ischemic stroke covid<NUMBER> patients often present hypoxemia due respiratory dysfunction <NUMBER> features sever patients acute respiratory distress syndrome <NUMBER> bodily oxygen content changes brain first organ affected <NUMBER> resulting series pathophysiological changes hypoxia dilate intracranial blood vessels increase intracranial blood flow cerebral capillary pressure tissue fluid production brain free radicals membrane lipid peroxidation endogenous inhibitors effects may impact cell energy metabolism <NUMBER> <NUMBER> anaerobic glycolysis brain produces increased lactic acid oxygen free radicals lipid peroxides weakened antioxidant system bloodbrain barrier dysfunction <NUMBER> metabolic acidosis caused hypoxia increases cerebral vasospasm permeability leading interstitial brain edema intracranial hypertension <NUMBER> decreased atp production caused hypoxia initiates injury cascade encompassing intracellular ca <NUMBER> overload glutamate excitotoxicity oxidonitrosative stress culminating neuronal astroglial necrosis apoptosis neurocognitive deficits <NUMBER> diagnosis confirmed case based suspected cases provide one following pathogenic serological evidence <NUMBER> realtime reverse transcriptasepolymerase chain reaction rrtpcr sarscov<NUMBER> <NUMBER> genome sequencing coronavirus showed highly homogeneity sarscov<NUMBER> <NUMBER> positive specific igm antibody igg antibody sarscov<NUMBER> serum test sarscov<NUMBER> specific igg antibody changes negative positive titer rising ≥<NUMBER> times recovery phase acute phase <NUMBER> prevention present lack effective treatments covid<NUMBER> virus infection clinical research underway effective therapeutic effective immediate action involves scientific prevention isolation people ages resistant novel coronavirus may infected transmission conditions satisfied however elderly individuals cerebrovascular diseases risk therefore prevention control populations particularly important presently effective way treat disease control source infection use personal protective measures reduce risk transmission protect vulnerable groups suggested elderly individuals cerebrovascular diseases reduce outdoor activities ensure good personal protection hygiene maintain good living habits take initiative monitor health individuals family members ventilate disinfect rooms frequently take medicine regularly eat healthily maintain positive mindset symptoms fever cough sore throat chest tightness muscle soreness present individuals undergo timely diagnosis isolation treatment treating nursing patients medical staff closer contact patients hence higher risk infection among <NUMBER> consecutive patients admitted zhongnan hospital wuhan university january <NUMBER> <NUMBER> proportion medical staff high <NUMBER> <NUMBER> retrospective analysis <NUMBER> patients diagnosed covid<NUMBER> <NUMBER> hospitals <NUMBER> provinces revealed proportion medical staff <NUMBER> <NUMBER> providing medical services diagnosed patients individuals suspected infection medical staff wear goggles protective clothing additional protective measures strengthen protection prevent crossinfection <NUMBER> <NUMBER> treatment currently lack specific antiviral drugs novel coronavirus clinically patients mainly treated empirical antiviral antiinfective glucocorticoid drugs andor supportive care critically ill patients <NUMBER> <NUMBER> nevert heless none approaches resulted curative effects therefore covid<NUMBER> patients cerebrovascular diseases personalized medication used according individual factors patients addition covid<NUMBER> symptoms necessary concurrently strengthen treatments basic cerebrovascular diseases effectively reduce covid<NUMBER>associated mortality improve prognosis main treatment principle cerebrovascular disease treat reversible etiology control risk factors reduce complications general treatment includes bed rest monitoring vital signs finger oxygen saturation symptomatic support treatment maintaining water electrolytes acidbase balance stability internal environment negative psychological impact quarantine evident <NUMBER> psychological support may conducive symptom improvement disease antiviral therapies <NUMBER> interferonalpha <NUMBER> million u per dose equivalent adults <NUMBER> ml sterilized water injection twice day nebulized inhalation lopinavirritonavir two tablets per administration twice day <NUMBER> days ribavirin recommended combination interferon lopinavirritonavir <NUMBER> mg adults two three times day intravenous infusion course treatment <NUMBER> days chloroquine phosphate <NUMBER> mg twice day adults <NUMBER> days abidol <NUMBER> mg three times day adults <NUMBER> days indicated nevertheless recommended use three antiviral drugs concurrently use related drugs stopped intolerable side effects experienced convalescent plasma therapy suitable patients rapid progression severe critical illness shufeng jiedu capsule sfjdc traditional chinese medicine may also improve condition <NUMBER> <NUMBER> recently retrospective study influenza sars mers published lancet reported use glucocorticoids patients sars mers viral infection improve prognosis caused problems delayed cure secondary infections osteoporosis therefore recommended glucocorticoids used treatment new coronary pneumonia <NUMBER> redaciclovir holds potential treatment <NUMBER>ncov present <NUMBER> results animal experiments demonstrated compared control treatment redaciclovir effectively reduced viral titer lung tissue merscovinfected mice improved lung tissue injury curative effects superior lopinavirritonavir combined interferonβ treatment first case novel coronavirus diagnosed united states entering critical state symptoms dyspnea significantly improved use redcevir oxygen therapy longer required however research development companies physicians state effectiveness safety drug proven clinical research needed drug currently clinical trials <NUMBER> china anticoagulant therapy recommended secondary prevention stroke patients acute cerebrovascular disease abnormal increase ddimer treatment patients admitted isolation ward infection department concurrent rounds neurologists isolation ward occur daily assist doctors patient management covid<NUMBER> may cause respiratory diseases well primary secondary nervous system diseases present neurological symptoms reported covid<NUMBER> patients acute cerebrovascular symptoms sudden speech confusion limb paralysis symptoms intracranial infection headache epilepsy disturbance consciousness symptoms muscle damage soreness weakness limbs occasionally symptoms neuralgia abnormal sensation period high incidence covid<NUMBER> neurologists need pay attention patient population especially patients nervous system symptoms indeed differential diagnosis covid<NUMBER> early detection diagnosis treatment prevention countermeasures warranted spread severe acute respiratory syndrome coronavirus<NUMBER> sarscov<NUMBER> already taken pandemic proportions infected <NUMBER> <NUMBER> people <NUMBER> countries <NUMBER> although major current focus public health authorities develop coordinated global response prepare health systems meet unprecedented challenge corollary concern identified particular interest clinicians investigators major interest hypertension hypertension coronary heart disease diabetes mellitus particularly elderly people increase susceptibility sarscov<NUMBER> infection <NUMBER> <NUMBER> <NUMBER> given ace<NUMBER> angiotensinconverting enzyme <NUMBER> receptor allows coronavirus entry cells idea come preexisting use reninangiotensin system ras blockers might increase risk developing severe fatal sarscov<NUMBER> infection <NUMBER> commentary discusses concern concludes based current evidence reason abandon ras blockers patients receiving important class antihypertensive agents concerns either increased risk contracting sarscov<NUMBER> worsening course <NUMBER> li et al <NUMBER> demonstrated ace<NUMBER> receptor responsible sars coronavirus entry binding ace<NUMBER> receptor requires surface unit viral spike protein s<NUMBER> figure <NUMBER> <NUMBER> subsequent cell entry relies priming serine protease tmprss<NUMBER> transmembrane protease serine <NUMBER> <NUMBER> two recent reports confirmed sarscov<NUMBER> also enters cell via route <NUMBER> <NUMBER> importantly sarscov<NUMBER> entry cell could blocked sprotein neutralizing antibodies tmprss<NUMBER> inhibitors camostat mesylate <NUMBER> lung ace<NUMBER> expression occurs type <NUMBER> pneumocytes macrophages generally however pulmonary ace<NUMBER> expression review low compared organs like intestine testis heart kidney <NUMBER> <NUMBER> <NUMBER> ace<NUMBER> ras ace<NUMBER> displays considerable homology ace angiotensinconverting enzyme <NUMBER> identity <NUMBER> similarity basis received name <NUMBER> <NUMBER> monocarboxypeptidase hydrolyzes multiple peptides including apelin opioids kinins angiotensins much work ace<NUMBER> centered biologic effects related formation angiotensin<NUMBER> angiotensin ii <NUMBER> <NUMBER> unlike ace ace<NUMBER> convert angiotensin angiotensin ii ace inhibitors block activity surprising homology concern active site ace<NUMBER> potent <NUMBER> enzymes known convert vasoconstrictor angiotensin ii angiotensin<NUMBER> <NUMBER> angiotensin<NUMBER> increasingly recognized organprotective properties oppose counterbalance angiotensin ii within ras known target peptide ace<NUMBER> cleavage angiotensin subsequent formation angiotensin<NUMBER> figure ace<NUMBER> membranebound enzyme soluble levels blood low <NUMBER> <NUMBER> cleavage membraneanchor shedding adam<NUMBER> disintegrin metalloprotease <NUMBER> figure underlies occurrence body fluids angiotensin ii via <NUMBER> angiotensin ii type <NUMBER> receptor upregulates adam<NUMBER> thus increasing soluble ace<NUMBER> levels <NUMBER> urine soluble ace<NUMBER> levels significant likely originate shedding proximal tubular membrane pathological states shedding ace<NUMBER> often increased resulting elevated soluble ace<NUMBER> levels blood urine body fluids <NUMBER> <NUMBER> indeed doubling soluble ace<NUMBER> reported cerebrospinal fluid hypertensive patients <NUMBER> however given far majority ace<NUMBER> membranebound even doubling unlikely significantly alter amount membranebound ace<NUMBER> instance <NUMBER> ace<NUMBER> occurs soluble form doubling would increase <NUMBER> still <NUMBER> ace<NUMBER> membranebound theoretically ras blockade might partly reverse thus returning percent membranebound ace<NUMBER> <NUMBER> unlikely seriously affect sarscov<NUMBER> entry depends membranebound fulllength ace<NUMBER> really crux question prevailing confusion panic witnessing medical community word came ace<NUMBER> receptor sarscov<NUMBER> part confusion social media public general stands times ace inhibitors confused ace<NUMBER> inhibitors <NUMBER> different enzymes <NUMBER> different active sites effect ace inhibitors ace<NUMBER> activity must therefore indirect one via respective substrates unlikely relationship sarscov<NUMBER> binding however limited reports ace inhibitors affect expression ace<NUMBER> heart kidney <NUMBER> <NUMBER> receptor blockers arbs alter ace<NUMBER> expression consistently several studies mrna protein level <NUMBER> <NUMBER> <NUMBER> upregulation best documented cardiac tissue renal vasculature yet even results diverse required high doses often differed per arb per organ given relationship adam<NUMBER> clear distinction made membranebound soluble ace<NUMBER> overview connections reninangiotensin system blockers ace<NUMBER> angiotensinconverting enzyme <NUMBER> coronavirus carboxypeptidase ace<NUMBER> converts ang ii angiotensin ii ang<NUMBER> ang ang<NUMBER> yet blocked ace angiotensinconverting enzyme inhibitors prevent conversion ang ang ii ace<NUMBER> also binds internalizes sarscov<NUMBER> severe acute respiratory syndrome coronavirus<NUMBER> b priming serine protease tmprss<NUMBER> transmembrane protease serine <NUMBER> shedding membranebound ace<NUMBER> disintegrin metalloprotease <NUMBER> adam<NUMBER> results occurrence soluble ace<NUMBER> longer mediate sarscov<NUMBER> entry might even prevent entry keeping virus solution <NUMBER> r ang ii via type <NUMBER> receptor upregulates adam<NUMBER> <NUMBER> r blockers arbs would prevent increase soluble ace<NUMBER> anything might imply decrease membranebound ace<NUMBER> measuring membranebound ace<NUMBER> vivo technically challenging publications humans reported levels ace<NUMBER> activity blood reflect soluble ace<NUMBER> protein circulating low levels <NUMBER> arbs drug class would truly upregulate membranebound ace<NUMBER> reasonable first assume <NUMBER> receptor blockade agreement assumption angiotensin ii acutely induced ace<NUMBER> internalization via <NUMBER> receptor ace<NUMBER>transfected neuroblastoma cells <NUMBER> ace inhibitors directional effect arbs although drugs limited data showing upregulation ace<NUMBER> esler esler <NUMBER> suggested difference due increased levels angiotensin ii occurring arb treatment ace inhibition high angiotensin ii levels would impose increased substrate load enzyme thus requiring upregulation stressed carboxypeptidase ace<NUMBER> multiple substrates alteration level one substrates angiotensin ii occurring fmolml levels ie many orders magnitude actual ace<NUMBER> concentration cannot possibly make meaningful difference substrate load taken together evidence animal studies arbs may upregulate membranebound ace<NUMBER> whereas ace inhibitors may current data however often conflicting vary arbs tissue eg heart versus kidney even reported upregulation tissue ace<NUMBER> arbs animal studies generally high doses could extrapolated humans would establish sufficient facilitate sarscov<NUMBER> entry like point potentially beneficial pulmonary effect arbs needs considered well acute lung injury alveolar ace<NUMBER> appears downregulated <NUMBER> <NUMBER> would decrease angiotensin ii metabolism thus resulting higher local levels peptide increases alveolar permeability fosters lung injury context one speculate increased ace<NUMBER> expression preexisting arbs treatment may actually protective course sarscov<NUMBER> infection clear hypertension coded recent sarscov<NUMBER> report <NUMBER> speculate might based use hypertension medication rather actual blood pressure measurement truly address whether patients hypertension likely get serious fatal sarscov<NUMBER> infections prospective cohort study incidence rates sarscov<NUMBER> infection cohort patients hypertension patients without hypertension required similar exposure history instead reported history hypertension versus sarscov<NUMBER> patients without adjustment eg age use ras blockers causal link assumption lacks evidence discussed therefore strongly recommend patients taking ace inhibitors arbs high blood pressure heart failure medical indications withdraw current treatment regimens unless specifically advised physician healthcare provider additional caveat resulting destabilizing blood pressure control hypertension might possibly occur medication changes would carry unacceptable risks precipitating strokes heart attacks risks clearly hypothetical simply discontinuing antihypertensive agents strongly discouraged option considering widespread use ras blockers throughout world particular asian people seem prone cough therefore arbs may preferable <NUMBER> available clinical database pandemic date insufficient provide sufficient detail variables interest hypertension diagnosis antihypertensive drugs prescribed test hypotheses proposed provide certitude hence information desperately needed although therapy currently established sarscov<NUMBER> patients field moving rapidly potential approaches considered include broad spectrum antivirals favipiravir remdesivir <NUMBER> tmprss<NUMBER> inhibition camostat mesylate <NUMBER> adam<NUMBER> upregulation specific approach might using soluble recombinant ace<NUMBER> protein intercept virus binding fulllength ace<NUMBER> anchored cell plasma membrane <NUMBER> approaches make sense treatment patients high risk acute respiratory distress syndrome preventive purposes goal course development sarscov<NUMBER> vaccine closing see reason abandon discontinue temporarily use ras blockers preventatively sarscov<NUMBER> patients <NUMBER> concerns agents particularly arbs affect expression ace<NUMBER> based animal models however challenged coronavirus infection evaluate impact ras blocker therapy since information lacking see rationale panic alter prescription critically important class antihypertensives therapeutic benefit opinion outweighs potential risk predisposing corona infection moreover unknown whether alternative antihypertensives carry risk another question infected individuals risk progress endstage renal disease decision based clinical judgment considering pros cons ras blockade acutely ill presence absence hypotension kidney function • ace<NUMBER> angiotensinconverting enzyme <NUMBER> receptor allows coronavirus entry cells • ace<NUMBER> fulllength form membranebound enzyme whereas shorter soluble form circulates blood low levels • ace inhibitors inhibit ace<NUMBER> ace ace<NUMBER> different enzymes • although angiotensin ii type <NUMBER> receptor blockers suggested upregulate ace<NUMBER> evidence fully consistent differs per angiotensin ii type <NUMBER> receptor blocker per organ • data supporting ace inhibitors angiotensin ii type <NUMBER> receptor blockers facilitate coronavirus entry increasing ace<NUMBER> expression • animal data support potential protective pulmonary cardiovascular effects elevated ace<NUMBER> expression • treatment ras blockers discontinued concerns coronavirus infection based currently available evidence ruan q <NUMBER> china <NUMBER> overlapping publication du r <NUMBER> china <NUMBER> overlapping publication chen <NUMBER> china <NUMBER> overlapping publication impact cardiovascular disease cardiac injury inhospital mortality patients covid<NUMBER> systematic review metaanalysis past two decades pandemic severe acute respiratory syndrome sars <NUMBER> middle east respiratory syndrome mers <NUMBER> taken severe death tolls worldwide <NUMBER> <NUMBER> deaths respectively <NUMBER> late <NUMBER> another virus lethal respiratory infection potential identified severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> emerged heralded another global pandemic <NUMBER> since outbreak wuhan <NUMBER> countries regions reported confirmed cases coined covid<NUMBER> describe coronavirus disease <NUMBER> declared outbreak public health emergency international concern <NUMBER> <NUMBER> april <NUMBER> nearly <NUMBER> <NUMBER> <NUMBER> infections <NUMBER> <NUMBER> deaths worldwide within less <NUMBER> months covid<NUMBER> registered mortality record higher sars mers combined <NUMBER> <NUMBER> overwhelming fatality cases caused covid<NUMBER> much concern raised determine risk factors poor prognosis advanced age male sex <NUMBER> <NUMBER> previous research reported patients underlying cardiovascular disease cvd prone viral infection also greater risk developing severe cases admitted intensive care unit <NUMBER> <NUMBER> sarscov<NUMBER> attack respiratory system targeting ace<NUMBER> however high tissuespecificity ace<NUMBER> expression cardiovascular system cardiomyocytes may particularly prone damage <NUMBER> several studies reported high incidence elevated cardiac troponin hospitalised patients especially critical conditions <NUMBER> <NUMBER> thus patients cvd complications may poor prognosis infected sarscov<NUMBER> therefore conducted systematic review metaanalysis available evidence evaluate association underlying cvd incident cardiac injury inhospital mortality risk patients covid<NUMBER> metaanalysis conducted accordance preferred reporting items systematic reviews metaanalyses statement <NUMBER> meta analysis observational studies epidemiology statement <NUMBER> comprehensive search performed pubmed embase web science databases <NUMBER> january <NUMBER> <NUMBER> april <NUMBER> following search terms included coronavirus covid<NUMBER> <NUMBER>ncov sarscov<NUMBER> cardiovascular disease coronary heart disease hypertension cardiac injury myocardia injury mortality death fatality addition reference lists relevant articles reviewed potential studies studies included metaanalysis met following criteria <NUMBER> exposure factor cvd coronary heart disease cardiac disease healthcare delivery economics global health figure <NUMBER> preferred reporting items systematic reviews metaanalyses flow diagram study selection chronic cardiac disease hypertension acute cardiac injury <NUMBER> outcome interest inhospital mortality <NUMBER> study population adult patients confirmed sarscov<NUMBER> infection avoid duplication contacted authors whose studies conducted hospital batch patients enrolled specific information identifying patients could provided study largest sample size included two researchers xl bg independently screened search results titles abstracts potentially relevant studies retrieved full texts evaluation two authors xl bg independently identified eligible studies based inclusion criteria disagreements resolved discussion another researcher ts two researchers xl bg independently extracted data enrolled studies via preset standardised form following information extracted first author publication year study design location patients enrolled period age sex prevalence comorbidities exposure factors level adjustment newcastleottawa scale terms <NUMBER> total score nine stars applied evaluate quality case series studies cohort studies separately studies <NUMBER> points considered high quality analyses performed using stata v<NUMBER> software unadjusted ors <NUMBER> cis calculated common risk estimates pooled due limited data multivariable adjusted outcomes heterogeneity among studies evaluated cochrans qstatistic <NUMBER> test <NUMBER> ≤<NUMBER> fixed effects model adopted otherwise random effects model applied metaanalysis metaregression analysis performed test potential sources heterogeneity among studies sensitivity analyses also performed omitting one study time evaluate influence individual study pooled results publication bias evaluated visual inspection asymmetry funnel plots patients public involved design conduct reporting dissemination plans research initial database search yielded <NUMBER> studies figure <NUMBER> removing duplicate publications <NUMBER> studies left screened title abstract identified <NUMBER> articles fulltext review <NUMBER> studies excluded due relevant outcome exposure interest duplicated publication primary study medical intervention study online supplementary file <NUMBER> additional studies met inclusion criteria screening reference lists several studies published institution authors contacted ensure overlapping cohorts analysed separate studies altogether <NUMBER> studies comprising <NUMBER> patients included metaanalysis <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> main characteristics included studies summarised table <NUMBER> <NUMBER> studies two case series design <NUMBER> <NUMBER> remaining eight cohort studies <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> studies conducted wuhan china except one study enrolled patients nationwide <NUMBER> patients accrued end december <NUMBER> february <NUMBER> mean age ranged <NUMBER> years old <NUMBER> <NUMBER> <NUMBER> years old proportion male patients ranged <NUMBER> <NUMBER> <NUMBER> <NUMBER> prevalence cvd hypertension ranged <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> respectively <NUMBER> <NUMBER> <NUMBER> <NUMBER> patients experienced cardiac injury hospitalisation table <NUMBER> eight studies <NUMBER> <NUMBER> <NUMBER> reported relationship underlying cvd inhospital mortality risk <NUMBER> patients <NUMBER> deaths unadjusted model five studies <NUMBER> <NUMBER> <NUMBER> consistently revealed significantly higher death risk cvd group remaining three studies <NUMBER> <NUMBER> <NUMBER> reported significant relationship cvd inhospital mortality figure <NUMBER> overall summary estimate demonstrated patients cvd approximately fivefold higher risk mortality compared noncvd patients unadjusted <NUMBER> p<NUMBER> <NUMBER> ci <NUMBER> <NUMBER> heterogeneity across studies nonsignificant <NUMBER> <NUMBER> p<NUMBER> seven studies <NUMBER> <NUMBER> <NUMBER> patients <NUMBER> deaths included preexisting hypertension inhospital mortality analysis unadjusted ors six studies <NUMBER> <NUMBER> reported significantly higher mortality risk patients previous hypertension remaining study <NUMBER> showed significant association figure <NUMBER> pooled unadjusted effect hypertension mortality risk <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p<NUMBER> moderate heterogeneity <NUMBER> <NUMBER> p<NUMBER> cardiac injury eight studies <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> patients <NUMBER> deaths except one <NUMBER> reported acute cardiac injury significantly associated high mortality risk unadjusted model figure <NUMBER> pooled effect studies unadjusted <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p<NUMBER> heterogeneity <NUMBER> <NUMBER> p<NUMBER> showed patients elevated troponin levels significant higher mortality risk normal troponin levels visual inspection funnel plots show significant asymmetry online supplementary file <NUMBER> sensitivity analyses conducted systematically excluding one study time results remained consistent primary analyses online supplementary file <NUMBER> explore potential sources heterogeneity metaregression applied test influence study design sample size mean age male proportion none factors contributed significantly observed heterogeneity online supplementary file <NUMBER> study evaluated impact underlying cvd hypertension acute cardiac injury inhospital mortality patients covid<NUMBER> results showed positive association previous cvd hypertension fatal outcomes unadjusted ors <NUMBER> cis <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> significant relationship acute cardiac injury inhospital mortality unadjusted <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> novel coronavirus <NUMBER>ncov singlestrand rna virus shares several similarities sarscov merscov genetic sequencing clinical presentation equipped robust capacity humantohuman transmission <NUMBER> <NUMBER> outset capacity <NUMBER>ncov spread infect people wuhan china alarming infection rippled throughout rest world causing severe morbidity mortality <NUMBER> therefore pressing need identify risk factors poor prognosis among patients covid<NUMBER> patients cardiovascular comorbidities found vulnerable coronavirus infection may poor prognoses <NUMBER> previous metaanalyses systematically tested relationship cvd severity disease nonuniform definitions clinical outcome <NUMBER> <NUMBER> metaanalysis zuin et al <NUMBER> included three studies reported positive association hypertension mortality risk patients covid<NUMBER> study reinforced conclusion found patients cvd history also almost fivefold higher risk mortality comparing noncvd patients however since results obtained using unadjusted ors exact role cvd risk stratification patients already known subject ► previous studies showed covid<NUMBER> patients preexisting cardiovascular disease cvd likely admitted intensive care unit inhospital cardiac injury commonly seen critically ill patients however relationship cvd cardiac injury fatal outcomes fully elucidated might study add ► systematic review metaanalysis found inhospital morality risk significantly higher covid<NUMBER> patients underlying cvd hypertension patients acute cardiac injury worse prognosis might impact clinical practice ► among patients covid<NUMBER> established cardiovascular comorbidities acute myocardial injury recognised earlier aggressive treatment may warranted elevated troponin may considered important predictor mortality risk covid<NUMBER> still undetermined may several mechanisms account high mortality risk covid<NUMBER> patients cvd history first patients underlying cvd likely decline unstable haemodynamic status infected <NUMBER>ncov <NUMBER> severe pneumonia places considerable workload cardiac ventricles may exacerbate preexisting left ventricular dysfunction even causing cardiogenic shock <NUMBER> second inflammatory reactions caused <NUMBER>ncov infection might convert chronic coronary artery disease acute coronary syndrome <NUMBER> <NUMBER> profound systemic inflammation wave along local inflammatory infiltration may lead hypercoagulative state atherosclerotic plaque rupture may culminate thrombotic events <NUMBER> third priority treatments favour limiting nosocomial viral transmission neglecting medical issues might predispose cvd patients unfavourable clinical outcomes current interim guidelines suggest patients stsegment elevation myocardial infarction consider thrombolysis first covid<NUMBER> era <NUMBER> severe adverse effects cerebral haemorrhage insufficient undesignated coronary revascularisation caused thrombolysis increase risk death acute cardiac injury commonly recorded patients covid<NUMBER> <NUMBER> incidence cardiac injury among enrolled studies ranged <NUMBER> <NUMBER> higher prevalence cvd <NUMBER> suggested <NUMBER>ncov might attack cardiomyocytes different pathways exacerbating already compromised cardiovascular system <NUMBER>ncov infection may lead cardiac injury secondary conditions causing oxygen supplement insufficiency severe pneumonia anaemia hypotension bradycardia furthermore attacking myocardium via highly expressed ace<NUMBER> directly <NUMBER>ncov precipitated release cytokine chemokine waves caused myocardial inflammation even leading fulminant myocarditis severe cases <NUMBER> <NUMBER> meanwhile results complied guo et al <NUMBER> reported death risk cardiac injury much higher preexisting cvd study revealed patients copresence cvd cardiac injury registered highest mortality rate <NUMBER> underlying cvd relatively favourable prognosis mortality rate <NUMBER> furthermore elevated troponin reported associated high risk acute respiratory distress syndrome hepatic dysfunction acute renal injury patients covid<NUMBER> <NUMBER> <NUMBER> study shi et al <NUMBER> demonstrated elevated troponin independent risk factor death adjusting confounders <NUMBER> thus index may considered biomarker predict mortality risk patients covid<NUMBER> studies warranted confirm finding provide probable suggestions risk stratification patients covid<NUMBER> best knowledge study first systematic review metaanalysis investigate association underlying cvd acute cardiac injury mortality risk patients covid<NUMBER> metaanalysis may provide insights prognosis stratification patients covid<NUMBER> however important limitations mentioned first metaanalysis conducted unadjusted ors due limited data multivariableadjusted outcomes observed association cvd cardiac injury mortality might confounded risk factors advanced age cofounder adjustment may distort metaanalysis results towards less significant risk thus large cohort studies multivariate analysis needed provide evidence issue second study could determine causal effects cardiovascular comorbidities mortality due inherent limitations observational studies future studies aiming investigate causal association warranted third heterogeneity among studies cardiac injury significantly high may caused study design patient inclusion criteria however metaregression exploring potential sources find significant results results remained consistent sensitivity analyses finally studies enrolled conducted wuhan china therefore results treated caution extrapolated populations since wuhan initial epicentre outbreak early evidence may provide clinical implications insights researchers clinicians parts world covid<NUMBER> patients underlying cardiovascular comorbidities including cvd hypertension may face greater risk fatal outcomes acute cardiac injury may act marker inhospital mortality risk given unadjusted results metaanalysis future welldesigned studies multivariate analysis warranted confirm findings dear sir today’s reports global number confirmed cases covid<NUMBER> surpassed <NUMBER> number known cases increasing several thousand every day march <NUMBER> <NUMBER> publicly characterized covid<NUMBER> pandemic issue serious concern deserves momentous attention coronaviruses family viruses cause respiratory illnesses cause illness animals seven known types coronaviruses cause illness humans coronavirus sarscov<NUMBER> severe acute respiratory syndromecoronavirus<NUMBER> one viruses – causes illness currently known coronavirus disease<NUMBER> covid<NUMBER> though still learning exactly puts someone greater risk developing severe illness covid<NUMBER> early information indicates older patients chronic medical conditions hypertension diabetes cardiocerebrovascular diseases may higher risk <NUMBER> <NUMBER> <NUMBER> infection caused covid<NUMBER> likely disturb metabolic regulation diabetic patients covid<NUMBER> may face altered immune response background already compromised health status owing diabetesrelated complications andor aging important findings patients hyperglycemia viral infection significant worsening symptoms implies greater morbidity patients compared without diabetes <NUMBER> however pathophysiology association remains uncertain known whether hyperglycemia changes virulence infection virus modifies glycemic metabolism know diabetic patients susceptible infection impact glucose metabolism <NUMBER> dm disorder glucose metabolism chronic inflammatory condition characterized multiple changes lipid carbohydrate protein profiles <NUMBER> inflammatory processes due hyperglycemia leads increased synthesis glycosylation end products ages activates macrophages cells immune system increase oxidative stress promote synthesis proinflammatory cytokines besides stimulating synthesis adhesion molecules facilitate inflammation tissues <NUMBER> inflammatory process complications might provide higher propensity infections greater severity conditions another important issue inflammatory immune response occur diabetic patients acquire viral infection well whether virus interferes insulin secretion glycemic control stage biological mechanism relationship covid<NUMBER> diabetes known association severity cases death pronounced need develop hypothesis explain causal path underlying severe clinical presentation covid<NUMBER> infection subsequent death diabetic patients biochemical tests also essential clarify molecular pathophysiology involved association covid<NUMBER> dm substantial public health importance deserves proper attention since large diverse population affected globally nowadays comorbidity poses relevant threat human health prospective welldesigned studies elucidate biological mechanism best clinical management association urgently neededhomephilipphiliphomenewcastleacuktranslational clinical research institute medical school framlington place newcastle upon tyne ne<NUMBER> <NUMBER>hu ukdear sirit useful see review published journal diabetes covid <NUMBER> infection <NUMBER> highlight people diabetes death rate perhaps around four times background population note suggested <NUMBER> deaths chinawuhan people diabetes <NUMBER> clearly important understand whythere confounders form associations risk factors dying covid<NUMBER> infection notably age cardiovascular disease cannot explain excess need understand better mitigate riskit reported deaths occurring context pneumonitis <NUMBER> particularly onset adult respiratory distress syndrome ards condition excess fluid alveoli blocks gas exchange air bloodpeople diabetes many cardiovascular disease cvd without diabetes permeable vasculature identified since <NUMBER>s albumin lead kidneys micro macroalbuminuria even prior late blush retina intravenous fluorescence marker injection <NUMBER> leaky vasculature associated vascular inflammation metabolic syndrome steatohepatitis well cvd per seit would seem far stretch absence research yet assume prior enhancement vascular permeability could account increased rate ards death people diabetes particularly type <NUMBER> diabetes also cvdaside research would suggest already albuminuria routine yearly test people diabetes higher liver enzyme markers alt perhaps diabetes associated dyslipidaemia low hdl cholesterol take particular steps selfisolateit unclear fast vascular inflammation ameliorated improved blood glucose control nearly glucoselowering medications reduce microalbuminuria time tight glucose control infected persons insulin would meanwhile seem sensible poor glucose control known interfere leukocytelymphocyte function <NUMBER>yours sincerelyphilip hometranslational clinical research institute newcastle university ukreferences<NUMBER>guptarghoshasinghakmisraaclinical considerations patients diabetes times covid<NUMBER>diabetes metabolic syndr clin res rev<NUMBER>e<NUMBER>joint commission report whochina joint mission coronavirus disease <NUMBER> covid<NUMBER> <NUMBER> february <NUMBER> available httpswwwwhointdocsdefaultsourcecoronavirusewhochinajointmissiononcovid<NUMBER>finalreportpdf accessed <NUMBER> march <NUMBER>the novel coronavirus pneumonia emergency response epidemiology team epidemiological characteristics outbreak <NUMBER> novel coronavirus diseases covid<NUMBER> — china <NUMBER> china cdc weekly <NUMBER> <NUMBER>x <NUMBER> available httpsgithubcomcmriversncovblobmastercovid<NUMBER>pdf china cvd weekly accessed <NUMBER> march <NUMBER>raskmadsenckingglvascular complications diabetes mechanisms injury protective factorscell metab<NUMBER>pozzilli p signore e leslie rdg infections immunity diabetes alberti kgmm zimmet p defronzo ra ed international textbook diabetes second edition chichester john wiley <NUMBER> <NUMBER> guptariteshfortis cdoc hospital chirag enclaverenin angiotensin system blockade covid<NUMBER> diseasedear editorwe recently published article highlighting special concerns managing patients diabetes times covid<NUMBER> pandemic<NUMBER> concerns use angiotensin converting enzyme ace inhibitors angiotensin receptor blockers arbs clarified publication<NUMBER> summarising current evidence regard try arrive reasonable conclusionin absence vaccine antiviral drug covid<NUMBER> infection several therapeutic approaches studied one approach use inhibitors renin angiotensin system namely ace inhibitors arbs hand concern raised fact patients agents might increased risk infection severe acute respiratory syndrome coronavirus<NUMBER> sars cov<NUMBER>angiotensin converting enzyme<NUMBER> ace<NUMBER> receptor sars cov<NUMBER> well coronaviruses expressed type <NUMBER> alveolar epithelial cells endothelium sglycoprotein surface coronavirus binds ace<NUMBER> leads conformational change sglycoprotein allows proteolytic digestion host cell proteases tmprss<NUMBER> ultimately leading internalization virion<NUMBER> viral sglycoprotein tmprss<NUMBER> ace<NUMBER> inhibition potential targets therapy possibly vaccine developmentas ace<NUMBER> essential coronavirus infection blockade thought beneficial preventingtreating infection retrospective analysis found reduced rates death endotracheal intubation patients viral pneumonia continued ace inhibitors<NUMBER> mice coronavirus induced lung injury showed improvement treated losartan<NUMBER> far cvid<NUMBER> infection concerned data ras activation effect blockade limited present hypokalaemia could marker ras activation high incidence hypokalaemia reported patients covid<NUMBER> infection<NUMBER>despite small studies suggesting benefit drugs acting ras data albeit scarce animal models human studies treatment ace inhibitors arb could cause regulation ace<NUMBER> ibuprofen thiazolidinediones also shown same<NUMBER> <NUMBER> increased expression ace<NUMBER> could theoretically increase risk infection sars cov<NUMBER> could concern people diabetes already elevated risk infections many factors however currently evidence support hypothesis view lack robust evidence either benefit harm reasonable patients continue using ace inhibitors arb recommended european society cardiology council hypertension european society hypertension<NUMBER> <NUMBER>references<NUMBER>guptarghoshasinghakmisraaclinical considerations patients diabetes times covid<NUMBER> epidemicdiabetes metab syndr<NUMBER> mar <NUMBER>fanglkarakiulakisgrothmare patients hypertension diabetes mellitus increased risk covid<NUMBER> infectionlancet respir med<NUMBER> mar <NUMBER>s<NUMBER>hoffmannmkleineweberhkrügernmüllermdrostencpöhlmannsthe novel coronavirus <NUMBER> <NUMBER>ncov uses sarscoronavirus receptor ace<NUMBER> cellular protease tmprss<NUMBER> e ntry target cellsbiorxiv<NUMBER>henryczaizafounmstockeghamandesarroligaacwhitehdimpact angiotensinconverting enzyme inhibitors statins viral pneumoniaproc bayl univ med cent<NUMBER>yangpguhzhaozwangwcaoblaicyangxzhanglduanyzhangschenwzhenwcaimpenningerjmjiangcwangxangiotensinconverting enzyme <NUMBER> ace<NUMBER> mediates influenza h<NUMBER>n<NUMBER> virusinduced acute lung injurysci rep<NUMBER>chen li x song q hu c su f daij ye huangj zhang x hypokalemia clinical implications patients coronavirus disease <NUMBER> covid<NUMBER> medrxiv preprint doi <NUMBER>lixczhangjzhuojlthe vasoprotective axes reninangiotensin system physiological relevance therapeutic implications cardiovascular hypertensive kidney diseasespharmacol res<NUMBER>qiaowwangcchenbzhangfliuyluqguohyancsunhhugyinxibuprofen attenuates cardiac fibrosis streptozotocininduced diabetic ratscardiology<NUMBER>zhangwxuyzliubwuryangyyxiaoxqzhangxpioglitazone upregulates angiotensin converting enzyme <NUMBER> expression insulinsensitive tissues rats highfat dietinduced nonalcoholic steatohepatitisscientific world journal<NUMBER>position statement esc council hypertension aceinhibitors angiotensin receptor blockers mar <NUMBER> <NUMBER> httpswwwescardioorgcouncilscouncilonhypertensionchtnewspositionstatementoftheesccouncilonhypertensiononaceinhibitorsandang<NUMBER>esh statement covid<NUMBER> march <NUMBER> <NUMBER> httpswwweshonlineorgspotlightseshstatementoncovid<NUMBER>accessed <NUMBER> march <NUMBER> clinical considerations patients diabetes times covid<NUMBER> pandemic dear sir todays reports global number confirmed cases covid<NUMBER> surpassed <NUMBER> number known cases increasing several thousand every day march <NUMBER> <NUMBER> publicly characterized covid<NUMBER> pandemic issue serious concern deserves momentous attention coronaviruses family viruses cause respiratory illnesses cause illness animals seven known types coronaviruses cause illness humans coronavirus sarscov<NUMBER> severe acute respiratory syndromecoronavirus<NUMBER> one viruses e causes illness currently known coronavirus disease<NUMBER> covid <NUMBER> though still learning exactly puts someone greater risk developing severe illness covid<NUMBER> early information indicates older patients chronic medical conditions hypertension diabetes cardiocerebrovascular diseases may higher risk <NUMBER>e<NUMBER> infection caused covid<NUMBER> likely disturb metabolic regulation diabetic patients covid<NUMBER> may face altered immune response background already compromised health status owing diabetesrelated complications andor aging important findings patients hyperglycemia viral infection significant worsening symptoms implies greater morbidity patients compared without diabetes <NUMBER> however pathophysiology association remains uncertain known whether hyperglycemia changes virulence infection virus modifies glycemic metabolism know diabetic patients susceptible infection impact glucose metabolism <NUMBER> dm disorder glucose metabolism chronic inflammatory condition characterized multiple changes lipid carbohydrate protein profiles <NUMBER> inflammatory processes due hyperglycemia leads increased synthesis glycosylation end products ages activates macrophages cells immune system increase oxidative stress promote synthesis proinflammatory cytokines besides stimulating synthesis adhesion molecules facilitate inflammation tissues <NUMBER> inflammatory process complications might provide higher propensity infections greater severity conditions another important issue inflammatory immune response occur diabetic patients acquire viral infection well whether virus interferes insulin secretion glycemic control stage biological mechanism relationship covid<NUMBER> diabetes known association severity cases death pronounced need develop hypothesis explain causal path underlying severe clinical presentation covid<NUMBER> infection subsequent death diabetic patients biochemical tests also essential clarify molecular pathophysiology involved association covid<NUMBER> dm substantial public health importance deserves proper attention since large diverse population affected globally nowadays comorbidity poses relevant threat human health prospective welldesigned studies elucidate biological mechanism best clinical management association urgently needed useful see review published journal diabetes covid <NUMBER> infection <NUMBER> highlight people diabetes death rate perhaps around four times background population note suggested <NUMBER>e<NUMBER> deaths chinawuhan people diabetes <NUMBER> clearly important understand confounders form associations risk factors dying covid<NUMBER> infection notably age cardiovascular disease cannot explain excess need understand better mitigate risk reported deaths occurring context pneumonitis <NUMBER> <NUMBER> particularly onset adult respiratory distress syndrome ards condition excess fluid alveoli blocks gas exchange air blood people diabetes many cardiovascular disease cvd without diabetes permeable vasculature identified since <NUMBER>s albumin lead kidneys microand macroalbuminuria even prior late blush retina intravenous fluorescence marker injection <NUMBER> leaky vasculature associated vascular inflammation metabolic syndrome steatohepatitis well cvd per se would seem far stretch absence research yet assume prior enhancement vascular permeability could account increased rate ards death people diabetes particularly type <NUMBER> diabetes also cvd aside research would suggest already albuminuria routine yearly test people diabetes higher liver enzyme markers alt perhaps diabetes associated dyslipidaemia low hdl cholesterol take particular steps selfisolate unclear fast vascular inflammation ameliorated improved blood glucose control nearly glucoselowering medications reduce microalbuminuria time tight glucose control infected persons insulin would meanwhile seem sensible poor glucose control known interfere leukocytelymphocyte function <NUMBER> dear editor recently published article highlighting special concerns managing patients diabetes times covid<NUMBER> pandemic <NUMBER> concerns use angiotensin converting enzyme ace inhibitors angiotensin receptor blockers arbs clarified publication <NUMBER> summarising current evidence regard try arrive reasonable conclusion absence vaccine antiviral drug covid<NUMBER> infection several therapeutic approaches studied one approach use inhibitors renin angiotensin system namely ace inhibitors arbs hand concern raised fact patients agents might increased risk infection severe acute respiratory syndrome coronavirus<NUMBER> sars cov<NUMBER> angiotensin converting enzyme<NUMBER> ace<NUMBER> receptor sars cov<NUMBER> well coronaviruses expressed type <NUMBER> alveolar epithelial cells endothelium sglycoprotein surface coronavirus binds ace<NUMBER> leads conformational change sglycoprotein allows proteolytic digestion host cell proteases tmprss<NUMBER> ultimately leading internalization virion <NUMBER> viral sglycoprotein tmprss<NUMBER> ace<NUMBER> inhibition potential targets therapy possibly vaccine development ace<NUMBER> essential coronavirus infection blockade thought beneficial preventingtreating infection retrospective analysis found reduced rates death endotracheal intubation patients viral pneumonia continued ace inhibitors <NUMBER> mice coronavirus induced lung injury showed improvement treated losartan <NUMBER> far cvid<NUMBER> infection concerned data ras activation effect blockade limited present hypokalaemia could marker ras activation high incidence hypokalaemia reported patients covid<NUMBER> infection <NUMBER> despite small studies suggesting benefit drugs acting ras data albeit scarce animal models human studies treatment ace inhibitors arb could cause regulation ace<NUMBER> <NUMBER> ibuprofen thiazolidinediones also shown <NUMBER> <NUMBER> increased expression ace<NUMBER> could theoretically increase risk infection sars cov<NUMBER> could concern people diabetes already elevated risk infections many factors however currently evidence support hypothesis view lack robust evidence either benefit harm reasonable patients continue using ace inhibitors arb recommended european society cardiology council hypertension european society hypertension <NUMBER> <NUMBER> article explains reninangiotensin system ras interacts severe acute respiratory syndrome coronavirus sarscov also novel coronavirus sarscov<NUMBER> causes infection subsequent acute lung probably heart injury covid<NUMBER> <NUMBER> well identifying potential therapeutic strategies treating acute lung injury myocarditis covid<NUMBER> see also <NUMBER> <NUMBER> <NUMBER> article provides background management patients essential hypertension accordance recommendations made joint statement issued heart failure society america american college cardiology american heart association <NUMBER> patients using drugs block ras continue use pandemic also describes use angiotensinconverting enzyme inhibitors aceis angiotensin receptor blockers arbs associated less severe covid<NUMBER> infections <NUMBER> <NUMBER> two major arms ras one arm angiotensin ii ang iiang ii type <NUMBER> receptor <NUMBER> r pathway proinflammatory cause acute lung injury <NUMBER> <NUMBER> arm angiotensinconverting enzyme <NUMBER> ace<NUMBER>ang<NUMBER>mas receptor masr pathway antiinflammatory ace<NUMBER> metabolizes ang ii thus reducing levels converting antiinflammatory peptide ang<NUMBER> figure <NUMBER>a <NUMBER> <NUMBER> ace<NUMBER> receptor coronaviruses including sarscov<NUMBER> <NUMBER> result sarscov<NUMBER> binding ace<NUMBER> enzyme longer functional <NUMBER> thus proinflammatory ang iiat <NUMBER> r longer blocked ace<NUMBER>ang<NUMBER>masr pathway imbalance causes acute lung injury <NUMBER> multicentered double blind clinical trial recently established test efficacy treating patients suffering covid<NUMBER> arb httpsclinicaltrialsgov ct<NUMBER>shownct<NUMBER> second investigating outcomes treatment covid<NUMBER> patients aceis arbs https clinicaltrialsgovct<NUMBER>shownct<NUMBER> coronaviruses group viruses recent years caused epidemics acute respiratory syndromes first major epidemic sars severe acute respiratory syndromecov <NUMBER> responsible <NUMBER> deaths second mers middle east respiratory syndrome occurred <NUMBER> recent sarscov<NUMBER> causes covid<NUMBER> first recognized china december <NUMBER> sweeping world sarscov<NUMBER> already responsible cases infection also deaths two previous coronavirus epidemics also number coronaviruses cause upper respiratory tract infections particular hcovnl<NUMBER> sarscov sarscov<NUMBER> enter cell binding ace<NUMBER> <NUMBER> <NUMBER> hcovnl<NUMBER> <NUMBER> hcovnl<NUMBER> like sarscov<NUMBER> cause mild respiratory infections commonly affects young <NUMBER> however associated bronchiolitis croup cause acute respiratory distress syndrome ards characteristic sarscov<NUMBER> infection differences severity illness caused two viruses could related differing affinity viruses ace<NUMBER> <NUMBER> fact entry hcovnl<NUMBER> cells requires intracellular acidification sarscov entry occur independent intracellular acidification <NUMBER> merscov binds different receptor dipeptidyldipeptidase<NUMBER> dpp<NUMBER> <NUMBER> another human coronavirus hcov<NUMBER>e uses aminopeptidase n apn receptor <NUMBER> receptors membranebound proteases affect production metabolism angiotensin peptides <NUMBER> <NUMBER> zhang et al clinical study <NUMBER> patients found hypertension diabetes two common comorbidities patients covid<NUMBER> <NUMBER> increase prevalence two comorbidities patients severe disease significant compared infections severe <NUMBER> study guan et al <NUMBER> patients <NUMBER> coexisting disorder <NUMBER> reached composite endpoint admission icu use mechanical ventilation death <NUMBER> <NUMBER> hypertension <NUMBER> diabetes <NUMBER> <NUMBER> respectively patients reached composite endpoint noted hypertension diabetes common comorbidities coexisting disorders prevalent cohort considerable debate use drugs block ras treatment hypertensive patients covid<NUMBER> <NUMBER> debate adequately considered roles local pulmonary circulating rass pathogenesis covid<NUMBER> put simply ace<NUMBER> receptor entry sarscov sarscov<NUMBER> also activates ras pathway prevents acute lung injury <NUMBER> <NUMBER> ying yang actions ace<NUMBER> caused apparent dilemma concerning use ras blocking drugs treatment hypertension diabetes upregulate sarscov<NUMBER> receptor ace<NUMBER> means viral entry cells also protect tissues proinflammatory actions ang ii could effective therapeutic strategy manage covid<NUMBER> induced lung injury see also <NUMBER> <NUMBER> seems case light recent clinical studies <NUMBER> <NUMBER> figure <NUMBER>a shows major arms ras involved pathogenesis coronavirusinduced acute lung injury avoided including number ras pathways involved metabolism ang ii simplicity thorough description pathways obtained elsewhere <NUMBER> seen figure <NUMBER>b two major pathways involved pathogenesis coronavirusinduced infections pathways involve formation ang ii ang peptide produced action renin angiotensinogen octapeptide ang ii formed action angiotensin converting enzyme ace ang ang ii bind two receptors <NUMBER> r <NUMBER> r broken number proteases smaller peptides variety biological actions important pathway ang ii break via removal one amino acid cterminus zincdependent carboxy peptidase ace<NUMBER> generate peptide ang<NUMBER> acts another receptor known masr pathways also generate ang<NUMBER> <NUMBER> two ras pathways ang iiat <NUMBER> r ace<NUMBER>ang<NUMBER>masr opposing actions addition ang ii act via <NUMBER> r produce effects similar generated ace<NUMBER>ang <NUMBER>masr pathway <NUMBER> ang iiat <NUMBER> r axis wellknown responsible hypertension raises blood pressure actions brain sympathetic nervous system peripheral blood vessels causing vasoconstriction axis also controls sodium reabsorption partly actions kidney also stimulates release sodium retaining hormone aldosterone adrenal gland actions pathway proinflammatory stimulate fibrosis ace<NUMBER>ang<NUMBER>masr pathway hand lowers blood pressure possibly production nitric oxide furthermore ace<NUMBER>ang<NUMBER>masr pathway antiinflammatory thus effects angiotensin peptides proliferation angiogenesis vasoconstriction inflammation fibrosis note effects angiotensin ii via angiotensin ii type receptor <NUMBER> r blocked interaction angiotensin ii type ii receptor <NUMBER> r metabolism ang<NUMBER> acting via mas receptor masr b sarscov<NUMBER> inhibiting ace<NUMBER> blocks metabolism angiotensin ii ang<NUMBER> blocking antiinflammatory pathway causing high levels angiotensin ii angiotensin converting enzyme inhibitors aceis prevent formation angiotensin ii angiotensin receptor blocking drugs arbs prevent angiotensin ii causing inflammation fibrosis ace<NUMBER> breaks ang ii also produces vasodilator antiinflammatory molecule ang<NUMBER> <NUMBER> circulating ras endocrine system capable reaching brain heart lungs also local tissue rass many organs heart kidney female reproductive tract brain also local lung ras <NUMBER> implicated etiology pulmonary fibrosis <NUMBER> <NUMBER> combination circulating tissue systems ras powerful effects lungs renin released kidneys venous blood renal lymphatics produces ang angiotensinogen produced liver ang venous blood returning heart lungs converted lung ace ang ii thus lung exposed high levels ang ii gene ace<NUMBER> located xp<NUMBER> contains <NUMBER> exons many similar ace gene zn carboxypeptidase one catalytic site <NUMBER> homology ace ectoenzyme nterminus catalytic site facing extracellular space metabolize circulating peptides <NUMBER> ace inhibitors aceis affect activity spike protein surface sarscov<NUMBER> covid<NUMBER> mediates receptor recognition membrane fusion spike protein trimeric fusion separates s<NUMBER> s<NUMBER> subunits s<NUMBER> contains receptor binding domain directly binds catalytic site ace<NUMBER> occurs cleavage site s<NUMBER> protein develops acted host proteases resulting membrane fusion <NUMBER> protein sarscov<NUMBER> binds catalytic site ace<NUMBER> efficiently sarscov <NUMBER> unfortunately antibodies recognize sarscov receptor binding domain rbd recognize sarscov<NUMBER> rbd <NUMBER> however sera convalescent sars patients cross neutralized sarsspike protein sdriven entry cells <NUMBER> polyclonal murine antibodies directed sarscov spike protein potently inhibit sarscov<NUMBER> cell entry <NUMBER> widespread distribution ace<NUMBER> throughout body <NUMBER> including lungs <NUMBER> heart <NUMBER> <NUMBER> kidney <NUMBER> coronaviruses gain access body via respiratory tract recently shown nasal goblet cells type ii pneumocytes ileal enterocytes possess necessary combination ace<NUMBER> tmprss<NUMBER> viral entry successful <NUMBER> <NUMBER> hcovnl<NUMBER> binds human airway epithelial cells vitro <NUMBER> lung ace<NUMBER> widely distributed throughout bronchial pulmonary epithelium pulmonary capillaries <NUMBER> ace<NUMBER> protects lung proinflammatory profibrotic actions circulating ang ii metabolizing ang ii ang<NUMBER> acting via masr inhibits ang iiat <NUMBER> r proinflammatory pathways figure <NUMBER>a <NUMBER> ace<NUMBER> levels vary age highest young animals lowest older animals levels older males females <NUMBER> <NUMBER> lower respectively <NUMBER> suggests young people likely get sars coronavirus infection older people appears case hand decreased production ace<NUMBER> elderly could one reason coronaviruses cause serious complications older persons said however systematic study relationships age ace<NUMBER> expression human tissues explained may species specific differences lungs <NUMBER> <NUMBER> heart <NUMBER> <NUMBER> kidney ace<NUMBER> <NUMBER> protects proinflammatory actions ang ii acting via <NUMBER> r figure <NUMBER>b shows two sites action drugs block activity ras mediated interaction ang ii <NUMBER> r one two classes drugs commonly used clinical practice blocks activity ras blocking formation ang ii inhibits activity ace ace zn containing carboxypeptidase removes dipeptide cterminal end decapeptide ang thus generating active peptide responsible actions ras ang ii drugs block enzyme known ace inhibitors aceis direct effect activity ace<NUMBER> except limiting amount ang ii produced second group drugs known angiotensin receptor blockers arbs block interaction ang ii <NUMBER> r arbs reduce ang ii levels use drugs could result two significant consequences ii results blocking ang iis effects blood pressure sodium water balance indirectly causing positive feedback renin release high levels ang ii result increased conversion ang ii ang<NUMBER> ace<NUMBER> increased interaction ang ii <NUMBER> r means proinflammatory effects ang iiat <NUMBER> r prevented antiinflammatory effects mediated ace<NUMBER>ang<NUMBER>masr axis enhanced ang iiat <NUMBER> rs antiinflammatory effects also sustained well shown heart arbs cause upregulation ace<NUMBER> prevent ang iiat <NUMBER> r mediated reductions ace<NUMBER> activity <NUMBER> known however upregulation ace<NUMBER> occurs lungs <NUMBER> aceis block formation ang ii associated enhancement antiinflammatory effects mediated ace<NUMBER>ang<NUMBER>masr axis <NUMBER> r would upregulation ace<NUMBER> withdrawal ang iiat <NUMBER> rs proinflammatory actions lung ace<NUMBER> receptor sarscov sarscov<NUMBER> <NUMBER> <NUMBER> spike protein binds ace<NUMBER> enters cell modified serine protease tmprss<NUMBER> protease essential cell entry virus <NUMBER> binding coronaviruses ace<NUMBER> modification spike protein tmprss<NUMBER> essential infection binding sarscov spike protein ace<NUMBER> results reduced ace<NUMBER> protein levels <NUMBER> kuba et al <NUMBER> showed ace<NUMBER> knockout mice get infected sarscov get acute lung inflammation <NUMBER> thus would appear low levels pulmonary ace<NUMBER> protect coronavirus infection however sinister side effect loss pulmonary ace<NUMBER> plays critical role preventing acute lung injury xie et al suggest greater prevalence sarscov young people higher ace<NUMBER> levels <NUMBER> yet paradox young people like mammals high levels pulmonary ace<NUMBER> susceptible symptomatic infection coronaviruses prevalence infection however based appearance symptoms young disease usually mild infection rates appear low fact milder nature disease young compared old could consequence agedependent nature ace<NUMBER> expression lung see hand possible animal data ace<NUMBER> expression age misleading human studies shown older patient higher level circulating ace<NUMBER> <NUMBER> <NUMBER> stated systematic study exploring effects age ace<NUMBER> expression human tissues differences animalbased studies human data may well related short life span animals used fact housed environments protect infections pollution etc also claimed arbs stimulate expression ace<NUMBER> lung accounts higher morbidity hypertensive patients suffering covid<NUMBER> <NUMBER> stated evidence arbs effect pulmonary ace<NUMBER> arbs upregulate cardiac ace<NUMBER> ang ii levels likely elevated patients treated arb ang ii major substrate ace<NUMBER> produces ang<NUMBER> <NUMBER> might expected high levels ang ii would upregulate ace<NUMBER> however ang ii ang<NUMBER> counter regulatory actions ace<NUMBER> expression via map kinasephosphatase pathways <NUMBER> furthermore ang ii downregulates ace<NUMBER> activity cardiac myocytes fibroblasts <NUMBER> therefore overall effects arbs pulmonary ace<NUMBER> could modified counteracting effects ang <NUMBER> hypertension diabetes common comorbidities found patients suffering covid<NUMBER> one study significant difference existence either comorbidity less severe severe cases <NUMBER> however study comparing <NUMBER> patients died covid<NUMBER> infections hypertension cardiovascular disease common patients recovered <NUMBER> furthermore acute cardiac injury heart failure like acute respiratory distress syndrome respiratory failure contributed critical nature illness <NUMBER> ace<NUMBER> protects lung acute lung injury reduces levels ang ii converting ang<NUMBER> <NUMBER> imai et al <NUMBER> showed ace<NUMBER> played critical role prevention lung injury briefly induced acute lung injury mice sepsis lipopolysaccharide lps endotoxin acid aspiration treatments caused severe lung inflammation ace<NUMBER>knockout mice mitigated intraperitoneal injections recombinant human ace<NUMBER> <NUMBER> second publication <NUMBER> kuba et al <NUMBER> showed ace<NUMBER> definitive receptor sarscov loss ace<NUMBER> lung caused binding viral spike protein responsible acute lung injury caused coronavirus infections also showed would expected known actions ace<NUMBER> viral infection associated raised ang ii levels caused acute lung injury via ang iiat <NUMBER> r pathway treatment arb losartan prevented sarscovinduced lung injury <NUMBER> suggest pulmonary ace<NUMBER> plays critical role protecting lung ang iiat <NUMBER> r induced inflammation local pulmonary ras lung also major site conversion ang inactive ang ii <NUMBER> therefore loss ace<NUMBER> binding sarscov<NUMBER> exposes pulmonary epithelium locally formed ang ii also ang ii formed lung circulating ang recently sarscov<NUMBER> infected patient presented acute heart failure week experiencing flulike symptoms diagnosed acute myocarditis without interstitial pneumonitis <NUMBER> known sars binds myocardial ace<NUMBER> downregulates myocardial ace<NUMBER> protein <NUMBER> protective effects ace<NUMBER> heart welldescribed <NUMBER> <NUMBER> major metabolic pathway breakdown ang ii heart <NUMBER> ace<NUMBER> protects heart ang iiat <NUMBER> r signaling induced injury <NUMBER> summarize data described demonstrate could problem treating coronavirus infections advisable prevent viral infection reduce viral load prevention coronavirusassociated lung cardiac injury saves lives dual role ace<NUMBER> receptor virus lungs heart protector lungs heart coronavirusinduced injury led debate concerning use antihypertensive drugs inhibit ras upregulate ace<NUMBER> lung increase receptor availability therefore may increase viral load doubt however ang iiacting via <NUMBER> r causes acute lung injury probably cardiac injury ace<NUMBER>ang<NUMBER>mas receptor pathway blocked downregulation ace<NUMBER> pathway also protects forms acute lung injury well sarscov induced injury arbs would prevent downregulation pathway infection occurred ameliorate unopposed proinflammatory effects ang ii mediated via <NUMBER> r aceis hand may upregulate ace<NUMBER> would prevent ang iiinduced inhibition ace<NUMBER> activity since approved serine protease inhibitor could used block tmprss<NUMBER> possible could used treat covid<NUMBER> another potential alternative could saturate airways recombinant ace<NUMBER> soluble ace<NUMBER> viral particles mopped leaving bronchial pulmonary ace<NUMBER> intact treatment recombinant human ace<NUMBER> could added beneficial effect protecting lung lung injury major problem facing treatment coronavirusinduced lung probably cardiac injury reduced ace<NUMBER> caused virus binding ace<NUMBER> means ang ii longer metabolized ace<NUMBER> antiinflammatory ang<NUMBER> pathway lost thus lung cardiac ang iiat <NUMBER> r proinflammatory pathways activated unopposed protective arm ras suggested kuba et al <NUMBER> arbs appropriate adjunct therapy treating coronavirusinduced lung injury recent analysis clinical data patients covid<NUMBER> support use ras blocking drugs treatment infection <NUMBER> <NUMBER> alternatives suggested imai et al include injection recombinant ace<NUMBER> haschke et al <NUMBER> shown rhace<NUMBER> welltolerated healthy human subjects publication first clinical trials test efficacy arbs aceis treatment acute lung injury induced sarscov<NUMBER> welcome news drugs widely used clinically results trials support clinical data already obtained improve outcome coronavirus infections would immeasurable benefit clinical management pandemic named international committee taxonomy viruses ictv severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> novel coronavirus origin associated city wuhan hubei province china spread rapidly worldwide causing thousands deaths characterizing infection public health problem global interest <NUMBER> <NUMBER> high infectivity rate coronavirus disease <NUMBER> caused sarscov<NUMBER> reached pandemic proportions <NUMBER> according report published world health organization june <NUMBER>st number confirmed cases reaches <NUMBER> distributed <NUMBER> countries emphasis european american continents two million cases together adding around <NUMBER> infected global number covid<NUMBER> already killed <NUMBER> people worldwide especially among elderly patients individuals comorbidities currently united states us already <NUMBER> confirmed cases despite large number infected people countries like spain <NUMBER> deaths italy <NUMBER> deaths united kingdom <NUMBER> deaths presented highest mortality rate exceeding <NUMBER> <NUMBER> disease evolution symptoms vary asymptomatic patients severe cases respiratory failure lead death <NUMBER> risk factors may associated evolution disease severity study conducted us march <NUMBER> <NUMBER> patients hospitalized covid<NUMBER> fourteen states <NUMBER> total history comorbidities total <NUMBER> hypertensive <NUMBER> obese patients chronic liver diseases totaled <NUMBER> diabetics represented <NUMBER> people cardiovascular diseases <NUMBER> <NUMBER> another study conducted wuhan city china <NUMBER> patients covid<NUMBER> followed <NUMBER> comorbidities hypertension <NUMBER> diabetes <NUMBER> coronary disease <NUMBER> <NUMBER> june <NUMBER>st <NUMBER> brazil <NUMBER> confirmed cases covid<NUMBER> <NUMBER> deaths associated comorbidities heart disease common comorbidity total <NUMBER> deaths followed diabetes kidney disease neurological disease pneumopathy obesity immunosuppression asthma total <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> deaths respectively <NUMBER> context metabolic syndrome ms inserted common denominator comorbidities since defined set metabolic disorders include insulin resistance dyslipidemia central obesity hypertension risk factors development type <NUMBER> diabetes cardiovascular diseases <NUMBER> <NUMBER> <NUMBER> estimated ms affected <NUMBER> north american population <NUMBER> european population approximately <NUMBER> chinese population <NUMBER> <NUMBER> scenario relationship ms comorbidities aggravate covid<NUMBER> prognosis cannot ignored also presence different ethnicities continents places sm important risk factor covid<NUMBER> thus review aimed providing overview metabolic changes associated ms relationship development worsening sarscov<NUMBER> infection well review proposed drugs treatment patients collated discussed available evidences emerged far presence obesity diabetes cardiovascular liver disease patients covid<NUMBER> proposed therapies systematically searched pubmed google scholar databases june <NUMBER>st <NUMBER> using keywords covid<NUMBER> metabolic syndrome following terms obesity diabetes liver nafld hypertension cardiovascular disease chloroquine hydroxychloroquine antiretroviral drugs treatment coronavirus also accessed full text relevant cross references search results points obesity global epidemic estimating <NUMBER> <NUMBER> million people aged <NUMBER> years obese worldwide <NUMBER> since obesity risk factor several diseases including infectious ones data become even alarming <NUMBER> bodies obese patients constant chronic inflammation due high concentrations chemokines adipokines proinflammatory cytokines chronic inflammation causes delayed inferior immune response decreased activation macrophages infection course addition immune memory obese individuals also impaired humoral cellular weakening adaptive response immune system disease immunization patients <NUMBER> <NUMBER> <NUMBER> obesity previously identified risk factor viral infections due influence immune response <NUMBER> <NUMBER> h<NUMBER>n<NUMBER> outbreak obese patients stringent complications care needs <NUMBER> relation covid<NUMBER> research points high rate obese patients complications need hospitalization <NUMBER> study carried new york city nyc us showed among <NUMBER> patients tested positive covid<NUMBER> <NUMBER> obesity <NUMBER> total body mass index bmi <NUMBER> kgm <NUMBER> severe obesity much likely develop severe forms disease patients greater need hospitalization care intensive care unit icu <NUMBER> another study also nyc followed <NUMBER> patients covid<NUMBER> <NUMBER> <NUMBER> hospitalized observed individuals bmi <NUMBER> kgm <NUMBER> six times likely hospitalized <NUMBER> retrospective study <NUMBER> patients covid<NUMBER> conducted hospital wuhan city bmi patients critical group bmi <NUMBER> kgm <NUMBER> significantly higher noncritical group <NUMBER> patients died <NUMBER> <NUMBER> bmi <NUMBER> kgm <NUMBER> <NUMBER> view alarming number cases countries like us estimated around <NUMBER> population obese <NUMBER> europe according recent estimates obesity affects <NUMBER> <NUMBER> population <NUMBER> obesity represents serious problem related covid<NUMBER> data reflect current alarming situation faced european countries already mentioned united kingdom italy spain also us brazil whose number serious cases deaths tops global statistics pointing obesity risk factor covid<NUMBER> mortality <NUMBER> <NUMBER> diabetes seventh deadly disease worldwide approximately <NUMBER> million deaths directly <NUMBER> represents risk factor development pathologies standing disease great medical interest <NUMBER> relationship infectious diseases yet fully understood however addition suppressing patients immunity cause metabolic dysfunction directly affects homeostasis entire organism <NUMBER> study relationship diabetes morbidity mortality rate among patients sarscov observed patients known history diabetes died <NUMBER> versus <NUMBER> diabetic survivors <NUMBER> diabetes patients reported four times chance hospitalization h<NUMBER>n<NUMBER> pandemic <NUMBER> like sarscov h<NUMBER>n<NUMBER> diabetes appears comorbidity potential aggravate lead death sarscov<NUMBER> infection metaanalysis included <NUMBER> infected people wuhan hubei province china <NUMBER> diabetic patients <NUMBER> another study conducted wuhan <NUMBER> patients followed <NUMBER> died among nonsurvivors <NUMBER> diabetic <NUMBER> death rate reported chinese center disease control <NUMBER> cases <NUMBER> increased <NUMBER> analyzed diabetics patients group <NUMBER> diabetes identified second common comorbidity among cases covid<NUMBER> hypotheses raised high incidence rate diabetic patients directly linked high gene expression angiotensinconverting enzyme <NUMBER> ace<NUMBER> cells used sarscov<NUMBER> enter human cells due treatment ace inhibitors angiotensin ii typei receptor blockers arbs <NUMBER> would increase risk patients infection would also make difficult control comorbidity treatment covid<NUMBER> relationship yet fully understood studies needed confirm since drug treatment protocols diabetic patients remain metabolic dysfunction <NUMBER> hypertension appeared research various countries continents common comorbidity among infected sarscov<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> well cardiovascular diseases cvd appear risk factors severe complications covid<NUMBER> arterial hypertension heart failure arrhythmia diseases cardiovascular system generate several complications sarscov<NUMBER> infection course <NUMBER> analysis <NUMBER> patients covid<NUMBER> observed <NUMBER> patients problems hypertension coronary heart disease <NUMBER> patients developed severe forms pneumonia caused sarscov<NUMBER> <NUMBER> individuals heart disease <NUMBER> metaanalysis involving <NUMBER> patients covid<NUMBER> found patients cvd five times likely develop disease critical stage <NUMBER> data chinese center disease control prevention pointed <NUMBER> mortality rate group <NUMBER> infected covid<NUMBER> however number much higher among patients hypertension cvd reaching <NUMBER> <NUMBER> respectively <NUMBER> addition history cvd aggravating factor covid<NUMBER> development cardiovascular complications also result infection acute myocardial injury observed <NUMBER> confirmed cases disease elevation highsensitivity cardiac troponin found <NUMBER> cases troponin among patients mild symptoms infection found low concentration <NUMBER> <NUMBER> investigation <NUMBER> patients covid<NUMBER> evaluated <NUMBER> patients history cvd died <NUMBER> high troponin levels <NUMBER> high concentration ace<NUMBER> cardiac tissue pointed possible mechanism lesions since enzyme used sarscov<NUMBER> invade cell making heart favorable site viral colonization diabetes many drugs used treat hypertension act ace inhibitors arbs increasing ace<NUMBER> expression individual <NUMBER> <NUMBER> <NUMBER> highly active tissue high demand energy produced mitochondria hypoxia promoted covid<NUMBER> cause damage myocardium severe consequences infected patient <NUMBER> <NUMBER> currently cvd main cause death responsible <NUMBER> deaths <NUMBER> much reflection eating habits sedentary lifestyle modern life provided population ms contributing factor development cvd current pandemic scenario sedentary lifestyle takes toll <NUMBER> liver important organ diverse body metabolic functions damage caused hepatic tissue covid<NUMBER> observed addition pathologies affect inserted risk factors complications severe manifestations pneumonia caused novel coronavirus <NUMBER> like organs liver cells especially bile duct cells ace<NUMBER> enzyme surface placing liver tissue possible infection site virus <NUMBER> previously <NUMBER> severe acute respiratory syndrome coronaviruses sarscov outbreak studies shown direct action virus hepatocytes causing apoptosis cells inducing injury elevated serum levels proinflammatory cytokines also found patients liver damage like <NUMBER> epidemic middle east respiratory syndrome mers coronavirus merscov liver damage caused infection observed infected patients however unlike sarscov sarscov<NUMBER> merscov uses another receptor invade cell dipeptidylpeptidase iv dpp<NUMBER> widely expressed hepatocytes sarscov infection high serum levels inflammatory cytokines described patients <NUMBER> <NUMBER> current pandemic caused novel coronavirus studies already observed abnormal concentrations liver function markers study <NUMBER> patients observed patients nafld higher risk covid<NUMBER> progression <NUMBER> patients progressive condition <NUMBER> <NUMBER> nafld inflammation liver tissue resulting proinflammatory cytokines released adipose tissue becomes even aggravated pathogen presence sarscov<NUMBER> complications fully clarified potentially severe infected patient <NUMBER> observed approximately <NUMBER> <NUMBER> patients covid<NUMBER> elevated transaminases especially metabolic disorders associated obesity nonalcoholic fatty liver disease nafld <NUMBER> <NUMBER> yet clear whether liver damage primary caused directly virus inflammatory reaction secondary caused drugs used treatment hypoxia caused pneumonia however even modest changes exist certainly history preexisting liver disease tends worsen infection prognosis <NUMBER> <NUMBER> context nafld considered hepatic manifestation ms characterized deposit fat liver tissue inserted comorbidity subject detailed observation <NUMBER> prevalence estimated <NUMBER> <NUMBER> population western countries <NUMBER> <NUMBER> among asian countries significantly increased obese diabetic patients <NUMBER> researches relationship nafld covid<NUMBER> still scarce absence known effective therapy due pandemic situation recently many drugs treatment covid<NUMBER> tested drugs previously proposed treatment viral diseases including previous outbreaks coronavirus sarscov merscov began tested emphasis chloroquine hydroxychloroquine analog associated azithromycin corticosteroids antiviral medications patients <NUMBER> proposed pharmacological treatments summarized table <NUMBER> shows mechanism action adverse effects drugs experimental studies suggested chloroquine cq proven antimalarial drug inhibit replication various intracellular microorganisms including coronavirus vitro <NUMBER> <NUMBER> suggested possible inhibition sarscov<NUMBER> replication terminal glycosylation ace<NUMBER> produced pulmonary vessels inhibiting link virus receptor inhibition viral infection raising endosomal ph also reported thus interfering viruscell fusion addition observed medicine contributed prevention viral spread cell cultures <NUMBER> hydroxychloroquine hcq also increase intracellular ph inhibit lysosomal activity antigenpresenting cells process reduces cell activation differentiation expression costimulatory proteins production cytokines cytoplasm interferes synthesis viral nucleic acids attenuating proinflammatory response mechanisms strengthen hypothesis hcq suppress sarscov<NUMBER> inhibiting hyperactivation immune system triggered virus thus reducing disease progression mild severe however still without clinical evidence <NUMBER> <NUMBER> although hcq cq shown antiviral activity sarscov<NUMBER> vitro hcq appears potent action furthermore hcq clinical safety superior cq longterm use allows use higher doses interactions drugs <NUMBER> nonrandomized controlled trial showed azithromycin associated hcq significantly efficient eliminate virus <NUMBER> patients detectable viral load <NUMBER> days treatment however drugs must used carefully azithromycin indiscriminate use antimicrobial cause bacterial resistance use cq may cause increase qt interval retinopathy cardiovascular disorders certainly concern hypertensive patients <NUMBER> research warns adverse effects real effectiveness medications according studies widespread use hcq expose patients fatal consequences including skin reactions liver failure ventricular arrhythmia especially prescribed association azithromycin furthermore risk cq phosphate cause acute poisoning even death <NUMBER> <NUMBER> <NUMBER> <NUMBER> researchers analyzed <NUMBER> patients covid<NUMBER> new york city <NUMBER> <NUMBER> treated hcq treated total <NUMBER> developed respiratory failure <NUMBER> intubated <NUMBER> died without intubation according analysis patients took hcq likely develop respiratory failure use <NUMBER> makes randomized controlled trials hcq extremely necessary patients covid<NUMBER> mainly associated metabolic disorders patients type <NUMBER> type <NUMBER> diabetes andor hypertension treated ace inhibitors andor arbs considerable increase eca<NUMBER> receptors expression may facilitate virus entry authors report patients using drugs develop severe fatal covid<NUMBER> <NUMBER> appropriate alternative treatment use calcium channel blockers antihypertensive agents suggested patientcentered approach used guide choice pharmacological agents considering age severity covid<NUMBER> cardiovascular comorbidities risk hypoglycemia <NUMBER> <NUMBER> another possibly promising drug favipiravir drug proven action ebola virus drugs efficiency reducing sarscov<NUMBER> infection due inhibition rna polymerase activity <NUMBER> <NUMBER> randomized clinical trial <NUMBER> patients china showed favipiravir <NUMBER> effective arbidol <NUMBER> treatment covid<NUMBER> patients hypertension andor diabetes used favipiravir experienced reduction fever cough relief faster patients used arbidol however difference auxiliary oxygen therapy noninvasive mechanical ventilation patients <NUMBER> antiretroviral drugs lopinavirritonavir oral combination agent approved us food drug administration fda treatment hiv demonstrated vitro activity coronaviruses inhibiting <NUMBER>chymotrypsinlike protease <NUMBER> adverse effects lopinavirritonavir include gastrointestinal discomfort nausea diarrhea <NUMBER> hepatotoxicity <NUMBER> <NUMBER> <NUMBER> patients covid<NUMBER> adverse effects may exacerbated combination therapy due viral infection <NUMBER> remdesivir gs<NUMBER> adenosine nucleoside analogue prodrug broadantiviral spectrum phyloviruses paramyxoviruses pneumoviruses coronaviruses <NUMBER> vitro studies shown ability remdesivir inhibit coronaviruses replication primary human lung cells <NUMBER> <NUMBER> patients hospitalized severe covid<NUMBER> treated compassionateuse remdesivir showed clinical improvement <NUMBER> <NUMBER> patients <NUMBER> <NUMBER> well showed shortened time recovery evidence lower respiratory tract infection remdesivir group <NUMBER> however another study remdesivir adults severe covid<NUMBER> associated significant clinical benefits patients received remdesivir numerically faster time clinical improvement receiving placebo symptom duration <NUMBER> days less <NUMBER> studies adverse events reported followup patients <NUMBER> <NUMBER> anemia decreased hemoglobin thrombocytopenia acute kidney injury decreased estimated glomerular filtration rate increased blood creatinine increased total bilirubin hyperglycemia increased aminotransferase levels suggests clinical investigation patients complications associated metabolic syndrome <NUMBER> <NUMBER> <NUMBER> another potential adjuvant therapy covid<NUMBER> use convalescent plasma hyperimmune immunoglobulins <NUMBER> justification treatment antibodies recovered patients help immune response virus individuals covid<NUMBER> preventive measure infection cases vulnerable individuals diverse metabolic disorders nitazoxanide traditionally anthelmintic agent broad antiviral activity relatively favorable safety profile demonstrated vitro antiviral activity mers sarscov<NUMBER> <NUMBER> <NUMBER> lack robust evidence antiviral activity immunomodulatory effects safety profile nitazoxanide justify study therapeutic option covid<NUMBER> current evidence demonstrates use corticosteroids decrease inflammatory responses lungs however benefit overcome adverse effects including delayed viral clearance respiratory tract blood high rates complications including hyperglycemia psychosis avascular necrosis well increased risk secondary infection although direct evidence use corticosteroids covid<NUMBER> limited result revisions viral pneumonias instructive observational studies patients sars mers reported association corticosteroids improved survival <NUMBER> <NUMBER> <NUMBER> risk hyperglycemia diabetic patients reduced although eliminated good glycemic control although several therapeutic agents evaluated treatment covid<NUMBER> therapy yet shown efficacious patients proposed treatments covid<NUMBER> drugs mechanisms action adverse effects chloroquine metabolic syndrome risk factor influences covid<NUMBER> progression prognosis prevalence obese diabetic hypertensive liver damage patients severe cases covid<NUMBER> multiple countries demonstrates importance care risk group prophylaxis monitoring treatment similarly drugs currently evaluated infection treatment promising need studies prove efficacy safety due adverse effects may exacerbated combination therapy due viral infection development vaccine immunization still best longterm solution prevention future outbreaks sarscov<NUMBER> addition people age preexisting diseases heart disease diabetes obesity among others also need redouble care measures prevent coronavirus era extremely aging society hypertension highly prevalent chronic condition elderly overlap many acute conditions infection surgery trauma intoxication infection unavoidable clinical problem elderly patient taking antihypertensive medications pneumonia influenza could fatal elderly patients cardiovascular complications result longterm hypertension risk factors fact vaccination pneumonia influenza highly recommended elderly without cardiovascular complications recent pandemic outbreak severe acute respiratory syndrome corona virus <NUMBER> sarscov<NUMBER> called coronavirus disease <NUMBER> posing similar challenge majority fatalities observed elderly hypertension diabetes andor complications antihypertensive drug therapy may impact clinical practice according wide variety patient conditions vary mild conditions poor oral intake volume depletion orthostatic hypotension severe conditions sepsis septic shock myocardial damage overt hear failure acute kidney injury andor multiple organ failure changes antihypertensive drug therapy based weighing risk benefit ratio specific recommendations guide use antihypertensive drugs terms vulnerability specific infection septic shock andor organ failure general aspects relation hypertension management antihypertensive drug use infection impending ongoing first hypertension basically dependent sodium balance sodium food intake stopped could increased risk unexpected blood pressure decrease hypotension negative sodium balance exacerbated febrile condition use potent diuretics situation increase reninangiotensinaldosterone system ras activation sympathetic nervous system acts compensatory mechanism mitigate hypotension patient taking potent long acting ras blockade beta blocker might vulnerable hemodynamic instability compared calcium antagonist issue diuretics blocking effect compensatory system could exacerbate underlying sodium depleting situation theoretical speculations might one possible explanation reason calcium antagonist superior profile term interindividual visit visit blood pressure variabilities despite speculations studies answer questions clinical practice patient asymptomatic hypotension orthostatic hypotension solely dependent physicians discretions ras blockade beta blocker recommended patient cardiovascular complications stopping drugs may harmful recent retrospective population based cohort study hsu w et al reported established ras blockade therapy sepsis protective sepsis related mortality <NUMBER> results seems line recent study showing depressed sympathetic modulation signal sepsis patient infection <NUMBER> mediators suppress sympathetic nervous system may required sustained hypotension mediators may effective additional blocking possible due already established sympathetic blockade similarly retrospective studies heart failure patients withdrawal ras blockade beta blocker associated poor prognosis <NUMBER> <NUMBER> evidence stop using drugs infection patients unless associated hemodynamic instability however patients volume depletion symptomatic hypotension would prudent stop antihypertensive medications diuretics blood pressure normalized volume status recovered patients hemodynamically stable temporarily stopping ras blockade beta blocker seems possible patient hypertension related complications heart failure coronary artery disease vascular complications even subjects one consider adverse events resulting rebound increase blood pressure moreover study ohkubo et al including <NUMBER> patients history stroke andor transient ischemic attack mean age <NUMBER> years reported perindopril decreased pneumonia risk asian nonasian subjects <NUMBER> even retrospective studies showing stopping ras blockade beta blocker associated poor prognosis usual use vasoconstrictor inotropic without temporary withdrawal ras blockade beta blocker real world clinical practice patient acute hypotension acute kidney injury hyperkalemia related infection <NUMBER> besides toxin supplied infectious organisms catecholamine stress induced cardiomyopathy tachycardia induced cardiomyopathy direct invasion infectious agents could precipitate hypotension infection acute hemodynamic instability hypotension serious condition acute infection requires stopping adjustment antihypertensive drug dosage according patients hemodynamic status yearly outbreak seasonal flu huge burden healthcare system survival extremely older patients patients high risk profiles older age diabetes chronic diseases heart kidney lung liver <NUMBER> fortunately key available strategies cope specific infectious agent antiviral therapy vaccination preventive approaches hypertension prevalent high risk flu patients usually older cardiovascular complications antihypertensive agents could adjusted according general hemodynamic conditions infection begins temporary even drugs need adjustments issue adjustment antihypertensive drug use protect infection preemptively direct involvement antihypertensive drugs infectious process contrast pandemic flu highlighted angiotensin converting enzyme <NUMBER> ace<NUMBER> lung type <NUMBER> alveolar epithelial cell acts noncatalytic receptor sarscov<NUMBER> presumably sarscov<NUMBER> infect cell <NUMBER> ace<NUMBER> reported predominantly localized endothelial cells mrna reported highly expressed testis kidney heart also expressed brain intestine lungs <NUMBER> thus growing concerns hypertension risk factor severe covid<NUMBER> possibility ras inhibitors aggravating factor severe covid<NUMBER> due theoretical increase expression systemic ace<NUMBER> use pandemic sarscov<NUMBER> began wuhan china december <NUMBER> spread rapidly around world severe lung damage high mortality rates reported particularly elderly comorbidities particular high prevalence hypertension diabetes suggests maybe risk factors severe covid<NUMBER> prevalence hypertension apparently high patients severe covid<NUMBER> however considering age patients actual prevalence hypertension seem higher zhou et al analyzed clinical characteristics <NUMBER> patients diagnosed wuhan among average age deaths n <NUMBER> <NUMBER> years prevalence hypertension <NUMBER> quite comparable prevalence hypertension representative population ages <NUMBER> none papers published multivariate analysis indicated hypertension independent risk factor severe covid<NUMBER> study guan et al reporting clinical features <NUMBER> covid<NUMBER> patients diagnosed wuhan prevalence hypertension higher severe patients n <NUMBER> mean age <NUMBER> years mild patients mean age <NUMBER> years<NUMBER> vs <NUMBER> particularly higher considering prevalence hypertension age group <NUMBER> therefore scientific evidence suggest hypertension independent risk factor severe infection mortality covid<NUMBER> higher prevalence hypertension patients covid<NUMBER> likely due fact age severe patients significantly older major complications hypertension chronic heart failure cerebral infarction chronic renal failure make patient much vulnerable progression severe infection death <NUMBER> since sarscov<NUMBER> outbreak asia coronavirus shown use ace<NUMBER> proteins epithelial cell membrane lung alveoli receptor viral spikes glycoprotein attaches ace<NUMBER> proteins shown facilitate viral entry theory make patient vulnerable lower respiratory tract infection viral pneumonia <NUMBER> <NUMBER> since covid<NUMBER> outbreak role ace<NUMBER> pathophysiology covid<NUMBER> drawn lot interest social media world well scientific groups due growing concerns increased expression ace<NUMBER> may increase risk severe covid<NUMBER> recent report main receptor spike glycoprotein sarscov<NUMBER> ace<NUMBER> affinity reported higher sarscov <NUMBER> <NUMBER> key point concern ras inhibitor ace inhibitor angiotensin receptor blocker drug commonly used hypertensive patients theoretically raise ace<NUMBER> expression classical feedback system biochemical pathway enzyme receptor blocked fig <NUMBER> ace<NUMBER> activated angiotensin <NUMBER> increased instead angiotensin ii angiotensin <NUMBER> known effect protecting cardiovascular diseases binding receptor mas receptor promote vasodilation antioxidant antiinflammatory effects <NUMBER> hand comes covid<NUMBER> possibility exists acei arb exacerbation factor increasing expression ace<NUMBER> increased incidence patients physicians change antihypertensive medications drugs discontinue drugs due concerns concerns whether real increased risk severe covid<NUMBER> however korean society hypertension would like emphasize currently scientific basis taking measures first epidemiologic evidence increased severe covid<NUMBER> mortality patients taking ras inhibitors second still unclear whether ras inhibition results increased expression ace<NUMBER> systemic level andor tissue including epithelial cells fig <NUMBER> even though reports concentration ace<NUMBER> blood rises administration first ras blockade conflicting reports also suggest otherwise <NUMBER> <NUMBER> third since ace<NUMBER> receptor sarscov<NUMBER> <NUMBER> ras blockade indeed exacerbates corona virus infection obvious increase mortality severe infection patients receiving ras inhibitor reported sarscov<NUMBER> epidemic know obviously case contrary reported ace<NUMBER> protects severe acute lung injury study deshotels et al shown angiotensin ii highly activated severe infection results increased ace<NUMBER> internalization ace<NUMBER> degradation <NUMBER> importance implications interaction ace<NUMBER> sarscov<NUMBER> complex net expression ace<NUMBER> cannot predictable real patient fig <NUMBER> b <NUMBER> moreover vivo studies shown decreased ace<NUMBER> sarscov<NUMBER> infection exacerbated acute lung injury imai et al conducted experiments inducing acute lung injury gastric acid aspiration mice ace knockout mice acute lung injury significantly inhibited whereas ace<NUMBER> knockout mice acute lung injury worsened compared wild type hand acute lung injury significantly improved recombinant ace<NUMBER> administration demonstrating protective effect ace<NUMBER> acute lung injury <NUMBER> addition kuba et al conducted experiments mice sarscov<NUMBER> model spike protein sarscov<NUMBER> attaches ace<NUMBER> downregulates ace<NUMBER> activates angiotensin ii exacerbate acute lung injury contrast ras blockade losartan <NUMBER> mgkg protective effect acute lung injury caused sarscov<NUMBER> infection fig <NUMBER> b given covid<NUMBER> similar pathophysiological mechanisms sarscov<NUMBER> infection increase ace<NUMBER> ras blockade might even protective severe infection death summary <NUMBER> prevalence hypertension patients severe covid<NUMBER> high however likely due fact severe patients tend older commonly complications hypertension heart failure coronary artery disease stroke ckd currently scientific evidence hypertension independent risk factor severe infection death proven otherwise <NUMBER> regarding concerns increased risk severe infection death due theoretical concerns taking ras inhibitors may increase lung ace<NUMBER> clinical evidence suggest patients taking ras inhibitors may adverse prognosis covid<NUMBER> fact possible ras blockade protective effect severe covid<NUMBER> based previous reports protective effect animal models sarscov<NUMBER> infection <NUMBER> ras inhibitors administered due high blood pressure cardiovascular disease stopped abruptly risk excessive increase blood pressure may precipitate cardiovascular complications however acknowledge abovementioned issues valid concerns deserve research quickly possible without scientific evidence suggest otherwise korean society hypertension endorse recent recommendation european society cardiology recommend <NUMBER> hemodynamically stable patients taking ras inhibitors maintained ras blockade <NUMBER> hemodynamically stable treatment naïve patients compelling indication using ras inhibitors administered ras inhibitors according current guidelines <NUMBER> patients without covid<NUMBER> prescribed ras inhibitors clinical indications <NUMBER> hemodynamically unstable patients covid<NUMBER> prudent reduction withdrawal antihypertensive medications considered consideration comorbidities indications using drugs infection conclusion use temporary adjustment antihypertension drugs infectious disease could individualized according volume status hemodynamic stability comorbid cardiovascular disease profiles antihypertensive drug class also use ras blockade sarscov<NUMBER> pandemic infection maintained based current scientific knowledge researches needed use antihypertensive drugs severe infection epidemics classical renin angiotensin system ace<NUMBER> convert angiotensin ii angiotensin <NUMBER> <NUMBER> respectively panel b complex interaction among sarscov<NUMBER> ace<NUMBER> tmprss<NUMBER> adam<NUMBER> lung epithelial cells sarscov<NUMBER> infection presumably sarscov<NUMBER> infection binding spike protein ace<NUMBER> together lysosome degradation resulting ace<NUMBER> regulation adam<NUMBER> mediated ace<NUMBER> shedding cell membrane resulting promotion viral entry facilitation ace<NUMBER> mediated viral entry tmprss<NUMBER> make complex expression interplay ace<NUMBER> virus ace angiotensin converting enzyme adam<NUMBER> disintegrin metallopeptidase domain <NUMBER> arb angiotensin receptor blocker spike protein sarscov severe acute respiratory syndrome corona virus tmprss<NUMBER> type ii transmembrane serine proteases coronavirus disease <NUMBER>covid<NUMBER> viral respiratory disease caused <NUMBER> novel coronavirus <NUMBER>ncov caused pneumonia epidemic world <NUMBER> <NUMBER> <NUMBER> march <NUMBER> <NUMBER> total <NUMBER> cases laboratoryconfirmed covid<NUMBER> infection detected world reported world health organization china <NUMBER> accumulated confirmed cases covid<NUMBER> <NUMBER> existing severe patients given rapid spread high mortality rate covid<NUMBER> absolutely necessary evaluate possible risk factors affecting progression disease covid<NUMBER> patients previous studies show covid<NUMBER> patients comorbidity may lead poor prognosis <NUMBER> identifying important risk groups essential making decisions anti<NUMBER>ncov therapy date systematic review comprehensively explores whether presence common comorbidities increase covid<NUMBER> patients risk guide clinical practice better therefore performed metaanalysis available studies explore relationship comorbidity patients covid<NUMBER> database searches identified total <NUMBER> potentially relevant articles exclusion duplicate references<NUMBER> articles considered metaanalysis these<NUMBER> studies excluded screening title abstract careful review full texts <NUMBER> articles excluded reviews cases insufficient data six studies qualified inclusion <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> flow diagram figure <NUMBER> showed detailed literature search steps total <NUMBER> samples <NUMBER> retrospective studies enrolled metaanalysis <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> six studies performed china six studies <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> reported hypertension diabetes copd five covered liver disease <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> four investigated malignancy <NUMBER> <NUMBER> <NUMBER> <NUMBER> renal disease <NUMBER> <NUMBER> <NUMBER> <NUMBER> cardiovascular disease <NUMBER> <NUMBER> <NUMBER> <NUMBER> three <NUMBER> <NUMBER> <NUMBER> researched cerebrovascular disease two studies <NUMBER> <NUMBER> used whether patients experienced icu care judge severity disease four studies used clinical symptoms judge severity disease articles high quality nos score less <NUMBER> detailed descriptions studies included shown table <NUMBER> six studies including <NUMBER> severe group cases <NUMBER> nonsevere group cases provided data terms hypertension diabetes copd <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> figure <NUMBER>c higher risk exacerbation four included studies reported relationship cardiovascular disease patients severe covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> significant heterogeneity found <NUMBER> <NUMBER> p<NUMBER> among trials fixed effect pattern selected results showed cardiovascular disease risk factor patients covid<NUMBER> or<NUMBER> <NUMBER> ci <NUMBER> p<NUMBER> figure <NUMBER>g three studies provided data terms cerebrovascular disease <NUMBER> <NUMBER> <NUMBER> fixedeffects model used since heterogeneity test suggested significant heterogeneity <NUMBER> <NUMBER> p<NUMBER> metaanalysis shows significant relationship patients severe covid<NUMBER> cerebrovascular disease or<NUMBER> <NUMBER> ci <NUMBER> p<NUMBER> figure <NUMBER>h five studies comprising <NUMBER> severe group cases <NUMBER> nonsevere group cases evaluated role liver disease patients covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> metaanalysis showed patients previous liver disease increase risk disease progression or<NUMBER> <NUMBER> ci <NUMBER> p<NUMBER> figure <NUMBER>d relative risk assessments associated malignancy kidney disease presented figure <NUMBER>e <NUMBER>f respectively metaanalysis suggested correlation malignant tumor <NUMBER> confidence interval includes <NUMBER> kidney disease p<NUMBER> covid<NUMBER> patients aggravation verify correlation comorbidity covid<NUMBER> patients aggravation subgroup analysis conducted results subgroup analysis presented table <NUMBER> subgroup analysis results support results hypertension copd liver disease renal disease clinical symptom group observed hypertension diabetes copd malignancy cardiovascular disease risk factor covid<NUMBER> patients risk publication bias analyzed following comorbidities hypertension diabetes copd liver disease figure <NUMBER> shows results publication bias evaluated funnel plots eggers test beggs test pr<NUMBER> eggers regression test p <NUMBER> suggest significant publication bias currently increasing number cases extensive geographical expansion covid<NUMBER> causing widespread concern world <NUMBER> tian et al <NUMBER> <NUMBER> therefore early identification severe patients great significance improving therapeutic effect covid<NUMBER> reducing mortality previous studies described presence common comorbidities increase covid<NUMBER> patients risk <NUMBER> besides scholars think presence coexisting illness common among patients severe disease among nonsevere disease <NUMBER> however specific comorbidity lead disease progression remain unknown covid<NUMBER> patients total <NUMBER> covid<NUMBER> patients included analyses <NUMBER> <NUMBER> severe metaanalysis retrospective studies confirms copd associated dramatically increased risk aggravation patients covid<NUMBER> covid<NUMBER> patients copd <NUMBER>fold higher risk progression patients without copd moreover identify increased risk aggravation aging individuals hypertension diabetes cardiovascular disease cerebrovascular disease metaanalysis provide sufficient evidence correlation liver disease malignant tumor kidney disease covid<NUMBER> patients aggravation however conclusion needs taken caution study several limitations firstly small sample size may reduce significance results secondly judgment criteria severe nonsevere patients included study uniform thirdly included patients aging one coexisting illness fourth quality different studies different might lead bias metaanalysis identified hypertension diabetes copd cardiovascular disease cerebrovascular disease significant risk factors covid<NUMBER> patients knowledge factors better define covid<NUMBER> patients higher risk thus allow targeted specific approach prevent deaths given limitations conclusion welldesigned trials high quality needed explore relationship comorbidity patients covid<NUMBER> metaanalysis performed according preferred reporting items systematic reviews metaanalysis prisma statement <NUMBER> relevant literature extracted systematic retrieval pubmed medline embase springer web science cochrane library databases date march <NUMBER> <NUMBER> search strategy included terms <NUMBER>ncov coronavirus covid<NUMBER> sarscov<NUMBER> <NUMBER>ncov wuhan coronavirus besides manually screened relevant potential article references selected process performed independently two participants inclusion criteria follows <NUMBER> types studies published studies reported relationship comorbidity patients covid<NUMBER> <NUMBER> subjects diagnosed patients covid<NUMBER> <NUMBER> exposure intervention covid<NUMBER> patients comorbidity included hypertension diabetes chronic obstructive pulmonary disease copd liver disease malignancy renal disease cardiovascular disease cerebrovascular disease <NUMBER> outcome indicator odds ratios <NUMBER> confidence intervals ci comorbidity exclusion criteria <NUMBER> case reports reviews summaries discussions <NUMBER> insufficient data information provided <NUMBER> patients stratified degree severity two participants separately conducted literature screening data extraction literature quality evaluation differences could resolved discussion third analyst information extracted included literature first author surname year publication country population sample size relevant data comorbidity severe nonsevere patients etc newcastleottawa scale nos adopted evaluate process terms queue selection comparability queues evaluation results <NUMBER> quality included studies assessed independently two participants nos scores least six considered highquality literature higher nos scores showed higher literature quality data analysis performed using stata<NUMBER> software stata corp college station texas relevant <NUMBER> ci used estimate pooled results studies heterogeneity test conducted p≥<NUMBER> <NUMBER> <NUMBER> performed indicated obvious heterogeneity fixedeffect model applied merger otherwise randomeffect model applied results considered significant statistically pvalue less <NUMBER> studies grouped according type disease severity judgment basis one subgroup based clinical symptoms patients subgroup based whether patients experience icu care subgroup sensitivity analyses conducted explore potential sources heterogeneity publication bias assessed using begg funnel plot egger test linear regression test least five studies available p <NUMBER> indicates obvious publication bias bolin wang made substantial contributions conception design work zhong lu ruobao li bolin wang searched selected materials extracted data bolin wang wrote manuscript yan huang bolin wang revised paper carefully also contributed statistical analysis authors read approved final manuscript authors declare conflicts interest research received external funding accepted may <NUMBER> <NUMBER> article press may <NUMBER> <NUMBER> published online may coronavirus disease<NUMBER> covid<NUMBER> emerged major cause morbidity mortality worldwide writing half million cases severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> infections recorded global arms race vaccine viable therapy currently underway however experts project development vaccine take least <NUMBER> mo <NUMBER> effective pharmacologic treatment yet discovered therefore appears increasingly likely covid<NUMBER> become embedded fabric modern medicine years come management chronic illnesses patients covid<NUMBER> considered priority hypertension affects <NUMBER> billion individuals worldwide <NUMBER> associated markedly increased morbidity mortality setting covid<NUMBER> <NUMBER> <NUMBER> angiotensinconverting enzyme inhibitors aceis angiotensin receptor blockers arbs among frequently prescribed antihypertensive agents throughout developed world <NUMBER> drugs safe welltolerated effective firstline therapy however emerging evidence suggests aceis arbs may increase patient susceptibility sarscov<NUMBER> host cell entry propagation upregulation angiotensinconverting enzyme <NUMBER> ace<NUMBER> viral binding site <NUMBER> <NUMBER> <NUMBER> insufficient data recommend withdrawal aceis arbs among individuals diagnosed covid<NUMBER> indeed major medical organizations including american heart association european society cardiology recommend maintaining acei arb therapy hypertensive patients covid<NUMBER> however propose alternative agent considered patients presenting covid<NUMBER> new diagnosis hypertension verapamil nondihydropyridine calcium channel blocker used management hypertension largely supplanted aceis arbs dihydropyridine calcium channel blockers modern era verapamil primarily used rate control supraventricular tachycardia migraine prophylaxis hypertension comorbid atrial fibrillation believe drug may appropriate firstline agent management hypertension patients covid<NUMBER> preliminary data animal studies demonstrated verapamil effect ace<NUMBER> expression furthermore shown ameliorate clinical pathological course viral myocarditis murine models indeed study mice inoculated encephalomyocarditis virus investigators found treated verapamil andor infection exhibited markedly less cardiac inflammation necrosis compared untreated group <NUMBER> cardiac involvement specifically sarscov<NUMBER>associated myocarditis represents serious potentially fatal manifestation covid<NUMBER> <NUMBER> management hypertension drug may reduce inflammation viral myocarditis pose theoretical risk promoting covid<NUMBER> proliferation would appear rational strategy optimize patient outcomes carvedilol nonselective βadrenoreceptor antagonist additional α<NUMBER>adrenergic blocking properties represents another promising antihypertensive agent setting covid<NUMBER> similar verapamil carvedilol attenuates inflammation murine models acute viral myocarditis study mice infected coxsackie b<NUMBER> virus receiving carvedilol exhibited superior survival compared untreated group treated metoprolol <NUMBER> mechanism action unclear postulated carvedilol exerts antiinflammatory effects via inhibition peroxidants myocardium carvedilol also added benefit reducing heart rate may reduce myocyte injury ventricular remodeling setting myocarditis <NUMBER> notably demonstrable antiinflammatory effects associated upregulation ace<NUMBER> indeed lung function improvement acei arb treatment described setting covid<NUMBER> <NUMBER> however irrespective purported benefits aceis arbs potential agents facilitate viral disease remains investigation conclusion believe verapamil carvedilol considered management hypertension patients risk covid<NUMBER> pathogenic mechanisms sarscov<NUMBER> remain investigation data suggest ace<NUMBER> receptor plays central role infection therefore theoretically possible drugs known increase ace<NUMBER> expression aceis arbs could promote covid<NUMBER> proliferation agreement recommendation major medical societies maintain acei arb therapy individuals already receiving treatment however patients new diagnosis hypertension risk covid<NUMBER> would likely benefit verapamil carvedilol agents effectively control blood pressure may conceivably attenuate inflammation necrosis sarscov<NUMBER> myocarditis recent outbreak lifethreatening severe acute respiratory syndrome sars many countries resulted deaths patients infected coronavirus <NUMBER> <NUMBER> <NUMBER> <NUMBER> addition sars acute respiratory distress syndrome ards induced various disorders accordingly investigations mechanism ards understanding yet unknown mechanism sars brief review present early recent studies animal human subjects either ards acute pulmonary edema pe series studies neurogenic pe resulting cerebral compression intracranial hypertension suggest brain injuries initiate massive central sympathetic activation turn causes systemic vasoconstriction shift blood systemic circulation lung <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> isolated lung subject air embolism ischemiareperfusion ir endotoxin nitric oxide detrimental lung tissues causes acute injury although reduces pulmonary hypertension <NUMBER> <NUMBER> <NUMBER> recently reported <NUMBER> patients diseases rare causes ards induced several mechanisms patients japanese b encephalitis viral infection destroys depressor areas medulla implying central sympathetic activation might cause ards hand cgmp serotonin possibly involved ards due fat embolism suggest investigation involvement central nervous lesions chemical factors advance understanding sars caused coronavirus infection early studies used whole animals mainly rats spraguedawley strain investigate mechanism neurogenic pe induced cerebral compression <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> right left heart bypass employed elucidate importance cardiac output venous return genesis pulmonary pathology <NUMBER> technique regional weighing described fell rushmer <NUMBER> used demonstrate shift blood volume systemic circulation lung <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> total heart bypass technique allowed us perfuse systemic pulmonary circulation constant flow examined systemic pulmonary hemodynamics response intracranial hypertension found intracranial hypertension causes increase systemic pulmonary vascular resistance decrease capacity <NUMBER> spectral analysis assessment steady pulsatile hemodynamics demonstrated intracranial hypertension causes increase characteristic impedance wave reflection total peripheral resistance along decrease cardiac output <NUMBER> spraguedawley rats endotoxin causes systemic hypotension increase cytokine inducible synthase inos mrna expression injured lung changes attenuated nos inhibitors nnitrolarginine methyl ester lname ssi<NUMBER>phenylenebis<NUMBER>ethanedinyt bisisothiourea dihydrobromide dexamethasone <NUMBER> good preparation study acute lung injury isolated lungs situ <NUMBER> <NUMBER> <NUMBER> previous method involved removing isolated lung body placing forcedisplacement transducer record change lung weight procedure rather complicated unstable invented device measuring change lung weight scale isolated perfused lung removed body instead whole body placed scale platform digitalanalogue converter records change lung weight recorder isolated lung preparation lung weight gain lung weightbody weight ratio microvascular permeability protein concentration bronchoalveolar lavage could measured calculated evaluate extent lung injury well determine pulmonary vascular tone wang et al <NUMBER> found isolated lung larginine inhaled increased lung injury induced air embolism lname attenuated mecaprine agent reduces oxygen free radicals also protects lung acute injury following ir <NUMBER> surprising find hypoxiainduced vasoconstriction associated increased release lung <NUMBER> observation contrast notion vasodilator reduction may lead vasoconstriction endotoxic shock shown harmful lung major site formation lung organs <NUMBER> also mediates lung damage following ir larginine inhaled enhance irinduced pe nos inhibitors reverse ir lung injury <NUMBER> recentlydeveloped animal model conscious unrestrained rats available <NUMBER> model condition animals observed arterial pressure heart rate biochemical factors measured <NUMBER> h without anesthesia used novel model investigate physiological chemical indicators early late stages sepsisassociated pulmonary injury <NUMBER> extensive studies using technique carried laboratory pe induced cerebral compression affected cholinergic blockers atropine betaadrenergic blockers propranol however prevented aadrenergic blocking agents phentolamine phenoxybenzamine norepinephrine depleter respine sympathetic neuronal blocker bretylium high doses intravenous norepinephrine angiotensin vasopressin induce severe systemic vasoconstriction pe <NUMBER> previous studies demonstrated vasodilators nitroprusside nitroglycerin cause dosedependent attenuation neurogenic pe oxidant scavengers dimethylthiourea superoxide dismutase exert significant effect centrogenic pe <NUMBER> important substance regulation arterial pressure <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> since free radical however may lead formation hydroxyl radical peroxynitrite toxic many organs including lung <NUMBER> <NUMBER> <NUMBER> thus effects exogenous endogenous investigated recent studies tung injury induced various disorders spraguedawley rats endotoxin produces systemic hypotension accompanied enhancement cytokines tumor necrosis factor interleukins inos mrna expression <NUMBER> isolated perfused lung exogenous endogenous detrimental lung following air embolism ir <NUMBER> <NUMBER> endotoxininduced ards found caused large amounts release lung <NUMBER> irinduced lung injury exacerbated inhalation larginine administration attenuated nos inhibitor lname <NUMBER> patients fat embolism due long bone fracture plasma levels cgmp nitratenitrite significantly increased suggesting involved ards associated fat embolization <NUMBER> early work indicated massive sympathetic drive responsible pathogenesis ofneurogenic pe pe induced cerebral compression affected vagotomy adrenalectomy prevented spinal transaction <NUMBER> <NUMBER> rats monitoring aortic pulmonary blood flow cerebral compression causes dramatic decrease aortic flow cardiac output less <NUMBER> basal value pulmonary flow slowly declines showed imbalance right left cardiac output resulted accumulation blood lung <NUMBER> furthermore used right left heart bypass study left heart bypass aortic flow kept constant lung change discernible following cerebral compression right heart bypass pulmonary flow constant left cardiac output allowed change cerebral compression produced severe pe findings suggest decrease left ventricular output major cause pe venous return however essential another study regional sympathectomy performed elucidate participation various vascular beds neurogenic pe <NUMBER> splanchnic sympathectomy dissection splanchnic nerves celiac plexus almost completely prevented pe induced cerebral compression hand pulmonary sympathetic denervation excising thoracic sympathetic chains stellate ganglia t<NUMBER> attenuated extent pe approximately <NUMBER> results suggest sympathetic splanchnic vasoconstriction essential production neurogenic pe pulmonary sympathetic vasoconstriction major factor involved lung distended accumulation blood volume pulmonary vasoconstriction however cause additional effect enhance pulmonary venous hypertension pe hypoxiainduced pulmonary vasoconstriction wellknown phenomenon physiological significance capillary flow hypoxic alveoli reduced flow thus shifted oxygenated alveoli speculated inadequate formation may responsible increased vascular tone pulmonary vasoconstriction hypertension reviews see ref <NUMBER> <NUMBER> contention challenged study laboratory <NUMBER> detector probe placed pulmonary vein isolated perfused tung realtime monitoring revealed release increased accompanied pulmonary arterial hypertension following hypoxia larginine able potentiate release reduce pulmonary hypertension lname produced opposite effects findings suggest continuous release lung maintains pulmonary arterial pressure insufficient formation cause hypoxiainduced pulmonary hypertension connection studies laboratory <NUMBER> <NUMBER> <NUMBER> also contest early consensus impairment endothelial function formation cause hypertension due reduction vasodilatory effect review see ref <NUMBER> pulmonary arterial pressure microvascular permeability lung weightbody weight ratio protein concentration bronchoalveolar lavage measured calculated air embolism ir endotoxin administration isolated perfused lung exerts beneficial effect increase pulmonary arterial pressure pulmonary hypertension substance mediates induction acute lung injury induced air embolism ir endotoxin administration <NUMBER> <NUMBER> <NUMBER> case sepsis concentration increased exhaled air thus acting early marker lung inflammation <NUMBER> <NUMBER> found production mainly lung furthermore extent acute lung injury concentration exhaled air greatly reduced tung perfused physiological solution compared lung perfused whole blood <NUMBER> finding suggests cellular elements essential production lung injury changes attenuated pretreatment lname aminoguanidine dexamethasone suggesting inos involved pathogenesis sepsisinduced pe exogenous endogenous also causes lung injury following ir <NUMBER> conscious unrestrained rats following intravenous infusion lipopolysaccharide lps <NUMBER> mgkg hypotension plasma nitritenitrate reached peak <NUMBER> h finding indicates increased release accounts systemic hypotension plasma amylase reached peak <NUMBER> h lps infusion increase plasma amylase may indication multiple organ damage late stage sepsis postmortem examination lung revealed slight increase lung weight compared normal lung lung injury mild <NUMBER> higher doses lps may required induce severe pe changes biochemical factors may used elucidate pathogenesis acute lung injury conscious rat model recent report ards patients suggests cerebral compression air embolism ir endotoxin causes ards <NUMBER> patients japanese b encephalitis viral destruction depressor areas may induce central sympathetic activation resulting ards disruption cerebral aneurysm cause severe intracranial hypertension ards obstruction lymphatic drainage also lead severe ards fat embolism biochemical mediators cgmp serotonin may involved pathogenesis ards japanese b encephalitis demonstrate viral destruction medullary depressor areas release sympathetic drive may cause ards due viral lesions brain chang et al <NUMBER> reported patients enterovirus infection demonstrated hand foot mouth lesions dramatic case ards ensued unfortunately pathological examination brain reported study outbreaks sars early mid<NUMBER> resulted high mortality mechanism coronavirusinduced sars still unknown may interesting see whether coronavirus andor enterovirus introduced animal produce brain lesions observed patients japanese b encephalitis recent observation hsu et al unpubl data revealed ards occurred rabies infection consequence brain lesion similar seen japanese b encephalitis research isolated lung used substrate blockers elucidate detrimental role acute injury caused air embolism ir endotoxin extending research measurement biochemical factors expression mrna cytokines nos conscious rat model investigation dosedependent changes physiological parameters biochemical factors pathological changes carried order observe dosedependent organ injury including lung experimental results animals chronic deprivation constitutive nos inos knockin knockout may elucidate involvement different nos forms pathogenesis ards certain underlying conditions including diabetes mellitus dm hypertension chronic cardiac disease chronic renal disease recognized risk factors illness death caused infection merscov <NUMBER> explored relationship among mers patients admitted referral hospital riyadh saudi arabia august <NUMBER> <NUMBER>august <NUMBER> <NUMBER> enrollment criteria data collection methods described <NUMBER> considered persons medical history dm documented dm persons multiple recorded periods hyperglycemia hospitalization possible dm <NUMBER> similarly identified patients hypertension chronic kidney disease ckd using documentation medical chart defined cardiovascular disease documentation coronary artery disease history heart failure stroke considered patients cardiovascular disease ckd chronic organ damdiabetes mellitus hypertension recognized risk factors severe clinical outcomes including death associated middle east respiratory syndrome coronavirus infection among <NUMBER> virusinfected patients saudi arabia severity illness frequency death corresponded closely presence multiple severe underlying conditions age cod performed statistical analysis using sas version <NUMBER> httpswwwsascom microsoft excel httpswwwmicrosoftcom <NUMBER> enrolled patients medical history available <NUMBER> medical charts underlying disease status among <NUMBER> patients dm hypertension cod n <NUMBER> dm without hypertension cod n <NUMBER> dm hypertension without cod n <NUMBER> dm hypertension cod n <NUMBER> <NUMBER> patients dm <NUMBER> dm documented medical chart <NUMBER> possible dm random glucose readings <NUMBER> mgdl hospitalization <NUMBER> patients hypertension concomitant dm figure appendix table <NUMBER> patients <NUMBER> survived discharge including <NUMBER> required supplemental oxygen hospitalization eleven died hospital required ventilatory support casepatients multiple severe underlying conditions generally worse clinical course outcomes without conditions figure appendix table <NUMBER> casepatients dm hypertension <NUMBER> survived patients dm without hypertension cod comparison <NUMBER> <NUMBER> <NUMBER> dm hypertension without cod died <NUMBER> <NUMBER> <NUMBER> dm hypertension cod died appendix table previous study <NUMBER> dm chronic lung disease heart disease smoking identified underlying health conditions behaviors associated primary infection merscov alqahtani et al reported dm hypertension cardiac disease renal disease bronchial asthma frequent underlying conditions associated death merscovinfected patients also found risk death increased patients multiple comorbidities <NUMBER> found dm hypertension cod cooccurred frequently merscovinfected patients severity illness frequency figure characteristics <NUMBER> casepatients infected middle east respiratory syndrome coronavirus underlying condition survival status saudi arabia <NUMBER> dm defined hyperglycemia recorded hospitalization n <NUMBER> <NUMBER>a chronic lung disease <NUMBER> patient dm htn survived <NUMBER> patient dm htn cod died <NUMBER> patient cvd ckd died <NUMBER>b epilepsy <NUMBER> patient cvd ckd died <NUMBER>c uterine cancer <NUMBER> patient cvd ckd died cod chronic organ damage ckd chronic kidney disease cvd cardiovascular disease dm diabetes mellitus htn hypertension death higher patients multiple severe underlying conditions studies necessary better clarify mechanisms lead severe outcomes among patients casepatients infected merscov presence compounding underlying conditions including dm hypertension ultimately cod corresponded increasingly complicated clinical course death findings indicate increased clinical vigilance warranted patients multiple severe underlying conditions suspected infected merscov influenza virus idv potentially cause respiratory diseases livestock isolated new idv strain diseased cattle japan strain phylogenetically antigenically distinguished previously described idvs <NUMBER> <NUMBER> <NUMBER> <NUMBER> addition idv rnas specific antibodies detected many animal species <NUMBER> <NUMBER> <NUMBER> date idvs phylogenetically classified <NUMBER> lineages dok d<NUMBER> japanese lineages isolated new idv strain cattle japan respiratory disease whose hemagglutininesterasefusion hef gene belong known phylogenetical lineages herd yamagata prefecture northern japan <NUMBER> holsteins <NUMBER> bred cattle herd respiratory signs develop january <NUMBER> <NUMBER> appendix table <NUMBER> httpwwwnccdcgov eidarticle<NUMBER>app<NUMBER>pdf collected nasal swab samples <NUMBER> <NUMBER> cows january <NUMBER> <NUMBER> samples subjected idvspecific realtime reverse transcription pcr rtpcr <NUMBER> found positive also subjected samples rtpcr analyses specific bovine viral diarrhea virus <NUMBER> <NUMBER> infectious bovine rhinotracheitis virus bovine parainfluenza virus <NUMBER> bovine respiratory syncytial virus bovine coronavirus bovine rhinitis virus mycobacterium bovis mycoplasma bovigenitalium mycoplasma dispar ureaplasma diversum mycoplasma bovirhinis samples found negative pathogens except sample cow <NUMBER> positive dispar despite cows receiving antimicrobial drug treatment isolated mannheimia haemolytica <NUMBER> nos <NUMBER> <NUMBER> <NUMBER> cow <NUMBER> died january <NUMBER> taken together <NUMBER> pandemic coronavirus affected three million people <NUMBER> countries causing two hundred thousand deaths end april <NUMBER> <NUMBER> etiologic agent disease severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> transmitted contact infected persons contaminated fluids <NUMBER> <NUMBER> several risk factors associated disease multicenter cohort study advanced age found significantly correlated overall covid<NUMBER> prevalence consistent higher incidence observed older adults <NUMBER> sex another risk factor higher prevalence seen men women <NUMBER> studies shown presence comorbidity increases chances covid<NUMBER> infection causing respiratory failure death patients <NUMBER> another study reports patients admitted intensive care unit icu higher number comorbidities <NUMBER> admitted icu <NUMBER> <NUMBER> hence comorbidities considered risk factor fatality data reports show <NUMBER> prevalence comorbidities fatal cases <NUMBER> cardiovascular diseases diabetes hypertension chronic obstructive pulmonary disease prevalent known comorbidities covid<NUMBER> cases <NUMBER> currently several published studies describe epidemiological clinical characteristics patients mortality cases affected covid<NUMBER> different parts world reason aim metaanalysis estimate prevalence geographical distribution comorbidities patients admitted icu mortality cases affected covid<NUMBER> using previously published data protocol systematic review published international prospective registry systematic reviews prospero <NUMBER> crd<NUMBER> implementation protocol final report developed based cochrane manual systematic reviews interventions <NUMBER> prevalence comorbidities patients patients admitted icu fatal cases affected new coronavirus covid<NUMBER> review considered studies conducted epidemiological clinical descriptions patients fatal cases different parts world order determine prevalence geographic distribution comorbidities patients affected covid<NUMBER> initial search limited medline performed using mesh index terms related keywords search followed analysis words text title abstract index terms used describe articles second search using identified keywords index terms conducted may <NUMBER> <NUMBER> using following databases latin american caribbean health sciences literature lilacs bibliographic database us national medicine medline elsevier database embase web science scopus mesh index term search included covid<NUMBER> sarscov<NUMBER> prevalence comorbidity covid<NUMBER> recent topic thesis dissertation papers yet published evaluated articles selected data recovery analyzed two independent reviewers assessed methodological validity text inclusion review quality publications included evaluated based criteria derived grading recommendations assessment development evaluation method grade points awarded studies present limitations study design execution risk bias inconsistency results evidence based indirect data imprecision publication bias score four five points considered high quality three points moderate quality zero two points low quality data added review manager revman <NUMBER> analysis data extraction table created assess quality demographic data study location sample size number cases number positives diagnostic test randomeffect model metaanalysis method used analyze pooled prevalence comorbidities patients fatal cases affected covid<NUMBER> different parts world heterogeneity among studies analyzed using higgins test <NUMBER> shows percentage variation among studies analyses compiled using stata software version <NUMBER> statacorp llc texas usa odds ratio test <NUMBER> confidence interval <NUMBER> ci calculated measure likelihood death patient comorbidity compared patient without comorbidities applying eligibility exclusion criteria duplicate texts articles related topics text excluded review criteria method quality <NUMBER> studies considered analyses <NUMBER> <NUMBER> <NUMBER> <NUMBER> used calculate total prevalence comorbidities patients affected covid<NUMBER> six used calculate prevalence comorbidities patients admitted icu <NUMBER> used calculate comorbidity prevalence fatal cases characteristics studies included metaanalysis shown table <NUMBER> results search strategy shown prisma flow chart figure <NUMBER> data extracted final selection shown supplementary table s<NUMBER> according criteria applied based grade studies met selection criteria presented high methodological quality score five <NUMBER> test indicated low heterogeneity among studies publication bias evaluated currently available methods considered useful studies proportions summaries methodological quality bias risk applicability study among included studies shown supplementary figures s<NUMBER> s<NUMBER> <NUMBER> studies used calculate pooled prevalence comorbidities <NUMBER> patients affected covid<NUMBER> analyzed <NUMBER> <NUMBER> presented one comorbidities <NUMBER> <NUMBER> admitted icu <NUMBER> <NUMBER> patients died patients age range <NUMBER> <NUMBER> years among studies one conducted usa <NUMBER> included large number patients <NUMBER> segregate patients according sex <NUMBER> studies <NUMBER> patients registered total <NUMBER> <NUMBER> males <NUMBER> <NUMBER> females reported comorbidities included hypertension heart disease diabetes cancer chronic obstructive pulmonary disease asthma chronic diseases liver kidneys digestive system autoimmune disorders immunodeficiencies stroke others one study specified diseases included category others regarding geographical distribution studied patients <NUMBER> <NUMBER> usa <NUMBER> analysis general population affected covid<NUMBER> indicated <NUMBER> pooled prevalence comorbidities <NUMBER> ci <NUMBER> weight <NUMBER> china geographical distribution analysis showed <NUMBER> prevalence comorbidities <NUMBER> ci <NUMBER> weight <NUMBER> followed usa <NUMBER> <NUMBER> ci <NUMBER> weight <NUMBER> india <NUMBER> <NUMBER> ci <NUMBER> weight <NUMBER> singapore <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> weight <NUMBER> figure <NUMBER> among one previous diseases total <NUMBER> comorbidities hypertension prevalent <NUMBER> <NUMBER> ci <NUMBER> weight <NUMBER> followed diabetes <NUMBER> <NUMBER> ci <NUMBER> weight <NUMBER> heart disease <NUMBER> <NUMBER> ci <NUMBER> weight <NUMBER> chronic obstructive pulmonary disease copd <NUMBER> <NUMBER> ci <NUMBER> weight <NUMBER> addition comorbidities also assessed kidney disease <NUMBER> cancer <NUMBER> asthma <NUMBER> liver disease <NUMBER> stroke <NUMBER> immunodeficiencies <NUMBER> others <NUMBER> pooled prevalence <NUMBER> ci values disease shown table <NUMBER> six studies conducted descriptions epidemiological clinical profiles patients admitted icu five divided data according sex five studies <NUMBER> patients described <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> among patients <NUMBER> <NUMBER> male <NUMBER> <NUMBER> female age range <NUMBER> <NUMBER> years clinical characteristics <NUMBER> patients also described indicating <NUMBER> <NUMBER> one comorbidities total <NUMBER> comorbidities among patients admitted icu pooled prevalence comorbidities icu patients <NUMBER> <NUMBER> ci <NUMBER> weight <NUMBER> geographical distribution analysis showed <NUMBER> prevalence comorbidities <NUMBER> ci <NUMBER> weight <NUMBER> china followed italy <NUMBER> <NUMBER> ci <NUMBER> weight <NUMBER> usa <NUMBER> <NUMBER> ci <NUMBER> weight <NUMBER> forest plot randomeffect metaanalysis comorbidities patients admitted icus covid<NUMBER> shown supplementary figure s<NUMBER> prevalent comorbidities icu population hypertension <NUMBER> <NUMBER> ci <NUMBER> weight <NUMBER> heart disease <NUMBER> <NUMBER> ci <NUMBER> weight <NUMBER> diabetes <NUMBER> <NUMBER> ci <NUMBER> weight <NUMBER> others <NUMBER> <NUMBER> ci <NUMBER> weight <NUMBER> addition diseases patients copd <NUMBER> cancer <NUMBER> kidney disease <NUMBER> liver disease <NUMBER> stroke <NUMBER> also evaluated pooled prevalence <NUMBER> ci values disease shown table <NUMBER> eleven studies included descriptions epidemiological clinical profiles total <NUMBER> cases mortality studies <NUMBER> patients males <NUMBER> females age range <NUMBER> <NUMBER> years among <NUMBER> fatal cases <NUMBER> patients one previous diseases totaling <NUMBER> comorbidities pooled prevalence comorbidities among fatal cases <NUMBER> <NUMBER> ci <NUMBER> weight <NUMBER> two countries analyzed geographical distribution china <NUMBER> <NUMBER> ci <NUMBER> weight <NUMBER> korea <NUMBER> <NUMBER> ci <NUMBER> weight <NUMBER> figure <NUMBER> prevalent comorbidities population hypertension <NUMBER> <NUMBER> ci <NUMBER> weight <NUMBER> diabetes <NUMBER> <NUMBER> ci <NUMBER> weight <NUMBER> heart disease <NUMBER> <NUMBER> ci <NUMBER> weight <NUMBER> copd <NUMBER> <NUMBER> ci <NUMBER> weight <NUMBER> addition diseases patients cerebrovascular accident <NUMBER> cancer <NUMBER> kidney disease <NUMBER> liver disease <NUMBER> <NUMBER> also evaluated pooled prevalence <NUMBER> ci values disease shown table <NUMBER> probability patient comorbidity dying covid<NUMBER> significance associations using fishers exact test calculated number patients comorbidities died survived addition patients without comorbidities died survived used calculate odds ratio <NUMBER> <NUMBER> ci <NUMBER> fishers exact test value p <NUMBER> metaanalysis based <NUMBER> studies including large number descriptions china united states studies conducted india italy united kingdom south korea singapore also analyzed higher prevalence male patients infected covid<NUMBER> observed compared females predisposition male sex also observed diseases merscov sarsco also caused viruses coronavirus family <NUMBER> <NUMBER> pooled prevalence comorbidities general population patients affected new coronavirus covid<NUMBER> <NUMBER> <NUMBER> ci <NUMBER> china country highest prevalence although also studies analyzed country however important highlight two studies united states resulted contrasting prevalence values <NUMBER> <NUMBER> since united states country leads statistics far highest number confirmed cases one million deaths coronavirus seventy thousand may <NUMBER> <NUMBER> utmost importance publish data clinical characteristics disease country results study confirm prevalence comorbidities increases patients clinical conditions worsens general population affected covid<NUMBER> prevalence comorbidities <NUMBER> <NUMBER> among patients admitted icu <NUMBER> among fatal cases males affected three groups hand mean age also increases compare group patients general group fatal cases previously described among risk factors age sex comorbidities <NUMBER> <NUMBER> <NUMBER> <NUMBER> regarding comorbidities three groups analyzed general population admission icu fatal cases hypertension prevalent comorbidity accounting <NUMBER> <NUMBER> <NUMBER> respectively general population diabetes secondmost prevalent <NUMBER> comorbidity followed heart disease <NUMBER> copd <NUMBER> however patients admitted icu diabetes <NUMBER> heart disease <NUMBER> showed similar values phenomenon observed fatal cases diabetes <NUMBER> heart disease <NUMBER> showing similar values considering type <NUMBER> diabetes mellitus usually manifests childhood adolescence type <NUMBER> diabetes frequently manifests adults heart diseases prevalent older patients one may think earlier onset diabetes may account rank second among comorbidities general population affected covid<NUMBER> hand group fatal cases composed predominantly older adults population hypertension diabetes heart disease prevalent odds ratio comorbidity <NUMBER> <NUMBER> ci <NUMBER> statistical significance p <NUMBER> words patient comorbidity <NUMBER> times chance dying covid<NUMBER> compared patient without comorbidity may explain high prevalence comorbidities among fatal cases developing study encountered several limitations firstly studies segregated epidemiological clinical data age sex percentage comorbidity patients hospitalized icu secondly studies classified comorbidities category one study described diseases comprised category thirdly since china primary focus rise pandemic studies included country studies africa oceania latin america found finally metaanalyses recommended publication bias always assessed statistical methods however currently available methods funnel plot egger regression test considered useful tools studies proportions <NUMBER> one conclude existence comorbidities increases probability dying covid<NUMBER> <NUMBER> times compared preexisting conditions relevant comorbidities shown hypertension heart disease diabetes thus comorbidities prevalent group mortality cases compared general population group however conclusions based evidence obtained mostly studies conducted china reason studies describing epidemiological clinical profiles covid<NUMBER> cases africa oceania latin america recommended clarify behavior disease regions thus able apply effective measures aimed safeguarding populations risk oae asz contributed create design study analyze interpret data write first final version manuscript efa fgl tam pfb contributed analyze data wrote first version manuscript authors approved final version manuscript responsible aspects work including ensuring accuracy integrity provide explicit statement questions addressed reference participants interventions comparisons outcomes study design picos methods review question indicate review protocol exists accessed eg web address available provide registration information including registration number specify study characteristics eg picos length followup report characteristics eg years considered language publication status used criteria eligibility giving rationale information sources <NUMBER> describe information sources eg databases dates coverage contact study authors identify additional studies search date last searched state process selecting studies ie screening eligibility included systematic review applicable included metaanalysis data collection process <NUMBER> describe method data extraction reports eg piloted forms independently duplicate processes obtaining confirming data investigators data items <NUMBER> list define variables data sought eg picos funding sources assumptions simplifications made methods data extractionquality assessment describe methods used assessing risk bias individual studies including specification whether done study outcome level information used data synthesis additional file figure s<NUMBER> additional file figure s<NUMBER> describe methods additional analyses eg sensitivity subgroup analyses metaregression done indicating prespecified give numbers studies screened assessed eligibility included review reasons exclusions stage ideally flow diagram study characteristics <NUMBER> study present characteristics data extracted eg study size picos followup period provide citations table <NUMBER> risk bias within studies <NUMBER> present data risk bias study available outcome level assessment see item <NUMBER> additional file figure s<NUMBER> figure s<NUMBER> outcomes considered benefits harms present study simple summary data intervention group b effect estimates confidence intervals ideally forest plot results additional file figure s<NUMBER> give results additional analyses done eg sensitivity subgroup analyses metaregression see item <NUMBER> summarize main findings including strength evidence main outcome consider relevance key groups eg healthcare providers users policy makers discuss limitations study outcome level eg risk bias reviewlevel eg incomplete retrieval identified research reporting bias discussion provide general interpretation results context evidence implications future research conclusion describe sources funding systematic review support eg supply data role funders systematic review na figure s<NUMBER> methodological quality summary bias risk concern applicability study methodological quality summary bias risk concern applicability across included studies severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> virus responsible covid<NUMBER> global pandemic catastrophic consequences healthcare systems populations around world sarscov<NUMBER> initially described december <NUMBER> wuhan china <NUMBER> virus rapidly escalated march <NUMBER> <NUMBER> world health organization declared pandemic sarscov<NUMBER> shares similarities sarscov virus responsible <NUMBER> sars epidemic middle eastern respiratory syndrome coronavirus mers virus responsible mers <NUMBER> following sars epidemic researchers extensively investigated pathophysiologic mechanisms sarscov infection including interaction virus heart lungs based studies researchers believe angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor located alveolar epithelial cells serves high affinity receptor cotransporter sarscov<NUMBER> enter lungs <NUMBER> medications angiotensinconverting enzyme inhibitors acei block ace<NUMBER> receptors may predispose protect covid<NUMBER> infection editorial summarizes current scientific evidence surrounding subject order guide clinical practice juan simon ricomesa averi white share first authorship reninangiotensinaldosterone system raas maintains plasma sodium concentration via feedback blood pressure baroreceptors sodium potassium levels first kidneys secrete renin metabolizes angiotensinogen angiotensin next kidneys lungs secrete ace converts angiotensin angiotensin ii finally angiotensin ii stimulates vasoconstriction cardiovascular response aldosterone adh production ultimately increases blood pressure body fluid volume sodium potassium free water resorption <NUMBER> ace<NUMBER> receptor homolog angiotensin iconverting enzyme ace receptor type transmembrane aminopeptidase high expression heart lung tissue <NUMBER> also expressed endothelium kidney see fig <NUMBER> illustrating raas activation pathway discovered <NUMBER> ace<NUMBER> receptor appears counterregulate raas activation degrading angiotensin ii <NUMBER> raas system widely implicated dm hypertension heart failure acei arb drugs based upon strong evidence efficacy commonly used management hypertension heart failure post myocardial infarction care slow progression renal disease associated diabetes exponential rise covid<NUMBER> cases worldwide observational studies identified risk factors infection poor outcomes three separate studies identified hypertension dm highly prevalent among covid<NUMBER> patients according yang et al among <NUMBER> critically ill patients dm present <NUMBER> cases <NUMBER> b according guan et al among <NUMBER> patients dm present <NUMBER> cases hypertension present <NUMBER> cases <NUMBER> c according zhang et al among <NUMBER> hospitalized patients dm present <NUMBER> cases hypertension present <NUMBER> cases <NUMBER> hypertension dm treated acei arb medication use assessed three aforementioned studies leading inconclusive hypothesis however one study date analyzed effect acei arb use covid<NUMBER> population according peng et al among <NUMBER> patients cardiovascular comorbidities led worse outcomes deaths occurring secondary fulminant inflammation lactic acidosis thrombotic states <NUMBER> acei arb use influence morbidity mortality <NUMBER> addition observations wellknown association viruses sarscov merscov deleterious cardiac events including cardiac injury sarscov well myocarditis heart failure merscov <NUMBER> furthermore sarscov<NUMBER> recently associated cardiac injury defined troponin <NUMBER> pgml electrocardiogramechocardiogram abnormalities <NUMBER> patients covid<NUMBER> cohort data demonstrate cardiac affinity three viruses <NUMBER> etiology cardiac damage patients covid<NUMBER> unclear ace<NUMBER> receptors may play role given high affinity sarscov ace<NUMBER> receptors <NUMBER> recent fig <NUMBER> raas pathway showing aceiarb mechanism action sars sarscov<NUMBER> infectious mechanism via ace<NUMBER> receptors commentary published lancet respiratory medicine hypothesizes use ace<NUMBER> receptor increasing drugs higher risk severe covid<NUMBER> infection acei initially inhibits ace leading decreased angiotensin levels causing possible negative feedback loop ultimately upregulates ace<NUMBER> receptor able interact decreased angiotensin substrate available <NUMBER> see fig <NUMBER> ace<NUMBER> receptor upregulation results increased binding sites sarscov<NUMBER> leading preferential covid<NUMBER> infection particularly observed patients diabetes andor hypertension since usually taking acei arb <NUMBER> comment released findings published peng et al <NUMBER> editorial response sommerstein et al <NUMBER> based findings ferrario et al showing <NUMBER>fold increase ace<NUMBER> levels lisinopril <NUMBER>fold increase ace<NUMBER> levels losartan <NUMBER> published british medical journal conversely investigators argue acei arb use may beneficial covid<NUMBER> infection prevention li et al example proposed acei inhibition ace may stimulate negative feedback given lack angiotensin ii upregulating ace<NUMBER> receptors decreasing overall inflammation <NUMBER> sun et al argued acei use im pairs aceangiotensin iiangiotensin<NUMBER> receptor pathway therefore impairing integrity ace<NUMBER>angiotensin <NUMBER> mas masrelated g proteincoupled receptor disruption ace<NUMBER>angiotensin <NUMBER>mas pathway could lead decreased production ace<NUMBER> decreasing chances sarscov<NUMBER> entering cell <NUMBER> raas inactivated animal models demonstrate symptom relief acute severe pneumonia respiratory failure vasoconstriction mechanisms <NUMBER> recent findings also demonstrate patients arb olmesartan increased secretion urinary ace<NUMBER> likely upregulation mechanism although unclear <NUMBER> despite hypothesis ace<NUMBER> upregulation causal relationship decreasing mortality demonstrated finally given contradictory hypotheses rapidly evolving nature disease social mediarelated hysteria several cardiology associations hfsaaccaha esc hypertension council released official statement regarding continuation acei arb covid<NUMBER> patients <NUMBER> associations strongly recommend continuing treatment aceiarb patients previously taking either class medication lack scientific evidence clinical data support discontinuing acearb use patients covid<NUMBER> coexisting heart failure hypertension ischemic heart disease wellstudied reduction mortality conferred acearb use beneficial effects patients diabetes chronic kidney disease proteinuria albuminuria currently outweigh theoretical risks covid<NUMBER> pandemic continues rapidly evolve affect patients cardiovascular comorbidities research needed clarify accuracy existing hypotheses conflict interest dr ricomesa ms white nothing disclose dr anderson received honoraria novartis pfizer consultant edwards lifesciences received research support abbott human animal rights informed consent manuscript contain studies human animal subjects reninangiotensin system ras maintains homeostasis blood pressure balance fluid salts <NUMBER> homeostasis ras critical physiological pathological regulation various organs including heart kidneys lungs <NUMBER> angiotensinconverting enzyme ace <NUMBER> potent negative regulator ras critical maintaining homeostasis ras <NUMBER> <NUMBER> human ace<NUMBER> gene located chromosome xp<NUMBER> includes <NUMBER> exons functioning typical zinc metallopeptidase ace<NUMBER> protein contains <NUMBER> amino acids type integral membrane glycoprotein containing single catalytic domain <NUMBER> ras ace<NUMBER> degrades angiotensin ang ii potent vasoconstriction proinflammation profibrosis converts ang <NUMBER> vasodialatic antiproliferative apoptotic <NUMBER> besides systemic effect blood pressure regulation ace<NUMBER> local regulatory effects pathological changes several organs including heart kidneys lungs <NUMBER> ace<NUMBER> also regulates amino acid absorption kidney gut modulates expression transporters amino acid <NUMBER> ace<NUMBER> identified receptor severe acute respiratory syndrome coronavirus sarscov could rapidly cause acute lung failure humans <NUMBER> hence ace<NUMBER> vital viral entry host cells sarscov infection coronavirus disease <NUMBER> covid<NUMBER> pandemic declared world health organization <NUMBER> march <NUMBER> <NUMBER> accumulated one million confirmed cases globally early april <NUMBER> <NUMBER> epidemiological study revealed covid<NUMBER> infected people ages <NUMBER> elderly comorbid patients higher risk poor clinical outcomes prognosis <NUMBER> <NUMBER> highthroughput sequencing identified pathogen covid<NUMBER> novel betacoronavirus <NUMBER> named severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> international committee taxonomy viruses <NUMBER> comparing sarscov sarscov<NUMBER> infective causing <NUMBER> times infections globally <NUMBER> confirmed cases covid<NUMBER> <NUMBER> april <NUMBER> <NUMBER> vs <NUMBER> sars patients <NUMBER> seems less virulent parts patients showed similar severity sarscov infection <NUMBER> also global case fatality rate covid<NUMBER> <NUMBER> <NUMBER> according data <NUMBER> april <NUMBER> <NUMBER> lower sarscov infection <NUMBER> <NUMBER> <NUMBER> similar sarscov sarscov<NUMBER> mainly transmits respiratory droplets direct contact according reported cases <NUMBER> <NUMBER> also entry sarscov<NUMBER> host cells requires binding receptor via sspike surface virus <NUMBER> computational modeling <NUMBER> <NUMBER> viral infection experiments using hela cells express ace<NUMBER> protein humans chinese horseshoe bats civets pigs mice <NUMBER> provided evidence ace<NUMBER> receptor sarscov<NUMBER> results cryoem experiments demonstrated sarscov<NUMBER> ten times higher affinity ace<NUMBER> comparing sarscov consistent higher efficiency infection sarscov<NUMBER> <NUMBER> findings indicated ace<NUMBER> might crucial human infection sarscov<NUMBER> progression prognosis covid<NUMBER> understanding expression activity ace<NUMBER> different physiological pathological conditions may help predict susceptibility sarscov<NUMBER> different cohorts people clinical outcomes prognosis covid<NUMBER> patients present review summarize regulation function ace<NUMBER> different physiological pathological states discuss potential implication sarscov<NUMBER> infectioninduced covid<NUMBER> organs express higher level ace<NUMBER> potential targets sarscov<NUMBER> infection therefore distribution abundance ace<NUMBER> organs may closely related clinical symptoms covid<NUMBER> known ace<NUMBER> enriched heart kidneys testes also broadly distributed lungs liver intestine brain <NUMBER> lung primary target organ sarscov<NUMBER> infection <NUMBER> <NUMBER> <NUMBER> hospitalized patients infected sarscov<NUMBER> developed pneumonia typically characterized groundglass opacity bilateral patchy shadowing chest computed tomography <NUMBER> <NUMBER> pathological examination biopsy samples obtained deceased covid<NUMBER> patient revealed diffused alveolar damage cellular fibromyxoid exudates lungs <NUMBER> analysis singlecell rna sequencing data obtained <NUMBER> human lung cells revealed <NUMBER> cells lungs expressed ace<NUMBER> <NUMBER> ace<NUMBER> expressed type ii apical surface epithelial cells at<NUMBER> <NUMBER> types cells including type apical epithelial cells airway epithelial cells fibroblasts endothelial cells macrophages also express ace<NUMBER> lower levels at<NUMBER> <NUMBER> results indicated at<NUMBER> likely primary target sarscov<NUMBER> lungs <NUMBER> addition respiratory symptoms common complications found patients infected sarscov<NUMBER> include acute cardiac injury acute kidney injury <NUMBER> <NUMBER> rectal swabs stool urine saliva sampled covid<NUMBER> patients positive sarscov<NUMBER> virus <NUMBER> findings demonstrated broad distribution sarscov<NUMBER> humans whose pattern similar distribution ace<NUMBER> analysis singlecell rna sequencing data human organs revealed cells express ace<NUMBER> included <NUMBER> cardiomyocyte <NUMBER> proximal tubular epithelial cells <NUMBER> bladder urothelial cells <NUMBER> ileum epithelial cells <NUMBER> esophageal epithelial cell <NUMBER> respiratory tract epithelial cells <NUMBER> sarscov<NUMBER> may attack cells binding ace<NUMBER> tissue damage inflammation may cause severe complications may worsen clinical outcomes moreover positive detection rna sarscov<NUMBER> samples gastrointestinal tissues stool covid<NUMBER> patients suggested fecaloral transmission might possible <NUMBER> noteworthy placental villi uterus also express ace<NUMBER> <NUMBER> <NUMBER> indicating possibility vertical maternalfetal transmission current reports clinical observations indicated transmission route possible <NUMBER> <NUMBER> <NUMBER> may low risk <NUMBER> <NUMBER> sex hormones affect homeostasis ras although ace<NUMBER> activity showed difference male female <NUMBER> males higher expression levels ace<NUMBER> lungs compared females <NUMBER> moreover least five types cells lungs males express ace<NUMBER> two four types females lungs <NUMBER> consistent findings sarscov<NUMBER> infected males slightly statistically significantly higher females <NUMBER> vs <NUMBER> survey included <NUMBER> patients <NUMBER> female sex hormones may affect ace<NUMBER> <NUMBER> aceace<NUMBER> activity ratio male serum higher females may partially attribute activation effect estrogen ace<NUMBER> activity <NUMBER> pregnancy fluctuation hormones may drastically change expression ace<NUMBER> reproductive system organs <NUMBER> ace<NUMBER> mrna expression uterus pregnant rats significantly higher one unpregnant rats <NUMBER> indicating implication progesterone regulation ace<NUMBER> expression <NUMBER> similar upregulation ace<NUMBER> expression also found kidneys pregnant rats <NUMBER> results suggested pregnant women infected sarscov<NUMBER> watched severe complications rapid progression according data collected <NUMBER> patients laboratoryconfirmed covid<NUMBER> <NUMBER> hospitals mainland china average age severe patients n <NUMBER> significantly older nonsevere ones n <NUMBER> seven years <NUMBER> among critically ill covid<NUMBER> patients nonsurvivors <NUMBER> years older survivors <NUMBER> years <NUMBER> data indicated aging might correlated pathological progression poor prognosis covid<NUMBER> results obtained genetic knockout mice model demonstrated ace<NUMBER> depletion caused physiological early aging independent ang <NUMBER> indicating regulatory role ace<NUMBER> aging <NUMBER> ace<NUMBER> expression lungs may decrease aging according results aged rats <NUMBER> humans ace<NUMBER> activity differ young aged males showed significant difference young aged females <NUMBER> <NUMBER> finding indicated effect aging ace<NUMBER> activity might gender difference <NUMBER> <NUMBER> study included <NUMBER> healthy chinese volunteers young chinese females showed significantly higher ace<NUMBER> activity aged females <NUMBER> however activity ace<NUMBER> women aging controversial spanish group reported lower ace<NUMBER> activity young females comparing aged females <NUMBER> controversy may due sample numberinduced deviation race requires validation investigation although children ages susceptible covid<NUMBER> accumulating clinical data indicated lower infection rates better clinical outcomes children compared adults <NUMBER> <NUMBER> recently retrospective study analyzed clinical data <NUMBER> pediatric cases covid<NUMBER> found <NUMBER> pediatric patients asymptomatic mild moderate cases <NUMBER> although currently lacks explanation phenomenon authors speculated potential implication ace<NUMBER> <NUMBER> results animal studies implied ace<NUMBER> expression adults might higher children sheep could used animal model studying development ras <NUMBER> expression ace<NUMBER> significantly lower neonatal sheep comparing li et al pharmacological research <NUMBER> <NUMBER> <NUMBER> adult ones <NUMBER> finding seems indicate lower ace<NUMBER> expression might correlated lower susceptibility children sarscov<NUMBER> however expression activity ace<NUMBER> development human children teenagers largely unclear <NUMBER> according latest study covid<NUMBER> <NUMBER> current smokers <NUMBER> patients severe neversmokers indicated severe rate smoker <NUMBER> <NUMBER> vs neversmoker <NUMBER> <NUMBER> <NUMBER> data suggested cigarette smoking may affect pathogenesis progression covid<NUMBER> ace<NUMBER> content blood healthy male volunteers decreased long term smoking experience <NUMBER> effect cigarette smoking may attribute nicotine could suppress activity ace<NUMBER>ang <NUMBER>mas receptor axis upregulate aceang ii ang ii type <NUMBER> receptor <NUMBER> decreased ace<NUMBER> level accompanied imbalance aceace<NUMBER> hence disturbance ras homeostasis animal experiments demonstrated downregulation ace<NUMBER> contributes pathogenesis cigarette smokinginduced pulmonary arterial hypertension pah <NUMBER> expression activity ace<NUMBER> may promptly modulated diets especially salt glucose fat high salt diet increased activity ace<NUMBER> urine mice low salt intake decreased <NUMBER> activity ace<NUMBER> urine may reflect ace<NUMBER> kidneys <NUMBER> indeed found high salt diet increased aceace<NUMBER> ratio glomeruli resulted renal dysfunction via inducing oxidative stress <NUMBER> ace<NUMBER> also implicated hypertension whose pathogenesis closely correlated high salt intake high salt intake increased prevalence hypertension human ace<NUMBER> rs<NUMBER> tt rs<NUMBER> gg genes <NUMBER> spontaneous hypertension rat model high salt diet profoundly worsened symptoms hypertension impaired kidneys via decreasing ace<NUMBER> <NUMBER> high glucose diet could also upregulate ace downregulate ace<NUMBER> leading imbalance aceace<NUMBER> heart <NUMBER> strikingly effect diet could affect offspring animal experiments using high salt dietfed pregnant sheep revealed suppress effect high salt diet ace<NUMBER> may affect embryo last post natal <NUMBER> western diet could decrease methylation ace<NUMBER> gene kidneys brain stem perinatal mice resulted autonomic dysfunctions male offspring <NUMBER> findings collectively demonstrated impact diet ace<NUMBER> may involved pathogenesis several chronic diseases may even affect offspring covid<NUMBER> patients comorbidities likely progress critically ill patients compared without comorbidities <NUMBER> <NUMBER> found patients coexisting disorders including chronic obstructive pulmonary disease copd hypertension coronary heart disease chronic kidney disease diabetes significantly severe patients without existing disorders table <NUMBER> <NUMBER> likely patients chronic diseases usually aged weak immunity poor respiratory tract function including weakened movement respiratory mucosal cilia cells reduced ability excrete cough reflexes several complications reported covid<NUMBER> patients closely correlated severity disease table <NUMBER> studying implication regulation ace<NUMBER> diseased status would help understanding progression covid<NUMBER> prognosis since sarscov<NUMBER> mainly transmits via respiratory droplets ace<NUMBER> mostly distributed at<NUMBER> cells lung preliminary target organ sarscov<NUMBER> infection pneumonia common complication seen covid<NUMBER> patients occurrence <NUMBER> <NUMBER> acute respiratory distress syndrome ards one severe complications covid<NUMBER> patients severity rate ranged <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> ace<NUMBER> wellestablished protective effects lungs <NUMBER> ace<NUMBER> polymorphism correlated severity ards <NUMBER> ace<NUMBER> knockout mice showed severe ardslike injury pathology lungs comparing wild type controls <NUMBER> symptoms alleviated treatment catalytically active enzymatically inactive recombinant ace<NUMBER> race<NUMBER> protein <NUMBER> moreover ace<NUMBER> also protective sarsinfection induced acute lung disease <NUMBER> expression ace<NUMBER> lungs mice infected sarscov greatly reduced aggravated lung failure <NUMBER> results convincingly proved ace<NUMBER> protective lung injury may therapeutic target ards shown covid<NUMBER> ace<NUMBER> mrna expression decreased lungs copd rats model comparing controls <NUMBER> reduction ace<NUMBER> copd lungs revealed dysregulation ras may attribute upregulation et<NUMBER> et<NUMBER> increased sputum serum samples copd patients <NUMBER> et<NUMBER> doseand timedependently decreased expression activity ace<NUMBER> cell culture human bronchial epithelial cells <NUMBER> recent data showed covid<NUMBER> patients copd coexisting disorder likely progress severe cases <NUMBER> may partially attribute decrease ace<NUMBER> many pulmonary diseases copd accompanied hypoxia <NUMBER> early phase hypoxia ace<NUMBER> expression profoundly elevated pulmonary artery smooth muscle cells later elevation hypoxiainducible factor<NUMBER>α hif<NUMBER>α expression ace target gene hif<NUMBER>α increased accompanied decrease ace<NUMBER> <NUMBER> animal experiments demonstrated similar regulation hif<NUMBER>α ace<NUMBER> level possibly via mirna let<NUMBER>b hypoxia rats <NUMBER> results indicated hypoxia cellular adaptation hypoxia could profoundly induce fluctuation ace<NUMBER> lungs ras dysregulation primarily implicated pathogenesis progression hypertension <NUMBER> negative regulator ras ace<NUMBER> decreases blood pressure animal models hypertension <NUMBER> decrease ace<NUMBER> reported lungs patients idiopathic pah <NUMBER> similarly ace<NUMBER> also decreased blood vessel kidneys brain hypertension models <NUMBER> <NUMBER> since ace<NUMBER> protective tissue injuries lungs <NUMBER> heart <NUMBER> results suggested covid<NUMBER> patients hypertension may likely develop complications progress severe cases indeed data table <NUMBER> showed covid<NUMBER> patients hypertension high severity rate <NUMBER> besides severe cases covid<NUMBER> significantly higher systolic pressure comparing nonsevere cases <NUMBER> mmhg vs <NUMBER> mmhg <NUMBER> phenomenon may due deprivation ace<NUMBER> sarscov<NUMBER> leading drastic decrease ace<NUMBER> ace<NUMBER> enriched heart known essential regulator heart function <NUMBER> suggesting heart may one primary target organs sarscov<NUMBER> infection patients infected sarscov<NUMBER> higher risk progressing severe cases coronal heart disease comorbidity <NUMBER> <NUMBER> acute cardiac injury one common complications found covid<NUMBER> patients <NUMBER> <NUMBER> according retrospective study published lancet included <NUMBER> covid<NUMBER> patients <NUMBER> developed acute cardiac injury <NUMBER> cases diagnosed severe cases <NUMBER> therefore coronal heart disease covid<NUMBER> patients closely watched baseline comorbidity complications pathogenesis progression cardiac injury one preliminary factors determined clinical outcomes prognosis covid<NUMBER> patients <NUMBER> <NUMBER> cardiac injury found covid<NUMBER> patients may least partially attributed fluctuation ace<NUMBER> rat model myocardial infarction infarcted periinfarcted regions showed increased ace<NUMBER> expression comparing surviving myocardial tissue three days infarction <NUMBER> <NUMBER> days infarction surviving tissue also showed elevated ace<NUMBER> expression comparing normal control <NUMBER> upregulation ace<NUMBER> heart myocardial infarction may triggered compensatory protective mechanism <NUMBER> however lungs patients pah ace<NUMBER> expression phosphorylation drastically decreased <NUMBER> therefore pulmonary function covid<NUMBER> may progressively deteriorate upon occurrence cardiac complications kidneys may major target organ sarscov<NUMBER> infection laboratory examinations demonstrated urine samples covid<NUMBER> patients found positive virus <NUMBER> acute kidney injury one severe complications covid<NUMBER> patients sarscov<NUMBER> may infect renal intrinsic cells proximal tubular epithelial cells directly induce renal dysfunction occurrence acute kidney injury complication covid<NUMBER> <NUMBER> <NUMBER> cases reported lancet developed severe cases <NUMBER> cohort <NUMBER> covid<NUMBER> patients occurrence acute kidney injury <NUMBER> severity rate <NUMBER> <NUMBER> consecutive cohort study included <NUMBER> covid<NUMBER> patients renal dysfunction characterized elevation serum creatine blood urea nitrogen appearance proteinuria hematuria showed significantly higher risk mortality compared normal renal function <NUMBER> renal dysfunction independent risk factor mortality hospitalized patients <NUMBER> studies demonstrated acute kidney injury one critical complications occurred covid<NUMBER> patients ace<NUMBER> enriched kidneys <NUMBER> activity ace<NUMBER> renal cortex even higher heart <NUMBER> expression level ace<NUMBER> decreased acute kidney injury <NUMBER> several models chronic kidney disease induced hypertension diabetes nephrectomy <NUMBER> disrupted homeostasis ras kidneys worsened pathological changes kidneys <NUMBER> <NUMBER> accumulating evidence also demonstrated ace<NUMBER> played crucial role pathogenesis progression renal diseases reviewed <NUMBER> ace<NUMBER> knockout could worsen renal dysfunction modeled ischemiareperfusion <NUMBER> aggravate fibrotic pathologies obstructive renal diseases <NUMBER> investigation implication ace<NUMBER> renal dysfunction occurred covid<NUMBER> patients clinical outcome covid<NUMBER> patients chronic kidney diseases comorbidity required ace<NUMBER> modulates expression neutral amino acid transporters cell surface epithelial cells including insulin secretion pancreatic βcells andor growth pancreatic islet cells <NUMBER> ace<NUMBER> knockout mice showed impairments islet dysfunction abnormality glucose tolerance <NUMBER> diabetic mice model infected adenovirus expressing human ace<NUMBER> showed increase production insulin reduction cellular apoptosis pancreatic islet <NUMBER> moreover ace<NUMBER> could improve endothelial function pancreatic islet microvascular unit <NUMBER> findings demonstrated ace<NUMBER> prevented pancreatic dysfunction diabetes ace<NUMBER> implicated diabetic nephrology human kidneys diabetic nephropathy ace<NUMBER> profoundly suppressed ace increased <NUMBER> ratio aceace<NUMBER> positively correlated systolic pressure fasting blood glucose level serum creatine proteinuria patients <NUMBER> race<NUMBER> showed promising prevention diabetic nephrology <NUMBER> covid<NUMBER> patients diabetes coexisting disorders worse clinical outcome phenomena may partially attribute deprivation ace<NUMBER> sarscov<NUMBER> infection sarscov<NUMBER> binds ace<NUMBER> enter host cells leading systematic deprivation ace<NUMBER> race<NUMBER> shown therapeutic effect pulmonary injury <NUMBER> diabetic nephrology hypertension <NUMBER> recently found human recombinant soluble ace<NUMBER> hrsace<NUMBER> already tested phase <NUMBER> phase <NUMBER> clinical trials effectively reduced recovery sarscov<NUMBER> vero cells prevented infection sarscov<NUMBER> engineered human blood vessel organoids human kidney organoids <NUMBER> progress suggested therapeutic potential hrsace<NUMBER> covid<NUMBER> since ace<NUMBER> activation demonstrated protective effect pulmonary injury including ards developing ace<NUMBER> activator potential therapy may promising approach covid<NUMBER> diminazene aceturate <NUMBER> resorcinolnaphthalein xanthenone <NUMBER> found activate ace<NUMBER> drug screening test showed potential candidate therapy covid<NUMBER> acei arb commonlyused treatments hypertension safety effect using drugs covid<NUMBER> patients hypertension still unclear animal experiments revealed drugs might decrease systolic pressure normal rats upregulate ace<NUMBER> <NUMBER> since ace<NUMBER> expression suppressed hypertension <NUMBER> may deprived sarscov<NUMBER> virus upon infection application arb may protective pulmonary injury careful blood pressure management ace<NUMBER> currently intensive investigation receptor sarscov<NUMBER> novel coronavirus causes covid<NUMBER> pandemic summarized increasingly emerging findings covid<NUMBER> discussed potential role ace<NUMBER> pathogenesis progression prognosis covid<NUMBER> susceptibility sarscov<NUMBER> different cohorts seemed correlate ace<NUMBER> level distribution target organs susceptible sarscov<NUMBER> infection complications covid<NUMBER> similar one ace<NUMBER> three functions ace<NUMBER> peptidase negatively modulates ras regulator amino acid transport kidneys receptor virus including sarscov<NUMBER> sarscov together local protective effect tissue injury implicated progression prognosis covid<NUMBER> findings indicated targeting ace<NUMBER> using hrsace<NUMBER> ace<NUMBER> activator may potential therapeutic strategy covid<NUMBER> prescription drugs may affect ace<NUMBER> acei arb covid<NUMBER> patients requires close observation blood pressure progression covid<NUMBER> authors declare known competing financial interests personal relationships could appeared influence work reported paper background covid<NUMBER> patients chronic diseases hypertension diabetes coronary heart diseases likely worsen mixed results covid<NUMBER> severity metaanalysis analyze correlation hypertension diabetes coronary heart disease covid<NUMBER> disease severity methods available data pubmed web science china national knowledge infrastructure database wanfang database vip database analyzed using fixed effects model metaanalysis derive overall odds ratios <NUMBER> cis funnel plots beggs used assess publication bias findings <NUMBER> articles found following initial search assessed <NUMBER> fulltext articles <NUMBER> articles <NUMBER> covid<NUMBER> patients met selection criteria metaanalysis significant heterogeneity studies significant correlations covid<NUMBER> severity hypertension or<NUMBER> december <NUMBER> cluster patients pneumonia unknown cause linked seafood wholesale market wuhan china <NUMBER> pathogen currently named severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> <NUMBER> covid<NUMBER> caused severe acute respiratory syndrome associated icu admission high mortality <NUMBER> major comorbidities fatality cases include hypertension diabetes coronary heart disease cerebral infarction chronic bronchitis <NUMBER> research results show covid<NUMBER> severe patients higher proportion hypertension diabetes coronary heart disease covid<NUMBER> patients combined cardiovascular disease associated higher risk mortality <NUMBER> study aimed analyze correlation hypertension diabetes coronary heart disease covid<NUMBER> disease severity certain clinical guiding significance development reasonable comprehensive treatment plan patients covid<NUMBER> strictly followed inclusion criteria increased exclusion criteria reduce selection bias mesh emtree meth terms freetext covid<NUMBER> sars cov<NUMBER> clinical characteristics clinical features epidemiological characteristics strategy follows included studies selected based strobe statement describe setting locations relevant dates give characteristics study participants eg eligibility criteria diagnostic criteria sources methods selection clearly define outcomes exposures etc inclusion criteria listed subjects laboratoryconfirmed covid<NUMBER> b defined degree severity covid<NUMBER> severe vs nonsevere intensive care unit icu vs nonicu progression improvementstabilization time admission using american thoracic society guidelines communityacquired pneumonia novel coronavirus pneumonia diagnosis treatment plan published national health committee peoples republic china trial version <NUMBER> c outcomes number covid<NUMBER> hypertension diabetes coronary heart disease severe patients nonsevere patients literature exclusion criteria literatures review review metaanalysis monographs conference abstracts duplicate literature data b observation group control group distinguish literature disease severity c reference quality evaluation scale newcastleottawa scale nos standard lowquality literature score <NUMBER> two independent reviewers determined whether observational studies met eligibility criteria reviewers screened qualified studies order title abstract full text publications managed using endnote x<NUMBER> software endnotex<NUMBER> trials excluded step recorded reasons indicated data extracted collected specialized spreadsheets extracted contents included number hypertension diabetes coronary heart disease covid<NUMBER> patients according disease severity discrepancies reviewers resolved third reviewer counts proportions categorical endpoints extracted statistical analyses conducted revman <NUMBER> software results dichotomous outcomes reported odds ratios <NUMBER> cis mantel haenszel statistical method fixed effect models analysis model used assess outcomes <NUMBER> value used evaluate heterogeneity <NUMBER> ≤ <NUMBER> results considered statistically homogeneous used fixed effect model used analysis heterogeneity studies large <NUMBER> ＞ <NUMBER> random effects model used analysis research data cannot combined analysis small probability event rights reserved reuse allowed without permission authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint occurs general description used qualitative evaluation descriptive analysis performed test level metaanalysis set α <NUMBER> forest plots visually showed effect estimates included studies funnel plots beggs used assess publication bias process used select observational studies followed preferred reporting items systematic reviews meta analyses prisma flow diagram <NUMBER> studies retrieved <NUMBER> studies finally included selection detailed screening process illustrated figure <NUMBER> studies conducted china published chinese english language baseline data shown table <NUMBER> except peng et al <NUMBER> scored <NUMBER> points studies scored <NUMBER> points study extracted data covid<NUMBER> comorbidities included literature listed included studies comorbidities covid<NUMBER> mainly included hypertension diabetes coronary heart disease chronic liver disease cancermalignant tumor cerebrovascular disease chronic obstructive pulmonary disease copd figure <NUMBER> efficacy outcomes systematic review <NUMBER> studies ultimately included statistical analysis n<NUMBER> participants authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint hypertension diabetes coronary heart disease affect severity covid<NUMBER> may related imbalance angiotensinconverting enzyme <NUMBER> ace<NUMBER> cytokine storm induced glucolipid metabolic disorders glmd angiotensinconverting enzyme <NUMBER> ace<NUMBER> homologue carboxypeptidase ace main active peptide reninangiotensinaldosterone system raas <NUMBER> targeting angiotensin ii ang ii ace<NUMBER> shown protective effects cardiovascular system many organs <NUMBER> even protects severe acute lung failure infections severe acute respiratory syndrome sars coronavirus <NUMBER> decreased ace<NUMBER> shifts balance raas angiotensin ii ang iiat<NUMBER>r axis resulting heart failure progression <NUMBER> sarscov<NUMBER> spike glycoprotein binds human ace<NUMBER> high affinity <NUMBER> covid<NUMBER> infection leads ace<NUMBER> reductions causing raas imbalance aggravate cardiovascular disease covid<NUMBER> addition views consider patients cardiac diseases hypertension diabetes treated ace<NUMBER>increasing drugs higher risk severe covid<NUMBER> infection <NUMBER> however reports find ace inhibitor acei may beneficial effects patients risk pneumonia use lipophilic hydrophilic acei associated decreased mortality patients communityacquired pneumonia <NUMBER> therefore covid<NUMBER> patients hypertension diabetes coronary heart disease monitored ace<NUMBER>modulating medications describe specific medications received research determine mechanisms effect covid<NUMBER> diseases severity hyperlipidemia diabetes nonalcoholic fatty liver atherosclerotic cardiovascular disease many metabolic disorders often combined affect professor jiao guo team proposed new concept glucolipid metabolic disorders glmd <NUMBER> glmd associated neuroendocrine disorders insulin resistance oxidative stress chronic inflammatory responses intestinal flora disorders <NUMBER> <NUMBER> <NUMBER> covid<NUMBER> patient activation cells lead severe immune injury <NUMBER> severe covid<NUMBER> patients higher concentrations proinflammatory cytokines nonsevere patients suggesting cytokine storm associated disease severity <NUMBER> hypothesized chronic inflammation glmd patients seems activated patients covid<NUMBER> infection cause cytokine storm hyperinduction proinflammatory cytokine production <NUMBER> cytokine storm caused covid<NUMBER> may lead exacerbation glmd suggest comprehensive analysis glmd patients covid<NUMBER> limited assess hypertension diabetes coronary heart disease also obesity dyslipidemia atherosclerosis metabolic disorders etc multitarget therapy help regulate dysfunction neuronalendocrineimmune system improve severity covid<NUMBER> disease acknowledged limitations metaanalysis may exist following points first included total <NUMBER> studies total <NUMBER> severe patients <NUMBER> nonsevere patients limited improve accuracy results large samples highquality research truly accurately reflect correlation hypertension diabetes coronary heart disease severity covid<NUMBER> second due relatively small number eligible studies possible perform subgroup analysis type severity addition literature carry correlation studies disease severity time outcome corresponding subgroup analysis cannot performed may also affect accuracy third many factors affect severity covid<NUMBER> disease addition hypertension diabetes coronary heart disease also related various factors age diseases living environment economic health conditions smoking viral virulence compliance included literature unable control factors may also affect results finally metaanalysis gray literature rarely published impact publication bias results study cannot completely ruled yyc jg designed study yyc xg undertook review activities including searches study selection data extraction calculation quality assessment yyc xg metaanalyses yyc wrote manuscript contributions jg lxw xg authors reviewed study rights reserved reuse allowed without permission authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint declare competing interests authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed httpsdoiorg<NUMBER> doi medrxiv preprint nanot applicable refers chronic cardiovascular disease rights reserved reuse allowed without permission authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed xaxis represents point estimate odds ratio corresponding <NUMBER> confidence interval yaxis represents source study patients odds ratio cl confidence interval fang x <NUMBER> guan w <NUMBER> huang c <NUMBER> liu w <NUMBER> wang <NUMBER> xiang <NUMBER> xiong j <NUMBER> yuan j <NUMBER> zhang j <NUMBER> total <NUMBER> ci heterogeneity chi² <NUMBER> df <NUMBER> p <NUMBER> i² <NUMBER> test overall effect z <NUMBER> p <NUMBER> rights reserved reuse allowed without permission authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed httpsdoiorg<NUMBER> <NUMBER> clinical outcomes observed raas inhibitors covid<NUMBER> patients human covs hcovs belong coronavirinae subfamily classified <NUMBER> phylogenic clusters α β γ δ covs f zhang et al <NUMBER> among covs <NUMBER> prominant strains α β subgroups infect humans madjid safavinaeini solomon vardeny <NUMBER> <NUMBER> humaninfectious covs <NUMBER> hcovnl<NUMBER> hcovhku<NUMBER> hcovoc<NUMBER> hcov<NUMBER>e cause selfresolving upper respiratory tract infections secondmost common cause <NUMBER> common cold killerby et al <NUMBER> su et al <NUMBER> clinical manifestation vary different strains covs hcovnl<NUMBER> hcovhku<NUMBER> hcovoc<NUMBER> hcov<NUMBER>e mainly cause mild symptoms cause organ damage individuals example giacomo et al reported hcovoc<NUMBER> triggered fulminant myocarditis <NUMBER>yearold woman veronese et al <NUMBER> van doremalen falzarano munster <NUMBER> three viruses induce respriratory distress distinctive properties table <NUMBER> sarscov<NUMBER> infectious reproductive number r <NUMBER> estimated <NUMBER> comparison sarscov merscov respective r <NUMBER> estimates <NUMBER> <NUMBER> respectively petrosillo sarscov<NUMBER> binds surface protein ace<NUMBER> merscov enters host cells via binding dipeptidyl peptidase <NUMBER> dpp<NUMBER> petrosillo et al <NUMBER> relative sarscov spike protein sarscov<NUMBER> spike protein contains several amino acid changes increase salt bridge formation hydrophobic interactions strengthen ace<NUMBER> binding gheblawi et al <NUMBER> changes may contribute virulence considerably larger global spread sarscov<NUMBER> compared sarscov gheblawi et al <NUMBER> ace<NUMBER> transmembrane protein plays central role downregulation raas gheblawi et al <NUMBER> coexpressed transmembrane protease serine <NUMBER> tmprss<NUMBER> ace<NUMBER> acts receptor sarscov<NUMBER> cell entry guzik et al <NUMBER> ace<NUMBER> expression considerably reduced sarscov sarscov<NUMBER> infection jung choi kim <NUMBER> interaction ace<NUMBER> receptor binding domain rbd s<NUMBER> subunit viral spike protein facilitates virus entrance endocytosis sarscov<NUMBER> along ace<NUMBER> endosomes reduces surface ace<NUMBER> expression k wang gheblawi oudit <NUMBER> viral entry sarscov<NUMBER> subsequently upregulates adam metallopeptidase domain <NUMBER> adam<NUMBER> mediates ectodomain shedding ace<NUMBER> patel et al <NUMBER> adam<NUMBER> activation also mediates liberation membrane bound cytokine precursors including il<NUMBER> ifnγ repress ace<NUMBER> mrna expression k sarscov<NUMBER> activation raas combined reduced ace<NUMBER>mediated conversion angiotensin ii ang ii ang<NUMBER> results increased angii accumulation ang ii activates angiotensin receptor type <NUMBER> j u r n l p r e p r f receptor at<NUMBER>r trigger signaling cascade whereby activation erkp<NUMBER> map kinase signaling results upregulation adam<NUMBER> initiate positive feedback loop limits ace<NUMBER> expression patel et al <NUMBER> addition inflammationinduced lung injury leads apoptosis clara cells type ii alveolar epithelial cells major ace<NUMBER>expressing cell subsets reduced survival cells also contributes downregulation ace<NUMBER> figure <NUMBER> wiener cao hinds ramirez williams <NUMBER> clinical outcomes covid<NUMBER> patients strongly associated preexisting health status infected patients cvd comorbidities increase mortality patients covid<NUMBER> shahid et al <NUMBER> cvd comorbidities direct consequences upon sarscov<NUMBER> infection example patients abnormally high blood pressure may exhibit increased apoptosis heart also kidney may exacerbated additional stress sarscov<NUMBER> infection gonzalez et al <NUMBER> hamet et al <NUMBER> course severe covid<NUMBER> biomarkers indicating heart injury become elevated mehta et al <NUMBER> washington state case series <NUMBER> critically ill covid<NUMBER> patients <NUMBER> patients <NUMBER> developed cardiomyopathy <NUMBER> <NUMBER> developed acute renal injury arentz et al <NUMBER> ace<NUMBER> expression human heart might one potential mechanism underlying heart injury infection sarscov<NUMBER> however sarscov<NUMBER> infectioninduced cytokine storm may also contribute cardiovascular injury l chen li chen feng xiong <NUMBER> tissue kallikrein produces kinin bradykinin peptides cleaving j u r n l p r e p r f substrate kininogen addition role production angiotensin ii ace mediates bradykinin degradation thus kinin bradykinin increased use ace inhibitors figure <NUMBER> increased bradykinin levels believed responsible dry cough adverse effect observed patients ace inhibitors moreover kinin bradykinin peptides also participate shock respiratory allergy thus wellknown side effects suggest ace inhibitors may aggravate lung inflammation cause lung dysfunction covid<NUMBER> despite potential adverse effect dry cough respiratory tract kallikreinkinin system kks many positive functions may ameliorate cvd figure <NUMBER> experimental models expression human tissue kallikrein caused significant reduction blood pressure fructoseinduced hypertension rats affect blood pressure nonfructosefed normal rats yao yin shen chao chao <NUMBER> accumulating evidence indicates kks capable exerting organ protection apart blood pressurelowing effect vivo study showed infusion kinin improved renal function hypertensive rats lowered corresponding increase capase<NUMBER> activity recombinant adenoassociated virus raav mediated human tissue kallikrein exerted protective effect myocardial apoptosis spontaneous hypertensive rats shrs specifically modulating activity caspase<NUMBER> b<NUMBER> receptor yan wang wang <NUMBER> tissue kallikrein reduced blood pressure also attenuated remodeling myocardium large blood vessels kidney wang et al <NUMBER> addition tissue kallikrein efficiently protected diabetic nephropathy chronic renal j u r n l p r e p r f failure tu et al <NUMBER> yuan et al <NUMBER> zhao et al <NUMBER> also suggested tissue kallikrein prevents apoptosis ventricular remodeling myocardial infarction yao et al <NUMBER> summary bradykinin may improve blood pressure regulation provide organ protection hypertensive patients since organ injury often determines mortality hypertensive patients infected sarscov<NUMBER> hypothesize product increased bradykinin levels induced ace inhibition may provide benefit harm cvdcomorbid covid<NUMBER> patients many studies demonstrated ang iiinduced hypertension accompanying vascular inflammation result organ damage chen et al <NUMBER> f chen et al <NUMBER> g e gonzalez et al <NUMBER> yang et al <NUMBER> il<NUMBER> markedly attenuates cardiac injury inflammation induced ang ii suggests il<NUMBER> acts downstream ang ii effector chen et al <NUMBER> f chen et al <NUMBER> g e gonzalez et al <NUMBER> yang et al <NUMBER> ang ii also induces production proinflammatory cytokines tnfα il<NUMBER>β guo et al <NUMBER> several studies suggest ang ii acts vasoactive peptide regulates blood pressure also works inflammatory cytokine causing cardiovascular remodeling gibbons pratt dzau <NUMBER> griendling minieri ollerenshaw alexander <NUMBER> sadoshima izumo <NUMBER> immune response activated sarscov<NUMBER> cytokine storm often observed severe cases serum j u r n l p r e p r f levels proinflammatory cytokines including il<NUMBER> il<NUMBER>r il<NUMBER>β elevated qin et al <NUMBER> xu et al <NUMBER> increased markers cytokine storm serum il<NUMBER> predict poor outcome patients severe covid<NUMBER> cao <NUMBER> covid<NUMBER> patients also elevated ang ii levels positively associated viral load lung injury thus sarscov<NUMBER> infection dysregulates ang ii overactivates immune response augments cytokine storm causes organ damage inhibition blockage raas may helpful attenuate inflammatory storm prevent endorgan damage ace<NUMBER> plays important role regulation angiotensin signaling generation ang ii well understood liverderived angiotensinogen atg cleaved renin ang processed ace ang ii converted ace<NUMBER> ang<NUMBER> ang<NUMBER> generally considered cvdprotective counters action ang ii g proteincoupled sarscov<NUMBER> uses ace<NUMBER> abundantly expressed pulmonary epithelium kidney heart intracellular entry figure <NUMBER> infection sarscov<NUMBER> ace<NUMBER> expression reduced crackower et al <NUMBER> kuba et al <NUMBER> animal models infection sarscov showed ace<NUMBER> downregulation resulted proinflammatory responses including lung injury cardiac contractility impairment crackower et al <NUMBER> imai et al <NUMBER> kuba et al <NUMBER> sarscov<NUMBER> infections progress similarly sarscov virus may deteriorate patients condition via two production contribute tissue damage covid<NUMBER> although ace inhibitors arbs directly affect ace<NUMBER> indirectly lead increased ace<NUMBER> activity ang<NUMBER> expression hanff harhay brown cohen mohareb <NUMBER> study ferrario coworkers showed ace inhibitor caused <NUMBER>fold rise plasma ang<NUMBER> concentrations approximately <NUMBER> increase ace<NUMBER> expression left ventricle ferrario et al <NUMBER> thus usage ace inhibitors arbs may potential benefit preventing covid<NUMBER>triggered organ damage via upregulation ang<NUMBER> depletion ang ii conclusion dysregulation raas due increased ang ii decreased ace<NUMBER> lead harmful inflammatory response worsening j u r n l p r e p r f elevated blood pressure ace inhibitors arbs may potential role preventing harmful effects directly countering ang ii upregulating ace<NUMBER> acute respiratory distress syndrome ards common devastating orfanos et al <NUMBER> ace activity considerably elevated bronchoalveolar lavage fluid balf j u r n l p r e p r f patients ards idell et al <NUMBER> polymorphic insert reduces ace expression activity associated reduced ards severity marshall et al <NUMBER> ace expression activates macrophage function stimulates interleukin il formation covid<NUMBER> associated increased proportion mononuclear phagocytes regulated raas merad martin <NUMBER> addition alveolar macrophages associated tissue repair fibrosis generation covid<NUMBER> patients ramachandran et al <NUMBER> lastly ace inhibitors decrease oxygen free radical production generated lung alveolar macrophages suzuki et al <NUMBER> yamamoto et al <NUMBER> ang ii also induce endothelial expression il<NUMBER> eselectin pselectin ccchemokine ligand<NUMBER> ccl<NUMBER> ccl<NUMBER> increase pulmonary leukocyte recruitment retention bernstein et al <NUMBER> moreover ang ii induces nicotinamide adenine dinucleotide phosphate nadph oxidase vascular smooth muscle cells endothelial cells increase reactive oxygen species ros cause vascular injury bernstein et al <NUMBER> addition ang ii reduces alveolar epithelial cell survival accelerating cellular j u r n l p r e p r f apoptosis ec <NUMBER> <NUMBER> nm r wang et al <NUMBER> epithelial apoptosis linked subsequent fibrotic responses shetty et al <NUMBER> uhal et al <NUMBER> finally severe ards covid<NUMBER> patients often suffer septic shock prolonged ang ii signaling induces at<NUMBER>r phosphorylation desensitization major cause vascular hyporesponsiveness leads pulmonary vasoplegia levy et al <NUMBER> together data suggests ang ii may potential therapeutic target treatement many vascular pathophysiologies covid<NUMBER> ang ii lower ace<NUMBER> deleterious cardiovascular consequences also worsens lung functional decline compared wt mice ace<NUMBER>deficient mice impaired lung function higher mortality sepsisinduced lung injury severe lung failure ace<NUMBER>deficient mice could rescued j u r n l p r e p r f inactivation ace at<NUMBER>r blockage arbs prevent downregulation ace<NUMBER> lpsinduced ards suggesting raas inhibitors may also protect lung damage patients sars wostenvan asperen et al <NUMBER> furthermore downregulation ace<NUMBER> lead elevated activation ace ang ii li et al <NUMBER> simoes e silva et al <NUMBER> exacerbate physiological progression ards covid<NUMBER> thus despite acting receptor sarscov<NUMBER> ace<NUMBER> activity likely protective covid<NUMBER> disease progression conclusion elevation ace ang ii downregulation ace<NUMBER> exacerbate sarscov<NUMBER> induced ards drugs target ace ang ii ace inhibitors arbs may play important role abrogating inflammatory response vasoconstriction vq mismatching causes clinical deterioration patients covid<NUMBER> animal models clinical experience suggest beneficial deleterious effects ace inhibitors arbs patients suffering covid<NUMBER> uncertainty raises concerns regarding overall effect raas inhibitors sarscov<NUMBER> infection sriram insel <NUMBER> concerns ignored examination clinical outcomes raas inhibitor application covid<NUMBER> patients top priority g l zhou et al <NUMBER> accumulated clinical data demonstrates hypertension associated higher mortality patients covid<NUMBER> sars middle east respiratory syndrome mers inhibitors covid<NUMBER>related outcomes south korea jung et al <NUMBER> among <NUMBER> confirmed sarscov<NUMBER> patients raas inhibitor use alter mortality adjusted <NUMBER> <NUMBER> ci <NUMBER> p<NUMBER> jung et al <NUMBER> among hospitalized covid<NUMBER> patients hypertension inhospital mortality lower <NUMBER> patients given raas inhibitors treated raas inhibitors <NUMBER> although difference statisticaly significant p<NUMBER> jung et al <NUMBER> multivariate analysis adjusted baseline comorbidities revealed independent association raas inhibitor use risk mortality among hypertensive covid<NUMBER> patients adjusted <NUMBER> <NUMBER> ci <NUMBER> p<NUMBER> jung et al <NUMBER> mancia et al <NUMBER> data suggest treatment ace inhibitorsarbs increase inhibitortreated subjects may seek routine intensive medical care heightened awareness leads diligent hygiene andor social distancing addition findings may replicate populations geographically ethnically diverse cohorts randomized controlled clinical trials needed better understand specific effect raas inhibitors covid<NUMBER> patients two recent studies suggest interesting finding ace inhibitors might reduce covid<NUMBER> morbidity arbs less pronounced effect khera et al reported <NUMBER> hypertensive sarscov<NUMBER> patients treated ace inhibitors <NUMBER> less likely hospitalized treated ace inhibitors reduction hospitalization patients treated arbs khera et al <NUMBER> milne et al j u r n l p r e p r f analyzed gene expression <NUMBER> lung tissue samples discovered ace inhibitor treatment associated significantly lower expression ace<NUMBER> coreceptor tmprss<NUMBER> contrast tmprss<NUMBER> expression altered patients treated arbs milne yang timens bosse sin <NUMBER> data provide potential mechanistic explanation protective role ace inhibitors arbs covid<NUMBER> treatment review recent literature suggests potential protective effects continued treatment cvd covid<NUMBER> subjects ace inhibitors andor authors declared competing interests exist arb angiotensinreceptor blocker coronavirus disease caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> global pandemic initially started wuhan china spread extremely quickly making way <NUMBER> countries novel coronavirus continues evolve still many limitations knowledge exactly virus would impact critically older adults people age underlying medical conditions hypertension diabetes shown worse prognosis <NUMBER> diabetic patients increased morbidity mortality rates linked hospitalization intensive care unit icu admissions <NUMBER> people chronic obstructive pulmonary disease copd respiratory illnesses also higher risk severe illness covid<NUMBER> <NUMBER> risk contracting covid<NUMBER> patients copd found <NUMBER>fold higher patients without copd <NUMBER> article part topical collection covid<NUMBER> adekunle sanyaolu sanyakunlehotmailcom <NUMBER> federal ministry health abuja nigeria retrospective study middleaged elderly patients covid<NUMBER> found elderly population susceptible illness likely admitted icu higher mortality rate <NUMBER> agerelated changes geriatric population may due changes lung anatomy muscle atrophy results changes physiologic function reduction lung reserve reduction airway clearance reduction defense barrier function <NUMBER> clinical outcomes length stay directly correlate underlying conditions age covid<NUMBER> patient researchers china studied <NUMBER> patients icu covid<NUMBER> <NUMBER> subjects <NUMBER> patients died <NUMBER>th day median survival <NUMBER> days <NUMBER> patients many different comorbidities <NUMBER> patients hypertension <NUMBER> survivors median duration hospitalization negative test result <NUMBER> days <NUMBER> furthermore another study conducted china studied <NUMBER> covid<NUMBER> patients <NUMBER> patients least one comorbidity concluded older individuals greater <NUMBER> years likely exhibit severe form covid<NUMBER> disease <NUMBER> study <NUMBER> patients median age <NUMBER> years died giving effective mortality rate <NUMBER> <NUMBER> concluded older patients likely succumb covid<NUMBER> disease usa centers disease control prevention cdc uses covidnet <NUMBER> states monitor demographics covid<NUMBER> patients hospitalized <NUMBER> march <NUMBER> <NUMBER> <NUMBER> total <NUMBER> patients covidnet <NUMBER> patients underlying comorbidity <NUMBER> <NUMBER> patients <NUMBER> aged <NUMBER> years older least comorbidity <NUMBER> common comorbidities found obesity hypertension diabetes mellitus <NUMBER> purpose paper review comorbidities given patients severe covid<NUMBER> cases comorbidity furthermore would like examine specific comorbidities relation covid<NUMBER> disease progression outcomes based literature report since outbreak electronic literature search performed using pubmed google scholar ebscohost mendeley medline plus search limited peerreviewed articles published january april <NUMBER> <NUMBER> article selected included keywords coronavirus covid<NUMBER> sarscov<NUMBER> clinical features comorbidity diabetes hypertension articles reviewed included based applicability topic confirmed reported cases covid<NUMBER> wide range symptoms mild complaints fever cough critical cases associated difficulty breathing <NUMBER> common symptoms include cough fever chills shortness breath sob muscle aches sore throat unexplained loss taste smell diarrhea headache <NUMBER> symptoms start mild become intense <NUMBER> <NUMBER> days worsening pneumonia develops patients <NUMBER> approximately <NUMBER> <NUMBER> infected individuals become seriously ill develop difficulty breathing especially elderly underlying health conditions <NUMBER> metaanalysis study covid<NUMBER> patients depicted fig <NUMBER> showed fever <NUMBER> common symptom followed dry cough <NUMBER> fatigue <NUMBER> <NUMBER> symptoms noted productive cough <NUMBER> sob <NUMBER> muscle pain <NUMBER> sore throat <NUMBER> headache <NUMBER> <NUMBER> least common symptoms diarrhea <NUMBER> nausea vomiting <NUMBER> rhinorrhea <NUMBER> abdominal pain <NUMBER> chest pain <NUMBER> <NUMBER> symptoms covid<NUMBER> may appear anytime <NUMBER> <NUMBER> days exposure therefore <NUMBER>day quarantine recommended <NUMBER> average incubation period covid<NUMBER> approximately <NUMBER> days <NUMBER> wuhan china common symptoms observed onset outbreak include fever cough fatigue features prevalent sputum production headache hemoptysis gastrointestinal gi symptom diarrhea <NUMBER> <NUMBER> another study conducted beijing china showed average age patients covid<NUMBER> <NUMBER> years mean <NUMBER> days onset symptoms admission hospital <NUMBER> study also showed fever present <NUMBER> patients persisted <NUMBER> days symptoms resolved <NUMBER> days negative test result <NUMBER> individuals infected develop symptoms <NUMBER> positive cases recover disease without treatment <NUMBER> however also instances transmissions covid<NUMBER> one person another person became aware sick symptoms mild person know heshe illness <NUMBER> becomes essential seek medical attention immediately person suspects heshe may infected confirmed case covid<NUMBER> experiencing respiratory distress blue lips constant pain pressure chest <NUMBER> also important note covid<NUMBER> infectious sarscov merscov due numerous epidemiological biological characteristics <NUMBER> due covid<NUMBER> relatively new understudied disease data available limited however cases emerged observed comorbidities increase chances infection <NUMBER> based current information clinical expertise elderly especially longterm care facilities people age serious underlying medical conditions greater risk getting covid<NUMBER> <NUMBER> elderly vulnerable population chronic health conditions diabetes cardiovascular lung disease higher risk developing severe illness also increased risk death become ill <NUMBER> people underlying uncontrolled medical conditions diabetes hypertension lung liver kidney disease cancer patients chemotherapy smokers transplant recipients patients taking steroids chronically increased risk covid<NUMBER> infection <NUMBER> metaanalysis study covid<NUMBER> comorbidities depicted fig <NUMBER> total <NUMBER> patients <NUMBER> male <NUMBER> female mean age <NUMBER> years old <NUMBER> common comorbidities identified patients hypertension <NUMBER> cardiovascular cerebrovascular conditions <NUMBER> diabetes <NUMBER> <NUMBER> <NUMBER> less common comorbidities coexisting infection hiv hepatitis b <NUMBER> malignancy <NUMBER> respiratory illnesses <NUMBER> renal disorders <NUMBER> immunodeficiencies <NUMBER> <NUMBER> patients moderate severe asthma disadvantage virus affects respiratory tracts leading increased asthmatic attacks pneumonia acute respiratory distress <NUMBER> according cdcs morbidity mortality weekly report <NUMBER> patients aged <NUMBER> <NUMBER> years old underlying chronic lung disease asthma <NUMBER> iran case study reported genetic predisposition covid<NUMBER> increase probabilities getting infected sarscov<NUMBER> lead death virus <NUMBER> genetic predisposition seen <NUMBER> brothers iran <NUMBER> years apart age <NUMBER> <NUMBER> <NUMBER> years died due covid<NUMBER> despite identified comorbidities living separately one another <NUMBER> january <NUMBER> <NUMBER> wuhan china <NUMBER> patients admitted hospital tested positive covid<NUMBER> <NUMBER> <NUMBER> men median age <NUMBER> years old <NUMBER> <NUMBER> patients exposed huanan market <NUMBER> <NUMBER> underlying diseases diabetes <NUMBER> <NUMBER> hypertension <NUMBER> <NUMBER> cardiovascular <NUMBER> <NUMBER> <NUMBER> patients hiv positive along low cd<NUMBER> count antiretroviral therapy higher risk incidence medical issues including covid<NUMBER> <NUMBER> according international aids society ias people <NUMBER> human immunodeficiency virus hiv positive taking antiretroviral treatment low cd<NUMBER> count risk covid<NUMBER> one without hiv <NUMBER> <NUMBER> depicted fig <NUMBER> populationbased surveillance report via covid<NUMBER>associated hospitalization surveillance network covidnet reported clinical data <NUMBER> covid<NUMBER>positive patient hospitalizations march <NUMBER> march <NUMBER> <NUMBER> <NUMBER> among <NUMBER> patients studied <NUMBER> adults showed clinical data underlying medical conditions prevalent hypertension <NUMBER> obesity close second <NUMBER> <NUMBER> medical conditions included chronic lung disease <NUMBER> diabetes mellitus <NUMBER> cardiovascular diseases <NUMBER> <NUMBER> outcome covid<NUMBER> cause severe disease leading hospitalization icu potentially death especially elderly comorbidities <NUMBER> according cdc <NUMBER> <NUMBER> deaths reported usa occurred adults <NUMBER> years old <NUMBER> roughly <NUMBER> covid<NUMBER>positive cases result full recovery illness without hospitalizations interventions <NUMBER> still many facts know covid<NUMBER> due gaps knowledge therefore many studies underway better understand virus <NUMBER> wuhan china <NUMBER> patients admitted hospital tested positive covid<NUMBER> december <NUMBER> <NUMBER> january <NUMBER> <NUMBER> clinical outcomes shown <NUMBER> <NUMBER> fig <NUMBER> <NUMBER> <NUMBER> patients confirmed covid<NUMBER> hospital <NUMBER> pneumonia <NUMBER> developed acute respiratory distress syndrome ards <NUMBER> exhibited acute cardiac injury <NUMBER> acquired secondary infection <NUMBER> majority patients <NUMBER> discharged <NUMBER> remained hospitalized <NUMBER> ended icu <NUMBER> ended death <NUMBER> february <NUMBER> march <NUMBER> <NUMBER> study conducted evergreen washington characteristics outcomes <NUMBER> critically ill patients confirmed covid<NUMBER> diagnosis <NUMBER> study showed <NUMBER> patients required mechanical ventilation acute respiratory arrest seen <NUMBER> within <NUMBER> h developing ards <NUMBER> patients showed increasing severity respiratory problems leading poor shortterm outcomes higher risk death <NUMBER> march <NUMBER> <NUMBER> mortality rate <NUMBER> patients <NUMBER> critically ill <NUMBER> discharged hospital <NUMBER> shown cdcs mortality morbidity weekly report fig <NUMBER> case mortality increased patients age increased <NUMBER> <NUMBER> among age group ≤ <NUMBER> years icu admission mortality reported <NUMBER> covid<NUMBER> also noticed children disease took moderate course compared adults prognosis also seemingly better deaths infrequent <NUMBER> april <NUMBER> <NUMBER> reported <NUMBER> million confirmed covid<NUMBER> cases worldwide <NUMBER> cases resulting mortality <NUMBER> majority <NUMBER> deaths within usa <NUMBER> followed italy <NUMBER> spain <NUMBER> <NUMBER> new york hit hardest novel coronavirus spreading across usa cases deaths per capita state table <NUMBER> reports <NUMBER> covid<NUMBER> deaths involved least one comorbidity according new york state department health <NUMBER> multiple comorbidities associated severity covid<NUMBER> disease progression many poorer outcomes covid<NUMBER> related cardiovascular comorbid conditions <NUMBER> however may direct result cardiovascular condition attributed comorbidities along cardiovascular condition <NUMBER> patients type <NUMBER> diabetes also likely increased severity covid<NUMBER> <NUMBER> cohort study <NUMBER> patients covid<NUMBER> without type <NUMBER> diabetes shown type <NUMBER> diabetes required increased interventions hospital stay versus nondiabetic <NUMBER> shown poorer blood glucose control allaround increased mortality rate better glucose control <NUMBER> study concluded patients blood glucose specifically range <NUMBER> <NUMBER> mmoll overall decreased composite adverse events mortality <NUMBER> noted poor blood glucose control resulted substantially increased risk complications death <NUMBER> among comorbidities chronic obstructive pulmonary disease copd also associated poor disease progression metaanalysis multiple studies china found fourfold increase mortality patients preexisting copd diagnosed covid<NUMBER> <NUMBER> analysis smoking status patients severity covid<NUMBER> also studied one study found association smoking severe course covid<NUMBER> <NUMBER> study removed significant association smoking severe covid<NUMBER> disease <NUMBER> patients acute respiratory distress syndrome respiratory failure associated novel coronavirus may linked prothrombotic coagulopathy <NUMBER> autopsy covid<NUMBER>related deaths revealed dispersed microthrombi pulmonary vasculature demonstrating occlusive etiology respiratory failure <NUMBER> <NUMBER> <NUMBER> improvement noted three cases covid<NUMBER>related acute respiratory distress syndrome ards respiratory failure following treatment intravenous iv antithrombotic alteplase <NUMBER> results although reassuring transient two three cases recovery succumbing posttreatment <NUMBER> use antithrombolytic therapy needs studied ascertain results due treatment chance alone <NUMBER> retrospective metaanalysis including <NUMBER> covid<NUMBER> patients conducted march <NUMBER> <NUMBER> subjects underlying comorbidities risk acquiring covid<NUMBER> <NUMBER> common comorbidities hypertension copd diabetes cardiocerebrovascular disease observed significant risk factors subjects compared underlying disease states <NUMBER> intense supportive measures definitive treatment yet identified <NUMBER> authorities speculate subjects comorbidities linked severe disease outcome infected novel coronavirus compared patients underlying disease <NUMBER> study met barriers due diminutive sample size subjects one underlying comorbidity <NUMBER> literature earlier research underlying diseases increase mortality rate patients acquired covid<NUMBER> cardiac disease diabetes significant risk factors <NUMBER> insufficient sample size inadequate time led limitations data collected <NUMBER> <NUMBER> countries affected covid<NUMBER> resulting mass death worldwide cases evolve globally noted persons underlying chronic illnesses likely contract virus become severely ill due sars cov<NUMBER> relatively new virus data available limited however patients comorbidities deteriorating outcomes compared patients without covid<NUMBER> patients history hypertension obesity chronic lung disease diabetes cardiovascular <NUMBER> disease worst prognosis often end deteriorating outcomes ards pneumonia also elderly patients longterm care facilities chronic kidney disease patients cancer patients risk contracting virus significantly increased risk death among groups patients cases reported worldwide symptoms covid<NUMBER> ranged mild respiratory disease severe illness requires intubation mechanical ventilation since period patient asymptomatic incubation period <NUMBER> <NUMBER> days difficult establish early diagnosis much less curb transmission infection patient unknowingly exposed however within period respiratory symptoms develop important seek immediate care therefore patients comorbidities take necessary precautions avoid getting infected sars cov<NUMBER> usually worst prognosis precautions include regular handwashing soap water use alcoholbased hand sanitizer limiting persontoperson contact practicing social distancing wearing face mask public places overall limiting going public areas time unless necessary hence need global public health campaign raise awareness reducing burden comorbidity illnesses causing deaths covid<NUMBER>infected patients reninangiotensin system ras plays critical role maintaining normal cardiovascular cv functions contributes spectrum cv diseases hypertension coronary heart disease myocarditis congestive heart failure <NUMBER> generally ras composed angiotensinogen renin angiotensin ii ang ii ang ii receptors at<NUMBER> at<NUMBER> receptors angiotensinconverting enzyme ace <NUMBER> <NUMBER> ace ubiquitously present many cell types tissues organs ace ectoenzyme plays role generation ang ii catalysing extracellular conversion decapeptide ang <NUMBER> past two decades new homologue enzyme termed angiotensinconverting enzyme <NUMBER> ace<NUMBER> identified ace<NUMBER> convert ang ii ang <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> convert ang ang<NUMBER> <NUMBER> <NUMBER> although ang ii increases blood pressure bp ang<NUMBER> vasodilator ace<NUMBER>ang<NUMBER> axis suggested act natural damping mechanism activation classical ras <NUMBER> besides crucial role cv disease ace<NUMBER> also considered functional potential coronavirus including severe acute respiratory syndrome sars coronavirus human coronavirus nl<NUMBER> hcovnl<NUMBER> severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> also called <NUMBER>ncov receptor binds directly viral spike protein <NUMBER> <NUMBER> <NUMBER> <NUMBER> addition ace<NUMBER> plays important role acute lung injury induced influenza viruses h<NUMBER>n<NUMBER> h<NUMBER>n<NUMBER> h<NUMBER>n<NUMBER> <NUMBER> <NUMBER> <NUMBER> suggesting ace<NUMBER> still unexpected facets clinical implications cv diseases common noncommunicable diseases globally <NUMBER> addition emerging viral infections also represent major global public health concern <NUMBER> coronavirus disease <NUMBER> covid<NUMBER>caused sarscov<NUMBER> china <NUMBER> <NUMBER> h<NUMBER>n<NUMBER> usa canada <NUMBER> ace<NUMBER> could novel therapeutic target cv diseases potential target treatment coronaviruses influenza viruses present review primarily focused findings indicating role ace<NUMBER> relationship coronaviruses influenza viruses cv disease figure <NUMBER> influenza viruses coronaviruses typically contagious viruses cause respiratory disease coronaviruses members subfamily coronavirinae coronaviridae family nidovirales order including four generaalphacoronavirus betacoronavirus gamma coronavirus deltacoronavirus <NUMBER> coronaviruses cause respiratory intestinal infections animals humans considered highly pathogenic humans outbreak sars <NUMBER> six humaninfecting types coronaviruses discovered <NUMBER> hcov<NUMBER>e hcovoc<NUMBER> hku<NUMBER> induce mild upper respiratory tract diseases immunocompetent hosts <NUMBER> <NUMBER> <NUMBER> <NUMBER> novel coronavirus sarscov<NUMBER> identified china world infected <NUMBER> <NUMBER> <NUMBER> population became public health emergency declared world health organization far pathology covid<NUMBER> pneumonia still clear human influenza viruses members orthomyxoviridae family based matrix nucleoprotein genes influenza viruses classified type b c humans influenza b viruses influenza b epidemiological public interest <NUMBER> although related viruses influenza c viruses may also cause least subclinical infections humans <NUMBER> despite production annually designed vaccines many improvements public health surveillance infrastructure year usa alone seasonal influenza b viruses continue evolve take lives <NUMBER> <NUMBER> people <NUMBER> highly transmissible pathogenic virus outbreaks cause significant disease burden terms morbidity associated complications huge economic impact <NUMBER> <NUMBER> <NUMBER> meanwhile cv disease also leading cause death disease burden worldwide <NUMBER> infection virus might one pathogeneses atherosclerosis related cv disease atherosclerosis chronic inflammatory disease arteries associated proinflammatory lipid abnormalities <NUMBER> infectious diseases suggested causative factor several viruses studied relationship cv diseases <NUMBER> <NUMBER> influenza trigger heart attacks vaccination influenza reduces risk cv events example influenza infection long thought directly contribute cv morbidity mortality <NUMBER> various influenza viruses involved development progression atherosclerosis related cv disease <NUMBER> influenza virus rna even found mouse human atherosclerotic plaques <NUMBER> <NUMBER> acute influenza infection shown accentuate progression atherosclerosis related cv disease <NUMBER> epidemiological data coronavirus cv disease scant however shown merscov patients high prevalence hypertension cv disease merscov patients prevalence chronic heart disease hypertension <NUMBER> <NUMBER> respectively <NUMBER> recently new pieces evidence show precondition cv disease may increase risk sarscov<NUMBER> infection among <NUMBER> admitted hospital patients infected sarscov<NUMBER> wuhan <NUMBER> hypertension <NUMBER> cv disease <NUMBER> another study included <NUMBER> patients infected sarscov<NUMBER> wuhan found <NUMBER> patients hypertension <NUMBER> cv disease <NUMBER> another retrospective study <NUMBER> patients pneumonia <NUMBER> cv cerebrovascular diseases <NUMBER> association coronaviruses cv disease still needs study ace<NUMBER> emerged key regulator ras <NUMBER> increasing evidence suggests ace<NUMBER> plays protective role cv disease pathologies <NUMBER> atherosclerosisprone apolipoprotein e knockout mice ace<NUMBER> deficiency results augmented vascular inflammation inflammatory response contributes increased atherosclerotic plaque formation <NUMBER> animal studies sarkissian et al found cardiac overexpression ace<NUMBER> exerted protective influence heart myocardial infarction preserving cardiac function left ventricular wall motion contractility <NUMBER> yamamoto et al reported ace<NUMBER> gene knockdown resulted severe cardiac dysfunction ie reduced contractility increased hypertrophy dilation <NUMBER> addition ace inhibitors at<NUMBER> receptor antagonists proven beneficial treatment myocardial infarction heart failure increase ace<NUMBER> gene expression attenuate ace<NUMBER> gene downregulation normalize at<NUMBER> receptor expression myocardium postmyocardial infarction <NUMBER> <NUMBER> <NUMBER> loss ace<NUMBER> enhances adverse remodelling susceptibility pressure volume overload <NUMBER> human recombinant ace<NUMBER> suppresses myocardial hypertrophy fibrosis inflammation bp <NUMBER> feng et al reported ace<NUMBER> overexpression reduced ang iiinduced cardiac hypertrophy partially decrease sympathetic drive synhace<NUMBER> transgenic mice <NUMBER> wysocki et al found ang ii infusion recombinant human ace<NUMBER> effectively degraded ang ii process normalized bp <NUMBER> one ace<NUMBER> activators xanthenone demonstrated decrease bp improve cardiac function inhibition cardiac renal fibrosis spontaneously hypertensive rats <NUMBER> key role ace<NUMBER> progressive deterioration cardiac remodelling systolic dysfunction found humans <NUMBER> circulating ace<NUMBER> activity increases increasing vascular tone suggests elevated ace<NUMBER> may compensatory response hypertension <NUMBER> ohtsuki et al reported upregulation ace<NUMBER> gene left ventricular myocardium patients severe heart failure associated degree left ventricular dilatation may thereby constitute important adaptive mechanism retard progression adverse left ventricular remodelling <NUMBER> studies recombinant human ace<NUMBER> shown beneficial cardiac effects <NUMBER> <NUMBER> human ace<NUMBER> endotheliumbound carboxymonopeptidase single active site catalytic region whose expression limited mainly endothelial cells arteries arterioles venules various organs including heart lungs kidneys <NUMBER> loss ace<NUMBER> leads age dependent cardiomyopathy kidney disease also enhancing pulmonary cardiac renal injuries <NUMBER> hand ace<NUMBER> identified functional sars coronavirus receptor <NUMBER> ace<NUMBER> at<NUMBER> receptor protect mice sars coronavirusinduced acute respiratory distress syndrome whereas ace ang ii at<NUMBER>a receptor promote impairment lung function mouse models <NUMBER> <NUMBER> kuba et al provided genetic proof ace<NUMBER> crucial sarscov receptor vivo sarscov infections spike protein sarscov reduce ace<NUMBER> expression <NUMBER> study also found blocking reninangiotensin pathway attenuate worsened acute lung failure induced injection sarscov spike protein mice furthermore antibodies directed ace<NUMBER> soluble ace<NUMBER> molecules derivatives demonstrated capable blocking sarscov infection <NUMBER> like sarscov hcovnl<NUMBER> also employs ace<NUMBER> receptor cellular entry <NUMBER> wevers hoek found hcovnl<NUMBER> infection induced reduction cellular ace<NUMBER> expression <NUMBER> tseng et al demonstrated transgenic mice expressing hace<NUMBER> highly susceptible sarscov infection resulting wide spectrum clinical manifestations including death depending upon transgenic lineages <NUMBER> letko munster first demonstrated sarscov<NUMBER> used cell entry receptor ace<NUMBER> sarscov <NUMBER> subsequent studies also confirmed result <NUMBER> <NUMBER> <NUMBER> <NUMBER> experimental mouse models zou et al found infection highly pathogenic avian influenza h<NUMBER>n<NUMBER> virus results downregulation ace<NUMBER> expression lung increased serum ang ii levels <NUMBER> genetic inactivation ace<NUMBER> causes severe lung injury h<NUMBER>n<NUMBER>challenged mice confirming role ace<NUMBER> h<NUMBER>n<NUMBER>induced lung pathologies <NUMBER> yang et al reported ace<NUMBER> could mediate severe acute lung injury induced influenza h<NUMBER>n<NUMBER> virus infection experimental mouse model moreover ace<NUMBER> deficiency worsened disease pathogenesis markedly mainly targeting at<NUMBER> receptor <NUMBER> result consistent study huang et al found plasma ang ii levels linked h<NUMBER>n<NUMBER>induced disease severity predicted fatal outcome h<NUMBER>n<NUMBER> patients <NUMBER> myocardial injury observed coronavirus infection <NUMBER> <NUMBER> pulmonary infection human sarscov mice led ace<NUMBER>dependent myocardial infection myocardial damage found patients sarscov hearts <NUMBER> thus use cardioprotective medications essential effect ace inhibitor acei treatment coronavirusesinfluenza virus infections humans unclear lei et al reported fusion proteins ace<NUMBER>ig exhibit potent inhibitory activity sarscov sarscov<NUMBER> vitro <NUMBER> huentelman et al identified n<NUMBER>aminoethyl<NUMBER> aziridineethanamine novel ace<NUMBER> inhibitor effective blocking sars coronavirus spike proteinmediated cell fusion <NUMBER> case study found treatment acei together plasma exchange improved condition patient scleroderma renal crisis complicated thrombotic microangiopathy triggered influenza b virus infection <NUMBER> another case study woman positive h<NUMBER>n<NUMBER> severe acute left ventricular failure found aggressive initial therapy followed betablockers aceis led restoration patients left ventricular function associated marked improvement symptoms <NUMBER> angiotensin ii receptor blockers arbs firstline therapy hypertension could inhibit actions ang ii selective binding at<NUMBER> receptors vascular smooth muscle <NUMBER> effective lowering bp preventing major cv outcomes <NUMBER> previous studies suggest arbs could upregulate ace<NUMBER> rats humans <NUMBER> <NUMBER> recent commentary suggested arb could used therapy reducing aggressiveness mortality coronavirus infections <NUMBER> urgent need study effect acei arb treatment coronavirusinfluenza virus infections humans vaccination constitutes primary approach controlling influenza recent decades numerous advances made development vaccines influenza viruses replacement inactivated wholevirus vaccines split subunit vaccines comprise less reactogenic alternatives <NUMBER> majority available annual trivalent influenza vaccines contain two influenza strains h<NUMBER>n<NUMBER> h<NUMBER>n<NUMBER> one influenza b virus <NUMBER> recently inactivated quadrivalent vaccines containing victoria yamagata lineages type b iv become available <NUMBER> <NUMBER> several epidemiological clinical studies demonstrated beneficial effects influenza vaccine patients cv disease <NUMBER> <NUMBER> <NUMBER> metaanalysis randomized clinical trials udell et al reported use influenza vaccine associated lower risk major adverse cv events <NUMBER> another metaanalysis including eight trials <NUMBER> <NUMBER> participants clar et al reported influenza vaccination may reduce cv mortality combined cv events patients cv disease <NUMBER> furthermore recent metaanalysis including six cohort studies <NUMBER> <NUMBER> participants also confirmed influenza vaccination associated significant decrease allcause mortality patients heart failure <NUMBER> date vaccine developed prevent sarscov<NUMBER> coronavirus infections scientists across world racing develop vaccine also promising tool prevent cv disease coronavirus tackle outbreak covid<NUMBER> role ace<NUMBER> involvement vascular protective actions postulated therefore hypothesize risk coronavirus influenza virus infection high among cv diseasesusceptible population least partly due high ace<NUMBER> expression population needs confirmed future hypotheses suggest protection employed patients cv disease coronavirus influenza virus vaccine usage high cv risk population could potential strategy prevent cv disease coronavirusinfluenza virus infections furthermore urgent need develop vaccine coronavirus prevention control important evaluate effect coronavirus vaccines cv protection conflict interest none declared two years disaster blood pressure remained significantly elevated by<NUMBER> mmhg average incidence rates obesity diabetes dyslipidemia well hypertension remained <NUMBER> times higher disaster <NUMBER> current situations <NUMBER> policy social distancing stay home selfrestraint going similar evacuation <NUMBER> sudden death familiar persons fear death stresses produced due family members house day long feeling detachment friends others job loss economic difficulties <NUMBER> year <NUMBER>th anniversary discovery ace <NUMBER> angiotensinconverting enzyme <NUMBER> <NUMBER> mystery molecule cleaves angiotensin ii one central players blood pressure cardiovascular homeostasis angiotensin <NUMBER> used entry severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> host target cells <NUMBER> reninangiotensin system relatively new endocrine system phyletic evolution produces high blood pressure deliver adequate oxygen nutrients throughout body survival ace<NUMBER> expressed pulmonary cells also intestinal renal epithelial cells cardiomyocytes vascular endothelial cells <NUMBER> vascular endothelial cells infected sarscov<NUMBER> resulting occurrence systemic vasculitis severe thromboembolism relation cytokine storm chromosome x harbors gene coding ace<NUMBER> activity transmembrane protease serine <NUMBER> tmprss<NUMBER> facilitates fusion viral cellular membranes androgen dependent <NUMBER> facts might related sex preference disease <NUMBER> regulation ace<NUMBER> expression sarscov<NUMBER> infection administration ace inhibitors angiotensin receptor blockers reported vitro cultured cells vivo animal models clinical implication covid<NUMBER> argued <NUMBER> along observation underlying cardiovascular diseases often caused complicated hypertension associated increased risk severity disease <NUMBER> constantly attempt discover investigate true picture covid<NUMBER> relation hypertension far delineated known yet known well prepared possible pandemic ncds including hypertension sincere scientific approach cope reality hypertension covid<NUMBER> would yield new normal hypertension medicine perspective opens new field hypertension research produce concept combined disease types communicable noncommunicable diseases specific persons particular lifestyle life environment new disease entity would include new type physicalmental stressinduced hypertension new type vasculitis hypertension diseases evoked lungmediated organ miscommunication cardiovascular dysregulation produced discordance human host microorganisms facing difficulty frequent facetoface examination patients performed old normal medical practice new normal hypertension medicine also prompts us cultivate digital transformation medical practice hypertension management realize lifelong care naturally maintain happy healthy life respecting diversity person hypertension establishment medical care system constant connection person hypertension various iot internet things technologies medical advisory system give personalized proper advice appropriate time according lifelog data person construction dynamic community remodeled mutual dependence persons diverse quality life expected among important requirement redesign image medical doctors engaged hypertension medicine welcome new normal hypertension medicine conflict interest author declares conflicts interest publishers note springer nature remains neutral regard jurisdictional claims published maps institutional affiliations coronavirus disease covid<NUMBER> represents public health crisis global proportions <NUMBER> caused severe acute respiratory syndrome corona virus <NUMBER> sarscov<NUMBER> covid<NUMBER> first announced december <NUMBER> wuhan capital chinas hubei province <NUMBER> <NUMBER> symptoms commonly reported include cough fever shortness breath pathophysiology disease explains respiratory symptoms common indeed virus accesses host cells via protein angiotensinconverting enzyme <NUMBER> ace<NUMBER> <NUMBER> <NUMBER> abundant lungs <NUMBER> nevertheless ace<NUMBER> also expressed endothelial cells <NUMBER> <NUMBER> major clinical events usually observed covid<NUMBER> patients eg high blood pressure <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> thrombosis <NUMBER> <NUMBER> <NUMBER> access host cells sarscov<NUMBER> uses surface glycoprotein peplomer known spike ace<NUMBER> shown coreceptor coronavirus entry <NUMBER> <NUMBER> <NUMBER> therefore density ace<NUMBER> tissue may correlate severity disease tissue <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> receptors surface human cells suggested mediate entry sarscov<NUMBER> <NUMBER> including transmembrane serine protease <NUMBER> tmprss<NUMBER> <NUMBER> <NUMBER> sialic acid receptors <NUMBER> <NUMBER> extracellular matrix metalloproteinase inducer cd<NUMBER> also known basigin <NUMBER> additionally catepsin b l shown critical entry factors pathogenesis covid<NUMBER> <NUMBER> <NUMBER> intriguingly factors involved entry sarscov<NUMBER> host cell known expressed endothelial cells <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> figure <NUMBER> ace<NUMBER> remains studied receptors <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> instance genetic inactivation shown cause severe lung injury h<NUMBER>n<NUMBER>challenged mice <NUMBER> whereas administration recombinant human ace<NUMBER> ameliorates h<NUMBER>n<NUMBER> virusinduced lung injury mice <NUMBER> sarscov<NUMBER> coronavirus accesses host cells via binding spike glycoprotein angiotensinconverting enzyme <NUMBER> ace<NUMBER> sialic acid receptor transmembrane serine protease <NUMBER> tmprss<NUMBER> extracellular matrix metalloproteinase inducer cd<NUMBER> catepsin b l also participate virus entry factors expressed endothelial cells endothelial dysfunction common feature clinical manifestations observed covid<NUMBER> patients drugs proposed potential therapeutic strategy treat covid<NUMBER> patients shown improve endothelial function including tocilizumab colchicine chloroquinehydroxychloroquine azithromycin famotidine see text details references figure <NUMBER> endothelial dysfunction major determinant covid<NUMBER> sarscov<NUMBER> coronavirus accesses host cells via binding spike glycoprotein angiotensinconverting enzyme <NUMBER> ace<NUMBER> sialic acid receptor transmembrane serine protease <NUMBER> tmprss<NUMBER> extracellular matrix metalloproteinase inducer cd<NUMBER> catepsin b l also participate virus entry factors expressed endothelial cells endothelial dysfunction common feature clinical manifestations observed covid<NUMBER> patients drugs proposed potential therapeutic strategy treat covid<NUMBER> patients shown improve endothelial function including tocilizumab colchicine chloroquinehydroxychloroquine azithromycin famotidine see text details references studies also raise numerous questions regarding association hypertension covid<NUMBER> indeed hypertension known one common diseases comorbidities worldwide considered silent killer worldwide population <NUMBER> speculate higher rate hypertension worse prognosis patients covid<NUMBER> infection could seen spy causeeffect mechanism casual preexisting association two different diseases ace inhibitors acei angiotensin ii receptor blockers arb represent effective strategies treatment hypertension <NUMBER> drugs reduce effects reninangiotensin axis inhibiting ace acei blocking angiotensin receptors arb shown figure <NUMBER> growing question scientific community physicians understand whether aceiarb could affect prognosis hypertensive covid<NUMBER> patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> ace inhibitors acei angiotensin ii receptor blockers arb represent effective strategies treatment hypertension <NUMBER> drugs reduce effects reninangiotensin axis inhibiting ace acei blocking angiotensin receptors arb shown figure <NUMBER> growing question scientific community physicians understand whether aceiarb could affect prognosis hypertensive covid<NUMBER> patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> exact role aceiarb control ace<NUMBER> molecular pathways controversial indeed preclinical studies evidenced selective blockade either angiotensin ii synthesis activity rats induces increases ace<NUMBER> gene expression activity <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> similarly treating infarcted rats arb increased plasma concentration angiotensin <NUMBER> ace<NUMBER> <NUMBER> mice arb treatment augmented ace<NUMBER> mrna protein levels <NUMBER> <NUMBER> prevented decrease ace<NUMBER> protein levels induced angiotensin ii <NUMBER> equally important mineralocorticoid receptor blockers prevented aldosteroneinduced reduction cardiac ace<NUMBER> mrna expression rat cardiomyocytes <NUMBER> increased ace<NUMBER> expression activity murine hearts monocytederived macrophages obtained ten patients heart failure <NUMBER> nevertheless clinical evidence acei could directly affect molecular pathways linked ace<NUMBER> activity instance urinary ace<NUMBER> levels reported higher patients treated olmesartan vs untreated controls finding observed patients treated arb enalapril <NUMBER> instead another study reported difference ace<NUMBER> activity patients taking acei arb vs untreated patients <NUMBER> note ace<NUMBER> functions carboxypeptidase <NUMBER> inhibited clinically prescribed acei particular ace<NUMBER> acts counterbalance effect ace <NUMBER> indeed whereas ace generates angiotensin ii angiotensin ace<NUMBER> converts angiotensin ii active heptapeptide angiotensin <NUMBER> binds mas receptor masr triggering vasodilative antioxidant antiinflammatory properties <NUMBER> <NUMBER> <NUMBER> <NUMBER> figure <NUMBER> angiotensin ii angiotensin <NUMBER> binds heptahelical receptors namely angiotensin ii activate at<NUMBER>r type <NUMBER> angiotensin ii receptor at<NUMBER>r type <NUMBER> angiotensin ii receptor whereas angiotensin <NUMBER> binds mas receptor masr actions mediated receptors depicted figure exact role aceiarb control ace<NUMBER> molecular pathways controversial indeed preclinical studies evidenced selective blockade either angiotensin ii synthesis activity rats induces increases ace<NUMBER> gene expression activity <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> similarly treating infarcted rats arb increased plasma concentration angiotensin <NUMBER> ace<NUMBER> <NUMBER> mice arb treatment augmented ace<NUMBER> mrna protein levels <NUMBER> <NUMBER> prevented decrease ace<NUMBER> protein levels induced angiotensin ii <NUMBER> equally important mineralocorticoid receptor blockers prevented aldosteroneinduced reduction cardiac ace<NUMBER> mrna expression rat cardiomyocytes <NUMBER> increased ace<NUMBER> expression activity murine hearts monocytederived macrophages obtained ten patients heart failure <NUMBER> nevertheless clinical evidence acei could directly affect molecular pathways linked ace<NUMBER> activity instance urinary ace<NUMBER> levels reported higher patients treated olmesartan vs untreated controls finding observed patients treated arb enalapril <NUMBER> instead another study reported difference ace<NUMBER> activity patients taking acei arb vs untreated patients <NUMBER> note ace<NUMBER> functions carboxypeptidase <NUMBER> inhibited clinically prescribed acei particular ace<NUMBER> acts counterbalance effect ace <NUMBER> indeed whereas ace generates angiotensin ii angiotensin ace<NUMBER> converts angiotensin ii active heptapeptide angiotensin <NUMBER> binds mas receptor masr triggering vasodilative antioxidant antiinflammatory properties <NUMBER> <NUMBER> <NUMBER> <NUMBER> figure <NUMBER> media sources recently called discontinuation acei arb prophylactically context suspected covid<NUMBER> <NUMBER> however several associations recommended suspend therapies <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> recommendations confirmed three recent studies first one performed <NUMBER> hypertensive patients showed aceisarbs associated severity mortality covid<NUMBER> <NUMBER> second one verified effects aceiarb <NUMBER> hypertensive covid<NUMBER> patients showing use aceiarb associated lower risk allcause mortality compared aceiarb nonusers <NUMBER> third one demonstrated without increasing risk sarscov<NUMBER> infection aceiarb outcompeted antihypertensive drugs reducing inflammatory markers like creactive protein procalcitonin levels covid<NUMBER> patients preexisting hypertension <NUMBER> consistent findings three observational studies performed different populations different designs <NUMBER> <NUMBER> <NUMBER> published issue new england journal medicine arrived consistent message continued use aceiarb unlikely harmful covid<NUMBER> patients notably one studies <NUMBER> use either acei statinstwo classes drugs known ameliorate endothelial function <NUMBER> <NUMBER> <NUMBER> <NUMBER> found associated lower risk inhospital death nonuse binding sarscov<NUMBER> spike protein ace<NUMBER> suggested cause downregulation ace<NUMBER> cell membrane <NUMBER> consequently ace<NUMBER> downregulation could lead loss protective effects exerted aceiarb humans <NUMBER> downregulation ace<NUMBER> attractive research field <NUMBER> <NUMBER> <NUMBER> <NUMBER> indeed could valid therapeutic target ameliorate response clinical prognosis hypertensive patients affected covid<NUMBER> moreover investigators proposed restoration ace<NUMBER> administration recombinant ace<NUMBER> reverse lunginjury process viral infections <NUMBER> actually effects investigated ongoing clinical trials clinicaltrialsgov nct<NUMBER> alongside use losartan first therapy covid<NUMBER> hospitalized nct<NUMBER> hospitalized patients nct<NUMBER> major role pathogenesis well clinical response covid<NUMBER> could also played ace<NUMBER> polymorphisms relatively underinvestigated compared ace <NUMBER> <NUMBER> finally consider higher rate cardiac injury adverse outcomes hypertensive patients covid<NUMBER> pandemic <NUMBER> <NUMBER> <NUMBER> therefore aceiarb chronic therapy discontinued hypertensive patients covid<NUMBER> indeed loss pneumoand cardioprotective effects could detrimental <NUMBER> addition absence adequate followup visits switching aceiarb another antihypertensive therapy could cause suboptimal control blood pressure thus suggested several medical associations <NUMBER> absence definitive clinical studies without clear evidence hypertensive patients avoid discontinuation andor therapeutic switching covid<NUMBER> infection another noteworthy feature covid<NUMBER> cardiologists significant decrease rates hospital admissions acute coronary syndromes reported italy <NUMBER> us <NUMBER> covid<NUMBER> outbreak despite initially attributed reduced air pollution better adherence treatment absence occupational stress lockdown phenomenon seems likely due fear going hospital andor seeking medical attention pandemic unfortunately current decline hospitalization acute coronary syndromes trigger increase cases heart failure near future acute kidney injury aki reported <NUMBER> critically ill deceased covid<NUMBER> patients percentage consistent studies china <NUMBER> italy <NUMBER> united states <NUMBER> important note aki proteinuria hematuria independently associated higher risk death covid<NUMBER> patients <NUMBER> furthermore metaanalysis including <NUMBER> covid<NUMBER> patients <NUMBER> prevalence underlying chronic kidney disease significantly frequent among severe covid<NUMBER> disease <NUMBER> vs <NUMBER> odds ratio <NUMBER> <NUMBER> ci <NUMBER> according immunohistochemistry assays <NUMBER> ace<NUMBER> seems expressed renal endothelial cells however study based singlecell analysis confirmed expression ace<NUMBER> tmprss<NUMBER> human renal endothelial cells <NUMBER> recently presence viral particles confirmed electron microscopy endothelial cells glomerular capillary loops covid<NUMBER> patient <NUMBER> besides endothelial damage common finding renal histopathological analyses <NUMBER> covid<NUMBER> patients absence interstitial inflammatory infiltrates <NUMBER> diabetes mellitus frequent comorbidity cause worse prognosis covid<NUMBER> patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> indeed evaluating pneumonia cases unknown causes reported wuhan patients history exposure huanan seafood market jan <NUMBER> <NUMBER> <NUMBER> diabetes <NUMBER> similarly among <NUMBER> covid<NUMBER> patients analyzed guan colleagues <NUMBER> diabetes percentage goes <NUMBER> among patients severe disease vs <NUMBER> patients nonsevere disease <NUMBER> furthermore <NUMBER> patients experiencing composite endpoint icu admission mechanical ventilation death diabetes vs <NUMBER> patients experience endpoint <NUMBER> data italy show twothirds covid<NUMBER> patients survive diabetes <NUMBER> summary diabetes frequent comorbidity risk factor independent prognostic factor covid<NUMBER> patients strong evidence negative effects diabetes covid<NUMBER> patients also corroborated two metaanalyses <NUMBER> <NUMBER> worse prognosis patients diabetes covid<NUMBER> could attributed fact pneumonia evolves towards clinical stages refractory medical therapies oxygen administration mechanical ventilation necessity icu care data investigated previous study conducted patients sars <NUMBER> relationship known history diabetes fasting plasma glucose fpg levels death morbidity rate assessed showing percentage patients diabetes significantly higher deceased vs survivors <NUMBER> vs <NUMBER> p <NUMBER> <NUMBER> moreover diabetic subjects hypoxemia sao <NUMBER> <NUMBER> higher fpg levels fpg independently associated increased hazard ratio mortality <NUMBER> <NUMBER> ci <NUMBER> hypoxia <NUMBER> <NUMBER> ci <NUMBER> controlling age gender <NUMBER> authors concluded diabetes <NUMBER> <NUMBER> ci <NUMBER> fpg <NUMBER> mmoll <NUMBER> <NUMBER> ci <NUMBER> independent predictors death <NUMBER> covid<NUMBER> patients incidence diabetes two times higher icusevere vs nonicusevere cases <NUMBER> indeed diagnosis diabetes cohort patients covid<NUMBER> infection evidenced subgroup patients <NUMBER>fold higher risk experiencing adverse disease outcome analyses <NUMBER> additionally patients obesity andor glucose intolerance seem particularly vulnerable covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> unfortunately data hitherto available antidiabetic medications glucose homeostasis covid<NUMBER> patients aspect really limiting diabetes altered glucose homeostasis condition severe pneumonia sars reported main factors worse prognosis death <NUMBER> covid<NUMBER> could also induce new onset diabetes augmenting insulin resistance andor direct action <NUMBER> islets langerhans supporting view previous studies shown ace<NUMBER> therapeutic target ameliorate microcirculation islets <NUMBER> ace<NUMBER> known expressed pancreatic beta cells <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> moreover frequent cases ketoacidosis covid<NUMBER> patients reported <NUMBER> therefore investigation antidiabetic medications glucose homeostasis could harnessed evaluate patients higher risk experiencing worse prognosis death covid<NUMBER> speculate amelioration glucose homeostasis diabetic covid<NUMBER> patients specific hypoglycemic drugs could result amelioration clinical outcomes death reduction however data reported trials covid<NUMBER> need investigated studies <NUMBER> patients covid<NUMBER> often show clotting disorders organ dysfunction coagulopathy resulting higher mortality <NUMBER> <NUMBER> <NUMBER> critical data came analysis coagulation tests including prothrombin time pt activated partial thromboplastin time aptt antithrombin activity fibrinogen fibrin degradation product fdp ddimer samples collected admission hospital stay covid<NUMBER> patients <NUMBER> nonsurvivors significantly higher ddimer fdp levels longer pt vs survivors admission <NUMBER> moreover significant reduction lowering fibrinogen levels observed nonsurvivors late stages hospitalization compatible clinical diagnosis disseminated intravascular coagulation dic <NUMBER> <NUMBER> specifically among <NUMBER> covid<NUMBER> patients seen two hospitals wuhan ddimer levels <NUMBER> µgl admission predicted <NUMBER>fold increase odds dying discharge <NUMBER> note dic caused systemic infection features acute systemic overinflammatory response strictly linked endothelial dysfunction <NUMBER> recently case covid<NUMBER> patient increase factor viii clotting activity massive elevation von willebrand factor vwf reported <NUMBER> supporting theory indeed vwf seen marker endothelial damage since normally stored weibelpalade bodies within endothelial cells <NUMBER> equally important angiotensin ii level plasma covid<NUMBER> patients markedly elevated linearly associated viral load lung injury <NUMBER> notably angiotensin ii known increase microvascular permeability <NUMBER> <NUMBER> induce transcription tissue factor endothelial cells <NUMBER> <NUMBER> <NUMBER> activate platelets <NUMBER> <NUMBER> <NUMBER> additionally angiotensin ii trigger release several components complement system endothelial cells <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> corroborating key role endothelium pathogenesis venous arterial thrombosis covid<NUMBER> patients <NUMBER> <NUMBER> dysregulated immune response observed covid<NUMBER> especially late stages disease plays decisive role endothelial dysfunction thrombosis <NUMBER> <NUMBER> microvascular permeability crucial viral infections <NUMBER> indeed pulmonary endothelium represent fundamental barrier blood interstitium vital regulatory functions specifically endothelial cells represent onethird cell population lung <NUMBER> pulmonary endothelial damage considered hallmark acute respiratory distress syndrome ards <NUMBER> animal models coronavirusinduced severe ards shown reduced ace<NUMBER> activity loss ace<NUMBER> lungs mirrored enhanced vascular permeability exacerbated pulmonary edema <NUMBER> functional role endothelium pulmonary disease also suggested previous reports <NUMBER> <NUMBER> instance h<NUMBER>n<NUMBER> influenza virus shown infect endothelial cells vitro trigger endothelial cell apoptosis known enhance platelet adhesion <NUMBER> endothelial cell death would cause exposure extracellular matrix circulating blood favoring platelet binding similarly endothelium shown contribute development severe disease h<NUMBER>n<NUMBER> influenza infection <NUMBER> deep vein thrombosis andor pulmonary embolism previously described patients sars <NUMBER> <NUMBER> <NUMBER> <NUMBER> cases thrombosis complicating influenzaassociated pneumonia also reported <NUMBER> <NUMBER> <NUMBER> excessive activation immune system response pathogens lead pathological inflammatory consequences case highly virulent <NUMBER> avian h<NUMBER>n<NUMBER> influenza virus infections recruitment inflammatory leukocytes followed excessive cytokine responses considered key contributor morbidity mortality infection <NUMBER> <NUMBER> cytokine storm syndromes css group disorders representing variety inflammatory etiologies final result overwhelming systemic inflammation hemodynamic instability multiple organ dysfunction potentially death <NUMBER> <NUMBER> specifically macrophage activation syndrome <NUMBER> hemophagocytic lymphohistiocytosis hlh <NUMBER> represent two clinically similar css unknown degree etiopathogenic overlap <NUMBER> interaction endothelial immune cells could play crucial role covid<NUMBER> especially severe cases late stages disease <NUMBER> instance cytokine storm might lead abrupt deterioration inflammatory response hypercoagulation increased vulnerability patients cardiovascular diseases andor diabetes might therefore simply reflect impact underlying chronic inflammation response sarscov<NUMBER> infection case endothelial alterations could seen epiphenomenon however according numerous investigators inflammatory response observed covid<NUMBER> patients considered mild compared one observed typical ards cytokinerelease syndrome <NUMBER> <NUMBER> <NUMBER> <NUMBER> indeed ards patients levels interleukin<NUMBER>β interleukin<NUMBER> shown <NUMBER> <NUMBER> fold higher covid<NUMBER> <NUMBER> <NUMBER> therefore mechanisms involved order explain systemic manifestations reported covid<NUMBER> patients endothelial cells known orchestrators cytokine amplification viral infections <NUMBER> seem one best candidates sense supporting view catecholamines considered essential component cytokine release syndrome <NUMBER> demonstrated endothelial cells able synthetize release catecholamines <NUMBER> acute pulmonary embolism reported covid<NUMBER> patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> shown cause clinical deterioration viral pneumonias <NUMBER> <NUMBER> endothelial dysfunction known key determinant hypertension thrombosis dic <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> henceforth important select covid<NUMBER> patients higher risk pulmonary embolism practice computed tomography pulmonary angiography diagnosis pulmonary thromboembolism especially case significant increase ddimer values anticoagulation could necessary therapy control reduce prothrombotic events well prevent pulmonary embolism <NUMBER> clinical course covid<NUMBER> consists two main phases viral infection immune inflammatory response figure <NUMBER> require distinct therapeutic approaches strikingly several drugs suggested potential therapeutic strategy covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> shown ameliorate endothelial function including interleukin <NUMBER> il<NUMBER> receptor antagonists eg tocilizumab <NUMBER> colchicine <NUMBER> azithromycin <NUMBER> famotidine <NUMBER> even antimalaric agents chloroquine hydroxychloroquine initially proposed therapy covid<NUMBER> based anecdotal data <NUMBER> <NUMBER> shown improve endothelial function <NUMBER> <NUMBER> theory correct <NUMBER> drugs might effective treating covid<NUMBER> patients beneficial effects endothelial cells include α<NUMBER> adrenergic receptor blockers eg doxazosin <NUMBER> modulators sigma receptors <NUMBER> <NUMBER> <NUMBER> metformin <NUMBER> indomethacin <NUMBER> endothelin receptor antagonists eg bosentan <NUMBER> however data randomized trials confirming actual efficacy drugs yet available discussed covid<NUMBER> infection could cause endothelial dysfunction hypercoagulation state condition aggravated hypoxia augments thrombosis increasing blood viscosity hypoxiainducible transcription factordependent signaling pathway <NUMBER> consequently phenomena could result pulmonary embolism occlusion microthrombosis pulmonary small vessels observed critical covid<NUMBER> patients <NUMBER> apart cases pulmonary embolism covid<NUMBER> cause sepsisassociated dic defined sepsisinduced coagulopathy sic <NUMBER> thus increasing interest anticoagulant therapy treat covid<NUMBER> <NUMBER> state condition aggravated hypoxia augments thrombosis increasing blood viscosity hypoxiainducible transcription factordependent signaling pathway <NUMBER> consequently phenomena could result pulmonary embolism occlusion microthrombosis pulmonary small vessels observed critical covid<NUMBER> patients <NUMBER> apart cases pulmonary embolism covid<NUMBER> cause sepsisassociated dic defined sepsisinduced coagulopathy sic <NUMBER> thus increasing interest anticoagulant therapy treat covid<NUMBER> <NUMBER> retrospective analysis conducted tongji hospital huazhong university science technology wuhan authors examined <NUMBER> patients affected severe covid<NUMBER> <NUMBER> diagnosis severe covid<NUMBER> disease made evidence respiratory rate ≥ <NUMBER> breathsmin arterial oxygen saturation ≤ <NUMBER> rest pao <NUMBER> fio <NUMBER> ≤ <NUMBER> mmhg <NUMBER> patients reviewed compared parameters coagulation tests clinical characteristics survivors nonsurvivors evaluate effects heparin therapy <NUMBER> <NUMBER> patients received low molecular weight heparin lmwh <NUMBER> mg enoxaparinday <NUMBER> received unfractionated heparin ufh <NUMBER> uday without anticoagulants <NUMBER> heparin therapy significantly reduced mortality patients sic score ≥<NUMBER> <NUMBER> vs <NUMBER> p <NUMBER> sic score <NUMBER> <NUMBER> vs <NUMBER> p <NUMBER> <NUMBER> ddimer pt age positively platelet count negatively correlated <NUMBER>day mortality <NUMBER> addition stratifying ddimer values study population authors reported heparin nonusers rise mortality linked rising ddimer <NUMBER> reduction mortality patients heparin ddimer exceeding <NUMBER> µgml <NUMBER> therefore heparin treatment appears associated better prognosis severe covid<NUMBER> patients coagulopathy beneficial effects heparinbased therapies also supported structural analogies heparin heparansulphate according investigators may confer heparin antiviral properties <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> absence contraindications suggest use enoxaparin <NUMBER> mgday covid<NUMBER> patients raised <NUMBER> mgkg every <NUMBER> h case ddimer <NUMBER> µgml apixaban <NUMBER> mg every <NUMBER> h could represent useful alternative course full clinical evaluation patients covid<NUMBER> infection cannot leave aside analysis laboratory imaging data believe ptptt fibrinogen ddimer monitored daily anticoagulation therapy recommended covid<NUMBER> patients ddimer value four times higher normal upper limit except patients anticoagulant contraindications confirmed diagnosis severe covid<NUMBER> disease patients hypercoagulation organ failure could evidence early stage sepsisinduced dic hand anticoagulant may benefit unselected patients consequently prospective studies needed confirm findings covid<NUMBER> patients also testing antiaggregants anticoagulants different doses author contributions conceptualization gs data curation cs jg mbm xw rm gs sr writingoriginal draft preparation cs jg gs writingreview editing jg mbm gs visualization mbm gs supervision gs funding acquisition gs jg preprint version manuscript sent preprintsorg <NUMBER> april <NUMBER> preprints <NUMBER> <NUMBER> doi<NUMBER>preprints<NUMBER>v<NUMBER> authors read agreed published version manuscript funding santullis lab supported part nih r<NUMBER>dk<NUMBER> r<NUMBER>hl<NUMBER> r<NUMBER>dk<NUMBER> r<NUMBER>dk<NUMBER> gs american heart association aha<NUMBER>post<NUMBER> jg oung athletes generally speaking represent one healthiest fittest groups society resumption sport exercise ultimately bring athletes closer proximity recommended current physical distancing practices potentially increasing ones risk infection data emerging highintensity exercise may increase aerosolization transmissibility severe acute respiratory syndrome coronavirus<NUMBER> sarscov<NUMBER> presymptomatic mildly symptomatic individuals <NUMBER> setting medical providers wondered best counsel athletes medical conditions may associated increased risk severe coronavirus disease covid<NUMBER> specifically diabetes asthma sickle cell trait sct hypertension obesity centers disease control prevention cdc guidance explicitly address young athletes returning sport recommends highrisk individuals age take extra precautions including chronic lung disease moderate severe asthma chronic kidney disease treated dialysis diabetes mellitus hemoglobin disorders liver disease serious heart conditions severe obesity body mass index bmi ≥<NUMBER> kgm <NUMBER> immunocompromised <NUMBER> limited epidemiologic evidence inform guidance individuals especially high school college age groups however young people general low risk poor outcomes including death hospitalization severe disease offer appraisal situation provide information may help frame discussions athletes vast majority deaths coronavirus occur older <NUMBER> years age aged <NUMBER> <NUMBER> years representing <NUMBER> deaths <NUMBER> younger <NUMBER> years age died virus <NUMBER> hypertension <NUMBER> obese <NUMBER> diabetes <NUMBER> prevalence conditions general adolescent population similar hypertension <NUMBER> <NUMBER> obesity <NUMBER> <NUMBER> much lower diabetes <NUMBER> <NUMBER> conclusions drawn based limited data outcomes age group consistent poor outcomes seen patients diabetes contract covid<NUMBER> general population <NUMBER> study showed <NUMBER>fold increased risk severecritical illness independent risk factors <NUMBER> athletes diabetes counseled regarding potential increased morbidity mortality infected covid<NUMBER> consider delaying return sports reintegration confirmed safe risk acquiring new infection better understood asthma affects <NUMBER> population <NUMBER> <NUMBER> years age <NUMBER> experiencing <NUMBER> asthma attacks per year <NUMBER> cdc guidelines suggest moderate severe asthma highrisk category mild wellcontrolled asthma considered risk poor outcomes <NUMBER> moderate asthma characterized daily symptoms cause limitation normal activities forced expiratory volume fev <NUMBER> <NUMBER> <NUMBER> exerciseinduced bronchospasm common among athletes especially winter endurance sports known confer higher risk poor outcomes sarscov<NUMBER> infection athletes asthma evaluated prior participation sports confirm treatment regimen optimized adherent medications additionally advised notify medical team exacerbations existing medical conditions illness participation avoided individual worsening asthma control sct also common <NUMBER> african americanblack individuals carrying gene although generally considered benign sct associated increased risk exertional death football athletes military recruits well increased risk venous thromboembolism <NUMBER> <NUMBER> although sickle cell disease thalassemia considered cdc higher risk adverse outcomes covid<NUMBER> infection sct additional precautions recommended returning athletes sct however athlete sct contracts sarscov<NUMBER> treating physicians vigilant issues related hypercoagulability acute illness several months recovery includes allowing adequate acclimatization reconditioning optimizing hydration minimizing heat stress avoiding blood flow restriction devices used rehabilitation strengthening prevalence hypertension athletes appears similar general adolescent population <NUMBER> however studies suggest american football lineman higher bmi likely affected <NUMBER> studies hypertension athletes limited often rely onetime blood pressure measurements rather standard diagnostic criteria frequency covid<NUMBER> patients hypertensive unexpected given age distribution sarscov<NUMBER> infection necessarily imply causal relationship however concern remains hypertension may independent risk factor poor outcomes even though cdc currently list hypertension predictor severe illness <NUMBER> <NUMBER> initial concern treatment hypertension angiotensinconverting enzyme ace inhibitors angiotensin receptor blockers arbs could increase susceptibility covid<NUMBER> infection worsen course however several large studies support hypotheses american heart association recommend stopping ace inhibitors arbs patients covid<NUMBER> <NUMBER> <NUMBER> thus athletes controlled hypertension maintain current regimen returning participation newly diagnosed hypertension treated clinically appropriate preparticipation screening include accurate measurement blood pressure repeat measurements abnormal presenting opportunity engage athlete discussions regarding treatment finally although athletes fit many sports recruit athletes larger build particularly american football lineman cdc groups people severe obesity bmi ≥<NUMBER> kgm <NUMBER> potentially risk severe illness although literature associated covid<NUMBER> employs variable definitions obesity including bmi ≥<NUMBER> kgm <NUMBER> <NUMBER> bmi intended marker excess fat may good measure athletes lean muscle mass typically increased lower percentages body fat studies shown increased association poor covid<NUMBER> outcomes higher bmis one study found true especially younger patients bmis ≥<NUMBER> kgm <NUMBER> even among bmi ≥<NUMBER> kgm <NUMBER> <NUMBER> general population higher bmi also likely comorbidities hypertension diabetes athletes high bmi particularly higher percentage body fat counseled overall adverse health effects obesity potential association complications covid<NUMBER> supported adopting healthy lifestyle lifestyle modifications athletes derive competitive advantage higher bmi unwilling consider weight reduction may limited addressed preparticipation guidance athletes include discussion risks sarscov<NUMBER> athletes diabetes appear higher risk poor outcomes however evidence athletes asthma sct hypertension higher risk poor outcomes unclear obese athletes higher risk athletes engaged shared decisionmaking process involves education acknowledgement uncertainty optimization medical treatment risk poor outcomes younger <NUMBER> years age remains low youth high levels fitness may effectively mitigate risk severe covid<NUMBER> outcomes athletes preexisting risk factors collection data critical better understanding interplay elements exercise sport beneficial physical mental health attempt mitigate risks returning athletes addressing potential risk factors encouraging compliance public health guidelines adjusting recommendations situation evidence evolve <NUMBER> months first report <NUMBER> cases atypical pneumonia wuhan china december <NUMBER> <NUMBER> cumulative number confirmed cases coronavirus disease <NUMBER> covid<NUMBER> city rose <NUMBER> <NUMBER> <NUMBER> deaths end february <NUMBER> january <NUMBER> wuhan city shut response quickly evolving epidemic public transportation within city suspended residents barred leaving estimated <NUMBER> million people remained city lockdown<NUMBER> strict social distancing measures also implemented including compulsory wearing face masks public early phase response wuhan number patients overwhelmed local fever clinics hospitals designated receive patients covid<NUMBER> media reported significant shortage hospital beds intensive care unit icu beds health care resources february <NUMBER> <NUMBER> <NUMBER> health care workers sent wuhan parts china help coronavirus response<NUMBER> total <NUMBER> hospitals including <NUMBER> new hospitals built specifically patients covid<NUMBER> <NUMBER> <NUMBER> inpatient beds designated isolation treatment patients confirmed severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> quarantine centers <NUMBER> <NUMBER> total beds also established isolate confirmed patients milder illness end february local government reported “finally patients don’t need wait beds beds waiting patients”<NUMBER> humantohuman transmission established countries mitigating potential consequences covid<NUMBER> local health care systems top priority clinical study china<NUMBER> reported <NUMBER> patients sarscov<NUMBER> detected experience mild disease <NUMBER> experience severe disease <NUMBER> experience critical disease however questions still remain regarding proportion asymptomatic patients clinical course disease preventing accurate prediction hospitalization icu needs transmission models describe icu hospitalization needs covid<NUMBER> <NUMBER> cities china ie wuhan epicenter china’s outbreak guangzhou metropolis experienced early importation cases cities china guangzhou implemented strict social distancing measures contact tracing quarantine protocols late january resulted much smaller outbreak size wuhan describing comparing resource needs cities may create benchmarks help large metropolises prepare potential outbreaks summed total patientdays critical andor severe condition estimate total icudays serious inpatient–days plotted raw number patients critical severe condition patients hospitalized day wuhan guangzhou estimated proportion hospitalizations icu admissions per <NUMBER> <NUMBER> adults based assumption <NUMBER> million people present wuhan lockdown<NUMBER> <NUMBER> aged <NUMBER> years older<NUMBER> <NUMBER> million people present guangzhou <NUMBER> aged <NUMBER> years above<NUMBER> projected number patients would severe critical covid<NUMBER> peak wuhanlike outbreak <NUMBER> populous us cities assuming associations age comorbidity patient outcomes would association covid<NUMBER> mortality derived case reports china february <NUMBER> specifically estimated stratumspecific critical care rate wuhan assuming risk factor critical care death ie adults age <NUMBER> years rate ratio <NUMBER> adults hypertention rate ratio <NUMBER> estimated probability critical condition peak epidemic age hypertension stratum using covid<NUMBER> mortality rate ratios age hypertension<NUMBER> proportion wuhan population stratum hypertension prevalence adults wuhan estimated <NUMBER> proportion population aged <NUMBER> years older estimated <NUMBER> applied stratumspecific critical care rates population structures us cities based crude hypertension prevalence adults <NUMBER> proportion adult population aged <NUMBER> years older cities<NUMBER> data us icu beds<NUMBER> empty icu beds<NUMBER> inpatient beds<NUMBER> population structure<NUMBER> used estimate inpatient bed capacity per <NUMBER> <NUMBER> adults used wuhanlike outbreak describe outbreak large metropolis minimal disease control measures implemented first <NUMBER> months community spread sarscov<NUMBER> followed citylevel lockdown measures suppress transmission analyses conducted r version <NUMBER> r project statistical computing prespecified level statistical significance set wuhan covid<NUMBER> accounted total <NUMBER> <NUMBER> icudays <NUMBER> <NUMBER> serious inpatient–days january <NUMBER> february <NUMBER> figure <NUMBER>a figure <NUMBER>b median interquartile range <NUMBER> <NUMBER> patients icu <NUMBER> <NUMBER> inpatients serious illness day <NUMBER>day period peak epidemic mid late february maximum <NUMBER> <NUMBER> patients <NUMBER> per <NUMBER> <NUMBER> adults hospitalized <NUMBER> patients <NUMBER> per <NUMBER> <NUMBER> adults considered serious condition <NUMBER> patients <NUMBER> per <NUMBER> <NUMBER> adults needed critical care per day guangzhou covid<NUMBER> accounted total <NUMBER> icudays <NUMBER> serious inpatient–days january <NUMBER> february <NUMBER> figure <NUMBER>c figure <NUMBER>d median interquartile range <NUMBER> <NUMBER> patients icu <NUMBER> <NUMBER> inpatients serious illness day <NUMBER>day period peak epidemic early february <NUMBER> patients critical condition <NUMBER> hospitalized classified serious unlike wuhan patients mild covid<NUMBER> disease isolated quarantine centers designated hospitals confirmed patients guangzhou hospitalized recovery maximum number hospitalizations guangzhou day <NUMBER> patients peak epidemic estimated critical care risk among adults younger <NUMBER> years <NUMBER> patients per <NUMBER> <NUMBER> adults among adults aged <NUMBER> years older <NUMBER> patients per <NUMBER> <NUMBER> adults among adults without hypertension <NUMBER> patients per <NUMBER> <NUMBER> adults among adults hypertension <NUMBER> patients per <NUMBER> <NUMBER> adults <NUMBER> populous cities us <NUMBER> <NUMBER> adults aged <NUMBER> years older<NUMBER> crude hypertension prevalence ranges <NUMBER> <NUMBER> projected number prevalent critically ill patients peak wuhanlike outbreak us cities ranged <NUMBER> <NUMBER> patients per <NUMBER> <NUMBER> adults difference age distribution taken account figure <NUMBER>a <NUMBER> <NUMBER> patients per <NUMBER> <NUMBER> adults differences hypertension prevalence taken account figure <NUMBER>b study several limitations relied officially reported statistics may represent change actual case counts time rather reflect capacity testing hospitalization thus number serious cases hospitalizations wuhan reflective actual need rather maximum capacity system diagnosis treatment therefore confident regarding hospitalization serious case counts wuhan midfebruary guangzhou capacities diagnosis treatment exceeded according official unofficial sources furthermore accounted differences age hypertension distribution wuhan us cities account potential risk factors diabetes cardiovascular diseases chronic respiratory diseases<NUMBER> mutually adjusted associations risk factors covid<NUMBER> serious illness death available time analysis cardiometabolic risk factors likely coexist population used hypertension adjustment proxy adjusting known comorbidities addition projection icu bed needs us cities consider scenarios local transmission differs wuhan contact rate wuhan early phase epidemic may much higher expect occur us cities increased number social contacts occurred wuhan lunar new year celebrations social distancing measures effectively implemented early us cities growth epidemic may delayed also possible us cities may able implement extreme social distancing measures put place later wuhan assumed settings equal age hypertensionspecific incidence rate severe critical covid<NUMBER> cases account differences contact patterns vulnerable populations nursing homes therefore actual number hospital icu beds needed course covid<NUMBER> outbreak us city impossible estimate precisely estimated capacity needs based wuhanlike outbreak could benchmark health care systems would expect see first <NUMBER> months local covid<NUMBER> epidemic outbreak control measures implemented wuhan even lockdown wuhan january <NUMBER> <NUMBER> number patients serious covid<NUMBER> cases continued rise exceeding local hospitalization icu capacities least month plans urgently needed mitigate consequences covid<NUMBER> outbreaks local health care systems us cities cvd diabetes mellitus hypertension respectively <NUMBER> italy recorded <NUMBER> confirmed cases <NUMBER> deaths april <NUMBER> <NUMBER> httpswwwworldometersinfocoronavirus according last available agerelated analysis mortality released italian istituto superiore di sanità iss march <NUMBER> <NUMBER> <NUMBER> <NUMBER> deceased patients <NUMBER> years old <NUMBER> <NUMBER> years old <NUMBER> <NUMBER> years old <NUMBER> <NUMBER> years old <NUMBER> <NUMBER> years old similar chinese statistics sarscov<NUMBER> shows higher mortality rates patients one comorbidities italy <NUMBER> deaths represented people documented comorbidity whereas <NUMBER> <NUMBER> <NUMBER> regarded patients one two three comorbidities respectively tentative hypothesis explaining epidemiologic findings high expression angiotensinconverting enzyme <NUMBER> ace<NUMBER> activated viral spike protein alveolar epithelial cells myocardium <NUMBER> ace<NUMBER> membrane aminopeptide catalytic subunit pointed towards extracellular space pulmonary cardiac renal intestinal tissues functions angiotensin iidegrading enzyme generates angiotensin <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> latter oligopeptide vasodilatory hypotensive diuretic effects <NUMBER> <NUMBER> far binding covid<NUMBER> spike protein ace<NUMBER> shown downregulate ace<NUMBER> turn decrease angiotensin <NUMBER> production mechanism may involved pathogenesis pulmonary hypertension insufficiency caused sarscov<NUMBER> infection <NUMBER> therefore different ace<NUMBER> expression occurring patients hypertension cvd diabetes taken account different mortality rate considered patients comorbidities one frequently reported epidemiologic data sexrelated covid<NUMBER> mortality evidence supports higher predominance men several countries thus male sex considered poor prognostic factor authors <NUMBER> male sex represents <NUMBER> deaths china <NUMBER> <NUMBER> south korea <NUMBER> italy iss reports prevalence <NUMBER> men among deceased people recent scoping review available epidemiological studies collecting data <NUMBER> patients <NUMBER> different countries shown association male sex higher mortality rate <NUMBER> findings suggest presence malerelated susceptibility indeed channappanavar colleagues <NUMBER> shown male mice susceptible sarscov infection agematched females increased susceptibility associated high virus titers increased vascular leakage alveolar edema changes accompanied increased accumulation inflammatory monocytemacrophages neutrophils lungs male mice depletion monocytemacrophages partially protected mice lethal sars addition sexspecific differences independent b cell responses due sexrelated intrinsic difference innate immunity <NUMBER> finally ovariectomy treatment female mice estrogen receptor antagonist increased mortality rate therefore suggesting protective effect estrogen receptor signaling pathway sarscov infected mice <NUMBER> context analysis possible hormonaldependency expression andor activity ace<NUMBER> various tissues relevance understand pathologic mechanisms behind epidemiologic findings ace<NUMBER> expressed mouse human adult leydig cells testosteroneindependent manner cells enzyme proposed play role steroidogenesis <NUMBER> ace<NUMBER> also described ovarian granulosa cells expression increases rise luteinizing hormone lh indeed stimulation human chorionic gonadotropic hcg improves ace<NUMBER>angiotensin <NUMBER>mas system <NUMBER> may represent compensatory mechanism could useful avoiding increase blood pressure postmenopausal women <NUMBER> addition gonadal expression studies shown expression activity ace<NUMBER> influenced sex hormones mouse adipose tissue kidneys myocardium <NUMBER> <NUMBER> <NUMBER> <NUMBER> gupte colleagues studied contribution ace<NUMBER> pathogenesis sexrelated difference obesityrelated hypertension male mice fed highfat diet showed decreased ace<NUMBER> expression kidney resulting reduced angiotensin <NUMBER> increased angiotensin <NUMBER> levels caused blood hypertension reversed administration losartan <NUMBER> authors previously shown low expression ace<NUMBER> adipose tissue male mice <NUMBER> contrast highfatfed female mice increased expression ace<NUMBER> adipose tissue leads high angiotensin <NUMBER> levels hypertension angiotensin <NUMBER> receptor antagonists administered ovariectomy results decrease ace<NUMBER> activity adipose tissue leads hypertension restored <NUMBER>ßestradiol administration <NUMBER> myocardium ace ace<NUMBER> expression well cardiac hypertrophy significantly higher spontaneously hypertensive male mice compared female mice orchiectomy significant decrease ace ace<NUMBER> expression cardiac hypertrophy found consequently increased cardiac performance observed finally ovariectomy causes increase ace<NUMBER> expression cardiac hypertrophy worsens function heart pump <NUMBER> taken together findings suggest role sex hormones sexrelated expressionfunction ace<NUMBER> may help interpretation epidemiologic data detail <NUMBER>ßestradiol may increase expressionactivity ace<NUMBER> adipose tissue kidney reported spontaneously hypertensive male mice showed higher ace<NUMBER> expression female mice <NUMBER> may provide possible explanation higher mortality men due severe cardiovascular damage viral infection capable causing since expression ace<NUMBER> myocardium appears modulated androgen <NUMBER> role androgen receptor ar gene polymorphisms cannot excluded pathogenesis cardiovascular adverse events hypertension covid<NUMBER>positive male patients another aspect needs highlighted increased cvd risk patients covid<NUMBER> prevalence venous thromboembolism vte patients reported <NUMBER> vte associated unfavorable prognosis <NUMBER> anticoagulant therapy mainly low molecular weight heparin appears associated better prognosis severe covid<NUMBER> patients sepsisinduced coagulopathy criteria markedly elevated ddimer levels <NUMBER> scientific debate regarding risk vte patients treated testosterone current recent casecrossover study <NUMBER> men enrolled <NUMBER> <NUMBER> hypogonadism ageadjusted models testosterone replacement therapy associated higher risk vte men odds ratio <NUMBER> without odds ratio <NUMBER> hypogonadism <NUMBER> among various causes hypogonadism greater attention paid forms associated greater risk vte patients klinefelter syndrome <NUMBER> use estrogen women could expose risk although cases increased awareness risk developing vte often preceded appropriate screening another aspect may explain sexrelated susceptibility may relate vitamin vitamin deficiency shown independently associated increased risk viral acute respiratory infection ari number observational studies metaanalysis clinical trials vitamin supplementation prevent ari onset shown moderate protective effects <NUMBER> respiratory monocytesmacrophages epithelial cells constitutively express vitamin receptor vdr thereby protecting respiratory infections interestingly <NUMBER>oh <NUMBER> vitamin d<NUMBER> vdr agonists lower significantly proinflammatory response antigen challenge cystic fibrosis airway epithelial cells vitro studies suggest low vitamin levels may increase risk severity respiratory viral infections interventional studies shown low levels associated increased expression secretion proinflammatory cytokines chemokines interestingly vitamin administration decreases inflammatory response viral infections airway epithelium without jeopardizing viral clearance suggests adequate vitamin levels would contribute reduced inflammation less severe disease respiratory syncytial virusinfected individuals <NUMBER> known many years vitamin deficiency adequately evaluated older men deficiency <NUMBER>ohd <NUMBER> ngml estimated <NUMBER> insufficiency <NUMBER> ngml <NUMBER> particular deficiency common among men winter spring especially northern communities oldest obese men <NUMBER> therefore speculate one factors involved sexrelated different susceptibility may due less vitamin supplementation men sixties compared agematched women conclusion role gonadal hormones possible replacement therapy reconsidered sexes historic moment sarscov<NUMBER> pandemic testosterone lhhcg administration could temporarily discontinued given lower posology patients hypogonadism contrast estrogen replacement therapy may fully considered hypogonadal postmenopausal women furthermore involvement polymorphisms ar activator repressor proteins <NUMBER> well role selective androgen receptor modulators <NUMBER> therapeutic agents men could deserving investigation however relationship much complex might seem first glance indeed taken account viral infection worsens function leydig cells recently shown <NUMBER> consequent hypogonadism exposes patient increased cardiovascular risk decreased vitamin level <NUMBER> <NUMBER> close monitoring serum testosterone levels patients would therefore helpful also continued acute phase disease ended would also interesting know length active disease sarscov<NUMBER> patients without hypogonadism since hypogonadism worsen systemic inflammatory response demonstrated peripheral blood leukocytes testosterone inhibits immune stimuliinduced secretion proinflammatory cytokines tnf ifnγ <NUMBER> finally vitamin deficiency regardless testosterone levels elderly men may worthy epidemiological evaluation better understand different susceptibility lethality sexes coronavirus disease <NUMBER> covid <NUMBER> systemic disease caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> quickly becoming one biggest challenges global population faced since world war ii <NUMBER> may <NUMBER> <NUMBER> <NUMBER> cases reported <NUMBER> confirmed deaths represents overall mortality rate <NUMBER> <NUMBER>•• well known numbers precise due low availability diagnostic tests needed assess true numbers infected <NUMBER> <NUMBER> <NUMBER> addition many patients minor symptoms may seek testing <NUMBER> <NUMBER> recent reports <NUMBER> <NUMBER> describe several risk factors associated major complications covid<NUMBER> severe acute respiratory syndrome mechanical ventilation death among risk factors including older age several comorbidities presence hypertension consistently reported marker worse prognosis patients covid<NUMBER> <NUMBER> <NUMBER> alarming situation considering <NUMBER> adult population classified hypertension <NUMBER> hypertension common article part topical collection resistant hypertension luciano f drager lucianodragerincorcombr patients infected previous coronavirus influenza outbreaks <NUMBER> potential prognostic implications hypertension never highlighted current coronavirus outbreak however concern related hypertension per se pathophysiology mechanism infection coronavirus cells brief review discuss three major topics highlighting current knowledge uncertainties around potential role hypertension covid<NUMBER> pandemic hypertension influence immunity angiotensinconverting enzyme <NUMBER> ace<NUMBER> expression favoring viral infections growing evidence suggests potential involvement innate natural killer cells γδ cells adaptive b lymphocytes well dendritic monocytemacrophages immune responses pathogenesis hypertension vascular inflammation common pathway favoring arterial remodeling increased blood pressure <NUMBER> <NUMBER> activated immune system seems play significant role endorgan damage associated hypertension <NUMBER> <NUMBER> overall contribution immune system particularly tlymphocytes hypertension widely accepted mechanistic processes preceding activation immune cells poorly understood <NUMBER> one possible mechanisms related increase sympathetic activation complex scenario sympathoexcitation may induce suppression excitatory effects tlymphocytes <NUMBER> specifically evidence suggests increased sympathetic outflow may directly attenuate ability naive tlymphocytes become fully activated also exacerbating inflammatory effects activated tlymphocytes <NUMBER> however clinical relevance findings still unclear despite use lymphocytetargeted immunosuppressant drugs shown attenuate experimental <NUMBER> human hypertension <NUMBER> lack robust consistent data prevents current indications treating hypertension therapies <NUMBER> immunology hypertension fuel predisposition infections best knowledge large prospective cohorts shown patients hypertension susceptible infection diseases unfavorable outcomes observed normotensive patients another critical concern related ace<NUMBER> protein facilitates entrance sarscov<NUMBER> cells <NUMBER> <NUMBER> theoretically increased ace<NUMBER> expression may potentially harmful covid<NUMBER> infection date definitive evidence hypertension associated increased ace<NUMBER> expression whether expression may contribute poor outcomes covid<NUMBER> <NUMBER> recent publication found ace<NUMBER> expression elevated lungs patients covid<NUMBER> presented comorbidities hypertension compared control participants <NUMBER> however due crosssectional design causeeffect determined acknowledge need additional research area evidence hypertension per se predisposes patients covid<NUMBER> poor prognosis question gained lot attention recent weeks potential impact management hypertension recent publications reviewed role reninangiotensin system ras inhibitors covid<NUMBER> infection <NUMBER>• <NUMBER>•<NUMBER> ace<NUMBER> enzyme physiological role ras activity plays crucial role covid<NUMBER> infection recent report postulated use ras inhibitors one prescribed classes hypertension may alter ace<NUMBER> expression influence virulence covid<NUMBER> infection china <NUMBER> however definitive evidence indicating harmful effects ras inhibitors despite ras inhibitors recommended one firstline hypertension treatments <NUMBER> use drugs china quite low estimated ras inhibitors used <NUMBER> treated patients <NUMBER> flat rate may implications study power previous reports animal preclinical studies evaluating ace<NUMBER> levels expression different tissues use ras inhibitors demonstrated conflicting data <NUMBER>• <NUMBER>•<NUMBER> angiotensinconverting enzyme inhibitors acei inhibit ace<NUMBER> ace ace<NUMBER> different enzymes making harmful effect class unlikely <NUMBER>• angiotensin ii type <NUMBER> receptor blockers arb shown upregulate ace<NUMBER> experimental animals <NUMBER> <NUMBER> findings seem translate clinical observations including setting covid<NUMBER> one first reports humans evaluated <NUMBER> patients covid<NUMBER> previous cardiovascular diseases <NUMBER> retrospective study china use ras inhibitors associated higher morbidity mortality <NUMBER> recently <NUMBER> observational studies shed light issue called definitive research area <NUMBER>• <NUMBER> <NUMBER> <NUMBER> retrospective multicenter analysis <NUMBER> patients hypertension diagnosed covid<NUMBER> compared patients taking aceiarb n <NUMBER> taking drugs n <NUMBER> <NUMBER>• mixedeffect cox model treating site random effect adjusting age sex comorbidities inhospital medications detected risk allcause mortality lower taking aceiarb group versus taking aceiarb fig <NUMBER>a results propensity score matched analysis performed subgroup patients indicated use aceiarbs compared antihypertensive drugs also associated decreased mortality fig <NUMBER>b note percentage diuretics betablockers used higher patients taking aceiarb may represent potential residual factors <NUMBER>• retrospective singlecenter study evaluated <NUMBER> patients covid<NUMBER> patients preexisting hypertension hubei provincial hospital traditional chinese medicine <NUMBER> patients allocated either aceiarbs group n <NUMBER> nonaceiarbs group n <NUMBER> according antihypertensive medication total <NUMBER> ageand sexmatched covid<NUMBER> patients without hypertension randomly selected nonhypertension controls among patients covid<NUMBER> hypertension received either aceiarbs nonaceiarbs comparable blood pressure however aceiarb group significantly lower concentrations creactive protein procalcitonin compared nonacei arb group significant differences proportion critical patients <NUMBER> vs <NUMBER> p <NUMBER> rates death <NUMBER> vs <NUMBER> p <NUMBER> <NUMBER> prospective single center study including <NUMBER> hospitalized patients covid<NUMBER> new york city area showed mortality rates patients hypertension taking aceis arbs taking aceis taking arbs similar <NUMBER> <NUMBER> <NUMBER> respectively <NUMBER> however noted authors results unadjusted known confounders including age sex race ethnicity socioeconomic status indicators comorbidities diabetes chronic kidney disease heart failure <NUMBER> using observational database <NUMBER> patients admitted <NUMBER> hospitals asia europe north america mehran colleagues <NUMBER>•• confirmed previous observations suggesting underlying cardiovascular disease hypertension associated increased risk inhospital death patients hospitalized covid<NUMBER> increased risk inhospital death found associated use ace inhibitors <NUMBER> vs <NUMBER> odds ratio <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> use arbs <NUMBER> vs <NUMBER> odds ratio <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> populationbased casecontrol study lombardy region italy including <NUMBER> case patients <NUMBER> matched beneficiaries regional health service controls according sex age municipality residence use ace inhibitors arbs frequent patients covid<NUMBER> controls higher prevalence cardiovascular disease however evidence ace inhibitors arbs associated increased risk covid<NUMBER> <NUMBER>•• finally reynolds colleagues <NUMBER>•• studied relation previous treatment acei arbs betablockers calciumchannel blockers thiazide diuretics likelihood covid<NUMBER> positive test result well infection severity defined intensive care mechanical ventilation death patients among <NUMBER> patients tested covid<NUMBER> found significant association five common classes antihypertensive medications positive test covid<NUMBER> greater infection severity collectively available clinical evidence points neutral even beneficial effect outcomes patients covid<NUMBER> receiving aceiarb observational nature investigations prevents definitive conclusion previously noted <NUMBER> <NUMBER> elderly patients high risk complications related covid<NUMBER> group social distancing identified top priority aging also wellestablished risk factor developing hypertension <NUMBER> indeed progressive increase prevalence hypertension parallel age stratification <NUMBER> according population statistics prevalence hypertension may reach <NUMBER> elderly <NUMBER> scenario reasonable expect hypertension frequent red flag warning statistics complications deaths covid<NUMBER> <NUMBER> recent national analysis china included <NUMBER> hospitalized patients <NUMBER> hospitals suggested potential role hypertension important comorbidity covid<NUMBER> <NUMBER> authors evaluated risk serious adverse outcomes composite endpoint consisted admission intensive care unit invasive ventilation death stratified comorbidity status adjusting age smoking status chronic obstructive pulmonary disease diabetes malignancy hypertension risk factors composite endpoint moreover number comorbidities also predicted outcomes fig <NUMBER> however comorbidities selfreported patients admission <NUMBER> results interpreted caution conceivable several patients aware hypertension status supporting concept <NUMBER> patients reported medical history hypertension investigation <NUMBER> represents <NUMBER> lower indicated adult population china <NUMBER> indeed mean age patients study <NUMBER> years prevalence hypertension china <NUMBER> <NUMBER> therefore reports date rigorously accounted age key factors contribute health potential confounders risk prediction <NUMBER>• relevance discussing investigating whether hypertension prognostic marker covid<NUMBER> pandemic clear epidemiologiceconomic perspective crucial stablish real risk factors priorities social distancing regardless age even several strategic areas including healthcare professionals scenario future investigations addressing impact hypertension prognosis may significant value adopting strict protocol confirm hypertension status medications chronic use associated comorbidities including overweightobesity reported investigations predictor poor outcomes covid<NUMBER> <NUMBER> <NUMBER> chronic kidney pulmonary disease share opinion age also relevant variables adjusted clarify potential role hypertension independent risk factor covid<NUMBER> treatment perspective important determine role hypertension treatments aceiarbs susceptibility viral infections particular attention devoted role ace<NUMBER> overexpression patients sense recombinant ace<NUMBER> genedelivery ace<NUMBER> angiotensin <NUMBER> analogs gcoupled protein receptor angiotensin <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> mas receptor agonists enhance ace<NUMBER> action may serve potential target therapies relevant studies humans lacking <NUMBER> also need definitive evidence regarding use ras inhibitors covid<NUMBER> infection currently <NUMBER> ongoing randomized trials registered clinicaltrialsgov aiming test impact acei andor arbs patients covid<NUMBER> table <NUMBER> four focusing safety issues classes acute phase <NUMBER> studies chronic scenario <NUMBER> study interestingly praetoriancovid trial testing whether arb valsartan may protective patients severe covid<NUMBER> without hypertension rationale study based assumption acute lung injury alveolar ace<NUMBER> appears downregulated <NUMBER> arbs would truly upregulate membranebound ace<NUMBER> thereby supporting protective rather deleterious effect covid<NUMBER> taken together evidence far unclear whether hypertension treatment real risk factor covid<NUMBER> infection future investigations necessary clarify complex multifaceted puzzle author contributions study concept design dr drager literature review analysis interpretation data authors drafting manuscript authors critical revision manuscript important intellectual content authors conflict interest authors declare conflicts interest relevant manuscript human animal rights informed consent article contain studies human animal subjects performed authors coronavirus disease covid<NUMBER> recent pandemic infection caused enveloped nonsegmented singlestranded ribonucleic acid rnaβ coronavirus <NUMBER> sarscov<NUMBER> sarscov<NUMBER> seventh member coronavirus <NUMBER> cause various symptoms ranging mild cold severe respiratory diseases severe acute respiratory syndrome sars middle eastern respiratory syndrome mers mortality rates <NUMBER> sars <NUMBER> mers <NUMBER> recent years two coronary viral infections spread led severe respiratory diseases sars mers sarscov first appeared <NUMBER> years ago <NUMBER> sars epidemic <NUMBER> <NUMBER> infected patients ages <NUMBER> deaths documented <NUMBER> countries <NUMBER> continents main clinical manifestations upper respiratory symptoms rapid progression pneumonia approximately <NUMBER> <NUMBER> admitted intensive care <NUMBER> patients <NUMBER> years age mortality rate <NUMBER> patients treated dying intensive care unit <NUMBER> developed disseminated intravascular coagulation covid<NUMBER> characterized exaggerated inflammatory response lead severe complications acute respiratory distress syndrome ards sepsis shortly onset symptoms <NUMBER> thrombotic events coagulopathy also described covid<NUMBER> <NUMBER> transition mild severe patients covid<NUMBER> rapid without predicting symptoms older male obese patients comorbidities higher risk developing severe symptoms <NUMBER> keywords ► reninangiotensin system ► angiotensin ► inflammation ► coagulopathy ► covid<NUMBER> activated reninangiotensin system induces prothrombotic state resulting imbalance coagulation fibrinolysis angiotensin ii central effector molecule activated reninangiotensin system degraded angiotensinconverting enzyme <NUMBER> angiotensin <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> novel coronavirus infection classified caused new coronavirus sarscov<NUMBER> characterized exaggerated inflammatory response lead severe manifestations acute respiratory distress syndrome sepsis death proportion patients mostly elderly patients preexisting comorbidities sarscov<NUMBER> uses angiotensinconverting enzyme <NUMBER> receptor enter target cells resulting activation reninangiotensin system downregulating angiotensinconverting enzyme <NUMBER> vasoconstrictor angiotensin ii increasingly produced counterregulating molecules angiotensin <NUMBER> reduced angiotensin ii increases thrombin formation impairs fibrinolysis elevated levels strongly associated viral load lung injury patients severe covid<NUMBER> therefore complex clinical picture patients severe complications covid<NUMBER> triggered various effects highly expressed angiotensin ii vasculopathy coagulopathy inflammation future treatment options focus blocking thrombogenic inflammatory properties angiotensin ii covid<NUMBER> patients acute lung failure pathology many diseases combination antiviral antiinflammatory treatments recommended covid<NUMBER> <NUMBER> unfortunately specific drug vaccine yet approved treatment human coronavirus therefore underlying pathomechanism covid<NUMBER>induced changes investigated identify specific treatment options total <NUMBER> cases covid<NUMBER> published chinese centre disease control prevention <NUMBER> mild symptoms <NUMBER> severe <NUMBER> critical manifestations <NUMBER> case fatality rate <NUMBER> <NUMBER> patients aged <NUMBER> older patients patients comorbidities higher body mass index likely serious complications covid<NUMBER> severe critical cases suffer sepsis ards coagulopathy occurs <NUMBER> cases <NUMBER> sepsis cytokine storm viral bypassing cellular immune response described connection human coronavirus infections <NUMBER> associated neutrophilia pulmonary infiltration neutrophils macrophages respiratory syndromes <NUMBER> <NUMBER> pulmonary symptoms pneumonia predominant covid<NUMBER> <NUMBER> pneumonia complicated hypoxic pulmonary vasoconstriction homeostatic reflex contraction pulmonary vascular smooth muscle response low regional oxygen partial pressure redirects blood oxygenated lung segments <NUMBER> study using remdesivir nucleoside analogue drug inhibits viral rna polymerases mortality rate <NUMBER> ventilated covid<NUMBER> patients <NUMBER> sepsis common cause acute lung injury ards <NUMBER> ards characterized diffuse alveolar damage often complicated pulmonary hypertension <NUMBER> patients ards subgroup ards survivors develop fibroproliferative response characterized fibroblast accumulation deposition collagen extracellular matrix components lung development severe fibroproliferative lung disease associated poor prognosis high mortality andor prolonged ventilator dependence <NUMBER> patients severe complications experienced extrapulmonary symptoms organ injuries multivariable analysis comparing clinical laboratory parameters <NUMBER> surviving patients <NUMBER> nonsurvivors death occurred median <NUMBER>th day hospital treatment mechanical ventilation <NUMBER> days <NUMBER> three patients attempt made perform extracorporeal membrane oxygenation <NUMBER> deceased patients developed sepsis <NUMBER> vs <NUMBER> survivors <NUMBER> patients suffered respiratory failure <NUMBER> vs <NUMBER> <NUMBER> patients suffered ards <NUMBER> vs <NUMBER> <NUMBER> patients suffered heart failure <NUMBER> vs <NUMBER> <NUMBER> patients suffered septic shock <NUMBER> vs <NUMBER> rate patients organ injury significantly higher patients severe outcome <NUMBER> patients <NUMBER> patients heart injury <NUMBER> heart failure <NUMBER> kidney injury china several studies investigated clinical course covid<NUMBER> differentiating severe nonsevere outcome collecting data organ injury <NUMBER> studies clinical course <NUMBER> patients investigated <NUMBER> developed severe manifestation disease <NUMBER> median age ranged <NUMBER> <NUMBER> years <NUMBER> years older patients nonsevere course male patients affected severe manifestations <NUMBER> <NUMBER> patients severe manifestations organ injuries <NUMBER> heart injuries <NUMBER> kidney injuries ►table <NUMBER> angiotensinconverting enzyme <NUMBER> ace<NUMBER> critical heart function angiotensin ii ang ii infusions mice resulted increased blood pressure myocardial hypertrophy fibrosis whereas effects could counteracted recombinant human ace<NUMBER> <NUMBER> loss ace<NUMBER> exacerbate cardiac damage <NUMBER> myocardial infarction appears important complication disease according chen et al also found autopsy <NUMBER>yearold female patient <NUMBER> metaanalysis cardiac troponin levels significantly increased patients severe covid<NUMBER> infection compared patients milder forms disease <NUMBER> cardiac injury shown crosssectional study <NUMBER> patients included <NUMBER> mild <NUMBER> severe cases <NUMBER> confirmed common condition among hospitalized patients associated higher risk inhospital mortality <NUMBER> total <NUMBER> patients <NUMBER> cardiac injury highly significant elevated levels highsensitive troponin levels mortality patients significantly higher <NUMBER> without cardiac injury <NUMBER> laboratory imaging findings suggest increased risk thrombotic events patients covid<NUMBER> infection incidence thrombosis patients covid<NUMBER> determined coagulopathy described <NUMBER> severe manifestations covid<NUMBER> shown increased ddimers measured hospital admission predict severe course covid<NUMBER> <NUMBER> ddimer derives cleavage crosslinked fibrin reflects thrombin production activation fibrinolysis besides known variability healthy subjects tendency increase age association increased ddimer levels fibrin degradation products conditions activated coagulation system thrombosis infection malignancy <NUMBER> large study included <NUMBER> covid positive patients <NUMBER> hospitals china ddimer levels threshold <NUMBER> μgl detected <NUMBER> patients <NUMBER> among developed severe manifestations patients ddimer levels fourfold increased <NUMBER> ugml <NUMBER> compared nonsevere patients <NUMBER> ugml <NUMBER> interestingly none nonsevere patients ddimer levels increasing three times admission <NUMBER> study <NUMBER> critically ill patients covid<NUMBER> <NUMBER> dutch hospitals <NUMBER> incidence thrombosis instead use standard doses thromboprophylaxis low molecular weight heparin majority patients suffered lung embolism stroke also occurred three patients <NUMBER> addition microthrombosis described case series four autopsies covid<NUMBER> infected patients new orleans sudden respiratory decompensation autopsy findings showed small vessels thromboembolism small thrombi together scattered areas diffuse alveolar damage findings usually worsened course disease could hardly diagnosed early ddimers found time death elevated two patients shows microthrombosis usually lead generalized coagulation activation <NUMBER> reninangiotensin system ras first described <NUMBER> years ago led broader understanding cardiovascular pathophysiology <NUMBER> ras known role regulation blood pressure electrolyte balance vascular remodeling <NUMBER> continuous basic clinical research enabled significant advances therapy developed treatment hypertension left ventricular dysfunction well severe heart failure renin released kidney response renal hypoperfusion reduced sodium intake sympathetic activation cascade proteolytic reactions leads formation ang peptides different functions ace zincdependent peptidase responsible conversion ang vasoconstrictive ang ii ace<NUMBER> counteracts activity ace reducing amount ang ii increasing ang <NUMBER> cleaving ang ang <NUMBER> thereby attenuating effects ang ii ras produces opposite effects ang <NUMBER> directly antagonizes effects ang ii mediates vasodilatory antiproliferative effects induces release nitric oxide prostaglandin i<NUMBER> stimulation endothelial at<NUMBER> receptor <NUMBER> <NUMBER> ace<NUMBER> expressed predominantly vascular endothelial cells lung also extrapulmonary tissue heart nervous system intestine kidneys blood vessels muscles cell surfaces <NUMBER> <NUMBER> addition ace<NUMBER> functions independent ras vitro vivo studies shown ace<NUMBER> acts functional sarscov<NUMBER> receptor well transmembrane serine protease tmprss<NUMBER> required host cell entry subsequent viral replication <NUMBER> remarkably sarscov<NUMBER> protein recognizes human ace<NUMBER> even higher binding affinity spike sarscov <NUMBER> preclinical studies shown binding sarscov receptor ace<NUMBER> activates ras leading downregulation expression ace<NUMBER> turn results excessive production ang ii <NUMBER> <NUMBER> <NUMBER> <NUMBER> therefore ace<NUMBER> plays dual role covid<NUMBER> initially acts receptor sarscov<NUMBER> entry context sarscov<NUMBER> infection ace<NUMBER> downregulated increases ang ii ang ii central effector molecule activated ras elevated levels ang ii reported mostly patients hypertension heart failure indicating benefit ras inhibitors <NUMBER> two ang ii receptors type <NUMBER> type <NUMBER> indicate effect ras inhibitors <NUMBER> cardiovascular effects ang ii attributed type <NUMBER> receptor notably ang ii one potent vasopressors known linked type <NUMBER> ang receptor vasopressor effects ang ii investigated multinational doubleblind randomized controlled trial athos<NUMBER> <NUMBER> patients vasodilatory shock <NUMBER> ang ii effectively raised blood pressure patients vasodilatory shock respond high doses conventional vasopressors however high rate thrombosis observed <NUMBER> patients use thromboprophylaxis recommended <NUMBER> interestingly skin problems possibly caused thrombosis small vessels also observed evidence important role ang ii vascular cell growth tissue remodeling hypertension vascular injury heart failure atherosclerosis <NUMBER> <NUMBER> recently ang ii shown stimulate production pulmonary fibroblast procollagen via at<NUMBER> receptor lung injury <NUMBER> addition ang ii promotes growth vascular smooth muscle cells vsmcs induces cellular hypertrophy pathology hypertension atherosclerosis ang ii contributes endothelial dysfunction development arteriosclerosis microvascular thrombosis ang ii stimulates tissue factor tf expression vitro vivo <NUMBER> tf physiological initiator blood coagulation consequence activation tf becomes dominant tf pathway inhibitor resulting prothrombotic endothelium addition ang ii stimulates plateletderived growth factor production increases platelet aggregation arterial thrombotic events stroke myocardial infarction associated increased platelet aggregation <NUMBER> addition endothelial microparticles key players pathogenesis vascular diseases inflammation coagulation angiogenesis increased many agerelated vascular diseases coronary artery disease also stimulated ang ii <NUMBER> also shown ang ii infusion leads abnormal inflammatory thrombotic reactions microcirculation hypertensive rats ang ii accelerates arterial thrombosis carotid artery via at<NUMBER> receptor <NUMBER> prothrombogenic effects restricted large arteries also accelerated microvascular thrombosis arterioles lesser extent venules ang ii infusions <NUMBER> clinical data also support role ang ii fibrinolysis plasminogen activator inhibitor <NUMBER> pai<NUMBER> major inhibitor fibrinolytic system elevated levels found associated coronary artery disease deep vein thrombosis malignancy <NUMBER> mature fat cells important source pai<NUMBER> expression correlates visceral fat mass vitro vivo studies shown ang ii stimulates expression release pai<NUMBER> ang ii also stimulates expression pai<NUMBER> messenger rna mrna endothelial cells increases plasma pai<NUMBER> levels dosedependent manner infusion ang ii healthy volunteers led significant increase pai<NUMBER> concentrations <NUMBER> heart study pai<NUMBER> concentrations significantly lower administering ramipril captopril <NUMBER> suppress formation ang ii adipose tissue <NUMBER> addition inhalation plasminogen whose conversion plasmin inhibited pai<NUMBER> improves lung lesions hypoxemia patients association activated ras increased ang ii inflammatory cytokine expression activation ang ii proinflammatory properties including increase interleukin il<NUMBER> demonstrated infusion ang ii healthy controls <NUMBER> furthermore ang ii shown induce il<NUMBER> transcription vsmc <NUMBER> vsmc expression il<NUMBER> could induced ang ii <NUMBER> may explain underlying mechanism progression ang iiinduced atherosclerosis il<NUMBER> multifunctional cytokine mediates proliferation blymphocytes antibody synthesis ang ii stimulates release il<NUMBER> contributing cytokine storm poorer outcomes patients covid<NUMBER> <NUMBER> function ace<NUMBER> also demonstrated ace<NUMBER> knockout mouse model loss ace<NUMBER> expression preceded acute lung damage various models ace<NUMBER> knockout mice showed severe lung damage caused increased hydrostatic pressure reduced perfusion severe pulmonary edema <NUMBER> administration recombinant ace<NUMBER> protects lungs severe lung damage consequently ang ii directly associated lung tissue damage ace<NUMBER> inversely associated lung tissue damage organ damage lung heart kidney major cause severe clinical manifestations covid patients already <NUMBER> ace<NUMBER> shown protect mouse lungs ards ace<NUMBER> knockout mice particular injection sarscov spikes mice exacerbates acute lung failure vivo attenuated blocking reninangiotensin signaling pathway suggesting activation pulmonary ras influences pathogenesis ards sars <NUMBER> <NUMBER> autopsies patients died sars <NUMBER> heart samples showed presence sarscov associated reduced ace<NUMBER> expression <NUMBER> remarkably unbalanced ras found covid<NUMBER> patients investigation epidemiological clinical laboratory chemical radiological characteristics potential biomarkers predict disease severity <NUMBER>ncovinfected patients shenzhen ang ii levels plasma sample <NUMBER>ncovinfected patients shown significantly elevated linearly associated viral load lung damage critically ill patients <NUMBER> ►table <NUMBER> summarizes possible effects ang ii clinical symptoms covid<NUMBER> patients complex clinical picture patients severe complications covid<NUMBER> triggered different effects highly expressed ang ii vasculopathy coagulopathy inflammation could shown patients covid<NUMBER> unbalanced ras highly expressed ang levels addition presence comorbidities arterial hypertension significantly associated worse outcome total <NUMBER> patients <NUMBER> studies hypertension common <NUMBER> patients significantly severe manifestations <NUMBER> <NUMBER> patients compared severe manifestations <NUMBER> <NUMBER> patients without hypertension ►table <NUMBER> presence hypertension associated significantly higher mortality odds ratio mortality hypertension <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> however data adjusted risk th open vol <NUMBER> <NUMBER> factors became clear studies whether hypertension previously known diagnosed hospital stay whether treatment example rasinhibiting drugs administered therefore rasinhibiting drugs ace inhibitors aceis angiotensin receptor blockers arbs may used covid<NUMBER>infected patients treat hypertension ang iirelated complications preclinical study showed arb drugs especially losartan effective relieving acute lung injury caused sarscov mice <NUMBER> however acei arb shown increase ace<NUMBER> expression heart tissue animal models <NUMBER> concern possible higher expression pulmonary membranebound ace<NUMBER> confirmed date may lead easier entry virus respiratory cells rasinhibiting drugs taken hand acei lisinopril arb losartan upregulate cardiac ace<NUMBER> mrna factor <NUMBER> <NUMBER> animal model acei enalapril attenuated downregulation cardiac ace<NUMBER> myocardial infarction <NUMBER> <NUMBER> clear benefit acei arb reducing thrombotic effects hypertensive patients <NUMBER> <NUMBER> protection severe lung damage could also achieved administering recombinant ace<NUMBER> ace<NUMBER> knockout mice showed severe lung damage caused increased hydrostatic pressure reduced perfusion severe pulmonary edema <NUMBER> administration recombinant ace<NUMBER> protects lungs severe lung damage consequently ang ii directly associated lung tissue damage ace<NUMBER> inversely associated lung tissue damage recently could shown human recombinant soluble ace<NUMBER> block early stages sarscov<NUMBER> infections <NUMBER> could future also used treat covid<NUMBER> patients currently tested phase <NUMBER> clinical trial currently numerous drugs studied clinical trials small cohort critically ill patients treated remdesivir nucleoside analogue inhibits viral rna polymerases clinical improvement observed <NUMBER> <NUMBER> patients <NUMBER> <NUMBER> randomized controlled trials ongoing soon provide evidence safety efficacy remdesivir covid<NUMBER> finally considering covid<NUMBER> procoagulant disease prophylactic anticoagulation low molecular weight heparin initiated soon possible prevent thrombotic events counteract proinflammatory influence cytokines <NUMBER> transition mild severe symptoms occur rapidly patients covid<NUMBER> without predicting signals older male obese patients comorbidities higher risk developing severe symptoms ras plays important role covid<NUMBER> ace<NUMBER> acts functional sarscov<NUMBER> receptor leads downregulation ace<NUMBER> higher expression ang ii ace<NUMBER> abbreviations ang ii angiotensin ii ards acute respiratory distress syndrome il<NUMBER> interleukin<NUMBER> pai<NUMBER> plasminogen activator inhibitor <NUMBER> pdgf plateletderived growth factor tf tissue factor predominantly expressed vascular endothelial cells lung also extrapulmonary tissue heart nervous system intestine kidneys blood vessels muscles cell surfaces may explain multiorgan dysfunction observed patients covid<NUMBER> complex clinical picture patients severe complications covid<NUMBER> includes pneumonia ards sepsis coagulopathy high rate thrombosis organ damage triggered various effects highly expressed ang ii vasculopathy coagulopathy inflammation combination numerous pathophysiological changes caused ang ii covid<NUMBER> could explain rapid development severe patients older obese patients particularly affected future treatment options focus blocking thrombogenic inflammatory properties ang ii covid<NUMBER> patients novel coronavirus cov emerged wuhan hubei province china december <NUMBER> known severe acute respiratory syndrome coronavirus type <NUMBER> sarscov<NUMBER> rapidly spread throughout chinese provinces subsequently propagated across globe <NUMBER> cases ≈ <NUMBER> deaths <NUMBER> countries httpswwwwho intemergenciesdiseasesnovelcoronavirus<NUMBER> situationreports world health organization therefore declared coronavirus disease <NUMBER> global pandemic march <NUMBER> <NUMBER> europe worlds covid<NUMBER> epicenter italy country highest number reported cases deaths march <NUMBER> italian institute health iss reported <NUMBER> cases <NUMBER> dea th italy httpswwwepicentroiss itcoronavirus overtook china country coronavirusrelated casualties pandemic propagating across usa <NUMBER> cases <NUMBER> deaths reported march <NUMBER> <NUMBER> currently sarscov<NUMBER> presents estimated r<NUMBER> ranging <NUMBER> <NUMBER> means infected individual may transmit disease <NUMBER> people susceptible population madjid et al <NUMBER> older adults dadamo et al <NUMBER> suffering multiple comorbidities sarscov<NUMBER> enveloped positivestrand rna virus belongs βcoronavirus βcov family presents <NUMBER> nucleotide identity sarslike covzxc<NUMBER> identified bats human sarscov nucleotide identity merscov reduced ≈ <NUMBER> chan et al <NUMBER> wan et al <NUMBER> lu et al <NUMBER> sarscov<NUMBER> mainly targets respiratory tract mammals including humans thereby inducing wide spectrum clinical features ranging asymptomatic paucisymptomatic forms interstitial pneumonia upon progressive alveolar damage severe acute respiratory failure may require advanced respiratory support intensive care two organ systems fact covid<NUMBER> may progress towards adult respiratory distress syndrome ards andor multiple organ acute failure eg kidney liver heart even death zhou et al <NUMBER>b wu et al <NUMBER>a wang et al <NUMBER>d although covid<NUMBER> respiratory disease one third patients severe covid<NUMBER> conjunctivitis wu et al <NUMBER>b patients showed gastrointestinal symptoms nausea vomiting diarrhea jin et al <NUMBER> interestingly epithelial cells several body compartments including oral nasal mucosa hamming et al <NUMBER> respiratory tree alveoli hamming et al <NUMBER> intestinal mucosa hamming et al <NUMBER> well human aqueous humor holappa et al <NUMBER> show high levels metallopeptidase named angiotensinconverting enzyme <NUMBER> ace<NUMBER> functional receptor sarscov<NUMBER> lan et al <NUMBER> ace<NUMBER> also expressed coronary intrarenal endothelial cells renal tubular epithelial cells donoghue et al <NUMBER> since ace<NUMBER> catalyzes cleavage angiotensin ii vasoconstrictor angiotensin <NUMBER> ang <NUMBER> vasodilator extrarespiratory localization supported hypotheses relationship sarscov<NUMBER> infection cardiovascular cv system indeed adult patients affected cvds arterial hypertension diabetes andor chronic obstructive pulmonary disease copd show worse clinical outcome following contraction viral illness fatality rate attaining <NUMBER> novel coronavirus pneumonia emergency response epidemiology team novel coronavirus pneumonia emergency response epidemiology team <NUMBER> patients covid<NUMBER> pneumonia developed ards acute cardiac injury shock arrhythmia represent common lifethreatening complications along acute kidney injury chen et al <NUMBER>b huang et al <NUMBER> wang et al <NUMBER>a long known acute respiratory infections including flu pneumonias may trigger severe cv disease cvd events vice versa madjid et al <NUMBER> although experimental evidence topic still infancy hypothesize discuss suggestive cellular molecular mechanisms whereby sarscov<NUMBER> may lead detrimental consequences cv system focus aging cytokine storm nlrp<NUMBER>inflammasome hypoxemia air pollution emerging cv risk factor associated rapid urbanization globalization finally discuss impact clinically available cv drugs clinical course covid<NUMBER> patients understanding role played sarscov<NUMBER> cv system indeed mandatory get insights covid<NUMBER> pathogenesis design therapeutic strategy cardioprotection frail patients zheng et al <NUMBER> sarscov<NUMBER> cardiovascular system suggestive relationship first reports describing clinical features patients affected covid<NUMBER> hinted relationship sarscov<NUMBER>mediated infection cv system mainly due high inflammatory burden affecting myocardium vessels table <NUMBER> zheng et al <NUMBER> madjid et al <NUMBER> although suggestive causal relationship translational research carefully performed order avoid confounding factors hasty conclusions order support mention clinical evidences emerged best knowledge prevalence risk death severe covid<NUMBER> higher elderly patients chronic comorbidities arterial hypertension type <NUMBER> diabetes cardiac cerebrovascular disorders copd note diagnosis major cardiac complications ie acute myocardial injury lethal arrhythmias recently emerged analysis initial representative populations covid<NUMBER> patients first report analyzed cohort <NUMBER> patients median table <NUMBER> demographics baseline characteristics major complications patients infected sarscov<NUMBER> summary major studies huang et al <NUMBER> chen et al <NUMBER>b wang et al <NUMBER>a zhou et al <NUMBER>a guan et al <NUMBER> ards acute respiratory distress syndrome copd chronic obstructive pulmonary disease cvd cardiovascular disease age <NUMBER> years <NUMBER> men majority n <NUMBER> <NUMBER> exposed huanan seafood liveanimal market original epicenter covid<NUMBER> outbreak underlying comorbidities reported <NUMBER> patients including diabetes n <NUMBER> <NUMBER> cvd n <NUMBER> <NUMBER> hypertension n <NUMBER> <NUMBER> moreover increased blood levels highsensitivity cardiac troponin ctni reported <NUMBER> patients <NUMBER> initial finding cautiously suggests onset acute cardiac ischemic injury covid<NUMBER> patients yet measurements ctni levels always associated electrocardiogram ecg imaging findings myocardial ischemia giannitsis katus <NUMBER> make diagnosis intriguingly rising levels ctni also independent predictors mortality critically ill patients hospitalized severe pneumonia without evidence acute coronary syndrome lee et al <NUMBER> regard cannot exclude onset transient myopericarditis mimicking acute myocardial infarction severe covid<NUMBER> patients due cytokine storm inciardi et al <NUMBER> previously observed severe ards patients fact increased serum level proinflammatory cytokines instance interleukin<NUMBER>β il<NUMBER>β interferon γ ifnγ mcp<NUMBER> reported icupatients nonicu patients observation consistent development cytokine storm syndrome previously reported sars sarscov middle east respiratory syndrome coronavirus merscov infections de wit et al <NUMBER> second report analyzed cohort <NUMBER> patients median age <NUMBER> <NUMBER> men half n <NUMBER> <NUMBER> also exposed huanan seafood market chen et al lancet <NUMBER>b large percentage subjects n <NUMBER> <NUMBER> suffered cvd cerebrovascular disorders represent common chronic comorbidities cohort chen et al <NUMBER>b cardiac injury diagnosed measuring changes myocardial zymogram evaluates activity metalloproteinases myocardial zymogram results however risk overinterpreted since assay timp tissue inhibitor metalloproteinases free environment lindsey <NUMBER> since considered gold standard assay diagnose acute cardiac injury hospital setting established cardiac specific biomarkers tested fact authors also reported high circulating levels creatine kinase lactate dehydrogenase <NUMBER> <NUMBER> <NUMBER> <NUMBER> patients respectively chen et al <NUMBER>b biomarkers generally used perform early diagnosis acute myocardial infarction yet since enzymes also present tissues myocardium diagnostic specificity limited diagnostic sensitivity also suffers presence sizeable baseline enzyme concentration circulation without cardiac pathology bodor <NUMBER> falsepositive results indeed may occur renal failure muscle fatigue vitamin deficiency pneumonia asthma malignancies pulmonary embolism hypoxia smokers particular <NUMBER> dead patients presented long history tobacco smoke exposure chen et al <NUMBER>b enhances risk respiratory cardiovascular disease well third report analyzed cohort <NUMBER> patients median age <NUMBER> <NUMBER> men hypertension n <NUMBER> <NUMBER> cvd n <NUMBER> <NUMBER> diabetes n <NUMBER> <NUMBER> cancer n <NUMBER> <NUMBER> common coexisting underlying comorbidities small fraction subjects n <NUMBER> <NUMBER> suffering cerebrovascular disease note admission rate icu n <NUMBER> <NUMBER> remarkably increased among patients age displaying hypertension n <NUMBER> <NUMBER> cvd n <NUMBER> <NUMBER> cerebrovascular disease n <NUMBER> <NUMBER> underlying comorbidities finally arrhythmias n <NUMBER> <NUMBER> acute cardiac injury n <NUMBER> <NUMBER> defined increased blood levels hypersensitive ctni common complications arising icu patients affected ards n <NUMBER> <NUMBER> acute kidney injury n <NUMBER> <NUMBER> fourth singlecenter study analyzed epidemiological clinical features <NUMBER> hospitalized covid<NUMBER> patients median age <NUMBER> <NUMBER> men none exposed huanan market ninety patients <NUMBER> suffered least <NUMBER> underlying comorbidity common hypertension n <NUMBER> <NUMBER> followed diabetes n <NUMBER> <NUMBER> note lower fraction severe covid<NUMBER> patients suffered preexisting arrhythmia n <NUMBER> <NUMBER> coronary heart disease n <NUMBER> <NUMBER> finally singlecenter large study conducted <NUMBER> patients affected covid<NUMBER> <NUMBER> hospitals <NUMBER> chinese provinces median age <NUMBER> <NUMBER> men confirmed <NUMBER> subjects preexisting comorbidities guan et al <NUMBER> hypertension n <NUMBER> <NUMBER> diabetes n <NUMBER> <NUMBER> coronary heart disease n <NUMBER> <NUMBER> cerebrovascular disease n <NUMBER> <NUMBER> guan et al <NUMBER> study acute cardiac injury defined increase circulating levels creatine kinase lactate dehydrogenase <NUMBER> <NUMBER> patients respectively guan et al <NUMBER> additional features acute myocardial infarction considered among different clinical reports retrospective multicenter cohort study including <NUMBER> adult covid<NUMBER> patients median age <NUMBER> <NUMBER> men confirmed preexisting comorbidities almost half individuals n <NUMBER> <NUMBER> hypertension n <NUMBER> <NUMBER> diabetes n <NUMBER> <NUMBER> coronary heart disease n <NUMBER> <NUMBER> zhou et al <NUMBER>a likewise nonsurvivors displayed higher rate comorbidities compared survivors including hypertension <NUMBER> vs <NUMBER> diabetes <NUMBER> vs <NUMBER> coronary heart disease <NUMBER> vs <NUMBER> zhou et al <NUMBER>a addition sepsis n <NUMBER> <NUMBER> respiratory failure n <NUMBER> <NUMBER> ards n <NUMBER> <NUMBER> acute kidney injury n <NUMBER> <NUMBER> common secondary outcomes cohort patients onset acute heart failure n <NUMBER> <NUMBER> acute cardiac injury n <NUMBER> <NUMBER> zhou et al <NUMBER>a note nonsurvivors presented higher rates acute heart failure <NUMBER> vs <NUMBER> acute cardiac injury <NUMBER> vs <NUMBER> compared survivors moreover laboratory findings showed high levels nonspecific biomarkers lactate dehydrogenase creatine kinase hypersensitive ctni amino acid sequence similar skeletal troponin c xu et al <NUMBER> proinflammatory biomarkers eg interleukin<NUMBER> il<NUMBER> serum ferritin zhou et al <NUMBER>a since measurement circulating biomarkers enough diagnose acute cardiac injury caused sarscov<NUMBER> certainty clinical investigations based multimodal approach encouraged similarly retrospective multicenter study conducted smaller cohort n <NUMBER> covid<NUMBER> patients confirmed risk death greater presence cvd note isolated myocardial injury resulted one main causes death patients <NUMBER> presence high levels il<NUMBER> creactive protein relationship sarscov<NUMBER> infection cvd corroborated recent descriptive analysis <NUMBER> covid<NUMBER> cases diagnosed china february <NUMBER> <NUMBER> novel coronavirus pneumonia emergency response epidemiology team novel coronavirus pneumonia emergency response epidemiology team <NUMBER> study confirmed fraction patients affected cvd <NUMBER> including arterial hypertension <NUMBER> although retrospective studies cannot helpful made causal association confirmed mortality rate increased cvd <NUMBER> diabetes <NUMBER> chronic respiratory disease <NUMBER> arterial hypertension <NUMBER> novel coronavirus pneumonia emergency response epidemiology team novel coronavirus pneumonia emergency response epidemiology team <NUMBER> madjid et al <NUMBER> cvds really make difference worse prognosis covid<NUMBER> patients although italy european country highest percentage population aged <NUMBER> mortality rate due covid<NUMBER> among highest world madjid et al <NUMBER> still unknown whether greater vulnerability illness depends higher percentage older patients meanwhile iss recently listed common comorbidities observed deceased patients italy march <NUMBER> <NUMBER> table <NUMBER> <NUMBER> screened patients comorbidities majority patients presented one <NUMBER> two <NUMBER> three <NUMBER> comorbidities finally assume clinical outcome covid<NUMBER> progressively worsened italian elderly patients due combined impact multiple comorbidities frailty since cardiometabolic disease common people <NUMBER> risk developing increases people get older conceivable underlying cv metabolic comorbidities ie hypertension ischemic heart disease atrial fibrillation stroke diabetes contribute unfavorable prognosis older covid<NUMBER> patients addition <NUMBER> patients died acute myocardial injury httpswwwepicentroiss itcoronavirussarscov<NUMBER>decessiitalia first independent analyses suggest besides arising frequently individuals suffering underlying cv comorbidities sarscov<NUMBER> may cause severe myocardial injury even absence ards multiple organ dysfunctions often leading death besides local ischemia fatal myocardial damage covid<NUMBER> patients may due acute myocarditis unresponsive conventional therapy recently autopsy male covid<NUMBER> patient revealed myocardial infiltration interstitial mononuclear inflammatory cells xu et al <NUMBER>b evidence severe myocarditis associated low cardiac output syndrome even observed covid<NUMBER> patients italy inciardi et al <NUMBER> china findings consistent reported upregulation il<NUMBER> serum covid<NUMBER> patients chronic il<NUMBER> production viral infection long known boost myocarditis fontes et al <NUMBER> however investigation underlying mechanisms required although wellknown epidemic viruses ie sarscov merscov flu viruses influenza b virus may lead arrhythmia myocardial infarction acute heart failure aberrant systemic release proinflammatory cytokines cannot exclude factors activated sarscov<NUMBER> exacerbate cardiac injury characterizing covid<NUMBER> herein analyze potential role angiotensin converting enzyme <NUMBER> ace<NUMBER> pathway nlrp<NUMBER>inflammasome hypoxemia aging air pollution role reninangiotensin system ace<NUMBER> sarscov<NUMBER>induced cardiac injury best knowledge critical initial step underlying sarscov<NUMBER> entry target cells binding receptor binding domain rbd viral spike protein ace<NUMBER> receptor follows protein priming ser proteases tmprss<NUMBER> furin hoffmann et al <NUMBER> lan et al <NUMBER> since binding affinity protein ace<NUMBER> receptor major determinant viral replication rates disease severity li et al <NUMBER> cleavage spike protein plays critical role covid<NUMBER> airborne viral illness therefore first ace<NUMBER>rich cells encountered sarscov<NUMBER> delivered particle droplets upper respiratory tract particular goblets ciliated cells nasal epithelium sungnak et al <NUMBER> however ace<NUMBER> expressed active many human tissues preliminary evidence indicated ace<NUMBER> cardiomyocytes coronary pericytes could play potential role myocardial vulnerability sarscov<NUMBER> infection onset acute cardiac injury ace<NUMBER> one major player reninangiotensin system ras acts balance angiotensinconverting enzyme ace tikellis et al <NUMBER> contrary ace converts angiotensin ang angiotensin ii ang ii ace<NUMBER> mainly involved degradation ang ii thereby resulting formation ang <NUMBER> tikellis et al <NUMBER> ang ii induces vasoconstrictive proinflammatory prooxidative effects increasing expression endothelial von willebrand factor activating endothelial ang ii receptor type <NUMBER> at<NUMBER> dushpanova et al <NUMBER> ang <NUMBER> mediates antiinflammatory antioxidative vasodilatory effects binding mas receptor masr thus exerting beneficial effect several pathological conditions hypertension diabetes cvd tikellis et al <NUMBER> reference therein order maintain homeostasis ace<NUMBER> opposes actions ang ii negatively regulates ras physiological mechanisms shift balance towards prevalence effects ace ace<NUMBER> yet clear ace<NUMBER> carboxypeptidase removes single amino acids cterminus peptides ace peptidyl dipeptidase removes cterminal dipeptides pagliaro penna <NUMBER> addition ace<NUMBER> considered important enzyme outside classical ras hydrolyzes apelin ghrelin desarg bradykinin desarg neurotensin dynorphin a<NUMBER> well peptide substrates pagliaro penna <NUMBER> however precise interaction tissue ace ace<NUMBER> substrates byproducts yet clear humans ace<NUMBER> gene located x chromosome region xp<NUMBER> well known local ace<NUMBER> gene polymorphisms associated hypertension cvd well yagil et al <NUMBER> donoghue et al <NUMBER> komatsu et al <NUMBER> crackower et al <NUMBER> harmer et al <NUMBER> warner et al <NUMBER> fan et al <NUMBER> lower risk fatal cv events females vangjeli et al <NUMBER> evidence really important since women seem protected sarscov<NUMBER> infection preferentially targets elderly men although mechanisms underlie genderbased tolerance still unknown localization ace<NUMBER> x chromosomes may pivotal conceivable second x chromosome could protect women fatal polymorphisms make infection aggressive males eg favoring viral binding even hormonal changes may responsible estrogeninduced ace<NUMBER> expression reduced postmenopausal women hilliard et al <NUMBER> would make less amenable sarscov<NUMBER> infection compared agematched men prone systemic toxic effects due higher ang ii levels despite scarcity data humans suggestion supports recent hypothesis supporting view worse outcome older covid<NUMBER> italian patients due upregulation ang ii proinflammatory pathways throughout body presence lower ace<NUMBER> levels alghatrif et al <NUMBER> mentioned ace<NUMBER> largely expressed lungs kidney heart small intestine colon rectum endothelium donoghue et al <NUMBER> turner et al <NUMBER> represent main organs targeted damaged sarscov<NUMBER> herein first recall ace<NUMBER> regulates respiratory kidneys functions focus attention ace<NUMBER> could contribute acute myocardial injury covid<NUMBER> patients ace<NUMBER> lungs ras activity known elevated lung tissues fact endothelium pulmonary vessels important site ace therefore one main sources systemic ang ii ace<NUMBER> also strongly expressed lung upper airway pulmonary ace<NUMBER> may play role regulating balance circulating levels ang iiang <NUMBER> note ang ii contributes pulmonary vasoconstriction response hypoxia important pathophysiological mechanism useful prevent shunt patients lung injury pneumonia however local increase ang ii levels increases vascular permeability thus promoting onset pulmonary edema ards ras appears crucial maintaining oxygenation lionetti et al <NUMBER> ace<NUMBER> knockout mice showed severe symptoms wildtype mice kiely et al <NUMBER> imai et al <NUMBER> overexpression appears protective correlation ace polymorphism ards severity described humans matsuda et al <NUMBER> acute lung injury ace ang ii at<NUMBER> receptor function factors promote lung injury oudit et al <NUMBER> despite normal lung structure function ace<NUMBER> knockout mice show serious pathology case ardsacute lung damage compared wildtype mice since ace<NUMBER> plays important antiinflammatory role ace<NUMBER> knockout mice characterized increased vascular permeability pulmonary edema neutrophil accumulation recent studies ace<NUMBER> protects pulmonary vasoconstriction chronic pulmonary lesions fibrosis moreover ace<NUMBER> inhibits neutrophil infiltration lung inflammation limiting il<NUMBER> signaling reducing activity stat<NUMBER> pathway response bacterial infection rats sodhi et al <NUMBER> therefore ace<NUMBER> proposed new therapeutic target acute lung injury chronic lung disease bacterial pneumonia well indeed efficacy recombinant soluble human ace<NUMBER> protein acute respiratory failure currently studied humans phase ii clinical trial kuba et al <NUMBER> addition drugs developed increase pulmonary ace<NUMBER> expression antidiabetic glucagonlike peptide <NUMBER> receptor glp<NUMBER>r agonist liraglutide order improve lung function normalizing expression surfactant protein b romanípérez et al <NUMBER> reduced patients severe viral pneumonia kerr paton <NUMBER> ace<NUMBER> kidney ace ace<NUMBER> highly expressed adult kidney even different areas ace<NUMBER> mainly expressed proximal tubule edge brush ace seems evenly distributed apical basolateral membrane polarized cells tubules interestingly renal development kidney function normal ace<NUMBER> knockout mouse crackower et al <NUMBER> however angiotensinogen ace at<NUMBER> receptor lack results series alterations kidney morphology therefore ace<NUMBER> marginal role regulating renal function least healthy state however action ace<NUMBER> critical ras activation fact ang <NUMBER> exerts limited renal effects healthy state plays profound beneficial effects diabetic patients states associated renal damage instance ace<NUMBER> deficiency mouse models associated increased agerelated glomerulosclerosis enhanced ang iiinduced renal oxidative stress leading greater renal injury particular downregulation tubular ace<NUMBER> associated albuminuria tubular injury diabetic kidney inhibition ace<NUMBER> results augmented renal damage doan et al <NUMBER> li et al <NUMBER> oudit et al <NUMBER> wong et al <NUMBER> soler et al <NUMBER> hence ace<NUMBER> proving protective molecule kidney disease especially context negative regulation classical ras axis deletion ace<NUMBER> leads spontaneous lateonset nephrotic glomerulosclerosis accelerates diabetic kidney injury indeed glomerular disease albuminuria occur pharmacological inhibition ace<NUMBER> soler et al <NUMBER> note several forms chronic kidney disease especially diabetes found tubular ace<NUMBER> expression reduced however studies showed glomerular expression ace<NUMBER> increases acute kidney injury likely differential expression pattern tubular glomerular ace<NUMBER> may important determinant determining progression kidney disease kuba et al <NUMBER> cardiac resident cells ie endothelial cells pericytes cardiomyocytes ace<NUMBER> main enzyme involved local clearance ang ii previous experimental evidences indicate ace<NUMBER> essential regulator cardiac function involved response various cardiac cells multiple injuries especially associated overactivation classical ras pathway imai et al <NUMBER> different experimental models indeed ace<NUMBER> deficiency induces progressive cardiac fibrosis aging andor pressure overload moreover ace<NUMBER> deficiency accelerates postinfarct adverse ventricular remodeling causes early cardiac hypertrophy mice detrimental effects may prevented reversed following treatment ace inhibitors at<NUMBER> receptor blockers sartans hand ang<NUMBER> peptide treatment hamper cardiac remodeling improve myocardial performance even survival rodent heart failure models schindler et al <NUMBER> furthermore use mas receptor selective ligands ave<NUMBER> exerts cardioprotective effects similar ang<NUMBER> ischemiareperfusion ir injury myocardial infarction zeng et al <NUMBER> hypertensioninduced cardiomyopathy models ferreira et al <NUMBER> observations suggest altered balance ace ace<NUMBER> cv system critical driver progressive heart disease reverted inhibiting classical ace upregulating ace<NUMBER> pathway however still unknown myocardial ace<NUMBER> may worsen covid<NUMBER> clinical scenario contribute vulnerability sarscov<NUMBER> infection least role cardiac ace<NUMBER> sarscov<NUMBER>induced myocardial injury facts hypotheses patients cvds higher risk severe covid<NUMBER> show worse prognosis presence systemic inflammatory response immune system deregulation zheng et al <NUMBER> madjid et al <NUMBER> far unclear whether cardiac ace<NUMBER> signaling may play role cardiac injury yet following clinical evidences helpful support next focused investigations firstly since epithelial ace<NUMBER> gateway sarscov<NUMBER> entry cells attractive hypothesis sarscov<NUMBER> may directly affect myocardial tissue ace<NUMBER> endothelial cells pericytes cardiomyocytes cannot discounted priori agreement hypothesis preliminary reports provided evidence symptoms myocarditis covid<NUMBER> patients xu et al <NUMBER>b ruan et al <NUMBER>b hu et al <NUMBER> inciardi et al <NUMBER> also consistent rise hypersensitive ctni levels even reports lack histological detection myocardial inflammation myocardial localization sarscov<NUMBER> remains confirmed certainty cannot ignore viruses seasonal flu parvovirus b<NUMBER> cause myocarditis fung et al <NUMBER> however detection sarscov viral rna <NUMBER> cardiac biopsies performed patients sars outbreak toronto <NUMBER> suggestive support hypothesis coronavirus cardiotropism furthermore pulmonary infection human sarscov led ace<NUMBER>dependent myocarditis mice oudit et al <NUMBER> therefore conceivable sarscov<NUMBER> also infects cardiomyocytes secondly loss ace<NUMBER> associated increased susceptibility heart failure augmented ace<NUMBER> levels prevent reverse heart failure phenotype emerging key protective pathway heart pathology patel et al <NUMBER> accordingly cvd associated decreased baseline levels ace<NUMBER> expression chamsipasha et al <NUMBER> replication sarscov able progressively downregulate ace<NUMBER> protein expression dijkman et al <NUMBER> therefore hypothesized loss ace<NUMBER> function may also occur sarscov<NUMBER> infection garami <NUMBER> henry et al <NUMBER> particular binding sarscov<NUMBER> ace<NUMBER> might reduce residual ace<NUMBER> activity thereby altering ace ace<NUMBER> balance generating ras dysregulation higher ace andor lower ace<NUMBER> combination phenomena result cooccurrence lung heart renal acute failure garami <NUMBER> henry et al <NUMBER> predominance aceang ii at<NUMBER> axis function compared ace<NUMBER>ang<NUMBER> mas counterpart could responsible typical vasoconstrictive proinflammatory prooxidative effects ang ii occurring conditions could ultimately evolve acute heart failure ards zhang baker <NUMBER> henry et al <NUMBER> accordingly ace<NUMBER> production dramatically impaired ards resulting dominant ace activity wöstenvan asperen et al <NUMBER> considering peripheral ang ii levels found significantly higher covid<NUMBER> patients respect healthy subjects positively correlated viral load lung injury liu et al <NUMBER>b hypothesis ras pathway dysregulation lung cardiac injury sarscov<NUMBER> infection investigated garami <NUMBER> henry et al <NUMBER> third sarscov<NUMBER>dependent ace<NUMBER> downregulation could trigger monocytemacrophage activation induce severe lung inflammation contributing pathogenesis acute lung injury onset respiratory failure sodhi et al <NUMBER> garami <NUMBER> hypoxemia consequent severe interstitial pneumonia stimulate renin secretion renin gene expression kramer et al <NUMBER> thereby leading vicious circle garami <NUMBER> could enhance cardiac damage covid<NUMBER> patients notably high ang ii levels associated hypertension heart failure packer mcmurray <NUMBER> diabetes hao et al <NUMBER> represent common underlying comorbidities patients vulnerable sarscov<NUMBER> infection course relationship virus load onset magnitude covid<NUMBER> ace<NUMBER> downregulationdependent ras dysregulation lungs heart requires lot compelling evidence moreover additional studies mandatory investigate whether acute myocardial injury due sarscov<NUMBER> infection might related ace<NUMBER> expression rather activity role ace inhibitors arbs development sarscov<NUMBER> infection inhibiting classical ras pathway ace inhibitors angiotensin receptor blocker arb represents firstline pharmacological strategy treat arterial hypertension paz ocaranza et al <NUMBER> usually associated reduced lung function schnabel et al <NUMBER>b intriguingly ace<NUMBER> expression humans enhanced treatments thomson <NUMBER> whereas arbs losartan olmesartan found increase threefold cardiac ace<NUMBER> expression rat model acute myocardial infarction ami gurwitz <NUMBER> observation led investigators speculate mechanistic link preexisting use drugs predisposition sarscov<NUMBER> infection thomson <NUMBER> kuster et al <NUMBER> esler esler <NUMBER> described ace<NUMBER> heart section however ace<NUMBER> confers protection lung cardiac injury also proposed use ace inhibitors arb therapeutics treating covid<NUMBER> patients prior ards development gurwitz <NUMBER> although ace inhibitors provide imperfect renoprotection advanced type <NUMBER> diabetes cv risk remains elevated zoja et al <NUMBER> preliminary evidence limited cohort patients n <NUMBER> demonstrated difference fatality rate covid<NUMBER> patients pretreated ace inhibitors arb guo et al <NUMBER>a moreover inhibition classical ras pathway proved exert beneficial outcome patients affected viral pneumonia likely reducing respiratory inflammatory burden cytokine storm induced virus infection increased ace<NUMBER> expression henry et al <NUMBER> effect drugs ace<NUMBER> levels lungs still unknown larger clinical studies required assess impact ace inhibitors arb severity sarscov<NUMBER> infection recent joint statement american heart association american college cardiology heart failure society american recommended interrupting medications covid<NUMBER> patients affected chronic arterial hypertension unless otherwise required changes patients conditions madjid et al <NUMBER> indeed lifesaving drugs difficult replace since common antihypertensive drugs betablockers cause bronchoconstriction aggravating lung function general population schnabel et al <NUMBER>a common calciumchannel blockers may cause cardiac conduction defects impair myocardial contractility cause peripheral edema involvement ace<NUMBER> sarscov<NUMBER>induced acute myocardial injury remains controversial doubt cytokine storm associated virus infection highly detrimental heart acute respiratory infections characterizing interstitial pneumonia sarscov merscov long known result major acute cardiac complications may lead <NUMBER> increase shortterm fatality rate corralesmedina et al <NUMBER> cardiac complications associated viral pneumonia include malignant arrhythmias ami heart failure likely result increased myocardial workload infections accelerate myocardial injury infarction bonow et al <NUMBER> addition sarscov<NUMBER> shown trigger exaggerated systemic inflammatory response besides acute lung injury ards may ultimately lead multiple cv complications zheng et al <NUMBER> including ami unstable angina tachycardia heart failure stroke gorla et al <NUMBER> interestingly sarscov<NUMBER> promotes aberrant release proinflammatory cytokines chemokines alveolar epithelial cells vascular endothelial cells activated monocytes lymphocytes express ace<NUMBER> cells surface furthermore sarscov<NUMBER> could also induce lymphocyte death pyroptosis would explain covid<NUMBER> patients undergo lymphopenia thereby contributing exacerbate organ injury cytokine hypothesis cardiac damage postulates deleterious effects chronic cytokine release myocardium vascular endothelium may facilitate onset ami heart failure instance proinflammatory cytokines ie interleukin<NUMBER> il<NUMBER> il<NUMBER> tnfα exert negative inotropic effect cardiac contractility likewise sustained activation inflammatory signaling eg tnfα il<NUMBER>β may induce massive cardiomyocyte apoptosis lead adverse left ventricular remodeling favors onset acute heart failure additionally cytokine storm stimulates monocytesmacrophages release matrix metalloproteinases mmps boost atherosclerotic plaque growth rupture favor secretion procoagulant factors induce hemodynamic changes thereby increasing probability ami occur mann <NUMBER> newby <NUMBER> toldo abbate <NUMBER> indeed shortterm il<NUMBER> release exerts cardioprotective effect chronic activation il<NUMBER> signaling leads autoimmune myocarditis fontes et al <NUMBER> scenario underlying cvds predicted worsen outcome patients viral infections heart already established pneumonia seasonal flu several observations support contribution deregulated inflammatory signaling sarscov<NUMBER>induced myocardial injury zheng et al <NUMBER> instance huang et al observed plasma levels inflammatory mediators including il<NUMBER>β ifnγ ip<NUMBER> cxcl<NUMBER> mcp<NUMBER> ccl<NUMBER> upregulated covid<NUMBER> patients interestingly study also showed cytokine levels remarkably higher critically ill patients particular serum levels granulocytecolony stimulating factor gcsf ip<NUMBER> mcp<NUMBER> mip<NUMBER>a ccl<NUMBER> tnfα higher icupatients require icu admission thereby suggesting cytokine storm clinical predictor mortality ifnγ signature cytokine thelper<NUMBER> th<NUMBER> response rose <NUMBER> findings suggest balance proinflammatory th<NUMBER> response antiinflammatory thelper<NUMBER> th<NUMBER> response tipped favor former zheng et al <NUMBER> line observations zhu et al reported hypersensitive ctnt inflammatory biomarkers eg serum ferritin il<NUMBER> significantly higher nonsurvivors covid<NUMBER> patients zhou et al <NUMBER>a high inflammatory burden severe covid<NUMBER> confirmed another independent study reported higher levels serum ferritin il<NUMBER> creactive protein patients survive likely fulminant myocarditis ruan et al <NUMBER>b note overproduction inflammatory cytokines chemokines common sarscov wong et al <NUMBER> merscov mahallawi et al <NUMBER> patients acute lung injury diagnosed investigations required elucidate potential role cytokine storm pathogenesis cv complications including cardiomyopathy acute myocardial injury myocarditis following sarscov<NUMBER> infection understand potential mechanistic relationships cvd covid<NUMBER> outcomes discussed next paragraph nlrp<NUMBER> inflammasome might play triggering role cytokine storm induced sarscov<NUMBER> nlrp<NUMBER>inflammasome common feature viral infections cvd covid<NUMBER> innate acquired immune systems represent crucial defense pathogens indeed conceivable viral antigens firstly enroll innate immunity activating pattern recognition receptors prrs suppress viral replication modulate adaptive immune responses expression type interferon proinflammatory cytokines bowie unterholzner <NUMBER> last decades nlrp<NUMBER>inflammasome pathway emerged important mediator virusinduced inflammation mechanisms nlrp<NUMBER>inflammasome activation nlrp<NUMBER> prr belonging nod nucleotide oligomerization domainlike receptors nlrs able recognize damageassociated molecular patterns damps pathogenassociated molecular patterns pamps schroder tschopp <NUMBER> specific virus molecules stimulating downstream pathways contribute systemic immune response farag et al <NUMBER> nlrp<NUMBER> inflammasome multiprotein platform made sensor protein nlrp<NUMBER> adaptor protein asc cysteine protease precursor procaspase<NUMBER> schroder tschopp <NUMBER> zhou et al <NUMBER> activated nlrp<NUMBER> induces inflammasome assembly interacting asc turn triggers conversion zymogen procaspase<NUMBER> active caspase<NUMBER> franchi núñez <NUMBER> lastly caspase<NUMBER> established inflammatory caspase martinon tschopp <NUMBER> converts inactive proil<NUMBER>β proil<NUMBER> active proinflammatory cytokines il<NUMBER>β il<NUMBER> epstein dinarello <NUMBER> finally il<NUMBER>β stimulates release tnfα il<NUMBER> whereas il<NUMBER> increases circulating levels ifnγ il<NUMBER> il<NUMBER> il<NUMBER> thereby contributing immune inflammatory responses il<NUMBER>β il<NUMBER> represent key factors host defense davis et al <NUMBER> role nlrp<NUMBER>inflammasome covid<NUMBER> viral infection always associated inflammation farag et al <NUMBER> viroporins seem play triggering role rather viral pamps viroporins new class virus proteins composed <NUMBER> amino acids homooligomerize forming hydrophilic pores across organelle membranes thereby increasing permeability monovalent divalent cations ie na k ca <NUMBER> wang et al <NUMBER> nieva et al <NUMBER> structures appear play crucial role virus infectionlife cycle genome replication assembly farag et al <NUMBER> paving way consider possibility target viroporins antiviral strategies scott griffin <NUMBER> increase intracellular ca <NUMBER> concentration well reduction cytosolic k regarded among suitable triggering signals nlrp<NUMBER>inflammasome activation note viroporins mediate nlrp<NUMBER>inflammasome activation excessive production il<NUMBER>β guo et al <NUMBER> farag et al <NUMBER> date nlrp<NUMBER> inflammasome activation following viral infection reported influenza virus iav hepatitis c virus hcv encephalomyocarditis virus emcv sarscov liu et al <NUMBER> ichinohe et al <NUMBER> farag et al <NUMBER> reported increase proinflammatory cytokines levels il<NUMBER> il<NUMBER>β plasma also lungs lymphoid tissues patients affected sars mers recently covid<NUMBER> potentially consistent nlrp<NUMBER>inflammasome activation chen et al <NUMBER> huang et al <NUMBER> well known coronaviruses encode viroproteins e <NUMBER>a responsible least replication virulence nlrp<NUMBER>inflammasome activation ie sarscov castañorodriguez et al <NUMBER> chen et al <NUMBER> farag et al <NUMBER> sarscov proteins e <NUMBER>a ic differ intracellular distribution biophysical properties protein e locates endoplasmic reticulum ergolgi intermediate compartment functionality strictly dependent lipid environment composition nietotorres et al <NUMBER> induces ca <NUMBER> efflux sarscov<NUMBER> infection activates inflammasome complex leading acute proinflammatory response associated virus pathogenicity hand detailed targeting protein <NUMBER>a remains still elusive castañorodriguez et al <NUMBER> chen et al <NUMBER> farag et al <NUMBER> addition vitro studies revealed also sarscov open reading frame <NUMBER>a orf<NUMBER>a accessory protein strong inducer nlrp<NUMBER> inflammasome siu et al <NUMBER> may serve viroprotein chen et al <NUMBER> therefore plausible sarscov<NUMBER> may use mechanism action induce nlrp<NUMBER>dependent storm cytokines resulting severe systemic inflammation often causes fatal outcome surprising inhibition nlrp<NUMBER>inflammasome recently put forward promising strategy treat prevent acute cardiac injury ir injury liu et al <NUMBER> toldo abbate <NUMBER> pasqua et al <NUMBER> likewise targeting nlrp<NUMBER>inflammasome may represent attractive therapeutic strategy treatment virusassociated diseases cvd liu et al <NUMBER> pasqua et al <NUMBER> instance demonstrated nlrp<NUMBER>inflammasome activation hypertension induces sterile inflammation results chronic lowgrade inflammation characterized increased activity nfκb zhu et al <NUMBER> bullón et al <NUMBER> sustained nfκb signaling turn leads increased tissue andor circulating levels proinflammatory mediators il<NUMBER>β il<NUMBER> induces activation immune cells consequent detrimental effects respiratory tract heart dalekos et al <NUMBER> rabkin <NUMBER> krishnan et al <NUMBER> based upon evidences reasonable refer nlrp<NUMBER>inflammasome common pathogenic mechanism included vicious cycle triggers supports covid<NUMBER> common cv comorbidities arterial hypertension context targeting nlrp<NUMBER>inflammasome might serve therapeutic tool counteracting severe systemic inflammation following sarscov<NUMBER> infection time also mitigating underlying cvd reducing mortality rate hospitalized patients regard promising data provided drug recently acquired novartis namely ifm<NUMBER> already clinical trial mullard <NUMBER> agreement pulmonary diseases covid<NUMBER> poses remarkable challenge health hurdled blood oxygenation oxygen delivery tissues oxygen supply tissues becomes insufficient sustain normal function situation called hypoxia ensues whereas organstissues survive short response nonsevere hypoxia periods organstissues hypoxia represents intolerable hit may lead lethal outcomes myocardium cerebral tissues endangered heart brain represent primary targets acute respiratory failure several criteria recommend transfer patients icu one arterial blood oxygen saturation <NUMBER> pao<NUMBER> <NUMBER> mmhg smith nielsen <NUMBER> covid<NUMBER> pathology mainly concerns lung dysfunction patients may face severe hypoxia several days treatments aim correcting hypoxia oxygen therapy mechanical ventilation several concerns related effects prolonged hypoxia cv system first hypoxiadriven hyperventilation response mediated carotid bodies aimed restoring normal oxygenation necessarily implies excessive washout carbon dioxide shifts acidbase balance towards alkalosis response found healthy subjects even moderate altitude periods time ranging days samaja et al <NUMBER> several months porcelli et al <NUMBER> although often partially compensated metabolic acidosis alkalosis either origin represents common finding critically ill patients maehle et al <NUMBER> kreü et al <NUMBER> although yet documented alkalosis expected damage brain pulmonary tissue enhances oxidantinduced apoptosis several cell lineages auer <NUMBER> ando et al <NUMBER> second chronic hypoxia weakens myocardial resistance stress milano et al <NUMBER> acute hypoxiainduced pulmonary vasoconstriction last induces histological changes right ventricular rv myocardium netzer et al <NUMBER> contributing increase rv systolic pressure hypertrophy common features pulmonary hypertension mclaughlin mcgoon <NUMBER> addition effects elicited acute hypoxia chronic hypoxia leads pulmonary remodeling include increased pulmonary vessel density increased frequency small <NUMBER> μm wall thickness vessels increased thickness pulmonary lamina nydegger et al <NUMBER> nydegger et al <NUMBER> changes imputable excessive stimulation bone marrowderived progenitor cells favre et al <NUMBER> chronic hypoxia well known contribute significantly pulmonary hypertension ramchandran et al <NUMBER> associated many pulmonary hypertensionrelated diseases including chronic obstructive pulmonary disease cystic fibrosis diffuse interstitial fibrosis bronchopulmonary dysplasia infiltrative lung tumors congenital hearts defects ischemic events third odds happens healthy subjects exposed altitude hypoxia well known stimulate erythropoiesis piperno et al <NUMBER> goetze et al <NUMBER> systemic hypoxia represses erythropoiesis ards patients often develop severe anemia <NUMBER> gdl correlates poor prognosis may require blood transfusion silver <NUMBER> jenq et al <NUMBER> clinical scenario common icu patients nguyen et al <NUMBER> may attributable anemia inflammation whose etiology scarcely known physiological response hypoxia compensatory increase hemoglobin requires increase iron transport use fact demands stabilization ferroportin transmembrane protein enables iron release cells increased intestinal absorption degradation ferroportin mediated hepcidin hep decreases healthy subjects thereby enabling compensatory response hypoxia gassmann muckenthaler <NUMBER> however hep levels increase ards patients galesloot et al <NUMBER> despite hypoxic condition consequent loss hep regulation may limit efficacy ironreplacement therapies lasocki et al <NUMBER> mechanism may relevant ards covid<NUMBER> patients iron release circulation deregulated uptake tissues use iron may saturate transferrin increase nontransferrinbound aliquot iron possibly triggering unspecific oxidative stress injury fourth although correction hypoxia oxygen therapy remains major lifesaving concern icu patients excess oxygen delivery hyperoxia may cause considerable harm ottolenghi et al <NUMBER> facts hyperoxia caused breathing mixtures <NUMBER> oxygen markedly elevates reactive oxygen species ros release circulation contributes tissue injury oxidative stress nagatomo et al <NUMBER> hyperoxiainduced injury may occur even patients undergoing laparoscopic surgery breathing mixtures containing <NUMBER> <NUMBER> oxygen ottolenghi et al <NUMBER> hyperoxiadriven oxidative stress expected alter expression genes regulate pathways underlying different responses oxidative stress terraneo samaja <NUMBER> intuitively direction alterations driven hyperoxia opposite elicited hypoxia however evidence case many instances example regulation gene transcription hypoxiainducible factors hifs hifs well known respond hypoxia acting transcriptional factors array genes participate various cell processes angiogenesis metabolism cell proliferation control rosinduced damage many others giordano <NUMBER> including apoptosis autophagy ziello et al <NUMBER> gui et al <NUMBER> recent studies show hif<NUMBER>α hif<NUMBER>α indeed upregulated response hyperoxia well least brain benderro et al <NUMBER> types cancer terraneo et al <NUMBER> terraneo et al <NUMBER> hepatocytes wikenheiser et al <NUMBER> marconi et al <NUMBER> heart gyongyosi et al <NUMBER> although injury led hyperoxia yet studied led hypoxia established hyperoxia reduces expression angiogenic vascular endothelial growth factor vegf signaling capillary density benderro et al <NUMBER> reduces antiapoptotic defense increasing expression proapoptotic proteins bax bad decreasing activation antiapoptotic proteins bcl<NUMBER> bclxl brutus et al <NUMBER> increases neuronal apoptosis concomitantly decreased protective pakt erythropoietin signaling accumulates oxidized lipids prot eins ta r k v e l <NUMBER> <NUMBER> <NUMBER> w n r e g u l e neurotrophins provide tropic support developing neurons felderhoffmueser et al <NUMBER> stimulates ferroptosis newly discovered irondependent form cell death thereby contributing brain damage li et al <NUMBER> striking feature covid<NUMBER> pandemics high incidence fatalities elderly patients guan et al <NUMBER> wang et al <NUMBER>a zhou et al <NUMBER>a recent analysis italian institute health revealed overallcase fatality rate increased aging china italy however fatality rate italy remarkable higher compared china <NUMBER> vs <NUMBER> higher death tolls italy among subjects aged <NUMBER> years <NUMBER> vs <NUMBER> among older <NUMBER> <NUMBER> vs <NUMBER> increase covid<NUMBER>related mortality rate italy may ascribed demographic characteristics country <NUMBER> population aged <NUMBER> years <NUMBER> onder et al <NUMBER> note aging represents one detrimental risk factors cv system obas vasan <NUMBER> addresses issue frailty older population critical parameter accounted control covid<NUMBER> pandemics frailty labeled problematic expression population ageing clegg et al <NUMBER> often confounded disability comorbidity frailty assuming separate distinguished features highlight presence welldefined phenotype characterizes elders many elders multiorgan dysfunction frailty representing unifying notion care elderly patients directs attention away organspecific diagnoses clegg et al <NUMBER> concept frailty universally defined individuals state increased vulnerability susceptibility adverse health outcomes death exposed stressor case pulmonary diseases arising sarscov<NUMBER> infection presence agedependent excess ros reactive nitrogen species rns frailty may viewed result disruption organisms homeostatic balance leads heterogeneous clinical manifestations individual exposed endogenous exogenous stressors minor non negligible number people <NUMBER> years old considered frail prevalence physical frailty ranges <NUMBER> <NUMBER> mean <NUMBER> higher prevalence persons <NUMBER> years old among patients multiple comorbidities collard et al <NUMBER> absence pandemics prevalence frailty cvd increase age making coexistence common epidemiological studies suggest frailty may represent important prognostic marker patients several types cvds including coronary artery disease heart failure well older people undergoing surgical transcatheter interventions afilalo et al <NUMBER> despite unclear biological underpinnings frailty unexplored interaction heart failure appears frailty cvd share common pathophysiological pathways bellumkonda et al <NUMBER> among cvds ami major cause death morbidity loss quality life industrialized countries accounting <NUMBER> million deaths per year worldwide steg et al <NUMBER> aging classically regarded greatest risk factor ami indeed endothelial cell senescence due increased ros production dysfunction nuclear factorerythroid<NUMBER>related factor <NUMBER> nrf<NUMBER>mediated antioxidant response pathway may compromise endothelial nitric oxide bioavailability exacerbate inflammatory response pathogenesis agerelated vascular diseases ie ami stroke older patients fulop et al <NUMBER> ungvari et al <NUMBER> excess ros rns central many pathways leading cardiac hypertrophy failure tocchetti et al <NUMBER> accordingly incidence ami casefatality mortality rate markedly higher elderly patients also prone develop postami heart failure afilalo et al <NUMBER> compared younger subjects aged patients less amenable receive percutaneous coronary intervention less sensitive fibrinolytics carro et al <NUMBER> therefore impaired resilience cardiovascular cells oxidative stressors presence deficiency relevant antioxidant mechanisms ie nrf<NUMBER>related pathway may lead sarscov<NUMBER> detrimental consequences aged heart vasculature moreover correct finetuning nitrosoredox balance fundamental function main components excitationcontraction coupling machinery tocchetti et al <NUMBER> despite predominance older patients cvd among population randomized clinical trials generally focused young subjects without comorbidities thereby generating data cannot extended elderly patients feature related higher case fatality rate older vs younger subjects hospitalized ami individuals aged ≥ <NUMBER> years old benefit pharmacological interventions established younger counterparts ami fleg et al <NUMBER> lower sensitivity cv drugs elderly depends ageassociated physiological changes pharmacodynamics pharmacokinetics together intrinsic deficits signaling pathways protection reasons higher incidenceseverity ami elderly subjects multifactorial easy reconcile single triggering event endothelial dysfunction regarded early mechanism among leading mismatch oxygen supply demand finally culminates ami moccia et al <NUMBER> addition aged endothelial cells lose capability proliferate replace neighboring damaged cells thereby aggravating impact coronary endothelium dysfunction moccia et al <NUMBER> consequently aged subjects susceptible develop coronary artery disease since aging endothelial cells coronary microcirculation unable express cytoprotective prosurvival antioxidant macromolecular damage repair antiinflammatory genes due deregulation relevant transcription factors pathways nrf<NUMBER> signaling oxidative damage quite remarkable microvascular endothelial cells affected nad depletion sirtuin <NUMBER> dysregulation kiss et al <NUMBER> dampening angiogenic activity thus leading microvascular rarefaction established hallmark aging valcarcelares et al <NUMBER> likewise nrf<NUMBER> signaling disrupted aging also cardiac myocytes silvapalacios et al <NUMBER> fibroblasts nacarelli et al <NUMBER> thereby contributing enhance cardiac vulnerability oxidative stress thus appears impairment nrf<NUMBER> transcriptional activity key increase cv risk aging could therefore worsen cv damage older covid<NUMBER> patients scenario could even worsened oxygen therapy required hyperoxiainduced ros release postulated exert stronger cytotoxic effect aged vasculature due lower resilience oxidative stress agreement hypotheses recent study demonstrated genetic depletion nrf<NUMBER> worsened agerelated impairment endothelial bioavailability endothelial monolayer integrity addition genetic silencing nrf<NUMBER> resulted dramatic increase secretion proinflammatory cytokines fulop et al <NUMBER> also known senescenceassociated secretory phenotype sasp cytokines include il<NUMBER>β tnfα ungvari et al <NUMBER> recently shown mediate covid<NUMBER>induced cytokine storm enhancing proinflammatory phenotype might represent another mechanism whereby agingdependent nrf<NUMBER> dysfunction contributes exacerbate detrimental consequences sarscov<NUMBER> cv system moreover aging associated significant perturbation ca <NUMBER> signaling toolkit cardiomyocytes leads dramatic impairment heart muscle contraction hamilton terentyev <NUMBER> higher mortality ami individuals linked agerelated decline endogenous protective mechanism myocardial ir injury indeed preand postconditioning powerful interventions aimed reduce infarct size eliciting endogenous cardioprotection response one several brief cycles sublethal myocardial ir precede follow respectively sustained potentially lethal ischemic insult conditioning protocols recruit complex cascade intracellular signaling pathways mainly risk safe converge mitochondria limit cell death pagliaro et al <NUMBER> although pharmacological conditioning recapitulates endogenous mechanisms cardioprotection induced preand postconditioning might exploited therapy ami conditioning protocols barely effective aged hearts thereby exacerbating ir injury loss cardioprotection elderly people irreversible might either rescued preserved alternative strategies exercise boengler et al <NUMBER> also promotes angiogenesis increases vascular density aging mouse models ami bei et al <NUMBER> presently experimental evidencebased difference clinical management young vs elderly presumably frail subjects least cvd conversely sharp decrease endogenous mechanisms cardioprotection angiogenic repair aging suggests older subjects undergo distinct treatment compared younger individuals older patients left effective therapeutic methods alleviate symptoms restore distal perfusion preserve tissue viability calling innovative approaches restore efficiency cardioprotective mechanisms aging example pursuing alternative strategies foster preconditioning postconditioning endogenous protection boengler et al <NUMBER> matter facts actual strategies treatments covid<NUMBER> patients essentially young elder patients cv patients respond differently depending age frailty shouldnt occur covid<NUMBER> patients one could however suggest restoring endothelial function eg microvascular level improving vascular health aging could represent effective strategy treat covid<NUMBER> critical patients instance activation nrf<NUMBER> drugs eg propofol mechanical ventilation oltipraz zhou et al <NUMBER>c ruan et al <NUMBER>a epigenetic compounds eg nicotinamide mononucleotide resveratrol histone deacetylase inhibitors csiszár et al <NUMBER> pooladanda et al <NUMBER> kiss et al <NUMBER> could rescue least partially stress resilience endothelial cardiac cells aging individuals affected covid<NUMBER> otherwise regular physical exercise dietary intake functional foods lionetti et al <NUMBER> also shown activate nrf<NUMBER> myocardium well across variety tissues could advised frail older people reduce risk develop major cv complications case sarscov<NUMBER> infection mcphee et al <NUMBER> done traustadóttir <NUMBER> correlation pm exposure cvd covid<NUMBER> conjecture preliminary evidence provided favor relationship number days exceeding limits particulate matter pm <NUMBER> ie fine material airborne diameter <NUMBER> μm recorded control units cities number hospitalizations covid<NUMBER> northern italy setti et al <NUMBER> area country suffered highest number cases fatalities pm worldwide recognized important prompt cvd inhalation pm certainly trigger multiple cv disorders ami heart failure stroke urban communities liang et al <NUMBER> inhalation smaller pm pm <NUMBER> ie fine material airborne diameter <NUMBER> μm leads pulmonary inflammation cardiotoxicity via secondary systemic effects mills et al <NUMBER> easily reach alveolar space irritating alveolar wall onset lung dysfunction xing et al <NUMBER> cohen colleagues reported four million deaths attributable pm <NUMBER> nearly <NUMBER> due cvds cohen et al <NUMBER> link emphasized countries air pollution concentration continuing rise mills et al <NUMBER> exposure pm still associated incidence coronary events europe even though limit value set <NUMBER> μgm <NUMBER> daily cesaroni et al <NUMBER> scientific literature reports air pollution pm associated plethora cv events angina ami arrhythmia heart failure dockery et al <NUMBER> samet et al <NUMBER> peters et al <NUMBER> mann et al <NUMBER> brook et al <NUMBER> bhatnagar <NUMBER> mills et al <NUMBER> hence comorbidity pathologies obesity hypertension seems impact cvdassociated mortality adults daily exposed higher levels pm mazidi speakman <NUMBER> timestratified casecrossover study design evaluated milan area lombardy region italy winter period <NUMBER> independent shortterm effect flu outbreaks air pollution temperature murtas russo <NUMBER> observed statistically significant relationship pm <NUMBER> levels flu cvd mortality flu temperature deaths natural causes wuhan region china air quality index extremely low average daily pm concentration <NUMBER> μgm <NUMBER> similar association air pollution mainly no<NUMBER> cvd mortality <NUMBER>year period <NUMBER> <NUMBER> <NUMBER> <NUMBER> observed albeit correlation found directly among pm <NUMBER> cvd liu et al <NUMBER> positive relationship pm <NUMBER> influenzalike illness flu season reported period january <NUMBER>december <NUMBER> observed via timeseries analysis beijing feng et al <NUMBER> lombardy wuhan areas hitherto clusters worldwide pandemic covid<NUMBER> higher number people deceased contrast rest nations italy china virus also spread less aggressiveness march <NUMBER> chen al provided evidence avian influenza h<NUMBER>n<NUMBER> may subjected intercontinental transportation via saharian dust chen et al <NUMBER> thus one wonders air pollution impact upon covid<NUMBER> spread ciencewicki jaspers <NUMBER> position paper italian society environmental medicine proposed pm could represent factor favors longterm persistence viruses atmosphere h p w w w n l u w p w p contentuploads<NUMBER>covid<NUMBER>positionpaper engpdf indeed lombardy region number infected persons quarantine lockdown mean number pm <NUMBER> exceedancesmonitoring stations results r<NUMBER> correlation <NUMBER> study concluded tangible risk pm may serve carrier viruses northern regions italy whereas investigation solid data necessary disentangle hypothesis strengthen hypothesis exceedance pm period february <NUMBER> <NUMBER> number covid<NUMBER> cases reported march <NUMBER> italian national institute health visually correlated clear analysis selected provinces lombardy piedmont emiliaromagna majority covid<NUMBER> cases occurred far pm <NUMBER> exceedances increment higher preliminary data hint correlation air pollution represents established risk factor covid<NUMBER> indepth retrospective crosssectional investigations required keeping mind quarantine drastically reduced pm concentration aforementioned regions httpswwweeaeuropaeuhighlightsairpollutiongoesdownas search effective treatment proposal repurposing antihypertensive drugs treat covid<NUMBER> covid<NUMBER> outbreak poses complex challenge biomedical community design immediate effective therapy reduce high fatality rate among patients especially older andor comorbidities present specific antiviral drugs provided satisfactory outcomes treatment disease whereas suitable largescale vaccine still far available regard worth noticing even sarscov pandemic emerged <NUMBER> years ago <NUMBER> <NUMBER> still awaits specific antivirals approved vaccines conventional safety protocols including quarantine affected individuals tracing patients contacts social distancing selfmonitoring use masks travel restriction adopted mitigate spread covid<NUMBER> nevertheless approach sufficient constrain disease propagation basic reproduction number r <NUMBER> lower <NUMBER> andor percentage identified contacts higher <NUMBER> mitjà clotet <NUMBER> scenario growing number patients throughout globe require effective treatment repurposing clinically available antivirals treat covid<NUMBER> already described case ebola sarscov outbreaks kruse <NUMBER> repurposing clinically approved drugs invocated effectively treat patients greater risk death instance raising hope lopinavir ritonavir employed human immunodeficiency virus hiv protease inhibitors could display clinical efficacy covid<NUMBER> recently dashed failure clinical trial china reviewed li de clercq li de clercq <NUMBER> clinical trials already launched china usa evaluate therapeutic efficacy multiple food drug administration fdaapproved antiviral treatments including nucleoside analogues favipiravir ribavirin experimental nucleoside analogue remdesivir nct<NUMBER> holshue et al <NUMBER> list antiviral agents proposed fight covid<NUMBER> include oseltamivir pencicloviracyclovir ganciclovir sarilumab galidesivir nitazoxanide rapamycin recombinant interferons chlorpromazine li de clercq <NUMBER> guo et al <NUMBER>b note randomized controlled clinical trial sarilumab nct<NUMBER> monoclonal antibody il<NUMBER> receptor currently assessing whether modification inflammatory response induced treatment could provide benefit reducing lung inflammation improving lung function covid<NUMBER> patients blocking sarscov<NUMBER> entry cytoplasm target vaccines plasmaderived therapy alternative mutually exclusive strategy consists identification small molecule drug could repurposed inhibit interaction virus target cells gunaratne et al <NUMBER>b kruse <NUMBER> mentioned section <NUMBER> sarscov<NUMBER> entry requires priming protein furin tmprss<NUMBER> hoffmann et al <NUMBER> walls et al <NUMBER> coutard et al <NUMBER> promising report revealed camostat mesylate fdaapproved drug blocks tmprss<NUMBER> activity effectively prevented sarscov<NUMBER> spread vitro hoffmann et al <NUMBER> addition fully surfaceexposed glycoprotein represents source accessible epitopes production neutralizing antibodies thus target ongoing vaccine design efforts walls et al <NUMBER> line use antibodyrich plasma donated patients fully recovered covid<NUMBER> evaluation determine could shorten length lessen severity illness blocking sarscov<NUMBER> entry targeting endosomal compartment chloroquine ca <NUMBER> antagonists finding opens way repurposing clinically available drugs interfering endocytic pathway mediating sarscov<NUMBER> entry target cell eg inhibition phmediated endocytosis bulk alkalinization endolysosomal el vesicles blockade el proteases instance fdaapproved cardiotonic steroids ouabain bufalin known selective blockage na k atpase significantly impair merscov infection endocytic pathway burkard et al <NUMBER> remarkably lysosomotropic compound chloroquine cheap widely available antimalarial drug shown block sarscov<NUMBER> infection vitro clinically relevant concentration wang et al <NUMBER>c according preliminary reports proved exert beneficial exerts covid<NUMBER> patients colson et al <NUMBER> mitjà clotet <NUMBER> gao et al <NUMBER> inciardi et al <NUMBER> chloroquine could indeed accumulate within acidic vesicles interfere el vesicle trafficking golden et al <NUMBER> note chloroquine also employed autoimmune disorders potential counteract cytokine storm associated covid<NUMBER> severity liu et al <NUMBER>a obviously therapeutic efficacy chloroquine covid<NUMBER> patients needs supported randomized clinical trials conducted large cohorts patients since margin effective therapeutic dose toxic dose narrow chloroquine poisoning associated serious cv disorders friskholmberg et al <NUMBER> nevertheless preliminary evidences endorse view usage single compound potentially able block viralhost cell interaction attenuate inflammatory response could provide effective weapon disease view hint alternative therapy covid<NUMBER> suggested cv comorbidities affecting patients ca <NUMBER> antagonists long used first line antihypertensive drugs due ability block ltype voltagegated ca <NUMBER> channels vascular smooth muscle cells godfraind <NUMBER> oparil et al <NUMBER> ca <NUMBER> antagonists include dihydropyridines eg nifedipine nicardipine nimodipine well phenylalkylamines eg verapamil benzothiazepine diltiazem godfraind <NUMBER> rosenfeldt et al <NUMBER> nifedipine verapamil diltiazem often used combination ace inhibitors sartans reduce arterial hypertension quite tolerable side effects godfraind <NUMBER> rosenfeldt et al <NUMBER> furthermore nicardipine strongly recommended antihypertensive agent stroke rosenfeldt et al <NUMBER> whereas verapamil largely employed treat hypertension ventricular arrhythmia godfraind <NUMBER> long known ca <NUMBER> antagonists may block endolysosomal el twopore channels <NUMBER> tpc<NUMBER> genazzani et al <NUMBER> moccia et al <NUMBER> play crucial role el trafficking patel <NUMBER> concentrations reported block ltype voltagegated ca <NUMBER> channels tpcs gated multiple agonists including nicotinic acid adenine dinucleotide phosphate naadp sphingosine el phospholipid phosphatidylinositol <NUMBER>bisphosphate galione <NUMBER> tpcsmediated ca <NUMBER> release recruits ellocated ca <NUMBER>sensitive decoders including calmodulin synaptotagmin vii arf<NUMBER> faris et al <NUMBER> regulate vesicular fusion trafficking galione <NUMBER> screening campaign aiming repurposing fdaapproved drugs novel antiviral compounds recently revealed classical ca <NUMBER> antagonists blocked ebola virus merscov infections vitro sakurai et al <NUMBER> gunaratne et al <NUMBER>a b ebola virus entry host cells occurs macropinocytosis followed relocation endosomal compartment thereafter virus binds endosomal membrane protein npc<NUMBER> fuse acidic late endosomeslysosomes release capside cytoplasm falzarano feldmann <NUMBER> recent series investigations demonstrated inhibiting tpcsmediated el ca <NUMBER> release nifedipine verapamil nicardipine diltiazem prevented viral genome entry cytoplasm sakurai et al <NUMBER> penny et al <NUMBER> subsequently strategy worked find clinically available tools treat mers first described saudi arabia <NUMBER> zaki et al <NUMBER> subsequently reported affect <NUMBER> subjects zumla et al <NUMBER> described sarscov<NUMBER> viral protein mediates merscov entry upon binding host cell receptor dipeptidyl peptidase <NUMBER> followed proteolytic priming via tmprss<NUMBER> raj et al <NUMBER> park et al <NUMBER> following clathrinmediated endocytosis merscov redirected el system protein proteolytically cleaved lysosomal proteases results vesicular fusion capside release cytoplasm millet whittaker <NUMBER> burkard et al <NUMBER> notably merscov pseudovirus translocation also attenuated blocking el tpcs verapamil nicardipine nimodipine gunaratne et al <NUMBER>b tpcs function homodimers subunit comprises two homologous sixtransmembrane domain motifs therefore represent molecular ancestors α cav subunits voltagegated na ca <NUMBER> channels share structural motifs within pore regions patel <NUMBER> line docking analysis ca <NUMBER> fluxes measurements confirmed ca <NUMBER> antagonists avidly bind tpc pore rahman et al <NUMBER> support proposal probe ca <NUMBER> antagonists treat covid<NUMBER> worth recalling chloroquine inhibits sarscov<NUMBER> virus entry promoting alkalinization el vesicles wang et al <NUMBER>c liu et al <NUMBER>a common strategy perturb el membrane fusion notably elevating el ph would also result significant reduction el ca <NUMBER> concentration usually around <NUMBER> μm el ca <NUMBER> refilling mainly driven h gradient morgan et al <NUMBER> faris et al <NUMBER> instance lysomotropic weak base nh <NUMBER> cl abrogates el ca <NUMBER> storage morgan et al <NUMBER> well merscov gunaratne et al <NUMBER>b sarscov yang et al <NUMBER> vincent et al <NUMBER> entry cytoplasm furthermore lysosomotropic agents also affected ace<NUMBER> localization vitro viral receptor remains trapped within perinuclear vacuoles upon pretreatment chloroquine nh<NUMBER>cl bafilomycin a<NUMBER> wang et al <NUMBER> besides supporting viral entry host cells preliminary evidence suggested tpcs contribute deliver el ca <NUMBER> signal responsible nlrp<NUMBER> inflammasome activation tseng et al <NUMBER> thus appears blocking tpcsmediated el ca <NUMBER> release either chloroquine ca <NUMBER> antagonists might represent potential perspective treat covid<NUMBER> patients interfering sarscov<NUMBER> infection subsequent inflammatory response hypothesis remains probed devoted experimental pipeline clinical trial launched china evaluate therapeutic outcome tetrandrine sarscov<NUMBER>infected subjects clinicaltrialsgov identifier nct<NUMBER> tetrandrine alkaloid isolated root stephania tetrandra vine grows china taiwan widely employed china treat autoimmune diseases cv disorders hypertension cancer tetrandrine targets multiple intracellular signaling pathways including ltype voltagegated ca <NUMBER> channels could explain beneficial effects cv system yao jiang <NUMBER> note tetrandrine recently shown inhibit tpcsmediated el ca <NUMBER> release attenuate ebola sakurai et al <NUMBER> merscov<NUMBER> gunaratne et al <NUMBER>b entry host cells findings however may suggest hypothesis repurposing ca <NUMBER> antagonists could prove effective treating sarscov<NUMBER> infection time attenuating cv respiratory dysfunction cooccurring older covid<NUMBER> patients covid<NUMBER> pandemic rapidly spread throughout globe preferentially affecting older individuals underlying cv comorbidities besides ards acute kidney injury cardiovascular complications also represent common consequence disease time cause adverse outcome covid<NUMBER> patients although cannot ignore emerging events druginduced sudden cardiac death among treated covid<NUMBER> patients chorin et al <NUMBER> clinical reports well support careful evaluation pathogenic mechanisms promote onset severe covid<NUMBER> due cvd following sarscov<NUMBER> infection include example classical ras pathway ace<NUMBER> nlrp<NUMBER>inflammasome hypoxemia fig <NUMBER> furthermore prevalence death toll covid<NUMBER> increases aging well frailty seems correlated prolonged exposure air pollution represent lifethreatening cv risk factors opinion understanding cellular molecular mechanisms exacerbate impact covid<NUMBER> patients existing cv pathologies lead major cardiac complications mandatory design truly cardioprotective therapy waiting vaccine fig <NUMBER> simplified scheme showing potential role regulation intracellular organelles calcium stores involved activation inflammasome following triggering cytokine storm inset top complex molecular mechanism plasma membrane level underlying different functional outcomes covid<NUMBER> infection vp viroporins caa calcium antagonists td tetrandrine cc chloroquine tpc two pore channels tmprss<NUMBER> serine protease el endolysosomes ace angiotensinconverting enzyme angiotensin ii receptor ang angiotensin apj apelin g protein coupled receptor mas angiopoietin <NUMBER> receptor evwf endothelial von willebrand factor et<NUMBER> endothelin <NUMBER> nitric oxide funding source involvement study design collection analysis interpretation data writing report decision submit paper publication conflict interest authors declare conflict interest availability data material applicable code availability applicable consent publication authors read approved revised manuscript willing publish purpose review increasing evidence indicating association several risk factors worse prognosis patients coronavirus disease <NUMBER> covid<NUMBER> including older age hypertension heart failure diabetes pulmonary disease hypertension particular interest common adults concerns related use reninangiotensin system ras inhibitors patients hypertension infected covid<NUMBER> levels angiotensinconverting enzyme <NUMBER> ace<NUMBER> protein facilitates entry coronavirus cells may increase patients using ras inhibitors thus chronic use ras inhibition could potentially lead severe fatal form covid<NUMBER> review provide critical review following questions <NUMBER> hypertension influence immunity ace<NUMBER> expression favoring viral infections <NUMBER> risks complications hypertension mediated treatment <NUMBER> aging major factor associated worse prognosis patients covid<NUMBER> hypertension recent findings despite potential involvement immune responses pathogenesis hypertension evidence supporting hypothesis hypertension ras inhibitors contributes unfavorable outcomes viral infections future investigations adopting strict protocol confirming hypertension status well assessing associated comorbidities may influence outcomes necessary therapeutic perspective recombinant ace<NUMBER> may serve potential therapy relevant studies humans lacking definitive evidence regarding use ras inhibitors patients covid<NUMBER> needed <NUMBER> randomized trials examining issue currently underway current scientific support claiming hypertension treatment ras inhibitors contribute unfavorable outcomes covid<NUMBER> hypertension real risk factor poor prognosis covid<NUMBER> pandemic since first report new coronavirus pneumonia wuhan hubei december <NUMBER> <NUMBER> cumulative number confirmed cases exceeded <NUMBER> million worldwide cumulative death toll exceeded <NUMBER> april <NUMBER> <NUMBER> raising serious global concern according previous reports coronavirus disease <NUMBER> covid<NUMBER> clinically manifested limited fever cough sputum headache fatigue diarrhea patients covid<NUMBER> comorbidities hypertension diabetes cardiovascular disease chronic liver disease <NUMBER> presence comorbidities shown related high mortality among hospitalized patients middle east respiratory syndrome coronavirus merscov infection <NUMBER> <NUMBER> <NUMBER> <NUMBER> patients h<NUMBER>n<NUMBER> comorbidities considered important factors poor prognosis <NUMBER> <NUMBER> similar conclusions reported several clinical reports patients influenza <NUMBER> <NUMBER> severe acute respiratory syndrome coronavirus sarscov <NUMBER> infections new coronavirus<NUMBER> extremely contagious estimated basic reproduction number ro <NUMBER> <NUMBER> <NUMBER> <NUMBER> comparable sarscov <NUMBER> meanwhile elderly people likely infected considerable part carry chronic diseases <NUMBER> resistance disease low prone develop serious cases adverse outcomes <NUMBER> <NUMBER> large number epidemiological studies analyzed proportion comorbidities mild severe groups proportion comorbidities severe case group higher mild <NUMBER> <NUMBER> <NUMBER> however clinical epidemiological characteristics patients without comorbidities studied relationship comorbidities serious adverse outcomes covid<NUMBER> remains unclear present study analyzed different manifestations patients covid<NUMBER> based presence type number comorbidities assessed relationship risk serious adverse outcomes large retrospective study collected data <NUMBER> patients diagnosed covid<NUMBER> january <NUMBER> february <NUMBER> <NUMBER> based chinese version covid<NUMBER> diagnosis treatment program <NUMBER>th edition <NUMBER> data clinical epidemiological characteristics collected health commission zhejiang province china patients assigned designated hospitals zhejiang province diagnosis treatment results analyses reported peoples government zhejiang province shared world health organization study approved clinical research ethics committee first affiliated hospital college medicine zhejiang university iit<NUMBER>c epidemiology data laboratory tests clinical features imaging data treatment methods clinical outcomes patients reported zhejiang health committee china designated hospital comorbidities determined according patients readme time admission data recorded electronic database independent researcher verified another experienced clinician patients underwent corresponding imaging examinations chest radiographcomputed tomography conventional respiratory virus screening including parainfluenza virus avian influenza adenovirus sars mers admission clinical outcomes followed february <NUMBER> <NUMBER> comorbidity presence number comorbidities mainly depend patients selfreport admission including hypertension heart diseases diabetes chronic obstructive pulmonary disease copd asthma chronic liver disease chronic kidney disease malignant tumor human immunodeficiency virus hiv infection hematologic disease comorbidities may influence illness including use immunosuppressants tuberculosishyperthyroidism hypothyroidism，and cerebrovascular diseases divided covid<NUMBER> cases severe common groups severe cases included severe critically ill patients common group included common types patients pneumonia upon imaging admission confirmed laboratory tests classification based chinese version diagnosis treatment covid<NUMBER> <NUMBER>th edition endpoint outcome comprised composite endpoint including admission icu owing disease progression failure organs mechanical ventilation caused respiratory failure shock death statistical analyses performed using spss software version <NUMBER> normally distributed continuous measurement data expressed mean ± standard deviation nonnormally distributed measurement data expressed median quartile q<NUMBER>q<NUMBER> categorical variables expressed number ttest chisquare test used comparisons groups nonparametric test used appropriate statistical significance defined twosided α value less <NUMBER> calculate survival time first time reach composite endpoint prevailed cox proportional hazard regression model used determine potential risk factors reaching composite endpoint results expressed hazard ratio hr <NUMBER> confidence interval ci age gender status adjusted using cox regression model february <NUMBER> <NUMBER> total <NUMBER> patients covid<NUMBER> zhejiang province included study patients comprised <NUMBER> <NUMBER> female <NUMBER> <NUMBER> male median age <NUMBER> <NUMBER> years total <NUMBER> <NUMBER> patients history contact epidemic area <NUMBER> <NUMBER> close contact covid<NUMBER> patients <NUMBER> <NUMBER> family cluster cases total <NUMBER> patients current smokers common symptoms admission fever <NUMBER> cough <NUMBER> expectoration <NUMBER> rare symptoms included fatigue <NUMBER> sore throat <NUMBER> muscle pain <NUMBER> headache <NUMBER> median time disease onset confirm diagnosis <NUMBER> <NUMBER> days nearly <NUMBER> patients changes imaging admission severe cases accounted <NUMBER> total patients <NUMBER> <NUMBER> patients reached composite endpoint study table <NUMBER> patients comorbidities older without <NUMBER> ± <NUMBER> vs <NUMBER> ± <NUMBER> years p <NUMBER> clinical manifestations including hemoptysis <NUMBER> vs <NUMBER> p <NUMBER> diarrhea <NUMBER> vs <NUMBER> p <NUMBER> shortness breath <NUMBER> vs <NUMBER> p <NUMBER> imaging abnormalities <NUMBER> vs <NUMBER> p <NUMBER> severe comorbidity group noncomorbidity group <NUMBER> <NUMBER> cases severe cases <NUMBER> group noncomorbidity differences statistically significant rate reaching composite endpoint significantly different comorbidity noncomorbidity groups <NUMBER> vs <NUMBER> p <NUMBER> table <NUMBER> <NUMBER> patients comorbidities <NUMBER> one type comorbidity <NUMBER> two comorbidities <NUMBER> three comorbidities higher number comorbidities older patients <NUMBER>  <NUMBER> vs <NUMBER>  <NUMBER> vs <NUMBER>  <NUMBER> years <NUMBER> <NUMBER> <NUMBER> comorbidity respectively p <NUMBER> number severe cases increased number comorbidities <NUMBER> vs <NUMBER> vs <NUMBER> p <NUMBER>as well number patients reaching composite endpoint <NUMBER> <NUMBER> <NUMBER> respectively significant difference observed patients reached composite endpoints groups one two comorbidities p <NUMBER> number patients three comorbidities reaching composite endpoints significantly different reported two groups table <NUMBER> listed clinical epidemiological characteristics common comorbidities including hypertension diabetes chronic hepatitis b malignant tumors heart disease chronic kidney disease incidence severe disease higher among patients comorbidities without severe covid<NUMBER> detected <NUMBER> <NUMBER> <NUMBER> <NUMBER> patients without hypertension <NUMBER> <NUMBER> <NUMBER> <NUMBER> patients without diabetes <NUMBER> <NUMBER> <NUMBER> <NUMBER> without chronic hepatitis b <NUMBER> <NUMBER> <NUMBER> <NUMBER> without malignant tumor <NUMBER> <NUMBER> <NUMBER> <NUMBER>with without heart disease <NUMBER> <NUMBER> <NUMBER> <NUMBER> without chronic kidney disease table <NUMBER> study <NUMBER> patients reached composite endpoint admitted intensive care unit <NUMBER> received invasive ventilation <NUMBER> received extracorporeal membrane oxygenation ecom <NUMBER> received continuous renal replacement therapycrrt <NUMBER> experienced shock <NUMBER> died comparison patients without comorbidities comorbidities significantly higher risk reaching composite endpoint number comorbidities increased risk reaching composite endpoint also increased figure <NUMBER> adjusting age gender status divided patients based type number comorbidities performed cox proportional hazard regression analysis figure <NUMBER> results multivariate regression analysis showed hypertension risk factor composite endpoint hr <NUMBER> <NUMBER> ci <NUMBER> also divided patients hypertension angiotensinconverting enzyme inhibitor aceiangiotensin receptor blocker arb nonaceiarb groups based medication compared epidemiology data clinical characteristics prognosis significant difference observed epidemiology data clinical characteristics two groups online supplement table e<NUMBER> used cox regression analysis explore risk reaching composite endpoint two groups adjusting age gender status significant difference found online supplement table e<NUMBER> comparison patients without comorbidities two comorbidities higher risk reaching composite endpoint hr <NUMBER> <NUMBER> ci <NUMBER> two comorbidities hr <NUMBER> <NUMBER> ci <NUMBER> three comorbidities large multicenter retrospective study conducted sarscov<NUMBER> infection cases zhejiang well representing epidemiological situation covid<NUMBER> central china comorbidity always risk factor many diseases including pandemic sars <NUMBER> mers <NUMBER> h<NUMBER>n<NUMBER> <NUMBER> even common influenza <NUMBER> communityacquired pneumonia <NUMBER> patients underlying diseases general show worse outcomes otherwise healthy patients resistance diseases low situation promotes progression disease condition patients covid<NUMBER> comorbidities common approximately <NUMBER> patients reported one comorbidities common hypertension <NUMBER> diabetes <NUMBER> cardiovascular disease <NUMBER> chronic liver disease <NUMBER> chronic kidney disease <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> patients comorbidities compromised immune status decreased disease resistance likely suffer severe infection without comorbidities study describes relationship comorbidities clinical outcomes covid<NUMBER> plays important role clinical diagnosis treatment prevention covid<NUMBER> results show severe covid<NUMBER> common among patients comorbidities without comorbidity consistent clinical manifestations imaging findings number reaching composite endpoint differences statistically significant corroborating previous finding comorbidity risk factor patients covid<NUMBER> many reports <NUMBER> shown advanced age closely related severely poor prognosis covid<NUMBER> comorbidities generally older patients without comorbidities p <NUMBER> may one factors contributing exacerbation condition patients comorbidities among comorbidities evaluated present study hypertension diabetes common probably related high incidence disease entire population evaluated relationship different comorbidities covid<NUMBER> outcomes using cox regression analysis adjusting age gender status results show hypertension hr <NUMBER> <NUMBER> ci <NUMBER> comorbidities associated covid<NUMBER> outcomes p <NUMBER> sarscov<NUMBER> binds angiotensinconverting enzyme <NUMBER> scholars pay close attention effect medications act reninangiotensin aldosterone system covid<NUMBER>we divided hypertension patients aceiarb nonaceiarb groups analyzed epidemiology data clinical characteristics prognosis however significant difference observed consistent results previous report <NUMBER> impact aceiarb drugs covid<NUMBER> remains controversial <NUMBER> given relatively cases except hypertension error may related small sample size studies warranted determine relationship comorbidities serious adverse outcomes observed number comorbidities related adverse outcomes patients higher number comorbidities greater risk adverse events figure <NUMBER> hr <NUMBER> <NUMBER> ci <NUMBER> patients two comorbidities <NUMBER> <NUMBER> ci <NUMBER> three comorbidities pvalue less <NUMBER> therefore upon admission hospital patients carefully interrogated existing comorbidities classified depending number comorbidities patients many comorbidities poor physical conditions high risk adverse outcomes therefore attention paid changes condition covid<NUMBER> patients underlying diseases particular elderly patients comorbidities carefully monitored prevent occurrence serious adverse events summary report systematically describes impact presence type number comorbidities clinical outcomes patients covid<NUMBER> relationship comorbidities adverse outcomes clarified would helpful prevention treatment epidemic first comprehensive investigation comorbidities patients covid<NUMBER> zhejiang province may represent global scenario research limitations important collection information comorbidities considering severity epidemic shortage medical resources admitted patients especially patients mild infection receive systemic imaging examination diagnosis rate basic disease varied hence mainly focused selfreport patients time admission however comorbidities underreported various reasons economic conditions lack awareness health may lower significance statistics comorbidities much actual situation proportion comorbidities report generally consistent existing literature country <NUMBER> additionally study retrospective analysis since error data collection may slightly reduce credibility need consider prospective cohort studies provide reliable data future patients continued hospitalized data expressed mean ± standard deviation median quartile q<NUMBER>q<NUMBER> number data expressed mean ± standard deviation median quartile q<NUMBER>q<NUMBER> number comparison timedependent risk reaching composite endpoints patients comorbidities red curve without comorbidities blue curve b comparison timedependent risk reaching composite endpoints among patients without comorbidity blue curve <NUMBER>comorbidity red curve <NUMBER> comorbidities black curve <NUMBER>or comorbidities green curve hypertensive disorders common medical complications pregnancy major cause maternal perinatal morbidity death <NUMBER> detection elevated blood pressure bp pregnancy one cardinal aspects optimal antenatal care routine prenatal visits therefore traditionally involved assessment weight bp urine protein dipstick queries symptoms suggestive preeclampsia outbreak novel coronavirus disease <NUMBER> covid<NUMBER> risk persontoperson spread virus desire minimize unnecessary visits health care facilities since bp measurement essential component prenatal care given hypertensionrelated issues affect considerable proportion pregnant women critical develop safe approach reducing frequency prenatal visits well develop approaches address women home quarantined may hypertension signs symptoms associated hypertensive disorders pregnancy hdp includes gestational hypertension ghtn preeclampsia superimposed preeclampsia planning frequency prenatal visits important appreciate rate ghtn preeclampsia well likely timing onset complications obstetrical population first prenatal visit woman classified low risk high risk hdp general healthy nulliparous women multiparous women prior history hdp singleton gestation considered low risk overall rate hdp <NUMBER> range <NUMBER> preeclampsia <NUMBER> onset hdp group typically occurs beyond <NUMBER> weeks approximately <NUMBER> cases addition rate hdp developing <NUMBER> weeks <NUMBER> <NUMBER> consequently prenatal visits safely reduced women prior <NUMBER> weeks gestation contrast women considered high risk previous history hdp preexisting severe chronic hypertension rate hdp <NUMBER> <NUMBER> onset complications typically occurs <NUMBER> weeks approximately <NUMBER> cases <NUMBER> <NUMBER> rate complications developing <NUMBER> weeks approximately <NUMBER> <NUMBER> review conditions high risk developing hypertensive disorders pregnancy <NUMBER> presented ►table <NUMBER> consequently prenatal visits well obstetric provider contact frequent women pandemic pregnant women encouraged obtain sphygmomanometer bring device office clinic ensure accuracy device arm cuff preferable however unavailable device wrist cuff acceptable patient cannot afford sphygmomanometer one provided insurance plan consideration given bp determinations pharmacy important points accurate clinical bp determination <NUMBER> outpatient reviewed ►table <NUMBER> important make decisions based clinical judgment common sense pregnant patients without known complications risk factors require quarantine recent travel endemic areas significant contact infected individual mild asymptomatic covid<NUMBER> infection delay antenatal visits <NUMBER> days authors previously reported properly monitored outpatient management nonsevere gestational hypertensionpreeclampsia associated similar maternal perinatal outcomes compared previously published results inpatient management <NUMBER> <NUMBER> hospitalization however recommended noncompliant patients show worsening course outpatients pregnant women suspected hdp due hypertension proteinuria hypertension signs symptoms associated severe end disease spectrum eg headaches visual symptoms epigastric pain pulmonary edema evaluation including complete blood count serum creatinine level liver transaminases aspartate aminotransferase alanine aminotransferase <NUMBER> <NUMBER> evidence disease progression • neither patient observer talk measurement • position arm major influence measured bp • patient refrain caffeine intake prior bp measurements • upper arm level right atrium arm hanging sitting position readings falsely high ►fig <NUMBER>b • arm heart level blood pressure readings falsely low ►fig <NUMBER>b note adapted pickering et al <NUMBER> acute severe hypertension develops prompt hospitalization suggested approximately <NUMBER> women affected hdp develop one nonspecific symptoms characterize severe spectrum disease signify need urgent evaluation possible delivery described mechanism headache well cerebrovascular symptoms preeclampsia poorly understood headache usually acute onset described worst headache ever headache may temporal frontal occipital diffuse although pathognomonic feature suggests preeclampsiarelated headache rather another type headache persists despite administration overthecounter analgesics acetaminophen doses <NUMBER> gday concerning signs symptoms relating headache pregnancy postpartum include worsening headaches women chronic headaches headache characteristic eg pain pattern different usual headaches headache altered mental status seizures papilledema changes vision stiff neck focal neurological signs symptoms <NUMBER> visual abnormalities scotomata photophobia blurred vision visual symptoms present also symptoms severe disease spectrum preeclampsia caused least part retinal arteriolar spasm macular edema vasogenic edema occipital lobes gastroesophageal reflux common pregnant women especially night severe persistent right upper quadrant pain epigastric pain unresponsive medication accounted alternate diagnoses may presenting symptom preeclampsia particularly hellp haemolysis elevated liver enzymes low platelet count syndrome significant associated abnormal liver enzymes include shortness breath retrosternal pressure tightness chest dyspnea orthopnea palpitations patients monitored hypertension outpatient receive written instructions important signs symptoms disease progression provided contact information report development concern change status sample instructions home management patients gestational hypertensionpreeclampsia <NUMBER> provided ►table <NUMBER> home bp assessment discussed methods bp measurements conveyed health care provider provided ►table <NUMBER> important institute process appropriate provider informed bp particularly outside prespecified range information interaction patient documented medical record suggestions bp determinations timing office visits confirmation patient remains candidate home management patient asked symptoms severe preeclampsia every encounter would useful check list included record • bp obtained thrice per day first bp assessment made morning breakfast especially caffeinated beverages chronic hypertension affects <NUMBER> pregnancies depending population studied prevalence risen past decade due various factors including delayed childbearing increasing prevalence obesity increasing number pregnancies significant medical comorbidities pregestational diabetes lupus renal disease <NUMBER> previously noted woman classified low risk high risk hdp first prenatal visit ►table <NUMBER> compares risk adverse maternal perinatal outcomes women lowrisk chronic hypertension versus high risk decision treat bp consider presence maternal comorbidities well level maternal bp time initial visit general agreement women comorbidities diabetes mellitus renal disease heart disease severe hypertension systolic bp <NUMBER> mm hg diastolic bp <NUMBER> mm hg require antihypertensive therapy keep maternal bp safe target range systolic bp <NUMBER> mm hg diastolic bp <NUMBER> mm hg <NUMBER> contrast uncertainty regarding optimal target goal bp achieve women uncomplicated nonsevere hypertension pregnancy general frequency evaluation women lowrisk chronic hypertension similar normotensive pregnancies management may table <NUMBER> methods blood pressure measurements conveyed health care provider • patient may email text video link phone information office clinic • patient may take cell phone picture blood pressure recordings electronic sphygmomanometer forward office clinic • information relayed directly office clinic via mobile application modified instances bp control requires medical intervention fetal testing warrants closer followup circumstances include exacerbation hypertension requiring treatment systolic bp <NUMBER> mm hg andor diastolic bp <NUMBER> mm hg fetal growth restriction estimated fetal weight <NUMBER>th percentile gestational age abnormal umbilical artery doppler findings oligohydramnios deepest vertical pocket <NUMBER> cm <NUMBER> women highrisk chronic hypertension require intensive followup given increased risk adverse maternal perinatal outcomes risk organ deterioration addition management hypertension comorbid medical conditions adequately controlled pregnancy may aggravate preexisting conditions liberal hospitalization manage morbidities may needed <NUMBER> • blood pressure obtained twice per day first bp assessment performed <NUMBER> <NUMBER> especially caffeinated beverages second bp assessment performed <NUMBER> <NUMBER> pm • follow blood pressure measurement guidelines presented ►table <NUMBER> • blood pressure measurements conveyed health care provider outlined ►table <NUMBER> instructions response blood pressure measurements patients gestational hypertension preeclampsia setting chronic hypertension patient receiving antihypertensive therapy however consideration could given increasing antihypertensive medication dose given limited information regarding outcome pregnancies complicated covid<NUMBER> infection important continue use clinical judgment obstetrical management pandemic concerned believe patient needs closer followup scheduled accordingly ►table <NUMBER> presents suggested antepartum postpartum guidelines management patients concern hdp ►table <NUMBER> presents suggested timing delivery covid<NUMBER> pandemic patients chronic hypertension categorized classification chronic hypertension ultrasound indicated evaluate amniotic fluid volume estimate fetal weight initial diagnosis gestational hypertension preeclampsia given increased risk oligohydramnios fetal growth restriction patients particularly true preeclampsia develops remote term <NUMBER> due reduced uteroplacental perfusion less likely patients diagnosis made near term goal employ maximum interval follow growth ultrasounds attempt made combine imaging prenatal visit ultrasound suite avoid waiting second waiting room seeing another provider team thereby reducing contact potentially infected individual data randomized trials base recommendations optimal type frequency antepartum fetal monitoring however daily fetal movement counts seem prudent weekly nonstress testing plus assessment amniotic fluid volume weekly biophysical profiles performed time diagnosis ghtnpreeclampsia continue delivery fetal testing promptly performed abrupt change maternal condition main objective management severe preeclampsia must always safety mother fetus although delivery always appropriate mother might best premature fetus decision delivery expectant treatment take consideration fetal gestational age fetal status severity maternal condition time assessment including criteria used make diagnosis presence severe preeclampsia mandates immediate hospitalization labor delivery unit <NUMBER> initial clinical laboratory evaluation decision must made immediate delivery vs expectant treatment current guidelines acog smfm management severe preeclampsia suggest delivery <NUMBER> weeks gestation outbreak covid<NUMBER> however adjustments algorithm considered including delivery <NUMBER> <NUMBER> weeks gestation setting severe preeclampsia ►fig <NUMBER> magnesium sulfate widely used medication labor delivery recommended seizure prophylaxis patients severe features preeclampsia <NUMBER> however magnesium sulfate therapy without risks one major albeit uncommon side effect respiratory depression serious implications maternal outcomes particularly persons investigation known covid<NUMBER>positive patients already compromised respiratory status patients preeclampsia gestational hypertension without severe features magnesium sulfate therapy administered <NUMBER> severe features however magnesium sulfate prophylaxis indicated suggested results magpie trial <NUMBER> iv intravenous loading dose <NUMBER> g magnesium sulfate <NUMBER> min followed iv maintenance dose <NUMBER> gh could used rather traditional higher loading <NUMBER> g maintenance doses <NUMBER> gh patients severe features preeclampsia requiring ventilatory support given covid<NUMBER> infection continue receive intravenous magnesium sulfate antiseizure prophylaxis respiratory rate adjusted settings mechanical ventilator comprehensive counseling signssymptoms preeclampsia given discharge following delivery outbreak covid<NUMBER> risk persontoperson spread virus desire minimize unnecessary visits health care facilities pregnant patients without known complications known risk factors covid <NUMBER> recent travel endemic areas significant contact infected individual mild asymptomatic covid<NUMBER> infection delay antenatal visits <NUMBER> days women classified low risk high risk hdp adjustments accordingly made frequency maternal fetal surveillance patient provided detailed instructions concerning outpatient management evidence disease progression acute severe hypertension develop prompt hospitalization suggested arbs direct renin inhibitors dris aceis enact blood pressurelowering effects blocking peptidyldipeptidase hydrolyzes angiotensin ai angiotensin ii aii addition inactivates bradykinin vasodilating peptide promoting release nitrogen monoxide prostacyclin arbs effect bradykinin metabolism block effects aii selectively aceis detail arbs determine antihypertensive effect preventing binding aii aii receptor type <NUMBER> <NUMBER> finally dris exert blood pressurelowering effects decreasing plasma renin activity inhibiting conversion angiotensinogen ai <NUMBER> vitro studies demonstrated aceis arbs significantly increase expression activity angiotensinconversion enzyme <NUMBER> ace<NUMBER> highly expressed heart lungs <NUMBER> coincidentally ace<NUMBER> receptorbinding site spike protein sarscov<NUMBER> target cell <NUMBER> hence fang et al <NUMBER> recently hypothesized lancet respiratory medicine patients cardiac diseases hypertension diabetes mellitus treated ace<NUMBER>increasing drugs might higher risk severe sarscov<NUMBER> infection accordingly authors suggested calcium channel blockers ccbs may suitable alternative antihypertensive treatment arbs aceis lack increased ace<NUMBER> expression activity hand recently published commentaries outlined mechanisms raas inhibitors may beneficial patients covid<NUMBER> discussed unclear effects drugs ace<NUMBER> levels activity humans recommending suspension withdrawal raas blockers <NUMBER> <NUMBER> present contribution scientific debate highlighting importance continuing aceiarb treatments reporting several arguments switching aceis arbs antihypertensive drugs specifically ccbs italian society pharmacology members listed acknowlegements first date sound evidence clinical studies replacing aceisarbs antihypertensive drugs including ccbs associated beneficial effects either prevention covid<NUMBER> prognosis infected patients scant available data mostly derived vitro studies reason nature cardiology zheng et al <NUMBER> reported whether patients covid<NUMBER> hypertension taking ace inhibitorarb switch another antihypertensive drug remains controversial evidence required <NUMBER> second studies carried sarscov probably generalizable sarscov<NUMBER> suggested paradoxically protective effect arbs covid<NUMBER> <NUMBER> interaction coronavirus spike protein ace<NUMBER> cellularbinding site leads ace<NUMBER> downregulation turn results excessive production angiotensin ace whereas less ace<NUMBER> capable converting angiotensin <NUMBER> heptapeptide vasodilator activity <NUMBER> <NUMBER> suggested exaggerated stimulation <NUMBER> aii determines increased pulmonary vascular permeability thereby mediating increased lung pathology expression ace<NUMBER> decreased <NUMBER> <NUMBER> thus higher ace<NUMBER> expression following chronic treatment arbs may protect patients infected sarscov<NUMBER> acute lung injury rather increasing risk developing covid<NUMBER> third switching among different antihypertensive drugs older patients relevant comorbidities may put frail population risk developing adverse cardiovascular events uncontrolled hypertensionsymptomatic hypotension even deterioration chronic diseases moreover considering proven effects aceis arbs reducing mortality cardiovascular diseases discontinuation therapies could increase occurrence negative outcomes patients affected cardiovascular diseases covid<NUMBER> <NUMBER> fourth aceis arbs currently approved differences across various compounds treatment hypertension heart failure diabetic nephropathy secondary prevention acute myocardial infarction whereas ccbs antihypertensive drugs approved indications finally none drug regulatory agencies worldwide recommend switching aceisarbs antihypertensive drugs vice versa covid<NUMBER> outbreak instead <NUMBER> march <NUMBER> italian drug agency issued warning change antihypertensive therapies patients wellcontrolled hypertension irrespective agents used lack clinical data <NUMBER> ten days later european medicines agency advised since clinical evidence drugs worsen sarscov<NUMBER> infections important patients discontinue treatment aceis arbs need switch medicines <NUMBER> recommendations line position statements nationalinternational scientific societies eg european society cardiology <NUMBER> italian society pharmacology <NUMBER> heart failure society america american college cardiology american heart association <NUMBER> international society hypertension <NUMBER> european society hypertension <NUMBER> recommend continuing raas inhibitor therapy patients currently prescribed agents indications known agents safe effective acute chronic heart failure <NUMBER> acute myocardial infarction <NUMBER> hypertension <NUMBER> regarding postulated protective effect aceisarbs never used healthy people patients affected diseases approved indications reported summary product characteristics specific information described dris nevertheless recommendations reported extended class raas inhibitors scenario experimental clinical studies cannot rapidly shed light association covid<NUMBER> aceiarb use realworld studies based dedicated covid<NUMBER> patient registries whenever available claims databases countries high incidence sarscov<NUMBER> infection urgently needed absence clinical evidence supporting change patients treated aceisarbs clinicians still follow old principle primum non nocere pneumonia caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> first time reported december <NUMBER> <NUMBER> <NUMBER> since covid<NUMBER> pandemic disease caused virus spread around world april <NUMBER> <NUMBER> million confirmed cases total almost <NUMBER> <NUMBER> deaths identified worldwide everything started wuhan hubei province china <NUMBER> months ago therefore practically relevant clinical data coming china findings showing arterial hypertension diabetes cardiovascular diseases chronic obstructive pulmonary disease common comorbidities patients covid<NUMBER> tables <NUMBER> <NUMBER> even though number studies followup rather limited data suggesting hypertension diabetes cardiovascular disease underlying conditions associated adverse outcomeadmission intensive care unit mechanic ventilation death <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> table <NUMBER> however findings inconsistent data epidemiological analytical majority studies analyze effect many confounding factors age sex obesity could significantly change interaction comorbidities outcome clear sudden outbreak covid<NUMBER> raised great attention forced rapid publication order explain epidemiology therapeutic approach outcome many parameters available inclusion risk factors obesity would probably interfere final results possible far therefore one careful interpretation available data indicating hypertension diabetes one responsible risk factors least global population aim review summarize currently available data regarding prevalence diabetes patients covid<NUMBER> role outcome patients hence comprehensive systematic search performed pubmed scopus web science google scholar find articles published april <NUMBER> <NUMBER> still unknown whether patients diabetes higher susceptibility covid<NUMBER> observation risk higher infection disease severity however percentage patients diabetes varies <NUMBER> <NUMBER> <NUMBER> <NUMBER> two largest metaanalyses included <NUMBER> <NUMBER> <NUMBER> <NUMBER> covid<NUMBER> patients respectively diabetes detected <NUMBER> <NUMBER> <NUMBER> <NUMBER> however noted large level heterogeneity exists published studies differ sample size age patients severity covid<NUMBER> hospital facilities investigated comorbidities therapeutic approach finally outcome one largest study published n <NUMBER> far diabetes present <NUMBER> covid<NUMBER> patients significantly prevalent patients severe form disease experienced primary outcome end point admission intensive care unit use mechanical ventilation death <NUMBER> group authors larger group covid<NUMBER> patients n <NUMBER> reported diabetes <NUMBER> significantly prevalent among covid<NUMBER> patients severe form patients nonsevere form disease <NUMBER> vs <NUMBER> <NUMBER> recent study included <NUMBER> noncritically ill covid<NUMBER> patients reported diabetes <NUMBER> patients <NUMBER> even though prevalence diabetes low covid<NUMBER> patients aggravation illness followup frequently diabetic comparison complication covid<NUMBER> lian et al <NUMBER> included <NUMBER> patients covid<NUMBER> divided patients two groups younger <NUMBER> years older <NUMBER> years thereby contributing explain diabetes related susceptibility severity covid<NUMBER> authors showed many comorbidities hypertension cardiovascular disease chronic obstructive pulmonary disease including diabetes prevalent patients older <NUMBER> years patients younger <NUMBER> years <NUMBER> difference age probably one main reasons risk ascribed diabetes patients covid<NUMBER> studies investigated cardiac injury covid<NUMBER> patients defined increased cardiospecific enzymes showed diabetes significantly frequent among patients cardiac injury patients without <NUMBER> <NUMBER> nevertheless prevalence hypertension cardiovascular diseases chronic renal disease significantly higher patients experienced cardiac injury would difficult separate effect diabetes underlying diseases moreover large difference age covid<NUMBER> patients detected cardiac injury cardiac injury also could contribute worse outcome cardiac injury <NUMBER> <NUMBER> authors concluded cardiac injury common covid<NUMBER> patients <NUMBER> associated significantly higher mortality population <NUMBER> <NUMBER> guo et al <NUMBER> investigated effect diabetes progression prognosis patients covid<NUMBER> limited sample found serum levels inflammationrelated biomarkers il<NUMBER> creactive protein serum ferritin coagulation index ddimer significantly higher patients diabetes compared without <NUMBER> indicates diabetic patients predisposed hyperinflammatory state ultimately leads prompt deterioration covid<NUMBER> significant difference age diabetics nondiabetics diabetics frequently cardiovascular disease nondiabetic counterparts <NUMBER> however even diabetic patients without comorbidities analyzed results remained sameinflammatory procoagulant factors significantly higher diabetic patients among patients diabetes <NUMBER> insulin therapy increased dose insulin admission whereas <NUMBER> oral antidiabetic therapy admission started insulin therapy admission <NUMBER> means patients poor glycemic control hospitalization diabetes hyperinflammatory condition seems may increase susceptibility covid<NUMBER> independently underlying diseases several possible mechanisms inflammation b hypercoagulable state c activation reninangiotensinaldosterone system raas dysregulation sympathetic nervous system evidence sarscov novel coronavirus responsible covid<NUMBER> uses ace<NUMBER> surfaces epithelial cells bind enter infected cells <NUMBER> ace<NUMBER> located cardiac kidney lung intestinal tissues converts angiotensin ii angiotensin <NUMBER> promotes vasodilation function raas diabetic patients already significantly modified <NUMBER> acute change activity ace<NUMBER> may final trigger hyperinflammatory hypercoagulable storm covid<NUMBER> however hypotheses without reliable clinical evidence observations covid<NUMBER> pandemic indicated raas inhibitors frequently taken covid<NUMBER> patients unfavorable outcome <NUMBER> raised large concerns use raas inhibitors often prescribed diabetic patients without concomitant hypertension another frequent comorbidity covid<NUMBER> patients recent findings covid<NUMBER> patients showed raas inhibitors improve outcome patients <NUMBER> confirmed recent position statements several societies strongly recommended continuation regular treatment raas inhibitors data regarding influence diabetes outcome diabetic patients still limited table <NUMBER> predictors mortality whereas ddimer <NUMBER> μgml independent predictor coagulable parameters findings challenging hypothesis hyperinflammation state diabetic patients may responsible mortality patients covid<NUMBER> nevertheless number patients study limited n <NUMBER> drawing conclusion easy task wu et al <NUMBER> compared covid<NUMBER> patients without acute respiratory distress syndrome ards found diabetes significant predictor ards hr <NUMBER> <NUMBER> ci <NUMBER> mortality hr <NUMBER> <NUMBER> ci <NUMBER> underlined multivariate analysis adjustment age sex possible confounding factors performed due small sample size n <NUMBER> metaanalysis included <NUMBER> patients covid<NUMBER> found diabetes well hypertension chronic obstructive pulmonary disease associated exacerbation admission intensive care unit <NUMBER> study aimed investigate effect diabetes progression prognosis patients covid<NUMBER> reported significantly higher mortality among diabetic patients without comorbidities <NUMBER> vs <NUMBER> <NUMBER> however diabetic patients almost twice old nondiabetics <NUMBER> vs <NUMBER> years must taken consideration majority inflammatory parameters creactive protein serum ferritin erythrocyte sedimentation rate interleukin<NUMBER> procoagulant factors ddimer fibrinogen also significantly higher among diabetic patients without comorbidities <NUMBER> diabetic complications prevalent patients died borderline statistical significance interestingly ketoacidosis infectious shock conditions would assumed responsible findings prevalent among covid<NUMBER> patients lethal outcome <NUMBER> initiation insulin admission speaks favor poor glycemic regulation also related higher mortality however <NUMBER> diabetic patients included study <NUMBER> comorbidities study may provide directions future studies conclusions coronary artery disease particularly asymptomatic form frequently present diabetic patients could excluded potential confounding factor additional limitation still many uncertainties whether diabetes interferes sarscov<NUMBER> facilities entrance coronavirus epi number limitations available data selfreporting comorbidities hospital admission used investigation cause significant underreporting comorbidities due lack awareness andor lack diagnostic testing could interfere relationship comorbidities clinical outcome furthermore followup short patients remained hospital data analyzed meaning actual outcome unknown directly influenced influence diabetes severity outcome covid<NUMBER> patients clear large gap evidence known antidiabetic therapy used diabetic patients many patients untreated many uncontrolled diabetes obesity one important comorbidities diabetic patients investigated large studies comprehensive analysis risk factors longer followup necessary answer questions raised surprised upcoming results western countries currently affected covid<NUMBER> different currently available data nevertheless patients diabetes hypertension particularly advanced age priority vaccine becomes available conflict interest httpsorcidorg<NUMBER> pandemic covid<NUMBER> taking lives worldwide caused novel coronavirus human lack defensive function whole population targets humans lung causes serious damage lungs based early reports people underlying heart issues concerns serious appears people <NUMBER> coronary heart diseases hypertension likely infected develop severe symptoms addition hospitalized covid<NUMBER> patients cardiovascular diseases china characteristic analysis covid<NUMBER> patients hypertension severe myocardial damage contribute severity <NUMBER> mortality covid<NUMBER> patients <NUMBER> therefore better understand development covid<NUMBER> impacts cardiovascular diseases add valuable measures management covid<NUMBER> patients coronavirus kind positivechain singlestranded rna virus diameter <NUMBER> nm classified α β δ γ type coronavirus characteristics various strains wide distribution cross species covid<NUMBER> belongs β genus capsule mushroomlike protein spike make virus crownlike round oval size often pleomorphic diameter <NUMBER> nm detection viral genes showed nucleotide sequences covid<NUMBER> genome share <NUMBER> identity severe acute respiratory syndrome virus sarscov genome <NUMBER> current studies shown covid<NUMBER> transmission route bathuman intermediate host studied transmitted mainly respiratory droplets well transmitted contact humanhuman transmission <NUMBER> <NUMBER> potential mechanism cardiovascular diseases induced covid<NUMBER> confirmed portion region amino terminal sarscov spike protein could bind human angiotensinconverting enzyme <NUMBER>ace<NUMBER> mediate fusion virus host cell <NUMBER> covid<NUMBER> likely similar infection pathways sarscov words ace<NUMBER> may also binding receptor covid<NUMBER> ace<NUMBER> homologous enzymes angiotensinconverting enzyme ace important components reninangiotensin system ras renin hydrolyzes angiotensinogen angiotensin ang converted angiotensin ii ang ii ace ang ii leads vasoconstriction elevated blood pressure vascular remodeling binding angiotensin type ii <NUMBER> receptor at<NUMBER>r ace<NUMBER> act ang generate ang <NUMBER> generate ang <NUMBER> dependent independent ace<NUMBER> pathways ace<NUMBER> directly hydrolyze ang ii ang <NUMBER> ang <NUMBER> bind g proteincoupled mas receptors mediate vasodilation antioxidant stress inhibit cell proliferation protect vascular endothelium damage well physiological functions like delaying reversing vascular remodeling protecting cardiovascular system aceang iiat<NUMBER>r axis ace<NUMBER>ang <NUMBER>mas axis antagonize balance maintain dynamic balance human vascular system ace<NUMBER> expressed human alveolar epithelial cells gateway virus invasion also mediates lung injury lung failure caused virus infection clinical observations showed plasma ang ii levels increased significantly covid<NUMBER> patients <NUMBER> suggests covid<NUMBER> binding ace<NUMBER> leads excessive release ang ii ras turn burdens heart vascular system increasing heart loading eventually cardiomyocyte hypertrophy high blood pressure virus replicates cells fusion host cells invasion lung surface cells directly causes lung inflammation invasion cardiomyocytes lead edema degeneration necrosis cardiomyocytes meanwhile proinflammatory cytokines released following cell lysis interleukin lung injury caused covid<NUMBER> leads hyoxemia partial pressure circulating oxygen oxygen saturation decrease continuously lead accumulation oxygen free radicals lactic acid metabolites again，by circulating around whole body myocardial cell injury becomes inevitable order ensure supply systemic cell metabolic energy demand heart pump blood intensified prone cardiac dysfunction heart failure addition hypoxemia also one inducing factors inflammatory response promote formation inflammatory storm certain extent <NUMBER> first strong reaction virus invasion activation human immune inflammatory responses interactions among tissues organs pathogens complex stress process especially severe infection time emotional response human like anxiety fear et al also increases stress patients process catecholamine released large quantities plasma catecholamine content related blood pressure level blood perfusion coronary heart disease sudden cardiac death high catecholamine direct myocardial toxicity lead microcirculation disturbance vasospasm arrhythmia <NUMBER> <NUMBER> first important clinical observations pointed patients infected covid<NUMBER> might sign respiratory symptoms patients complained palpitation chest tightness shortness breath exercises et al soon patients confirmed suspected covid<NUMBER> sudden acute myocardial infarction heart failure occur immediately important early identify patients acquired quarantine measures covid<NUMBER> patients show increased respiratory rate lower blood pressure even shock electrocardiogram ecg prolonged qrs interval clinical characteristics covid<NUMBER> patients showed hypertension closely related severity covid<NUMBER> infection <NUMBER> inpatients <NUMBER> intensive care unit icu patients <NUMBER> death cases known covid<NUMBER> infects human combining spike protein surface ace<NUMBER> alveolar cell membrane turn activates immune system releases cytokines inflammatory factors ace<NUMBER> important protective protein human body covid<NUMBER> infection causes downregulation ace<NUMBER> level body obvious effect ace <NUMBER> <NUMBER> angiotensinconverting enzyme inhibitor aceiangiotensin receptor antagonist arb associated ras regulation animal studies shown aceiarb drugs significantly increase expression level ace<NUMBER> biological activity rat cardiomyocytes <NUMBER> <NUMBER> unclear whether aceiarb application upregulate expression activity ace<NUMBER> lung tissue therefore evidence aceiarb increases susceptibility covid<NUMBER> lung damage following infection high blood pressure patients currently receiving aceiarb treatment antihypertensive drugs advised change treatment plan without <NUMBER> clear contraindications serious adverse reactions affect blood pressure homeostasis increase risk hypertension emergencies patients hypertension covid<NUMBER> treatments aceiarb depend conditions patients mild illness given longterm medication aceiarb may continue severe critical illness treatment plan decided careful monitoring vital signs hemodynamics damage target organs avoid dry cough caused acei covid<NUMBER> infection patients recommended use acei delayed american heart society acc published clinical bulletin cardiac implications novel wuhan coronavirus stated covid<NUMBER> potential effects heart especially patients cardiovascular disease among covid<NUMBER> patients <NUMBER> diagnosed chronic diseases <NUMBER> cardiovascular cerebrovascular diseases patients chronic potential diseases obesity hypertension diabetes chronic obstructive pulmonary disease chronic kidney disease higher risk complications death infection virus infection destroy stability atherosclerotic plaque promote occurrence coronary atherosclerosis coronary heart disease experts suggest outbreak people previous cardiovascular diseases strictly accept tailored optimized drug treatments provide additional protection including statins β receptor blockers acei drugs aspirin accordance doctors advice guidance <NUMBER> people basic cardiovascular disease likely infected virus poor prognosis virus infection also lead deterioration basic heart disease covid<NUMBER> patients complicated cardiovascular basic diseases recommended give priority treatment meanwhile pay attention vigilance recurrence aggravation original basic diseases <NUMBER> <NUMBER> <NUMBER> although pathogenic mechanism covid<NUMBER> fully elucidated ace<NUMBER> currently found key molecular target covid<NUMBER> occurrence progression heart lung tissues important target organs covid<NUMBER> hypoxemia respiratory distress inflammatory storms caused covid<NUMBER> adverse effects heart pay attention cardiovascular damage induced covid<NUMBER> early identification timely effective treatment maintenance hemodynamics electrophysiological stability great significance alleviate disease save lives ensure longterm prognosis <NUMBER> emergence novel covid<NUMBER> disease swift global expansion represents health emergency humanity novel virus causes severe acute respiratory disease believed member family coronaviruses severe acute respiratory syndrome coronavirus sarscov middle east respiratory syndrome coronavirus merscov <NUMBER> unprecedented efforts currently made identify risk factors increase severity disease world health organisation suggested patients certain medical conditions elderly people greatest risk developing severe disease <NUMBER> june <NUMBER> <NUMBER> <NUMBER> million people infected <NUMBER> died disease majority deaths thought associations existence one comorbidity general believed patients compromised immune system especially high risk <NUMBER> number researchers examined clinicalepidemiological characteristics patients suffering covid<NUMBER> insufficient investigation regarding mortality risk factors <NUMBER> identification principal risk factors employing appropriate clinical interventions mitigate could save numerous lives numerous studies indicate kidney disease copd coronary heart disease liver disease cardiovascular disease diabetes mellitus hypertension amongst important risk factors covid<NUMBER> paper undertake systemic review literature illuminate way impact covid<NUMBER> virus made severe existence comorbidities extant conditions research looked relevant published articles dates december <NUMBER> <NUMBER> may <NUMBER> <NUMBER> ie related comorbidity influence severity covid<NUMBER> papers excluded related adult patients written english peer reviewed original eg reviews editorials letters commentaries duplications papers mainly focused severe vs nonsevere groups patients considered severe group develop severe illnesses cases likely result icu admission death search undertaken covid<NUMBER> open research dataset cord <NUMBER> regularly updated <NUMBER> dataset contains <NUMBER> scholarly articles <NUMBER> articles full text relates coronavirus sarscov<NUMBER> covid<NUMBER> search engine running bm<NUMBER> search index created articles dataset could screened <NUMBER> bm<NUMBER> retrieval function creates document ranking dataset basis whether searched terms appear documents matter proximate may indexing papers occurs simple application preprocessing functions clean tokenize abstracts indexed documents document vectors created loading optimized cached json tokens subsequent application document similarity index founded annoy <NUMBER> annoy c library python bindings searching documents within space make close match specific query efficient simple process creates substantial readonly filebased data structures used memory mapping allowing several processes work identical data detail implantation found httpgithubcomdgunningcord<NUMBER> articles filtered employing questions keywords effects diabetes covidnormal coronavirussarscov<NUMBER>ncovcovid<NUMBER> disease severity search undertaken every comorbidity consideration research figure <NUMBER> ccbync <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint additionally independent search undertaken two researchers nz ea systematically examined pubmed europe pmc google scholar databases searches obtained information regarding name author year publication publication name age gender severitynonseverity disease presence clinical symptoms ie chest tightnesspain respiratory failureards dyspnoea myalgiafatigue diarrhea cough fever either vital nonvital information absent requirement admission icu employed indicate severe disease articles remained underwent independent screening two researchers nz ea disagreement settled either consensus casting vote third researcher si research completed may <NUMBER> th <NUMBER> stages systemic literature search illustrated figure <NUMBER> metaanalysis undertaken employing python library meta odds ratios ors employed describing risk factors various comorbidities patients severe disease compared mild disease due internal external heterogeneities random effect modeling employed estimation average effects precision offering cautious estimate regarding <NUMBER> confidence intervals cis statistical heterogeneity assessed using <NUMBER> statistic machine learning techniques based regression eg support vector machine svm <NUMBER> linear regression multiperceptron <NUMBER> random forest <NUMBER> attribute selection techniques wrapper subset evaluator <NUMBER> correlation ranking filter relieff ranking filter <NUMBER> implemented weka <NUMBER> employed determination useful significant different elements terms prediction levels severe instances covid<NUMBER> consideration given conditions kidney disease coronary heart disease copd liver disease cardiovascular disease cancer diabetes mellitus hypertension clinical symptoms added consideration independent attributes diarrhea chest tightnesspain respiratory failure dyspnoea fatigue coughing fever incubation period current smoking status patient gender authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint results <NUMBER> articles found search europe pmc pubmed covid<NUMBER> database <NUMBER> excised duplicates total <NUMBER> text articles examined see eligible <NUMBER> articles removed due fact englishlanguage articles full text duplicates editorials letters reviews irrelevant peerreviewed ultimately metaanalysis group comprised <NUMBER> articles met quantitative qualitative standards table <NUMBER> shows median age severe cases <NUMBER> years nonsevere cases <NUMBER> years <NUMBER> patients male metaanalysis demonstrated highest levels comorbidity hypertension <NUMBER> diabetes <NUMBER> cardiovascular disease <NUMBER> liver disease <NUMBER> coronary heart disease <NUMBER> kidney disease <NUMBER> copd <NUMBER> terms clinical symptoms common fever <NUMBER> cough <NUMBER> myalgiafatigue <NUMBER> dyspnoea <NUMBER> respiratory failureards <NUMBER> diarrhea <NUMBER> chest tightnesspain <NUMBER> metaanalysis indicated neither length incubation period current smoking status associations disease severity <NUMBER> p <NUMBER> i<NUMBER> <NUMBER> significant correlation found disease severity kidney liver disease <NUMBER> test heterogeneity ranged nought percent <NUMBER> indicating fair level statistical heterogeneity copd coronary heart disease <NUMBER> equal <NUMBER> meaning heterogeneity found making research adequately homogenous ccbync <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> ccbync <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> fig <NUMBER> forestplots indicate comorbidities diabetes mellitus hypertension coronary heart disease cardiovascular disease associations composite poor outcomes severe covid<NUMBER> icu care requirements true cancer liver disease kidney disease patients ccbync <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> evaluation publication bias article metaanalysis employed r metapackage visualization funnel plots outcomes publication bias shown figs <NUMBER> <NUMBER> ccbync <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint coronary heart disease cardiovascular disease analysis employed sevenmachine learningfeature selection techniques outlined methodology section indicating diabetes listed top <NUMBER> crucial attributes <NUMBER> techniques heart <NUMBER> hypertension <NUMBER> copd <NUMBER> clinical conditions like cough <NUMBER> fever <NUMBER> chest pain <NUMBER> fatigue <NUMBER> similarly listed top <NUMBER> important attributes ccbync <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint research offered comprehensive vision reviewmetaanalysis regarding influence comorbidities eg diabetes hypertension severity covid<NUMBER> metaanalysis employed data gathered <NUMBER> studies covering <NUMBER> patients chinese hospitals covid<NUMBER> diagnosis confirmed laboratory patients severe group higher age median age <NUMBER> patients nonsevere group median age <NUMBER> males females study <NUMBER> males <NUMBER> females two studies <NUMBER> <NUMBER> indicated significant correlation gender disease severity every study examined agreed female significant correlation disease severity <NUMBER> <NUMBER> ci <NUMBER> rather sarscov merscov patients <NUMBER> simply greater likelihood infection males generally higher exposure levels metaanalysis comorbidity found diabetes mellitus <NUMBER> hypertension <NUMBER> two prevalent conditions patient cohort almost exactly parallels levels hypertension diabetes amongst population china whole hypertension <NUMBER> <NUMBER> diabetes mellitus <NUMBER> <NUMBER> <NUMBER> found human pathogenic coronaviruses eg sarscov sarscov<NUMBER> achieve binding target cells using angiotensinconverting enzyme <NUMBER> ace<NUMBER> originates epithelial cells blood vessels kidneys intestines lungs <NUMBER> ace<NUMBER> levels considerably higher patients suffering type type ii diabetes given treatment ace inhibitors andor angiotensin ii type<NUMBER> receptor blockers arbs medications also used treatment hypertension causes upregulation ace<NUMBER> <NUMBER> ace<NUMBER> may also increased using either ibuprofen thiazolidinediones higher levels ace<NUMBER> would therefore promote covid<NUMBER> infection thus agree hypothesis treating hypertension diabetes ace<NUMBER>stimulators could predispose patients severe covid<NUMBER> thus concur fang et al <NUMBER> patients diabetes hypertension cardiac disease medicated ace<NUMBER>increasing medication must regarded greater risk developing severe covid<NUMBER> closely monitored effects selfmedication zhao q et al recent review <NUMBER> found extant copd makes four times likely severe covid<NUMBER> develop authors also examine influence smoking covid<NUMBER> severity coming conclusion significant correlation accords findings metaanalysis always assumption smoking may association less favorable disease outcomes copious research regarding detrimental effects smoking lung health causal correlation many different forms respiratory disease <NUMBER> furthermore smoking injurious immune system bodys ability respond infection means smokers susceptible contracting infections <NUMBER> accords papers metaanalysis although lippi g henry bm <NUMBER> indicate research necessary evidence becomes available limited data available present acknowledging findings adjusted elements may influence disease pathway seems probable smoking correlation severe undesirable outcomes covid<NUMBER> cases ccbync <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint patients exhibiting abnormal liver results regarded significantly likely develop severe pneumonia employing ritonavir lopinavir makes patients four times likely suffer liver injury <NUMBER> metaanalysis find significant correlation liver disease negative outcomes accords recent research <NUMBER> stated common covid<NUMBER> patients exhibit abnormal liver function index significant factor covid<NUMBER> patients may associated serious negative clinical outcomes study guan w et al <NUMBER> one <NUMBER> articles review found significant correlation kidney disease covid<NUMBER> severity examining articles total significant correlation found p <NUMBER> clinical symptoms frequently exhibited fever <NUMBER> cough <NUMBER> myalgiafatigue <NUMBER> dyspnoea <NUMBER> respiratory failureards <NUMBER> diarrhea <NUMBER> chest tightnesspain <NUMBER> accords majority published research terms heterogeneity majority cases zero low heterogeneity displayed <NUMBER> relative homogeneity majority cases examined research metaanalysis certain limitations could mitigated future research firstly patients chinese hospitals included studies review generalisability assumed research including populations incorporated secondly presence multiple comorbidities single patients considered element virtually every review overlooked also finally metaanalysis encompass laboratory radiographic clinical demographic data linked different pathways physiological effect flexibility helps body respond quickly coordinately specific stimuli whole body local area plays essential role maintaining homeostasis paper specifically examine organ protection ace<NUMBER> body discuss potential role coronavirus disease <NUMBER> covid<NUMBER> ace<NUMBER> homolog ace discovered <NUMBER> <NUMBER> despite similarities ace ace<NUMBER> functions two enzymes entirely different ace<NUMBER> active tissues widely distributed heart kidney lung testis <NUMBER> <NUMBER> <NUMBER> <NUMBER> widely present human alveolar epithelial cells small intestinal epithelial cells well arterial venous endothelial cells arterial smooth muscle cells epidermal basal cell layer skin basal layer nonkeratinized squamous epithelium nasal oral mucosa nasopharynx ace<NUMBER> expression ace<NUMBER> strongly expressed type ii epithelial cells glomerular tubules show ace<NUMBER> low glomerular mesangial glomerular endothelial cells express ace<NUMBER> kupffer cells hepatocytes spleen thymus lymph nodes bone marrow b lymphocytes macrophages show ace<NUMBER> <NUMBER> ace<NUMBER> tissue activity higher plasma activity <NUMBER> activity inhibited traditional angiotensinconverting enzyme inhibitors aceis <NUMBER> ace<NUMBER> high affinity ang ii <NUMBER> catalytic efficiency ang ii <NUMBER> times greater ang ace<NUMBER> may show differences different ages sexes <NUMBER> <NUMBER> <NUMBER> ace<NUMBER> acute lung injury sars coronavirus lung tissue high ras activity leading site ang ii synthesis ang ii effective pulmonary vasoconstrictor ras activated hypoxia ang ii promote growth response vascular smooth muscle cells also directly promote vascular remodeling prevent pneumonia shunts related lung injury <NUMBER> however ang ii also promote occurrence pulmonary edema impair lung function <NUMBER> acute respiratory distress syndrome ards severe form acute lung injury characterized mainly increased pulmonary vascular permeability pulmonary edema often induced sepsis aspiration pneumonia including caused sars coronavirus bird flu human influenza viruses clinical highdeathrate disease ace<NUMBER> highly expressed lung imai et al <NUMBER> ace<NUMBER> also one primary receptors sarscov invasion human body <NUMBER> puzzling sarscov infection leads highly lethal pneumonia compared common cold symptoms coronavirus infections researchers found sarscovinfected recombinant sarsspike proteintreated wildtype mice exhibited significantly reduced ace<NUMBER> expression lungs mice showed increased severity pathological conditions acute lung injury treating ace<NUMBER> ko mice sarsspike protein aggravate ards symptoms therefore downregulation ace<NUMBER> expression sarscov infection may play causal role pathogenesis sars provides reasonable explanation progression sars patients ards recent outbreakcausing novel coronavirus pneumonia covid<NUMBER> virus <NUMBER>ncov sarscov<NUMBER> also shown invade human alveolar epithelial cells mainly ace<NUMBER> <NUMBER> covid<NUMBER> ards patients sars patients typical ards pathology lung <NUMBER> believe sarscov<NUMBER> sarscov may share similar pathogenesis pathological manifestations f g u r e <NUMBER> classical counterregulatory ras ace angiotensinconverting enzyme ace<NUMBER> angiotensinconverting enzyme <NUMBER> ang <NUMBER> angiotensin <NUMBER> ang angiotensin ang ii angiotensin ii ang iii angiotensin iii at<NUMBER>r type <NUMBER> angiotensin ii receptor masr mas protooncogene receptor ras reninangiotensin system <NUMBER> risk factors covid<NUMBER> prognosis ace<NUMBER> early outbreak covid<NUMBER> epidemiological analyses <NUMBER> patients <NUMBER> <NUMBER> patients <NUMBER> showed average age patients close <NUMBER> years incidence infections men higher infections women nearly half cases complicated chronic underlying diseases hypertension diabetes cardiovascular disease etc <NUMBER> studies shown protective mechanism ace<NUMBER> hypertension likely achieved degradation ang ii <NUMBER> studies ferrario et al <NUMBER> others showed ace<NUMBER> levels increased <NUMBER> <NUMBER> times blood pressure decreased applying aceis lisinopril arbs losartan rats ace<NUMBER> affects development hypertension also potentially affects response treatment rasblocked spontaneously hypertensive rats inhibition vascular effects ang <NUMBER> may reduce antihypertensive response drugs <NUMBER> animal experiments found ang <NUMBER> infusion treatment significantly improve vascular endothelial function inhibit atherosclerotic lesion development ang <NUMBER> transgenic apolipoprotein e knockout apoe ko mice receiving atherogenic highfat diets <NUMBER> studies thomas et al <NUMBER> provided direct evidence occurrence development ace<NUMBER> atherosclerotic plaques also found ras blockade could prevent atherosclerosis apoeace<NUMBER> double knockout mice study provided basis acei combined ace<NUMBER> treatment reduce atherosclerosis ace<NUMBER> also antagonize cardiac fibrosis ventricular remodeling caused longterm effects ang ii wysocki et al <NUMBER> kassiri et al <NUMBER> others provided strong evidence direct roles ace<NUMBER> ang <NUMBER> ventricular remodeling expression regulation diabetic nephropathy downregulation renal tubular ace<NUMBER> associated proteinuria tubular damage <NUMBER> inhibition ace<NUMBER> aggravates renal damage <NUMBER> rhace<NUMBER> reduce blood pressure reducing renal damage <NUMBER> ace<NUMBER> provides pathway sarscov<NUMBER> invade body increases chance viral infection however aceis directly affect ace<NUMBER> activity use aceis instead increase ace<NUMBER> activity shown animal experiments mixeduse enhances cardiovascular protection therefore consider appropriate patients covid<NUMBER> discontinue longterm ras blockers <NUMBER> <NUMBER> determine whether aceiarb drugs used patients lack traditional indications prospective controlled studies needed provide evidence covid<NUMBER> prognosis related age sex expression ace<NUMBER> decreases increasing age ace<NUMBER> expression higher young people elderly individuals higher females males <NUMBER> <NUMBER> pattern match characteristic severely ill covid<NUMBER> patients mostly elderly males believe whether level ace<NUMBER> expression high low key factor affecting prognosis patients covid<NUMBER> relationship sex prognosis requires additional data verify prognosis severely ill patients covid<NUMBER> may related decrease ace<NUMBER> activity elderly patients chronic underlying diseases sarscov<NUMBER> infection reduces ace<NUMBER> activity receptor consumption exacerbating pathophysiological mechanisms ang iiace<NUMBER> regulation imbalance showed figure <NUMBER> several potential approaches address ace<NUMBER>mediated covid<NUMBER> spike proteinbased vaccine rely fact ace<NUMBER> covid<NUMBER> receptor inhibition transmembrane protease activity essential entry interaction ace<NUMBER> receptor blocking ace<NUMBER> receptor delivering soluble form ace<NUMBER> many studies conducted explore therapeutic potential ace<NUMBER> likely clinically significant potential cardioprotective effect rhace<NUMBER> proven enhance vascular protective effect patients using acei arb drugs <NUMBER> <NUMBER> fortyfour patients <NUMBER> ards well tolerated using rhace<NUMBER> likely represent first clinical application field ards ace<NUMBER> essential part ras extensive vascular organ protection functions hypertension diabetes cardiovascular disease ards similar sarscov sarscov<NUMBER> also invades human body ace<NUMBER> according existing research men <NUMBER> years old chronic underlying diseases hypertension diabetes cardiovascular disease etc secondary ards carry risk factors affecting prognosis covid<NUMBER> currently effective drug treatment covid<NUMBER> speculate ace<NUMBER> spike proteinbased vaccine rhace<NUMBER> may become one promising approaches future treatment improve prognosis patients covid<NUMBER> study supported national natural science foundation china <NUMBER> yw <NUMBER>th fiveyear national science technology major project <NUMBER>zx<NUMBER> yw <NUMBER>zx<NUMBER> gqw novel coronavirus covid<NUMBER> outbreak first reported <NUMBER> december <NUMBER> hubei province china designated pandemic world health organization <NUMBER> march <NUMBER> disease recognized infection new betacoronavirus dr zhang jixian hubei provincial hospital integrated chinese western medicine spreading exponentially almost countries around world epicentre shifted china europe februarymarch <NUMBER> usa marchapril <NUMBER> current data presenting information international case numbers case fatality provided johns hopkins university jhu coronavirus resource center httpswwwarcgiscomappsopsdash boardindexhtmlbda<NUMBER>fd<NUMBER>b<NUMBER>e<NUMBER>ecf<NUMBER> <NUMBER> <NUMBER> several webbased resources provide informative graphics spread disease outcomes pandemic covid<NUMBER> multiple medical psychological socioeconomic consequences covid<NUMBER> represents probably greatest threat societies face <NUMBER>st century therefore understanding pathophysiology clinical implications development novel preventive therapeutic strategies primary importance based reviewing available data public databases risk infection mortality increases advancing age shows sexual dimorphism male elderly individuals highest risk infection well death despite tropism lungs causes interstitial pneumonitis severe cases multiorgan failure develops cardiovascular cv system appears complex interactions covid <NUMBER> published reports medrxiv biorxiv personal communications experience coauthors detail evidence myocardial injury <NUMBER> hospitalized cases manifesting cardiac chest pain fulminant heart failure cardiac arrhythmias cardiac death indeed symptoms cardiac chest pain palpitations presenting features patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> covid<NUMBER> nondiscriminatory involving healthy persons comorbid conditions approximately half admitted hospitals huabei province covid<NUMBER> known comorbidities number patients comorbid conditions increased twothirds requiring intensive care unit icu admission survive patients preexisting cv conditions hypertension particular highest morbidity <NUMBER> following infection <NUMBER> <NUMBER> noncv comorbidities including diabetes lung diseases obesity latter identified current italian dutch cohorts also major predictors poor clinical outcomes similarly recent analysis <NUMBER> patients hospitalized covid<NUMBER> new york city area common comorbidities hypertension <NUMBER> obesity <NUMBER> diabetes <NUMBER> <NUMBER> aspects emphasize importance need multidisciplinary assessment treatment including cv evaluation therapy course covid<NUMBER> reduce mortality rapid review summarize stateoftheart knowledge available currently regarding covid<NUMBER> focusing key mechanistic clinical aspects coronaviruses singlestranded positivesense rna viruses <NUMBER> <NUMBER> kb length within family coronaviridae four genera subfamily orthocoronavirinae namely alpha beta gamma deltacoronaviruses alphaand betacoronaviruses infect mammals gammaand deltacoronaviruses infect birds seven coronaviruses infect humans alphacoronaviruses hcovnl<NUMBER> <NUMBER>e tend cause mild illness adults betacoronaviruses middle east respiratory syndrome mers virus severe acute respiratory syndrome sars virus cause severe respiratory illness oc<NUMBER> hku<NUMBER> associated mild illness example electron microscopy image betacoronavirus shown figure <NUMBER> covid<NUMBER> caused novel betacoronavirus probably originating bats following gainoffunction mutations within receptorbinding domain rbd acquisition furinprotease cleavage site named severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> <NUMBER> coronavirus receptor binding occurs via spike protein encoded structural gene two subunits subunit s<NUMBER> mediates binding trimeric s<NUMBER> stalk mediates fusion infected cell s<NUMBER> subunit divided two domains nterminal domain s<NUMBER>ntd cterminal domain s<NUMBER>ctd regions mediate binding variety cellular receptors containing carbohydrate protein binding domains sarscov sarscov<NUMBER> alphacoronavirus hcovnl<NUMBER> bind via s<NUMBER>ctd angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor figure <NUMBER> <NUMBER> sarscov<NUMBER> higher affinity binding ace<NUMBER> sarscov binding involves larger number interaction sites <NUMBER> <NUMBER> prerequisite binding sarscov<NUMBER> ace<NUMBER> cleavage protein virus transmembrane serine protease tmprss<NUMBER> <NUMBER> figure <NUMBER> replication occurs via rnadependent rna polymerase involves discontinuous transcription subgenomic mrnas encode six major open reading frames common coronaviruses multiple accessory proteins importantly sarscov<NUMBER> transmission occurs higher basic reproduction rate r <NUMBER> <NUMBER> <NUMBER> sarscov caused outbreak severe respiratory infection <NUMBER> influenza <NUMBER> associated higher viral loads infected people billion rna copies per milliltre sputum longterm resistance contaminated surfaces sarscov<NUMBER> stable plastic stainless steel copper cardboard viable virus may detected <NUMBER> h application surfaces <NUMBER> patients severe covid<NUMBER> tend high viral load long virusshedding period finding suggests viral load sarscov<NUMBER> might useful marker assessing disease severity prognosis <NUMBER> time pronounced nucleic acid shedding sarscov<NUMBER> observed <NUMBER> days mild cases <NUMBER> better appreciate links cardiovascular disease cvd covid<NUMBER> important understand underlying pathobiology coronavirus infection sarscov<NUMBER> binds transmembrane ace<NUMBER> protein homologue ace enter type ii alveolar epithelial cells macrophages cell types <NUMBER> figure <NUMBER> process requires priming viral protein cellular serine protease tmprss<NUMBER> <NUMBER> thus infection sarscov<NUMBER> requires coexpression ace<NUMBER> tmprss<NUMBER> cell type proteolytic cleavage viral protein essential binding virus ace<NUMBER> exploitation ace<NUMBER> coronavirus important predicting potential pathology ace<NUMBER> particularly highly expressed pericytes addition type ii alveolar epithelial cells according singlecell human heart atlas <NUMBER> high expression ace<NUMBER> pericytes could lead development microvascular dysfunction <NUMBER> explaining greater propensity acute coronary syndromes acs <NUMBER> moreover ace<NUMBER> expression upregulated failing human hearts suggesting plausible explanation higher infectivity virus higher mortality patients heart failure <NUMBER> moreover cellular entry coronaviruses ace<NUMBER> implications vascular instability hypotension well increased mortality infected patients preexisting hypertension albeit latter association confounded older age patients comorbidities addition pathogenicity transmissibility virus findings also therapeutic implications inhibition cellular serine protease tmprss<NUMBER> sera containing blocking antibodies ace<NUMBER> potential block viral entry hence prevent attenuate covid<NUMBER> figure <NUMBER> murine model tmprss<NUMBER> inhibition blocked viral entry attenuated severity coronavirus infection improved survival <NUMBER> <NUMBER> two clinical trials started test efficacy inhibition tmprss<NUMBER> camostat mesilate treatment patients covid<NUMBER> nct<NUMBER> nct<NUMBER> understanding covid<NUMBER> pathomechanisms natural clinical history possible therapies evolving continuously review collated contemporary literature regarding pandemic enable comprehensive overview numerous methodological considerations need taken account regarding study design data collection sources used generate review original articles published pubmed posted medrxiv biorxiv chinaxiv listed clinical trial databases clinicaltrialgov eudract addition public databases world health organization centers disease control crcs jhu coronavirus resource center utilized early studies pandemic might suffer inclusion bias baseline demographics premorbid status study populations expected reflect characteristics individuals exposed disease early outbreak addition availability access upon viral spike protein priming transmembrane protease serine <NUMBER> tmprss<NUMBER> sarscov<NUMBER> uses host angiotensinconverting enzyme <NUMBER> ace<NUMBER> enter infect cell inhibiting tmprss<NUMBER> activity camostat mesylate could used prevent proteolytic cleavage sarscov<NUMBER> spike protein protect cell viruscell fusion <NUMBER> another approach could neutralizing virus entering cells keeping solution activation disintegrin metalloprotease <NUMBER> adma<NUMBER> leads shedding membranebound ace<NUMBER> release soluble extracellular domain ace<NUMBER> <NUMBER> treatment antiace<NUMBER> antibodies leading blockage interaction virus receptors <NUMBER> administration soluble recombinant human ace<NUMBER> protein acting competitive interceptor sarscov<NUMBER> <NUMBER> alternatively purified polyclonal antibodies targetingneutralizing viral spike protein may offer protection sarscov<NUMBER> <NUMBER> interestingly angiotensin receptor blockers arbs angiotensinconverting enzyme inhibitors aceis frequently used treat hypertension could alter ace<NUMBER> expression intensify sarscov<NUMBER> infection diagnostic testing well high threshold diagnostic testing hospital treatment suitability icu admission finite resources expected affect characteristics study populations clinical outcomes disease example large number healthcare workers inpatients exposed covid<NUMBER> hospital early rather later phase pandemic china <NUMBER> demographics patients early studies china different reported later largest aggregate study covid<NUMBER> patients guan et al china <NUMBER> table <NUMBER> data cardiac involvement unfortunately extensively presented study guan et al <NUMBER> national health commission peoples republic china prc guidance <NUMBER> recommends use traditional chinese medicine alongside considered conventional interventions published reports provide details traditional treatment regimens patients covid<NUMBER> therefore different choices therapy made positivenegative impacts interventions may influenced outcomes might introduced additional bias finally also difficult assess true prevalence occurrence mortality spectrum clinical course disease since proportion inoculated individuals might asymptomatic therefore never tested silico modelling infection expansion well initial reports iceland italy suggest asymptomatic group perhaps high <NUMBER> infected individuals decode genetics iceland probably exists finding considerable implications estimating prevalence preventing spread disease likewise reports show <NUMBER> infected individuals mild symptoms theory represent group might seek medical carethey might therefore tested contribute prevalence case fatality rate cfr estimates secondly practically countries experience shortage testing kits therefore limiting testing selected groups individuals moreover deaths caused sarscov<NUMBER> attributed covid<NUMBER> due lag time severe complications tend develop even <NUMBER> weeks following initial infection <NUMBER> incubation period contact first set symptoms typically <NUMBER> days <NUMBER> days individual cases <NUMBER> median time registered exposure first symptoms <NUMBER> days mean <NUMBER> days <NUMBER> duration viral nucleic acid shedding ranges <NUMBER> <NUMBER> days median <NUMBER> days initial symptoms figure <NUMBER> main clinical symptoms develop within <NUMBER> days <NUMBER> confidence interval ci <NUMBER> <NUMBER> days include fever dry cough fatigue ageusia anosmia headache <NUMBER> nonspecific symptoms also reported included nasal congestion rhinorrhea sore throat myalgia poor appetite diarrhoea <NUMBER> fever cough typically appear concomitantly followed shortness breath severe fatigue appear around day <NUMBER> <NUMBER> associated development severe bilateral occasional unilateral pneumonia figure <NUMBER> common radiological findings include multiple patchy shadows interstitial changes moderate disease consolidation ground glass appearance <NUMBER> <NUMBER> cases <NUMBER> occasional pleural effusions severe cases <NUMBER> severe cases pneumomediastinum pneumothorax described <NUMBER> <NUMBER> pathological investigations lungs deceased individuals indicate blockade bronchi bronchioles large amounts mucus plugs bronchial epithelial cell damage <NUMBER> lymphocyte mononuclear cell infiltrates present alveolar septal spaces fibrinous exudate high hyaline membranes fill alveolar cavities polynuclear giant cells prominent marked proliferation type ii alveolar epithelial cells severe manifestations appear fraction patients recent study covid<NUMBER> cases china reported <NUMBER> january <NUMBER> indicated severe illness may occur <NUMBER> cases <NUMBER> leading overall mortality rate estimated <NUMBER> total reported cases <NUMBER> <NUMBER> reports accessed <NUMBER> march <NUMBER> geographical regions due unexplained reasons mortality may higher current estimates <NUMBER> italy <NUMBER> spain <NUMBER> uk according jhu coronavirus resource center accessed <NUMBER> april <NUMBER> <NUMBER> important note however great care must taken calculating fatality rates based currently available data overestimated relation insufficient testing community underestimated due long lagtime test positivity death fact large differences attributing covidrelated mortality dying versus dying well differences performing postmortem testing limitations healthcare systems abruptly overwhelmed surge patients needing mechanical invasive ventilation also considered potential source differences finally differences may result population structure italian patients older average age reported chinese patients typical clinical course disease summarized figure <NUMBER> heterogeneity responses individual patients striking indicates unlikely covid<NUMBER> considered point view single disease phenotype rather seems likely host characteristics moment remain unknown promote progression disease range different presentarions eg mild severe multiorgan failure cytokine release storm clinical symptoms disease predominantly respiratory associated severe pneumonia direct indirect involvement organs common cv system particularly affected moreover preexisting conditions largely linked cvd increase risk severe outcomes infection number key comorbidities associated worse clinical outcomes patients covid<NUMBER> table <NUMBER> association age seems dominate relationship <NUMBER> may affect actual importance factors reported univariate analyses older patients mean age <NUMBER> years old range <NUMBER> likely experience composite endpoint icu admission mechanical ventilation death compared younger patients mean age <NUMBER> years old range <NUMBER> <NUMBER> table <NUMBER> males seem susceptible covid<NUMBER>related complications representing <NUMBER> <NUMBER> hospitalized patients four publications report data table <NUMBER> recent report italy <NUMBER> table <NUMBER> summarizes key comorbidities identified major studies china showing presence preexisting morbidities increases severity hospitaltreated covid <NUMBER> notably large heterogeneity reporting studies comparing death survival others comparing icu nonicu cases table <NUMBER> however regardless approach preexisting cv conditions seem particularly important predictors covid<NUMBER> severity <NUMBER> investigators found fatality rate patients comorbidities <NUMBER> whereas cfr much higher patients comorbidities included mortality <NUMBER> patients cvd <NUMBER> diabetes <NUMBER> subjects hypertension <NUMBER> <NUMBER> chronic respiratory disease <NUMBER> cancer <NUMBER> <NUMBER> <NUMBER> high <NUMBER> <NUMBER> patients <NUMBER> years age <NUMBER> <NUMBER> interesting italian dutch cohorts reports higher severity younger obese individuals well severe cases accounted <NUMBER> <NUMBER> critical cases accounted <NUMBER> cases significance cvd occurrence affects mortality rate larger extent presence preexisting chronic obstructive pulmonary disease copd case sars <NUMBER> observations confirmed recent metaanalysis based largely studies additional <NUMBER> <NUMBER> patient data set reported china cdc <NUMBER> large cohort cvd reported <NUMBER> total population <NUMBER> <NUMBER> died <NUMBER> extension expected comorbidities associated higher rates hospitalization patients covid<NUMBER> effects comorbidities may susceptibility infection remain conjectural accordingly published frequencies comorbidities china included table <NUMBER> surprisingly history smoking chronic pulmonary disease appear far less powerful determinants severity hospitalized patients history cvd curiously prevalence smoking hospitalized covid<NUMBER> patients appears far lower might expected assumed population prevalence primary respiratory infection clear hypertension risk factor susceptibility sarscov<NUMBER> infectionthe available data show prevalence rates <NUMBER> largely line rates high blood pressure general population <NUMBER> <NUMBER> <NUMBER> first glance hypertension prevalent subjects severe course disease recent analysis china <NUMBER> present <NUMBER> subjects nonsevere disease <NUMBER> <NUMBER> subjects severe disease study also included composite outcome also associated higher prevalence hypertension poor composite outcome <NUMBER> vs <NUMBER> <NUMBER> cohort <NUMBER> <NUMBER> patients reported china cdc <NUMBER> hypertension prevalence reported <NUMBER> whole group patients <NUMBER> patients eventually died <NUMBER> analysed context recent european data appeared submission paper <NUMBER> guan et al present data based disease severity time assessment using american thoracic society guidelines communityacquired pneumonia according composite endpoint status ep icu admission ventilation death  reported increase odds ratio death <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> patients covid <NUMBER> associations may however largely confounded higher prevalence hypertension older people older individuals significantly worse outcomes severe course disease higher mortality rate younger patients <NUMBER> thus summary hypertension appear associated severe disease higher risk acute respiratory distress syndrome ards increased mortality unadjusted analyses strong evidence indicate increased susceptibility patients hypertension covid<NUMBER> association adjusted risk factors <NUMBER> mechanisms possible relationship clinical relevance reviewed recent statement european society hypertension <NUMBER> putative relationship figure <NUMBER> key symptoms biochemical radiological features clinical course covid <NUMBER> hypertension covid<NUMBER> may relate role ace<NUMBER> ace<NUMBER> key element reninangiotensinaldosterone system raas critically involved pathophysiology hypertension <NUMBER> experimental studies demonstrated inhibition raas ace inhibitors aceis angiotensin ii receptor blockers arbs may result compensatory increase tissue levels ace<NUMBER> <NUMBER> leading suggestions drugs may detrimental patients exposed sarscov<NUMBER> <NUMBER> important however emphasize clear evidence aceis arbs lead upregulation ace<NUMBER> human tissues <NUMBER> thus currently justification stopping aceis arbs patients risk covid <NUMBER> <NUMBER> endorsed officially many learned societies including european society hypertension international society hypertension european society cardiology <NUMBER> also appears experimental models raas blockers may exert potentially protective influence <NUMBER> indeed angiotensin ii promoted internalization intracellular degradation ace<NUMBER> losartan reduced effect suggesting arbs may offer protection viral entry cells <NUMBER> recent integrative antiviral drug repurposing analysis implicated another arbirbesartanas potential repurposable medication covid <NUMBER> <NUMBER> fact known effect arbs potassium metabolism may seen clinically advantageous patients infected covid<NUMBER> given hypokalaemia reported fairly common manifestation covid<NUMBER> possibly increased kaliuresis rather gastrointestinal loss <NUMBER> hypokalaemia covid<NUMBER> patients difficult manage correlates severity disease suggested driven activation raas <NUMBER> aceis arbs might offer protection setting also needs emphasized hypokalaemia reported studies example patient characterization guan et al <NUMBER> median value potassium level reported <NUMBER> mmoll lower margin interquartile range iqr <NUMBER> mmoll nevertheless antihypertensive medications known increase serum levels potassium including carvedilol eplerenone implicated potential drug repurposing opportunities patients covid<NUMBER> infection <NUMBER> moreover observations icus italy suggest hypocalcaemia common metabolic abnormality patients infected covid<NUMBER> could linked due reduced albumin levels commonly seen andor ca <NUMBER>þ consumption excessive activation coagulation cascade another mechanism linking hypertension covid<NUMBER> immune system dysregulated hypertension sarscov<NUMBER> infection <NUMBER> <NUMBER> poor control blood pressure may contribute dysregulation immune system example shown hypertension humans associated circulating lymphocyte counts <NUMBER> cd<NUMBER>þ cell dysfunction observed patients hypertension <NUMBER> immunosenescent cd<NUMBER>þ cells unable efficiently combat viral infections contribute pathological overproduction cytokinesa situation providing possible link covid<NUMBER> one may also postulate aceis arbs providing better control blood pressure may restore least partially dysregulated immune system hypertension overall essential ensure blood pressure control hypertensive patients viral infections optimized unnecessary uncontrolled changes therapy discouraged hypertensive patients carefully monitored cv complications covid<NUMBER> infection severe covid<NUMBER> associated rapidly progressing systemic inflammation proinflammatory cytokine storm sepsis leading multiorgan failure death figure <NUMBER> selected evidence manifestations cv injury covid<NUMBER> patients summarized table <NUMBER> importantly delay initiation symptoms myocardial damage studies reported far table <NUMBER> viral infections associated metabolic dysfunction myocardial inflammation activation sympathetic nervous system predispose cardiac arrhythmia recent report <NUMBER> hospitalized covid<NUMBER> patients <NUMBER> <NUMBER> <NUMBER> patients developed arrhythmias ranked second among serious complications ards arrhythmia observed <NUMBER> patients require icu treatment <NUMBER> subjects admitted icu <NUMBER> details manifestations remain elusive included atrial fibrillation conduction block ventricular tachycardia ventricular fibrillation arrhythmias also observed viral myocarditis interestingly report national health commission china estimates initial outbreak patients reported primarily cv symptoms palpitations chest tightness rather respiratory symptoms <NUMBER> reports indicate almost hospitalized covid<NUMBER> patients show elevated serum creatine kinase ck lactate dehydrogenase ldh levels <NUMBER> <NUMBER> <NUMBER> addition number studies indicate cardiac complications including fulminant myocarditis potential outcomes sarscov<NUMBER> infection heart failure reported outcome <NUMBER> covid subjects recent report inhospital chinese subjects approximately <NUMBER> nonsurvivors heart failure compared <NUMBER> survivors <NUMBER> evidence myocardial injury increase highsensitivity cardiac troponin ctni levels <NUMBER> pgml detected <NUMBER> first <NUMBER> patients diagnosed covid<NUMBER> enter host cells including type <NUMBER> pneumocytes macrophages endothelial cells pericytes cardiac myocytes leading inflammation multiorgan failure particular infection endothelial cells pericytes could lead severe microvascular macrovascular dysfunction furthermore conjunction immune overreactivity potentially destabilize atherosclerotic plaques explain development acute coronary syndromes infection respiratory tract particularly type <NUMBER> pneumocytes sarscov<NUMBER> manifested progression systemic inflammation immune cell overactivation leading cytokine storm results elevated level cytokines il<NUMBER> il<NUMBER> il<NUMBER> cxcl<NUMBER> subsequently possible activated cells macrophages may infiltrate infected myocardium resulting development fulminant myocarditis severe cardiac damage process could intensified cytokine storm similarly viral invasion could cause cardiac myocyte damage directly leading myocardial dysfunction contribute development arrhythmia wuhan <NUMBER> <NUMBER> <NUMBER> recent reports indicate <NUMBER> <NUMBER> <NUMBER> <NUMBER> hospitalized covid<NUMBER> patients sustain acute myocardial injury may form acute myocarditis see injury secondary oxygen supplydemand mismatch type <NUMBER> myocardial infarction mi analysis <NUMBER> fatal cases wuhan <NUMBER> patients <NUMBER> died respiratory failure <NUMBER> <NUMBER> patients myocardial damage died circulatory failure <NUMBER> patients <NUMBER> died <NUMBER> similarly analysis <NUMBER> covid<NUMBER> patients reported elevated levels nterminal pro btype natriuretic peptide ntprobnp <NUMBER> cases ctni <NUMBER> deceased patients respectively indicating effects cv injury systemic stability may important ignored another report <NUMBER> inpatients covid<NUMBER> wuhan levels biomarkers myocardial injury significantly higher patients treated icu compared requiring icu care median ckmb level <NUMBER> ul vs <NUMBER> ul p <NUMBER> hsctni level <NUMBER> <NUMBER> pgml vs <NUMBER> <NUMBER> pgml p <NUMBER> <NUMBER> study <NUMBER> patients <NUMBER> ctni levels strongly associated increased mortality univariate analysis association tested multivariate model similar associations ctni elevation disease severity shown analysing cohorts basis need icu care <NUMBER> <NUMBER> thus patient monitoring include number laboratory tests summarized table <NUMBER> based current experience studies mechanisms underlying myocardial injury remain unknown unclear whether reflect systemiclocal andor ischaemicinflammatory process still known whether acute injury primary infective phenomenon secondary lung disease associations ctni elevation preexisting cv conditions precovid features yet examined detect evidence causality detailed analyses patients cv complications covid <NUMBER> published date elevated ctni level associated poorer outcomes noncovid systemic illnesses <NUMBER> reported association could simply reflect severity systemic illness eg hypoxia hypotension rather indicating specific cardiac pathology context cytokine storm triggered immunological dysregulation <NUMBER> may key mediator plasma interleukin<NUMBER> il<NUMBER> concentrations elevated covid<NUMBER> patients cardiac injury <NUMBER> abnormalities variety cytokines prominent patients severe covid<NUMBER> disease cardiacspecific mechanisms may also important since ace<NUMBER> expressed cv system <NUMBER> direct cardiomyocyte infection sarscov<NUMBER> may possibility discussed moreover therapies used treatment severe multiorgan dysfunction covid<NUMBER> patients well antiviral drugs may result cardiac toxicity attempts treat covid<NUMBER> cardiac injury included use steroids iv immunoglobins hydroxychloroquine antivirals active mechanical life support <NUMBER> remains uncertain therapies successfully limit myocardial injury detection cardiac damage hospitalized covid<NUMBER> patients may help identify subset patients greater risk covid<NUMBER> complications cardiac injury acute myocarditis wellrecognized complications acute viral infections myocyte necrosis mononuclear cell infiltrates reported cardiac muscle autopsy specimens recent report national health commission prc <NUMBER> finding along case reports <NUMBER> fulminant myocarditis suggests myocarditis may important cause acute cardiac injury covid<NUMBER> patients however prevalence clinical importance mechanisms myocardial inflammation covid<NUMBER> disease remain unclear <NUMBER> <NUMBER> clinically covid<NUMBER> myocarditis may manifest mild chest discomfort palpitations may impossible distinguish causes patients however myocarditis results fulminant disease figure <NUMBER> transient ecg changes common may help detect presence severity myocardial injury myocarditis may progress conduction block tachyarrhythmias impairment left ventricular function clinical settings myocarditis often suspected cardiac injury detected absence acs diagnosis often confirmed cardiac magnetic resonance imaging mri detects typical acute myocardial injury signals <NUMBER> endomyocardial biopsy emb long considered gold standard diagnostic test directly demonstrate myocyte necrosis mononuclear cell infiltrates <NUMBER> emb detect evidence viral cause cases though others immunologically autoimmunemediated cause myocarditis suspected <NUMBER> biopsy studies patients acute myocarditis europe indicate viral aetiology ranges <NUMBER> <NUMBER> <NUMBER> <NUMBER> covid<NUMBER> evidence moment sparse based individual case series emphasizing need systematic assessment several reports emphasize fulminant myocarditis may important clinical presentation disease <NUMBER> real prevalence complication remains unclear cardiac mri embs diagnostic tools likely inappropriate current covid<NUMBER> pandemic associated healthcare crisis considered future table <NUMBER> animal models viral myocarditis suggest discrete pathological phases begin viralmediated myocyte lysis <NUMBER> cardiac injury leads activation innate immune response release proinflammatory cytokines <NUMBER> proteins released cell lysis might display epitopes similar viral antigens presented via major histocompatibility complex mhc myosin heavy chain cardiac sarcomere protein appears prime example molecular mimicry <NUMBER> stage embs may show inflammatory changes detectable viral particles clearance virus innate immune response acquired immune response predominant feature evidenced activation antibodies lymphocytes cd<NUMBER>þ helper th cells cytotoxic cd<NUMBER>þ cells mediate responses ntpro bnpbnp conflicting data ntprobnp merscov cohort ntprobnp increased may normal covid<NUMBER>affected patients higher ntprobnp levels chinese cohort associated greater need icu care troponin highsensitivity troponin assay may helpful risk assessment patients requiring icu care identify individuals silent myocardial injury reports initial outbreak wuhan show key relationship requirement icu care mortality procalcitonin marker bacterial infection likely raised patients require icu care low platelets associated adverse outcome il<NUMBER> available high concentrations associated adverse outcome marker poor outcome significant changes reported covid<NUMBER> patients cardiac ct considered uncertain cases patients elevated troponins without signs obstructive coronary artery disease eacvi position <NUMBER> merscov <NUMBER>lead ecg generally shows diffuse wave inversion myocardial involvement dynamic changes covid<NUMBER> also described may show global regional myocardial systolic dysfunction without pericardial effusion vice versa <NUMBER> final stage either recovery low levels chronic inflammation concomitant development left ventricular dysfunction <NUMBER> interestingly myocarditis appears covid<NUMBER> patients prolonged period <NUMBER> days onset symptoms table <NUMBER> moreover investigators china point lack viral particle identification emb personal communication given observations experimental context question central potential therapeutic options extent myocardial injury results viral replication cytopathic immune mediated due mechanisms given acute myocardial injury said begin <NUMBER> weeks onset symptomatic covid<NUMBER> <NUMBER> adaptive tcellmediated immunity dysregulated innate effector pathways likely play pivotal development myocardial inflammation context notable increase highly proinflammatory ccr<NUMBER>þ th<NUMBER> cd<NUMBER>þ cells prominent inflammatory mediators myocarditis <NUMBER> reported severe cases together data suggest delay myocardial inflammation consistent least two pathogenic mechanisms first cytokine storm unleashes subclinical autoimmune myocarditis secondly myocardial damage andor molecular mimicry initiate de novo autoimmune reaction targeted therapeutic options remain elusive case myocarditis settings management strategy uses broad range supportive therapies remains key case report recently described effectiveness early application steroids iv immunoglobins neuraminidase inhibitors active mechanical life support <NUMBER> little known regarding effects covid<NUMBER> acs several pathways associated viral diseases may contribute destabilize plaques covid<NUMBER> patients <NUMBER> heart failure patients increased risk acute events exacerbation viral illness potentially destabilize atherosclerotic plaques systemic inflammatory responses <NUMBER> cytokine storm well specific changes immune cell polarization towards unstable phenotypes observed covid <NUMBER> case sars mers acute mi <NUMBER> reported two five deaths early reports <NUMBER> important consider type <NUMBER> mi common subtype viral conditions thus usefulness invasive management view toward coronary revascularization especially type <NUMBER> mi limited decision invasive vs noninvasive management patients acs covid<NUMBER> illness carefully considered moreover recent singlecell atlas human heart indicated pericytes express particularly high levels ace<NUMBER> heart <NUMBER> one implications finding possible local microvascular inflammation sarscov<NUMBER> infection pericytes leading severe microvascular dysfunction contributing myocardial infarction nonobstructive coronary arteries minoca could explain recent reports clinical course cases mi covid <NUMBER> addition cytokine storm contribute development endothelial dysfunction wellcharacterized mechanisms <NUMBER> <NUMBER> <NUMBER> <NUMBER> features disseminated intravascular coagulation dic pulmonary embolism characterized increased ddimer levels fibrin degradation products highly prevalent covid <NUMBER> dic observed <NUMBER> <NUMBER> nonsurvivors <NUMBER> massive pulmonary embolism reported <NUMBER> might surprising given critical condition subjects although early appearance dic features often evident notably experience china indicates ddimer increase highly predictive adverse outcomes covid <NUMBER> retrospective cohort study elevated ddimer levels <NUMBER> gl strongly associated inhospital mortality relationship maintained multivariate analysis <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p <NUMBER> <NUMBER> moreover chinese italian experience emphasizes discrete changes ddimer levels observed earlier course disease preceding rapid progression stage lungs immune organs second affected system covid <NUMBER> pathological investigations covid<NUMBER> victims <NUMBER> demonstrated splenic atrophy significant reduction number lymphocytes neutrophils well necrosis haemorrhages similarly lymphocytes depleted lymph nodes numbers cd<NUMBER>þ cd<NUMBER>þ cells decreased <NUMBER> corresponds lymphopenia peripheral blood observed severe cases interestingly increase systemic il<NUMBER> il<NUMBER> il<NUMBER> granulocyte colonystimulating factor cxc motif chemokine <NUMBER> cxcl<NUMBER> chemokine cc motif ligand <NUMBER> ccl<NUMBER> tumour necrosis factora tnfa observed subjects covid<NUMBER> <NUMBER> corresponds characteristics cytokine release syndrome crs <NUMBER> <NUMBER> <NUMBER> crs development covid<NUMBER> associated covid<NUMBER> severity crs characterized complication immune targeted therapies oncology particular relation severe chimeric antigen receptor car tcellinduced crs <NUMBER> also reminiscent cytokine profile noted haemophagocytic lymphohistiocytosis hlh syndromes <NUMBER> resemblance latter brought considerations covid<NUMBER> may cause secondary hlh cytopenias significant haemophagocytosis bone marrow low fibrinogen concentration clinical classifications introduced aid recognition secondary hhl <NUMBER> fluorescenceactivated cell sorting facs analyses covid<NUMBER> active cases also shown hyperactivated lymphocytes large fractions hladrþ cd<NUMBER>þ cd<NUMBER>þcd<NUMBER>þ cells ccr<NUMBER>þ th<NUMBER> cd<NUMBER>þ cells high concentrations cytotoxic granules cytotoxic cd<NUMBER> cells observed thus uncontrolled overactivation cells may account part severe immune injury <NUMBER> similarly atherosclerosis cv conditions <NUMBER> <NUMBER> aspects also considered light sexual dimorphism related susceptibility cv inflammation <NUMBER> <NUMBER> <NUMBER> high serum il<NUMBER> levels common feature crs patients indeed recent retrospective multicentre analysis <NUMBER> patients wuhan circulating il<NUMBER> levels clinical predictor mortality covid <NUMBER> <NUMBER> il<NUMBER> important biomarker possible target cv morbidity mortality linked atherosclerosis <NUMBER> <NUMBER> <NUMBER> important therapeutic targeting il<NUMBER> receptor il<NUMBER>r tocilizumab used preventing treating crs caused cancer therapies hlh <NUMBER> tocilizumab approved <NUMBER> countries treatment rheumatoid arthritis ra juvenile idiopathic arthritis jia <NUMBER> castlemans diseases giant cell takayasu arteritis <NUMBER> il<NUMBER>rtargeting agents eg sarilumab similarly potentially use therefore possible use covid<NUMBER> may attractive tackle crs however considering immunomodulation one bear mind primary problem infectious disease rather complications cancer therapy therefore potentially utility must carefully considered initial outbreak china use tocilizumab stop severe crsassociated organ failure death covid<NUMBER> patients attempted <NUMBER> twentyone severe covid<NUMBER> cases treated tocilizumab initial pilot trial nineteen discharged <NUMBER>lead ecg initial visit periodically needed serum highsensitivity troponin ntprobnp according index clinical suspicion echocardiography assess global regional wall motion abnormalities function cardiac rhythm monitoring cardiac mri clinically indicated cardiac autoantibody titres may helpful acute phase hospital within <NUMBER> weeks reported chinas national health commission drug approved china treat patients developing severe complications covid<NUMBER> showing elevated plasma levels il<NUMBER> <NUMBER> multicentre singlearm openlabel phase ii study assess mortality <NUMBER> month <NUMBER> patients affected covid<NUMBER> pneumonia inclusion criteria comprise patients showing signs respiratory distress syndrome subject tracheal intubation preceding <NUMBER> h study led instituto nazionale tumori irccs fondazione pascale naples similarly <NUMBER> participants enrolled marche region interventional clinical trial tocilizumab roactemra early treatment patients affected sarscov<NUMBER> infection severe multifocal interstitial pneumonia clinicaltrialsgov identifier nct<NUMBER> usa evaluation efficacy safety sarilumab hospitalized patients covid<NUMBER> clinicaltrialsgov identifier nct<NUMBER> started aiming recruit <NUMBER> patients shortly followed tocilizumab prevent clinical decompensation hospitalized noncritically ill patients covid<NUMBER> pneumonitis covidose clinicaltrialsgov identifier nct<NUMBER> trial expected start soon finally recently registered trial recruiting <NUMBER> patients study evaluate safety efficacy tocilizumab patients severe covid<NUMBER> pneumonia covacta clinicaltrialsgov identifier nct<NUMBER> <NUMBER> initiated similar trials registered france belgium denmark noted however currently published clinical trial data il<NUMBER> targeting safety efficacy virus moreover tocilizumab received approval chinas national medical product administration sold covid<NUMBER> treatment cytokine storm increase il<NUMBER> signalling observed covid<NUMBER> patients could profound cv consequences causing tachycardia hypotension left ventricular dysfunction crsrelated cardiotoxicity also reported mainly form conduction abnormalities atrial fibrillation elevation bnp ctnis <NUMBER> covid<NUMBER> patients mediumto longterm cv consequences may caused increased il<NUMBER> signalling experimental evidence supports atherogenic role il<NUMBER> crsrelated cytokines <NUMBER> well effects cardiac fibrosis failure <NUMBER> cytokine increases adhesion molecule expression human endothelial cells vitro <NUMBER> time stimulation human macrophages oxidized ldls oxldls leads increased release il<NUMBER> <NUMBER> experimental atherosclerosis il<NUMBER> mrna detectable aorta hyperlipidaemic mice <NUMBER> administration recombinant il<NUMBER> increased plaque formation <NUMBER> similarly reduced pathology observed ldlr mice treated fusion protein il<NUMBER> transsignalling inhibitor soluble glycoprotein <NUMBER> sgp<NUMBER> <NUMBER> plasma il<NUMBER> levels also associated development progression abdominal aortic aneurysm <NUMBER> il<NUMBER> shown influence lipid homeostasis mice <NUMBER> il<NUMBER> transsignalling contributes experimental cardiac fibrosis <NUMBER> upregulation membranebound il<NUMBER>r causes vascular remodelling pulmonary arterial hypertension <NUMBER> genetic variants leading increased circulating levels il<NUMBER>r therefore reduced il<NUMBER> cell signalling shown protect coronary heart disease chd <NUMBER> <NUMBER> similarly il<NUMBER> transsignalling associated increased cv risk <NUMBER> <NUMBER> il<NUMBER> routinely used inflammatory biomarker cv disease canakinumab antiinflammatory thrombosis outcomes study cantos trial demonstrated stronger effect il<NUMBER>b inhibition reducing secondary cv events patients higher circulating levels il<NUMBER> creactive protein crp indicative residual inflammatory risk <NUMBER> whether observed cytokine storm il<NUMBER> increase covid<NUMBER> patients transient sustained remains unknown accordingly monitoring inflammatory biomarkers patients medium long term major importance similarly cv risk closely evaluated acute phase response following years however likely range additional cytokine moieties emerge pathwayspecific contributions severe spectrum covid<NUMBER> syndrome include pathways driven granulocytemacrophage colonystimulating factor gmcsf tnfa il<NUMBER> il<NUMBER> ifnc moreover imminent prospect singlecell immunological analyses offer systematic insight immune dysregulation syndromes emerging especially disease trajectoryin essence pathways directing covidrelated crs simply adding inflammatory tissue damage burden upon comorbidities operating thus propose useful way thinking would inflammatory burden might considered direct effector ie crstype secondary amplificatory factor terms contribution pathways make pathogenesis clinical outcome <NUMBER> novel coronavirus sarscov emerged china crossing bats humans eventually leading <NUMBER> cases death <NUMBER> people sars utilized ace<NUMBER> cell attachment infection viral envelope spike protein <NUMBER> subsequent interaction cellular protease tmprss<NUMBER> primes protein cell entry <NUMBER> closely related sarscov<NUMBER> also thought originated bats <NUMBER> encodes protein <NUMBER> amino acid similarity sarscov importantly sarscov<NUMBER> already discussed also recently demonstrated use cellular entry pathway via ace<NUMBER> tmprss<NUMBER> <NUMBER> discussed novel coronaviruses different another recently emergent coronavirus mers virus crossed dromedary camel humans also caused acute respiratory failure although utilizing different cell entry mechanism via receptor dipeptidyl peptidase <NUMBER> dpp<NUMBER> <NUMBER> overall highlights potential divergence respiratory coronavirus infections humans emphasizes close relationship sarscov sarscov<NUMBER> learn knowledge sarscov associated cv risk help current battle covid<NUMBER> human sarscov infection murine lung ace<NUMBER> utilized subsequently almost completely lost protein level <NUMBER> importantly delivery viral protein alone also led downregulation ace<NUMBER> decreased lung function normal mice worsened lung pathology acid challenge model acute lung failure furthermore disease pathology reduced presence arb losartan intriguingly acute lung disease triggered acid respiration sepsis ace<NUMBER> also shown directly protective acting partnership angiotensin type <NUMBER> receptor <NUMBER> r administration recombinant ace<NUMBER> model protective <NUMBER> taking together evidence multiple experimental studies beneficial effects aceis arbs also ace<NUMBER> supplementation various animal models lung injury sars shown supported concept loss ace<NUMBER> expression promotes disease lung injury models reviewed kreutz et al <NUMBER> <NUMBER> ace<NUMBER> also directly regulated cytokines <NUMBER> decreased ace<NUMBER> levels could direct consequence viral infection andor subsequent inflammatory immune responses occur infected lung interestingly ace<NUMBER> also reported detectable macrophages <NUMBER> knockout leucocytes promotes adipose inflammation <NUMBER> highlighting role ace<NUMBER> inflammatory response patients suffering sars overwhelming immune inflammatory responses high mortality rates acute respiratory failure furthermore also associated cardiac sequelae example sars patients also suffer systolic diastolic dysfunction arrythmias leading sudden death <NUMBER> <NUMBER> murine models intranasal administration human sarscov results ace<NUMBER>mediated infection myocardium <NUMBER> observations support role sarscov direct myocardial infection possible causative role cardiac disease subsequent respiratory infection murine heart ace<NUMBER> also almost completely downregulated protein level following infection moreover autopsied cardiac tissue sars patients sarscovpositive lung infection viral rna detected heart combined decreased cardiac ace<NUMBER> protein levels elevated cardiac macrophage infiltration downregulation ace<NUMBER> without compensatory effects ace may lead raas tipped towards detrimental aceang iiat <NUMBER> r axis away protective ace<NUMBER>ang<NUMBER>mas axis ace<NUMBER> also upregulated mi rodents humans macrophages endothelial cells smooth muscle cells <NUMBER> <NUMBER> cardiomyocytes <NUMBER> may play role restoring raas homeostasis heart postmi fact viral vectormediated overexpression ace<NUMBER> rodents also protects heart adverse cardiac remodelling dysfunction postmi <NUMBER> overall findings highlight ace<NUMBER> key protective function lung heart therefore sarscov infectionmediated downregulation ace<NUMBER> direct mechanistic consequence viral infection andor result subsequent inflammatory responses may lead imbalance raas signalling consequent cv sequelae knowledge systemic spread sars primary lung infection cv tissues including heart also important given ace<NUMBER> functions receptor virus entry cell downregulation ace<NUMBER> upon infectioin sarscov expected prevent viral entry serving negative regulatory mechanism clearly additional investigations needed increase understanding pathological mechanisms acute disease potential increased cv risk covid<NUMBER> patients managing covid<NUMBER> challenging specific treatments sarscov<NUMBER> virus obtaining highquality randomized clinical trial data outbreak difficult research clinical efforts focus parallel development new drugs coronavirus well repurposing already approved drugs treatment disease clinicaltrialsgov site lists <NUMBER> studies testing various interventions covid<NUMBER> patients emphasis trials opposed compassionate use case reports major lesson previous pandemics good see community moving robustly direction meanwhile public health measures rely mostly social measures intended prevent viraldisease spread order avoid massive surge patients healthcare facilities overload supportive treatment patients considered mainstay management available treatments clinically evident classified supportive immunesuppressive antiretroviral potential novel therapies supportive treatment mainstay management coordinated relevant specialistmultidisciplinary team approaches provided numerous scientific clinical societies early stages european outbreak continuously updated includes concise comprehensive guidelines società italiana di anestesia analgesia rianimazione e terapia intensiva <NUMBER> disease progresses severe phenotype supportive treatment includes use oxygen therapy spo<NUMBER> <NUMBER> room air <NUMBER> well haemodynamic support early intubation invasive mechanical ventilation essential progressive symptoms increasing oxygen requirement high flow nasal cannulae noninvasive positive pressure ventilation nippv may play role patients especially resources mechanical ventilation likely stretched lungprotective ventilation strategy recommended conservative use iv fluids aiming maintain tissue perfusion negative fluid balance aids lung recovery <NUMBER> extracorporeal membrane oxygenation ecmo may required severe cases per standard indications considered early venovenous mode could initiated prior intubation cardiac damage highly prevalent heart failure therapies initiated appropriate similarly broadspectrum antibioticsantifungal treatments treatment arrhythmias needed finally due growing evidence dic cause organ injury anticoagulation considered <NUMBER> approximately <NUMBER> patients early chinese cohort received antiviral therapy <NUMBER> <NUMBER> <NUMBER> <NUMBER> italian recommendation commence treatment antiviral therapy covid<NUMBER> confirmed patients mild symptoms high mortality risk category moderatesevere signs infection numerous antiviral therapies used try limit viral replication include protease inhibitors liponovirritonavir used treatment hiv however recent rapid randomized nonplacebocontrolled trial including <NUMBER> patients arm showed difference outcome <NUMBER> remdesivir nucleotide analogue polymerase inhibitor previously used experimental treatment ebola large phase iii study <NUMBER> acceptable safety profile remdesivir gs<NUMBER> arm halted due higher antiviral efficacy monoclonal antibodies trial finally chloroquine hydroxychloroquine suggested antiviral activity many rna viruses including sars sarscov<NUMBER> increase endosomal ph interference glycosylation process <NUMBER> however never shown conclusively antiviral effect vivo alphavirus infection demonstrating antiviral effect vitro found associated clinical effects randomized clinical trial may even associated prolonged viraemia vivo <NUMBER> observations cannot directly translated covid<NUMBER> large phase iii trials underway hydroxychloroquine inform possible therapeutic value approach includes recently initiated hydroxychloroquine chemo prophylaxis healthcare personnel contact covid<NUMBER> patients phydra trial clinicaltrialsgov identifier nct<NUMBER> cytokine storm appears key pathogenetic process patients exhibiting rapid deterioration immune suppression immune modulation approaches tried includes glucocorticoids recommended chinese guidelines italian guidelines patients evidence lung fibrosis severe cardiac involvement icu may benefit approach methylprednisolone used combination iv immunoglobulins treatment subjects fulminant myocarditis <NUMBER> immunomodulatory therapies used include monoclonal antibodies il<NUMBER>r discussed ifnb registered treatment multiple sclerosis enhances suppressor cell activity reducing proinflammatory cytokine production may also helpful patients myocarditis develop left ventricular systolic dysfunction however current experience limited enteroviruses <NUMBER> also tried inhaled preparation finally <NUMBER> patients early chinese cohort received iv immunoglobulins approach based evidence beneficial effects cases myocarditisinduced dilated cardiomyopathy recommended cases viral myocarditis refractory standard heart failure therapies <NUMBER> list planned ongoing completed clinical trials found httpsclinicaltrialsgovct<NUMBER>resultscondcovid<NUMBER>termcntry statecitydist addition many ongoing clinical trials new trial europe investigate effects apn<NUMBER> recombinant form human ace<NUMBER> rhace<NUMBER> clinicaltrialsarenacom hrace<NUMBER> dual mode action first potential block infection host cells sarscov<NUMBER> secondly may reduce lung injury protective actions endogenous ace<NUMBER> phase ii clinical trial conducted germany austria denmark potential therapies covid<NUMBER> discussed important cv side effects toxicities well comorbid conditions require caution avoidance drugs listed table <NUMBER> noted data side effects toxicities come patients use drugs chronically treatment autoimmune diseases chloroquinehydroxychloroquine rocilizumab hepatitis ribavarin ifna hiv infection lopinivirritonivir thus effect shortterm use medications patients without underlying conditions clear remdesivir experimental drug used treatment ebola <NUMBER> thus cv effects toxicities unknown antimalarial drugs chloroquine hydroxychloroquine recently received considerable attention interest treatment possible prophylaxis covid <NUMBER> however data date support drugs weak cardiac toxicities considerable systematic review literature performed patients treated drugs albeit extended period time median <NUMBER> years high cumulative dose demonstrated conduction disorders main side effect <NUMBER> <NUMBER> adverse cardiac events included ventricular hypertrophy <NUMBER> hypokinesia <NUMBER> heart failure <NUMBER> pulmonary arterial hypertension <NUMBER> valvular dysfunction <NUMBER> cardiac function normalizes significant number patients <NUMBER> upon withdrawal chloroquine hydroxychloroquine others continue show irreversible damage <NUMBER> death <NUMBER> <NUMBER> thus careful consideration given use drugs particularly without stronger data regarding efficacy note tocilizumab treatment shown influence lipid metabolism ra patients following tocilizumab total ldl hdlcholesterol increased cv risk biomarkers hdlsaa secretory phospholipase a<NUMBER> iia lipoproteina significantly reduced <NUMBER> recently entrace clinical trial supported cv safety tocilizumab ra patients <NUMBER> however date il<NUMBER> targeting tested secondary prevention cvd currently evidencebased recommendations considering clinical presentation reasonable propose patients cardiac involvement initially seen every <NUMBER> months periodic evaluation addition detailed history taking physical examination include <NUMBER>lead ecg <NUMBER>ddoppler echocardiography <NUMBER> preferably cardiac mri late gadolinium enhancement appropriate heart failure therapy initiated maintained required plans put place optimize doses patients given standard advice regarding physical activity regards unknown longterm consequences covid<NUMBER> regular cv risk assessment considered patients survive covid<NUMBER> covid<NUMBER> brings unprecedented ethical problems situations facing medical profession around world light huge imbalance therapeutic needs resource availability unprecedented scale generation italian society anesthesiology intensive care siaarti <NUMBER> along national societies provided ethical statement aimed guarantee correct psychological framework physicians massively exposed need apply hard triage rules facing huge ethical dilemmas <NUMBER> derived fact need intensive care must integrated elements clinical suitability thus including type severity disease presence comorbidities impairment organs systems reversibility <NUMBER> clinicians either deontologically training accustomed reasoning criteria maxiemergency triage current exceptional situation <NUMBER> impact covid<NUMBER> routine emergency cardiovascular care preparation covid<NUMBER> pandemic many healthcare providers scale outpatient services also defer elective cardiac procedures surgeries instances led positive integration technology development virtual clinics <NUMBER> however uptake virtual clinics universal also compromised redeployment workforce help manage pandemic longterm clinical impact scaling outpatient activity reduced access diagnostics deferral routine procedures likely significant extend beyond pandemic similarly perceived risk exposed covid<NUMBER> led decline delay presentation acute cardiac emergencies likely contribute cardiac mortality morbidity covid<NUMBER> implications wider effects disease individual patients practically countries affected disease developed mitigation containment strategies based social distancing cv consequences social distancing may profound experimental clinical research shown effects social isolation loneliness cognition memory <NUMBER> metabolic disorders <NUMBER> <NUMBER> <NUMBER> <NUMBER> cancer <NUMBER> <NUMBER> <NUMBER> immune disorders <NUMBER> <NUMBER> <NUMBER> context cvds absence positive relationships reduced chance interaction people social distancing identified major risk factors cv mortality <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> recent metaanalysis including total <NUMBER> <NUMBER> participants <NUMBER> demonstrated risk ischaemic heart disease stroke increased <NUMBER> <NUMBER> respectively lonely socially isolated people similar results reported uk biobank analysis <NUMBER> mechanisms detrimental effects social isolation multiple related activation hypothalamicpituitaryadrenocortical hpa axis <NUMBER> <NUMBER> <NUMBER> <NUMBER> changes sympathetic vascular tone <NUMBER> <NUMBER> <NUMBER> elevated levels cortisol <NUMBER> <NUMBER> <NUMBER> reduced responsivity glucocorticoid receptor <NUMBER> <NUMBER> <NUMBER> <NUMBER> social distancing strategies used covid<NUMBER> consider effects aim mitigate using available technological advances comprehensive review aimed highlight current state art information regarding covid<NUMBER> cvd table <NUMBER> understanding cv risk consequences covid<NUMBER> developing continuously however many knowledge gaps many unanswered questions point burning unknowns moment factors genetic otherwise influence interindividual variability susceptibility covid<NUMBER> severity clinical outcomes mechanisms cvds worsen prognosis covid<NUMBER> unknown remains addressed extent individual cvds exacerbated covid <NUMBER> preexisting hypertension cvds increase infection risk andor worsen course disease progression severity cvds related high expression levels ace<NUMBER> sarscov<NUMBER> receptor heart blood vessels influence inhibitors raas susceptibility covid<NUMBER> clinical outcomes factors therapies cvds may confer protective effects covid<NUMBER> clinical outcomes preexisting cvd worsen cardiac involvement specifically transferable knowledge learned pathogen would advance understanding cv risk sarscov<NUMBER> influenza virus infections future finally probably important question remains determinants heterogeneous host responses sarscov<NUMBER> infection answers found integrated approaches cv immunological id expertise coming together use systems based hypothesisfree silico methodologies essential pandemic unlike arriving time humankind possession remarkable molecular data science informatic tools major test ability harness capacity greater good questions need answered highest quality science clinical research since current pandemic coronavirus might last • cardiovascular patients increased risk severe covid<NUMBER> complications intensive preventive measures followed group accordance cdc guidelines include wider use telemedicine tools day day monitoring patients outbreak limit exposure • heterogeneity responses individual patients indicates unlikely considered single disease phenotype host characteristics promotes less severe progression disease • common cardiac complications include arrhythmia af ventricular tachyarrhythmia ventricular fibrillation cardiac injury elevated hsctni ck fulminant myocarditis heart failure • cardiac complications often appear <NUMBER> days initiation fever symptoms • evaluation cardiac damage particularly ctni levels immediately hospitalization covid<NUMBER> well monitoring hospital stay may help identifying subset patients possible cardiac injury thereby predict progression covid<NUMBER> complications • medications used covid<NUMBER> treatment may contribute cardiac toxicity effectiveness treating covid<NUMBER> unconfirmed • hypertension one common riskassociated comorbidities association cofounded age clear hypertension ageindependent risk factor covid<NUMBER>associated outcomes precaution essential hypertension remains well controlled • evidence aceis arbs associated worse prognosis patients discontinue use medications • based experimental evidence conditions particularly arbs possibly also aceis might exert potentially protective influence setting covid <NUMBER> • covid<NUMBER> may lead plaque instability mi common cause death sarscovid<NUMBER> patients however evidence effectiveness primary pci type <NUMBER> mi acute viral disease limited • ace<NUMBER> considered cinderella cardiovascular medicine molecule underappreciated cardiovascular pathology taking centre stage understanding potentially combating covid <NUMBER> endorgan damage part mediated activation infiltrated cells <NUMBER> lab showed mice lacking cd<NUMBER> cells efficiently protected hypertensioninduced cardiac damage cd<NUMBER> cells thus sense hypertension independent cell receptor <NUMBER> importantly cd<NUMBER> cells required macrophage infiltration myocardium subsequent activation cd<NUMBER> cells secreted ifnγ cd<NUMBER> cells respond hypertension one study suggests mineralocorticoid receptor cd<NUMBER> cells directly sense blood pressure promote inflammatory milieu secreting ifnγ <NUMBER> <NUMBER> furthermore hypertension trigger oxidative modification proteins dc cells highly reactive γketoaldehydes isoketals activate dc produce il<NUMBER> il<NUMBER>β il<NUMBER> activated dcs promote cell particularly cd<NUMBER> cell proliferation production ifnγ il<NUMBER>a <NUMBER> intriguingly secondary hemophagocytic lymphohistiocytosis associates massive cd<NUMBER> cell macrophage activation decreased nk cell activity noted covid<NUMBER> patients european icus taken together results suggest cd<NUMBER> cells may function key hypertension effector drives macrophagemediated cardiac damage severe covid<NUMBER> patients also showed increased il<NUMBER> il<NUMBER>β ifnγ <NUMBER> worthy studying whether blockade il<NUMBER> il<NUMBER>β currently clinical trials would reduce cardiac injury inhibition cd<NUMBER> cellmacrophage infiltration overactivation glucocorticoid treatment icu patients shall also closely monitored potential beneficial detrimental effect cd<NUMBER> cell activation lastly ccr<NUMBER> major chemoattracting receptor cd<NUMBER> cells involves various pathogenic conditions including viral infections <NUMBER> antiviral drugs selzentry maraviroc leronlimab pro <NUMBER> successfully used treatment aids <NUMBER> therefore great interest study whether drugs block cardiac infiltration cd<NUMBER> cells thereby reduce hypertensive cardiac injury covid<NUMBER> patients competing interests authors declare competing interests coronavirus disease covid<NUMBER> spread around world short period time recent data showing significant prevalence arterial hypertension cardiovascular diseases cvd among patients covid<NUMBER> raised many questions higher susceptibility patients comorbidities novel coronavirus well role hypertension cvd progression prognosis covid<NUMBER> patients limited amount data usually obtained small population regarding effect underlying disease outcome patients covid<NUMBER> evaluation treatment comorbidities baseline covid<NUMBER> scarce results conflicting hypertension cvd adjustment clinical demographic parameters primarily age remain independent predictors lethal outcome covid<NUMBER> patients investigations speculated association reninangiotensinaldosterone system raas susceptibility covid<NUMBER> well relationship raas inhibitors adverse outcome patients withdrawing switching raas inhibitors would uncertain benefits would definitely many disadvantages uncontrolled hypertension cardiac function deterioration renal function impairment could potentially induce complications patients covid<NUMBER> infection coronavirus aim review article summarize prevalence hypertension cvd patients covid<NUMBER> influence outcome effect treatment hypertension cvd covid<NUMBER> patients covid<NUMBER> hypertension cardiovascular diseases change therapy zhou et al provided first evidence covid<NUMBER> associated novel coronavirus strain <NUMBER> used nextgeneration sequencing pancov polymerase chain reaction pcr primers determine cause disease <NUMBER> patients covid<NUMBER> hubei seafood market sellers deliverers <NUMBER> findings significantly strengthened etiological association reported investigators india <NUMBER> switzerland <NUMBER> places china <NUMBER> also isolated novel coronavirus patients covid<NUMBER> efforts corroborated statements chinese authorities conclusively led identification sarscov<NUMBER> causative agent covid<NUMBER> outbreak <NUMBER> since discovery sequence complete genome sarscov<NUMBER> determined <NUMBER> <NUMBER> <NUMBER> <NUMBER> nucleotides length like covs contains least six open reading frames orfs several accessory genes <NUMBER> according chen et al <NUMBER> genome sequence sarscov<NUMBER> <NUMBER> identical bat sarslikecovzxc<NUMBER> <NUMBER> identical human sarscov <NUMBER> addition phylogenetic analysis indicated two bat sarslike covs nearest homologs sarscov<NUMBER> <NUMBER> based genomic structure phylogenetic analysis subfamily coronavirinae divided four genera namely alphacoronavirus betacoronavirus gammacoronavirus deltacoronavirus <NUMBER> <NUMBER> <NUMBER> currently seven human covs reported <NUMBER>e hcov<NUMBER>e oc<NUMBER> hcovoc<NUMBER> nl<NUMBER> hcovnl<NUMBER> hku<NUMBER> hcovhku<NUMBER> sarscov merscov sarscov<NUMBER> hcov<NUMBER>e hcovnl<NUMBER> belong alphacoronavirus genus hcovhku<NUMBER> sarscov merscov hcovoc<NUMBER> betacoronavirus members <NUMBER> sarscov<NUMBER> also classified novel betacoronavirus belonging subgenus sarbecovirus coronaviridae family <NUMBER> <NUMBER> <NUMBER>’ terminal onethird sarscov<NUMBER> genome sequence encodes four structural proteins namely spike protein envelope protein e membrane protein nucleocapsid protein n among gene particularly important receptor binding host specificity <NUMBER> infection cov begins binding protein surface antigen determining viral tropism cellsurface molecules expressed host cells <NUMBER> shown table <NUMBER> host receptors seven human covs include human aminopeptidase n cd<NUMBER> hcov<NUMBER>e <NUMBER> <NUMBER>oacetylated sialic acid hcovoc<NUMBER> <NUMBER> angiotensinconverting enzyme <NUMBER> ace<NUMBER> sarscov <NUMBER> ace<NUMBER> hcovnl<NUMBER> <NUMBER> <NUMBER> <NUMBER>oacetylated sialic acid hcovhku<NUMBER> <NUMBER> <NUMBER> dipeptidyl peptidase <NUMBER> dpp<NUMBER> merscov <NUMBER> ace<NUMBER> sarscov<NUMBER> <NUMBER> presentation common symptoms covid<NUMBER> patients fever dry cough shortness breath whereas headache diarrhea vomiting rare <NUMBER> <NUMBER>–<NUMBER> however early neurological symptoms eg headache epilepsy unconsciousness without obvious respiratory symptoms reported numerous covid<NUMBER> patients <NUMBER> <NUMBER> <NUMBER> case report xu et al provided first direct evidence sarscov ability infect central nervous system cns <NUMBER> predicted cdna fragment specific sarscov amplified nested rtpcr veroe<NUMBER> cell cultures inoculated brain tissue extract symptomatic patient presence enveloped virus particles <NUMBER>–<NUMBER> nm diameter found transmission electronic microscopy <NUMBER> shortly finding another study reported case <NUMBER>yearold woman sars whose cerebrospinal fluid tested positive sarscov <NUMBER> findings supported experiments mice demonstrated ability various covs cause cns infections <NUMBER>–<NUMBER> indeed sarscov<NUMBER> shares similar characteristics sarscov anecdotal statistical data indicate neurologic symptoms common covid<NUMBER> patients <NUMBER> since well known cerebral hemorrhage may result viral infection cns compromising neurovascular unit <NUMBER>–<NUMBER> available evidence strongly suggest sarscov<NUMBER> infection may greatly increase incidence hemorrhagic stroke especially atrisk patients hypertension important risk factor cerebral hemorrhage <NUMBER> <NUMBER> note <NUMBER> covid<NUMBER> confirmed cases analyzed wang et al <NUMBER> <NUMBER> patients <NUMBER> hypertensive proportion reflects relative diseases higher susceptibility sarscov<NUMBER> infection conferred hypertension similar results recently reported guan et al <NUMBER> novel coronavirus pneumonia emergency response epidemiology team <NUMBER> sarscov<NUMBER> infection humans mediated binding receptorbinding domain rbd viral glycoprotein ace<NUMBER> receptors host cells turn may lead downregulation ace<NUMBER> expression <NUMBER> <NUMBER> since reduced ace<NUMBER> expression implies increased ang ii availability covid<NUMBER> patients preexisting hypertension may experience large blood pressure bp fluctuations making especially susceptible hemorrhagic stroke episodes close relationship systolic bp variability sbpv poor prognosis cerebral hemorrhage divani et al reported elevated sbpv first <NUMBER> h admission related unfavorable inhospital prognosis patients intracerebral hemorrhage ich <NUMBER> since bp elevations resulting downregulation ace<NUMBER> expression may occur sarscov<NUMBER> infection higher sbpv may present admission hemorrhagic stroke patients affected covid<NUMBER> therefore management bp might require additional attention hyperacute acute hemorrhagic stroke phases covid<NUMBER> patients high absolute bp levels high bp fluctuations main determinants cerebral hemorrhage prognosis diabetes also independent risk factor hemorrhagic stroke <NUMBER> huang et al reported among <NUMBER> patients laboratory confirmed sarscov<NUMBER> infection <NUMBER> <NUMBER> cases diabetes represents higher proportion comorbidity cases compared diseases <NUMBER> indeed available data suggest among covid<NUMBER>confirmed cases underlying chronic diseases diabetes ranks second hypertension <NUMBER> <NUMBER> elevated plasma ddimer levels associated increased risk hemorrhagic stroke <NUMBER> recently chen et al conducted retrospective singlecenter study including <NUMBER> patients covid<NUMBER> found elevated ddimer levels <NUMBER> patients <NUMBER> <NUMBER> however mortality rate subgroup reported meanwhile similar study assessing <NUMBER> covid<NUMBER>confirmed patients ddimer greater <NUMBER> mgl admission associated significantly increased odds p <NUMBER> inhospital death <NUMBER> note recently posted preprint article reporting <NUMBER> consecutive covid<NUMBER> cases wuhan found ddimer elevation ≥ <NUMBER> mgl <NUMBER> <NUMBER> patients ddimer levels correlated disease severity values <NUMBER> mgl predicted inhospital mortality sensitivity <NUMBER> specificity <NUMBER> <NUMBER> surprisingly two recent studies reported association sarscov<NUMBER> infection incidence stroke <NUMBER> <NUMBER> single center retrospective observational study li et al reported <NUMBER> risk ischemic stroke <NUMBER> risk cerebral hemorrhage <NUMBER> patients sarscov<NUMBER> infection wuhan china <NUMBER> cohort patients new onset stroke obviously older likely present severe covid<NUMBER> risk factors including hypertension diabetes elevated plasma ddimer levels <NUMBER> another study <NUMBER> patients reported <NUMBER> <NUMBER> developed acute cerebrovascular diseases including <NUMBER> <NUMBER> patients ischemic stroke <NUMBER> <NUMBER> cerebral hemorrhage severe patients covid<NUMBER> <NUMBER> nevertheless studies including larger sample sizes exhaustive assessment patients’ clinical histories additional molecular analysis clearly needed determine cases stroke directly triggered sarscov<NUMBER> infection occurs coincidentally <NUMBER> inflammatory monocytemacrophages imms neutrophils major sources cytokines chemokines involved pathogenicity sarscov<NUMBER> <NUMBER> factors represent classical inflammatory biomarkers associated secondary brain injury following cerebral hemorrhage may prognostic value hemorrhagic stroke patients <NUMBER>–<NUMBER> lattanzi et al recently reviewed available evidence pointing relevance assessing neutrophiltolymphocyte ratio nlr determine inflammatory status ich patients <NUMBER> turn newer studies confirmed nlr’s predictive value prognosis ich <NUMBER> <NUMBER> neutrophilderived matrix metalloproteinases mmps upregulated acute ich contributing significantly tissue destruction activation neuroinflammatory cascades <NUMBER> accordingly research suggests may possible mitigate brain damage early shortterm inhibition mmps <NUMBER> napoli et al reported increased concentrations serum creactive protein crp marker inflammation may independent predictor ich outcome <NUMBER> nevertheless considered interethnic genomic differences may influence crp status predictive values different stroke phenotypes another marker namely serum neutrophil gelatinaseassociated lipocalin ngal member lipocalin family proteins associated transport small hydrophobic molecules plays important role innate immune response also identified independent predictor outcome following hemorrhagic stroke <NUMBER> given inflammatory biomarkers associated sarscov<NUMBER>related cytopathic effects hemorrhagic stroke outcome would worthwhile explore changes inflammatory biomarkers occur hemorrhagic stroke predictive value patients without covid<NUMBER> would allow better define reliable indices hemorrhagic stroke severity functional recovery substantially reduced peripheral lymphocyte counts evident severe covid<NUMBER> cases <NUMBER>–<NUMBER> <NUMBER> <NUMBER> xu et al reported pathological findings lung liver heart biopsies well blood cell analysis patient died covid<NUMBER> <NUMBER> findings showed infiltration imms lung whereas peripheral cd<NUMBER> cd<NUMBER> cells reduced number overactivated authors suggested severe immune injury patient due overactivation cells manifested increased representation highly proinflammatory ccr<NUMBER> th<NUMBER> cd<NUMBER> cell subsets enhanced cytotoxic capacity cd<NUMBER> cells data suggest although lymphopenia common feature patients covid<NUMBER> may paralleled proinflammatory phenotypic switching cell subsets could critically associated disease severity mortality <NUMBER> <NUMBER> addition suggested like sarscov sarscov<NUMBER> also acts lymphocytes respiratory mucosa leading systemic “cytokine storm” concomitant reduced peripheral blood lymphocytes impairs cellular immune function <NUMBER> effect clearly potentiated immune senescence welldescribed phenomenon many middleaged elderly people <NUMBER> aggravated underlying conditions hypertension diabetes cerebrovascular disease evidence points worsened outcomes patients covid<NUMBER> cerebral hemorrhage comorbidity soon covid<NUMBER> outbreak investigations confirmed ace<NUMBER> receptor abundantly expressed lung alveolar epithelial cells enables sarscov<NUMBER> entry host cells rbd virus’ glycoprotein <NUMBER> <NUMBER> <NUMBER> rbd confers ace<NUMBER> binding specificity part s<NUMBER> subunit large ectodomain protein ectodomain contains also s<NUMBER> subunit mediates fusion viral host cell membranes <NUMBER> ternary structure rbd sarscov<NUMBER> obtained molecular simulation revealing structure essentially superimposable <NUMBER> identity sarscov except flexible loop cngvegfnc replaces rigid loop ctppalnc present sarscov <NUMBER> analysis indicated unique f<NUMBER> residue flexible loop penetrate deep hydrophobic pocket ace<NUMBER> formed f<NUMBER> l<NUMBER> y<NUMBER> l<NUMBER> <NUMBER> ace<NUMBER> identified <NUMBER> homolog angiotensinconverting enzyme ace although different substrate specificity <NUMBER> ace<NUMBER> primarily acts angiotensin ii angii major bioactive peptide <NUMBER> generate vasodilatory heptapeptide ang<NUMBER> ace acts angiotensin angi generate angii <NUMBER> ace<NUMBER> counterbalances vasopressor effect aceangiiat<NUMBER> axis stimulating vasodilation ace<NUMBER>ang<NUMBER>masr axis <NUMBER> <NUMBER> demonstrating adversarial relationship ace ace<NUMBER> crackower et al reported heart function impaired ace<NUMBER>deficient mice effect rescued ablation ace expression <NUMBER> ace<NUMBER> expression widely distributed across different cells tissues date identified epithelial cells oral mucosa <NUMBER> pulmonary alveolar type ii cells <NUMBER>–<NUMBER> esophagus upper stratified epithelial cells absorptive enterocytes ileum colon <NUMBER> cholangiocytes <NUMBER> myocardial cells kidney proximal tubule cells bladder urothelial cells <NUMBER> addition ace<NUMBER> expression also detected vascular endothelial smooth muscle cells <NUMBER> neurons <NUMBER> <NUMBER> <NUMBER>–<NUMBER> including cardiorespiratory center brainstem <NUMBER> widespread expression ace<NUMBER> thus consistent reported effects sarscov<NUMBER> multiple tissues organs binding sarscov<NUMBER> ace<NUMBER> receptors brain blood vessels may trigger release proinflammatory cytokines chemokines interleukin<NUMBER> il<NUMBER> tumor necrosis factor tnf leading activation extravasation lymphocyte subsets neutrophils macrophages subsequent neurological manifestations <NUMBER> hand neuronal ace<NUMBER> expression could also significant factor covid<NUMBER> cases associated cerebral hemorrhage research <NUMBER> sars outbreak concluded downregulation ace<NUMBER> expression occurred infected organs including lungs <NUMBER> kidney <NUMBER> heart <NUMBER> liver <NUMBER> brain <NUMBER> similarly study chen et al reported decreased ace<NUMBER> expression lungs covid<NUMBER> patients <NUMBER> downregulation ace<NUMBER> expression may increase risk hemorrhagic stroke several ways ace<NUMBER> deficiency brain may impair endothelial function cerebral arteries leading <NUMBER>fold elevation risk cerebrovascular events including hemorrhagic stroke <NUMBER> ii downregulation ace<NUMBER> expression may increase local angii levels acting at<NUMBER> receptors may rise bp facilitate hypertrophy fibrosis <NUMBER> iii decreased ace<NUMBER> expression would also lead reduced generation ang <NUMBER> depression ang <NUMBER>masr signaling thus preventing vasodilatory growth inhibiting antifibrotic actions <NUMBER> <NUMBER> figure <NUMBER> calls special attention fact covid<NUMBER> may exacerbate underlying hypertension put patients higher risk hemorrhagic stroke several mechanisms may contribute hemorrhagic stroke hypertensive patients infected sarscov<NUMBER> include fibrinoid necrosis promoted increased vascular pressure <NUMBER> extensive structural functional alterations endothelium smooth muscle intracerebral arteries often aggravated atherosclerosis especially elderly <NUMBER> bbb semipermeable structure consisting welldefined basement membrane endothelial cells bound tight junctions limit passage macromolecules brain parenchyma bbb lies close apposition brain cell types including pericytes astrocytes microglia neurons especially susceptible damage hypertension diabetes <NUMBER> <NUMBER> xu et al reported chemokine ie monokinemigcxcl<NUMBER> induced ifng mostly glial cells might involved brain immunopathology triggered sars <NUMBER> elevated mig levels blood correlated brain infiltration cd<NUMBER> monocytesmacrophages cd<NUMBER> lymphocytes brain <NUMBER> given similarities sarscov<NUMBER> sarscov mechanism deserves exploration may lead therapeutic strategies prevent attenuate brain pathology covid<NUMBER> patients bbb dynamic complex structure helps maintain brain homeostasis compensates fluctuations systemic circulation <NUMBER> expression ace<NUMBER> endothelial cells bbb may gateway sarscov<NUMBER> entry brain <NUMBER> moreover ensuing ace<NUMBER> downregulation compounded agerelated ace<NUMBER> deficiency older patients might increase endothelial dysfunction risk ich <NUMBER> studies needed ascertain impact ace<NUMBER> expression bbb effect sarscov<NUMBER>mediated cns symptoms particularly ich accruing evidence viral cns infections may cause hemorrhage stroke <NUMBER> <NUMBER> <NUMBER> pathogenesis may involve cytokine chemokine protease actions increasing bbb permeability damage andor demise neurovascular unit necrotizing process <NUMBER> although specific mechanisms remain unclear obvious type extent immune response triggered sarscov<NUMBER> determine symptoms severity recent study anderson et al revealed bats likely source novel sarscov<NUMBER> evolved highly specific innate immune response characterized large expansion type interferon gene family <NUMBER> may clarify basis bats’ immune resistance sarscov<NUMBER> still many open questions mechanisms mediating immune defense cov<NUMBER> humans regard valuable ascertain compare immunological ie cell status cytokine expression genetic ie hla haplotypes profiles symptomatic asymptomatic covid<NUMBER> patients shown influence responses recent viral outbreaks <NUMBER> allow predicting high viral replication early course infection would lead “cytokine storm” characteristic severe covid<NUMBER> cases <NUMBER> current covid<NUMBER> outbreak undoubtedly increased anxiety fear stress many people around world social stress anxiety depression potential risk factors hemorrhagic stroke therefore adequate management conditions key aspect primary prevention cerebrovascular disease <NUMBER> <NUMBER> locus coeruleus structure brainstem consists mainly adrenergic neurons play crucial role genesis anxiety releasing catecholamines critically influence stress response <NUMBER> indeed research shown excessive adrenergic stimulation catecholamines could lead severe vasospasm microcirculation disturbances thus increasing risk hemorrhagic stroke <NUMBER> although people ages infected middleaged elderly people severely affected covid<NUMBER> suggesting aging prominent risk factor accordingly seems logical risk hemorrhagic stroke covid<NUMBER> patients would increase significantly age although recent article oxley et al reported covid<NUMBER>related stroke episodes occurred five young patients <NUMBER> based available evidence camacho et al concluded age strong risk factor hemorrhagic stroke deadliest stroke type <NUMBER> study highlights several agerelated processes pathologies including cerebral microembolism white matter lesions vascular basement membrane thickening increased bbb permeability determine endothelial damage changes vessel elasticity ensuing fluctuations blood flow pressure cause loss autoregulation increase risk ich <NUMBER> research animal models humans indicated aging closely associated endothelial dysfunction oxidative stress cerebral arteries <NUMBER>–<NUMBER> moreover studies rodents suggested deleterious effects promoted alterations ras system aged brains specifically works penasilva et al <NUMBER> labandeiragarcia et al <NUMBER> suggested agerelated downregulation ace<NUMBER> at<NUMBER> expression may promote vascular dysfunction antiinflammatoryantioxidant effects angiiat<NUMBER> ang<NUMBER>masr signaling overridden proinflammatoryprooxidant signaling angiiat<NUMBER> axis although confirmatory data humans still needed studies provide strong support overall concept brain ras activity critical effect cerebrovascular function aging may contribute endothelial dysfunction oxidative stress risk hemorrhagic stroke covid<NUMBER> emerged new human infectious disease caused sarscov<NUMBER> novel coronavirus significant proportion covid<NUMBER> cases especially older patients manifest neurological rather respiratory symptoms admission may higher risk developing cerebral hemorrhage mechanisms covid<NUMBER> may promote hemorrhagic stroke elderly yet clear may involve downregulation ace<NUMBER> expression secondary sarscov<NUMBER> binding neurovascular ace<NUMBER> receptors might increase angii expression decrease ang <NUMBER> expression leading severe bp elevation increased bbb permeability extensive alterations endothelium smooth muscle function intracerebral arteries patients gravelly affected covid<NUMBER> underlying hypertension disease greatly increases risk hemorrhagic stroke since sbpv first <NUMBER> h admission predicts cerebral hemorrhage outcome special attention paid management bp atrisk covid<NUMBER> patients predisposing factors may compounded covid<NUMBER> patients inability immune system efficiently prevent counteract pernicious effects proinflammatory cytokines released upon infection addition anxiety stress may lead enhancement adrenergic tone trigger vasospasm microcirculation disturbances contributing cerebrovascular symptoms light exploring changes inflammatory biomarkers occurring covid<NUMBER> patients cns symptoms suggestive incipient stroke would aid diagnosis treatment avoid irreversible outcomes first case new coronavirus disease <NUMBER> mexico confirmed february <NUMBER> th <NUMBER> <NUMBER> since government mexico launched series preventive measures adhere world health organization sarscov<NUMBER> strategic preparedness response plan aimed limiting spread virus <NUMBER> national campaign healthy distance implemented march <NUMBER> rd may <NUMBER> th <NUMBER> included social distance hand washing general confinement selfisolation covid<NUMBER> associated symptoms <NUMBER> days limited economic mobility <NUMBER> globally individual factors associated covid<NUMBER> mortality found male sex age <NUMBER> years ethnicity hypertension diabetes cardiovascular disease respiratory disease among others <NUMBER> <NUMBER> according <NUMBER> national health nutrition survey ensanut<NUMBER> mexico <NUMBER> adults age <NUMBER> obese <NUMBER> overweight <NUMBER> diabetic <NUMBER> hypertensive <NUMBER> considering states mexico hold heterogeneous distribution prevalence comorbidities regions increased burden diseases sociodemographic related factors higher risk encountering severe manifestations covid<NUMBER> might require hospitalization critical care well higher covid<NUMBER> mortality rates deemed order curb pandemic national decisions ought coordination local level united states sociodemographic health factors related covid<NUMBER> vary importantly across counties <NUMBER> <NUMBER> <NUMBER> mexico <NUMBER> municipalities distributed <NUMBER> states basis territorial organization political administrative division <NUMBER> june <NUMBER> st <NUMBER> federal government gave states country responsibility deciding reopening social educational economic activities based traffic light system established moh <NUMBER> covid<NUMBER> however expected linger within communities several months even years come targeted public policy interventions regions highly vulnerable covid<NUMBER> crucial safeguard protect strengthen communities facing pandemic therefore objective study analyze municipalitylevel factors associated higher mortality rate mr covid<NUMBER> mexico pinpoint locations expected suffer high covid<NUMBER> mortality coronavirus pandemic surveillance mexico carried using sentinel model proposed pan american health organization paho <NUMBER> model works <NUMBER> nationally representative health facilities monitor coronavirus cases test sarscov<NUMBER> conducted ten percent suspected cases <NUMBER> suspected severe acute respiratory syndrome signs breathing difficulty deaths hospitalized suspected covid<NUMBER> cases operational definition suspected case mexico individual last <NUMBER> days presented least <NUMBER> following signs symptoms cough fever headache accompanied least one following signs symptoms dyspnea arthralgia myalgia odynophagiapharyngeal burning rhinorrhea conjunctivitis andor chest pain <NUMBER> confirmed case covid<NUMBER> defined person diagnosis given national network public health laboratories recognized institute epidemiological diagnosis reference indre met criteria suspected case <NUMBER> used daily updated open data source general directorate epidemiology mexican moh includes demographic health information confirmed negative suspect cases covid<NUMBER> <NUMBER> extracted data june <NUMBER> th <NUMBER> number confirmed symptomatic cases deaths municipalitylevel level obtained data variables hypothesized could linked differential testing practices exposure sarscov<NUMBER> recent complete information census records identify municipalitylevel factors associated mortality rate covid<NUMBER> adjusted negative binomial regression model dependent variable sum confirmed covid<NUMBER> deaths symptomatic cases n<NUMBER> <NUMBER> municipality residence independent variables quintiles distribution sociodemographic health outcomes within municipality expected mortality rates emr municipality incidence rate ratios irr <NUMBER> confidence intervals estimated better understand association mr covid<NUMBER> municipalitylevel factors addition main objective study also fitted ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted july <NUMBER> <NUMBER> <NUMBER> <NUMBER> observations <NUMBER> positive symptomatic cases covid<NUMBER> <NUMBER> negative <NUMBER> suspect cases proportion deaths <NUMBER> positive cases <NUMBER> negative cases <NUMBER> suspect cases moment analysis two thirds municipalitylevel symptomatic cases almost half reported deaths due covid<NUMBER> data shown table <NUMBER> authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> table <NUMBER> municipalitylevel factors associated high cumulative incidence rate covid<NUMBER> similar associated high mortality except authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> states oaxaca chihuahua guerrero casefatality rates covid<NUMBER> higher <NUMBER> individual level also explored characteristics confirmed symptomatic cases associated higher lethality covid<NUMBER> order observed risk factors observed countries remain mexican context supplementary table <NUMBER> concordance municipalitylevel results diabetes belonging indigenous ethnic group obesity associated higher risk mortality due coronavirus individual risk factors lethalitycase age <NUMBER> male sex hypertension ckd copd immunosuppression addition received medical care private health institutions associated lower lethality covid<NUMBER> compared cared public health services individuals sought medical attention <NUMBER> <NUMBER> days onset symptoms higher risk dying compared received medical care <NUMBER> <NUMBER> days onset symptoms supplementary table <NUMBER> illustrate municipalitylevel factors associated cumulative incidence lethality rates june <NUMBER> th <NUMBER> disaggregated month found municipalitylevel factors association cumulative incidence mortality rate covid<NUMBER> varied within course pandemic mexico ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> municipalitylevel factors found associated higher risk mortality covid<NUMBER> population density prevalence diabetes obesity mortality rate diabetes proportion indigenous population economically active population rate economic units operate essential activities covid<NUMBER> outbreak first high proportion population economically active may reflect lower confinement increased mobility higher population density may related less social distancing high connectivity secondly high mortality rate diabetes means inadequate control glucose levels negative impact immune cardiovascular systems crucial bodys response covid<NUMBER> <NUMBER> also lower access quality medical care weaker local health care systems <NUMBER> despite individual level hypertension associated higher lethality covid<NUMBER> municipality level mortality rate hypertension associated high mortality covid<NUMBER> within states highest prevalence hypertension lower mortality risk covid<NUMBER> result could explained fact prevalence used model came adults already diagnosed hypertension according previous surveys represented approximately <NUMBER> total cases hypertensive population access health care services antihypertensive medication <NUMBER> nevertheless unknown unobserved variables prior demand healthcare services might reflecting inverse association hypertension covid<NUMBER> mortality ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint important note cumulative incidence cases indigenous populations low however risk mortality coronavirus higher municipalities lower proportion indigenous population findings could indicate lower access healthcare services testing combined dynamic epidemic migrates marginalized areas higher proportion indigenous population countries found many mechanisms underlying higher lethality covid<NUMBER> ethnic minorities related marginalization conditions locality residence work conditions health inequalities <NUMBER> <NUMBER> marginalized conditions nonsewage service dirt floors inversely associated mortality covid<NUMBER> communities household characteristics mostly remote low connectivity could protective sarscov<NUMBER> exposure notwithstanding marginalized remote communities could also lower access testing sarscov<NUMBER> health care could lead underreporting cases deaths special screening strategies tracing isolation contacts within vulnerable communities essential favor prevention deaths covid<NUMBER> <NUMBER> may <NUMBER> mexican moh published list <NUMBER> municipios de la esperanza hope municipalities last <NUMBER> days prior may <NUMBER> confirmed cases covid<NUMBER> adjacent municipalities confirmed cases list guide state governors restart nonessential activities may <NUMBER> <NUMBER> <NUMBER> however according results <NUMBER> municipalitylevel high risk worse outcomes event outbreak june <NUMBER> <NUMBER> <NUMBER> symptomatic cases <NUMBER> deaths due covid<NUMBER> confirmed municipalities identification municipalities high burden risk factors severe illness death covid<NUMBER> critical establish convenient health policies ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint municipality level many municipalities locations susceptible outbreak onset pandemic evolves mexico municipalities confirmed cases yet populations risk becoming seriously ill covid<NUMBER> could greater burden disease upcoming months contingency measures mobility restrictions eased soon targeted approach crucial prevent control onset new outbreaks within municipalities include testing isolation contact tracing well general measures according threestage traffic light system established mexico reactivate economy reduce contingency measures <NUMBER> additional municipalitylevel factors associated cumulative incidence mortality covid<NUMBER> identified municipalities condition extreme poverty higher casefatality rate covid<NUMBER> example oaxaca chihuahua guerrero states municipalities casefatality rates higher <NUMBER> finding suggests low availability tests communities per limitations within study que precision estimations depends quality databases example aging data variables <NUMBER> years may reflect heterogeneous changes within municipalities <NUMBER> nevertheless data previous years still holds relation following years useful find expected associations obesity diabetes hypertension prevalence information ensanut<NUMBER> representatively state level reducing variability within municipalities however rest variables mortality rates diabetes hypertension information disaggregated municipality finally ecological design study prevented us establishing causal associations ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint knowledge first study estimated mortality rate covid<NUMBER> using burden related comorbidities sociodemographic characteristics order identify municipalities risk high mortality rates coronavirus mexico findings could contribute national strategic preparedness response plans towards new normality <NUMBER> informing municipalitylevel level factors ought consider decisionmaking process public health interventions minimize negative impact covid<NUMBER> health livelihoods atrisk communities based results considered good moment modify current epidemiological surveillance strategy confirming covid<NUMBER> positive cases deaths populations might underreported sentinel surveillance approach instance indigenous communities communities extreme poverty could affected risks covid<NUMBER> afflicting health population also increasing food insecurity domestic violence disrupting routine care chronic diseases economic repercussions might bring critical count data impact covid<NUMBER> amongst populations identify prioritize address needs vulnerable populations using small area demographic characteristics burden comorbidities covid<NUMBER> useful identify locations risk covid<NUMBER> mortality mexico municipalitylevel risk factors associated high mortality rates covid<NUMBER> high proportion population economically active high population density high proportion indigenous population high diabetes mortality based characteristics many municipalities experienced high mortality yet prone epidemic curve progresses therefore warn overconfidence premature easing ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint mobility restrictions contingency measures local governments ought reinforce local strategies prevent outbreaks vulnerable communities covid<NUMBER> since november <NUMBER> rapid outbreak coronavirus disease <NUMBER> covid <NUMBER> arose severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> infection recently become public health emergency international concern <NUMBER> covid<NUMBER> contributed enormous adverse impact globally hitherto <NUMBER> laboratoryconfirmed cases <NUMBER> deaths globally march <NUMBER> th <NUMBER> <NUMBER> clinical manifestations covid<NUMBER> according latest reports <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> heterogeneous admission <NUMBER> patients reported least one comorbidity diabetes <NUMBER> hypertension <NUMBER> cardiovascular cerebrovascular diseases <NUMBER> common <NUMBER> <NUMBER> <NUMBER> previous studies demonstrated presence comorbidity associated <NUMBER>fold increased risk developing acute respiratory distress syndrome patients h<NUMBER>n<NUMBER> infection <NUMBER> similar influenza <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> severe acute respiratory syndrome coronavirus sarscov <NUMBER> middle east respiratory syndrome coronavirus merscov <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> covid<NUMBER> readily predisposed respiratory failure death susceptible patients <NUMBER> <NUMBER> nonetheless previous studies certain limitations study design including relatively small sample sizes single center observations studies address limitations needed explore factors underlying adverse impact objective evaluate risk serious adverse outcomes patients covid<NUMBER> stratification according number type comorbidities thus unraveling subpopulations poorer prognosis retrospective case study collected data patients covid<NUMBER> throughout china coordination national health commission mandated reporting clinical information individual designated hospitals admitted patients covid<NUMBER> careful medical chart review compiled clinical data laboratoryconfirmed hospitalized cases <NUMBER> hospitals representing <NUMBER> certified hospitals admitting patients december <NUMBER> th <NUMBER> january <NUMBER> st <NUMBER> diagnosis covid<NUMBER> made based world health organization interim guidance <NUMBER> urgency data extraction complete random sampling could applied settings clinical profiles outside hubei province centrally provided national health commission three respiratory experts guangzhou dispatched wuhan raw data extraction wuhan jinyintan hospital cases wuhan located cohort included <NUMBER> patients wuhan jinyintan hospital one <NUMBER> hospitals cohort represented overall situation jan <NUMBER> st taking account proportion hospitals one fourth patient number <NUMBER> <NUMBER> cases well broad coverage covering major provincescitiesautonomous regions confirmed cases denoted patients whose highthroughput sequencing realtime reversetranscription polymerase chain reaction rtpcr assay findings nasal pharyngeal swab specimens positive <NUMBER> see online supplement details interval potential earliest date transmission source wildlife suspected confirmed cases contacts potential earliest date symptom onset ie cough fever fatigue myalgia adopted calculate incubation period light latest date recorded patients continuous exposure contamination sources incubation periods less <NUMBER> day would included analysis incubation periods summarized based patients delineated specific date exposure clinical data including recent exposure history clinical symptoms signs comorbidities laboratory findings upon admission reviewed extracted experienced respiratory clinicians subsequently entered data computerized database doublecheck cases manifestations chest xray computed tomography ct summarized integrating documentation description medical charts available review medical staff major disagreement radiologic manifestations two reviewers resolved consultation another independent reviewer disease severity reportedly predicted poorer clinical outcomes avian influenza <NUMBER> patients classified severe nonsevere covid<NUMBER> based <NUMBER> american thoracic society infectious disease society america guidelines <NUMBER> taking account global acceptance severity stratification communityacquired pneumonia although validation conducted patients viral pneumonia predictive ability need icu admission mortality validated previously <NUMBER> <NUMBER> briefly severe cases denoted least one major criterion septic shock requiring vasoactive medications respiratory failure requiring mechanical ventilation least three minor criteria respiratory rate <NUMBER> times per minute greater oxygen index <NUMBER> lower multiple lobe infiltration delirium loss consciousness blood urea nitrogen level <NUMBER> mgdl greater blood leukocyte count <NUMBER> per deciliter lower blood platelet count <NUMBER> per deciliter lower body temperature lower <NUMBER> degrees hypotension necessitating vasoactive drugs maintaining blood pressure comorbidities determined based patients selfreport admission comorbidities initially treated categorical variable yes vs subsequently classified based number single vs multiple furthermore comorbidities sorted according organ systems ie respiratory cardiovascular endocrine comorbidities classified organ system ie coronary heart disease hypertension would merged single category primary endpoint study composite measure consisted admission intensive care unit icu invasive ventilation death composite measure adopted individual components serious outcomes h<NUMBER>n<NUMBER> infections <NUMBER> secondary endpoint mortality rate statistical analyses conducted spss software version <NUMBER> chicago il usa formal sample size estimation made published nationwide data covid<NUMBER> nonetheless sample size deemed sufficient power statistical analysis given representativeness national patient population continuous variables presented means standard deviations medians interquartile ranges iqr appropriate categorical variables presented counts percentages light random sampling conducted statistical analyses descriptive p values would presented statistical comparisons except cox proportional hazards regression model cox proportional hazards regression models applied determine potential risk factors associated composite endpoints hazards ratio hr <NUMBER> confidence interval <NUMBER>ci reported findings indicated statistical assumption proportional hazards analysis violated moreover cox regression model considered appropriate logistic regression model taken account potential impact various duration followup individual patients age smoking status adjusted proportional hazards regression model recognized risk factors comorbidities even general population smoking status stratified current smokers exsmokers never smokers regression models national health commission issued <NUMBER> patients laboratoryconfirmed covid<NUMBER> china january <NUMBER> st <NUMBER> time point data cutoff database included <NUMBER> cases <NUMBER> hospitals <NUMBER> provinceautonomous regionsprovincial municipalities see online supplement details <NUMBER> cases mean age <NUMBER> years <NUMBER> patients <NUMBER> females <NUMBER> <NUMBER> patients managed inside hubei province <NUMBER> <NUMBER> patients contact history wuhan city common symptom fever hospitalization <NUMBER> followed dry cough <NUMBER> fatigue <NUMBER> productive cough <NUMBER> less common least one abnormal chest ct manifestation including groundglass opacities pulmonary infiltrates interstitial disorders identified <NUMBER> patients severe cases accounted <NUMBER> study population <NUMBER> <NUMBER> patients reached composite endpoints study table <NUMBER> overall median followup duration <NUMBER> days interquartile range <NUMBER> <NUMBER> <NUMBER> cases <NUMBER> <NUMBER> reported least one comorbidity prevalence specific identified <NUMBER> <NUMBER> patients reported two comorbidities two comorbidities commonly seen severe cases nonsevere cases <NUMBER> vs <NUMBER> patients two comorbidities older mean <NUMBER> vs <NUMBER> years likely shortness breath <NUMBER> vs <NUMBER> nausea vomiting <NUMBER> vs <NUMBER> unconsciousness <NUMBER> vs <NUMBER> less abnormal chest xray <NUMBER> vs <NUMBER> compared patients single comorbidity table <NUMBER> nonsevere cases furthermore comorbidities common patients treated hubei province compared managed outside hubei province well patients exposure history wuhan compared without table <NUMBER> overall <NUMBER> patients <NUMBER> reached composite endpoints study <NUMBER> patients <NUMBER> died <NUMBER> patients <NUMBER> admitted icu <NUMBER> patients <NUMBER> received invasive ventilation composite endpoint documented <NUMBER> <NUMBER> patients least one comorbidity opposed <NUMBER> <NUMBER> patients without comorbidities figure <NUMBER> cases <NUMBER> patients two comorbidities significantly patients hypertension <NUMBER> vs <NUMBER> cardiovascular diseases <NUMBER> vs <NUMBER> cerebrovascular diseases <NUMBER> vs <NUMBER> diabetes <NUMBER> vs <NUMBER> copd <NUMBER> vs <NUMBER> chronic kidney diseases <NUMBER> vs <NUMBER> malignancy <NUMBER> vs <NUMBER> reached composite endpoints compared without table <NUMBER> patients two comorbidities significantly escalated risks reaching composite endpoint compared single comorbidity even compared without p<NUMBER> figure <NUMBER> adjusting age smoking status patients copd hr <NUMBER> <NUMBER>ci <NUMBER> diabetes hr <NUMBER> <NUMBER>ci <NUMBER> hypertension hr <NUMBER> <NUMBER>ci <NUMBER> malignancy hr <NUMBER> <NUMBER>ci <NUMBER> likely reach composite endpoints without figure <NUMBER> results unadjusted analysis presented table e<NUMBER> <NUMBER> overall findings unadjusted adjusted analysis materially altered compared patients without comorbidity hr <NUMBER>ci <NUMBER> <NUMBER>ci <NUMBER> among patients least one comorbidity <NUMBER> <NUMBER>ci <NUMBER> among patients two comorbidities figure <NUMBER> subgroup analysis stratifying patients according age <NUMBER> years vs ≥<NUMBER> years reveal substantial difference strength associations number comorbidities mortality covid<NUMBER> table e<NUMBER> study first nationwide investigation systematically evaluates impact comorbidities clinical characteristics prognosis patients covid<NUMBER> china circulatory endocrine comorbidities common among patients covid<NUMBER> patients least one comorbidity even associated poor clinical outcomes findings provided objective evidence large sample size extensive coverage geographic regions across china take account baseline comorbid diseases comprehensive risk assessment prognosis among patients covid<NUMBER> hospital admission overall findings echoed recently published studies terms commonness comorbidities patients covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> despite considerable variations proportion individual studies due limited sample size region patients managed circulatory diseases including hypertension coronary heart diseases remained common category comorbidity <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> apart circulatory diseases endocrine diseases diabetes also common patients covid<NUMBER> notwithstanding commonness circulatory endocrine comorbidities patients covid<NUMBER> rarely reported comorbid respiratory diseases particularly copd reasons underlying observation scant could arisen lack awareness lack spirometric testing community settings collectively contributed underdiagnosis respiratory diseases <NUMBER> stressed observed frequency comorbidity may also reflect transmission dynamics within particular age groups case detection testing practices hospital admission policies early phases epidemic consistent recent reports <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> percentage patients comorbid renal disease malignancy relatively low findings therefore added existing literature spectrum comorbidities patients covid<NUMBER> based larger sample sizes representativeness whole patient population china number existing literature reports documented escalated risks poorer clinical outcomes patients avian influenza <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> sarscov <NUMBER> merscov infections <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> common comorbidities associated poorer prognosis included diabetes <NUMBER> <NUMBER> hypertension <NUMBER> respiratory diseases <NUMBER> <NUMBER> cardiac diseases <NUMBER> <NUMBER> pregnancy <NUMBER> renal diseases <NUMBER> malignancy <NUMBER> findings suggested similar severe acute respiratory outbreaks comorbidities copd diabetes hypertension malignancy predisposed adverse clinical outcomes patients covid<NUMBER> strength association different comorbidities prognosis however less consistent compared literature reports <NUMBER> <NUMBER> <NUMBER> <NUMBER> instance risk cardiac diseases poor clinical outcomes influenza sarscov merscov infections inconclusive <NUMBER> <NUMBER> <NUMBER> <NUMBER> except diabetes comorbidities identified predictors poor clinical outcomes patients merscov infections <NUMBER> studies however explored well accepted comorbidities frequently coexist instance diabetes <NUMBER> copd <NUMBER> frequently coexist hypertension coronary heart diseases therefore patients coexisting comorbidities likely poorer baseline wellbeing importantly verified significantly escalated risk poor prognosis patients two comorbidities compared single comorbidity findings implied category number comorbidities taken account predicting prognosis patients covid<NUMBER> findings suggested patients comorbidities greater disease severity compared without furthermore greater number comorbidities correlated greater disease severity covid<NUMBER> proper triage patients implemented carefully inquiring medical history help identify patients would likely develop serious adverse outcomes covid<NUMBER> moreover better protection given patients coivd<NUMBER> comorbidities upon confirmation diagnosis main limitation selfreport comorbidities admission underreporting comorbidities could stemmed lack awareness andor lack diagnostic testing might contribute underestimation true strength association clinical prognosis underreporting comorbidities could also lead overestimation strength association adverse outcome however significant underreporting unlikely spectrum report largely consistent existing literature <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> patients subject thorough history taking hospital admission relatively low age might help explain low prevalence copd cohort moreover duration followup relatively short patients remained hospital time writing studies explore associations sufficiently long time frame warranted caution exercised extrapolating findings countries outbreaks covid<NUMBER> since prevalence comorbidities may differ among different countries therefore future studies include external validation results would desirable although temperature systolic blood pressure differed subgroups unlikely clinically relevant finally rapid evolving outbreak globally ongoing studies inclusion patients would needed increase statistical power lend support subgroup analyses stratified specific comorbidities ie copd association risk death data mean ± standard deviation nn n total number patients available data copdchronic obstructive pulmonary disease icu intensive care unit data mean ± standard deviation nn n total number patients available data copdchronic obstructive pulmonary disease icu intensive care unit data mean ± standard deviation nn n total number patients available data copdchronic obstructive pulmonary disease icu intensive care unit cox proportional hazard regression models applied determine potential risk factors associated composite endpoints hazards ratio hr <NUMBER> confidence interval <NUMBER>ci reported shown figure hazards ratio hr <NUMBER> confidence interval <NUMBER>ci risk factors associated composite endpoints admission intensive care unit invasive ventilation death comorbidities classified according organ systems well number scale bar indicates hr cox proportional hazard regression models applied determine potential risk factors associated composite endpoints hazards ratio hr <NUMBER> confidence interval <NUMBER>ci reported model adjusted age smoking status b comorbidity impact <NUMBER> patients covid<NUMBER> china nationwide analysis  significance high prevalence diabetes hypertension severe covid<NUMBER> patients hidekatsu yanai severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> causes coronavirus disease <NUMBER> covid <NUMBER> reached pandemic level recent retrospective cohort study covid<NUMBER> comorbidities diabetes hypertension present nearly half patients <NUMBER> odds inhospital death significantly higher patients diabetes <NUMBER> hypertension <NUMBER> <NUMBER> remains unknown prevalence diabetes hypertension high covid<NUMBER> patients diseases risk severe covid<NUMBER> including death elucidate clinical questions searched prevalence diabetes hypertension controlling status diseases covid<NUMBER> patients severe nonsevere covid<NUMBER> patients using pubmed prevalence disease severe nonsevere covid<NUMBER> patients metaanalyzed petos exact method odds ratio <NUMBER> confidence interval ci shown prevalence diabetes covid<NUMBER> patients severe nonsevere covid<NUMBER> patients shown table <NUMBER> <NUMBER> <NUMBER> half studies showed statistically significantly higher prevalence diabetes severe patients nonsevere patients metaanalysis prevalence diabetes severe patients significantly higher nonsevere patients <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> unfortunately three studies available analyze controlling status diabetes three studies showed plasma glucose levels severe patients significantly higher nonsevere patients although data present sufficient evidence elevation plasma glucose likely associated severity covid<NUMBER> zhu et al performed retrospective multicentered study <NUMBER> cases covid<NUMBER> hubei province china among <NUMBER> preexisting type <NUMBER> diabetes <NUMBER> found subjects type <NUMBER> diabetes required medical interventions significantly higher mortality <NUMBER> vs <NUMBER> multiple organ injury nondiabetic individuals wellcontrolled blood glucose associated markedly lower mortality compared individuals poorly controlled blood glucose supporting significance hyperglycemia severe covid<NUMBER> prevalence hypertension covid<NUMBER> patients severe nonsevere covid<NUMBER> patients shown table <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> five <NUMBER> studies showed statistically significantly higher prevalence hypertension severe patients nonsevere patients metaanalysis prevalence hypertension severe patients significantly higher nonsevere patients <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> seven studies available analyze controlling status hypertension five studies show difference blood pressure severe nonsevere patients huang et al showed systolic blood pressure significantly higher severe patients nonsevere patients <NUMBER> itelman et al showed minimal systolic blood pressure significantly lower severe patients nonsevere patients maximal systolic blood pressure significantly higher severe patients nonsevere patients <NUMBER> blood pressure unlikely associated severity covid<NUMBER> since hypertension one significant risk factors severe disease mortality covid<NUMBER> angiotensinconverting enzyme ace <NUMBER> entry receptor sarscov<NUMBER> <NUMBER> <NUMBER> effects ace inhibitors aceis angiotensin receptor blockers arbs covid<NUMBER> patients received much focus recent study shown protective effects aceis arbs mortality covid<NUMBER> <NUMBER> challenging association aceisarbs use severe covid<NUMBER> hypertension one significant risk factors severe disease mortality covid<NUMBER> diabetes hypertension crucial coronary risk factors diabetes hypertension closely interlinked similar risk factors endothelial dysfunction vascular inflammation arterial remodelling atherosclerosis dyslipidemia obesity <NUMBER> common mechanisms upregulation reninangiotensinaldosterone system oxidative stress inflammation activation immune system likely contribute close relationship diabetes hypertension <NUMBER> high prevalence diabetes hypertension severe covid<NUMBER> patients explained vascular damage prevalence cardiovascular disease cvd covid<NUMBER> patients severe nonsevere covid<NUMBER> patients shown table <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> four <NUMBER> studies showed statistically significantly higher prevalence cvd severe patients nonsevere patients metaanalysis prevalence dm htn severe covid<NUMBER> patients j clin med res <NUMBER> cvd severe patients significantly higher nonsevere patients <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> cvd significantly associated increased odds death <NUMBER> <NUMBER> supporting significant association vascular damage severity covid<NUMBER> ddimer detected injured vascular endothelium <NUMBER> von willebrand factor produced endothelial cells response injury high von willebrand factor level observed systemic vasculitis <NUMBER> multivariable regression showed increasing odds inhospital death associated ddimer greater <NUMBER> µgml <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p <NUMBER> admission <NUMBER> elevated von willebrand factor levels observed covid<NUMBER> patients intensive care unit <NUMBER> ddimer also reported significantly increased kawasaki disease coronary artery lesions independent risk coronary artery lesions kawasaki disease <NUMBER> von willebrand factor parameters reported represent potential biomarkers disease activity coronary artery lesion patients kawasaki disease <NUMBER> recent article reported development kawasaki disease covid<NUMBER> patient <NUMBER> supporting association endothelial injury severe covid<NUMBER> conclusion endothelial injury may associated severity covid<NUMBER> partially explain high prevalence diabetes hypertension severe covid<NUMBER> thank staffs yukie kawamura keiko nakamura harue author financial disclosures report author declares conflict interest concerning article applicable hy designed research collected analyzed data wrote approved final paper author declares data supporting findings study available within article since last november almost <NUMBER> million confirmed covid<NUMBER> infections <NUMBER> <NUMBER> deaths reported <NUMBER> evidence mounting become clear covid<NUMBER> initially affects airways lungs inflammatory storm occurring later infection also involves cardiovascular system leads venous thrombosis pulmonary embolism <NUMBER> heart blocks <NUMBER> myocardial infarction well myocarditis <NUMBER> <NUMBER> <NUMBER> heart failure <NUMBER> furthermore cardiac condition seems represent major risk factor unfavourable outcome covid<NUMBER> infection finally less apparent initially lockdown affected countries produced extensive collateral damage patients afraid visit hospitals acute cardiac conditions deprived necessary care outpatient elective inpatient services cancelled second focus issue covid<NUMBER> cardiovascular disease addresses issues starts fast track association hypertension antihypertensive treatment covid<NUMBER> mortality retrospective observational study fei li colleagues china investigated whether treatment hypertension especially reninangiotensinaldosterone system raas inhibitorsas suggested initially <NUMBER> would influence mortality patients covid<NUMBER> infection admitted huoshenshan hospital wuhan china <NUMBER> hospital designed treating covid<NUMBER> opened <NUMBER> february <NUMBER> hypertension treatment stratified according medical history medications prior infection among <NUMBER> patients <NUMBER> history hypertension adjustment confounders patients hypertension twofold increased relative mortality risk compared without hypertension patients history hypertension without antihypertensive treatment even higher risk mortality compared treatment hazard ratio <NUMBER> quarter patients treated least one raas inhibitor rest received betablockers calcium antagonists diuretics raas inhibitors mortality numerically lower reach significance figure <NUMBER> thus largest cohort published far issue hypertension appears independently associated mortality covid<NUMBER> furthermore data support hypothesis raas inhibitors worsen outcomes among persons infection important findings put context debate role ace<NUMBER> covid<NUMBER> thoughtprovoking editorial luis ruilope hospital <NUMBER> de octubre madrid spain <NUMBER> troponins known risk factors outcome patients acute coronary syndromes <NUMBER> <NUMBER> heart failure <NUMBER> valvular heart disease <NUMBER> pulmonary embolism <NUMBER> even normal individuals important also study aspect patients covid<NUMBER> infection article entitled characteristics clinical significance myocardial injury patients severe coronavirus disease <NUMBER> bo yang colleagues wuhan university renmin hospital china investigated aspect <NUMBER> patients severe covid<NUMBER> infection <NUMBER> <NUMBER> died patients comorbidities commonly myocardial injury ie <NUMBER> vs <NUMBER> survivors area receiver operator characteristic curve highsensitivity cardiac troponin inhospital mortality <NUMBER> optimal cutoff points ie <NUMBER> ngml high levels highsensitivity cardiac troponin predicted inhospital death hazard ratio <NUMBER> <NUMBER> respectively multivariable logistic regression older age comorbidities hypertension coronary artery disease chronic renal failure chronic obstructive pulmonary disease high level creactive protein predictors myocardial injury thus risk inhospital death among patients severe covid<NUMBER> predictable markers myocardial injury associated inflammatory response cardiovascular comorbidities additionally covid<NUMBER> pandemic affected infection also cardiac patients large appears recommendations governmental agencies stay home probably deterred cardiac patients visiting hospital acute symptoms occurred outlined article reduction hospitalizations myocardial infarction italy covid<NUMBER> era authored ciro indolfi division cardiology magna graecia university catanzaro italy colleagues società italiana di cardiologia ccu academy investigators group <NUMBER> conducted multicentre observational nationwide survey admissions acute myocardial infarction italian intensive cardiac care units <NUMBER>week period covid<NUMBER> outbreak compared equivalent week <NUMBER> observed <NUMBER> reduction admissions compared equivalent week <NUMBER> reduction significant stsegment elevation myocardial infarction stemi admission <NUMBER> reduction nonstemi nstemi <NUMBER> reduction among stemis reduction greater women <NUMBER> men <NUMBER> similar reduction acute myocardial infarction admissions registered north italy <NUMBER> central italy <NUMBER> surprisingly also southern italy <NUMBER> fewer covid<NUMBER> cases observed thus covid<NUMBER> pandemic led significant collateral damage even noncovid<NUMBER> patients cardiac disease outlined insightful editorial chadi alraies wayne state university washington dc usa <NUMBER> causes may multifactorial may related fact patients may afraid visit hospital pandemic fewer plaque ruptures occurred due standstill life lockdown finally comprehensive review entitled covid<NUMBER> epidemiology treatment jose miro colleagues hospital clinicidibaps barcelona spain reminds us cardiologists cardiovascular surgeons must aware virus infections patients impact general <NUMBER> healthcare workers educated trained tackle enormous challenge posed sarscov<NUMBER> viruses wards operating theatres icus cardiac catheterization laboratories review provides necessary knowledge covid<NUMBER> focuses relevant aspects prevention management specialists within cardiovascular field much patients clinical service suffered covid<NUMBER> pandemic research running clinical trials particular indeed countries running protocols stopped impacted recruitment followup eventually integrity safety results trials issue discussed current opinion article conducting clinical trials heart failure covid<NUMBER> pandemic expert consensus position paper heart failure association hfa european society cardiology esc stefan anker charité berlin germany colleagues figure <NUMBER> <NUMBER> heart failure trials covid<NUMBER> may particularly impactful patients heart failure likely greater risk infection covid<NUMBER> consequences might also serious furthermore also risk adverse outcomes clinical care compromised authors note physicians clinical trialists moral ethical duty ensure safe effective care delivered trial participants without affecting integrity trial many regulatory authorities different world regions issued guidance statements regarding conduct clinical trials covid<NUMBER> crisis however international trials may benefit expert guidance global panel experts supplement local advice regulations thereby enhancing safety participants integrity trial accordingly heart failure association european society cardiology conducted webbased meetings clinical trialists europe north america south america australia asia article authors highlight challenges pandemic poses conduct clinical trials heart failure offers advice might overcome practical examples panel experts focused heart failure clinical trials discussions recommendations may apply clinical trials therapeutic areas issue complemented discussion forum contributions contribution entitled clinically suspected myocarditis course coronavirus infection krzysztof ozieranski colleagues warszawski uniwersytet medyczny poland comment recent article coronavirus fulminant myocarditis saved glucocorticoid human immunoglobulin yuan fang colleagues sichuan university west china hospital china <NUMBER> <NUMBER> fang et al respond ozieranski separate contribution <NUMBER> <NUMBER> finally contribution entitled reninangiotensinaldosterone system dysregulation severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> infection thadathilankal john colleagues stellenbosch university faculty medicine health sciences bellville south africa comment recent viewpoint article sarscov<NUMBER> inhibitors reninangiotensin system withdrawn patients covid<NUMBER> gabriela kuster fro university hospital basel switzerland <NUMBER> <NUMBER> kuster et al respond comment separate manuscript <NUMBER> editors hope readers issue european heart journal find interest angiotensin ii type <NUMBER> receptor <NUMBER> r <NUMBER> fig <NUMBER> ang ii signaling <NUMBER> r mediates effects vasoconstriction inflammation fibrosis whereas <NUMBER> r activation opposing effects vasodilation antiinflammatory response antifibrosis effects <NUMBER> angiotensinconverting enzyme <NUMBER> ace<NUMBER> homolog ace distinct enzyme active sites key counterregulatory enzyme degrades ang ii ang<NUMBER> thereby attenuating effects vasoconstriction sodium retention inflammation fibrosis mas receptor <NUMBER> ace<NUMBER> also cleaves angiotensin angiotensin<NUMBER> <NUMBER> effects ace<NUMBER> suppressed ace inhibitors aceis <NUMBER> normal physiological conditions activities aceang iiat <NUMBER> r axis ace ang iiat <NUMBER> r axis ace<NUMBER>ang<NUMBER>mas receptor axis dynamic equilibrium state maintaining normal function corresponding system <NUMBER> aceis <NUMBER> r blockers arbs inhibit aceang iiat <NUMBER> r pathway also modulate aceang iiat <NUMBER> r pathway ace<NUMBER>ang<NUMBER>mas receptor pathway <NUMBER> previous studies revealed cellspecific expression pattern ace<NUMBER> multiple organs ace<NUMBER> broadly expressed heart kidneys intestine well alveolar epithelial cells lungs principal target main site injury caused sarscov<NUMBER> <NUMBER> normal conditions ace<NUMBER> expression lungs lower organs including heart kidneys intestine <NUMBER> degree expression biological relevance ace<NUMBER> may vary depending tissue clinical state functional role ace<NUMBER> lungs appears relatively minimal normal conditions <NUMBER> ace<NUMBER> may upregulated certain clinical states probably organ protection shown experimental models ace<NUMBER> upregulated relatively high doses aceis arbs heart kidneys arteries leading organ protection <NUMBER> however evidence always consistent among diverse ras inhibitors distinct organs <NUMBER> tannosobetsu study japanese populationbased cohort previously showed urinary level ace<NUMBER> derived mainly kidneys significantly higher hypertensive patients treated olmesartan arb <NUMBER> year untreated control subjects patients treated calcium channel blockers including amlodipine longacting nifedipine acei enalapril arbs including losartan candesartan valsartan telmisartan <NUMBER> finding suggests olmesartan uniquely increases renal expression urinary excretion ace<NUMBER> potentially leading additional renal protection via pleiotropic effects however data showing effects ras inhibitors including aceis arbs expression ace<NUMBER> lungs lacking experimental animal models humans similar entry receptor sarscov sars sarscov<NUMBER> covid<NUMBER> invades host ace<NUMBER> host cellular receptor viral spike protein <NUMBER> fig <NUMBER> therefore expression distribution ace<NUMBER> key determinants coronavirus entry cells two distinct mechanisms sarscov<NUMBER> infection reported endocytosis ace<NUMBER>binding sarscov<NUMBER> entry <NUMBER> <NUMBER> transmembrane protease serine <NUMBER> tmprss<NUMBER>mediated cleavage sarscov<NUMBER> accompanied ace<NUMBER> <NUMBER> <NUMBER> fig <NUMBER> given ace<NUMBER> receptor allows coronavirus entry cells pretreatment ras inhibitors aceis arbs might modulate sarscov<NUMBER> infection development lung injury organ damage caused virus reported sarscov infection sars reduces ace<NUMBER> expression resulting lung injury via imbalance aceang iiat <NUMBER> r axis ace<NUMBER>ang<NUMBER>mas receptor axis <NUMBER> addition exposure sarscov spike protein mouse model induced acute lung injury rescued losartan arb <NUMBER> indicating activation aceang ii <NUMBER> r pathway involved lung injury also shown dysregulation ace<NUMBER> mediates acute lung injury mouse models infection viruses influenza virus respiratory syncytial virus <NUMBER> furthermore continued viral infection replication contribute reduced membrane ace<NUMBER> expression cultured cells <NUMBER> initial engagement sarscov<NUMBER> spike protein subsequent downregulation ace<NUMBER> abundance cell surfaces seen sarscov <NUMBER> conditions ace<NUMBER> converts ang ii angiotensinconverting enzyme ace converts angiotensin ang angiotensin ii ang ii ang ii signaling leads organ damage lung injury promoting inflammation fibrosis ang ii type <NUMBER> receptor <NUMBER> r opposing effects ang ii type <NUMBER> receptor <NUMBER> r angiotensinconverting enzyme <NUMBER> ace<NUMBER> converts ang ii ang<NUMBER> ang ang<NUMBER> ang<NUMBER> signaling attenuates effects inflammation fibrosis mas receptor masr suggested ace<NUMBER> upregulated ace inhibitors aceis <NUMBER> r blockers arbs ace<NUMBER> also receptor severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> ace<NUMBER>binding sarscov<NUMBER> internalized endocytosis cell membraneanchored ace<NUMBER> cell surface downregulated downregulation ace<NUMBER> promotes organ damage activation aceang iiat <NUMBER> r pathway deactivation ace<NUMBER>ang<NUMBER>masr pathway another mechanism sarscov<NUMBER> infection transmembrane protease serine <NUMBER> tmprss<NUMBER>mediated cleavage sarscov<NUMBER> accompanied ace<NUMBER> ace<NUMBER> also shed membrane disintegrin metalloproteinase <NUMBER> adam<NUMBER> soluble form ace<NUMBER> may intercept virus binding membraneanchored ace<NUMBER> cell plasma membrane possible increases expression soluble form ace<NUMBER> induced ras inhibitors would beneficial effects protection lung injury organ damage infection sarscov<NUMBER> ang<NUMBER> unable exert protective effects organs reported ang ii levels higher patients covid<NUMBER> n <NUMBER> healthy controls n <NUMBER> elevated plasma ang ii levels correlated total viral load degree lung injury <NUMBER> data regarding effects ras inhibitors lungspecific expression ace<NUMBER> lacking however even ras inhibitors modify expression ace<NUMBER> lungs possibility facilitation greater engagement entry sarscov<NUMBER> spike protein sarscov<NUMBER> infection conversely possible increase ace<NUMBER> expression induced ras inhibitors would protect lung injury organ damage covid<NUMBER> inhibiting downregulation ace<NUMBER>induced activation aceang iiat <NUMBER> r pathway fig <NUMBER> clinical trials currently underway test safety efficacy several arbs including losartan clinicaltrialsgov number nct<NUMBER> nct<NUMBER> nct<NUMBER> valsartan nct<NUMBER> telmisartan nct<NUMBER> patients covid<NUMBER> hand ace<NUMBER> membranebound enzyme distinctly shed membrane disintegrin metalloproteinase <NUMBER> adam<NUMBER> soluble form ace<NUMBER> exists body fluids <NUMBER> fig <NUMBER> pathological states shedding ace<NUMBER> increased resulting elevated soluble ace<NUMBER> levels blood urine body fluids <NUMBER> suggested soluble recombinant ace<NUMBER> protein intercepts virus binding membraneanchored ace<NUMBER> cell plasma membrane <NUMBER> restoration ace<NUMBER> administration recombinant ace<NUMBER> reported reverse lung injury mouse models viral infections <NUMBER> furthermore treatment recombinant human ace<NUMBER> safely reduced ang ii levels patients acute respiratory distress syndrome <NUMBER> clinical trials test whether administration recombinant ace<NUMBER> protein may beneficial restoring balance ras network potentially preventing organ injury also arranged patients covid<NUMBER> nct<NUMBER> nct<NUMBER> possible induction ace<NUMBER> lungs ras inhibitors would result increased soluble ace<NUMBER> may beneficial effect protection membraneanchored ace<NUMBER>mediated infection sarscov<NUMBER> fig <NUMBER> lack evidence still concerns increased risk sarscov<NUMBER> infection worsening lung injury covid<NUMBER> patients receiving ras inhibitors however withdrawal ras inhibitors switching ras inhibitor therapy another antihypertensive therapy may require careful followup avoid unstable control blood pressure clinical trials currently underway evaluate effects continuation nct<NUMBER> switching nct<NUMBER> discontinuation nct<NUMBER> nct<NUMBER> aceis arbs covid<NUMBER> patients based currently available evidence multiple societies specialty announced administration ras inhibitors continued stable hypertensive patients risk evaluated covid<NUMBER> <NUMBER> interestingly reported covid<NUMBER> patients hypertension receiving ras inhibitor acei arb n <NUMBER> significantly lower peak viral load sarscov<NUMBER> cells covid<NUMBER> patients receiving ras inhibitor n <NUMBER> <NUMBER> retrospective multicenter study hubei china unadjusted mortality rate significantly lower covid<NUMBER> patients hypertension taking acei arb n <NUMBER> <NUMBER> taking acei arb n <NUMBER> <NUMBER> <NUMBER> furthermore mixedeffect cox model adjustment age sex comorbidities inhospital medications showed risk allcause mortality lower group patients treated acei arb group patients treated acei arb <NUMBER> hand according report new york city area mortality rates patients hypertension taking acei arb n <NUMBER> taking acei n <NUMBER> taking arb n <NUMBER> <NUMBER> <NUMBER> <NUMBER> respectively though results unadjusted known confounders including age sex race ethnicity socioeconomic status comorbidities <NUMBER> detailed investigations using large number patients regarding ras inhibitors covid<NUMBER> need addressed conflict interest authors declare conflicts interest publishers note springer nature remains neutral regard jurisdictional claims published maps institutional affiliations <NUMBER> april <NUMBER> <NUMBER> confirmed cases novel coronavirus disease <NUMBER> covid <NUMBER> reported worldwide <NUMBER> examination fulllength genome revealed coronavirus responsible covid<NUMBER> namely severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> βcoronavirus subgenus severe acute respiratory syndrome sars virus different clade <NUMBER> structure receptorbinding gene region similar sars coronavirus employ angiotensinconverting enzyme <NUMBER> ace<NUMBER> cell entry <NUMBER> ace<NUMBER> negative regulator reninangiotensin system ras homolog ace expression identified principally heart kidney airway epithelial cells <NUMBER> functions carboxypeptidase converting angiotensin ii angiotensin<NUMBER> thereby opposing vasoconstrictive effect angiotensin ii <NUMBER> currently available epidemiological studies reported increased prevalence cardiovascular disease cvd including hypertension among patients developed severe subtype covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> example study guan et al <NUMBER> one earliest analyses characteristics chinese patients covid<NUMBER> reported prevalence coronary heart disease fourfold higher among patients developed combined primary endpoint admission intensive care unit mechanical ventilation death relative patients less severe outcomes addition recent studies <NUMBER> <NUMBER> evaluated covid<NUMBER>associated cardiac injury observed high prevalence hypertension <NUMBER> coronary heart disease <NUMBER> cardiomyopathy <NUMBER> chronic heart failure <NUMBER> among covid<NUMBER> patients complicated cardiac injury independently associated mortality covid<NUMBER> since researchers tend favor association cvd severity covid<NUMBER> <NUMBER> <NUMBER> nevertheless interpreting association done caution since validity association hampered unclear definition cvd including hypertension adopted studies <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> without knowing baseline cvd status patients hard suggest cvd added risk factor developing severe covid<NUMBER> infection moreover available studies originated china therefore generalizability association global population limited patients underlying cvd likely experience excessive morbidity cause diminished circulatory reserve meet excessive demands cardiovascular system furthermore since prevalence cvd increased age age may act confounding factor available studies also reported older patients covid<NUMBER> tend develop severe course disease including development cardiac injury <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> future studies agestratified analysis could shed light association cvd severity covid<NUMBER> infection hand researchers called consider safety ras inhibitors including ace inhibitors angiotensin ii type receptor blockers arbs among patients covid<NUMBER> <NUMBER> <NUMBER> speculation patients covid<NUMBER> receiving agents may increased risk adverse outcomes given ace<NUMBER> functional receptor sarscov<NUMBER> ras inhibitors increase ace<NUMBER> levels <NUMBER> <NUMBER> however increased level ace<NUMBER> upon exposure ras inhibitors universal finding animal studies <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> noticed increased expression ace<NUMBER> upon exposure ace inhibitors arbs studies reported otherwise <NUMBER> <NUMBER> findings human studies <NUMBER> <NUMBER> <NUMBER> <NUMBER> discredited association levels ace<NUMBER> use ace inhibitors arbs although one study <NUMBER> notice increased urinary secretion ace<NUMBER> hypertensive patients treated arb olmesartan ace inhibitors arbs furthermore another study <NUMBER> demonstrated increased gene expression ace<NUMBER> small intestine patients ace inhibitorarb treatment compared untreated controls addition elevation serum ace<NUMBER> found patients unsatisfactory blood pressure control utilizing ace inhibitor therapy reported study among hypertensive subjects <NUMBER> therefore effect ras inhibitors ace<NUMBER> among human subjects mainly due expression ace<NUMBER> plasma kidney gastrointestinal system known effect ras inhibitors expression ace<NUMBER> human airway epithelial cells furthermore increased expression ace<NUMBER> correspond increased ace<NUMBER> activity animal study <NUMBER> known biological effect ace<NUMBER> would wane immediately upon discontinuation ace inhibitors arbs role ace<NUMBER> coronavirus infection still controversial although ace<NUMBER> prerequisite infectivity sarscov presence cofactors seems important efficient cellular infection since sarscov also identified cell types lacking ace<NUMBER> expression <NUMBER> addition upregulation ace<NUMBER> entirely harmful since paradoxically increased level ace<NUMBER> might protect coronavirusinduced lung injury <NUMBER> binding coronavirus spike protein ace<NUMBER> leads ace<NUMBER> downregulation turn results excessive production angiotensin ii <NUMBER> angiotensin ii increases pulmonary vascular permeability could produce lung injury impair lung function <NUMBER> <NUMBER> coincidentally study investigated clinical biochemical parameters patients covid<NUMBER> observed levels angiotensin ii higher compared healthy controls <NUMBER> moreover angiotensin ii levels linearly associated lung injury supporting hypothesis angiotensin ii responsible lung injury covid<NUMBER> previously mentioned clinical course covid<NUMBER> complicated cardiac injury manifested increased biomarkers portends worse prognosis ace<NUMBER> plays significant role myocardial recovery response <NUMBER> <NUMBER> <NUMBER> indeed heart samples patients died sars presence viral rna identified associated reduced ace<NUMBER> protein expression <NUMBER> safety issue ace inhibitors arbs since created great concerns social media sites emerging data reassuring retrospective observational study <NUMBER> published chinese language reported use ace inhibitors arbs differ significantly patients recovered patients died covid<NUMBER> suggesting use ras inhibitors may result worse prognosis although conclusion safe use ras inhibitors could firmly drawn study due limited number patients receiving ras inhibitors n <NUMBER> however another recent retrospective study <NUMBER> reported covid<NUMBER> patients underlying hypertension taking ace inhibitorsarbs much lower proportion critical disease <NUMBER> vs <NUMBER> p <NUMBER> lower mortality rate <NUMBER> vs <NUMBER> p <NUMBER> hypertensive counterparts receiving ace inhibitorarb furthermore patients taking ace inhibitorsarbs significantly lower levels creactive protein procalcitonin compared patients receiving ace inhibitorarb suggesting potential antiinflammatory function covid<NUMBER> ras inhibitors could indicated chronic heart failure chronic kidney disease selfdiscontinuation agents without prior consultation physicians may lead decompensation within days weeks compromising cardiopulmonary reserve patients risk covid<NUMBER> <NUMBER> <NUMBER> benefits specific ace inhibitorsarbs may recapitulated antihypertensive agents diseases data reported effect temporary discontinuation ras inhibitors mortality among patients covid<NUMBER> shreds evidence extrapolated patient settings suggest harm studies veterans affairs healthcare system showed nonresumption arbs table <NUMBER> position statements selected major cardiovascular societies use reninangiotensin system inhibitors context covid<NUMBER> american heart association heart failure society america american college cardiology … recommend continuation raas antagonists patients currently prescribed agents indications agents known beneficial heart failure hypertension ischemic heart disease <NUMBER> march <NUMBER> https wwwaccorglates tincardi ology artic les<NUMBER>hfsaaccahastate mentaddre ssesconce rnsreusing raasantag onist sincovid <NUMBER> within <NUMBER> days ace inhibitors within <NUMBER> days surgery associated higher <NUMBER>day mortality rates <NUMBER> <NUMBER> risk fall elderly population abruptly stopping longterm medication eg ace inhibitors could result significant adverse consequences increasing risk fractures bleeding conclusion although cvd reported one common comorbidities among patients severe covid<NUMBER> association cvd severity covid<NUMBER> yet confirmed since thus far biological connection cvd viral replication addition established benefits ace inhibitors arbs cvd outweigh uncertain risks among patients risk covid<NUMBER> since available evidence demonstrated direct pathological relationship ras blockade covid<NUMBER> therefore echo position statements table <NUMBER> major cardiovascular societies <NUMBER> discourage discontinuation ace inhibitors arbs patients covid<NUMBER> statements provide reassurance clinicians would like continue using ace inhibitors arbs among patients risk covid<NUMBER> furthermore ongoing clinical trial covid<NUMBER>infected patients receiving ace inhibitorarb randomized either alternative antihypertensive medication continuation ace inhibitorarb therapy may provide definitive answer debate <NUMBER> funding external funding used preparation manuscript december <NUMBER> severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> previously <NUMBER> known <NUMBER>ncov first reported wuhan city capital hubei province china <NUMBER> subsequently spread regions china <NUMBER> countries territories <NUMBER> sarscov<NUMBER> belongs unique clade sarbecovirus subgenus <NUMBER> orthocoronavirinae subfamily <NUMBER> later designated coronavirus disease <NUMBER> <NUMBER> february <NUMBER> world health organization <NUMBER> patients covid<NUMBER> present primarily fever dry cough fatigue myalgia <NUMBER> <NUMBER> although patients covid<NUMBER> thought favorable prognosis older patients <NUMBER> chronic diseases may worse outcomes <NUMBER> patients chronic underlying <NUMBER> conditions may develop viral pneumonia dyspnea hypoxemia within <NUMBER>week onset <NUMBER> disease may progress respiratory endorgan failure even death <NUMBER> <NUMBER> several studies reported clinical characteristics risk factors associated death <NUMBER> patients covid<NUMBER> pneumonia <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> aware systematic review meta<NUMBER> analysis summarized available findings regard thus aimed systematically <NUMBER> review present evidences association age gender hypertension diabetes <NUMBER> chronic obstructive pulmonary disease copd cardiovascular diseases cvds risk death <NUMBER> covid<NUMBER> infection summarize available findings metaanalysis <NUMBER> study protocol <NUMBER> present systematic review metaanalysis planned conducted reported <NUMBER> adherence preferred reporting items systematic reviews metaanalyses prisma <NUMBER> guidelines <NUMBER> search strategy <NUMBER> performed literature search using online databases isi web science pubmed <NUMBER> scopus google scholar relevant publications <NUMBER> march <NUMBER> following medical <NUMBER> subject headings mesh nonmesh keywords used search strategy novel <NUMBER> coronavirus sarscov<NUMBER> covid<NUMBER> death mortality survival <NUMBER> fatal outcome literature search done two independent researchers mp sy <NUMBER> also searched reference lists relevant articles identify missed studies restriction <NUMBER> applied language time publication facilitate screening process articles <NUMBER> databases literature searches downloaded endnote library version x<NUMBER> <NUMBER> thomson reuters philadelphia usa metaanalysis eligible articles included met following inclusion criteria <NUMBER> studies assessing association age gender comorbidities mortality risk <NUMBER> covid<NUMBER> infection major outcomes interest <NUMBER> observational studies retrospective <NUMBER> ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint newcastleottawa scale nos used assessing quality included retrospective <NUMBER> cohort studies based following three major components selection study patients <NUMBER> adjustment potential confounding variables assessment outcome <NUMBER> based <NUMBER> scale maximum nine points awarded study present study articles <NUMBER> nos score ≥ <NUMBER> considered high quality publications statistical analysis <NUMBER> used hrs ors rrs <NUMBER> confidence intervals reported association <NUMBER> risk factors mortality covid<NUMBER> infection calculate log rrs <NUMBER> standard errors ses overall effect size mortality relation risk factors <NUMBER> calculated using randomeffects model examining betweenstudy heterogeneity <NUMBER> ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint httpsdoiorg<NUMBER> <NUMBER> performed cochrans q test <NUMBER> ≥ <NUMBER> considered betweenstudy heterogeneity <NUMBER> <NUMBER> identify potential sources heterogeneity subgroup analysis according predefined <NUMBER> criteria follows age ≥<NUMBER> vs <NUMBER> gender male vs female hypertension yes vs diabetes <NUMBER> yes vs copd yes vs cvds yes vs addition main analysis carried <NUMBER> sensitivity analysis find overall estimate depended effect size single <NUMBER> study assessing publication bias done formal test egger <NUMBER> statistical <NUMBER> analyses conducted using stata version <NUMBER> stata corp college station tx usa p<NUMBER> values considered significant level <NUMBER> initial search found <NUMBER> papers <NUMBER> duplicates <NUMBER> nonenglish <NUMBER> nonhuman <NUMBER> <NUMBER> reviews <NUMBER> studies fulfill eligibility criteria excluded leaving <NUMBER> <NUMBER> papers evaluation remaining <NUMBER> papers <NUMBER> excluded <NUMBER> following reason report hrs ors rrs <NUMBER> cis finally included <NUMBER> <NUMBER> retrospective studies current systematic review metaanalysis figure <NUMBER> study characteristics <NUMBER> studies conducted wuhan china used retrospective cohort design <NUMBER> <NUMBER> <NUMBER> <NUMBER> sample size studies varied <NUMBER> <NUMBER> patients mean age <NUMBER> years five studies used <NUMBER> ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint httpsdoiorg<NUMBER> <NUMBER> realtime reverse transcriptasepolymerase chain reaction rtpcr <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> one study <NUMBER> used clinical features <NUMBER> identify covid<NUMBER> infection nos scores ranged <NUMBER> <NUMBER> demographic characteristics risk death metaanalysis six effect sizes obtained six studies <NUMBER> <NUMBER> <NUMBER> <NUMBER> patients <NUMBER> <NUMBER> cases death found older age ≥<NUMBER> years old associated <NUMBER> pheterogeneity<NUMBER> risk death covid<NUMBER> figure <NUMBER> found hypertension <NUMBER> diabetes copd cvds associated <NUMBER> threefold <NUMBER> threefold <NUMBER> ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint httpsdoiorg<NUMBER> doi medrxiv preprint <NUMBER> sevenfold <NUMBER> sevenfold higher risk covid<NUMBER> mortality findings current systematic review metaanalysis supported hypothesis older <NUMBER> age ≥<NUMBER> years old hypertension diabetes copd cvds associated higher risk <NUMBER> mortality covid<NUMBER> infection best knowledge current study first meta<NUMBER> analysis summarize earlier retrospective studies association demographic <NUMBER> characteristics comorbidities risk death covid<NUMBER> <NUMBER> findings partially agreement previous narrative review <NUMBER> previously older age <NUMBER> reported important risk factor mortality sars middle east respiratory <NUMBER> syndrome mers <NUMBER> <NUMBER> current metaanalysis confirmed increased age ≥<NUMBER> years <NUMBER> old associated death covid<NUMBER> patients agedependent defects bcell t<NUMBER> cell function excess production type <NUMBER> cytokines could lead prolonged <NUMBER> proinflammatory responses deficiency control viral replication potentially leading <NUMBER> ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint <NUMBER> <NUMBER> previous studies suggested covid<NUMBER> infection likely affect older males <NUMBER> comorbidities result fatal respiratory diseases acute respiratory disease <NUMBER> syndrome <NUMBER> <NUMBER> interestingly sars mers also infected males compared females <NUMBER> <NUMBER> <NUMBER> differences levels type circulating sex hormones males females might <NUMBER> influence susceptibility covid<NUMBER> infection previous study showed sex hormones <NUMBER> modulate responses adaptive innate immunity <NUMBER> however findings showed <NUMBER> gender risk factor mortality covid<NUMBER> patients risk factors related death include hypertension diabetes respiratory system disease <NUMBER> cvds previous study showed hypertension diabetes prevalent patients <NUMBER> severe mers infection <NUMBER> similarly mortality rate influenza significantly higher <NUMBER> patients hypertension metabolic disease cvds respiratory system disease <NUMBER> <NUMBER> previous studies reported high protein expression angiotensin converting enzyme <NUMBER> ace<NUMBER> <NUMBER> receptor receptor covid<NUMBER> specific organs correlated organ failures sars <NUMBER> patients <NUMBER> shown circulating ace<NUMBER> levels higher patients <NUMBER> hypertension diabetes cvds <NUMBER> <NUMBER> therefore patients comorbidities may <NUMBER> prone die covid<NUMBER> infection high expression ace<NUMBER> receptor <NUMBER> though research mechanism needed pathogenesis covid<NUMBER> still completely understood cytokine storm thought <NUMBER> play important role disease severity <NUMBER> neutrophilia found lung ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint figure <NUMBER> forest plot association age gender risk mortality covid<NUMBER> using randomeffects model ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint httpsdoiorg<NUMBER> <NUMBER> december <NUMBER> cluster patients pneumonia unknown cause appeared wuhan hubei province china <NUMBER> january <NUMBER> china rapidly isolated novel coronavirus shared viral genome sequence world health organization <NUMBER> novel coronavirus identified novel enveloped rna betacoronavirus named <NUMBER> novel coronavirus later named severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> international committee taxonomy viruses phylogenetic similarity severe acute respiratory syndrome coronavirus sarscov contagosity higher sarscov middle east respiratory syndrome coronavirus merscov <NUMBER> order prevent epidemic contagion chinese government made decision temporarily shut traffic departing wuhan <NUMBER> january <NUMBER> adopted series control measures declared spread sarscov<NUMBER> listed public health emergency international concern subsequently designated pneumonia infected sarscov<NUMBER> coronavirus disease <NUMBER> covid<NUMBER> <NUMBER> <NUMBER> april <NUMBER> covid<NUMBER> swept across <NUMBER> countries regions reported <NUMBER> <NUMBER> <NUMBER> confirmed cases <NUMBER> <NUMBER> deaths largest number confirmed cases united states followed spain italy <NUMBER> phenomenon signified fighting covid<NUMBER> matter china imperative event global nowadays majority studies covid<NUMBER> china focused wuhan hardesthit area little known clinical features covid<NUMBER> outside wuhan <NUMBER> <NUMBER> <NUMBER> study chang et al <NUMBER> included <NUMBER> cases beijing research xu et al <NUMBER> enrolled <NUMBER> cases zhejiang however due small sample size clinical characteristics might comprehensive researches larger number confirmed cases urgently needed outside wuhan clinical spectrum covid<NUMBER> appears wide comprising mild type without pneumonia common type pneumonia severe type respiratory distress critical type respiratory failure shock even death <NUMBER> diverse subtypes unique features whether epidemiology laboratory results study <NUMBER> <NUMBER> cases reported chinese center disease control prevention china cdc showed casefatality rate <NUMBER> among critical cases <NUMBER> therefore mastering characteristics different subtypes early identification severity illness great significance treatment hence aim study summarize epidemiologic clinical characteristics laboratory radiograph findings treatments outcomes different subtypes patients covid<NUMBER> zhejiang province basis want explore risk factors severity illness patients covid<NUMBER> appeal clinicians attach importance factors conducted retrospective study investigating epidemiological clinical laboratory radiograph treatments outcomes characteristics confirmed cases covid<NUMBER> zhejiang province <NUMBER> january <NUMBER> february <NUMBER> diagnosis covid<NUMBER> accordance interim guidance <NUMBER> confirmed case covid<NUMBER> defined positive result realtime reverse transcriptase polymerase chain reaction rtpcr assay sputum throat swab specimens laboratoryconfirmed patients enrolled study data uniformly collected health commission zhejiang province patients allocated specific hospitals unified treatment according government emergency rule data enrolled study shared preliminary results reported authority zhejiang province information medical records gathered sent data collection center hangzhou demographic epidemiological clinical laboratory treatments outcomes data exacted electronic medical records using standardized data collection form group doctors experiences treating patients covid<NUMBER> reviewed disposed data information incomplete working team hangzhou would contact doctor charge explanation study approved clinical research ethics committee first affiliated hospital college medicine zhejiang university iit<NUMBER>c written informed consent waived ethics commission designated hospital oral consent obtained patients sputum throat swab specimens collected patients tested rtpcr sarscov<NUMBER> rna briefly cdc zhejiang province municipal level first affiliated hospital school medicine zhejiang university responsible confirmation sarscov<NUMBER> national authorization laboratory tests conducted admission including blood routine examinations serum biochemical tests coagulation function examinations infectionrelated biomarkers identification respiratory pathogens influenza virus influenza b virus parainfluenza virus adenovirus respiratory syncytial virus chest radiograph computed tomography ct done inpatients admission treatment measures outcomes followed <NUMBER> february <NUMBER> illness severity covid<NUMBER> defined according chinese management guideline covid<NUMBER> version <NUMBER> <NUMBER> patients covid<NUMBER> categorized mild common severe critical according illness severity mild type defined mild symptoms pneumonia imaging common type defined respiratory tract symptoms imaging pneumonia severe type defined satisfying following items <NUMBER> respiratory distress respiratory frequency ≥ <NUMBER>min <NUMBER> blood oxygen saturation ≤ <NUMBER> rest <NUMBER> pao <NUMBER> fio <NUMBER> ratio ≤ <NUMBER> mmhg <NUMBER> lung infiltrates <NUMBER> within <NUMBER> h critical type defined satisfying following items <NUMBER> respiratory failure occurs require mechanical ventilation <NUMBER> shock occurs <NUMBER> combined organ failure requires icu monitoring treatment incubation period defined time exposure onset illness estimated among patients could provide exact data close contact confirmed suspected individuals family cluster defined occurring two cases fever andor respiratory symptoms within family recent <NUMBER> weeks fever defined axillary temperature least <NUMBER>°c gastrointestinal symptoms included nausea emesis diarrhea temperature returned normal <NUMBER> days respiratory symptoms significantly improved imaging lung obviously absorbed two consecutive negative results sarscov<NUMBER> antigen sampling interval least <NUMBER> day patients could discharged hospital continuous variables presented median interquartile range iqr compared using kruskalwallis categorical variables presented frequency percentages compared using χ <NUMBER> test fishers exact test appropriate analyze risk factors severity illness patients covid<NUMBER> univariate multivariate ordinal logistic regression models used variables p <NUMBER> univariate models selected multivariate model calculating twosided α <NUMBER> considered statistically significant analyses done spss version <NUMBER> ibm corporation armonk ny usa kaplanmeier method used estimate hospitalization time log rank test applied comparisons among mild common severe type kaplanmeier analysis performed using survival packages r version <NUMBER> r foundation vienna austria <NUMBER> january <NUMBER> <NUMBER> february <NUMBER> clinical data collected <NUMBER> patients covid<NUMBER> zhejiang province according definition clinical classification divided <NUMBER> cases <NUMBER> mild type <NUMBER> cases <NUMBER> common type <NUMBER> cases <NUMBER> severe type <NUMBER> cases <NUMBER> critical type shown table <NUMBER> median age mild common severe critical type <NUMBER> years iqr <NUMBER> <NUMBER> respectively hypertension common underlying disease significant differences among four subtypes <NUMBER> vs <NUMBER> vs <NUMBER> vs <NUMBER> p <NUMBER> severe critical type ratio patients gastrointestinal symptoms exceeded <NUMBER> admission majority leucocyte subtypes normal decreased shown table <NUMBER> four types significant differences neutrophil count lymphocyte count platelets count albumin alb aspartate aminotransferase ast sodium blood urea nitrogen bun creatinine cr creatinine kinase ck lactate dehydrogenase ldh creactive protein crp procalcitonin pct p <NUMBER> contrast significant differences hemoglobin international normalized ration inr alanine aminotransferase alt total bilirubin tb potassium p <NUMBER> multiple mottling groundglass opacity typical imaging manifestations patients covid<NUMBER> proportion common severe critical type <NUMBER> <NUMBER> <NUMBER> respectively patients covid<NUMBER> quarantined designated hospital total <NUMBER> patients received antiviral treatments research shown table <NUMBER> interferonα inhalation lopinavirritonavir arbidol commonplace antiviral regimen subtypes glucocorticoids used mild type critical types significant differences use among four types <NUMBER> vs <NUMBER> vs <NUMBER> vs <NUMBER> p <NUMBER> similar glucocorticoids significant differences among four types based use intravenous immunoglobulin <NUMBER> vs <NUMBER> vs <NUMBER> vs <NUMBER> p <NUMBER> till <NUMBER> february <NUMBER> none patients used extracorporeal membrane oxygenation ecmo continuous renalreplacement therapy crrt endpoint study <NUMBER> cases <NUMBER> mild type <NUMBER> cases <NUMBER> common type <NUMBER> cases <NUMBER> severe type <NUMBER> case <NUMBER> critical type discharged hospital none patients died kaplanmeier analysis showed significant difference hospitalization time among mild type common type severe type fig <NUMBER> shown table <NUMBER> outbreak covid<NUMBER> becoming enormous threat public health research structure infection mechanism respiratory scientists found angiotensin converting enzyme <NUMBER> ace<NUMBER> might site sarscov<NUMBER> binding surface cells route infection sarscov <NUMBER> proved ace<NUMBER> might play important role virus transmission infection sarscov<NUMBER> attacked lung also caused damages many organs including heart kidney liver central nervous system <NUMBER> <NUMBER> <NUMBER> <NUMBER> diagnosis covid<NUMBER> complicated diversity symptoms imaging findings severity illness therefore describing features subtype exploring risk factors severity illness could help clinicians better tackle disease respective study median age critical types higher three types reason low immunity degeneration related physiological function older length incubation period related many factors number pathogens time required toxin production transmission human immunity incubation period shorter severe type probably due poor immunity higher viral load <NUMBER> fever cough dominant symptoms subtypes hemoptysis rare fever protective mechanism activating immune systems resist pathogens cough reflective defense invaders individual infected two symptoms generally appeared early stage although hemoptysis atypical symptom reported covid<NUMBER> patient admitted hemoptysis initial symptom <NUMBER> moreover alert patients didnt fever due <NUMBER> severe type without fever study hypertension diabetes pervasive underlying diseases subtypes proportion higher critical type consideration aged constituting majority critical type common rates comorbidities increased according laboratory results decrease lymphocyte occurred <NUMBER> critical type decrease lymphocyte prominent feature critical type cohort consistent previous study <NUMBER> sarscov<NUMBER> might mainly act lymphocyte especially lymphocytes sarscov <NUMBER> addition increased ast ldh implied potential liver heart damage common severe critical types currently effective antiviral treatment covid<NUMBER> <NUMBER> light previous clinical experience interferonα lopinavirritonavir arbidol applied antiviral therapy hospital however therapeutic regimen researched consensus among hospitals retrospective study identified proper use corticosteroid critical type sars could lead lower mortality shorter hospitalization stay <NUMBER> study dosage glucocorticoids limited <NUMBER> mgd avoid side effects <NUMBER> february <NUMBER> <NUMBER> cases <NUMBER> mild type <NUMBER> cases <NUMBER> common type <NUMBER> cases <NUMBER> severe type <NUMBER> case <NUMBER> critical type discharged hospital compared initial patients infected sarscov<NUMBER> wuhan illness condition patients zhejiang province relatively milder none patients died end followup feature obviously different researches wuhan reported higher mortality <NUMBER> <NUMBER> early stage outbreak covid<NUMBER> wuhan shortage local medical resources insufficient understanding disease effective drugs might contribute phenomenon several risk factors severity illness patients covid<NUMBER> identified study including male fever cough hemoptysis gastrointestinal symptoms hypertension higher agegrading several studies demonstrated differences covid<NUMBER> disease prevalence severity associated sex similar results <NUMBER> <NUMBER> <NUMBER> one study using singlecell sequencing found expression ace<NUMBER> predominant asian men <NUMBER> evolution females develop enhanced innate adaptive immune responses males less susceptible viral infections <NUMBER> two points might reasons higher prevalence severity covid<NUMBER> men women additionally study presence one comorbidities higher male compared female <NUMBER> vs <NUMBER> p <NUMBER> thought result might also partly explain men prone severity illness study found increasing odds severity illness associated gastrointestinal symptoms bioinformatics analysis singlecell transcriptomes demonstrated ace<NUMBER> highly expressed lung at<NUMBER> cells esophagus upper stratified epithelial cells also absorptive enterocytes ileum colon recently two independent laboratories china declared successfully isolated live sarscov<NUMBER> stool patients <NUMBER> increasing number studies remind us digestive system might serve alternative route infection sarscov<NUMBER> <NUMBER> consider digestive tract transmission sarscov<NUMBER> might impair function intestinal mucosal barriers increase production inflammatory factors aggravating severity illness addition covid<NUMBER> patients combined hypertension higher risk illness severity study reninangiotensin system ras plays important role pathogenesis hypertension could simply summarized two axes one aceang iiat<NUMBER> axis responsible constriction blood vessels ace<NUMBER>ang<NUMBER>mas axis opposite effect <NUMBER> <NUMBER> generally two axes could interact maintain blood pressure balance however balance would broken hypertension result lower expression ace<NUMBER> infected sarscov<NUMBER> level ace<NUMBER> would even lower followed intensified ang ii activity ang ii would promote vasoconstriction increase vascular permeability mediate inflammatory responses leading illness aggravation several limitations study firstly retrospective design study might affect integrality data diminish credibility prospective cohort studies agenda future secondly patients enrolled study come zhejiang province largescale researches national level urgently needed could provide reliable comprehensive data thirdly changes illness different subtypes needed investigated model predicting changes disease necessary clinicians better guide treatments moreover laboratory results included ordinal logistic regression model explore risk factors severity illness due normal range indicators varied different hospitals summary study reported largest cases patients covid<NUMBER> zhejiang province indicated risk factors illness severity great significance early identification prompt treatment based research findings recommend clinicians pay close attention features patients covid<NUMBER> including older age male fever cough hemoptysis gastrointestinal symptoms hypertension strengthen selfprotection outbreak covid<NUMBER> hypertensive disorders common medical complications pregnancy major cause maternal perinatal morbidity death detection elevated blood pressure pregnancy one cardinal aspects optimal antenatal care outbreak novel coronavirus disease <NUMBER> covid<NUMBER> risk persontoperson spread virus desire minimize unnecessary visits health care facilities women classified low risk high risk hypertensive disorders pregnancy adjustments accordingly made frequency maternal fetal surveillance pandemic pregnant women encouraged obtain sphygmomanometer patients monitored hypertension outpatient receive written instructions important signs symptoms disease progression provided contact information report development concern change status clinical management gestational hypertension preeclampsia assessment urinary protein unnecessary management diagnosis hypertensive disorder pregnancy made pregnant women suspected hypertensive disorders pregnancy signs symptoms associated severe end disease spectrum eg headaches visual symptoms epigastric pain pulmonary edema evaluation including complete blood count serum creatinine level liver transaminases aspartate aminotransferase alanine aminotransferase evidence disease progression acute severe hypertension develops prompt hospitalization suggested current guidelines american college obstetricians gynecologists acog society maternalfetal medicine smfm management preeclampsia severe features suggest delivery <NUMBER> <NUMBER> weeks gestation outbreak covid<NUMBER> however adjustments algorithm considered including delivery <NUMBER> <NUMBER> weeks gestation setting preeclampsia severe features key points · outbreak novel coronavirus disease <NUMBER> covid<NUMBER> warrants fewer office visits · women classified hypertension risk pregnancy · earlier delivery suggested covid<NUMBER> hypertensive disorder proposed plan prenatal care minimize risks covid<NUMBER> patients providers focus hypertensive disorders pregnancy thank joshua brown kevin lo colleagues christopher tignanelli colleagues responses correspondence <NUMBER> welcome opportunity reply fastdeveloping pandemic corona virus disease <NUMBER> caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> first reported wuhan china <NUMBER> spread globally march <NUMBER> <NUMBER> <NUMBER> <NUMBER> people infected sarscov<NUMBER> <NUMBER> <NUMBER> deaths <NUMBER> <NUMBER> people recovered several reports summarised clinical epidemiological features covid<NUMBER> shown specific comorbidities associated increased risk infection developing severe fatal case <NUMBER> infected patients <NUMBER> severe disease common comorbidities hypertension <NUMBER> diabetes <NUMBER> coronary heart disease <NUMBER> cerebrovascular disease <NUMBER> <NUMBER> second cohort <NUMBER> patients hospitalised covid<NUMBER> <NUMBER> diabetes <NUMBER> hypertension <NUMBER> cardiovascular disease <NUMBER> frequent comorbidities among <NUMBER> patients hospitalised covid<NUMBER> <NUMBER> common comorbidities significant effects mortality hypertension <NUMBER> p<NUMBER>·<NUMBER> diabetes <NUMBER> p<NUMBER>·<NUMBER> coronary heart disease <NUMBER> p<NUMBER>·<NUMBER> analysis <NUMBER> patients covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> patients developed acute respiratory distress syndrome hypertension <NUMBER> diabetes <NUMBER> common comorbidities hypertension diabetes cardiovascular disease seem common comorbidities patients covid<NUMBER> typically treated drugs inhibit reninangiotensin system ras including angiotensinconverting enzyme inhibitors aceis angiotensin receptor blockers arbs long history use thorough investigation drugs means efficacy safety ras inhibitors well documented management blood pressure also protection diseaseassociated inflammation organ remodelling <NUMBER> high proportion patients severe covid<NUMBER> comorbidities suggests causative link led hypothesis <NUMBER> <NUMBER> also presented others <NUMBER> based drugs frequently given patients treat comorbidities ie aceis arbs postulated whether drugs might increase risk severe fatal covid<NUMBER> <NUMBER> hypothesis supported observation organspecific expression angiotensin converting enzyme <NUMBER> ace<NUMBER> correlates vulnerability infection sarscov<NUMBER> <NUMBER> concern initiated investigating molecular mechanism sarscov<NUMBER> attaches infects cells sarscov<NUMBER> severe acute respiratory syndrome coronavirus sarscov bind host cells membrane via ace<NUMBER> <NUMBER> specifically highly expressed epithelial cells oral mucosa <NUMBER> ace<NUMBER> widely expressed protein lung intestine kidney blood vessels immunoreactive cells <NUMBER> moreover circulating amounts ace<NUMBER> increased patients hypertension diabetes levels increased different drugs including aceis arbs <NUMBER> <NUMBER> also emphasised specific alleles control ace<NUMBER> expression activity response aceis <NUMBER> addition animal models humans given aceis arbs increased ace<NUMBER> levels intestine luminal cells <NUMBER> context noted modification glyco sylation essential binding sarscov<NUMBER> spike protein inhibition ace<NUMBER> glycosylation either chloroquine hydrochloroquine serine protease inhibitor significantly reduces infection host cells sarscov sarscov<NUMBER> vitro <NUMBER> <NUMBER> <NUMBER> aware beneficial effects aceis arbs protecting heart kidney patients hypertension diabetes opposing hypothesis suggested upregulation ace<NUMBER> expression infusion human recombinant ace<NUMBER> might protect sarscov<NUMBER> infections <NUMBER> <NUMBER> however emphasised role ace<NUMBER> protective effects well understood <NUMBER> <NUMBER> <NUMBER> furthermore noted aceis reported modify adaptive immune response <NUMBER> suggesting longterm use aceis might suppress adaptive immune response key defence viral infections similar effects adaptive immune response known nonsteroid antiinflammatory drugs effects need addressed extended discussion investigated clinical trials context covid<NUMBER> pandemic available published data indicate ace<NUMBER> doubleedged sword particularly considering patients sarscov<NUMBER> infection comorbidities hypertension diabetes cardiovascular disease final answer whether drugs treat comorbidities ie aceis arbs beneficial harmful current pandemic unclear hypotheses investigated rather interpreted evidence work special importance coronaviruses general always part common influenza season future new sarscov probably develop overinterpretation hypothesis lead changing drugs patients hypertension diabetes without first consulting expert clinician nevertheless angiotensinconverting enzyme ace homologue ace<NUMBER> discovered <NUMBER> ace related caroxypeptidase inhibited captopril <NUMBER> <NUMBER> ace<NUMBER> firstly shown expressed kidneys normotensive spontaneously hypertensive rat strains <NUMBER> subsequent studies demonstrated downregulation renal ace<NUMBER> three different models hypertension <NUMBER> moreover circulating cardiac levels angiotensin ii atii shown increase ace<NUMBER>null mice ace<NUMBER> principal pathway ang<NUMBER> formation atii ang<NUMBER> protecting excessive activation at<NUMBER> receptor heart tissues however newer findings suggested ace<NUMBER> important element reninangiotensin aldosterone system <NUMBER> following studies ace ace<NUMBER> focused attention researchers contribution diverse human disorders recently new coronavirus <NUMBER>ncov sarscov<NUMBER> outbreak affected people world highlighted role ace<NUMBER> virus <NUMBER> sequence identity severe acute respiratory syndrome sarsrelated coronaviruses sarscovs <NUMBER> sequence identity bat coronavirus remarkably sarscov<NUMBER> shown utilize similar cell entry receptor ace<NUMBER> sarscov <NUMBER> <NUMBER> recent study shown ace<NUMBER>binding pocket sarscov<NUMBER> spike protein receptorbinding domain rbd almost identical one sarscov rbd structural protein modeling led identification amino acid residues sarscov<NUMBER> rbd critical ace<NUMBER> binding notably residues either highly conserved comparable side chain chemical properties sarscov rbd similarity structure amino acid sequence stimulated intensive debate convergent evolution viruses rbds pressure enhanced binding ace<NUMBER> <NUMBER> ace<NUMBER> shown expressed membrane bound protein several human tissues lung intestine heart kidney surface expression protein j u r n l p r e p r f demonstrated ciliated bronchial cells lung alveolar epithelial cells also endothelial cells stated noticeable discovery <NUMBER> moreover recent silico analysis rnaseq profiles verified expression ace<NUMBER> mucosa oral cavity <NUMBER> figure <NUMBER> shows molecular mechanisms initiated sarscovs entry cells significance ace ace<NUMBER> processes ace converts ati atii finally ace<NUMBER> cleaves atii produce at<NUMBER> atii bind at<NUMBER>r initiate inflammation fibrosis lung tissue however binding at<NUMBER> masr inhibits process sarscovs exploits ace<NUMBER> entrance cells transmembrane serine protease tmprss<NUMBER> crucial role activation fusion virus cell membrane moreover furin protease proconvertase physiologically required activate proteins golgi apparatus mediates proteolysis spike protein s<NUMBER> subunit unique feature sarscov<NUMBER> <NUMBER> ace<NUMBER> levels decreased sarscov infected cells leading increase atii decrease <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> j u r n l p r e p r f levels based receptor effects proteins mediated at<NUMBER>r masr two alterations synergic effects induction lung fibrosis moreover atii role degradation ace<NUMBER> ubiquitination <NUMBER> sarscovs also enhance expression levels mir<NUMBER>c<NUMBER>p mir<NUMBER> infected cells regarded ace<NUMBER> targeting mirnas <NUMBER> <NUMBER> ace angiotensin converting enzyme acei ace inhibitor angiotensinogen arb angiotensin ii receptor blocker current review discuss expression pattern function ace proteins relation underlying disorders administration certain medications existence common genomic variants within ace genes explain differences response affected individuals sarscov<NUMBER> agreement role ace<NUMBER> virus uptake cells upregulation human ace<NUMBER> increased disease severity mice infected sarscov <NUMBER> moreover injecting sarscov spike mice led downregulation ace<NUMBER> thus aggravating lung injury <NUMBER> <NUMBER> consequently ace<NUMBER> functions cellular receptor sarscov entrance also confers protective mechanism lung injury <NUMBER> based investigations level expression ace<NUMBER> important factor sarscov infection thus comorbid conditions influence expression protein might affect severity disease table <NUMBER> summarizes available data abnormal expression ace ace<NUMBER> human animal disorders several medications shown alter expression levels ace ace<NUMBER> administration medications modify risk infection sarscov also affect disease course table <NUMBER> summarizes results studies reported alteration ace ace<NUMBER> levels following administration certain medications j u r n l p r e p r f several potentially functional gene polymorphisms identified ace ace<NUMBER> table <NUMBER> shows results studies assessed association ace polymorphisms human disorders micorna mirnas regulators gene expression involved several acerelated pathways shown alter expression ace proteins altered ace proteins smallsized rnas bind <NUMBER>′ untranslated region <NUMBER>′ utr targets stimulate degradation target mrna suppress translation moreover mirnas interact <NUMBER>′ utr coding regions promoters thus regulating gene expression various mechanisms secretion mirnas extracellular components provides ability participate cellcell communication <NUMBER> table <NUMBER> shows results studies assessed association mirnas ace proteins hand metaanalysis reported association administration ace inhibitors reduction risk pneumonia notably ace inhibitors may efficient reducing risk pneumonia asian patients also treatment ace j u r n l p r e p r f inhibitors associated significant reduction risk pneumoniarelated mortality compared controls <NUMBER> may also related dual effect ace<NUMBER> viral infection protection acute respiratory distress syndrome although aceace<NUMBER> regulation complicated seems absence ace accumulation angiotensin may lead upregulation ace<NUMBER> whether could facilitate viral infection plausible ace<NUMBER> considered specific target coronavirus treatment <NUMBER> means populationbased differences ace<NUMBER> expression may affect efficacy future antiviral treatment brief summarize coronaviruses sarscov sarscov<NUMBER> utilize ace<NUMBER> receptor cell entry infection know severe consequence expression addition routine models investigation pathological events infections tissue engineering methods particularly advanced biomaterials functionalized scaffolds <NUMBER> would provide study models investigate potential approaches treatment disorder advance field functional studies obtained results safe invitro models work without additive applied human models <NUMBER> taken together data presented show diversity factors modulate ace severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> novel highly pathogenic human coronavirus recently recognized cause coronavirus disease <NUMBER> outbreak sparked wuhan capital city hubei province china spread rapidly countries reaching devastating pandemic proportion <NUMBER> italy one hardest hit countries covid<NUMBER> <NUMBER> laboratoryconfirmed cases may <NUMBER> <NUMBER> <NUMBER> clinical course covid<NUMBER> may complicated several lifethreatening conditions including sepsis respiratory failure heart failure acute kidney cardiac injury septic shock <NUMBER> little still known patient clinical characteristics predisposing occurrence lifethreatening conditions acute distress respiratory syndrome ards one frequent encountered complication covid<NUMBER> associated significantly lower patients survival hospitalization although pathophysiology completely understood interplay inflammation coagulation seems central role <NUMBER> whether antiinflammatory drugs anticoagulants might influence onset ards yet investigated aim multicenter study evaluate prevalence antithrombotic therapies admission patients covid<NUMBER> potential association antithrombotic therapy ards disease clinical presentation inhospital mortality admission patients underwent medical history physical examination laboratory evaluation chest xray andor computed tomography ct scan also performed rule pneumonia one multiple sites covid<NUMBER> population divided two groups according diagnosis isolated pneumonia pneumonia ards according inhospital mortality ards diagnosis defined according berlin definition <NUMBER> prevalence type antithrombotic therapy compared groups discontinuation antithrombotic therapy hospitalization considered exclusion criterion institutional ethics committee approved protocol verbal written informed consent participation provided patients distribution continuous data tested kolmogorovsmirnov shapirowilk test normally distributed variables expressed mean ± standard deviation sd whereas nonnormal distributed ones median interquartile range iqr categorical variables reported numbers percentages continuous normallydistributed variables compared using student ttest differences nonnormally distributed variables tested mannwhitney u test categorical variables compared chisquared test fisher exact test appropriate unadjusted adjusted risk ratios rr outcomes interest calculated using logistic regression models presented rr <NUMBER> confidence intervals ci used propensity score weighting account potential selection bias treatment assignment two study groups average treatment effect weights propensity score model developed incorporating preprocedural covariates potentially related outcome andor treatment decision regardless statistical significance collinearity variables included model following baseline covariates j u r n l p r e p r f included propensity score model age smoke chronic obstructive pulmonary disease copd hypertension diabetes coronary artery disease cad heart failure obesity dyslipidemia stroke chronic kidney disease ckd weighting standardized mean differences calculated assess balance covariates included propensity score model values higher <NUMBER> considered statistically significant differences among groups test p value <NUMBER> considered statistically significant analysis performed using r version <NUMBER> r foundation statistical computing vienna austria characteristics study population reported table <NUMBER> figure <NUMBER> shows proportion death according preadmission antiplatelet anticoagulant therapy spite significant differences among survived survived covid<NUMBER> patients baseline characteristics inverse probability weighting produced good covariate balance absolute standardized differences less <NUMBER> variables figure <NUMBER> shows graphically antiplatelet anticoagulant arms balanced terms allocation probability respect patients taking antithrombotic drugs admission unadjusted adjusted regression models risk ards death according preadmission antithrombotic therapy reported table <NUMBER> preadmission antithrombotic therapy antiplatelets anticoagulants result associated increased risk ards admission inhospital mortality covid<NUMBER> patients main findings present study summarized follows large proportion patients admitted covid<NUMBER> treatment antithrombotic agents antithrombotic therapy stratified patients older age higher prevalence comorbidities patients survived older showed higher prevalence comorbidities neither antiplatelet therapy anticoagulant therapy affected risk severe clinical presentation ards admission death hospitalization among study population including italian hospitalized covid<NUMBER> patients confirmed epidemiological association cardiovascular risk cv factors individual susceptibility sarscov<NUMBER> infection previously described chinese american cohort studies <NUMBER> <NUMBER> particularly hypertension diabetes coronary artery disease j u r n l p r e p r f prevalent comorbidities moreover previously showed early chinese data <NUMBER> <NUMBER> prevalence cv diseases particular hypertension significantly increased critically ill covid<NUMBER> patients ards compared milder forms disease way hypertension cad significantly increased nonsurvived covid<NUMBER> patients compared survivors among study population af prevalence preexisting comorbidity admission <NUMBER> higher expected general population <NUMBER> however difference af prevalence shown covid<NUMBER> patients severe form disease characterized ards poor clinical outcome pathogenesis ards clinical context covid<NUMBER> may related direct effect sarscov<NUMBER> alveolar epithelial cells indirect effects infectionrelated hypoxia conditions predisposing thrombotic events moreover preliminary reports <NUMBER> <NUMBER> suggest severe inflammatory response disseminated intravascular coagulation dic may occur covid<NUMBER> patients predisposing microvascular pulmonary thrombosis based pathophysiological hypothesis covid<NUMBER>induced ards patients may driven microvascular thrombotic processes decided investigated preadmission antithrombotic therapy including antiplatelet anticoagulant drugs might impact clinical course prognosis hospitalized covid<NUMBER> patients present analysis antithrombotic therapy admission influence clinical presentation covid<NUMBER> terms ards inhospital mortality results suggest pathophysiology microvascular pulmonary thrombosis clinical context covid<NUMBER>induced pneumonia influenced preadmission antithrombotic treatment probably due complex interplay clotting system activation sarscov<NUMBER> immunomediated inflammatory response two processes mutually reinforce coronavirus disease <NUMBER> covid<NUMBER> outbreak spread across world <NUMBER> million confirmed cases <NUMBER> early reports clinical characteristics identified hypertension common comorbidity reported covid<NUMBER> patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> zhou et al documented preexisting hypertension risk factor inhospital death covid<NUMBER> <NUMBER> observation great interest since reninangiotensin system ras important component regulating blood pressure transmembrane angiotensinconverting enzyme <NUMBER> ace<NUMBER> catalyzes cleavage angiotensin ii vasoconstrictor vasodilatory peptides also cellular entry receptor sarscov<NUMBER> given common use angiotensinconverting enzyme inhibitors aceis angiotensin ii receptor blockers arbs patients cardiovascular diseases <NUMBER> wide discussion whether administration aceiarb might modulate covid<NUMBER> disease severity concerns raised whether hypertensive patients stop taking aceiarb switch antihypertensive drugs context covid<NUMBER> pandemic <NUMBER> <NUMBER> also counterarguments favor use aceiarb covid<NUMBER> patients based previous studies showing aceiarb associated improvements pneumoniarelated outcomes <NUMBER> <NUMBER> well protective role arbs sarscov influenza infected animals <NUMBER> <NUMBER> reninangiotensin system ras plays central role regulating blood pressure maintaining hemodynamic homeostasis hypovolemic conditions angiotensinogen serially cleaved renin angiotensinconverting enzyme ace angiotensin ang angiotensin ii ang ii respectively ang ii acts cellular receptor angiotensin ii receptor at<NUMBER> constrict blood vessels increases blood pressure fig <NUMBER> counteract vasoconstrictive effect ras fig <NUMBER> physiology aceangiiat<NUMBER> ace<NUMBER>ang <NUMBER> mas axes schematic structures angiotensin derivatives threeletter codes used represent amino acid residues b physiology angiotensin processing blood regulation hypovolemic conditions renin secreted cells macula densa kidney cleaves angiotensinogen decapeptide angiotensin ang angiotensinconverting enzyme ace cleaves peptide octapeptide angiotensin ii ang ii acts cellular receptor angiotensin ii receptor at<NUMBER> constrict blood vessels increases blood pressure yang ace<NUMBER> monocarboxypeptidase transforming ang ii angiotensin<NUMBER> ang <NUMBER> binds g proteincoupled receptor mas dilate blood vessels counterbalance aceang ii blood pressure regulation yin figure generated biorender human body developed another system exquisite yinyang balance ace<NUMBER> homolog ace <NUMBER> <NUMBER> metabolizes ang ii angiotensin<NUMBER> ang <NUMBER> dilates blood vessels counterbalance aceang ii blood pressure regulation <NUMBER> fig <NUMBER> note rat model lipopolysaccharideinduced acute respiratory distress syndrome ards reduced pulmonary levels ang <NUMBER> contribute disease pathogenesis administration peptide arb losartan reduces development ards <NUMBER> nonangiotensinase function ace<NUMBER> recognized identified cellular receptor severe acute respiratory syndrome coronavirus sarscov <NUMBER> well recently sarscov<NUMBER> <NUMBER> <NUMBER> <NUMBER> ace<NUMBER> expression documented various human organs including oral nasal mucosa lung intestine kidney heart arterialvenous endothelium others <NUMBER> <NUMBER> <NUMBER> <NUMBER> highquality clinical evidence aceiarb usage covid<NUMBER> patients insufficient draw definitive conclusions whether chronic aceiarb continued stopped <NUMBER> several recent retrospective hospitalbased studies reported adverse marginal protective effect aceiarb clinical outcomes covid<NUMBER> patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> contribute discussion performed secondary analysis previouslyreported singlecenter retrospective cohort covid<NUMBER> patients wuhan china <NUMBER> previously collected data <NUMBER> hospitalized adult covid<NUMBER> patients admitted jinyintan hospital wuhan china definite outcome dead discharged december <NUMBER> <NUMBER> february <NUMBER> <NUMBER> <NUMBER> data extracted medical records electronic data collection form two independent researchers electronic medical records screened medical history hypertension past medical history admitting diagnosis oral antihypertensive treatment hospitalization antihypertensive treatments included analysis acei arb βblockers calcium channel blockers ccbs diuretics others αblockers traditional chinese medicine patients definitive longterm antihypertensive treatments either recorded medical history prescribed medication chart standing order hospitalization included final analysis comorbidities either selfreported patients evaluated attending physicians recorded admitting diagnosis study approved research ethics commission jinyintan hospital ky<NUMBER> informed consent waived research ethics commission fever defined axillary temperature least <NUMBER>°c sepsis septic shock evaluated based sepsis<NUMBER> international consensus <NUMBER> ards diagnosed according berlin definition <NUMBER> acute kidney injury defined according kdigo clinical practice guidelines <NUMBER> diagnosis acute cardiac injury made serum levels highsensitive cardiac troponin <NUMBER>th percentile upper reference limit <NUMBER> secondary infection hypoproteinemia coagulopathy defined previously <NUMBER> continuous variables expressed median interquartile range iqr categorical variables number proportion twogroup comparisons aceiarb vs nonaceiarb conducted mannwhitney u test c <NUMBER> fisher exact test appropriate risk death icu admission invasive mechanical ventilation corresponding odds ratio without adjustment age gender calculated logistic model comparing patients aceiarb group nonaceiarb group four previouslyreported risk factors death age history diabetes qsofa score ddimer included univariable multivariable analysis logistic model <NUMBER>sided α less <NUMBER> considered statistically significant statistical analyses conducted using sas software version <NUMBER> sas institute spss software version <NUMBER> ibm total <NUMBER> adult laboratoryconfirmed covid<NUMBER> patients admitted jinyintan hospital definite clinical outcome february <NUMBER> <NUMBER> screened study <NUMBER> patients medical history hypertension among <NUMBER> patients antihypertensive treatment medications recorded medical records included final analysis schematic patient selection shown fig <NUMBER> patients took acei arb part antihypertensive therapy included aceiarb cohort n <NUMBER> without categorized nonaceiarb cohort n <NUMBER> patients aceiarb group nonaceiarb group comparable age median <NUMBER> vs <NUMBER> years p <NUMBER> gender distribution male <NUMBER> vs <NUMBER> p <NUMBER> shown table <NUMBER> also similar phase disease median time symptom onset admission <NUMBER> days iqr <NUMBER> days <NUMBER> days iqr <NUMBER> days respectively addition hypertension patients two groups also shared similar proportions comorbidities smoking history vital signs laboratory test results admission generally similar two groups table <NUMBER> comparable proportions patients two groups lymphocyte count less <NUMBER> â <NUMBER> <NUMBER> l <NUMBER> vs <NUMBER> p <NUMBER> increased serum cardiac troponin <NUMBER> vs <NUMBER> p <NUMBER> increased serum ddimer levels <NUMBER> vs <NUMBER> p <NUMBER> percentages heart failure defined brain natriuretic peptide bnp value ≥ <NUMBER> pgml admission also similar among two groups <NUMBER> vs <NUMBER> p <NUMBER> values inflammatory markers including serum ferritin procalcitonin interleukin<NUMBER> different two groups chest imaging features distinguishable sequential organ failure assessment sofa scores aceiarb group median <NUMBER> iqr <NUMBER> numerically smaller nonaceiarb group median <NUMBER> iqr <NUMBER> although difference statistically significant p <NUMBER> among <NUMBER> patients recorded antihypertensive medication <NUMBER> cases therapies based aceiarb either monotherapy combined βblockers ccb thiazide diuretics spironolactone tables <NUMBER> <NUMBER> usage sacubitrilvalsartan reported cohort nonaceiarb therapy mostly based calcium channel blockers tables <NUMBER> <NUMBER> usage antihypertensive medications αblocker βblocker diuretics comparable two groups table <NUMBER> similar percentages patients optimal blood pressure control based vital signs taken admission table <NUMBER> chronic treatment ras antagonists associated statistically significant changes serum electrolyte sodium potassium serum creatinine levels table <NUMBER> compared hypertensive patients given aceiarb observed significant differences percentages inhospital mortality <NUMBER> vs <NUMBER> p <NUMBER> icu admission <NUMBER> vs <NUMBER> p <NUMBER> mechanical ventilation <NUMBER> vs <NUMBER> p <NUMBER> receiving regimen included acei arb note percentages major outcomes uniformly smaller aceiarb group similarly numerically fewer patients aceiarb group developed respiratory failure <NUMBER> vs <NUMBER> p <NUMBER> sepsis <NUMBER> vs <NUMBER> p <NUMBER> ards <NUMBER> vs <NUMBER> p <NUMBER> heart failure n coronary heart disease n <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> respiratory rate<NUMBER> min n <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> creatinine<NUMBER> mmoll n <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> hospitalization hospital length stay duration viral shedding discharged patients similar aceiarb nonaceiarb groups table <NUMBER> include nonsurvivors analysis viralshedding duration previously reported nonsurvivors prolonged viral shedding death <NUMBER> multivariable analysis adjusted age gender provide statistical evidence association aceiarb treatment severe clinical outcome covid<NUMBER> patients table <NUMBER> previously reported total population <NUMBER> older age increased ddimer values <NUMBER>µgml higher qsofa scores associated higher risks inhospital mortality hypertensive covid<NUMBER> patients logistic model table <NUMBER> hypothesis acei arb treatment changes covid<NUMBER> disease progression based part potential impact ras antagonists ace<NUMBER> expression theoretically administration acei arb impact ace<NUMBER> expression activity first shown aceis affect ace<NUMBER> activity <NUMBER> terms ace<NUMBER> expression olmesartan aceis arbs calcium channel blockers found increase urinary ace<NUMBER> levels hypertensive patients <NUMBER> <NUMBER> also acei treatment reported increase serum ace<NUMBER> activity diabetic patients <NUMBER> yet soluble ace<NUMBER> sace<NUMBER> levels always reflect tissue ace<NUMBER> expression lung organs fact reasonable hypothesize sace<NUMBER> may even negatively correlate tissue ace<NUMBER> since sace<NUMBER> cleaved membranebound enzyme released blood stream also noted increase ace<NUMBER> enzymatic activity always match upregulation ace<NUMBER> expression <NUMBER> <NUMBER> therefore change pulmonary tissue ace<NUMBER> acei arb treatment directly studied provide answers question although studies upper respiratory tract ace<NUMBER> expression ace<NUMBER> enzyme activity bronchoalveolar lavage fluid might provide indirect evidence <NUMBER> <NUMBER> hypertensive animal models might surrogate clinical evidence available rat cardiac myocytes ang ii significantly reduces ace<NUMBER> activity downregulates ace<NUMBER> mrna expression effects blocked arb losartan indicating ang ii regulates ace<NUMBER> <NUMBER> mice deficient ace show markedly improved disease ards model induced acid aspiration sepsis recombinant ace<NUMBER> protect mice severe acute lung injury <NUMBER> mice rat models arb treatment consistently increases ace<NUMBER> mrna protein levels heart kidney aorta tissue although effect lung ace<NUMBER> expression studied also effects acei administration ace<NUMBER> expression differs among experiment models tissues <NUMBER> animal models sarscov<NUMBER> infection recapitulate pathogenesis severe covid<NUMBER> needed better understand effects ace inhibitors arbs singlecenter retrospective study observe difference clinical presentations patients without aceiarb treatment admission find important differences severe clinical outcomes namely inhospital death icu admission mechanical ventilation two groups however preliminary analysis limited retrospective nature cohort small sample size possibly nonrecorded data prescription records drugs directly relevant covid<NUMBER> treatment may incomplete patients complete antihypertensive treatment information included analysis strategy excluding half hypertensive cases original hypertensive cohort reduced statistical power study based percentages inhospital mortality icu admission reported cohort around <NUMBER> patients group would necessary provide total <NUMBER> antihypertensive treatment either monotherapy combined therapies one <NUMBER> patients took valsartan benazepril <NUMBER> patients either acei arb monotherapy means angiotensinconverting enzyme inhibitor acei angiotensin ii receptor blocker arb b means βblocker c means calcium channel blocker ccb means diuretics acei refers benazepril cohort arb medications include valsartan irbesartan telmisartan candesartan βblockers used cohort include metoprolol bisoprolol ccbs include amlodipine nifedipine felodipine lacidipine lercanidipine diuretics include hydrochlorothiazide spironolactone uncommon medications listed table terazosin αblocker traditional chinese medicine unspecified formula statistical difference given twotailed α <NUMBER> β <NUMBER> although cohort enough power detect association older age increased covid<NUMBER> mortality table <NUMBER> underpowered marginal effect aceiarb altered clinical outcome association confounding factors including age carefully evaluated drawing final conclusion retrospective analysis noted aceiarb popular antihypertensive drug us <NUMBER> ccbs widely used china <NUMBER> <NUMBER> partially explains high ccb usage nonaceiarb group tables <NUMBER> <NUMBER> adjustment difference ccb prescription aceiarb still show association covid<NUMBER> mortality <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p <NUMBER> observe association ccb usage covid<NUMBER> mortality either cohort data shown preexisting heart failure also assessed ras antagonists including acei arb aldosterone inhibitors basic treatment options chronic heart failure proper multivariable adjustment confounding factors implemented retrospective analysis adjust history heart failure concerning small sample size selfreporting nature factor information viral load patients admission qualitative rtpcr test results available medical records would interesting examine whether chronic acei arb treatment would affect virus replication future studies similar findings association observed aceiarb prescription poor clinical prognosis severe disease covid<NUMBER> several retrospective cohorts china <NUMBER> <NUMBER> <NUMBER> <NUMBER> globally <NUMBER> <NUMBER> <NUMBER> <NUMBER> compared reports patients cohort sicker admission inhospital mortality higher <NUMBER> likely related study hospital referral center severe cases early epidemic wuhan accumulating information multiple large cohort studies seems clear prior receipt acei arb bring additional risks hospital admission poor prognosis covid<NUMBER> discussion therefore gradually shifted whether chronic treatment acei arb covid<NUMBER> onset associated less severe illness acei arb reported protective effect previous metaanalysis pneumoniarelated mortality general <NUMBER> terms covid<NUMBER> de abajo et al found decreased risk covid<NUMBER> hospital admission subgroup analysis diabetic patients ras inhibitors <NUMBER> information large covid<NUMBER> case series preferably populationbased cohort studies optimally linked serologic testing necessary determine whether receipt acei arbs associated reduced risk symptomatic sarscov<NUMBER> infection especially severe covid<NUMBER> illness systematic analysis combining data multiple studies would helpful answering question also randomized clinical trials progress studying efficacy acute initiation acei treatment covid<NUMBER> eg nct<NUMBER> nct<NUMBER> conclusion accumulating evidence association chronic aceiarb treatment severe outcome covid<NUMBER> meanwhile current studies pointing toward putative protective role prior acei arb receipt covid<NUMBER> illness awaits evidence confirmation several professional societies released statements continuing current antihypertensive treatment covid<NUMBER> pandemic <NUMBER> considering risk destabilizing blood pressure changing medications agree best option continue previous therapy wait evidence dr frederick g hayden declares served noncompensated consultant cidara glaxosmithkline gilead sciences restorbio regeneron sab biotherapeutics coronavirus interventions outside submitted work authors declare competing interests study performed accordance helsinki declaration <NUMBER> approved research ethics commission jinyintan hospital ky<NUMBER> informed consent waived research ethics commission abbreviation odds ratio qsofa quick sequential organ failure assessment past <NUMBER> decades witnessed three lethal zoonotic diseases humans caused novel coronaviruses severe acute respiratory syndrome sars <NUMBER> middle east respiratory syndrome mers april <NUMBER> currently coronavirus disease<NUMBER> covid<NUMBER> caused sarscov merscov sarscov<NUMBER> respectively three coronaviruses listed blueprint list priority pathogens <NUMBER> coronaviruses members coronaviridae family heterogeneous family rna viruses cause respiratory tract infections humans hcov<NUMBER>e hcovnl<NUMBER> hcovoc<NUMBER> hcovhku<NUMBER> cause mild infections whilst merscov like sarscov sarscov<NUMBER> cause spectrum clinical manifestations mild severe disease death <NUMBER> ongoing global pandemic sars coronavirus<NUMBER> sarscov<NUMBER> affected almost <NUMBER> millions people continents <NUMBER> high death rate attributed comorbidities diabetes hypertension coronary artery disease amongst others <NUMBER> reninangiotensin system ras blockers extensively used worldwide treat many cardiovascular disorders effective reducing mortality morbidity drugs known induce increased expression angiotensinconverting enzyme <NUMBER> ace<NUMBER> patients diabetes hypertension treated ace inhibitors arbs results upregulation ace<NUMBER> theoretically could enhance sarscov<NUMBER> infection <NUMBER> therefore since sarscov<NUMBER> strongly interacts ace<NUMBER> patients undergoing chronic ras blocker treatment may prone sarscov<NUMBER> infection develop worse forms covid<NUMBER> review discuss aspects viralcell interaction pathophysiology aceisarbs action mechanism lastly suggest scientific rationale continuing ras blockers therapy patients covid<NUMBER> infection thus providing clinicians working emergency setting facing acute cardiovascular diseases following outpatients receiving aceiarbs covid<NUMBER> pandemic basis therapeutic decisionmaking widely described literature <NUMBER> complex reninangiotensin system ras plays crucial role pathophysiology several morbidities hypertension diabetes mellitus myocarditis <NUMBER> heart failure myocardial infarction use ras blockers essential management ace inhibitors aceis andor angiotensin ii receptor blockers arbs delay prevent onset heart failure asymptomatic patients left ventricular systolic dysfunction importantly reduce mortality morbidity patients heart failure reduced ejection fraction patients aceisarbs titrated upper tolerated dose achieve adequate ras inhibition <NUMBER> <NUMBER> recent esc guidelines recommend employing aceisarbs antihypertensive treatment prevent cardiovascular events heart failure diabetic patients particularly cardiovascular complications <NUMBER> also esc guidelines hypertension give ia recommendation employment aceis arbs antihypertensive drugs demonstrated efficacy blood pressure cardiovascular events reduction <NUMBER> hemodynamic changes acute myocardial infarction cause strong activation circulating local ras <NUMBER> adaptive response <NUMBER> could dangerous contributes development cardiac structural electrophysiological remodelling <NUMBER> <NUMBER> effects ras inhibition beneficial <NUMBER> patients myocardial infarction prominent severe patients <NUMBER> one systematic overview including <NUMBER> patients observed significant shortterm survival benefit occurs treatment aceis started within first <NUMBER> days <NUMBER> days <NUMBER> <NUMBER> <NUMBER> days <NUMBER> <NUMBER> <NUMBER> subsequently <NUMBER> line guidelines provide class iaib recommendation commence aceisarbs treatment within first <NUMBER>h acute event stsegment elevation myocardial infarction stemi patients left ventricular systolic dysfunction heart failure anterior stemi diabetes <NUMBER> <NUMBER> treatment aceisarbs also recommended class iaib nonstsegment elevation myocardial infarction nstemi patients left ventricular systolic dysfunction heart failure hypertension diabetes mellitus order reduce mortality risk recurrent ischaemic event hospitalization heart failure <NUMBER> <NUMBER> context sarscov<NUMBER> infection important note aceisarbs increase local expression activity angiotensinconverting enzyme <NUMBER> ace<NUMBER> <NUMBER> zinc metalloprotease exists membraneassociated form secreted form ace<NUMBER> ubiquitously expressed highest levels transcripts found lung heart gastrointestinal urinary systems ace<NUMBER> mostly expressed lung alveolar type ii at<NUMBER> cells myocardial cells vascular endothelia buccal epithelial cells b lymphocytes proximal tubule epithelial cells kidney testes <NUMBER> <NUMBER> cardiac cell components ie endothelial cells smooth muscle cells cardiac myocytes fibroblasts macrophages express ace<NUMBER> although highest levels observed vascular cells especially pericytes <NUMBER> <NUMBER> upregulation ace<NUMBER> expression documented patients affected myocardial infarction heart failure however animal models ageing pressure overload chronic ischaemia ace<NUMBER> downregulation associated cardiac hypertrophy adverse remodelling fibrosis <NUMBER> <NUMBER> <NUMBER> conversely ace<NUMBER> expression reduced hypertension advanced diabetes mellitus atherosclerotic plaques experimentally angiotensin ii ang ii endothelin <NUMBER> <NUMBER> <NUMBER> <NUMBER> importantly estimated heritability accounts <NUMBER> variability ace<NUMBER> circulating levels moreover ace<NUMBER> genetic variants associated essential hypertension coronary heart disease chd whilst act disease modifiers hypertrophic dilated cardiomyopathies <NUMBER> concerning development shown ace<NUMBER> protein levels activity high gestation decline postnatally <NUMBER> ace<NUMBER> acts negative regulator ras degrading angii heptapeptide angiotensin <NUMBER> ang<NUMBER> <NUMBER> exerts biological activity via mas receptor modulating release nitric oxide antagonizing intracellular effect angii stimulation thus tempering production reactive oxygen species least part activating intracellular phosphatases <NUMBER> result ang<NUMBER> exerts many positive effects cardiovascular system eg increased endothelial function reduced fibrosis antiproliferative effects smooth muscle cells anticardiac hypertrophy well organs lungs exerts antifibrotic antiinflammatory antiapoptotic effects <NUMBER> <NUMBER> <NUMBER> moreover ace<NUMBER> cleaves peptides plays central role inactivating desarginine<NUMBER>bradykinin desarg<NUMBER>bk potent metabolite kininkallikrein system increases vascular permeability thus promoting angioedema acting b<NUMBER> type receptors turn upregulated inflammatory cytokines <NUMBER> <NUMBER> according authors leakage plasma subendothelial compartment conjunction inflammatory response triggered hostvirus interaction may central pathogenetic role endotheliitis disseminated intravascular coagulation documented occur covid<NUMBER> patients <NUMBER> <NUMBER> <NUMBER> ace<NUMBER> plays important role heart failure diabetic microvascular macrovascular disease <NUMBER> inflammatory lung disease <NUMBER> aceis arbsmediated increase ace<NUMBER> exerts protective role many conditions atherosclerosis myocardial infarction myocardial dysfunction heart failure diabetes mellitus acute lung injury ali although details completely elucidated yet sarscov<NUMBER> originated either result natural selection took place host zoonotic transfer natural selection humans zoonotic transfer occurred <NUMBER> <NUMBER> importantly selection process virus acquires furin cleavage site three predicted olinked glycans around site likely associated acquisition highly pathogenic phenotype <NUMBER> coronaviruses sarscov sarscov<NUMBER> spike protein binds high affinity human ace<NUMBER> <NUMBER> figure <NUMBER> sarscov<NUMBER> sarscov cell entry protein subjected priming process via serine protease tmprss<NUMBER> order permit attachment viral particles ace<NUMBER> thus cell surface <NUMBER> entry mechanism confirmed fact tmprss<NUMBER> inhibition tmprss<NUMBER>ko mice show decreased though abolished protein priming reduced viral entry spread inflammatory chemokine cytokine release <NUMBER> <NUMBER> sarscov<NUMBER> internalized mainly endocytosis process phosphatidylinositol <NUMBER>phosphate <NUMBER>kinase pikfyve two pore channel subtype <NUMBER> tpc<NUMBER> cathepsin l critical virus entry <NUMBER> sarscov binding also induces releaseshedding catalytically active ace<NUMBER> ectodomains via adam<NUMBER>⁄tace activity <NUMBER> <NUMBER> <NUMBER> <NUMBER> line inhibition adam<NUMBER>tace blocks ace<NUMBER> shedding limits viral entry vitro vivo <NUMBER> intriguingly recent data show soluble ace<NUMBER> sace<NUMBER> could inhibit smediated infection vitro although sace<NUMBER> able completely abrogate viral entry ace<NUMBER> shedding may help contrasting viral diffusion different organs <NUMBER> conversely demonstrated ace<NUMBER> downregulation following infection detrimental effect pathogenesis ali <NUMBER> although effect could limited judging amount ace<NUMBER> expressed at<NUMBER> cells lungs ratio ace<NUMBER> circulating sace<NUMBER> <NUMBER> <NUMBER> <NUMBER> altogether results suggest ace<NUMBER> might receptor sarscov<NUMBER> fact recent structural predictive studies proposed receptormediated mechanisms sarscov<NUMBER> cell entry indicating three aminopeptidases alanyl aminopeptidase anpep glutamyl aminopeptidase enpep dipeptidyl peptidase <NUMBER> dpp<NUMBER> probable additional receptors <NUMBER> <NUMBER> known virus survival strategy elude suppress host innate immune defences gene deactivation inhibition <NUMBER> <NUMBER> <NUMBER> inhibits host gene translation <NUMBER> precisely marked downregulation ace<NUMBER> mrna protein expression associated presence sarscov hcovnl<NUMBER> another human coronavirus causing mild severe respiratory tract infections excluding sars target tissues <NUMBER> however whilst sarscov induced ace<NUMBER> shedding cell surface hcovnl<NUMBER> suggesting ace<NUMBER> shedding directly related prognostic severity <NUMBER> <NUMBER> <NUMBER> additionally viral titreand infection timerelated sarscov effect ace<NUMBER> mrna shown lower viral titre associated upregulation instead higher dosage time infection correlated reduced ace<NUMBER> expression <NUMBER> last since interleukin il<NUMBER> il<NUMBER> il<NUMBER> gcsf ip<NUMBER> mcp<NUMBER> mip<NUMBER>a tnfa highly increased patients severe sarscov infection respect patients mild symptoms hypothesized ace<NUMBER> suppression could result direct cell driven effect rather virus mediated line vitro data could support suppressive role il<NUMBER> il<NUMBER> ace<NUMBER> expression <NUMBER> part conundrum related role ace<NUMBER> sarscov<NUMBER> infection designated coronavirus disease<NUMBER> covid<NUMBER> related role exerted enzyme ali indeed ali caused number aetiological agents eg influenza coronaviruses bacterial pneumonia sepsis <NUMBER> cigarette smoking <NUMBER> particulate matter <NUMBER> aspiration pneumonia <NUMBER> associated activation local ras <NUMBER> ang ii acting angii type <NUMBER> receptor at<NUMBER>r activates several signal transduction pathways including mitogenactivated protein kinase mapk janusactivated kinase jak signal transducer activator transcription <NUMBER> stat<NUMBER> phosphatidylinositol <NUMBER> kinase pi<NUMBER>k promoting vascular permeability vasoconstriction myofibroblast smooth muscle cell macrophage activation fibrosis expression inflammatory cytokines <NUMBER> <NUMBER> <NUMBER> latter effect mainly attributed ability angii activate transcription factor nfjb via at<NUMBER>r <NUMBER> angii may also bind receptors studied type <NUMBER> receptor at<NUMBER>r however net effect at<NUMBER>r stimulation less clear since proand antiinflammatory effects described <NUMBER> corroborate crucial role exerted pulmonary ras ali shown angii levels increased animal models ali <NUMBER> importantly recent reports sarscov<NUMBER>infected patients showed significant increase ang ii plasma level inversely correlated viral load <NUMBER> line survivors acute respiratory distress syndrome ards associated lower plasmatic ace levels preliminary report <NUMBER> moreover evaluating levels angiotensinogen metabolites shown ards outcome associated higher ang<NUMBER>ang<NUMBER> ang<NUMBER>ang<NUMBER> ratios suggesting higher activity ace ace<NUMBER> survivors <NUMBER> conversely at<NUMBER>r blockage resulted protection animal models lung injury <NUMBER> accumulating body literature showing protective role exerted ace<NUMBER> ali indeed ace<NUMBER> knockout animals develop severe forms ali response series injurious stimuli <NUMBER> <NUMBER> <NUMBER> conversely results clinical trials experimented administration soluble ace<NUMBER> treat patients suffering ards although early phase designed test efficacy show promising results <NUMBER> moreover anticipated ace<NUMBER> downregulation causes also accumulation desarg<NUMBER>bk interacts type b<NUMBER> bradykinin receptor possibly leading observed development angioedema coagulation cascade triggering <NUMBER> last protective effect ace<NUMBER> may also postulated considering ace<NUMBER> levels decrease age although children vulnerable infection patients usually less severe <NUMBER> relevance myocardial involvement sarscov<NUMBER> infection related high frequency patients showing evidence acute cardiac injury especially amongst necessitated icu care <NUMBER> finding similar observed patients succumbed sars crisis toronto duration disease almost <NUMBER> times shorter patients showed cardiac involvement vs evidence cardiac infection <NUMBER> line recent report suggests sarscov<NUMBER> infection complicated acute fulminant myocarditis <NUMBER> scenario left ventricular function completely recovered early immunomodulation therapy <NUMBER> suggesting organ damage patients consequence cytokine storm uncontrolled viral replication <NUMBER> <NUMBER> <NUMBER> complete picture presence viral particles infecting myocardial interstitial cells neither endothelial cells myocytes recently described occur one patient died covid<NUMBER> clinical scenario characterized respiratory distress hypotension cardiogenic shock <NUMBER> consistently sarscov<NUMBER>infected patients characterized high amounts plasmatic il<NUMBER>b ifnc ip<NUMBER> mcp<NUMBER> levels additionally severe patients higher concentrations gcsf ip<NUMBER> mcp<NUMBER> mip<NUMBER>a tnfa strongly supporting relevance cytokines dictating prognosis <NUMBER> observation stimulated early trials experimenting il<NUMBER> axis inhibition covid<NUMBER> patients <NUMBER> cytokinemediated systemic response infections associated transient cardiac dilatation dysfunction <NUMBER> however local viral replication could depress cardiac function indeed sarscov activate nlrp<NUMBER> inflammasome <NUMBER> thus promoting release il<NUMBER>b possibly il<NUMBER> mediator known cause systolic impairment <NUMBER> notably extrapulmonary multiorgan sarscov dissemination time death described patients died sars toronto outbreak <NUMBER> sarscov viral rna detected <NUMBER> cardiac autopsy samples <NUMBER> <NUMBER> histology studies conducted hearts showed cardiomyocyte hypertrophy fibrosis inflammatory infiltrate mainly constituted cd<NUMBER> macrophages <NUMBER> however necropsy <NUMBER>yearold woman died sarscov severe left ventricular dysfunction echocardiographic evaluation shown slight left ventricular enlargement without evidence interstitial lymphocytic infiltrate cardiomyocyte necrosis <NUMBER> importantly one postmortem cardiac specimen <NUMBER>yearold patient died sarscov<NUMBER> infection limited interstitial mononuclear cell infiltrates without significant injury described <NUMBER> similar findings characterized cd<NUMBER> macrophage infiltrates showing evidence cytopathic effect recently reported case report <NUMBER>yearold patient died covid<NUMBER> <NUMBER> paucity lymphocyte infiltrate observed reports may explained severe lymphopenia accompanies covid<NUMBER> <NUMBER> mechanism negative effect myocardial tissue sarscov infection hypothesized related ace<NUMBER> downregulation cytokine storm <NUMBER> <NUMBER> outlined ace<NUMBER> expression may reduced binding sarscov ace<NUMBER> leading endocytosis latter <NUMBER> result activation adam<NUMBER>tace sars spike protein known cleave internalize promote ace<NUMBER> shedding endothelial cells <NUMBER> downregulation ace<NUMBER> results unbalance detrimental action angii cardioprotective effects ang<NUMBER> chronic negative consequences cardiovascular system might related ace<NUMBER> downregulation via desarg<NUMBER>bk accumulation consequential increase vascular permeability inflammation leads increased atherosclerotic plaques formation <NUMBER> adam<NUMBER>⁄tace activation induced spike protein promotes tnfa release thus increasing macrophage mobilization activation <NUMBER> <NUMBER> moreover sarscov nucleocapsid n protein potentiates tgfbmediated fibrosis <NUMBER> basis increase ace<NUMBER> associated aceisarbs treatment speculated drugs might rise chances severe covid<NUMBER> <NUMBER> according last report <NUMBER> th april <NUMBER> italian istituto superiore di sanit <NUMBER> patients positive sarscov<NUMBER> died observed mortality higher amongst males age groups patients comorbidities <NUMBER> total sample data regarding comorbidities available <NUMBER> deceased patients <NUMBER> comorbidities arterial hypertension <NUMBER> diabetes mellitus <NUMBER> chd <NUMBER> similar data regarding comorbidities gender differences mortality observed china covid<NUMBER> emergency <NUMBER> prior hospitalization <NUMBER> covid<NUMBER>positive deceased italian patients treatment aceis <NUMBER> receiving arbs gender difference mortality could related smoking prevalence sexbased immunological differences moreover recent study suggests ace<NUMBER> expression seems higher women men decrease age <NUMBER> <NUMBER> <NUMBER> severe prognosis patients older age may also related distinct mechanisms ageassociated decline molecular machinery involved removing cytosolic dna <NUMBER> also patients hypertension diabetes show high rate ace<NUMBER> genetic polymorphism could influence ace<NUMBER> ang<NUMBER> levels human body <NUMBER> <NUMBER> <NUMBER> <NUMBER> therefore negative correlation ace<NUMBER> expression mortality suggested <NUMBER> indications aceisarbs treatment change patients covid<NUMBER> enormous body literature shows aceis arbs given early possible patients acute myocardial infarction asymptomatic patients left ventricular systolic dysfunction patients heart failure reduced ejection fraction well hypertensive diabetic patients important benefits patient survival conversely abrupt discontinuation aceis survivors myocardial infarction longterm treatment <NUMBER> <NUMBER> patients heart failure <NUMBER> potentially harmful time pandemic covid<NUMBER> experimental strong clinical data contraindicate therapy whilst contrary supporting opposite <NUMBER> <NUMBER> calcium channel blockers suggested alternative treatment aceis arbs <NUMBER> however since development progression remodelling process myocardial infarction setting heart failure hypertension diabetes mellitus depends neurohormonal activation medications block effect neurohormones <NUMBER> demonstrated reduce morbidity mortality patients calcium channel blockers spite beneficial hemodynamic activities evidence supporting ability exert favourable effect early acute myocardial infarction preventing heart failure diabetics hypertension general mortality reduction <NUMBER> <NUMBER> <NUMBER> lastly calcium channel blockers strong interaction antiviral drugs lopinavirritonavir used treat covid<NUMBER> patients recent retrospective observational study wuhan including <NUMBER> hypertensive subjects affected covid<NUMBER> treatment aceisarbs associated lower allcause mortality <NUMBER> furthermore large populationbased casecontrol study performed lombardy ongoing covid<NUMBER> epidemic spread <NUMBER> covid<NUMBER> patients show evidence use either arbs aceis affects risk covid<NUMBER> infection <NUMBER> italian regulatory agency aifa recommended <NUMBER> march <NUMBER> modify therapy progress antihypertensives whatever therapeutic class wellcontrolled hypertensive patients expose frail patients potential new side effects increase risk adverse cardiovascular events appear justified reasons compared hypothesis using ace inhibitors sartans also healthy people prophylactic purposes remembered drugs used exclusively treatment pathologies approved <NUMBER> depicted figure <NUMBER> interaction sarscov<NUMBER> host cell promotes series complex alterations leading downregulation ace<NUMBER> expression increased production release inflammatory cytokines net loss ace<NUMBER>ang<NUMBER> antiinflammatory properties along dysregulated vascular permeability ace<NUMBER>desarg<NUMBER>bk mediated proinflammatory properties secreted cytokines may therefore responsible large part detrimental effects caused covid<NUMBER> taking account evidences presented review present data demonstrating adverse outcomes amongst covid<NUMBER> patients therapy acearbs contrary seems treatment discontinuation could plausible negative effects thus according recommendations main cardiovascular international <NUMBER> <NUMBER> italian scientific societies <NUMBER> <NUMBER> patients chronically taking aceiarbs contract covid<NUMBER> infection discontinue treatment neither temporarily figure <NUMBER> researches needed indagate uncleared controversial aspects pandemics first report related ongoing pandemic coronavirus dis <NUMBER> january <NUMBER> world health organization declared outbreak public health emergency international concern <NUMBER> january <NUMBER> elevated level emergency recognizing pandemic <NUMBER> march <NUMBER> <NUMBER> thus far <NUMBER> million confirmed covid<NUMBER> cases <NUMBER> <NUMBER> related deaths reported worldwide <NUMBER> yan et al reported trimer spike glycoprotein virion surface docking onto angiotensinconverting enzyme ace <NUMBER> dimer structure essential step attack sarscov<NUMBER> human cells leads systemic organ injury <NUMBER> <NUMBER> sarscov<NUMBER>ace<NUMBER> interaction generated great interest development reninangiotensin system rasbased therapeutic strategies covid<NUMBER> <NUMBER> ras key hormone system regulates blood pressure fluid electrolyte balance systemic vascular function particularly maintaining plasma sodium concentration arterial blood pressure extracellular volume <NUMBER> organs ras activation result hypertension inflammation cell proliferation fibrosis <NUMBER> <NUMBER> manipulating ras stabilizing renin angiotensin ii ang ii levels promoting ace<NUMBER> expression prevent numerous chronic acute diseases <NUMBER> <NUMBER> <NUMBER> <NUMBER> ras signal transduction system regulated two main axes aceang iiang ii type <NUMBER> receptor at<NUMBER>r axis promotes vasoconstriction hypertension inflammation fibrosis proliferation b ace<NUMBER>ang <NUMBER>mas axis induces opposite effects aceang iiat<NUMBER>r axis activation inhibit detrimental consequences figure <NUMBER> several studies indicated circulating ang ii levels signifi f g u r e <NUMBER> steadystate ras normal physiological conditions ras signal transduction system activated via aceang iiat<NUMBER>r axis promotes vasoconstriction hypertension inflammation fibrosis proliferation studies biological functions at<NUMBER>r receptor ang ii scant although at<NUMBER>r activation induces effects opposite at<NUMBER>r activation at<NUMBER>r expression lower at<NUMBER>r expression adult tissues functions ang ii performed via at<NUMBER>r ace<NUMBER>ang <NUMBER>mas axis induces opposite effects suppress harmful effects aceang iiat<NUMBER>r axis induction recent cohort study <NUMBER> <NUMBER> confirmed cases china reported considerably increased mortality rate patients covid<NUMBER> cardiovascular disease <NUMBER> diabetes <NUMBER> hypertension <NUMBER> compared comorbidities <NUMBER> <NUMBER> <NUMBER> addition analysis medical records <NUMBER> patients died due covid<NUMBER> italy revealed <NUMBER> patients comorbidities <NUMBER> moreover <NUMBER> patients approximately half least three comorbidities approximately onequarter two comorbidities approximately onequarter one comorbidity <NUMBER> moreover approximately <NUMBER> hypertension approximately <NUMBER> diabetes approximately <NUMBER> heart disease <NUMBER> <NUMBER> therefore hypothesize higher mortality rate patients covid<NUMBER> comorbidities may attributable two hits ras first hit originates chronic inflammation activates aceang iiat<NUMBER>r axis ras lung primary target sarscov<NUMBER> infection mainly large surface area high ace<NUMBER> expression alveolar epithelial type ii cells addition highly expressed lungs ace<NUMBER> highly expressed tissues heart kidney endothelial intestinal tissues might explain multiple organ dysfunction noted patients covid<NUMBER> <NUMBER> one study indicated low covid<NUMBER> severity patients hypertension receiving ace inhibitors acei angiotensinreceptor blockers arb moreover patients tended low blood interleukin <NUMBER> levels <NUMBER> compared antihypertensive drugs acei arb use also reported increase blood cd<NUMBER> cd<NUMBER> tcell counts reduce peak viral load <NUMBER> finally ace<NUMBER> activation reduce severity lipopolysaccharideinduced acute lung injury via activated serinethreonine protein kinase ampkmammalian targetofrapamycin mtor pathway <NUMBER> regulation ras may serve therapeutic target covid<NUMBER> treatment therefore underlying mechanism effects requires urgent clarification f g u r e <NUMBER> two hits ras chronic inflammation covid<NUMBER> infection aceang iiat<NUMBER>r axis ras activated chronic inflammation including hypertension diabetes obesity cancer furthermore sarscov<NUMBER> induces ace<NUMBER> internalization shedding lead inactivation ace<NUMBER>ang <NUMBER> mas axis therefore two hits ras may primary reason mortality rate high among patients covid<NUMBER> comorbidities brief first hit originates chronic inflammation activating aceang iiat<NUMBER>r axis second hit originates covid<NUMBER> infection inactivating ace<NUMBER>ang <NUMBER>mas axis entry sarscov<NUMBER> cells mediated efficient binding spike viral protein <NUMBER> amino acid long protein belongs viral envelope protrudes outwards corona like appearance angiotensin converting enzyme <NUMBER> ace<NUMBER> receptors <NUMBER> <NUMBER> ace<NUMBER> receptor discovered two independent groups year <NUMBER> <NUMBER> <NUMBER> transmembrane type glycoprotein monocarboxypeptidase composed <NUMBER> amino acids uses single extracellular catalytic domain remove one single amino acid octapeptide angiotensin ii generate angiotensin <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> ace<NUMBER> receptor also converts angiotensin angiotensin <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> turn converted angiotensin <NUMBER> ace neprilisin figure <NUMBER> catalytic efficiency ace<NUMBER> <NUMBER> times higher angiotensin ii angiotensin <NUMBER> ace<NUMBER> shows <NUMBER> structural identity ace <NUMBER> although aceinhibitors block ace<NUMBER> different conformational structure catalytic site <NUMBER> ace<NUMBER> mediates cell entry three strains coronavirus sarscov nl<NUMBER> sarscov<NUMBER> <NUMBER> notably sarscov sarscov<NUMBER> share <NUMBER> identity amino acid sequence <NUMBER> thereby explaining propensity viruses binding ace<NUMBER> structural variations human ace<NUMBER> identified characterized lower binding affinity spike viral protein potential protective implications <NUMBER> first step viral entry process binding nterminal portion viral protein unit s<NUMBER> pocket ace<NUMBER> receptor second step believed utmost importance viral entry protein cleavage s<NUMBER> s<NUMBER> units operated receptor transmembrane protease serine <NUMBER> tmprss<NUMBER> member hepsintmprss subfamily <NUMBER> tmprss<NUMBER> stechiometrically contiguous ace<NUMBER> receptor <NUMBER> cleavage viral protein tmprss<NUMBER> crucial step s<NUMBER> detachment remaining viral s<NUMBER>unit undergoes conformational rearrangement drives completes fusion viral cellular membrane subsequent entry virus cell release content replication infection cells importance tmpsrr<NUMBER> supported evidence entry sarscov sarscov<NUMBER> cells partially blocked camostat mesylate inhibitor tmpsrr<NUMBER> <NUMBER> <NUMBER> site ace<NUMBER> receptors ace<NUMBER> genes map x chromosome <NUMBER> expression seems higher asian white africanamerican people <NUMBER> receptors ubiquitous particular ace<NUMBER> receptors expressed heart endothelium coronary arteries myocites fibroblasts epicardial adipocites vessels vascular endothelial smooth cells gut intestinal epithelial cells lung tracheal bronchial epithelial cells type <NUMBER> pneumocytes macrophages kidney luminal surface tubular epithelial cells testis brain <NUMBER> <NUMBER> <NUMBER> <NUMBER> lung wide surface alveolar epithelial cells might explain vulnerability organ consequences virus invasion ace<NUMBER> mostly bound cell membranes scarcely present circulation soluble form disintegrin metalloproteinase <NUMBER> adam<NUMBER> upregulated angiotensin ii type <NUMBER> receptors at<NUMBER> receptors cleaves membraneanchored ace<NUMBER> thereby releasing circulating active form ace<NUMBER> loss catalytically activity remaining part enzyme anchored membrane <NUMBER> elevated circulating levels soluble ace<NUMBER> markers different disease states characterized increased activity reninangiotensin system associated worse prognosis <NUMBER> <NUMBER> <NUMBER> ace<NUMBER> angels devils current sarscov<NUMBER> pandemic ace<NUMBER> receptors considered devils entry door virus evidence phenomenon strong convincing hoffmann et al <NUMBER> walls et al <NUMBER> provided unequivocal evidence sarscov<NUMBER> gain access cells ace<NUMBER> receptors happened sarscov <NUMBER> evidences complete picture example mouse model sarscov infection virus entry enhanced overexpression ace<NUMBER> <NUMBER> antiace<NUMBER> antibodies antiace antibodies able block sarscov viral invasion <NUMBER> also blocked n<NUMBER>aminoethil<NUMBER> aziridineethamine specific ace<NUMBER> inhibitor <NUMBER> pulmonary lesions induced experimental sarscov infection less aggressive ace<NUMBER>knockout mice wildtype mice <NUMBER> time however ace<NUMBER> receptors exert salutary biological functions turn angels several aspects pivotal protective function ace<NUMBER> degradation angiotensin ii <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> although ace<NUMBER> able metabolize biological peptides including desarg<NUMBER>bradykinin <NUMBER> degradation angiotensin ii angiotensin <NUMBER> blocked selective ace<NUMBER> inhibitors like mln<NUMBER> <NUMBER> understand relevance angiotensin ii degradation ace<NUMBER> results important review biological effects angiotensin ii angiotensin ii serves potent vasoconstrictor stimulant aldosterone release different experimental clinical models angiotensin ii triggered variety important adverse reactions included myocardial hypertrophy dysfunction interstitial fibrosis endothelial dysfunction enhanced inflammation obesityassociated hypertension oxidative stress increased coagulation <NUMBER> <NUMBER> <NUMBER> <NUMBER> detailed discussion mechanisms angiotensin ii mediates reactions purposes review current pandemic sarscov<NUMBER> infection associated pulmonary inflammation acute respiratory distress syndrome ards interesting note angiotensin ii also interferes adaptive immunity activating machrophages <NUMBER> cells immune system consequent increased production il<NUMBER> <NUMBER> tnfα inflammatory citokynes <NUMBER> <NUMBER> important remark deleterious effects angiotensin ii summarized almost entirely result stimulation at<NUMBER> receptors chain events defined ace→angiotensin ii→at<NUMBER> receptor axis ace<NUMBER> receptors reduce adverse effects angiotensin ii degrading angiotensin ii thereby eliminating limiting deleterious potential also generating angiotensin <NUMBER> angiotensin <NUMBER> exerts numerous salutary opposite counterregulatory effects angiotensin ii efficient binding g proteincoupled receptor mas angiotensin ii type <NUMBER> receptors at<NUMBER> receptors therefore ace<NUMBER>→angiotensin <NUMBER> →mas receptor axis counterregulatory ace→angiotensin ii→at<NUMBER> receptor axis santos et al provided excellent review multiple effects ace<NUMBER>→angiotensin <NUMBER> →mas receptor axis <NUMBER> <NUMBER> ace<NUMBER>→angiotensin <NUMBER> →mas receptor axis lung studies addressing pulmonary effects angiotensin <NUMBER> appear particularly appealing mas receptors expressed surface bronchial smooth muscle cells alveolar epithelium <NUMBER> <NUMBER> experimental clinical models lung inflammation angiotensin <NUMBER> exerted antiinflammatory effects less infiltrates lymphocytes neutrophils reduced perivascular peribronchial inflammation prevention subsequent fibrosis <NUMBER> <NUMBER> <NUMBER> <NUMBER> ace<NUMBER> expressed luminal side bronchial ciliated epithelia removes single amino acid residue also polypeptide desarg <NUMBER> bradykinin dabk <NUMBER> thereby preventing binding dabk bradykinin receptor b<NUMBER> receptor <NUMBER> presence reduced ace<NUMBER> function lung induced endotoxins increase free dabk turn activates b<NUMBER> receptors release proinflammatory cytokines intense lung inflammatory injury <NUMBER> <NUMBER> ace<NUMBER>→angiotensin <NUMBER> →mas receptor axis thrombosis ace<NUMBER>→angiotensin <NUMBER> →mas receptor axis exerts antithrombotic effects <NUMBER> <NUMBER> <NUMBER> <NUMBER> mas receptors expressed platelets <NUMBER> stimulation mas receptors angiotensin <NUMBER> increases prostacyclin release <NUMBER> <NUMBER> animals knockout mas receptors shorter bleeding time increased size thrombi <NUMBER> animals administration angiotensin <NUMBER> induces marked antithrombotic effect directly related plasma levels angiotensin <NUMBER> <NUMBER> inhibited a<NUMBER> antagonist mas receptors <NUMBER> thus angiotensin <NUMBER> plays important role opposing prothrombotic proinflammatory effects angiotensin ii <NUMBER> <NUMBER> <NUMBER> ace<NUMBER>→angiotensin <NUMBER> →mas receptor axis endocrine system ace<NUMBER>→angiotensin <NUMBER> →mas receptor axis well expressed pancreas improves insulin secretion possibly improving periinsular blood flow inhibiting fibrosis result increased release <NUMBER> <NUMBER> ace<NUMBER> receptors also expressed adipose tissue <NUMBER> <NUMBER> reduction ace<NUMBER> noted adipose tissue obese animals <NUMBER> animal experiments diets rich fats decreased ace<NUMBER> activity angiotensin <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> increased angiotensin ii blood pressure levels male female animals reactions inhibited at<NUMBER> blockade losartan <NUMBER> ovariectomy female animals showed similar reactions males <NUMBER> data suggest ace<NUMBER> deficiency may favor obesityinduced hypertension <NUMBER> ace<NUMBER> also expressed cardiac adipocytes <NUMBER> obese patients heart failure increased amount epicardial adipose tissue <NUMBER> suggested ace<NUMBER> deficiency induce heart failure preserved ejection fraction animals <NUMBER> phenomenon attributed adipose tissue inflammation local activation macrophages possess at<NUMBER> receptors cellular membrane <NUMBER> <NUMBER> happen ace<NUMBER> sarscov binding sarscov sarscov<NUMBER> bind ace<NUMBER> receptors subsequent membrane fusion virus entry cell leads downregulation receptors <NUMBER> <NUMBER> <NUMBER> terms virus appears entry cell along membrane receptor functionally removed external site membrane result ace→angiotensin ii→mas receptor axis markedly attenuated amplification ace→angiotensin ii→at<NUMBER> receptor axis since pulmonary inflammation resulting acute respiratory distress syndrome ards potentially deadly complications sarscov sarscov<NUMBER> studies addressing lung complications ace<NUMBER> downregulation outmost importance studies using different models lung injury showed downregulation ace<NUMBER> receptors triggers important inflammatory lesions respiratory tree alveolar wall thickening edema infiltrates inflammatory cells bleeding appear mediated angiotensin ii <NUMBER> <NUMBER> <NUMBER> <NUMBER> tracheal instillation cigarette smoke <NUMBER> particulate matter aerodynamic diameter less <NUMBER> ɥm <NUMBER> induces acute lung injury release inflammatory cytokines il<NUMBER> tnfα tgfβ<NUMBER> increased expression ace consistent ace→angiotensin ii→at<NUMBER> receptor axis overactivity <NUMBER> reactions increased ace<NUMBER> knockout mice <NUMBER> model acid aspiration induces acute lung injury lung inflammatory lesions severe lethal ace<NUMBER> knockout animals <NUMBER> animals injection recombinant ace<NUMBER> well at<NUMBER> receptor blockers attenuate degree lung injury <NUMBER> findings strongly suggest ace<NUMBER> protects lung injury induced acid aspiration <NUMBER> notably lung injury induced isolated spike viral protein sarscov ligand ace<NUMBER> binding absence viral components <NUMBER> model merit investigate impact ace<NUMBER> downregulation absence confounding effects viral invasion replication authors found even isolated spike viral protein induced downregulation ace<NUMBER> receptors concomitant increase angiotensin ii lung tissue precipitation severe pulmonary inflammatory lesions <NUMBER> also model at<NUMBER> receptor blockers attenuated pulmonary lesions induced spike viral protein <NUMBER> key point remark ace<NUMBER> mainly expressed pneumocytes type ii small cylindrical cells represent <NUMBER> pneumocytes <NUMBER> pneumocytes type <NUMBER> responsible production alveolar surfactant time function stem cells progenitors pneumocytes type <NUMBER> pneumocytes responsible gas exchanges <NUMBER> therefore damage pneumocytes type ii due binding coronavirus ace<NUMBER> receptors devastating least three reasons <NUMBER> local unopposed ace→angiotensin ii→at<NUMBER> receptor axis overactivity <NUMBER> reduced production alveolar surfactant injured pneumocytes type ii leading reduced lung elasticity <NUMBER> reduced repair pneumocytes type leading impaired gas exchanges fibrosis <NUMBER> <NUMBER> clinical characteristics patients infected sarscov sarscov<NUMBER> studies china italy shown hypertension diabetes history cardiovascular disease frequent comorbidities patients infected sarscov<NUMBER> <NUMBER> <NUMBER> <NUMBER> older age male sex two additional factors associated sarscov<NUMBER> infection <NUMBER> <NUMBER> <NUMBER> similar picture emerged years ago sarscov infection <NUMBER> <NUMBER> study conducted <NUMBER> patients infected sarscov<NUMBER> patients men <NUMBER> patients mean age <NUMBER> years frequent comorbidities hypertension <NUMBER> diabetes <NUMBER> history cardiovascular disease <NUMBER> <NUMBER> notably patients developed ards older higher prevalence hypertension <NUMBER> vs <NUMBER> diabetes <NUMBER> vs <NUMBER> compared develop ards <NUMBER> multivariate analysis factors associated progression ards syndrome death included older age neutrophilia hypercoagulation mainly reflected higher ddimer <NUMBER> abnormal coagulation parameters enhanced thrombosis predict poor prognosis patients sarscov<NUMBER> <NUMBER> metaanalysis <NUMBER> studies conducted china total <NUMBER> patients infected sarscov<NUMBER> confirmed hypertension diabetes history cardiovascular disease frequent comorbidities patients <NUMBER> hypertension history cardiovascular disease significantly prevalent among severe patients <NUMBER> recent analysis <NUMBER> infected patients italy mean age patients <NUMBER> years men <NUMBER> prevalence patients hypertension diabetes previous cardiovascular disease <NUMBER> <NUMBER> <NUMBER> respectively <NUMBER> patients hypertension older without hypertension <NUMBER> vs <NUMBER> years p<NUMBER> comparing patients died intensive care unit survived former older higher prevalence hypertension <NUMBER> vs <NUMBER> p<NUMBER> <NUMBER> <NUMBER> ace<NUMBER> deficiency central role sarscov<NUMBER> infection interesting note several conditions associated viral infection severity disease share variable degree ace<NUMBER> deficiency example ace<NUMBER> expression lungs markedly decreases ageing <NUMBER> greater extent men women <NUMBER> diabetes mellitus associated reduced ace<NUMBER> expression possibly effect glycosylation <NUMBER> <NUMBER> <NUMBER> several experimental clinical studies indicate ace<NUMBER> deficiency obtained deletion inhibition may causative factor hypertension <NUMBER> <NUMBER> treatment soluble recombinant ace<NUMBER> reduces blood pressure rise provoked angiotensin ii increases angiotensin <NUMBER> reduces angiotensin ii <NUMBER> ace<NUMBER> deficiency associated exacerbation hypertension cardiac hypertrophy induced angiotensin ii <NUMBER> maladaptive left ventricular remodeling myocardial infarction <NUMBER> furthermore deficiency ace<NUMBER> enhances susceptibility heart failure <NUMBER> heterozygote loss ace<NUMBER> believed sufficient increase susceptibility heart disease <NUMBER> given premises tempting speculate figure <NUMBER> ace<NUMBER> deficiency may play central role pathogenesis sarscov<NUMBER> infection downregulation ace<NUMBER> induced viral invasion could especially detrimental individuals baseline ace<NUMBER> deficiency due example older age diabetes hypertension prior heart diseases including heart failure possibility mild moderate ace<NUMBER> deficiency may protect viral invasion seems unlikely intrinsically high affinity sarscov<NUMBER> ace<NUMBER> receptors <NUMBER> <NUMBER> contrast setting ace<NUMBER> deficiency ace<NUMBER> downregulation induced virus could amplify imbalance ace→angiotensin ii→at<NUMBER> receptor axis adverse ace<NUMBER>→angiotensin <NUMBER> i→mas receptor axis protective lung level dysregulation would much facilitate progression inflammatory hypercoagulation processes share dependency upon local angiotensin ii hyperactivity insufficiently opposed angiotensin <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> chain events would deny concomitant role mechanisms including impaired immune response initial viral invasion genetic susceptibility hyperinflammation thrombosis <NUMBER> <NUMBER> context administration soluble recombinant ace<NUMBER> <NUMBER> angiotensin <NUMBER> <NUMBER> could promising therapeutic approaches requiring urgent evaluation clinical trials two trials losartan additional treatment sarscov<NUMBER> infection hospitalized nct<NUMBER> hospitalized nct<NUMBER> patients announced supported background huge adverse impact ace→angiotensin ii→at<NUMBER> receptor axis overactivity patients possibility ace inhibitors angiotensin ii receptor blockers arbs may discontinued even temporarily drugs appear increase expression ace<NUMBER> receptors site viral entry human organism <NUMBER> <NUMBER> <NUMBER> <NUMBER> actively debated <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> several scientific societies various experts area expressed position discontinuation drugs justified evidence could dangerous <NUMBER> <NUMBER> <NUMBER> <NUMBER> hand several experimental data discussed suggest potential utility arbs particularly limit lung inflammation viral invasion <NUMBER> <NUMBER> hoped results mentioned nct<NUMBER> nct<NUMBER> trials answer question suggest ace<NUMBER> downregulation induced cell entry sarscov nl<NUMBER> sarscov<NUMBER> may particularly detrimental subjects preexisting ace<NUMBER> deficiency degree ace<NUMBER> deficiency associated variety conditions including older age hypertension diabetes cardiovascular disease also characterize people likely infected present severe complications setting enhanced ace<NUMBER> deficiency produced viral invasion marked dysregulation adverse ace→angiotensin ii→at<NUMBER> axis protective ace<NUMBER>→angiotensin <NUMBER> →mas axis would contribute enhance progression inflammatory thrombotic processes considerations provide rationale investigating role therapeutic approaches conceptually linked ace<NUMBER> receptor activity include use soluble recombinant ace<NUMBER> angiotensin <NUMBER> angiotensin ii type <NUMBER> receptor blockers currently evaluated spread novel coronavirus <NUMBER>ncov shook world highly virulent transmissibility manifesting largely severe acute respiratory syndrome <NUMBER> million people confirmed infectedwith approximately <NUMBER> million cases usaand <NUMBER> deaths worldwide time writing <NUMBER> originating china covid<NUMBER> epidemic surpassed predecessors number hospitalizations intensive care unit admissions required handle infectious process within short period time grand scale <NUMBER> early sars epidemic emerged <NUMBER> similarly involved humantohuman transmission animal vectors linked outbreaks confirmed laboratory isolates <NUMBER> initially described pneumonia unknown origin covidishan asokan soniya v rabadia contributed equally work coprimary authors article part topical collection cardiooncology <NUMBER> believed linked bats based genomic similarity known bat coronavirus batcov ratg<NUMBER> <NUMBER> though coronaviruses mild two betacoronaviruses severe acute respiratory syndrome sarscov middle east respiratory syndrome coronavirus merscov also took place within last two decades <NUMBER> two unique predecessors preceded pandemic began china <NUMBER> virus originating wuhan hubei province china late december resulted nearly <NUMBER> cases initially considered worldwide pandemic <NUMBER> routes transmission virus documented include respiratory droplets contact fomites fecaloral transmission <NUMBER> <NUMBER> common symptoms onset illness include fever cough myalgia fatigue rare complaints sputum production headache hemoptysis loss taste andor smell diarrhea addition clinical characteristics patients showcased groundglass opacities chest computed tomography scans however half patients early studies notably developed dyspnea correlated patchy infiltrates chest radiographs mean duration symptoms roughly <NUMBER> days progression acute respiratory distress syndrome ards occurring days <NUMBER> <NUMBER> <NUMBER> patients receiving mechanical ventilation wuhan cohort typically required icu admission <NUMBER> weeks following symptom development foreshadowed scale pandemic mirrored data obtained mers epidemic <NUMBER> <NUMBER> <NUMBER> epidemiological data china confirmed median age patients impacted disease <NUMBER> years disease distribution disproportionately impacting males <NUMBER> data hypothesized children might less likely become infected infected demonstrated far milder symptoms italy documented nearly <NUMBER> cases march <NUMBER> largest proportion cases fatalities impacting males greater <NUMBER> years age <NUMBER> lombardy study <NUMBER> patients least one existing comorbidity hypertension frequently cited predisposing factors included cardiovascular disease hypercholesterolemia rare subset preexisting lung disease manifesting chronic obstructive pulmonary disease roughly <NUMBER> lombardy patients managed noninvasive ventilatory support <NUMBER> need invasive ventilatory support varied across regions world wuhan cohort directly transitioned extracorporeal membrane oxygenation ecmo resuscitation purposes <NUMBER> underlying risk factors hypertension diabetes cardiovascular disease immunosuppression explored prognosticators regarding clinical outcomes covid<NUMBER> infections hospitalized patients <NUMBER>• however impact pandemic patients history cancer preexisting andor cancer treatmentassociated cardiovascular diseasethe cardiooncology patientis unknown theoretically population likely higher risk morbidity mortality covid<NUMBER> infection unique healthcare needs put higher risk exposure community healthcarerelated transmission examples risks include needing ongoing cancer treatments outpatient inpatient setting well imagingrelated procedures operations cancerrelated staging treatments patients also preexisting cardiovascular disease andor acquired cardiotoxicity treatments also warrant additional evaluation finally appears strong correlation worse outcomes hospitalized covid<NUMBER> patients cardiovascular andor cancerrelated comorbidities reviewed multiple retrospective analyses including china usa italy shown high cardiovascular disease cvd prevalence patients develop covid<NUMBER> particularly severe disease worse outcomes mechanism cardiovascular patients higher risk contracting covid<NUMBER> developing severe disease unknown potentially may due poor cardiovascular reserve greater associated age cardiovascular conditions dysregulated immunity existing inflammation underlying diseases hypertension diabetes <NUMBER> observational database surgical outcomes collaborative registry comprised <NUMBER> hospitalized covid<NUMBER> patients <NUMBER> hospitals asia europe north america found age greater <NUMBER> diagnosis history coronary artery disease heart failure andor cardiac arrhythmias independently associated increased risk inhospital death <NUMBER> n <NUMBER> cohort dying hospital <NUMBER> studies analyzing risk factors associated clinical outcomes geography described metaanalysis <NUMBER> chinese studies evaluating <NUMBER> affected patients showed prevalent cardiovascular metabolic comorbidities included hypertension <NUMBER> cardiac andor cerebrovascular disease <NUMBER> diabetes <NUMBER> importantly patients hypertension cardiac cerebrovascular disease significantly accounted icu cases compared nonicu cases prevalence <NUMBER> rr <NUMBER> hypertension <NUMBER> rr <NUMBER> cardiac andor cerebrovascular disease <NUMBER> data world health organization chinese center disease control prevention confirm patients comorbidities higher case fatality rate cfr without comorbidities <NUMBER> <NUMBER> <NUMBER> laboratoryconfirmed cases china <NUMBER> cfr higher rates seen cvd <NUMBER> diabetes <NUMBER> hypertension <NUMBER> <NUMBER>• cohort study <NUMBER> patients wuhan jinyintan hospital showed hypertension significantly associated patients progressing acute respiratory distress syndrome ards <NUMBER> vs <NUMBER> p <NUMBER> later death <NUMBER> vs <NUMBER> p <NUMBER> <NUMBER> march <NUMBER> <NUMBER> cfr italy <NUMBER> total <NUMBER> cases detailed chart review subsample <NUMBER> deceased patients found high underlying disease prevalence ischemic heart disease <NUMBER> diabetes <NUMBER> atrial fibrillation <NUMBER> cancer <NUMBER> <NUMBER> case series patients covid<NUMBER> icus lombardy region demonstrated hypertension common comorbidity <NUMBER> cardiovascular disease <NUMBER> second furthermore statistically significant higher prevalence hypertension among patients died compared discharged icu <NUMBER> vs <NUMBER> p <NUMBER> <NUMBER> epidemiologic data usa remains dynamic limited studies date major urban centers report <NUMBER> confirmed cases linked longterm facility washington state also conferred similar findings showing high underlying disease prevalence hypertension <NUMBER> cardiac disease <NUMBER> diabetes <NUMBER> <NUMBER> large new york study examined total <NUMBER> patients median age <NUMBER> years age new york cohort found hypertension <NUMBER> patients obesity <NUMBER> patients diabetes <NUMBER> patients patients died diabetes likely mechanically ventilated hospitalized icu <NUMBER>• another case series <NUMBER> patients admitted new york hospitals found <NUMBER> patients hypertension <NUMBER> cardiovascular disease <NUMBER> studies detailed specifics defined cardiac disease therefore difficult delineate covid<NUMBER> direct associations coronary artery disease cardiomyopathy heart failure large sample size standpoint however case series seattle washington state <NUMBER> <NUMBER> critically ill patients covid<NUMBER> underlying congestive heart failure <NUMBER> addition underlying cvd risk factor contracting covid<NUMBER> patients develop acute myocardial injury worse outcomes even without baseline cardiovascular dysfunction <NUMBER> <NUMBER> <NUMBER> <NUMBER> acute myocardial injury categorized three varieties elevated troponin levels <NUMBER>th percentile upper reference limit development new worsening heart failure myocarditis several studies china found elevated troponin levels significantly associated higher mortality <NUMBER> <NUMBER> <NUMBER> case series <NUMBER> patients seventh hospital wuhan city china found patients elevated troponin tnt levels significantly higher mortality rate normal tnt levels <NUMBER> vs <NUMBER> p <NUMBER> patients underlying cvd including underlying hypertension coronary heart disease cardiomyopathy likely elevated tnt levels hospital course <NUMBER> lipid metabolism also observed dysregulated patients sarscov infection serum concentrations f r e e f c l p h p h l c h l n e n phosphatidylglycerol remained elevated contributed chronic cardiovascular damage post infection patients sarscov <NUMBER> longterm cardiovascular atherosclerotic changes patients suffer covid<NUMBER> documented yet given recent nature pandemic case series <NUMBER> critically ill covid<NUMBER> patients seattle also found onethird patients developed new cardiomyopathy cardiogenic shock absence prior systolic dysfunction progression illness <NUMBER> unclear patients developed cardiomyopathy truly myocarditis underlying cvd predisposed clinical course however covid<NUMBER> shown directly cause myocarditis otherwise healthy individuals several case reports <NUMBER> <NUMBER> thus covid<NUMBER> demonstrates various patterns myocardial injury higher mortality risk associated elevated troponin levels addition cardiooncology population elevated cardiac biomarkers pose additional layer complexity challenge dealing management abnormal elevations troponin bnp biomarkers indicative cardiotoxicity cancer physiology treatments <NUMBER> elevations may nonspecific reflective subclinical cardiotoxicity patients receiving anthracyclines andor antiher<NUMBER> agents stable patients medically managed <NUMBER> <NUMBER> however patients receiving agents certain tyrosine kinase inhibitors prothrombotic risk ie ponatinib fluoropyridines ie <NUMBER>fluorouracil may suffer cardiotoxicity form coronary ischemiavasospasm may warrant invasive diagnostictreatment strategies <NUMBER> <NUMBER> <NUMBER> elevated cardiac biomarkers also associated worse outcomes cardiac hemodynamic instability including cytokine release syndrome chimeric antigen therapy cart heart failure proteasome inhibitor use ie carfilzomib myocarditis immune checkpoint inhibitor therapy <NUMBER> <NUMBER> <NUMBER> <NUMBER> disease processes may confound treatment cancer patient also afflicted covid<NUMBER> thus multidisciplinary assessment particularly cardiooncologist may essential provide optimal care highrisk population cancer patients shown higher risk contracting virus likely immune dysregulation setting malignancy various treatments remain high risk sustaining severe outcomes <NUMBER> <NUMBER> per joint mission report cfr cancer patients <NUMBER> higher overall cfr <NUMBER> covid<NUMBER> patients china <NUMBER>• reports italy washington also support cancer patients similar findings <NUMBER> <NUMBER> <NUMBER> however specific type cancer neither reported studies linked specific outcome several studies indicated cancer patients trend toward severe disease case series patients admitted new york hospitals identified <NUMBER> patients cancer <NUMBER> patients required invasive ventilation support <NUMBER> prospective cohort study following <NUMBER> covid<NUMBER> patients china demonstrated <NUMBER> patients cancer lung cancer frequently incurred malignancy moreover cohort history cancer associated higher risk severe events icu admission requiring ventilation death faster progression severe events median time cancer patients <NUMBER> days vs <NUMBER> days noncancer patients history chemotherapy surgery past month higher risk severe events even adjusted risk factors including age <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p <NUMBER> <NUMBER> described wuhan group roughly <NUMBER> received chemotherapy <NUMBER> targeted therapy however age alone also independent risk factor severe events cancer group patients history lung cancer versus cancer types predict severe outcome <NUMBER> another study china evaluating cancer patients admitted zhongnan hospital wuhan university determined cancer patients <NUMBER> infection rate compared overall citys <NUMBER> infection rate total <NUMBER> patients affected <NUMBER> nonsmall cell lung carcinoma nsclc approximately <NUMBER> undergoing treatment chemotherapy resulting mortality rate march <NUMBER> <NUMBER> <NUMBER> additionally nsclc patients greater age <NUMBER> higher incidence covid<NUMBER> compared younger patients nsclc <NUMBER>• findings corroborated study examined <NUMBER> cancer patients admitted <NUMBER> hospitals china lung cancer common cancer type among patients <NUMBER> diabetes <NUMBER> chronic cardiovascular cerebrovascular disease <NUMBER> common comorbidities listed clinical factors significantly predicted worse outcomes group patients included age patchy consolidation imaging receipt antitumor treatment last <NUMBER> days <NUMBER> studies suggest patients cancer higher risk covid<NUMBER> older age cancer even higher risk poor outcomes lung cancer reported common studies total sample size cancer patients remains low draw meaningful conclusions malignancy may associated severity covid<NUMBER> infections lastly although recent anticancer treatment increases risk severe outcomes unclear anticancer agents associated higher risk acquiring covid<NUMBER> infection severity infection andor mortality although formal studies assessed direct impact covid<NUMBER> cardiooncology patients study shown cvd patients cancer patients increased risk cardiac injury independent predictor mortality <NUMBER> additionally since data suggests cvd cancer potentially independent risk factors virus acquisition severe outcomes reasonable assume patients risk factors may posit higher cumulative risk also concern cancer treatments may induce disease states hypertension cardiovascular diseaseboth frequently associated risk factors worse outcomes covid<NUMBER> patients <NUMBER>• example clinical scenario could involve metastatic renal carcinoma patients develop hypertension antivegf tyrosine kinase therapy cardiomyopathy antiher<NUMBER> anthracycline therapy breast cancer <NUMBER> <NUMBER> however definition cardiovascular disease patients classified studies always clearly delineated thus risk stratification patients regard covid<NUMBER> risk requires refined investigation longterm followup regarding outcomes elevated risk cancer patients face covid<NUMBER> pandemic poses many challenges include providing ongoing cancer treatments especially patients undergoing curative therapy enrolling patients experimental drug trials continuing close cardiotoxicity surveillance providing treatments patients optimal window adequate functional status <NUMBER> <NUMBER> given concerns hospitalacquired covid<NUMBER> infections additional risk factor impact continuation therapy initiation regimens aggressive malignancy require hospitalization closer monitoring <NUMBER> <NUMBER> <NUMBER> moreover patients may rely drugs stem cell donations treatment may necessitate access unique global sources rendered disadvantage due travel restrictions quarantine policies <NUMBER> response climactic changes national comprehensive cancer network national cancer institute provided guidance providers providing care oncology patients resource allocation managing drug trials <NUMBER> referenced unique source transmission cardiooncology population healthcare exposure healthcarerelated exposure given greater importance attributable vector past experience sarscov demonstrated virus transmitted via aerosolizing procedures endotracheal intubation placing anesthesiologists great risk acquiring infection <NUMBER> <NUMBER> outbreak covid<NUMBER> implementation infection control establishment safe personal protective equipment ppe remained remains key intense aerosolizing procedures emergent intubations cardiopulmonary resuscitation bronchoscopies require stringent ppe maintain adequate protection despite attempting roll precautions review whochina joint mission covid confirmed nearly <NUMBER> healthcare workers tested positive covid<NUMBER> infection resulting <NUMBER> deaths <NUMBER> initial understanding pathogen remained poor longtime exposure largescale infected patients directly increased risk infection healthcare workers risk asymptomatic carrier <NUMBER> fatigue lack available healthcare workers limited resources intensity response led several healthcare workers succumbing infection though unsettling doubly important place value healthcarerelated exposure established risk factor dealing cancer patients preexisting risk factors coronaviruses large collection singlestranded enveloped nonsegmented positivesense rna viruses fall within family coronaviridae order nidovirales <NUMBER> six specific coronaviruses identified humansusceptible among alpha beta subsets demonstrated lower pathogenicity caused milder respiratory symptoms respectively genomic analysis sarscov<NUMBER> showcased <NUMBER> shared sequencing bat cov ratg<NUMBER> thus positing bat variant served natural host virus <NUMBER> however severe acute syndromes belong bgenus envelopeanchored spike protein mediating viral entry host cells first binding host receptor subsequently fusing membranes <NUMBER> covid<NUMBER> infection welldefined capsular structure <NUMBER> binding residues <NUMBER> conserved prior sarscov infections viral genome contains several open reading frames majority viral rnaencoding nonstructural proteins nsps play role pathogenesis disease recent research studies focusing nsp<NUMBER> nsp<NUMBER> demonstrated vivo role subunits may play infectious capability differentiation covid<NUMBER> <NUMBER> mechanistically covid<NUMBER> found linked angiotensinconverting enzyme <NUMBER> membranebound aminopeptidase highly expressed lung intestinal heart tissue beyond implicated hypertension diabetes ace<NUMBER> functions receptor coronaviruses <NUMBER>• covid<NUMBER> translocates lung parenchyma via damaging epithelial cells resulting respiratory symptoms symptom severity worsening patients cardiovascular disease ace<NUMBER> secretion noted elevated cvd patients due increased reliance angiotensinreceptor blockers management hypertension receptor level receptorbinding domain sarscov spike protein specifically recognizes ace<NUMBER> contributes crossspecies humantohuman transmission <NUMBER> <NUMBER> documented variability demonstrated various strains sarscov terms binding affinity viral attachment preserved across humans animal models disease transmission <NUMBER> preserved domains across merssars may contribute heightened inflammatory response cytokine milieu leads severe pneumonia <NUMBER> molecular level specific associations descriptive characteristics patients identified cytokine abnormalities iculevel patients versus noniculevel admissions compared nonicu patients icu patients higher plasma levels il<NUMBER> il<NUMBER> il<NUMBER> gcsf ip<NUMBER> mcp<NUMBER> mip<NUMBER>a tnfa <NUMBER>• though cytokine thumbprint linked covid<NUMBER> infection ards similarly showcases elevations inflammatory markers questioning origin role virally mediated hyperinflammation <NUMBER> multiple treatments assessed various trials including antivirals antiinflammatories immunotherapies cardiovascular medications treatment covid<NUMBER> although therapies potential provide benefit numerous potential cardiac toxicities drugdrug interactions may harmful cardiooncology patients critically relevant since high percentage covid<NUMBER> patients cardiovascular comorbidities <NUMBER> <NUMBER> <NUMBER> <NUMBER> appraisal agents potential cardiotoxicitiesof current proven efficacy timeis beyond scope review however agents actively used treatment cardiovascular disease andor cancerrelated conditions unique disease states cardiooncology population may yield insights mechanisms covid<NUMBER> pathophysiology instance idea using medications already wellstudied target host responses boosting host immunity discussion prior significant outbreaks epidemics including ebola influenza <NUMBER> <NUMBER> ace inhibitors acei angiotensinreceptor blockers arb statins particular importance current pandemic theoretical uncertainty regard safety aceiarb use patients covid<NUMBER> based ace<NUMBER> viral entry mechanism <NUMBER> <NUMBER> virus gains cellular entry attaching ace<NUMBER> receptor <NUMBER> ace<NUMBER> expression activity shown increased aceiarb use <NUMBER> although theoretical risk ace<NUMBER> upregulation may increase susceptibility infection conflicting evidence indicates upregulation ace<NUMBER> fact protective effect studies mouse models shown ace<NUMBER> protective acute lung injury blocking reninangiotensinaldosterone system pathway decreases lung failure <NUMBER> <NUMBER> based review literature date heart failure society america recommends continuation aceiarb use patients prescribed heart failure hypertension ischemic disease <NUMBER>•• abrupt discontinuation medications recommended worsen clinical stability especially patients existing cardiovascular conditions <NUMBER> additionally statins long shown antiinflammatory properties multiple studies instance simvastatin shown decrease pulmonary inflammation human subjects <NUMBER> although benefits cardiovascular patients numerous lipid lower standpoint important note ability statins decrease inflammation also improves mortality <NUMBER> retrospective analysis patients veterans administration showed statin use acei use arb use independently improved <NUMBER> day mortality patients <NUMBER> years old hospitalized pneumonia <NUMBER> however era covid<NUMBER> pandemic studies needed evaluate role covid<NUMBER>related illness although cancer patients considered immunosuppressed result underlying malignancy cytoreduction therapies patients undergo immunotherapy including immune checkpoint inhibitors icis cart cell therapy may different immunophysiology responds covid<NUMBER> differently <NUMBER> antipd<NUMBER>pdl<NUMBER> antictla<NUMBER> icis approved fda use variety cancers drugs primarily work enhancing patients immune response tumors inhibiting negative regulators cell function <NUMBER> cart cell therapy involves reprogramming patients cells directly target specific tumor <NUMBER> adverse effect occur either antipd<NUMBER> therapy cart cell therapy involves cytokine release syndrome crs similar cytokine storm phenomenon occurs patients severe covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> crs occurs result hyperimmune activation response tumor death whereas cytokine storm covid<NUMBER> patients occurs result cell hyperactivation immune dysregulation <NUMBER> <NUMBER> similar markers elevated phenomena including il<NUMBER> tnfalpha ifnλ il<NUMBER> also shown mortality predictor covid<NUMBER> patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> covid<NUMBER> patients develop cytokine storm syndrome risk developing ards multiorgan failure <NUMBER> <NUMBER> immunosuppression tocilizumab il<NUMBER> inhibitor used treat crs associated cart cell therapy <NUMBER> <NUMBER> additionally tocilizumab immunosuppression used treat immunerelated adverse events iraes pd<NUMBER> inhibitors refractory steroids iraes also occur result hyperimmune activation <NUMBER> <NUMBER> moreover cytokine storm observed covid<NUMBER> also noted similar secondary hemophagocytic lymphohistiocytosis hlh also treated immunosuppression <NUMBER> current trials underway using tocilizumab sarilumab another il<NUMBER> inhibitor treat covid<NUMBER> patients <NUMBER> <NUMBER> <NUMBER> although immunotherapy may thought reinstate cancer patients immunocompetence potential synergy crs covid<NUMBER> cytokine storm pathogenesis worsen patients mortality risk unfavorable synergy ici immunerelated adverse events iraes also seen potentially pneumonitis icis cause lung involvement covid<NUMBER> <NUMBER> pneumonitis occurs <NUMBER> patients treated antictla<NUMBER> antipd<NUMBER> icis potentially lifethreatening <NUMBER> therefore combined lung injury covid<NUMBER> theoretical potential poor outcomes potential cancer treatments may counteract pathogenesis covid<NUMBER> ccr<NUMBER> treatments tyrosine kinase inhibitors tkis <NUMBER> <NUMBER> <NUMBER> ccr<NUMBER> receptor g proteincoupled receptor selectively expressed macrophages cells eosinophils dendritic cells microglia implicated chemokinemediated signaling <NUMBER> receptor historically targeted hiv antiviral therapy setting disrupting viral entry specifically small molecule inhibition maraviroc vicriviroc monoclonal antibody treatment leronlimab <NUMBER> moreover multiple cancers shown overexpress ccr<NUMBER> linked cancers metastatic potential ccr<NUMBER> therapies currently studied metastatic colorectal breast cancers <NUMBER> <NUMBER> due immune system restorative properties leronlimab investigated compassionate use treatment covid<NUMBER> patients <NUMBER> <NUMBER> studies examining receptor blockade leronlimab preliminarily shown decreases il<NUMBER> restoration cd<NUMBER>cd<NUMBER> ratios reduction overall covid<NUMBER> viremia <NUMBER> collective findings suggest possible therapeutic role establishing immune reconstitution patients critically ill may provide dual benefit patients shared cancer diagnoses tkis like sunitinib erlotinib specifically inhibit aak<NUMBER> protein regulator allows passage virus cells theorized utility <NUMBER> sunitinib antivascular endothelial growth factor vegf tki used firstline treatment advanced renal cell carcinoma <NUMBER> erlotinib antiepidermal growth factor receptor egfr tki used firstline treatment metastatic egfrmutant nonsmall cell lung cancer <NUMBER> tkis shown reduce infectivity dengue ebola vivo studies murine models showed decreased viremia mortality treatments moreover vitro studies cultured cells hepatitis c study showed use tkis reduced intracellular trafficking inhibited viral entry <NUMBER> however high doses required achieve effect may potentially exhibit harm patients <NUMBER> <NUMBER> regardless potential cancer patients receiving therapies achieve dual benefit referenced warrant investigation studies warranted tracking outcomes cancer patients covid<NUMBER> type treatments received patients underlying hypertension diabetes cancer higher risk developing thrombotic events coagulopathy coronavirus infection associated high mortality manifests high ddimer elevations <NUMBER> lung inflammation impaired pulmonary gas exchange contributes cytokine storm leads spike ddimer proinflammatory response impaired endothelial function tissue factor tf expressed tumor cells contributes thrombosis metastasis tumor growth tumor angiogenesis leading release procoagulant microparticles circulation triggering thromboembolism patients cancer <NUMBER> tf circulating tumor cells leads coating cells fibrin traps within microvasculature thereby contributing worsening endothelial dysfunction <NUMBER> patients preexisting cancer diagnoses shared covid infection well hypoxia places even greater risk developing incurring thrombotic events <NUMBER> early heparin initiation posited delay spike inflammatory biomarkers may reduce contributions procoagulopathic state <NUMBER> retrospective study china examined <NUMBER> patients classified severe covid<NUMBER> infection <NUMBER> one chronic underlying diseases hypertension heart disease patients assigned receive various forms heparin treated heparin lower mortality rate <NUMBER> vs <NUMBER> p <NUMBER> <NUMBER> data regarding initiation choice anticoagulation remains limited randomized clinical trials necessary determine prophylactic treatment strategies cardiooncology patients infected covid<NUMBER> represent population elevated theoretical risk suffering thromboembolic events covid<NUMBER> pandemic added significant layer complexity patient care delivered due concerns bidirectional transmission protective algorithm widely place dictate ongoing management cancer patients <NUMBER>•• initiating cancer treatments targeted immunotherapies chemotherapy require special consideration covid<NUMBER> era previously described compromised immune systems render patients cancer higher risk acquiring covid<NUMBER> infection sequelae may ensue cancer treatment centers cardiooncologists must consider patient also integral healthcare workers regularly interfacing highrisk exposures devising strategies ensure robust testing services clearance mechanisms protect patient healthcare personnel one many methods employed continue ongoing treatments <NUMBER> <NUMBER> <NUMBER> though clear evidencebased modifications systems care reduce transmission risk balancing highstandard cardiooncology care various strategies proposed table <NUMBER> lifeprolonging surgeries procedures slowly pursued continued although risks delaying advanced treatmentsincluding bone marrow transplantation chimeric antigen receptor treatmentneed weighed carefully covid<NUMBER> screening testing prior surgeriesprocedures infallible considered available due rising concern asymptomatic carriers following completing anticancer treatments patients may additionally benefit receiving immune system restorative treatments filgastrim additionally transition telemedicine conduct interval cardiovascular oncologic appointments potentially protect patients unnecessarily harmful nosocomial exposures <NUMBER> <NUMBER> certain chronic conditions ie hypertension stablecompensated congestive heart failure may necessarily require facetoface visit whereas highly symptomatic patients still seen cardiooncology clinic preferably day cancer outpatient visits deferring primary prevention assessments example cholesterol monitoring unless otherwise indicated augment protective mechanisms place cardiovascularrelated blood draws necessary coincided cancerrelated treatments addition specter cardiotoxicity related certain cancer treatments also requires reexamination risk benefit respect frequent cardiac monitoring due previously mentioned concerns perichemotherapeutic events development cardiomyopathy ischemia lifethreatening arrhythmias worsened simultaneous covid infection reducing reliance frequent cardiac imaging otherwise asymptomatic patients providing inmail ambulatory rhythm monitors patients symptomatic possible arrhythmias assist mitigating exposure risk limited cardiacimaging protocols ie focused ventricular function andor pericardial disease necessary symptomatic patients necessitating cardiotoxicity surveillance also devised reduce exposure time healthcare setting addition patients low risk cardiotoxicity andor prior serialdocumented normal cardiac function considered defer serial cardiac imaging certain treatments ie antiher<NUMBER> without anthracyclines brafmek treatments multidisciplinary discussions oncology patient asymptomatic <NUMBER> covid<NUMBER> pandemic caused unprecedented global impact healthcare delivery trajectory continues remain unclear vulnerable patient populations include cardiovascular disease cancer cardiooncology patient possessed risk factors may unfortunately significantly increased risk experiencing worse outcomes related covid<NUMBER> infection writing known studies focusing cardiooncology population remain many opportunities study epidemiology unique also significant group patients clinical trials ongoing rigorous randomized highquality science warranted study efficacy previously mentioned treatments also may potentially reveal critical mechanistic insights covid<NUMBER>s pathophysiology overlap cardiovascular cancer disease states <NUMBER> addition abrupt possibly permanent alteration cardiovascular cancer systems carewith dramatic rise telemedicine changesto mitigate transmission risk covid<NUMBER> era also warrants close study evaluate clinical outcomes much remains unknown pandemic affect cardiooncology population cared certain ongoing close multidisciplinary care communication cardiac cancer care providers patients remains critical ever order guarantee best care possible bmt bone marrow transplantation cart chimeric antigen receptor therapy hcw healthcare workers ppe personal protective equipment cvd cardiovascular disease cad coronary artery disease chf congestive heart failure lvef left ventricular ejection fraction worldwide outbreak respiratory illness first identified wuhan china ongoing disease caused novel coronavirus sarscov<NUMBER> february <NUMBER> <NUMBER> officially named coronavirus disease <NUMBER> covid<NUMBER> world health organizationwho <NUMBER> <NUMBER> many covid<NUMBER> patients early outbreak wuhan reportedly link large seafood animal market suggesting animaltoperson spread virus however growing number patients reportedly exposure animal markets indicating persontoperson spread occurring <NUMBER> <NUMBER> present investigation clinical characteristics <NUMBER> patients covid<NUMBER> collected patients admitted january <NUMBER> february <NUMBER> <NUMBER> study included <NUMBER> covid<NUMBER> patients admitted department infectious diseases hanchuan city peoples hospital january <NUMBER> february <NUMBER> <NUMBER> subjects selected according novel coronavirus infection pneumonia diagnosis treatment standards fifth edition national health committee general information clinical symptoms laboratory data ct data collected analysis blood tests performed day admission patients included blood cell differential count creactive protein crp procalcitonin pct erythrocyte sedimentation rate esr alanine aminotransferase alt aspartate aminotransferase ast total bilirubin tbil serum creatinine cr blood urea nitrogen bun patients subjected chest ct imaging using somatom definition <NUMBER> instrument results analyzed syngovia software siemens berlin germany one day admission total rna extracted exfoliated cells pharynx nasal cavity throat swabs sputum using trizol sigmaaldrich st louis mo usa <NUMBER> onestep realtime pcr kit vr<NUMBER> detection <NUMBER>ncov orf<NUMBER>abn gene purchased shanghai huirui biotechnology shanghai chinathe pcr reactions performed using roche <NUMBER> thermocycler roche molecular systems branchburg nj usa pcr program consisted <NUMBER>°c <NUMBER> min <NUMBER>°c <NUMBER> min <NUMBER> cycles <NUMBER>°c <NUMBER> sec <NUMBER>°c <NUMBER> terminated dissociation data analyzed using sigmastat software spss inc chicago il usa count data expressed rate compared using χ<NUMBER> test difference considered statistically significant p <NUMBER> patients diagnosed basis clinical manifestations laboratory findings subjects positive sarscov<NUMBER> virus rna detected rtpcr patients included <NUMBER> males <NUMBER> females contact wuhan huanan seafood market average age <NUMBER> ± <NUMBER> years major clinical symptoms fever <NUMBER> patients cough <NUMBER> patients dyspnea <NUMBER> patients expectoration fatigue chills headache chest pain pharyngalgia <NUMBER> <NUMBER> hypertension present <NUMBER> subjects severe covid<NUMBER> diagnosed <NUMBER> <NUMBER> patients antimicrobial agent moxifloxacin used <NUMBER> cases moreover <NUMBER> patients received ribavirin <NUMBER> patients received abidol <NUMBER> patients received oseltamivir methylprednisolone administered <NUMBER> cases antiinflammatory drugs supportive care used patients one two weeks later patients respiratory symptoms began improve infiltrates lung began absorb gradually counts white blood cells wbcs lymphocytes returned normal values twenty nonsevere covid<NUMBER> patients recovered discharged february <NUMBER> <NUMBER> two cases death <NUMBER> underlying disease bacterial coinfection admission counts wbcs lymphocytes normal decreased <NUMBER> <NUMBER> patients respectively crp increased <NUMBER> patients mean <NUMBER> ± <NUMBER> normal range <NUMBER> mgl pct increased <NUMBER> patients mean <NUMBER> ± <NUMBER> normal range <NUMBER> mgl esr increased <NUMBER> patients mean <NUMBER> ± <NUMBER> normal range <NUMBER> mmh alt ast tbil cr bun within normal ranges ct results documented patients lung infiltrates multiple patchy glassy shadows present lungs particularly peripheral areas <NUMBER> covid<NUMBER> patients progression disease lesions increased scope size number expanded glassy shadows coexisted solid stripe shadows fig <NUMBER> hypertension found frequent severe covid<NUMBER> group nonsevere group <NUMBER> n <NUMBER> vs <NUMBER> n <NUMBER> x <NUMBER> <NUMBER> p <NUMBER> significant sexual difference morbidity male group female group <NUMBER> n <NUMBER> vs <NUMBER> n <NUMBER> x <NUMBER> <NUMBER> p <NUMBER> december <NUMBER> wuhan china spread suburbs rest china entire world <NUMBER> <NUMBER> <NUMBER> <NUMBER> fever cough multiple patchy glassy shadows ct images peripheral posterior lungs normal decreased white blood cells common clinical feature covid<NUMBER> patients showed severe acute respiratory syndrome sars death early epidemic investigation showed wuhan huanan seafood market may first identified source infection <NUMBER> solid data shown possibility persontoperson spread <NUMBER> <NUMBER> none patients included current study direct indirect connection huanan seafood market known sars coronavirus utilizes angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor enter cell <NUMBER> ace<NUMBER> receptor relatively new member reninangiotensin system maintenance normal ace<NUMBER> levels lung promotes resistance inflammatory lung disease <NUMBER> sarscov<NUMBER> novel coronavirus mechanism sarscov<NUMBER> viruses enter damage cells still unclear studies huang et al <NUMBER> zhang et al <NUMBER> found respectively <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> covid<NUMBER> patients hypertension present investigation incidence hypertension <NUMBER> <NUMBER>of <NUMBER>patients severe covid<NUMBER> group compared <NUMBER> <NUMBER> <NUMBER> patients nonsevere group finding consistent notion hypertension high risk covid<NUMBER> patients however mechanism underlying link unknown possibility raised high blood pressure may damage ace<NUMBER> receptorexpressing endothelial alveolar epithelial cells lung hanchuan smaller city population <NUMBER> located <NUMBER> km wuhan patients covid<NUMBER> type city near wuhan previously described detail present investigation provides clinical laboratory imaging findings emerging sarscov<NUMBER> coronavirus pneumonia humans represent realworld scenario epidemics suburbia initial breakout covid<NUMBER> epicenter wuhan china fever cough conspicuous groundgrass opacity lesions lungs apparent ct images combined normal decreased count wbcs highly suspected clinical features covid<NUMBER> pneumonia found patients city near wuhan without history epidemic exposure clinical characteristics covid<NUMBER> similar identified wuhan lower mortality attributed better supplies medical devices better understanding disease possibly lower levels toxic substances environment defining role factors require studies study confirmed hypertension highrisk factor disease collected data provide insights covid<NUMBER> caused sarscov<NUMBER> smaller city near wuhan china study approved human ethics committee research ethics committee hanchuan city peoples hospital hubei china data records deidentified completely anonymous informed consent waived datasets used andor analyzed current study available corresponding author reasonable request authors declare known competing interest funding received work <NUMBER> chest ct imaging day <NUMBER> one day admission day <NUMBER> day <NUMBER> image obtained day <NUMBER> shows slight opacities left right upper lobes evolution mixed pattern groundglass opacities consolidation apparent day <NUMBER> day <NUMBER> healing consolidations groundglass opacities evident viral entry host results activation innate immune mechanism together synthesis secretion inflammatory mediators interaction specific viral components pattern recognition receptors host immune system activates cellular signalling pathways culminate production various cytokines cytokines elicit host response like extravasation leukocytes activation proliferation cell differentiation adaptive innate immune system <NUMBER> <NUMBER> interleukin il<NUMBER>αβ il<NUMBER> il<NUMBER> tumor necrosis factor tnfα interferon ifnαβ transforming growth factortgfβ major cytokines ccl<NUMBER>monocyte chemoattractant protein mcp<NUMBER> mcp<NUMBER> ccl<NUMBER>macrophage inflammatory protein mip<NUMBER>α ccl<NUMBER> chemokine cc motif ligand <NUMBER>rantes regulated activation normal cell expressed secreted ifnγinducible protein<NUMBER> ip<NUMBER>cxcl<NUMBER> cxc motif chemokine <NUMBER> chemokines released influenza virusinduced infection <NUMBER> <NUMBER> cytokines exert host antiviral responses different ways ifnαβ type <NUMBER> interferon inhibit viral replication thus inducing potent antiviral state host <NUMBER> tnfα triggers immune cells localization infection site activation caspases promote apoptosis <NUMBER> il<NUMBER> pleiotropic cytokine enhances inflammatory cell infiltration increasing membrane permeability activation mast cells subsequent release histamine vasodilator <NUMBER> il<NUMBER> mediates monocyte differentiation macrophages enhances mononuclear cell infiltration inflammation loci <NUMBER> moreover synergistically il<NUMBER> tgfβ induces maturation naive helper cells cd<NUMBER> helper <NUMBER> th<NUMBER> cells potential effectors pathogens interestingly il<NUMBER> also hinders treg expansion tgfβ <NUMBER> <NUMBER> enhancement type <NUMBER> immunity activation natural killer cells nkt cells thus forming early line defence viral infection biological actions il<NUMBER> viral infection <NUMBER> <NUMBER> although cytokines released either host protection response viral entry exacerbated cytokine release adversely affect host overreacting system organs named cytokine storm observed sars mers infection resulting associated severe complications multiple organ failure <NUMBER> studies established similar hypercytokinemiacytokine storm also taking part sarscov<NUMBER>covid<NUMBER> infection review highlight pathology pathogenesis j u r n l p r e p r f mers cov sars cov sars cov<NUMBER> main focus role cytokines pathology relation comorbidities covid<NUMBER> infection <NUMBER> epidemic outbreak <NUMBER> sarscov case fatality ratio <NUMBER> <NUMBER> higher older age group greater <NUMBER> less <NUMBER> younger age group sars cov entry cells mediated ace<NUMBER> angiotensin converting enzyme <NUMBER> receptor extremely expressed lung kidney heart liver tongue viral spike protein binds receptor followed viral fusion cell membrane involves priming protein proteases cell surface finally ends entry replication virus inside cell <NUMBER> shown ace<NUMBER> protective role ali <NUMBER> ace<NUMBER> play key role reninangiotensin system ras maintains blood pressure water electrolyte balance decreased expression ace<NUMBER> negatively affects ras system followed increased microvascular permeability inflammation <NUMBER> ace<NUMBER> expression also found regulated sars cov infections augments intensity lung injury <NUMBER> moreover increased viral load excessive immune cell infiltration increased innate immune response proinflammatory mediators also lead widespread lung injury sars suggesting cytokine storm direct cytopathogenic effect virus cause physiological decompensation observed sars cov infection <NUMBER> profiling systemic cytokine levels individuals suffering sarscov disease showed elevated concentrations helper <NUMBER> th<NUMBER> cytokines like ifnγ il<NUMBER> il<NUMBER> additionally cytokines promote inflammation like il<NUMBER> il<NUMBER> mcp<NUMBER> ip<NUMBER> cxcl<NUMBER>mig monokine induced gamma interferon il<NUMBER> tgfβ il<NUMBER> also increased <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> interestingly sars patients showed change blood il<NUMBER> il<NUMBER> j u r n l p r e p r f levels <NUMBER> increased amount mig mcp<NUMBER> ip<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> blood correlated disease severity sars patients <NUMBER> <NUMBER> interstitial infiltrates observed chest radiography merscov infected individuals laboratory investigation showed increased concentration ldh aspartate aminotransferase ast low eosinophil platelet count decreased albumin level <NUMBER> another major cytokine mediate organ damage cytokine storm il<NUMBER> excessive secretion il<NUMBER> results activation coagulation pathway conversion naive cells increase vascular permeability reduced cardiac function contribute increased disease severity <NUMBER> <NUMBER> sars patients also showed increased levels il<NUMBER> correlated disease progression <NUMBER> increased levels th<NUMBER> cd<NUMBER> cells seen covid<NUMBER> patients explained high levels il<NUMBER> implicated helper <NUMBER> th<NUMBER> cells development <NUMBER> <NUMBER> interestingly spike protein sars cov induced activation nfκb signalling resulting il<NUMBER> tnfα secretion murine macrophages <NUMBER> later another study reported inhibiting nfκb signalling demonstrated decreased il<NUMBER> levels increased animal survival sars <NUMBER> studies implicate il<NUMBER> key contributor pathophysiology cytokinestorm seen sars cov infections one proposed mechanisms decreased cells covid<NUMBER> infection could mediated increased levels il<NUMBER> increased interaction fas ligand moreover increased number lymphocytes observed patients sars cov<NUMBER> infection treated tocilizumab il<NUMBER> receptor antagonist <NUMBER> <NUMBER> yet studies required speculating exact mechanism sars cov<NUMBER> induced lymphopenia although occurrence copd covid<NUMBER> patients reported <NUMBER> <NUMBER> rate disease severity mortality rate markedly high <NUMBER> <NUMBER> respectively death rate covid<NUMBER> patients cvd <NUMBER> <NUMBER> observational studies shown bcg vaccination could reduce neonatal well childhood death rate <NUMBER> <NUMBER> retrospective crosssectional study conducted subsaharan african children <NUMBER> years demonstrated positive association bcg vaccination lower threat malaria <NUMBER> additionally epidemiological studies also established protective role bcg respiratory tract infections children predominantly virusmediated <NUMBER> <NUMBER> vaccination bcg enhanced ifnγ il<NUMBER> level thus providing immunity respiratory tract infection even elderly age group <NUMBER> bcg also provides nonspecific immune assistance like immunity pathogens mycobacteria like virus parasites reduces occurrence allergy attained mechanism termed trained immunity immunological recall innate immune system via epigenetic reprogramming <NUMBER> innate immune cells like monocytes nk cells macrophages undergo epigenetic modifications histones include methylation acetylation enhances gene expression il<NUMBER> tnfα il<NUMBER>β upon bcg vaccination thus trained phenotype innate immune cells results increase secretion proinflammatory cytokines exposure nonspecific pathogen enhancing host protection <NUMBER> <NUMBER> experimentally shown healthy subjects immunized bcg show increased production tnfα il<NUMBER>β response bacterial nonbacterial stimulants increased h<NUMBER>k<NUMBER>me<NUMBER> trimethylation histone h<NUMBER> lysine <NUMBER> exposed promoter regions proinflammatory cytokines leading increased expression <NUMBER> another study bcg vaccination reduced viremia experimental human yellow fever virus infection model inducing trained immunity epigenetic modification monocytes resulting increased production il<NUMBER>β <NUMBER> moreover bcg could enhance heterologous th<NUMBER>th<NUMBER> responses inducing longlasting release il<NUMBER> ifnγ il<NUMBER> thereby attaining nonspecific immune response infections <NUMBER> line several vivo studies murine models also reported bcg immunized mice expressed antimicrobial peptides bestowed protection malarial parasitemia <NUMBER> additionally prior bcg vaccination influenza virus challenged mice found considerable protection via secretion antibody activation cellmediated immunity <NUMBER> study conducted mice model understand effect bcg various viral infections like herpes simplex type <NUMBER> influenza a<NUMBER> encephalomyocarditis viruses showed increased resistance bcg immunised mice viruses compared control mice j u r n l p r e p r f <NUMBER> specifically bcg vaccinated newborn mice shown resistant herpes simplex type <NUMBER> infection <NUMBER> based observations proposed bcg vaccine potential act protective agent sars cov<NUMBER> provides antiviral immunity <NUMBER> sarscov<NUMBER> virus enhances generation il<NUMBER> ifnγ tnfα il<NUMBER>β mild severely infected patients <NUMBER> discussed earlier trained immunity bcg vaccine involves release cytokines thus providing antiviral state earlier protection sarscov<NUMBER> figure <NUMBER> ozdemir malini laloraya conceptualization writingreviewing editing supervision none authors declare known competing financial interests personal relationships could appeared influence work reported paper since origin china severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> infection become pandemic spread <NUMBER> countries coronavirus disease <NUMBER> covid<NUMBER> rapidly emerging disease organspecific studies related reported apart respiratory findings studies highlighted inflammatory consequences heart kidney andor liver well cardiac involvement covid<NUMBER> seems result inflammatory storm response infection moreover direct viral invasion cardiomyocytes well myocardial injury due oxidative stress may account acute cardiac injury covid<NUMBER> nevertheless mechanism heart injury covid<NUMBER> clear yet however multiple studies highlight clinical features laboratory findings prognosis acute myocardial injury ami covid<NUMBER>affected individuals published review summarized findings studies well clinical features management cardiac injury discussed case reports cardiac manifestations coronavirus disease <NUMBER> covid<NUMBER> comprehensive review february <NUMBER> coronavirus study group international committee taxonomy viruses named new virus sarscov<NUMBER> march <NUMBER> disease declared pandemic <NUMBER> last three months disease spread rapidly <NUMBER> cases <NUMBER> million cases worldwide <NUMBER> basic reproduction number r <NUMBER> indicator transmissibility virus shows expected number new infections generated infected individual susceptible population r <NUMBER> <NUMBER> number new cases likely increase <NUMBER> mean r <NUMBER> sarscov<NUMBER> <NUMBER> <NUMBER> <NUMBER> comparable sars widespread rapid rise number cases indicates higher transmissibility sarscov<NUMBER> <NUMBER> covid<NUMBER> rapidly emerging disease new evidence information reported daily however due emergence large number studies diseaseand organspecific reviews necessary provide updated comprehensive summary literature physicians currently cannot spare precious hours go vast online databases hence searched pubmed embase scopus google scholar sciencedirect wiley coronavirus collections major publishing groups identify literature related cardiac involvement covid <NUMBER> review summarize cardiac manifestations covid<NUMBER> prognoses december <NUMBER> people wuhan china started visiting local hospitals pneumonialike symptoms due unknown causes many index cases history linked exposure huanan seafood wholesale market china notified outbreak december <NUMBER> <NUMBER> closed huanan market january <NUMBER> <NUMBER> cleaning disinfection <NUMBER> january <NUMBER> <NUMBER> scientists able isolate identify sequence <NUMBER>ncov genome sequences different patients almost identical indicating recent emergence disease humans <NUMBER> since origin china sarscov<NUMBER> infection become pandemic spread <NUMBER> countries according latest covid<NUMBER> situation report april <NUMBER> <NUMBER> <NUMBER> cases total <NUMBER> deaths reported far overwhelming number <NUMBER> new deaths reported last <NUMBER> hours three countries highest number cases till april <NUMBER> <NUMBER> united states <NUMBER> spain <NUMBER> italy <NUMBER> <NUMBER> increase percentage mortality time observed covid<NUMBER> status reports january <NUMBER> april <NUMBER> <NUMBER> figure <NUMBER> <NUMBER> xaxis shows number patients yaxis shows days covid<NUMBER> coronavirus disease <NUMBER> coronaviruses covs broad family viruses primarily affect respiratory system four genera cov identified alpha beta gamma delta sarscov<NUMBER> ribonucleic acid rna virus belongs subgenus sarbecovirus genus betacov total six covs infect humans also identified widely known members cov family identified earlier include sarscov merscov belonging beta genus capable causing lifethreatening respiratory infections four human coronavirus hcov<NUMBER>e hcovnl<NUMBER> hcovhku<NUMBER> hcovoc<NUMBER> cause milder disease <NUMBER> <NUMBER> <NUMBER> gross structure sarscov<NUMBER> identified patients wuhan appeared spherical degree pleomorphism electron micrographs <NUMBER> diameters viral particles <NUMBER> <NUMBER> nm size spikes <NUMBER> nm appeared like crown <NUMBER> strain sarscov<NUMBER> <NUMBER> kb <NUMBER> open reading frames orfs vary number <NUMBER> cov genome first orf twothirds viral rna encodes nonstructural proteins translates two polyproteins pp<NUMBER>a pp<NUMBER>b structural accessory proteins encoded orfs four essential structural proteins include <NUMBER> spike glycoprotein <NUMBER> nucleocapsid n protein <NUMBER> matrix protein <NUMBER> envelope e protein <NUMBER> <NUMBER> <NUMBER> sarscov merscov genomes <NUMBER> kb <NUMBER> kb respectively <NUMBER> sarscov<NUMBER> closely related two sarslike covs derived bats batslcovzc<NUMBER> batslcovzxc<NUMBER> <NUMBER> similarity identity distant sarscov merscov identity <NUMBER> <NUMBER> respectively <NUMBER> <NUMBER> evidence suggests possible origin bats <NUMBER> based origin spread wuhan market abundance sorts animals highly possible covid<NUMBER> zoonotic origin transmitted humans intermediate host <NUMBER> identification sarslike covs bats similar sarscov<NUMBER> shows possibility bats reservoir host progenitor <NUMBER> also indicates mammals likely link humans covid<NUMBER> <NUMBER> based recent research two species snake could also possible reservoir sarscov<NUMBER> <NUMBER> however study yet found substantial evidence reservoir sarscov<NUMBER> birds mammals humantohuman transmission sarscov<NUMBER> possible accounts majority cases <NUMBER> <NUMBER> <NUMBER> sarscov<NUMBER> highly infective transmission disease direct contact affected individual respiratory droplets produced coughing sneezing recent evidence possible vertical transmission mother newborn <NUMBER> recent study luo et al also shown virus unlikely weakened high temperatures humidity cluster transmission possible even conditions earlier thought unsuitable viral transmission <NUMBER> higher infectivity sarscov<NUMBER> also understood higher viability air well different surfaces <NUMBER> sarscov<NUMBER> remain viable air three hours plastic steel <NUMBER> hours copper cardboard viability sarscov<NUMBER> less four hours <NUMBER> hours respectively <NUMBER> high viability time period different surfaces lead indirect transmission sarscov<NUMBER> healthy individuals come contact objects used covid<NUMBER> patients stethoscope thermometer <NUMBER> cases fecaloral transmission date airborne transmission possible situations aerosol production bronchoscopy open suctioning nebulization tracheostomy intubation cardiopulmonary resuscitation <NUMBER> <NUMBER> <NUMBER> aerosol generation fecal matter affected individuals flushing toilets treatment excreta rural areas may cause viral spread <NUMBER> sarscov<NUMBER> uses angiotensinconverting enzyme <NUMBER> receptor ace<NUMBER>r entry cells protein virus binds ace<NUMBER>r binding causes conformational change protein leads fusion viral envelope host cell membrane sarscov<NUMBER> rna released host cell genome rna translated polyproteins pp<NUMBER>a pp<NUMBER>b broken proteinases viral proteins produced translation subgenomic messenger rna mrna endoplasmic reticulum er golgi apparatus viral genome proteins assembled virions newly formed virions transferred cell membrane released cell <NUMBER> ace<NUMBER> found lower respiratory tract humans virus transmitted airway directly respiratory droplets touching nose touching infected surface <NUMBER> <NUMBER> initial clinical presentation disease usually asymptomatic mild symptoms cough sore throat rhinorrhea headache fever shortness breath sob nausea vomiting diarrhea fatigue patients disease progress pneumonia respiratory failure acute cardiac injury aci multiorgan failure mof ultimately death <NUMBER> <NUMBER> recently published study huang et al reported detailed symptoms <NUMBER> patients affected covid<NUMBER> <NUMBER> symptoms onset commonly included fever <NUMBER> cough <NUMBER> myalgiafatigue <NUMBER> less common presenting symptoms production sputum <NUMBER> headache <NUMBER> hemoptysis <NUMBER> diarrhea <NUMBER> illness progressed dyspnea leukopenia lymphopenia developed <NUMBER> <NUMBER> <NUMBER> patients respectively admitted patients developed pneumonia bilateral pulmonary involvement multiple consolidations bilateral groundglass opacity visible ct scan total <NUMBER> admitted patients expired complications developed patients included acute respiratory distress syndrome ards <NUMBER> rnaaemia <NUMBER> aci <NUMBER> secondary infection <NUMBER> complications requiring intensive care unit icu admissions <NUMBER> <NUMBER> level inflammatory chemokines cytokines interleukin il <NUMBER>β il<NUMBER>ra il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> basic fibroblast growth factor <NUMBER> bfgf<NUMBER> granulocytecolony stimulating factor gcsf granulocytemacrophage colonystimulating factor gmcsf interferongamma ifnγ interferoninducible protein <NUMBER> ip<NUMBER> monocyte chemoattractant protein<NUMBER> mcp<NUMBER> macrophage inflammatory proteins mip <NUMBER>α mip<NUMBER>β plateletderived growth factor subunit b pdgfb tumor necrosis factoralpha tnfα vascular endothelial growth factor vegfa elevated icu nonicu patients <NUMBER> proinflammatory cytokines namely il<NUMBER> il<NUMBER> il<NUMBER> gcsf ip<NUMBER> mcp<NUMBER> mip<NUMBER>a tnfα elevated icu patients suggesting possible association increased disease severity <NUMBER> covid<NUMBER> lead cardiac involvement injury via following possible mechanisms <NUMBER> indirect injury due increased cytokines immuneinflammatory response <NUMBER> direct invasion cardiomyocytes sarscov<NUMBER> <NUMBER> respiratory damage virus causing hypoxia leading oxidative stress injury cardiomyocytes <NUMBER> <NUMBER> <NUMBER> mechanisms graphically represented figure <NUMBER> adapted <NUMBER> along presence ace<NUMBER> respiratory tract also found heart sarscov<NUMBER> use ace<NUMBER> enter cells <NUMBER> <NUMBER> mechanism heart injury covid<NUMBER> still entirely clear ie unclear whether binding sarscov<NUMBER> alters expression ace<NUMBER> causes abnormality regulation reninangiotensinaldosterone system raas <NUMBER> however multiple studies analyzing acute myocardial injury ami covid<NUMBER>affected individuals published ami detected high levels serum creactive protein crp creatine kinase ck troponins affected individuals often history chronic diseases diabetes chronic obstructive pulmonary disease copd hypertension coronary artery disease cad ami also associated longer hospital stay <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> critically ill patients higher likelihood myocardial injury associated poor outcomes increased risk inhospital mortality <NUMBER> <NUMBER> <NUMBER> <NUMBER> multiple studies highlight clinical features laboratory findings prognosis ami covid<NUMBER>affected individuals published far studies discussed singlecenter retrospective case series wang et al delineated epidemiological clinical characteristics novel coronavirusinfected pneumonia ncip among <NUMBER> consecutively hospitalized patients zhongnan hospital wuhan <NUMBER> epidemiological demographic clinical laboratory radiological treatment data collected january <NUMBER> <NUMBER> <NUMBER> authors compared outcomes critically ill noncritically ill patients among patients <NUMBER> n<NUMBER> male median age <NUMBER> years comorbidities found <NUMBER> n<NUMBER> patients among cardiovascular disease cvd appreciated <NUMBER> n<NUMBER> among icubound patients n<NUMBER> <NUMBER> n<NUMBER> reported cardiovascular comorbidity median heart rate hr patients icu found <NUMBER> beats per minute bpm <NUMBER> bpm respectively similarly mean arterial pressure map patients patients bound icu recorded <NUMBER> mmhg <NUMBER> mmhg respectively aci appreciated <NUMBER> n<NUMBER> <NUMBER> n<NUMBER> <NUMBER> n<NUMBER> icu bound nonicubound n<NUMBER> patients respectively p<NUMBER> furthermore arrhythmia found <NUMBER> n<NUMBER> <NUMBER> n<NUMBER> <NUMBER> n<NUMBER> icubound nonicubound patients respectively p<NUMBER> recapitulate authors established mortality rate <NUMBER> <NUMBER> huang et al investigated clinical features patients infected <NUMBER>ncov wuhan china <NUMBER> total <NUMBER> hospitaladmitted patients identified laboratoryconfirmed covid<NUMBER> majority n<NUMBER> <NUMBER> men less half underlying comorbidities diabetes n<NUMBER> <NUMBER> hypertension n<NUMBER> <NUMBER> cvd n<NUMBER> <NUMBER> median age <NUMBER> years aci n<NUMBER> <NUMBER> third common complication patients ards rnaemia <NUMBER> patients admitted icu four <NUMBER> aci five died study concluded severe respiratory illness <NUMBER>ncov infection deteriorating complications associated icu admission higher mortality rate <NUMBER> zhang et al retrospectively evaluated clinical characteristics <NUMBER> hospitalized patients died covid<NUMBER> january <NUMBER> february <NUMBER> <NUMBER> renmin hospital wuhan <NUMBER> study majority deceased patients male <NUMBER> n<NUMBER> higher mortality rate found among older individuals significantly <NUMBER> n<NUMBER> nonsurvivors <NUMBER> years age major bulk <NUMBER> n<NUMBER> deceased individuals existing comorbidity among <NUMBER> n<NUMBER> heart disease cardiac damage found <NUMBER> n<NUMBER> patients cardiac failure cf <NUMBER> n<NUMBER> third common cause death acute respiratory failure arf <NUMBER> n<NUMBER> sepsis syndromemof <NUMBER> n<NUMBER> along abnormal laboratory findings levels crp <NUMBER> ul cardiac troponin tnt <NUMBER> pgml ck <NUMBER> ul myoglobin <NUMBER> μgl lactate dehydrogenase ldh <NUMBER> ul creatine kinase myocardial band ckmb <NUMBER> ngml found much higher <NUMBER> n<NUMBER> <NUMBER> n<NUMBER> <NUMBER> n<NUMBER> <NUMBER> n<NUMBER> <NUMBER> n<NUMBER> <NUMBER> n<NUMBER> deceased cases respectively authors concluded either virus storm released cytokines response might aggravated damage vital organs including heart <NUMBER> retrospective singlecenter study medical records hui et al investigated correlation clinical features aci among patients affected covid<NUMBER> pneumonia <NUMBER> study records <NUMBER> consecutive cases covid<NUMBER> <NUMBER> males <NUMBER> females beijing youan hospital china january <NUMBER> february <NUMBER> <NUMBER> studied including two deaths view <NUMBER>th guidance provided national health commission china <NUMBER> n<NUMBER> <NUMBER> n<NUMBER> <NUMBER> n<NUMBER> <NUMBER> n<NUMBER> patients labeled light mild severe critical cases respectively median age patients found <NUMBER> years adult males found prone develop severe infection underlying comorbidities hypertension cad diabetes mellitus dm type <NUMBER> tumor found <NUMBER> n<NUMBER> patients severe critical cases notably substantial cardiacrelated chronic disease group moreover compared normal value troponin tni <NUMBER>fold increase peak value higher crp level <NUMBER> mgl recorded among critical patients translated higher risk cardiac injury atrial fibrillation afib hr inclining <NUMBER> bpm recognized <NUMBER> n<NUMBER> patients critical category eventually died reduced epicardial adipose tissue eat density shown ct scans severe <NUMBER> hu critical <NUMBER> hu cases indicating cardiac inflammation authors concluded patients light mild categories rarely exhibited cardiac injury whereas found commonly among severe critical patients tachycardia elevated levels tni low eat density regarded main risk factors intercept fatality among covid<NUMBER> patients authors suggested close monitoring cardiac functioning patients especially severe critical ones seek possible interventions patients evincing features abnormal cardiac injury <NUMBER> wu et al conducted singlecenter retrospective cohort study explore whether heart injury occurs covid<NUMBER> aggravates mortality later <NUMBER> among <NUMBER> patients covid<NUMBER> mean age <NUMBER> years range <NUMBER> years <NUMBER> <NUMBER> male older patients patients comorbidity especially hypertension tended increased highsensitivity troponin hstni levels admission high mortality rate associated high hstni admission ≥<NUMBER> pgml noticed high hstni levels associated increased inflammatory levels neutrophils il<NUMBER> crp procalcitonin pct decreased immune levels lymphocytes monocytes cluster differentiation cd<NUMBER> cd<NUMBER> cells raised ckmb levels tended occur male patients current smokers associated higher mortality increased inflammatory levels decreased lymphocytes similarly increased ldh αhydroxybutyrate dehydrogenase αhbdh tended occur older hypertensive patients associated higher mortality rates increased inflammatory decreased immune levels subsequently hstni p<NUMBER> ldh levels p<NUMBER> admission day negatively correlated survival days hence concluded heart injury signs arise covid<NUMBER> especially older patients hypertensives male patients current smoking habits elevated levels heart injury indicators associated higher mortality shorter survival days authors suggested covid<NUMBER> might attack heart inducing inflammatory storm patients signs heart injury must identified primarily carefully treated cardiologists <NUMBER> investigate clinical characteristics eventual prognosis covid<NUMBER> patients already existing cvd peng et al retrospectively analyzed <NUMBER> patients visited union hospital wuhan january <NUMBER> february <NUMBER> <NUMBER> <NUMBER> depending clinical severity disease patients grouped two categories critical n<NUMBER> general n<NUMBER> comparison general group lymphocyte count <NUMBER>×<NUMBER> <NUMBER> l <NUMBER> <NUMBER> <NUMBER> found much lower category keeping view either critical general groups survivor nonsurvivor groups medication ace inhibitor angiotensin receptor blocker arb impact morbidity mortality related covid<NUMBER> patients preexisting cardiac disease hence authors concluded higher risk mortality existed among covid<NUMBER> patients already existing cardiac diseases fulminant inflammation lactic acid accumulation thrombotic events regarded main exacerbating factors <NUMBER> crosssectional study chen et al evaluated cardiovascular damage patients covid<NUMBER> <NUMBER> total <NUMBER> covid<NUMBER> cases included tongji hospital wuhan patients divided groups mild cases n<NUMBER> critical care cases n<NUMBER> age hypersensitive crp hscrp serum creatinine levels patients observed higher critical care cases mild cases p<NUMBER> critical care patients higher prevalence males elevated nterminal probtype natriuretic peptide ntprobnp cardiac troponin ctni hypertension coronary heart disease chd p<NUMBER> elevated ctni odds ratio <NUMBER> <NUMBER> ci <NUMBER> p<NUMBER> chd <NUMBER> <NUMBER> ci <NUMBER> p<NUMBER> found independent risk factors critical disease status according multivariate logistic regression analysis authors concluded covid<NUMBER> could significantly affect heart function lead myocardial injury two crucial independent determinants clinical disease status patients covid<NUMBER> past medical history chd increased level ctni <NUMBER> xu et al investigated clinical characteristics risk factors ami covid<NUMBER> patients <NUMBER> total <NUMBER> consecutive laboratoryconfirmed hospitalized covid<NUMBER> patients included study <NUMBER> <NUMBER> patients cardiac complications majority n<NUMBER> elevated cardiac enzymes followed diastolic dysfunction n<NUMBER> tachycardia n<NUMBER> electrocardiography abnormalities n<NUMBER> ami n<NUMBER> patients ami aged <NUMBER> years five also two comorbidities hypertension diabetes cvd copd furthermore noticed severity novel coronavirus pneumonia ncp higher patients patients nondefinite ami p<NUMBER> three ami patients died two remained hospitalized icu covid<NUMBER> patients ami higher mean systolic pressure groups p<NUMBER> according multivariate analysis major risk factor cardiac abnormalities covid<NUMBER> patients elevated crp levels p<NUMBER> <NUMBER> <NUMBER> ci <NUMBER> ncp severity p<NUMBER> <NUMBER> <NUMBER> ci <NUMBER> underlying comorbidities p<NUMBER> <NUMBER> <NUMBER> ci <NUMBER> occurrence hypertension higher ami group n<NUMBER> <NUMBER> similarly cvd frequently found ami patients n<NUMBER> <NUMBER> history cad one prior coronary artery bypass grafting cabg comorbidities like diabetes copd found patients significant occurrence ami patients diabetes n<NUMBER> copd n<NUMBER> compared groups <NUMBER> covid<NUMBER> patients exhibited elevated cardiac markers ami nondefinite ami patients higher cardiac markers groups p<NUMBER> ddimer levels admission also elevated ami patients median<NUMBER> µgml patients abnormal cardiac markers median<NUMBER> µgml subsequently higher patients normal cardiac markers median<NUMBER> µgml p<NUMBER> among <NUMBER> patients exhibiting echo abnormalities higher frequency found ami patients manifesting left ventricular lv wall thickening diastolic dysfunction left atrial enlargement lv enlargement mitral aortic triple valve regurgitation <NUMBER> liu et al conducted singlecenter retrospective study analyze association cardiovascular manifestations inhospital outcomes covid<NUMBER> cases <NUMBER> case details <NUMBER> consecutive hospitalized health staff confirmed covid<NUMBER> collected central hospital wuhan china mean age population <NUMBER> ± <NUMBER> years <NUMBER> <NUMBER> cases cardiovascular manifestation cvm patients cvm comparatively lower baseline lymphocyte count p<NUMBER> incidence positive nucleic acid detection throat swab p<NUMBER> received oxygen support p<NUMBER> similarly rate inhospital effects significantly higher cvm group p<NUMBER> multivariate logistic regression analysis indicated coexistence cvm ncp independently associated inhospital adverse effects <NUMBER> <NUMBER> ci <NUMBER> p<NUMBER> however tendency significance noticed baseline lymphocyte count two groups model <NUMBER> <NUMBER> ci <NUMBER> p<NUMBER> <NUMBER> et al analyzed clinical characteristics severe critically ill patients covid<NUMBER> evaluated impact complicated myocardial injury prognosis patients <NUMBER> fiftyfour patients met criteria severe critical conditions covid<NUMBER> included retrospective study median age patients <NUMBER> <NUMBER> <NUMBER> patients hypertension <NUMBER> <NUMBER> diabetes eight <NUMBER> chd three <NUMBER> previous cerebral infarction noticed <NUMBER> <NUMBER> patients complicated myocardial injury <NUMBER> <NUMBER> patients died hospital stay patients myocardial injury higher inhospital mortality rates without myocardial injury n<NUMBER> <NUMBER> myocardial injury vs n<NUMBER> <NUMBER> without myocardial injury p<NUMBER> moreover patients significant myocardial injury exhibited significantly higher levels crp <NUMBER> ngl vs <NUMBER> ngl ntprobnp <NUMBER> ngl vs <NUMBER> ngl patients without myocardial injury p<NUMBER> study postulated severe critically ill covid<NUMBER> patients higher prevalence myocardial injury patients face significantly higher risk inhospital mortality hence vital monitor manage myocardial injury hospitalization severe critically ill covid<NUMBER> patients <NUMBER> another retrospective comparison clinical features recovered versus deceased patients covid<NUMBER> deng et al collected data two hospitals wuhan <NUMBER> total enrolled covid<NUMBER> patients <NUMBER> died hospitalization whereas <NUMBER> recovered median age higher deceased group compared recovered group <NUMBER> years vs <NUMBER> years p <NUMBER> levels creatinine <NUMBER> μmoll vs <NUMBER> μmoll p <NUMBER> crp <NUMBER> mgl vs <NUMBER> mgl p <NUMBER> found significantly higher deceased group versus recovered one complications recorded higher among deceased group aci <NUMBER> vs <NUMBER> p <NUMBER> found much higher compared recovered group <NUMBER> investigate epidemiological clinical features patients infected covid<NUMBER> cardiac injury liu et al collected analyzed data medical records january <NUMBER> february <NUMBER> <NUMBER> <NUMBER> among <NUMBER> patients guangzhou eighth peoples hospital <NUMBER> n<NUMBER> cardiac injury patients cardiac injury comparatively older without injury median age found <NUMBER> years male predominance among cardiac injury patients <NUMBER> n<NUMBER> male hypertension <NUMBER> n<NUMBER> chd <NUMBER> n<NUMBER> predominant comorbidities among individuals presenting cardiac injury moreover common symptoms covid<NUMBER> like fever <NUMBER> n<NUMBER> cough <NUMBER> n<NUMBER> headache fatigue <NUMBER> n<NUMBER> dyspnea <NUMBER> n<NUMBER> without complaints chest pain palpitations appreciated group patients cardiac injury showed relatively higher systolic blood pressure bp <NUMBER> mmhg vs <NUMBER> mmhg tni <NUMBER> ugl vs <NUMBER> ugl bnp <NUMBER> pgml vs <NUMBER> pgml levels compared without cardiac injury nevertheless levels crp found raised among patients cardiac injury n<NUMBER> among enrolled patients ards <NUMBER> n<NUMBER> severe pneumonia <NUMBER> n<NUMBER> reported commonly cases cardiac injury complicated disease authors concluded cardiac injury commonly found among patients covid<NUMBER> worsens clinical outcomes hence regarded potential prognostic risk indicator <NUMBER> zhou et al studied clinical characteristics myocardial injury patients covid<NUMBER> <NUMBER> total <NUMBER> patients covid<NUMBER> included study divided two groups patients severe covid<NUMBER> n<NUMBER> severe covid<NUMBER> n<NUMBER> median age <NUMBER> years severe covid<NUMBER> group <NUMBER> years severe group authors noted significantly increased ctni <NUMBER> ngl vs <NUMBER> ngl ck <NUMBER> ul vs <NUMBER> ul αhbdh <NUMBER> ul vs <NUMBER> ul ldh <NUMBER> ul vs <NUMBER> ul severe group compared severe group percentage severe patients elevated ctni levels markedly higher eight patients severe disease exhibited increased ctni one patient severe disease raised ctni levels p<NUMBER> study concluded patients severe covid<NUMBER> higher percentage increased ctni levels mortality rate improved protecting myocardial injury <NUMBER> explore association cardiac injury mortality patients covid<NUMBER> shi et al conducted singlecenter cohort study renmin hospital wuhan university china <NUMBER> included total <NUMBER> hospitalized patients covid<NUMBER> final analysis median age <NUMBER> years <NUMBER> patients <NUMBER> declared cardiac injury comparison patients without cardiac injury individuals older p<NUMBER> comorbidities hypertension p<NUMBER> higher leukocyte counts median <NUMBER> higher levels crp median <NUMBER> pct median <NUMBER> ckmb median <NUMBER> myohemoglobin median <NUMBER> hstni median <NUMBER> ntprobnp median <NUMBER> aspartate aminotransferase ast median <NUMBER> creatinine median <NUMBER> higher proportion multiple mottling groundglass opacity radiographic findings <NUMBER> patients cardiac injury required greater proportion noninvasive mechanical ventilation p<NUMBER> invasive mechanical ventilation p<NUMBER> similarly complications like ards p<NUMBER> acute kidney injury aki p<NUMBER> electrolyte disturbances p<NUMBER> hypoproteinemia p<NUMBER> coagulation disorders p<NUMBER> higher patients cardiac injury higher mortality rate p<NUMBER> noticed patients cardiac injury <NUMBER> without cardiac injury <NUMBER> additionally patients cardiac injury higher risk death time onset symptoms hr <NUMBER> <NUMBER> ci <NUMBER> admission endpoint hr <NUMBER> <NUMBER> ci <NUMBER> according cox regression model study concluded cardiac injury prevalent condition among hospitalized patients covid<NUMBER> wuhan china associated higher risk inhospital mortality <NUMBER> order depict clinical characteristics <NUMBER> deceased patients owing covid<NUMBER> infection chen et al retrospectively evaluated case series among cohort <NUMBER> confirmed cases covid<NUMBER> admitted tongji hospital january <NUMBER> february <NUMBER> <NUMBER> <NUMBER> comparison recovered cases deceased patients mostly male <NUMBER> n<NUMBER> median age <NUMBER> years among died chronic hypertension <NUMBER> n<NUMBER> cardiovascular abnormalities <NUMBER> n<NUMBER> predominant comorbidities vital signs revealed higher median systolic bp <NUMBER> mm hg arterial pressure ≥<NUMBER> mm hg hr <NUMBER> bpm among deceased patients apart abnormal laboratory findings considerably higher levels crp ck ldh ctni <NUMBER> pgml ntprobnp <NUMBER> pgml appreciated among deceased patients moreover eight deceased patients exhibited <NUMBER> pgml ctni whereas two <NUMBER> pgml disease frequently complicated among deceased patients occurrence aci n<NUMBER> hf n<NUMBER> <NUMBER> <NUMBER> individuals respectively also observed individuals cardiovascular comorbidity susceptible development cardiac complications however cardiac injury hf still common among deceased patients compared recovered ones regardless history cardiac disease authors concluded aci hf among common complications affected prognosis critically ill patients <NUMBER> evaluate association underlying cvd myocardial injury fatal outcomes patients covid<NUMBER> guo et al conducted retrospective singlecenter study <NUMBER> total <NUMBER> patients confirmed covid<NUMBER> selected demographic data laboratory findings comorbidities treatments analyzed regardless elevation tnt levels overall <NUMBER> <NUMBER> patients underlying cvd manifested hypertension chd cardiomyopathy <NUMBER> <NUMBER> patients exhibited myocardial injury indicated elevated tnt levels patients cvd elevated tnt levels higher mortality rate <NUMBER> groups ie patients without underlying cvd normal tnt <NUMBER> patients underlying cvd normal tnt <NUMBER> patients without underlying cvd elevated tnt <NUMBER> similarly patients underlying cvd likely present elevated tnt without cvd <NUMBER> vs <NUMBER> plasma tnt levels depicted significantly positive linear correlation plasma hscrp β<NUMBER> p<NUMBER> ntprobnp levels β<NUMBER> p<NUMBER> similarly plasma tnt ntprobnp levels elevated significantly hospitalization median <NUMBER> plasma tnt median <NUMBER> plasma ntprobnb indicated impending death median <NUMBER> serum tnt median <NUMBER> serum ntprobnp compared admission values median <NUMBER> serum tnt median <NUMBER> serum ntprobnp patients died however significant changes tnt ntprobnp observed survivors patients elevated tnt developed frequent malignant arrhythmias required glucocorticoids <NUMBER> vs <NUMBER> mechanical ventilation <NUMBER> vs <NUMBER> compared normal tnt levels mortality rate patients without usage acei arb <NUMBER> <NUMBER> respectively observations concluded significant association myocardial injury fatal outcome covid<NUMBER> patients underlying cvd without myocardial injury relatively favorable prognosis <NUMBER> figure <NUMBER> provides summarized flowchart studies discussed <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> case reports also depicted distinctive involvement cardiovascular system covid<NUMBER> infection first case report cvm covid<NUMBER> presented zeng et al <NUMBER> article highlighted fulminant myocarditis complication covid<NUMBER> <NUMBER>yearold patient known comorbidity presented fever cough dyspnea chest tightness hospitalization myocardial enzymes showed elevated tni <NUMBER> gl myoglobin <NUMBER> ngml ntprobnp <NUMBER> pgml electrocardiogram ecg showed sinus tachycardia stsegment elevation however enlarged lv <NUMBER> mm diffuse myocardial dyskinesia along low left ventricular ejection fraction lvef <NUMBER> pulmonary hypertension <NUMBER> mmhg decreased inferior vena cava ivc collapse rate noticed bedside echocardiography severe pneumonia ards fulminant myocarditis multiple organ dysfunction syndrome mods considered differentials improvement patients condition supportive treatment ventricular septum thickened <NUMBER> mm il<NUMBER> increased <NUMBER> pgml extracorporeal membrane oxygenation ecmo used reduce cardiopulmonary burden showed reduction tni <NUMBER> gl ntprobnp <NUMBER> pgml il<NUMBER> <NUMBER> pgml lvef gradually recovered <NUMBER> lv wall regained normal thickness treatment <NUMBER> inciardi et al highlighted cardiac involvement complication covid<NUMBER> without symptoms signs interstitial pneumonia <NUMBER>yearold patient <NUMBER> ecg patient showed diffuse st elevation elevated hstnt ntprobnp levels also detected findings chest radiography normal cardiac mri showed increased wall thickness diffuse biventricular hypokinesis predominantly apical segments severe lv dysfunction lvef <NUMBER> short tau inversion recovery stir t<NUMBER>mapping sequences depicted marked biventricular myocardial interstitial edema diffuse late gadolinium enhancement involving entire biventricular wall circumferential pericardial effusion especially around right cardiac chambers also observed findings consistent acute myopericarditis patient treated dobutamine antiviral drugs steroids chloroquine medical treatment hf progressive clinical instrumental stabilization <NUMBER> similarly bilateral pericardial pleural effusion complication covid<NUMBER> infection reported albarello et al <NUMBER> <NUMBER>ncov infection may also involve organs like heart vessels liver kidney demonstrated yao et al <NUMBER> minimal invasive autopsies three covid<NUMBER> cases revealed degeneration necrosis parenchymal cells formation hyaline thrombus small vessels pathological changes chronic diseases organs tissues evidence coronavirus infection observed organs authors suggested conducting studies investigate mechanism underlying extrapulmonary pathological changes disease <NUMBER> cui et al highlighted multiple organ damage rapid disease changes <NUMBER>dayold infant diagnosed covid<NUMBER> pneumonia <NUMBER> laboratory investigations day admission revealed mildly abnormal myocardial zymogens altered liver function tests lfts deterioration patients condition increase tni <NUMBER> μgl noticed indicated myocardial injury intravenous sodium creatine phosphate added regimen protection heart later myocardial zymogen liver function improved supportive treatment patient discharged <NUMBER> summary important findings aforementioned case reports given table <NUMBER> female acute myocardial inflammation covid<NUMBER> patient recovered influenzalike syndrome developed fatigue signs symptoms heart failure week upper respiratory tract symptoms albarello et al <NUMBER> conclude aci common covid<NUMBER> especially among adult males regarded potential prognostic risk indicator higher levels cytokines il cardiac injury markers troponin ck crp usually appreciated patients consequently myocarditis ventricular dysfunction without pericardial effusion subsequently hf cumulatively increase mortality rate hence careful monitoring immediate management plan avoid treat cardiac injuries vital achieving decline number deaths due hf secondary covid<NUMBER> importance data lacking whether patients hypertension taking angiotensinconverting enzyme inhibitors aceis angiotensin receptor blockers arbs increased severity risk mortality hospitalization coronavirus disease <NUMBER> covid<NUMBER> objective investigate association aceisarbs severity illness mortality patients hypertension hospitalized covid<NUMBER> infection design setting participants retrospective singlecenter case series <NUMBER> hospitalized patients covid<NUMBER> infections central hospital wuhan china january <NUMBER> march <NUMBER> <NUMBER> main outcomes measures covid<NUMBER> confirmed realtime reverse transcriptionpolymerase chain reaction epidemiologic clinical radiologic laboratory drug therapy data analyzed patients percentage patients hypertension taking aceisarbs compared severe vs nonsevere illness survivors vs nonsurvivors results <NUMBER> patients covid<NUMBER> median age <NUMBER> years interquartile range <NUMBER> years <NUMBER> <NUMBER> men overall inhospital mortality <NUMBER> <NUMBER> patients hypertension <NUMBER> total group median age <NUMBER> years interquartile range <NUMBER> years <NUMBER> <NUMBER> men <NUMBER> <NUMBER> taking aceiarbs inhospital mortality patients hypertension <NUMBER> percentage patients hypertension taking aceisarbs differ severe nonsevere infections <NUMBER> vs <NUMBER> p <NUMBER> differ nonsurvivors survivors <NUMBER> vs <NUMBER> p <NUMBER> similar findings observed data analyzed patients taking aceis taking arbs conclusions relevance study provides clinical data association aceisarbs outcomes patients hypertension hospitalized covid<NUMBER> infections suggesting aceisarbs associated severity mortality covid<NUMBER> patients data support current guidelines societal recommendations treating hypertension covid<NUMBER> pandemic association reninangiotensin system inhibitors severity risk death patients hypertension hospitalized coronavirus disease <NUMBER> covid<NUMBER> infection wuhan china importance data lacking whether patients hypertension taking angiotensinconverting enzyme inhibitors aceis angiotensin receptor blockers arbs increased severity risk mortality hospitalization coronavirus disease <NUMBER> covid<NUMBER> objective investigate association aceisarbs severity illness mortality patients hypertension hospitalized covid<NUMBER> infection design setting participants retrospective singlecenter case series <NUMBER> hospitalized patients covid<NUMBER> infections central hospital wuhan china january <NUMBER> march <NUMBER> <NUMBER> main outcomes measures covid<NUMBER> confirmed realtime reverse transcriptionpolymerase chain reaction epidemiologic clinical radiologic laboratory drug therapy data analyzed patients percentage patients hypertension taking aceisarbs compared severe vs nonsevere illness survivors vs nonsurvivors results <NUMBER> patients covid<NUMBER> median age <NUMBER> years interquartile range <NUMBER> years <NUMBER> <NUMBER> men overall inhospital mortality <NUMBER> <NUMBER> patients hypertension <NUMBER> total group median age <NUMBER> years interquartile range <NUMBER> years <NUMBER> <NUMBER> men <NUMBER> <NUMBER> taking aceiarbs inhospital mortality patients hypertension <NUMBER> percentage patients hypertension taking aceisarbs differ severe nonsevere infections <NUMBER> vs <NUMBER> p <NUMBER> differ nonsurvivors survivors <NUMBER> vs <NUMBER> p <NUMBER> similar findings observed data analyzed patients taking aceis taking arbs conclusions relevance study provides clinical data association aceisarbs outcomes patients hypertension hospitalized covid<NUMBER> infections suggesting aceisarbs associated severity mortality covid<NUMBER> patients data support current guidelines societal recommendations treating hypertension covid<NUMBER> pandemic association reninangiotensin system inhibitors severity risk death patients hypertension hospitalized coronavirus disease <NUMBER> covid<NUMBER> infection wuhan china hypertension could active comparator antihypertensive agents also provide information association inpatients conducted study association ace inhibitors arbs mortality among people hypertension hospitalized covid<NUMBER> stratified assessments insurance groups due substantial differences two populations conducted <NUMBER> studies patients hypertensionthe first study included individuals tested positive sarscov<NUMBER> outpatient second included patients hospitalized covid <NUMBER> addition diagnosis hypertension prespecified study population include individuals receiving least <NUMBER> antihypertensive agent account medical comorbidities created robust propensity score matched cohorts patients treated ace inhibitors arbs antihypertensive agents evaluated success matching algorithms explicit assessments covariate balance across comparisons evaluation exposure groups falsification endpoints due systematic differences among enrollees medicare advantage commercial insurance programs enhanced risk adverse outcomes covid<NUMBER> among older individuals overrepresented medicare <NUMBER> <NUMBER> <NUMBER> <NUMBER> evaluated association drugs outcomes analyses stratified insurance groups ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint used deidentified administrative claims medicare advantage commercially insured members research database single large us health insurance provider database contains medical emergency inpatient outpatient pharmacy claims services submitted third party reimbursement available international classification diseases tenth revision clinical modification icd<NUMBER>cm national drug codes ndc claims respectively claims aggregated completion care encounters submission claims reimbursement two additional data sources included information covid<NUMBER> could linked claims first limited outpatient testing dataset included information sarscov<NUMBER> test results members underwent outpatient testing sarscov<NUMBER> <NUMBER> hospitalbased freestanding outpatient thirdparty labs states across united states <NUMBER> tests submitted thirdparty lab vendors second inpatient covid<NUMBER> dataset included dailyupdated record covid<NUMBER> inpatient admissions insurance enrollees claims information representing admitted hospital primary secondary diagnosis covid<NUMBER> etable <NUMBER> along current disposition admitted discharged transferred expired unknown ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint constructed cohorts patients two studies first outpatient study identified outpatients tested positive sarscov<NUMBER> included individuals least <NUMBER> years age least <NUMBER> months enrollment medicare advantage commercial insurance january december <NUMBER> available claims data diagnosis hypertension one claims receiving one antihypertensive agents tested positive sarscov<NUMBER> positive outpatient setting march <NUMBER> <NUMBER> may <NUMBER> <NUMBER> efigure <NUMBER> database satisfied inclusion criteria evaluated association ace inhibitors arbs respectively risk hospitalization outpatient cohort compared patients antihypertensive medications second second inpatient study identified inpatient cohort adults hospitalized covid <NUMBER> included patients age ≥<NUMBER> years least <NUMBER> months health insurance enrollment <NUMBER> available claims data diagnosis hypertension one claims receiving one antihypertensive agents hospitalized principal secondary diagnosis covid<NUMBER> january <NUMBER> <NUMBER> may <NUMBER> <NUMBER> efigure <NUMBER> evaluated association ace inhibitors arbs respectively mortality hospitalized individuals cohort compared patients antihypertensive medications studies diagnosis hypertension based icd<NUMBER> codes etable <NUMBER> drug treatment hypertension defined receipt one agents included <NUMBER> american heart association hypertension ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint guidelines <NUMBER> include firstline agents ace inhibitors arbs thiazide thiazidelike diuretics dihydropyridine nondihydropyridine calcium channel blockers well secondline agents betaadrenergic antagonists alpha blockers centrally acting alpha agonists loop diuretics potassium sparing diuretics mineralocorticoid receptor antagonists direct vasodilators individual drugs listed etable <NUMBER> information latter derived pharmacy claims defined cumulative supply greater <NUMBER> days july <NUMBER> <NUMBER> december <NUMBER> <NUMBER> identified <NUMBER> mutually exclusive exposure groups <NUMBER> patients receiving ace inhibitors <NUMBER> receiving arb without agents used active comparator analyses included remaining patients diagnosis hypertension received one antihypertensive agents drug classes ace inhibitor arb agents include first second line antihypertensive agents based <NUMBER> aha guidelines hypertension <NUMBER> use individual agents defined one pharmacy claims least <NUMBER> days medication supply agent july december <NUMBER> sensitivity analyses restricted control group individuals receiving least one first line antihypertensive agent drug classes ace inhibitor arb ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> combined information inpatient outpatient claims <NUMBER> identify potential confounders association ace inhibitors arb use patient outcomes included patient age sex race conditions would represent potential indications selective use ace inhibitors arbs diabetes myocardial infarction heart failure chronic kidney disease additional comorbidities included charlson comorbidity index peripheral vascular disease cerebrovascular disease hemior paraplegia dementia chronic pulmonary disease rheumatologic disease diabetes chronic complications malignancy metastatic solid tumor mild liver disease moderatetosevere liver disease acquired immunodeficiency syndrome human immunodeficiency virus icd<NUMBER> codes corresponding variables included etable <NUMBER> appendix race available medicare advantage members included information total number antihypertensive agents prescribed patients using pharmacy claims finally regional clustering cases identified using location sites submitting claims laboratory testing sarscov<NUMBER> hospital site inhospital outcomes outpatient study primary outcome inpatient hospitalization covid<NUMBER> defined hospitalization principal secondary diagnosis covid<NUMBER> linked inpatient dataset etable <NUMBER> assessed mortality inpatient hospitalization secondary outcome ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint inpatient study primary outcome inhospital mortality addition evaluated secondary composite outcome death discharge hospice hospital length stay outpatient inpatient studies created propensity scorematched cohorts patients hypertension treated ace inhibitors arbs antihypertensive medications constructed nonparsimonious multivariable logistic regression model receipt ace inhibitors arb antihypertensive dependent variable example modeled receipt ace inhibitor another antihypertensive excluding arb determine patients likelihood receiving agents based measured clinical characteristics applied strategy different pairs treatment comparisons ace inhibitor vs others arb vs others ace inhibitor vs arb briefly performed <NUMBER> matching recipients based propensity scores caliper width onetenth standard deviation logit propensity score <NUMBER> pursued <NUMBER> iterations find lowest mean absolute standardized difference among matched variables matched cohorts age gender race insurance type conditions may lead selective use ace inhibitors arbs ie diabetes myocardial infarction heart failure chronic kidney disease comorbidities charlson comorbidity index number antihypertensive agents used patient account regional clustering care practices response covid<NUMBER> ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint pandemic explicitly accounted census region lab testing site inpatient facility models evaluated performance propensity score matching using several strategies first assessed propensity score distributions unmatched matched cohorts calculated equipoise metric summarize degree overlap characteristics patients receiving drugs <NUMBER> <NUMBER> represents proportion individuals unmatched groups propensity score <NUMBER> <NUMBER> representing state equipoise two drugs value greater <NUMBER> implies two drugs empirical equipoise higher value indicating lower likelihood confounding indication <NUMBER> next evaluated standardized difference matched covariates propensity score matching specifically evaluated whether matching algorithm achieved standardized difference <NUMBER> matched cohort suggestive adequately matched groups <NUMBER> second evaluated success matching algorithm using priori defined negative control outcomes chose two negative control falsification endpointsclaims gastroesophageal reflux disease ingrown nail unlikely affected treatment assignment directional effect would represent covariate imbalance <NUMBER> third evaluated whether propensity matched cohort also adequately matched therapeutic classes nonantihypertensive agents directly included matching algorithm strategies designed evaluate potential residual confounding creating propensity score matched cohorts finally evaluated observations robustness assessing treatment effects <NUMBER> iterations propensity score ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint matching algorithm evaluating whether findings consistent across iterations varied degree matching individual covariates describe differences patients treated ace inhibitors arbs compared antihypertensive agents treated ace inhibitors using chi square test categorical variables ttest continuous variables duration follow expected vary across individuals outpatient inpatient covid<NUMBER> cohorts evaluated effects timetoevent analyses coxproportional hazards models unadjusted propensity scorematched cohorts reduce bias residual differences matched covariates evaluation patient outcomes included covariates included propensity score matching algorithm independent variables models <NUMBER> repeated analyses without additional covariate adjustment outpatient study index date represented day positive covid<NUMBER> test outpatient period study measured days positive covid<NUMBER> outcome interest hospitalization inpatient study index date represented first day hospitalization covid<NUMBER> period study measured days admission outcome interest death since hospitalization could end either patients death discharged alive created causespecific cox proportional hazards model competing risk analysis <NUMBER> <NUMBER> <NUMBER> analyses censored end observation period may <NUMBER> <NUMBER> ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint given systematic differences patients enrolled medicare advantage commercial insurance particularly older age higher comorbidity burden higher risk covid<NUMBER> complications among medicare advantage enrollees evaluated quantitative qualitative interactions insurance type treatment groups assessment outcomes also created propensity scorematched cohorts within two insurance subgroups analyses performed using open source r <NUMBER> cran python <NUMBER> hypothesis tests <NUMBER>sided level significance set <NUMBER> except interaction tests level significance set <NUMBER> given exploratory nature study statistical tests adjusted multiple testing yale affairs exempted study review activities limited retrospective analysis deidentified data accessed accordance health insurance portability accountability act regulations ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint median age individuals <NUMBER> years <NUMBER> women medicare advantage patients <NUMBER> african american patients receiving ace inhibitors arbs likely men diabetes without chronic complications receiving <NUMBER> antihypertensive drugs table <NUMBER> less likely chronic heart failure moderatetosevere renal disease compared patients receiving antihypertensive treatments patients receiving ace inhibitors similar receiving arbs higher rate dementia peripheral vascular disease table <NUMBER> matched <NUMBER> patients receiving ace inhibitors <NUMBER> patients receiving antihypertensive agents efigure <NUMBER> achieving <NUMBER> standardized differences covariates figure <NUMBER> similarly matched <NUMBER> patients receiving arb <NUMBER> patients receiving antihypertensive agents efigure <NUMBER> equipoise comparisons ace inhibitors drugs ace inhibitors arb <NUMBER> lower arb comparisons table <NUMBER> among <NUMBER> patients hospitalized covid<NUMBER> linked claims data <NUMBER> diagnosis hypertension outpatient prescription least one antihypertensive drug efigure <NUMBER> inpatient cohort included patients <NUMBER> states us efigure <NUMBER> included patients <NUMBER> medicare advantage enrollees median age hospitalized individuals <NUMBER> years <NUMBER> women <NUMBER> medicare advantage enrollees african american differences hospitalized patients treated ace inhibitors arbs agents included table <NUMBER> inpatient cohort <NUMBER> patients receiving ace ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint inhibitors <NUMBER> patients receiving arbs propensity scorematched patients receiving antihypertensive agents efigure <NUMBER> covariate standardized differences <NUMBER> matching figure <NUMBER> equipoise comparisons ace inhibitors drugs ace inhibitors arb <NUMBER> lower arb comparisons table <NUMBER> outpatient cohort median <NUMBER> iqr <NUMBER> <NUMBER> days sarscov<NUMBER> testing patients receiving ace inhibitors less frequently hospitalized receiving antihypertensive agents <NUMBER> vs <NUMBER> p <NUMBER> significant association arb therapy hospitalization rates <NUMBER> vs <NUMBER> individuals insurance p <NUMBER> propensity scorematched cohorts efigure table <NUMBER> differences priori chosen falsification endpoints propensity scorematched populations etable <NUMBER> differences association ace inhibitors hospitalization risk across insurance groups p interaction <NUMBER> lower risk hospitalization medicare advantage patients hr <NUMBER> <NUMBER> <NUMBER> p <NUMBER> observed commercially insured individuals hr <NUMBER> <NUMBER> <NUMBER> p <NUMBER> table <NUMBER> ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint propensity scorematched analyses arb use associated significantly lower hospitalization risk individuals receiving antihypertensive agents hr <NUMBER> <NUMBER> <NUMBER> p <NUMBER> figure <NUMBER> significant differences hospitalization rates propensity score matched cohorts patients receiving ace inhibitor compared arb hr <NUMBER> <NUMBER> <NUMBER> p <NUMBER> significant interactions insurancetype association arb outcomes pinteraction <NUMBER> among individuals outpatient cohort hospitalized association ace inhibitor arb use subsequent inhospital mortality etable <NUMBER> <NUMBER> patients hospitalized covid<NUMBER> <NUMBER> <NUMBER> died hospitalization <NUMBER> <NUMBER> discharged alive <NUMBER> <NUMBER> still hospitalized end observation period majority deaths <NUMBER> among medicare advantage population median length stay including patients died well discharged alive covid<NUMBER> hospitalizations <NUMBER> iqr <NUMBER> <NUMBER> days similar across patients died <NUMBER> iqr <NUMBER> <NUMBER> days discharged alive <NUMBER> iqr <NUMBER> <NUMBER> days observation period overall proportion covid<NUMBER> patients died differ significantly ace inhibitor therapy hospitalization compared antihypertensive agents <NUMBER> vs <NUMBER> p <NUMBER> propensity matchedcohort patients receiving ace inhibitors hospitalization inhospital mortality ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity table <NUMBER> similarly arb significantly different risk mortality compared antihypertensive agents <NUMBER> <NUMBER> <NUMBER> p <NUMBER> significant differences mortality patients receiving ace inhibitors arbs overall population without significant interaction insurance group treatment assignment patient outcome figure <NUMBER> table <NUMBER> findings consistent secondary outcome inhospital death discharge hospice etable <NUMBER> also association treatment ace inhibitor arb hospital length stay etable <NUMBER> sensitivity analyses focused individuals receiving least one first line antihypertensive agent control group varied covariate adjustment strategies consistent primary analysis etables <NUMBER> <NUMBER> iterations propensity score matching algorithm found lower risk hospitalization ace inhibitors across iterations pvalue less <NUMBER> <NUMBER> <NUMBER> iterations medicare advantage population first national study ace inhibitors arbs outpatients testing positive sarscov<NUMBER> found overall drugs confer additional risk benefit however among medicare advantage ace inhibitors associated almost <NUMBER> significantly lower risk hospitalization covid<NUMBER> effect observed arbs among hospitalized covid<NUMBER> find benefit harm medications collectively findings support change current use medications given lack effective therapies mitigate ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint harm virus study provide rationale testing use ace inhibitors older patients reduce risk severe sarscov<NUMBER> infection design several attributes provide confidence findings even though observational study restricted people hypertension receiving least one antihypertensive agent thereby limiting assessment individuals receiving treatment chronic illness therefore equally likely seek care healthcare needs covid<NUMBER> analyses explicitly compared individuals equipoise receiving either drug treatment moreover find evidence confounding disease severity choice therapy assessment priori defined falsification endpoints study included individuals across united states thereby limiting effect hospital regional care practices may bias evaluation treatment effects observations extends prior evidence supporting safety ace inhibitor treatment covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> show safety agents outpatient sarscov<NUMBER> infected individuals complements studies hospitalized <NUMBER> <NUMBER> <NUMBER> also national study complements single center single region studies <NUMBER> study intriguing finding subgroup individuals enrolled medicare advantage find ace inhibitors associated significantly lower risk hospitalization following infection sarscov<NUMBER> outpatient setting patients older frequently comorbidities vulnerable severe covid<NUMBER> disease <NUMBER> <NUMBER> findings particularly relevant medicare advantage group represented <NUMBER> covid<NUMBER> hospitalizations ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint inpatient cohort also interestingly find association arbs despite clinical equipoise use drugs findings consistent prior evidence randomized clinical trials reduced risk pneumonia ace inhibitors observed arb <NUMBER> study inhospital outcomes adds literature studies reached contrasting conclusions regarding role ace inhibitor therapy inhospital mortality among hospitalized covid<NUMBER> patients find significant association mortality consistent others found association <NUMBER> <NUMBER> <NUMBER> however findings contrast certain studies found lower mortality hospitalized covid<NUMBER> patients treated ace inhibitors <NUMBER> <NUMBER> notably studies evaluated mortality risk covid<NUMBER> consistently designed detect potential causal association drug therapy outcomes <NUMBER> relied case control designs <NUMBER> pursued potentially biased assessment using comparators receiving therapy <NUMBER> <NUMBER> based data single health centers <NUMBER> moreover studied ace inhibitors arbs together despite potentially different mechanisms effects patient outcomes <NUMBER> rationale may specific ace inhibitor effect preclinical evidence suggests possible protective role ace inhibitors covid<NUMBER> ace inhibitors arbs associated upregulation ace<NUMBER> receptors <NUMBER> <NUMBER> receptors modulate local reninangiotensinaldosterone system interactions lung tissue <NUMBER> presence ace<NUMBER> receptors therefore exerts protective effect development acute lung injury infections sars coronaviruses lead dysregulation mechanisms endothelial ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> study important implications <NUMBER> ongoing randomized trials none align observations study <NUMBER> <NUMBER> trials <NUMBER> testing use ace inhibitors arbs treatment hospitalized covid<NUMBER> patients <NUMBER> using <NUMBER>day course arbs positive sarscov<NUMBER> test prevent hospitalization <NUMBER> however study suggests appropriate strategy test trial would prophylactic use ace inhibitor prevent hospitalization tested current study findings study interpreted light following limitations first study observational despite robust methods explicit assessments residual confounding understanding potential protective role ace inhibitors covid<NUMBER> requires dedicated randomized controlled trial second know proportion patients receiving antihypertensive agents continued treated drugs illness association continued use cessation patient outcomes third included data elements contingent upon individuals seeking care ailment filling medication using insurance provider would captured chose selfpay however expect sizeable proportion insured individuals would defer insurance coverage care fourth cannot account differences timing ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint presentation patients relative symptom onset however limited effect differential presentation patients across exposure groups focusing patients receiving treatment medical comorbidity ie hypertension varying class drugs moreover included patients across us accounted clustering patients thereby limiting effect local practice patterns may affect hospitalization thresholds therefore unlikely patients care seeking ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint ant ihypert ensi e agent use roups propensit score ching roups aft er propensit score ching ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint inclusion criteria icd<NUMBER> codes hypertension i<NUMBER> i<NUMBER> i<NUMBER> i<NUMBER> i<NUMBER> i<NUMBER> i<NUMBER> g<NUMBER> i<NUMBER> g<NUMBER> i<NUMBER> g<NUMBER> i<NUMBER> i<NUMBER> i<NUMBER> i<NUMBER> i<NUMBER> i<NUMBER> i<NUMBER> g<NUMBER> i<NUMBER> i<NUMBER> h<NUMBER> i<NUMBER> i<NUMBER> g<NUMBER> i<NUMBER> i<NUMBER> g<NUMBER> i<NUMBER> i<NUMBER> i<NUMBER> i<NUMBER> i<NUMBER> i<NUMBER> i<NUMBER> g<NUMBER> i<NUMBER> i<NUMBER> g<NUMBER> i<NUMBER> i<NUMBER> i<NUMBER> i<NUMBER> i<NUMBER> i<NUMBER> i<NUMBER> hypertension could active comparator antihypertensive agents also provide information association inpatients conducted study association ace inhibitors arbs mortality among people hypertension hospitalized covid<NUMBER> stratified assessments insurance groups due substantial differences two populations conducted <NUMBER> studies patients hypertensionthe first study included individuals tested positive sarscov<NUMBER> outpatient second included patients hospitalized covid <NUMBER> addition diagnosis hypertension prespecified study population include individuals receiving least <NUMBER> antihypertensive agent account medical comorbidities created robust propensity score matched cohorts patients treated ace inhibitors arbs antihypertensive agents evaluated success matching algorithms explicit assessments covariate balance across comparisons evaluation exposure groups falsification endpoints due systematic differences among enrollees medicare advantage commercial insurance programs enhanced risk adverse outcomes covid<NUMBER> among older individuals overrepresented medicare <NUMBER> <NUMBER> <NUMBER> <NUMBER> evaluated association drugs outcomes analyses stratified insurance groups ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint used deidentified administrative claims medicare advantage commercially insured members research database single large us health insurance provider database contains medical emergency inpatient outpatient pharmacy claims services submitted third party reimbursement available international classification diseases tenth revision clinical modification icd<NUMBER>cm national drug codes ndc claims respectively claims aggregated completion care encounters submission claims reimbursement two additional data sources included information covid<NUMBER> could linked claims first limited outpatient testing dataset included information sarscov<NUMBER> test results members underwent outpatient testing sarscov<NUMBER> <NUMBER> hospitalbased freestanding outpatient thirdparty labs states across united states <NUMBER> tests submitted thirdparty lab vendors second inpatient covid<NUMBER> dataset included dailyupdated record covid<NUMBER> inpatient admissions insurance enrollees claims information representing admitted hospital primary secondary diagnosis covid<NUMBER> etable <NUMBER> along current disposition admitted discharged transferred expired unknown ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint constructed cohorts patients two studies first outpatient study identified outpatients tested positive sarscov<NUMBER> included individuals least <NUMBER> years age least <NUMBER> months enrollment medicare advantage commercial insurance january december <NUMBER> available claims data diagnosis hypertension one claims receiving one antihypertensive agents tested positive sarscov<NUMBER> positive outpatient setting march <NUMBER> <NUMBER> may <NUMBER> <NUMBER> efigure <NUMBER> database satisfied inclusion criteria evaluated association ace inhibitors arbs respectively risk hospitalization outpatient cohort compared patients antihypertensive medications second second inpatient study identified inpatient cohort adults hospitalized covid <NUMBER> included patients age ≥<NUMBER> years least <NUMBER> months health insurance enrollment <NUMBER> available claims data diagnosis hypertension one claims receiving one antihypertensive agents hospitalized principal secondary diagnosis covid<NUMBER> january <NUMBER> <NUMBER> may <NUMBER> <NUMBER> efigure <NUMBER> evaluated association ace inhibitors arbs respectively mortality hospitalized individuals cohort compared patients antihypertensive medications studies diagnosis hypertension based icd<NUMBER> codes etable <NUMBER> drug treatment hypertension defined receipt one agents included <NUMBER> american heart association hypertension ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint guidelines <NUMBER> include firstline agents ace inhibitors arbs thiazide thiazidelike diuretics dihydropyridine nondihydropyridine calcium channel blockers well secondline agents betaadrenergic antagonists alpha blockers centrally acting alpha agonists loop diuretics potassium sparing diuretics mineralocorticoid receptor antagonists direct vasodilators individual drugs listed etable <NUMBER> information latter derived pharmacy claims defined cumulative supply greater <NUMBER> days july <NUMBER> <NUMBER> december <NUMBER> <NUMBER> identified <NUMBER> mutually exclusive exposure groups <NUMBER> patients receiving ace inhibitors <NUMBER> receiving arb without agents used active comparator analyses included remaining patients diagnosis hypertension received one antihypertensive agents drug classes ace inhibitor arb agents include first second line antihypertensive agents based <NUMBER> aha guidelines hypertension <NUMBER> use individual agents defined one pharmacy claims least <NUMBER> days medication supply agent july december <NUMBER> sensitivity analyses restricted control group individuals receiving least one first line antihypertensive agent drug classes ace inhibitor arb ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> combined information inpatient outpatient claims <NUMBER> identify potential confounders association ace inhibitors arb use patient outcomes included patient age sex race conditions would represent potential indications selective use ace inhibitors arbs diabetes myocardial infarction heart failure chronic kidney disease additional comorbidities included charlson comorbidity index peripheral vascular disease cerebrovascular disease hemior paraplegia dementia chronic pulmonary disease rheumatologic disease diabetes chronic complications malignancy metastatic solid tumor mild liver disease moderatetosevere liver disease acquired immunodeficiency syndrome human immunodeficiency virus icd<NUMBER> codes corresponding variables included etable <NUMBER> appendix race available medicare advantage members included information total number antihypertensive agents prescribed patients using pharmacy claims finally regional clustering cases identified using location sites submitting claims laboratory testing sarscov<NUMBER> hospital site inhospital outcomes outpatient study primary outcome inpatient hospitalization covid<NUMBER> defined hospitalization principal secondary diagnosis covid<NUMBER> linked inpatient dataset etable <NUMBER> assessed mortality inpatient hospitalization secondary outcome ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint inpatient study primary outcome inhospital mortality addition evaluated secondary composite outcome death discharge hospice hospital length stay outpatient inpatient studies created propensity scorematched cohorts patients hypertension treated ace inhibitors arbs antihypertensive medications constructed nonparsimonious multivariable logistic regression model receipt ace inhibitors arb antihypertensive dependent variable example modeled receipt ace inhibitor another antihypertensive excluding arb determine patients likelihood receiving agents based measured clinical characteristics applied strategy different pairs treatment comparisons ace inhibitor vs others arb vs others ace inhibitor vs arb briefly performed <NUMBER> matching recipients based propensity scores caliper width onetenth standard deviation logit propensity score <NUMBER> pursued <NUMBER> iterations find lowest mean absolute standardized difference among matched variables matched cohorts age gender race insurance type conditions may lead selective use ace inhibitors arbs ie diabetes myocardial infarction heart failure chronic kidney disease comorbidities charlson comorbidity index number antihypertensive agents used patient account regional clustering care practices response covid<NUMBER> ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint pandemic explicitly accounted census region lab testing site inpatient facility models evaluated performance propensity score matching using several strategies first assessed propensity score distributions unmatched matched cohorts calculated equipoise metric summarize degree overlap characteristics patients receiving drugs <NUMBER> <NUMBER> represents proportion individuals unmatched groups propensity score <NUMBER> <NUMBER> representing state equipoise two drugs value greater <NUMBER> implies two drugs empirical equipoise higher value indicating lower likelihood confounding indication <NUMBER> next evaluated standardized difference matched covariates propensity score matching specifically evaluated whether matching algorithm achieved standardized difference <NUMBER> matched cohort suggestive adequately matched groups <NUMBER> second evaluated success matching algorithm using priori defined negative control outcomes chose two negative control falsification endpointsclaims gastroesophageal reflux disease ingrown nail unlikely affected treatment assignment directional effect would represent covariate imbalance <NUMBER> third evaluated whether propensity matched cohort also adequately matched therapeutic classes nonantihypertensive agents directly included matching algorithm strategies designed evaluate potential residual confounding creating propensity score matched cohorts finally evaluated observations robustness assessing treatment effects <NUMBER> iterations propensity score ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint matching algorithm evaluating whether findings consistent across iterations varied degree matching individual covariates describe differences patients treated ace inhibitors arbs compared antihypertensive agents treated ace inhibitors using chi square test categorical variables ttest continuous variables duration follow expected vary across individuals outpatient inpatient covid<NUMBER> cohorts evaluated effects timetoevent analyses coxproportional hazards models unadjusted propensity scorematched cohorts reduce bias residual differences matched covariates evaluation patient outcomes included covariates included propensity score matching algorithm independent variables models <NUMBER> repeated analyses without additional covariate adjustment outpatient study index date represented day positive covid<NUMBER> test outpatient period study measured days positive covid<NUMBER> outcome interest hospitalization inpatient study index date represented first day hospitalization covid<NUMBER> period study measured days admission outcome interest death since hospitalization could end either patients death discharged alive created causespecific cox proportional hazards model competing risk analysis <NUMBER> <NUMBER> <NUMBER> analyses censored end observation period may <NUMBER> <NUMBER> ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint given systematic differences patients enrolled medicare advantage commercial insurance particularly older age higher comorbidity burden higher risk covid<NUMBER> complications among medicare advantage enrollees evaluated quantitative qualitative interactions insurance type treatment groups assessment outcomes also created propensity scorematched cohorts within two insurance subgroups analyses performed using open source r <NUMBER> cran python <NUMBER> hypothesis tests <NUMBER>sided level significance set <NUMBER> except interaction tests level significance set <NUMBER> given exploratory nature study statistical tests adjusted multiple testing yale affairs exempted study review activities limited retrospective analysis deidentified data accessed accordance health insurance portability accountability act regulations ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint median age individuals <NUMBER> years <NUMBER> women medicare advantage patients <NUMBER> african american patients receiving ace inhibitors arbs likely men diabetes without chronic complications receiving <NUMBER> antihypertensive drugs table <NUMBER> less likely chronic heart failure moderatetosevere renal disease compared patients receiving antihypertensive treatments patients receiving ace inhibitors similar receiving arbs higher rate dementia peripheral vascular disease table <NUMBER> matched <NUMBER> patients receiving ace inhibitors <NUMBER> patients receiving antihypertensive agents efigure <NUMBER> achieving <NUMBER> standardized differences covariates figure <NUMBER> similarly matched <NUMBER> patients receiving arb <NUMBER> patients receiving antihypertensive agents efigure <NUMBER> equipoise comparisons ace inhibitors drugs ace inhibitors arb <NUMBER> lower arb comparisons table <NUMBER> among <NUMBER> patients hospitalized covid<NUMBER> linked claims data <NUMBER> diagnosis hypertension outpatient prescription least one antihypertensive drug efigure <NUMBER> inpatient cohort included patients <NUMBER> states us efigure <NUMBER> included patients <NUMBER> medicare advantage enrollees median age hospitalized individuals <NUMBER> years <NUMBER> women <NUMBER> medicare advantage enrollees african american differences hospitalized patients treated ace inhibitors arbs agents included table <NUMBER> inpatient cohort <NUMBER> patients receiving ace ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint inhibitors <NUMBER> patients receiving arbs propensity scorematched patients receiving antihypertensive agents efigure <NUMBER> covariate standardized differences <NUMBER> matching figure <NUMBER> equipoise comparisons ace inhibitors drugs ace inhibitors arb <NUMBER> lower arb comparisons table <NUMBER> outpatient cohort median <NUMBER> iqr <NUMBER> <NUMBER> days sarscov<NUMBER> testing patients receiving ace inhibitors less frequently hospitalized receiving antihypertensive agents <NUMBER> vs <NUMBER> p <NUMBER> significant association arb therapy hospitalization rates <NUMBER> vs <NUMBER> individuals insurance p <NUMBER> propensity scorematched cohorts efigure table <NUMBER> differences priori chosen falsification endpoints propensity scorematched populations etable <NUMBER> differences association ace inhibitors hospitalization risk across insurance groups p interaction <NUMBER> lower risk hospitalization medicare advantage patients hr <NUMBER> <NUMBER> <NUMBER> p <NUMBER> observed commercially insured individuals hr <NUMBER> <NUMBER> <NUMBER> p <NUMBER> table <NUMBER> ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint propensity scorematched analyses arb use associated significantly lower hospitalization risk individuals receiving antihypertensive agents hr <NUMBER> <NUMBER> <NUMBER> p <NUMBER> figure <NUMBER> significant differences hospitalization rates propensity score matched cohorts patients receiving ace inhibitor compared arb hr <NUMBER> <NUMBER> <NUMBER> p <NUMBER> significant interactions insurancetype association arb outcomes pinteraction <NUMBER> among individuals outpatient cohort hospitalized association ace inhibitor arb use subsequent inhospital mortality etable <NUMBER> <NUMBER> patients hospitalized covid<NUMBER> <NUMBER> <NUMBER> died hospitalization <NUMBER> <NUMBER> discharged alive <NUMBER> <NUMBER> still hospitalized end observation period majority deaths <NUMBER> among medicare advantage population median length stay including patients died well discharged alive covid<NUMBER> hospitalizations <NUMBER> iqr <NUMBER> <NUMBER> days similar across patients died <NUMBER> iqr <NUMBER> <NUMBER> days discharged alive <NUMBER> iqr <NUMBER> <NUMBER> days observation period overall proportion covid<NUMBER> patients died differ significantly ace inhibitor therapy hospitalization compared antihypertensive agents <NUMBER> vs <NUMBER> p <NUMBER> propensity matchedcohort patients receiving ace inhibitors hospitalization inhospital mortality ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity table <NUMBER> similarly arb significantly different risk mortality compared antihypertensive agents <NUMBER> <NUMBER> <NUMBER> p <NUMBER> significant differences mortality patients receiving ace inhibitors arbs overall population without significant interaction insurance group treatment assignment patient outcome figure <NUMBER> table <NUMBER> findings consistent secondary outcome inhospital death discharge hospice etable <NUMBER> also association treatment ace inhibitor arb hospital length stay etable <NUMBER> sensitivity analyses focused individuals receiving least one first line antihypertensive agent control group varied covariate adjustment strategies consistent primary analysis etables <NUMBER> <NUMBER> iterations propensity score matching algorithm found lower risk hospitalization ace inhibitors across iterations pvalue less <NUMBER> <NUMBER> <NUMBER> iterations medicare advantage population first national study ace inhibitors arbs outpatients testing positive sarscov<NUMBER> found overall drugs confer additional risk benefit however among medicare advantage ace inhibitors associated almost <NUMBER> significantly lower risk hospitalization covid<NUMBER> effect observed arbs among hospitalized covid<NUMBER> find benefit harm medications collectively findings support change current use medications given lack effective therapies mitigate ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint harm virus study provide rationale testing use ace inhibitors older patients reduce risk severe sarscov<NUMBER> infection design several attributes provide confidence findings even though observational study restricted people hypertension receiving least one antihypertensive agent thereby limiting assessment individuals receiving treatment chronic illness therefore equally likely seek care healthcare needs covid<NUMBER> analyses explicitly compared individuals equipoise receiving either drug treatment moreover find evidence confounding disease severity choice therapy assessment priori defined falsification endpoints study included individuals across united states thereby limiting effect hospital regional care practices may bias evaluation treatment effects observations extends prior evidence supporting safety ace inhibitor treatment covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> show safety agents outpatient sarscov<NUMBER> infected individuals complements studies hospitalized <NUMBER> <NUMBER> <NUMBER> also national study complements single center single region studies <NUMBER> study intriguing finding subgroup individuals enrolled medicare advantage find ace inhibitors associated significantly lower risk hospitalization following infection sarscov<NUMBER> outpatient setting patients older frequently comorbidities vulnerable severe covid<NUMBER> disease <NUMBER> <NUMBER> findings particularly relevant medicare advantage group represented <NUMBER> covid<NUMBER> hospitalizations ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint inpatient cohort also interestingly find association arbs despite clinical equipoise use drugs findings consistent prior evidence randomized clinical trials reduced risk pneumonia ace inhibitors observed arb <NUMBER> study inhospital outcomes adds literature studies reached contrasting conclusions regarding role ace inhibitor therapy inhospital mortality among hospitalized covid<NUMBER> patients find significant association mortality consistent others found association <NUMBER> <NUMBER> <NUMBER> however findings contrast certain studies found lower mortality hospitalized covid<NUMBER> patients treated ace inhibitors <NUMBER> <NUMBER> notably studies evaluated mortality risk covid<NUMBER> consistently designed detect potential causal association drug therapy outcomes <NUMBER> relied case control designs <NUMBER> pursued potentially biased assessment using comparators receiving therapy <NUMBER> <NUMBER> based data single health centers <NUMBER> moreover studied ace inhibitors arbs together despite potentially different mechanisms effects patient outcomes <NUMBER> rationale may specific ace inhibitor effect preclinical evidence suggests possible protective role ace inhibitors covid<NUMBER> ace inhibitors arbs associated upregulation ace<NUMBER> receptors <NUMBER> <NUMBER> receptors modulate local reninangiotensinaldosterone system interactions lung tissue <NUMBER> presence ace<NUMBER> receptors therefore exerts protective effect development acute lung injury infections sars coronaviruses lead dysregulation mechanisms endothelial ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> study important implications <NUMBER> ongoing randomized trials none align observations study <NUMBER> <NUMBER> trials <NUMBER> testing use ace inhibitors arbs treatment hospitalized covid<NUMBER> patients <NUMBER> using <NUMBER>day course arbs positive sarscov<NUMBER> test prevent hospitalization <NUMBER> however study suggests appropriate strategy test trial would prophylactic use ace inhibitor prevent hospitalization tested current study findings study interpreted light following limitations first study observational despite robust methods explicit assessments residual confounding understanding potential protective role ace inhibitors covid<NUMBER> requires dedicated randomized controlled trial second know proportion patients receiving antihypertensive agents continued treated drugs illness association continued use cessation patient outcomes third included data elements contingent upon individuals seeking care ailment filling medication using insurance provider would captured chose selfpay however expect sizeable proportion insured individuals would defer insurance coverage care fourth cannot account differences timing ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint presentation patients relative symptom onset however limited effect differential presentation patients across exposure groups focusing patients receiving treatment medical comorbidity ie hypertension varying class drugs moreover included patients across us accounted clustering patients thereby limiting effect local practice patterns may affect hospitalization thresholds therefore unlikely patients care seeking ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint ant ihypert ensi e agent use roups propensit score ching roups aft er propensit score ching ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint investigations reported hypertension diabetes cardiovascular diseases prevalent comorbidities among patients coronavirus disease <NUMBER> covid<NUMBER> hypertension appeared consistently prevalent risk factors covid<NUMBER> patients investigations speculated association reninangiotensinaldosterone system raas susceptibility covid<NUMBER> well relationship raas inhibitors increased mortality patients raised concern potential association hypertension treatment propensity covid<NUMBER> followup studies investigated impact comorbidities outcome patients conflicting findings hypertension proven prevalent patients adverse outcome admission intensive care unit use mechanical ventilation death far study demonstrated independent predictive value hypertension mortality covid<NUMBER> patients many speculations coronavirus relation different risk factors underlying diseases aim review summarize current knowledge relationship hypertension covid<NUMBER> role hypertension outcome patients covid<NUMBER> arterial hypertension hypothesis evidence december <NUMBER> novel coronavirus disease caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> emerged wuhan hubei province china disease rapidly spread wuhan areas march <NUMBER> <NUMBER> <NUMBER> <NUMBER> cases reported <NUMBER> countries areas <NUMBER> continents current crude case fatality rate cfr <NUMBER> <NUMBER> thus accumulating cases high cfr covid<NUMBER> posed great challenge public health according recent report <NUMBER> patients infected sarscov<NUMBER> diagnosed pneumonia hospitalization including <NUMBER> severe disease <NUMBER> however underlying pathophysiological mechanisms virus causes disease remain unclear sarscov<NUMBER> sarscov coronaviruses two viruses share <NUMBER> identity nucleotide sequence <NUMBER> early studies established sarscov uses retrospective study complied declaration helsinki approved hubei provincial hospital traditional chinese medicine hphtcms ethical review board clinical ethical approval hbzy<NUMBER>c<NUMBER> hphtcm responsible treatments covid<NUMBER> assigned wuhan government patients confirmed covid<NUMBER> according guideline sarscov<NUMBER> fifth trial version chinese national health commission admitted hphtcm january <NUMBER> february <NUMBER> <NUMBER> included initial screen <NUMBER> covid<NUMBER> patients preexisting hypertension retrospectively allocated two subgroups arbsaceis nonarbsaceis group according usage antihypertensive drugs ageand sexmatched cases randomly selected remaining covid<NUMBER> patients without hypertension nonhypertension controls clinical outcomes ie discharges mortality length stay monitored march <NUMBER> <NUMBER> final date followup addition medication history <NUMBER> hypertension patients admitted hphtcm november <NUMBER> december <NUMBER> <NUMBER> covid<NUMBER> outbreak also reviewed external comparison written informed consent waived ethics commission hospital emerging infectious diseases medical records patients analyzed research team hphtcm disease onset defined date symptom noticed data use aceis arbs prior admission hospital stay collected information including demographic data medical history exposure history comorbidities symptoms rights reserved reuse allowed without permission authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint signs laboratory findings treatment measures ie antiviral therapy corticosteroid therapy extracted electronic medical records recorded standardized data collection forms data reviewed trained team physicians assessment disease status followed guideline sarscov<NUMBER> fifth trial version chinese national health commission mild type slight clinical symptoms imaging presentations pneumonia common type fever respiratory tract symptoms imaging findings pneumonia severe type following conditions respiratory distress respiratory frequency ≥<NUMBER> timesminutes finger oxygen saturation rest ≤<NUMBER> oxygenation index pao <NUMBER> fio <NUMBER> ≤<NUMBER> mmhg <NUMBER> mmhg<NUMBER> kpa critical type following conditions respiratory failure requires mechanical ventilation shock combined organ failure requires intensive care unit care treatment <NUMBER> laboratory parameters including complete blood count creactive protein crp arterial blood gas analysis myocardial injury markers coagulation profile serum biochemical tests including renal liver function lactate dehydrogenase procalcitonin pct btype natriuretic peptide bnp measured according manufacturers instructions data analysis performed using spss statistical package social sciences version <NUMBER> categorical variables reported absolute relative frequencies compared χ² tests fishers exact tests continuous variables expressed mean sd normally distributed median interquartile range iqr compared independent group tests mannwhitney u tests respectively p<NUMBER> considered rights reserved reuse allowed without permission authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint statistically significant initial screen <NUMBER> covid<NUMBER> patients allocated two groups hypertension group includes <NUMBER> patients preexisting hypertension nonhypertension group comprising <NUMBER> ageand sexmatched patients randomly selected remaining patients without hypertension figure <NUMBER> covid<NUMBER> patients hypertension allocated two subgroups based usage arbsaceis antihypertensive drugs <NUMBER> arbsaceis subgroup <NUMBER> nonarbsaceis subgroup figure <NUMBER> median ages patients two subgroups <NUMBER> iqr <NUMBER> <NUMBER> iqr <NUMBER> years respectively major differences characteristics two subgroups except higher usage antibiotics nonarbsaceis subgroup baseline characteristics shown table <NUMBER> age distribution complication ratio hypertension group nonhypertension rights reserved reuse allowed without permission authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed compared nonhypertensive controls covid<NUMBER> patients preexisting hypertension lower arterial partial pressure oxygen <NUMBER> <NUMBER> vs <NUMBER>· <NUMBER> <NUMBER>· <NUMBER>· <NUMBER> p<NUMBER>· <NUMBER> rights reserved reuse allowed without permission authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed table <NUMBER> retrospective investigation knowledge first casecontrol study aimed examine correlation arbsaceis pathogenesis sarscov<NUMBER> infection patients preexisting hypertension major finding report arbsaceis treatment associated reduced inflammatory response mitigated disease progression covid<NUMBER> patients preexisting hypertension compared antihypertensive treatment hypertension leading cause mortality globally <NUMBER> adults estimated hypertension worldwide <NUMBER> <NUMBER> since emerge sarscov<NUMBER> infection hypertension frequently observed major comorbidity covid<NUMBER> patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> reported <NUMBER> <NUMBER> <NUMBER> covid<NUMBER> patients admitted hphtcm preexisting hypertension incidence similar reported rights reserved reuse allowed without permission authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed <NUMBER> <NUMBER> discordance could explained age difference latter two studies median age <NUMBER> <NUMBER> years respectively compared <NUMBER> years report covid<NUMBER> patients hypertension appeared higher death rate frequently seen severe cases <NUMBER> also examined death rate incidence critical cases cohort compared nonhypertension controls covid<NUMBER> patients hypertension higher death rate <NUMBER> <NUMBER> differences failed reach statistical significance however find patients remained hospital significantly longer disease course covid<NUMBER> patients hypertension without <NUMBER>±<NUMBER> vs <NUMBER>±<NUMBER> p<NUMBER> therefore results together groups provided ample evidence hypertension critical risk factor poor clinical outcome covid<NUMBER> patients indeed notion supported laboratory testing results covid<NUMBER> patients hypertension much lower blood oxygen index p<NUMBER> well higher blood urea p<NUMBER> alt p<NUMBER> without hypertension mechanisms hypertension results poor clinical outcome covid<NUMBER> remain obscure found compared nonhypertension controls covid<NUMBER> patients hypertension markedly increased levels inflammatory hscrp p<NUMBER> procalcitonin p<NUMBER> il<NUMBER> p<NUMBER> suggesting dysregulated inflammatory response might contribute fact hypertension wellknown capacity rights reserved reuse allowed without permission authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed httpsdoiorg<NUMBER> doi medrxiv preprint stimulating adaptive response inducing elevated production inflammation cytokines <NUMBER> <NUMBER> ii effector peptide ras responsible pathophysiology hypertension <NUMBER> also demonstrated capable inducing production il<NUMBER> il<NUMBER>β tnfα ifnγ il<NUMBER> il<NUMBER> multiple animal models <NUMBER> surprisingly treatment hypertension patients aceis arbs functional reducing level ii increasing expression ace<NUMBER> effectively downregulated production inflammatory cytokines <NUMBER> increased levels inflammatory cytokines also observed covid<NUMBER> patients without hypertension coexisting illness huang et al reported plasma concentrations il<NUMBER>β il<NUMBER>ra ifnγ tnfα cytokines significantly higher icu patients nonicu patients sarscov<NUMBER> infection healthy adults comparison found il<NUMBER> il<NUMBER> il<NUMBER> ip<NUMBER> mcp<NUMBER> mip<NUMBER>a tnfα higher icu patients nonicu patients <NUMBER> elevated concentration il<NUMBER> also demonstrated covid<NUMBER> patients severe critical disease compared mild common illness <NUMBER> <NUMBER> based evidence multicenter randomized controlled trial recently registered chinese clinical trial registry chictr<NUMBER> evaluate efficacy safety il<NUMBER>r blockade tocilizumab treatment covid<NUMBER> mentioned inhibiting dysregulated inflammatory response represents promising therapeutic strategy covid<NUMBER> hypertension patients therefore aceis arbs capable reducing production inflammatory cytokines potential candidate drugs treatment covid<NUMBER> patients preexisting hypertension rights reserved reuse allowed without permission authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint suggested several groups <NUMBER> <NUMBER> however clinical evidence still missing report found <NUMBER> covid<NUMBER> patients hypertension treated arbsaceis diagnosed sarscov<NUMBER> infection concentrations inflammatory crp procalcitonin significantly lower compared treated nonarbsaceis arbsaceis treatment also resulted lower death rate less critical cases patients find concentrations il<NUMBER> arbsaceis group significantly different nonarbsaceis controls suggests arbsaceis treatment alone might efficient modulating production cytokine however combining arbsaceis il<NUMBER>r blockade could presumably synergic effect regulating elevated inflammatory response covid<NUMBER> patients preexisting hypertension could tested future clinical trials arbsaceis treatment reported increase expression ace<NUMBER> <NUMBER> also cellular receptor sarscov<NUMBER> infection <NUMBER> arbsaceis treatment pose added risk sarscov<NUMBER> infection study cohort ace<NUMBER> reported bind sarscov<NUMBER> approximately <NUMBER>to <NUMBER>fold higher rights reserved reuse allowed without permission authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed httpsdoiorg<NUMBER> doi medrxiv preprint affinity bind sarscov finding together fact people different races different ages sexes susceptible sarscov<NUMBER> infection suggest physiological expression ace<NUMBER> may already sufficient sarscov<NUMBER> infection upregulation might increase risk arbs aceis antihyperhensive drugs discovered maintain blood pressure thus arbsaceis treatment could result hypotension healthy subjects may prevent application covid<NUMBER> patients without hypertension alternatively novel therapeutic options using ace<NUMBER> target promising treating sarscov<NUMBER> infection without affecting blood pressure study several limitations first due retrospective nature study fact conducted single hospital interpretation findings might limited sample size selection bias also realize additional risk factors may wellcontrolled despite many confounders possible corrected nevertheless far know largest retrospective cohort study designed examine usage arbsaceis effect covid<NUMBER> patients preexisting hypertension second severity disease course identical among patients resulted difficulty collecting laboratory indicators time point therefore selected extreme values beyond normal range laboratory indicators could reflect severity condition comparison however strategy might still cause biases presenting laboratory indicators third expression ace<NUMBER> inflammatory factors determined study due sample availability limited technical resources hospital limitation prevented us exploring rights reserved reuse allowed without permission authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint mechanisms arbsaceis regulate inflammatory status covid<NUMBER> patients hypertension evidence presented study supports use arbsaceis antihypertensive drugs treating covid<NUMBER> patients preexisting hypertension large prospective studies required confirm finding explore mechanisms arbsaceis regulate inflammatory response prevent disease progression efforts might eventually lead development novel therapeutic agents targeting ace<NUMBER> treat nonhypertensive covid<NUMBER> patients without affecting blood pressure declare competing interests rights reserved reuse allowed without permission authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed httpsdoiorg<NUMBER> doi medrxiv preprint novelty significance  hypertension reported leading coexisting illness covid<NUMBER> patients patients frequently treated arbsaceis control blood pressure  effects arbsaceis pathogenesis covid<NUMBER> yet defined  conducted first largest case series evaluate effect arbsaceis pathogenesis covid<NUMBER> patients preexisting hypertension  found without increasing risk sarscov<NUMBER> infection arbsaceis outcompeted antihypertensive drugs containing exaggerate inflammatory response curbing disease progression covid<NUMBER> patients preexisting hypertension results support use arbsaceis antihypertensive drugs treating covid<NUMBER> patients preexisting hypertension large prospective studies required confirm finding explore mechanisms arbsaceis regulate inflammatory response prevent disease progression rights reserved reuse allowed without permission authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed httpsdoiorg<NUMBER> doi medrxiv preprint rights reserved reuse allowed without permission authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint p values tests mannwhitney u tests p <NUMBER> considered statistically significant bold rights reserved reuse allowed without permission authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint figure <NUMBER> rights reserved reuse allowed without permission authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint figure <NUMBER> rights reserved reuse allowed without permission authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint 